PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lucas, A; MacPherson, G				Lucas, A; MacPherson, G			Langerhans cells: immigrants or residents?	NATURE IMMUNOLOGY			English	Editorial Material								The source of Langerhans cells is controversial. New data show that the repopulation of these cells depends on how and to what extent, they are depleted from the skin.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Lucas, A (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.							Brand C U, 1993, Exp Dermatol, V2, P274, DOI 10.1111/j.1600-0625.1993.tb00044.x; Howard CJ, 1996, IMMUNOLOGY, V88, P558, DOI 10.1046/j.1365-2567.1996.d01-680.x; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; KATZ SI, 1979, NATURE, V282, P324, DOI 10.1038/282324a0; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Steinman RM, 1997, ADV EXP MED BIOL, V417, P1; Strobl H, 1998, IMMUNOBIOLOGY, V198, P588, DOI 10.1016/S0171-2985(98)80080-6; Turnbull E, 2001, IMMUNOL REV, V184, P58, DOI 10.1034/j.1600-065x.2001.1840106.x	9	7	7	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1125	1126		10.1038/ni1202-1125	http://dx.doi.org/10.1038/ni1202-1125			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12447368				2022-12-18	WOS:000179467800008
J	van der Merwe, PA				van der Merwe, PA			Do T cell receptors do it alone?	NATURE IMMUNOLOGY			English	Editorial Material								The recent demonstration that T cells can recognize a single foreign pMHC complex suggests that TCR triggering does not require aggregation. Or does it?.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		van der Merwe, P. Anton/F-8539-2011					Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; STEFANOVA I, 2002, NATURE          1128; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8	10	7	7	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1122	1123		10.1038/ni1202-1122	http://dx.doi.org/10.1038/ni1202-1122			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12447366				2022-12-18	WOS:000179467800006
J	Sun, XH; Kincade, PW				Sun, XH; Kincade, PW			Gatekeeper mechanisms for immature B cells	NATURE IMMUNOLOGY			English	Editorial Material							BAFF; SURVIVAL	Lymphocyte maturation and survival depend on a canonical NF-kappaB activation pathway. BAFF, however, uses an alternative NF-kappaB pathway to mediate signaling in maturing B cells.	Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Sun, XH (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Kincade@omrf.ouhsc.edu						Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; KINCADE PW, 2002, IN PRESS IMMUNOL REV, V187; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804	11	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					898	899		10.1038/ni1002-898	http://dx.doi.org/10.1038/ni1002-898			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352965				2022-12-18	WOS:000178242100008
J	Petit, I				Petit, I			G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and upregulating CXCR4 (vol 3, pg 687, 2002)	NATURE IMMUNOLOGY			English	Correction													Petit, isabelle/AAF-5620-2020	Petit, isabelle/0000-0002-9782-0683				Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813	1	7	7	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					787	787		10.1038/ni0802-787	http://dx.doi.org/10.1038/ni0802-787			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF		Bronze			2022-12-18	WOS:000177118500019
J	Normark, S; Albiger, B; Jonsson, AB				Normark, S; Albiger, B; Jonsson, AB			Gonococci cause immunosuppression by engaging a coinhibitory receptor on T lymphocytes	NATURE IMMUNOLOGY			English	Editorial Material							NEISSERIAL OPA PROTEINS; SALMONELLA-TYPHIMURIUM; GONORRHOEAE	Gonococci that bind the coinhibitory receptor CEACAM1 appear to down-regulate the activation and proliferation of CD4(+) T cells. Such infection-induced immunosuppression helps explain why there is little specific immune response associated with gonococcal disease.	Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; Swedish Inst Infect Dis Control, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control	Normark, S (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden.							Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Eisenstein TK, 2001, MICROBES INFECT, V3, P1223, DOI 10.1016/S1286-4579(01)01482-4; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hedges SR, 1999, INFECT IMMUN, V67, P3937, DOI 10.1128/IAI.67.8.3937-3946.1999; JERSE AE, 1988, J EXP MED, V168, P911; Kallstrom H, 2001, CELL MICROBIOL, V3, P133, DOI 10.1046/j.1462-5822.2001.00095.x; MacFarlane AS, 1999, INFECT IMMUN, V67, P891, DOI 10.1128/IAI.67.2.891-898.1999; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Wetzler LW, 1996, J EXP MED, V183, P1151, DOI 10.1084/jem.183.3.1151; WICK MJ, 1995, MOL MICROBIOL, V16, P465, DOI 10.1111/j.1365-2958.1995.tb02411.x; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343; Zaffran Y, 2001, J IMMUNOL, V167, P6780, DOI 10.4049/jimmunol.167.12.6780	15	7	8	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					210	211		10.1038/ni0302-210	http://dx.doi.org/10.1038/ni0302-210			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875456	Bronze, Green Published			2022-12-18	WOS:000174074000005
J	Dorner, T; Lipsky, PE				Dorner, T; Lipsky, PE			Smaller role for pol eta?	NATURE IMMUNOLOGY			English	Letter							HEAVY-CHAIN GENES		Univ Hosp Charite, Dept Med Rheumatol & Clin Immunol, D-10098 Berlin, Germany; NIAMSD, NIH, Bethesda, MD 20892 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Dorner, T (corresponding author), Univ Hosp Charite, Dept Med Rheumatol & Clin Immunol, D-10098 Berlin, Germany.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041127] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; Dorner T, 1997, J IMMUNOL, V158, P2779; Dorner T, 1998, EUR J IMMUNOL, V28, P3384; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	6	7	7	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					982	983		10.1038/ni1101-982	http://dx.doi.org/10.1038/ni1101-982			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685213				2022-12-18	WOS:000172049800003
J	Lebecque, S				Lebecque, S			A new job for dendritic cells	NATURE IMMUNOLOGY			English	News Item							DIFFERENTIATION; RESPONSES; IMMUNITY; GROWTH; INNATE	Dendritic cells can prime naive lymphocytes. New data show how dendritic cells provide early activation cues by expression of IL-2, which may greatly enhance both T and B cell responses.	Schering Plough Corp, Res Inst, Lab Immunol Res, F-69571 Dardilly, France	Merck & Company; Schering Plough Corporation	Lebecque, S (corresponding author), Schering Plough Corp, Res Inst, Lab Immunol Res, 27 Chemin Peupliers,BP11, F-69571 Dardilly, France.			lebecque, serge/0000-0003-4006-8061				Akiyama Y, 2000, GENE THER, V7, P2113, DOI 10.1038/sj.gt.3301353; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Dubois B, 1999, J LEUKOCYTE BIOL, V66, P224, DOI 10.1002/jlb.66.2.224; Dubois B, 1995, ADV EXP MED BIOL, V378, P397; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kronin V, 1998, INT IMMUNOL, V10, P237, DOI 10.1093/intimm/10.2.237; Winkel KD, 1997, EUR J IMMUNOL, V27, P3350, DOI 10.1002/eji.1830271234	12	7	8	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					830	831		10.1038/ni0901-830	http://dx.doi.org/10.1038/ni0901-830			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526397				2022-12-18	WOS:000170781200022
J	Xu, XN; Screaton, G				Xu, XN; Screaton, G			HIV-1 Nef: negative effector of Fas?	NATURE IMMUNOLOGY			English	News Item							T-CELLS; APOPTOSIS; ACTIVATION; PROTEIN; MACROPHAGES; GP120; TAT		John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Xu, XN (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.			Screaton, Gavin/0000-0002-3549-4309				Chang HY, 1999, P NATL ACAD SCI USA, V96, P1252, DOI 10.1073/pnas.96.4.1252; Chen ZY, 1999, T NONFERR METAL SOC, V9, P1; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Conti L, 2000, J IMMUNOL, V165, P3293, DOI 10.4049/jimmunol.165.6.3293; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Meinl E, 1998, IMMUNOL TODAY, V19, P474, DOI 10.1016/S0167-5699(98)01309-7; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Strack PR, 1996, P NATL ACAD SCI USA, V93, P9571, DOI 10.1073/pnas.93.18.9571; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489	17	7	7	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					384	385		10.1038/87682	http://dx.doi.org/10.1038/87682			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323689				2022-12-18	WOS:000168549800009
J	Pinkoski, MJ; Green, DR				Pinkoski, MJ; Green, DR			Murder by proxy	NATURE IMMUNOLOGY			English	News Item							T-CELL APOPTOSIS; FAS LIGAND; HASHIMOTOS-THYROIDITIS; SURVIVAL; PATHWAY; DEATH		La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Pinkoski, MJ (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Batteux F, 2000, J IMMUNOL, V164, P1681, DOI 10.4049/jimmunol.164.4.1681; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; Hill LL, 1999, SCIENCE, V285, P898, DOI 10.1126/science.285.5429.898; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; Sabelko-Downes KA, 1999, J EXP MED, V189, P1195, DOI 10.1084/jem.189.8.1195; Stassi G, 2000, NAT IMMUNOL, V1, P483, DOI 10.1038/82725; Stassi G, 1999, J IMMUNOL, V162, P263; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	18	7	7	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					461	462		10.1038/82701	http://dx.doi.org/10.1038/82701			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101863				2022-12-18	WOS:000165724600006
J	Csomos, K; Ujhazi, B; Blazso, P; Herrera, JL; Tipton, CM; Kawai, T; Gordon, S; Ellison, M; Wu, K; Stowell, M; Haynes, L; Cruz, R; Zakota, B; Nguyen, J; Altrich, M; Geier, CB; Sharapova, S; Dasso, JF; Leiding, JW; Smith, G; Al-Herz, W; Dorna, MD; Fadugba, O; Fronkova, E; Kanderova, V; Svaton, M; Henrickson, SE; Hernandez, JD; Kuijpers, T; Kandilarova, SM; Naumova, E; Milota, T; Sediva, A; Moshous, D; Neven, B; Saco, T; Sargur, R; Savic, S; Sleasman, J; Sunkersett, G; Ward, BR; Komatsu, M; Pittaluga, S; Kumanovics, A; Butte, MJ; Cancro, MP; Pillai, S; Meffre, E; Notarangelo, LD; Walter, JE				Csomos, Krisztian; Ujhazi, Boglarka; Blazso, Peter; Herrera, Jose L.; Tipton, Christopher M.; Kawai, Tomoki; Gordon, Sumai; Ellison, Maryssa; Wu, Kevin; Stowell, Matthew; Haynes, Lauren; Cruz, Rachel; Zakota, Bence; Nguyen, Johnny; Altrich, Michelle; Geier, Christoph B.; Sharapova, Svetlana; Dasso, Joseph F.; Leiding, Jennifer W.; Smith, Grace; Al-Herz, Waleed; Dorna, Mayra de Barros; Fadugba, Olajumoke; Fronkova, Eva; Kanderova, Veronika; Svaton, Michael; Henrickson, Sarah E.; Hernandez, Joseph D.; Kuijpers, Taco; Kandilarova, Snezhina Mihailova; Naumova, Elizaveta; Milota, Tomas; Sediva, Anna; Moshous, Despina; Neven, Benedicte; Saco, Tara; Sargur, Ravishankar; Savic, Sinisa; Sleasman, John; Sunkersett, Gauri; Ward, Brant R.; Komatsu, Masanobu; Pittaluga, Stefania; Kumanovics, Attila; Butte, Manish J.; Cancro, Michael P.; Pillai, Shiv; Meffre, Eric; Notarangelo, Luigi D.; Walter, Jolan E.			Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet(+) B cells	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-SECRETING CELLS; AUTOANTIBODY PRODUCTION; T-BET; MUTATIONS; RECOMBINATION; EXPANSION; ACTIVATION; REPERTOIRE; POPULATION; EXPRESSION	Patients with partial recombination-activating gene (RAG) deficiency (pRD) present variable late-onset autoimmune clinical phenotypes. Walter and colleagues identified a restricted primary B cell antigen receptor repertoire enriched for autoreactivity and clonal persistence in pRD. They described dysregulated B cell maturation with expansion of T-bet(+) B cells revealing how RAG impacts stringency of tolerance and B cell fate in the periphery. The recombination-activating genes (RAG) 1 and 2 are indispensable for diversifying the primary B cell receptor repertoire and pruning self-reactive clones via receptor editing in the bone marrow; however, the impact of RAG1/RAG2 on peripheral tolerance is unknown. Partial RAG deficiency (pRD) manifesting with late-onset immune dysregulation represents an 'experiment of nature' to explore this conundrum. By studying B cell development and subset-specific repertoires in pRD, we demonstrate that reduced RAG activity impinges on peripheral tolerance through the generation of a restricted primary B cell repertoire, persistent antigenic stimulation and an inflammatory milieu with elevated B cell-activating factor. This unique environment gradually provokes profound B cell dysregulation with widespread activation, remarkable extrafollicular maturation and persistence, expansion and somatic diversification of self-reactive clones. Through the model of pRD, we reveal a RAG-dependent 'domino effect' that impacts stringency of tolerance and B cell fate in the periphery.	[Csomos, Krisztian; Ujhazi, Boglarka; Blazso, Peter; Gordon, Sumai; Ellison, Maryssa; Wu, Kevin; Stowell, Matthew; Haynes, Lauren; Cruz, Rachel; Zakota, Bence; Dasso, Joseph F.; Leiding, Jennifer W.; Walter, Jolan E.] Univ S Florida, Div Pediat Allergy Immunol, Johns Hopkins All Childrens Hosp, St Petersburg, FL 33701 USA; [Blazso, Peter] Univ Szeged, Dept Pediat, Szeged, Hungary; [Herrera, Jose L.; Komatsu, Masanobu] Johns Hopkins All Childrens Hosp, Canc & Blood Disorders Inst, St Petersburg, FL USA; [Herrera, Jose L.; Komatsu, Masanobu] Johns Hopkins All Childrens Hosp, Dept Surg, St Petersburg, FL USA; [Herrera, Jose L.; Komatsu, Masanobu] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD USA; [Tipton, Christopher M.] Emory Univ, Dept Med, Div Rheumatol, Atlanta, GA 30322 USA; [Kawai, Tomoki; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nguyen, Johnny] Johns Hopkins All Childrens Hosp, Dept Pathol & Lab Med, St Petersburg, FL USA; [Altrich, Michelle] Eurofins Viracor Labs, Lee Summits, MO USA; [Geier, Christoph B.] Immunol Outpatient Clin, Vienna, Austria; [Sharapova, Svetlana] Belarusian Res Ctr Pediat Oncol, Minsk, BELARUS; [Smith, Grace; Pittaluga, Stefania] NCI, Lab Pathol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Kuwait, Kuwait; [Dorna, Mayra de Barros] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Fadugba, Olajumoke] Univ Penn, Perelman Sch Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Fronkova, Eva; Kanderova, Veronika; Svaton, Michael] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Childhood Leukemia Invest Prague, Prague, Czech Republic; [Fronkova, Eva; Kanderova, Veronika; Svaton, Michael; Milota, Tomas; Sediva, Anna] Univ Hosp Motol, Prague, Czech Republic; [Henrickson, Sarah E.] Childrens Hosp Philadelphia, Dept Pediat Allergy Immunol Div, Philadelphia, PA 19104 USA; [Henrickson, Sarah E.] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Hernandez, Joseph D.] Stanford Univ, Div Allergy Immunol & Rheumatol, Dept Pediat, Stanford, CA 94305 USA; [Kuijpers, Taco] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Immunol Rheumatol & Infect Dis, Amsterdam, Netherlands; [Kandilarova, Snezhina Mihailova; Naumova, Elizaveta] Med Univ, Univ Hosp Alexandrovska, Dept Clin Immunol, Sofia, Bulgaria; [Milota, Tomas; Sediva, Anna] Charles Univ Prague, Dept Immunol, Fac Med 2, Prague, Czech Republic; [Moshous, Despina; Neven, Benedicte] Univ Paris, Paris, France; [Moshous, Despina; Neven, Benedicte] Necker Enfants Malad Univ Hosp, Assistance Publ Hop Paris, Pediat Hematol Immunol & Rheumatol Unit, Paris, France; [Moshous, Despina] Inst Imagine, Lab Genome Dynam Immune Syst, INSERM UMR1163, Paris, France; [Neven, Benedicte] Inst Imagine, Lab Immunogenet Pediat Autoimmune Dis, INSERM UMR1163, Paris, France; [Saco, Tara] Windom Allergy Asthma & Sinus, Sarasota, FL USA; [Sargur, Ravishankar] Sheffield Teaching Hosp, Dept Immunol & Allergy, Sheffield, S Yorkshire, England; [Savic, Sinisa] St James Univ Hosp, Dept Clin Immunol & Allergy, Leeds, W Yorkshire, England; [Savic, Sinisa] St James Univ Hosp, Leeds Musculoskeletal Biomed Res Ctr, Natl Inst Hlth Res, Leeds, W Yorkshire, England; [Savic, Sinisa] St James Univ Hosp, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Sleasman, John] Duke Univ, Sch Med, Div Allergy Immunol & Pulm Med, Durham, NC USA; [Sunkersett, Gauri] Johns Hopkins All Childrens Hosp, Canc & Blood Disorder Inst, St Petersburg, FL USA; [Ward, Brant R.] Virginia Commonwealth Univ, Childrens Hosp Richmond, Div Allergy & Immunol, Richmond, VA USA; [Kumanovics, Attila] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Butte, Manish J.] Univ Calif Los Angeles, Div Immunol Allergy & Rheumatol, Dept Pediat, Los Angeles, CA USA; [Butte, Manish J.] Univ Calif Los Angeles, Jeffrey Modell Diagnost & Res Ctr, Los Angeles, CA USA; [Cancro, Michael P.] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Pillai, Shiv] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA; [Meffre, Eric] Yale Univ, Dept Immunobiol, New Haven, CT USA; [Meffre, Eric] Yale Sch Med, Sect Rheumatol Allergy & Clin Immunol, New Haven, CT USA; [Walter, Jolan E.] Massachusetts Gen Hosp Children, Div Allergy & Immunol, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of South Florida; Szeged University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kuwait University; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Pennsylvania; Pennsylvania Medicine; Charles University Prague; Motol University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Stanford University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Medical University Sofia; Charles University Prague; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sheffield; Saint James's University Hospital; Saint James's University Hospital; Saint James's University Hospital; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Virginia Commonwealth University; Mayo Clinic; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Yale University; Yale University	Csomos, K; Walter, JE (corresponding author), Univ S Florida, Div Pediat Allergy Immunol, Johns Hopkins All Childrens Hosp, St Petersburg, FL 33701 USA.	kcsomos@usf.edu; jolanwalter@usf.edu	Svaton, Michael/AAB-3869-2019; Sediva, Anna/AAE-2774-2019	Sediva, Anna/0000-0001-7730-2304; Blazso, Peter/0000-0003-4404-8068; Haynes, Lauren/0000-0003-0011-3104; Savic, Sinisa/0000-0001-7910-0554	National Institutes of Health (NIH National Institute of Allergy and Infectious Diseases (NIAID) [5K08AI103035, sub-R01AI100887-05, R01AI153830-05]; Robert A. Good Endowment, University of South Florida; Jeffrey Modell Foundation; NIH/NIAID [AI-061093]; Division of Intramural Research, NIAID, NIH [ZIA AI001222-04]	National Institutes of Health (NIH National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert A. Good Endowment, University of South Florida; Jeffrey Modell Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Fesus and R. Kiraly (University of Debrecen) for providing recombinant human tissue transglutaminase. We thank G. Mueller for her contribution to the experiments (Johns Hopkins All Children's Hospital/Children's Research Institute). We thank B. Schachter (Beth Schachter Consulting) for careful review and editing of the manuscript. We thank A. Leiss-Piller (Immunology Outpatient Clinic) and I. Kingyue Chinn (Center for Human Immunobiology, Texas Children's Hospital) for assisting in variant resolution. We thank H. L. Monforte (Johns Hopkins All Childrens Hospital) for providing a paraffin-embedded spleen tissue block from a healthy individual. This work was supported by the National Institutes of Health (NIH National Institute of Allergy and Infectious Diseases (NIAID) 5K08AI103035, sub-R01AI100887-05 and R01AI153830-05 to J.E.W.), Robert A. Good Endowment, University of South Florida (to J.E.W.), Jeffrey Modell Foundation (to J.E.W.), NIH/NIAID grant AI-061093 (to E.M.) and by the Division of Intramural Research, NIAID, NIH (grant ZIA AI001222-04 to L.D.N.). Research laboratory studies were performed on de-identified samples under IRB approved protocols at University of South Florida (USF-Pro00035468 (PI, J.E.W.), USF-Pro00025693 (PI, J.E.W.)) and Johns Hopkins Medical Institute/Johns Hopkins All Children's Hospital (JHMI-IRB00175372 (PI, J.E.W.), JHMI-IRB00097062 (PI, J.W.L.) and JHMI-IRB00097938 (PI, J.W.L.)).	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Cancro MP, 2020, ANNU REV IMMUNOL, V38, P315, DOI 10.1146/annurev-immunol-092419-031130; Cassani B, 2010, J EXP MED, V207, P1525, DOI 10.1084/jem.20091928; Chitty-Lopez M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01954; Dalal I, 2005, CLIN IMMUNOL, V115, P70, DOI 10.1016/j.clim.2004.08.016; Dorna MB, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00122; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; Farmer JR, 2019, J ALLER CL IMM-PRACT, V7, P1970, DOI 10.1016/j.jaip.2019.02.038; Furudoi A, 2016, AM J SURG PATHOL, V40, P958, DOI 10.1097/PAS.0000000000000661; Geier CB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.574738; Giltiay NV, 2013, J EXP MED, V210, P2773, DOI 10.1084/jem.20122798; Goda V, 2018, J ALLER CL IMM-PRACT, V6, P1769, DOI 10.1016/j.jaip.2018.01.015; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Henderson LA, 2013, J ALLERGY CLIN IMMUN, V132, P969, DOI 10.1016/j.jaci.2013.06.032; IJspeert H, 2014, J ALLERGY CLIN IMMUN, V133, P1124, DOI 10.1016/j.jaci.2013.11.028; Jenks SA, 2019, IMMUNOL REV, V288, P136, DOI 10.1111/imr.12741; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Keller B, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh0891; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Labrie JE, 2004, J EXP MED, V200, P411, DOI 10.1084/jem.20040845; Lawless D, 2018, J ALLERGY CLIN IMMUN, V141, P2303, DOI 10.1016/j.jaci.2018.02.007; Lee YN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6109; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Masilamani M, 2003, EUR J IMMUNOL, V33, P2391, DOI 10.1002/eji.200323843; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Min Q, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.148887; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Neven B, 2017, CLIN INFECT DIS, V64, P83, DOI 10.1093/cid/ciw675; Notarangelo LD, 2016, NAT REV IMMUNOL, V16, P234, DOI 10.1038/nri.2016.28; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PASCUAL V, 1991, J IMMUNOL, V146, P4385; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rigoni R, 2016, J EXP MED, V213, P355, DOI 10.1084/jem.20151116; Romberg N, 2013, J CLIN INVEST, V123, P4283, DOI 10.1172/JCI69854; Rowe JH, 2017, J ALLERGY CLIN IMMUN, V140, P1739, DOI 10.1016/j.jaci.2017.08.001; Rubtsov AV, 2015, J IMMUNOL, V195, P71, DOI 10.4049/jimmunol.1500055; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458; Scharer CD, 2019, NAT IMMUNOL, V20, P1071, DOI 10.1038/s41590-019-0419-9; Scharer CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27030; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Schuetz C, 2014, J ALLERGY CLIN IMMUN, V133, P1211, DOI 10.1016/j.jaci.2013.10.021; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Uduman M, 2011, NUCLEIC ACIDS RES, V39, pW499, DOI 10.1093/nar/gkr413; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Vander Heiden JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02206; Walter JE, 2015, J CLIN INVEST, V125, P4135, DOI 10.1172/JCI80477; Walter JE, 2010, J EXP MED, V207, P1541, DOI 10.1084/jem.20091927; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Warnatz K, 2002, IMMUNOBIOLOGY, V206, P502, DOI 10.1078/0171-2985-00198; Wu KY, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00235; Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457	66	6	6	7	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1256	+		10.1038/s41590-022-01271-6	http://dx.doi.org/10.1038/s41590-022-01271-6		JUL 2022	49	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35902638	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000832482500002
J	Fonseca, R; Burn, TN; Gandolfo, LC; Devi, S; Park, SL; Obers, A; Evrard, M; Christo, SN; Buquicchio, FA; Lareau, CA; McDonald, KM; Sandford, SK; Zamudio, NM; Zanluqui, NG; Zaid, A; Speed, TP; Satpathy, AT; Mueller, SN; Carbone, FR; Mackay, LK				Fonseca, Raissa; Burn, Thomas N.; Gandolfo, Luke C.; Devi, Sapna; Park, Simone L.; Obers, Andreas; Evrard, Maximilien; Christo, Susan N.; Buquicchio, Frank A.; Lareau, Caleb A.; McDonald, Keely M.; Sandford, Sarah K.; Zamudio, Natasha M.; Zanluqui, Nagela G.; Zaid, Ali; Speed, Terence P.; Satpathy, Ansuman T.; Mueller, Scott N.; Carbone, Francis R.; Mackay, Laura K.			Runx3 drives a CD8(+) T cell tissue residency program that is absent in CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							CHROMATIN ACCESSIBILITY; MEMORY; MIGRATION; MAINTENANCE; REPRESSION; DIVERSITY; INSTRUCT; LINEAGE; TRIGGER; BETA	Tissue-resident memory T cells (T-RM cells) provide rapid and superior control of localized infections. While the transcription factor Runx3 is a critical regulator of CD8(+) T cell tissue residency, its expression is repressed in CD4(+) T cells. Here, we show that, as a direct consequence of this Runx3-deficiency, CD4(+) T-RM cells lacked the transforming growth factor (TGF)-beta-responsive transcriptional network that underpins the tissue residency of epithelial CD8(+) T-RM cells. While CD4(+) T-RM cell formation required Runx1, this, along with the modest expression of Runx3 in CD4(+) T-RM cells, was insufficient to engage the TGF-beta-driven residency program. Ectopic expression of Runx3 in CD4(+) T cells incited this TGF-beta-transcriptional network to promote prolonged survival, decreased tissue egress, a microanatomical redistribution towards epithelial layers and enhanced effector functionality. Thus, our results reveal distinct programming of tissue residency in CD8(+) and CD4(+) T-RM cell subsets that is attributable to divergent Runx3 activity. Mackay and colleagues show that distinct programs of tissue residency are induced in CD8(+) and CD4(+) T-RM cell subsets, a difference attributable to the activity of the transcription factor Runx3.	[Fonseca, Raissa; Burn, Thomas N.; Gandolfo, Luke C.; Devi, Sapna; Park, Simone L.; Obers, Andreas; Evrard, Maximilien; Christo, Susan N.; McDonald, Keely M.; Sandford, Sarah K.; Zamudio, Natasha M.; Zanluqui, Nagela G.; Mueller, Scott N.; Carbone, Francis R.; Mackay, Laura K.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Gandolfo, Luke C.; Speed, Terence P.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia; [Gandolfo, Luke C.; Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Buquicchio, Frank A.; Lareau, Caleb A.; Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Buquicchio, Frank A.; Lareau, Caleb A.; Satpathy, Ansuman T.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Zanluqui, Nagela G.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Zaid, Ali] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast Campus, Southport, Qld, Australia; [Satpathy, Ansuman T.] Stanford Univ, Parker Inst Canc Immunotherapy, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Gladstone UCSF Inst Genom Immunol, San Francisco, CA USA	University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; Stanford University; Stanford University; Universidade de Sao Paulo; Griffith University; Stanford University	Mackay, LK (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	lkmackay@unimelb.edu.au	Mackay, Laura K/HGC-6580-2022	Mackay, Laura K/0000-0002-8496-6632; Lareau, Caleb/0000-0003-4179-4807; Gandolfo, Luke/0000-0002-3599-2455; McDonald, Keely/0000-0003-2788-4478; Zaid, Ali/0000-0002-2528-2783; Evrard, Maximilien/0000-0002-2105-1160	Howard Hughes Medical Institute; Bill and Melinda Gates International Research Scholarship [OPP1175796]; Health and Medical Research Council (NHMRC) [AP1113293]; NHMRC EL1 Investigator Grant [GNT1175626]; FAPESP [BEPE 2019/12431-2]; National Institutes of Health [U01CA260852, UM1HG012076]; Parker Institute for Cancer Immunotherapy; Pew-Stewart Scholars for Cancer Research Award; Sylvia and Charles Viertel Charitable Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates International Research Scholarship; Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC EL1 Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Pew-Stewart Scholars for Cancer Research Award; Sylvia and Charles Viertel Charitable Foundation	We thank the Flow Cytometry Unit and Bioresources Facility at Peter Doherty Institute (University of Melbourne) for technical assistance. This work was supported by a Howard Hughes Medical Institute and Bill and Melinda Gates International Research Scholarship OPP1175796, National Health and Medical Research Council (NHMRC) AP1113293 to F.RC. and L.K.M. S.L.P. was supported by a NHMRC EL1 Investigator Grant GNT1175626. N.G.Z. was supported by FAPESP (BEPE 2019/12431-2). A.T.S. was supported by the National Institutes of Health (U01CA260852 and UM1HG012076), the Parker Institute for Cancer Immunotherapy and a Pew-Stewart Scholars for Cancer Research Award. L.K.M is a Senior Medical Research Fellow supported by the Sylvia and Charles Viertel Charitable Foundation.	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Beura LK, 2019, J EXP MED, V216, P1214, DOI 10.1084/jem.20181365; Cheroutre H, 2013, SEMIN IMMUNOL, V25, P273, DOI 10.1016/j.smim.2013.10.022; Christo SN, 2021, NAT IMMUNOL, V22, P1140, DOI 10.1038/s41590-021-01004-1; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Collins N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11514; Delacher M, 2021, IMMUNITY, V54, P702, DOI 10.1016/j.immuni.2021.03.007; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Durand A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02458-4; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hirai T, 2019, IMMUNITY, V50, P1249, DOI 10.1016/j.immuni.2019.03.002; Hondowicz BD, 2018, EUR J IMMUNOL, V48, P80, DOI 10.1002/eji.201746928; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Keller HR, 2021, CELL MOL LIFE SCI, V78, P5789, DOI 10.1007/s00018-021-03877-9; Klicznik MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav8995; Kok L, 2022, NAT REV IMMUNOL, V22, P283, DOI 10.1038/s41577-021-00590-3; Kok L, 2020, J EXP MED, V217, DOI 10.1084/jem.20191711; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Luckey MA, 2014, NAT IMMUNOL, V15, P638, DOI 10.1038/ni.2917; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Moreau JM, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abi4613; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Nguyen QP, 2019, IMMUNOLOGY, V157, P3, DOI 10.1111/imm.13059; Oh DY, 2021, IMMUNITY, V54, P2701, DOI 10.1016/j.immuni.2021.11.015; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schreiner D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02394; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shin B, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019655118; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stolley JM, 2020, J EXP MED, V217, DOI 10.1084/jem.20192197; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	49	6	6	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1236	+		10.1038/s41590-022-01273-4	http://dx.doi.org/10.1038/s41590-022-01273-4		JUL 2022	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35882933	Green Accepted			2022-12-18	WOS:000830286700003
J	Chen, W; Chen, SF; Yan, CH; Zhang, YG; Zhang, RH; Chen, M; Zhong, SF; Fan, WG; Zhu, SL; Zhang, DY; Lu, X; Zhang, J; Huang, YY; Zhu, L; Li, XZ; Lv, DW; Fu, YD; Iv, HK; Ling, ZY; Ma, LY; Jiang, H; Long, G; Zhu, JF; Wu, D; Wu, B; Sun, B				Chen, Wen; Chen, Shuangfeng; Yan, Chenghua; Zhang, Yaguang; Zhang, Ronghua; Chen, Min; Zhong, Shufen; Fan, Weiguo; Zhu, Songling; Zhang, Danyan; Lu, Xiao; Zhang, Jia; Huang, Yuying; Zhu, Lin; Li, Xuezhen; Lv, Dawei; Fu, Yadong; Iv, Houkun; Ling, Zhiyang; Ma, Liyan; Jiang, Hai; Long, Gang; Zhu, Jinfang; Wu, Dong; Wu, Bin; Sun, Bing			Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion	NATURE IMMUNOLOGY			English	Article							AIRWAY INFLAMMATION; SUPPRESSION; MODULATION; CLEAVAGE; ASTHMA; DAMAGE; IL-33	Sun and colleagues describe that the secretion of interleukin-33 is dependent on a p40 N-terminal fragment of gasdermin D, whose generation is independent of inflammatory caspase-1 and caspase-11. Interleukin-33 (IL-33), an epithelial cell-derived cytokine that responds rapidly to environmental insult, has a critical role in initiating airway inflammatory diseases. However, the molecular mechanism underlying IL-33 secretion following allergen exposure is not clear. Here, we found that two cell events were fundamental for IL-33 secretion after exposure to allergens. First, stress granule assembly activated by allergens licensed the nuclear-cytoplasmic transport of IL-33, but not the secretion of IL-33. Second, a neo-form murine amino-terminal p40 fragment gasdermin D (Gsdmd), whose generation was independent of inflammatory caspase-1 and caspase-11, dominated cytosolic secretion of IL-33 by forming pores in the cell membrane. Either the blockade of stress granule assembly or the abolishment of p40 production through amino acid mutation of residues 309-313 (ELRQQ) could efficiently prevent the release of IL-33 in murine epithelial cells. Our findings indicated that targeting stress granule disassembly and Gsdmd fragmentation could reduce IL-33-dependent allergic airway inflammation.	[Chen, Wen; Chen, Shuangfeng; Yan, Chenghua; Zhang, Yaguang; Zhang, Ronghua; Zhong, Shufen; Fan, Weiguo; Zhu, Songling; Zhang, Danyan; Lu, Xiao; Zhang, Jia; Huang, Yuying; Zhu, Lin; Li, Xuezhen; Fu, Yadong; Iv, Houkun; Ling, Zhiyang; Ma, Liyan; Jiang, Hai; Sun, Bing] Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, Shanghai, Peoples R China; [Chen, Wen; Lv, Dawei; Long, Gang] Chinese Acad Sci, Univ Chinese Acad Sci Univ, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Chen, Shuangfeng; Zhang, Danyan; Iv, Houkun; Sun, Bing] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Chen, Min; Wu, Dong; Wu, Bin] Guangdong Med Coll, Affiliated Hosp, Inst Resp Dis, Dept Resp & Crit Care Med, Zhanjiang, Peoples R China; [Zhu, Jinfang] NIAID, Lab Immune Syst, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); ShanghaiTech University; Guangdong Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhang, YG; Sun, B (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, Shanghai, Peoples R China.; Sun, B (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Wu, D; Wu, B (corresponding author), Guangdong Med Coll, Affiliated Hosp, Inst Resp Dis, Dept Resp & Crit Care Med, Zhanjiang, Peoples R China.	zhangyaguang@sibcb.ac.cn; wudong98@126.com; wubin621011@126.com; bsun@sibs.ac.cn	Fu, Yadong/AHD-3204-2022; Zhu, Jinfang/B-7574-2012	Fu, Yadong/0000-0002-4133-6067; Zhu, Jinfang/0000-0002-0117-4745; Fan, Weiguo/0000-0002-2382-5473; Zhang, Yaguang/0000-0002-2417-6516	Ministry of Science and Technology of China [2018YFA0507402]; National Natural Science Foundation of China [81761128009, 32000667]; Shanghai Science and Technology Innovation Action [21ZR1470600]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2022264]; Affiliated Hospital of Guangdong Medical University `Clinical Medicine+' CnTech Co-operation Project [CLP2021B001, CLP2021B017]; Discipline Construction Project of Guangdong Medical University [4SG21231G]; Project of Zhanjiang City [2018A01025, 2020A01016, 2021A05052]; Natural Science Foundation of Guangdong Province, China [2021A1515011062, 2022A1515011731]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation Action; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Affiliated Hospital of Guangdong Medical University `Clinical Medicine+' CnTech Co-operation Project; Discipline Construction Project of Guangdong Medical University; Project of Zhanjiang City; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	We thank F. Shao (National Institute of Biological Sciences, China) for helpful suggestions on the study and for providing Gsdmd-deficient mice and cell lines. This work was supported by the Ministry of Science and Technology of China (2018YFA0507402), the National Natural Science Foundation of China (81761128009 and 32000667), Shanghai Science and Technology Innovation Action (21ZR1470600), the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2022264), the Affiliated Hospital of Guangdong Medical University `Clinical Medicine+' CnTech Co-operation Project (CLP2021B001 and CLP2021B017), the Discipline Construction Project of Guangdong Medical University (4SG21231G), the Project of Zhanjiang City (2018A01025, 2020A01016 and 2021A05052) and the Natural Science Foundation of Guangdong Province, China (2021A1515011062 and 2022A1515011731).	Advani VM, 2020, CELL MOL LIFE SCI, V77, P4827, DOI 10.1007/s00018-020-03565-0; Alvarez MJ, 2000, ALLERGY, V55, P185, DOI 10.1034/j.1398-9995.2000.00398.x; Barnes PJ, 2018, NAT REV IMMUNOL, V18, P454, DOI 10.1038/s41577-018-0006-6; Brusilovsky M, 2021, NAT IMMUNOL, V22, P1316, DOI 10.1038/s41590-021-01011-2; Carayol N, 2008, J BIOL CHEM, V283, P8601, DOI 10.1074/jbc.M707934200; Dai XJ, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165719; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Florsheim E, 2015, J IMMUNOL, V194, P4621, DOI 10.4049/jimmunol.1402493; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gorski SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003615; Hara K, 2014, J IMMUNOL, V192, P4032, DOI 10.4049/jimmunol.1400110; Hatzioannou A, 2020, NAT IMMUNOL, V21, P75, DOI 10.1038/s41590-019-0555-2; Ho JJD, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109806; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kakkar Rahul, 2012, J Biol Chem, V287, P6941, DOI 10.1074/jbc.M111.298703; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Liu T, 2019, J ALLERGY CLIN IMMUN, V144, P777, DOI 10.1016/j.jaci.2019.05.006; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Nabe T, 2015, EUR J PHARMACOL, V757, P34, DOI 10.1016/j.ejphar.2015.03.015; Namvar S, 2015, CLIN EXP ALLERGY, V45, P982, DOI 10.1111/cea.12426; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Souza CO, 2012, BBA-GEN SUBJECTS, V1820, P1867, DOI 10.1016/j.bbagen.2012.08.013; Srisomboon Y, 2020, J PHYSIOL-LONDON, V598, P1829, DOI 10.1113/JP279379; Szaflarski W, 2016, ONCOTARGET, V7, P30307, DOI 10.18632/oncotarget.8728; Taniguchi S, 2020, SCIENCE, V369, P269, DOI 10.1126/science.aay1813; Tauber D, 2020, CELL, V180, P411, DOI 10.1016/j.cell.2019.12.031; Travers J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05485-x; Wheeler JR, 2017, METHODS, V126, P12, DOI 10.1016/j.ymeth.2017.04.020; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wilmore S, 2021, CELL MOL LIFE SCI, V78, P6337, DOI 10.1007/s00018-021-03910-x; Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5; Yang PG, 2020, CELL, V181, P325, DOI 10.1016/j.cell.2020.03.046; Zhang K, 2018, CELL, V173, P958, DOI 10.1016/j.cell.2018.03.025	42	6	6	16	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1021	+		10.1038/s41590-022-01255-6	http://dx.doi.org/10.1038/s41590-022-01255-6		JUL 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35794369	Green Submitted			2022-12-18	WOS:000824820700001
J	Dobes, J; Ben-Nun, O; Binyamin, A; Stoler-Barak, L; Oftedal, BE; Goldfarb, Y; Kadouri, N; Gruper, Y; Givony, T; Zalayat, I; Kovacova, K; Bohmova, H; Valter, E; Shulman, Z; Filipp, D; Husebye, ES; Abramson, J				Dobes, Jan; Ben-Nun, Osher; Binyamin, Amit; Stoler-Barak, Liat; Oftedal, Bergithe E.; Goldfarb, Yael; Kadouri, Noam; Gruper, Yael; Givony, Tal; Zalayat, Itay; Kovacova, Katarina; Bohmova, Helena; Valter, Evgeny; Shulman, Ziv; Filipp, Dominik; Husebye, Eystein S.; Abramson, Jakub			Extrathymic expression of Aire controls the induction of effective T(H)17 cell-mediated immune response to Candida albicans	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; T-CELLS; AUTOIMMUNE REGULATOR; NEGATIVE SELECTION; BETA; TOLERANCE; DEFICIENCY; DECTIN-1; RECOGNITION	Patients with loss of function in the gene encoding the master regulator of central tolerance AIRE suffer from a devastating disorder called autoimmune polyendocrine syndrome type 1 (APS-1), characterized by a spectrum of autoimmune diseases and severe mucocutaneous candidiasis. Although the key mechanisms underlying the development of autoimmunity in patients with APS-1 are well established, the underlying cause of the increased susceptibility to Candida albicans infection remains less understood. Here, we show that Aire(+)MHCII(+) type 3 innate lymphoid cells (ILC3s) could sense, internalize and present C. albicans and had a critical role in the induction of Candida-specific T helper 17 (T(H)17) cell clones. Extrathymic Rorc-Cre-mediated deletion of Aire resulted in impaired generation of Candida-specific T(H)17 cells and subsequent overgrowth of C. albicans in the mucosal tissues. Collectively, our observations identify a previously unrecognized regulatory mechanism for effective defense responses against fungal infections. Abramson and colleagues show that Aire(+)MHCII(+) ILC3s sense, internalize and present Candida albicans and modulate the induction of C. albicans-specific T(H)17 cells.	[Dobes, Jan; Ben-Nun, Osher; Binyamin, Amit; Stoler-Barak, Liat; Goldfarb, Yael; Kadouri, Noam; Gruper, Yael; Givony, Tal; Zalayat, Itay; Shulman, Ziv; Abramson, Jakub] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Dobes, Jan; Kovacova, Katarina; Bohmova, Helena; Valter, Evgeny] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Oftedal, Bergithe E.; Husebye, Eystein S.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Oftedal, Bergithe E.; Husebye, Eystein S.] Haukeland Hosp, Dept Med, Bergen, Norway; [Filipp, Dominik] Czech Acad Sci, Inst Mol Genet, Lab Immunobiol, Prague, Czech Republic	Weizmann Institute of Science; Charles University Prague; University of Bergen; University of Bergen; Haukeland University Hospital; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Abramson, J (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	jakub.abramson@weizmann.ac.il	Dobeš, Jan/AAL-1287-2020; Dobes, Jan/AAF-4922-2020; Oftedal, Bergithe Eikeland/I-7217-2019	Dobeš, Jan/0000-0003-1853-1603; Dobes, Jan/0000-0003-1853-1603; Oftedal, Bergithe Eikeland/0000-0003-4248-7737; Kadouri, Noam/0000-0002-2978-4318; Filipp, Dominik/0000-0003-2506-9330; Binyamin, Amit/0000-0002-0046-0029; Kovacova, Katarina/0000-0002-0718-4047	European Research Council [ERC-2016-CoG-724821]; Israel Science Foundation [1796/16, 1819/21]; Chan Zuckerberg Initiative; Bill and Marika Glied and Family Fund; Binational Science Foundation; Pasteur-Weizmann Delegation; Enoch Foundation; Ruth and Samuel David Gameroff Family Foundation; Erica Drake Fund; Lilly Fulop Fund for Multiple Sclerosis Research; Dean of Faculty Fellowship by Weizmann Institute of Science; Weizmann Institute of Science - Czech Academy of Sciences Bilateral Fellowship by Czech Academy of Sciences; Charles University PRIMUS grant [Primus/21/MED/003]; Czech Science Foundation JUNIOR STAR grant [21-22435M]; K.G. Jebsen Center for autoimmune disorders; Norwegian Research Council; Novo Nordisk Foundation; Regional Health Authorities of Western Norway; Grant Agency of the Czech Republic [17-25365S]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Chan Zuckerberg Initiative; Bill and Marika Glied and Family Fund; Binational Science Foundation(US-Israel Binational Science Foundation); Pasteur-Weizmann Delegation; Enoch Foundation; Ruth and Samuel David Gameroff Family Foundation; Erica Drake Fund; Lilly Fulop Fund for Multiple Sclerosis Research; Dean of Faculty Fellowship by Weizmann Institute of Science; Weizmann Institute of Science - Czech Academy of Sciences Bilateral Fellowship by Czech Academy of Sciences; Charles University PRIMUS grant; Czech Science Foundation JUNIOR STAR grant; K.G. Jebsen Center for autoimmune disorders; Norwegian Research Council(Research Council of NorwayEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Regional Health Authorities of Western Norway; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	Research in the Abramson laboratory is kindly supported by the European Research Council (ERC-2016-CoG-724821); Israel Science Foundation (1796/16 and 1819/21); Chan Zuckerberg Initiative; Bill and Marika Glied and Family Fund, Binational Science Foundation; Pasteur-Weizmann Delegation; Enoch Foundation, Ruth and Samuel David Gameroff Family Foundation; and Erica Drake Fund and Lilly Fulop Fund for Multiple Sclerosis Research. J.D. was supported by the Dean of Faculty Fellowship by Weizmann Institute of Science and by the Weizmann Institute of Science - Czech Academy of Sciences Bilateral Fellowship by Czech Academy of Sciences. J.D., K.K., H.B. and E.V. are also supported by Charles University PRIMUS grant (Primus/21/MED/003) and Czech Science Foundation JUNIOR STAR grant (21-22435M). B.E.O. and E.S.H. are supported by the K.G. Jebsen Center for autoimmune disorders, the Norwegian Research Council, the Novo Nordisk Foundation and the Regional Health Authorities of Western Norway. D.F. is supported by the Grant Agency of the Czech Republic (17-25365S).	Abramson J, 2016, IMMUNOL REV, V271, P127, DOI 10.1111/imr.12419; Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blasi E, 2005, FEMS IMMUNOL MED MIC, V44, P69, DOI 10.1016/j.femsim.2004.12.005; Break TJ, 2021, SCIENCE, V371, P252, DOI 10.1126/science.aay5731; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Bruserud O, 2016, J CLIN ENDOCR METAB, V101, P2975, DOI 10.1210/jc.2016-1821; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; Conti HR, 2015, J IMMUNOL, V195, P780, DOI 10.4049/jimmunol.1500909; DiToro D, 2020, IMMUNITY, V52, P650, DOI 10.1016/j.immuni.2020.03.013; Dobes J, 2018, EUR J IMMUNOL, V48, P546, DOI 10.1002/eji.201747267; Dobes J, 2015, GASTROENTEROLOGY, V149, P139, DOI 10.1053/j.gastro.2015.05.009; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; FONZI WA, 1993, GENETICS, V134, P717; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Husebye ES, 2018, NEW ENGL J MED, V378, P1132, DOI 10.1056/NEJMra1713301; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Karner J, 2013, CLIN EXP IMMUNOL, V171, P263, DOI 10.1111/cei.12024; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kohen R, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2728-2; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Lyu M., BIORXIV, DOI [10.1101/2022.04.25.489463(2022), DOI 10.1101/2022.04.25.489463(2022)]; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Melo-Gonzalez F, 2019, J EXP MED, V216, P728, DOI 10.1084/jem.20180871; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shao TY, 2019, CELL HOST MICROBE, V25, P404, DOI 10.1016/j.chom.2019.02.004; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Sonnenberg GE, 2019, NAT REV IMMUNOL, V19, P599, DOI 10.1038/s41577-019-0194-8; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Wang JX, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl5053; Yamano T, 2019, J EXP MED, V216, P1027, DOI 10.1084/jem.20181430	65	6	6	7	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1098	+		10.1038/s41590-022-01247-6	http://dx.doi.org/10.1038/s41590-022-01247-6		JUN 2022	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35761088				2022-12-18	WOS:000817057200002
J	Yshii, L; Pasciuto, E; Bielefeld, P; Mascali, L; Lemaitre, P; Marino, M; Dooley, J; Kouser, L; Verschoren, S; Lagou, V; Kemps, H; Gervois, P; de Boer, A; Burton, OT; Wahis, J; Verhaert, J; Tareen, S; Roca, CP; Singh, K; Whyte, CE; Kerstens, A; Callaerts-Vegh, Z; Poovathingal, S; Prezzemolo, T; Wierda, K; Dashwood, A; Xie, JH; Van Wonterghem, E; Creemers, E; Aloulou, M; Gsell, W; Abiega, O; Munck, S; Vandenbroucke, RE; Bronckaers, A; Lemmens, R; De Strooper, B; Van Den Bosch, L; Himmelreich, U; Fitzsimons, CP; Holt, MG; Liston, A				Yshii, Lidia; Pasciuto, Emanuela; Bielefeld, Pascal; Mascali, Loriana; Lemaitre, Pierre; Marino, Marika; Dooley, James; Kouser, Lubna; Verschoren, Stijn; Lagou, Vasiliki; Kemps, Hannelore; Gervois, Pascal; de Boer, Antina; Burton, Oliver T.; Wahis, Jerome; Verhaert, Jens; Tareen, Samar; Roca, Carlos P.; Singh, Kailash; Whyte, Carly E.; Kerstens, Axelle; Callaerts-Vegh, Zsuzsanna; Poovathingal, Suresh; Prezzemolo, Teresa; Wierda, Keimpe; Dashwood, Amy; Xie, Junhua; Van Wonterghem, Elien; Creemers, Eline; Aloulou, Meryem; Gsell, Willy; Abiega, Oihane; Munck, Sebastian; Vandenbroucke, Roosmarijn E.; Bronckaers, Annelies; Lemmens, Robin; De Strooper, Bart; Van Den Bosch, Ludo; Himmelreich, Uwe; Fitzsimons, Carlos P.; Holt, Matthew G.; Liston, Adrian			Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation	NATURE IMMUNOLOGY			English	Article							REG-CELLS; EXPRESSION; MICROGLIA; THERAPY; PACKAGE; SYSTEM; REPAIR	The ability of immune-modulating biologics to prevent and reverse pathology has transformed recent clinical practice. Full utility in the neuroinflammation space, however, requires identification of both effective targets for local immune modulation and a delivery system capable of crossing the blood-brain barrier. The recent identification and characterization of a small population of regulatory T (T-reg) cells resident in the brain presents one such potential therapeutic target. Here, we identified brain interleukin 2 (IL-2) levels as a limiting factor for brain-resident T-reg cells. We developed a gene-delivery approach for astrocytes, with a small-molecule on-switch to allow temporal control, and enhanced production in reactive astrocytes to spatially direct delivery to inflammatory sites. Mice with brain-specific IL-2 delivery were protected in traumatic brain injury, stroke and multiple sclerosis models, without impacting the peripheral immune system. These results validate brain-specific IL-2 gene delivery as effective protection against neuroinflammation, and provide a versatile platform for delivery of diverse biologics to neuroinflammatory patients. Liston and colleagues design a gene-delivery system to specifically target astrocytes in the central nervous system to express IL-2 and thereby expand/maintain T-reg cells to suppress neuroinflammation.	[Yshii, Lidia; Pasciuto, Emanuela; Mascali, Loriana; Lemaitre, Pierre; Marino, Marika; Verschoren, Stijn; Lagou, Vasiliki; de Boer, Antina; Wahis, Jerome; Verhaert, Jens; Kerstens, Axelle; Poovathingal, Suresh; Prezzemolo, Teresa; Wierda, Keimpe; Creemers, Eline; Munck, Sebastian; Lemmens, Robin; De Strooper, Bart; Van Den Bosch, Ludo; Holt, Matthew G.; Liston, Adrian] VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium; [Yshii, Lidia; Pasciuto, Emanuela; Mascali, Loriana; Lemaitre, Pierre; Lagou, Vasiliki; Prezzemolo, Teresa; Liston, Adrian] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Yshii, Lidia; Pasciuto, Emanuela; Marino, Marika; Verschoren, Stijn; de Boer, Antina; Wahis, Jerome; Verhaert, Jens; Kerstens, Axelle; Wierda, Keimpe; Creemers, Eline; Munck, Sebastian; Lemmens, Robin; De Strooper, Bart; Van Den Bosch, Ludo; Holt, Matthew G.] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Bielefeld, Pascal; Abiega, Oihane; Fitzsimons, Carlos P.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Bielefeld, Pascal; Dooley, James; Kouser, Lubna; Burton, Oliver T.; Tareen, Samar; Roca, Carlos P.; Singh, Kailash; Whyte, Carly E.; Dashwood, Amy; Aloulou, Meryem; Liston, Adrian] Babraham Inst, Immunol Programme, Babraham Res Campus, Cambridge, England; [Kemps, Hannelore; Gervois, Pascal; Bronckaers, Annelies] Hasselt Univ, Biomed Res Inst BIOMED, Cardio & Organ Syst COST, Diepenbeek, Belgium; [Kerstens, Axelle; Munck, Sebastian] VIB Bioimaging Core, Leuven, Belgium; [Callaerts-Vegh, Zsuzsanna] Katholieke Univ Leuven, Lab Biol Psychol, Fac Psychol, Leuven, Belgium; [Wierda, Keimpe; Creemers, Eline] VIB KU Leuven Ctr Brain & Dis Res, Electrophysiol Expertise Unit, Leuven, Belgium; [Xie, Junhua; Van Wonterghem, Elien; Vandenbroucke, Roosmarijn E.] VIB Ctr Inflammat Res, Ghent, Belgium; [Xie, Junhua; Van Wonterghem, Elien; Vandenbroucke, Roosmarijn E.] Univ Ghent, Fac Sci, Dept Biomed Mol Biol, Ghent, Belgium; [Aloulou, Meryem] CNRS UMR 5051, INSERM UMR1291, Toulouse Inst Infect & Inflammatory Dis Infin, Toulouse, France; [Gsell, Willy; Himmelreich, Uwe] Katholieke Univ Leuven, Biomed MRI, Dept Imaging & Pathol, Leuven, Belgium; [Lemmens, Robin] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [De Strooper, Bart] UCL, Dementia Res Inst, London, England; [Holt, Matthew G.] Univ Porto, Inst Invest & Inovacao Saude i3S, Porto, Portugal	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Amsterdam; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Hasselt University; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; KU Leuven; University Hospital Leuven; University of London; University College London; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Holt, MG; Liston, A (corresponding author), VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium.; Liston, A (corresponding author), Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.; Holt, MG (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium.; Liston, A (corresponding author), Babraham Inst, Immunol Programme, Babraham Res Campus, Cambridge, England.; Holt, MG (corresponding author), Univ Porto, Inst Invest & Inovacao Saude i3S, Porto, Portugal.	mholt@i3S.up.pt; al989@cam.ac.uk	Yshii, Lidia/GQA-4796-2022; Yshii, Lidia M/I-6039-2013; Aloulou, Meryem/AAA-6713-2020	Yshii, Lidia M/0000-0002-1988-6855; Aloulou, Meryem/0000-0003-4590-230X; Xie, Junhua/0000-0003-0684-8515; Holt, Matthew/0000-0002-8958-4027; Verschoren, Stijn/0000-0001-6733-3481; Fitzsimons, Carlos P./0000-0002-1556-2650; Kemps, Hannelore/0000-0001-9248-1697; Whyte, Carly/0000-0001-6556-6855; Dooley, James/0000-0003-3154-4708; Munck, Sebastian/0000-0002-5182-5358; Pasciuto, Emanuela/0000-0002-5391-9585; Dashwood, Amy/0000-0002-4340-377X; Lemaitre, Pierre/0000-0003-0687-8685; Himmelreich, Uwe/0000-0002-2060-8895; Marino, Marika/0000-0001-6773-6176; Singh, Kailash/0000-0002-6771-7757	VIB, an ERC Consolidator Grant TissueTreg; ERC Proof of Concept Grant TreatBrainDamage; ERC Starting Grant AstroFunc; ERCProof of Concept Grant AD-VIP; FWO Research Grant [1513616N, 1503420N, 1513020N]; Thierry Latran Foundation Grant SOD-VIP; ERNAET Chair (H2020-WIDESPREAD-2018-2020-6) [NCBio: 951923]; SAO-FRA pilot grant [20190032]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0427, BBS/E/B/000C0428]; Biotechnology and Biological Sciences Research Council Core Capability Grant; FWO; ERA-NET-NEURON grant EJTC 2016; Netherlands Organization for Scientific research (NWO)	VIB, an ERC Consolidator Grant TissueTreg; ERC Proof of Concept Grant TreatBrainDamage; ERC Starting Grant AstroFunc; ERCProof of Concept Grant AD-VIP; FWO Research Grant(FWO); Thierry Latran Foundation Grant SOD-VIP; ERNAET Chair (H2020-WIDESPREAD-2018-2020-6); SAO-FRA pilot grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council Core Capability Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FWO(FWO); ERA-NET-NEURON grant EJTC 2016; Netherlands Organization for Scientific research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work was supported by the VIB, an ERC Consolidator Grant TissueTreg (to A.L.), an ERC Proof of Concept Grant TreatBrainDamage (to A.L.), an ERC Starting Grant AstroFunc (to M.G.H.), an ERC Proof of Concept Grant AD-VIP (to M.G.H.), FWO Research Grant 1513616N (to M.G.H.), Thierry Latran Foundation Grant SOD-VIP (to M.G.H.), an ERNAET Chair (H2020-WIDESPREAD-2018-2020-6; NCBio: 951923; to M.G.H.), FWO Research Grants 1503420N (to E.P.) and 1513020N (to J.W.), an SAO-FRA pilot grant (20190032, to E.P.), and the Biotechnology and Biological Sciences Research Council through Institute Strategic Program Grant funding BBS/E/B/000C0427 and BBS/E/B/000C0428, and the Biotechnology and Biological Sciences Research Council Core Capability Grant to the Babraham Institute. E.P., V.L., M.M., P.G., J.W. and A.d.B. were supported by fellowships from the FWO. R.L. is a senior clinical investigator of FWO Flanders. P.B., O.A. and C.P.F. were supported by an ERA-NET-NEURON grant EJTC 2016 to C.P.F. and by the Netherlands Organization for Scientific research (NWO). The authors acknowledge the important contributions of J. Haughton (VIB) for mouse husbandry, M. Rincon (VIB) for advice on AAV design and production, K. Vennekens for technical support, P. -A. Penttila and the KUL FACS Core, J. Wouters and the KUL Molecular Small Animal Imaging Center (MoSAIC), S. Walker and the Babraham Institute Imaging Core, the VIB Bio-Imaging Core, the VIB Single Cell Sequencing Core, and R. Breedijk, M. Hink and the Leeuwenhoek Center for Advanced Microscopy at the University of Amsterdam.	Alves S, 2017, BRAIN, V140, P826, DOI 10.1093/brain/aww330; Asano T, 2017, BLOOD, V129, P2186, DOI 10.1182/blood-2016-09-741629; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Deliyanti D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00751-w; Deverman BE, 2018, NAT REV DRUG DISCOV, V17, P641, DOI 10.1038/nrd.2018.110; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dokalis N, 2019, SEMIN IMMUNOPATHOL, V41, P699, DOI 10.1007/s00281-019-00764-1; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; Esenwa C, 2015, VASC HEALTH RISK MAN, V11, P437, DOI 10.2147/VHRM.S63791; Fripont S, 2019, JOVE-J VIS EXP, DOI 10.3791/58960; Ghoochani A, 2016, ONCOGENE, V35, P6246, DOI 10.1038/onc.2016.160; Gilhus NE, 2019, NAT REV NEUROL, V15, P429, DOI 10.1038/s41582-019-0227-8; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Gorle N, 2018, BRAIN BEHAV IMMUN, V69, P35, DOI 10.1016/j.bbi.2017.12.010; Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Keeler AM, 2019, ANNU REV VIROL, V6, P601, DOI 10.1146/annurev-virology-092818-015530; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kerstens A, 2019, BMC BIOL, V17, DOI 10.1186/s12915-018-0614-4; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Ladwig A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7189421; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Llovera G, 2014, JOVE-J VIS EXP, DOI 10.3791/51729; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meola Danielle, 2013, J Alzheimers Dis Parkinsonism, V3, P1000127; Meythaler J, 2019, BRAIN INJURY, V33, P679, DOI 10.1080/02699052.2019.1566968; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mundt S, 2019, TRENDS NEUROSCI, V42, P667, DOI 10.1016/j.tins.2019.07.008; Pasciuto E, 2020, CELL, V182, P625, DOI 10.1016/j.cell.2020.06.026; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; R Core Team, 2018, R LANG ENV STAT COMP, P10, DOI [DOI 10.1038/SJ.HDY.6800737, 10.1108/eb003648]; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Rincon MY, 2018, GENE THER, V25, P83, DOI 10.1038/s41434-018-0005-z; Roca C. P., PREPRINT; Roca CP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23126-8; Saraiva J, 2016, J CONTROL RELEASE, V241, P94, DOI 10.1016/j.jconrel.2016.09.011; Sehara Y, 2017, HUM GENE THER CL DEV, V28, P74, DOI 10.1089/humc.2017.010; Shaked I, 2004, J NEUROIMMUNOL, V146, P84, DOI 10.1016/j.jneuroim.2003.10.049; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Stienne C, 2016, IMMUNITY, V45, P774, DOI 10.1016/j.immuni.2016.09.010; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tsivgoulis G, 2020, NEUROLOGY, V94, pE1241, DOI 10.1212/WNL.0000000000008904; Verkhratsky A, 2016, EMBO J, V35, P239, DOI 10.15252/embj.201592705; Voet S, 2019, TRENDS MOL MED, V25, P112, DOI 10.1016/j.molmed.2018.11.005; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Whyte C. E., 2020, PREPRINT, DOI [10.1101/2020.2012.2018.423431, DOI 10.1101/2020.2012.2018.423431]; Wylezinski LS, 2016, J BIOL CHEM, V291, P22913, DOI 10.1074/jbc.M116.729038; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Zhang HY, 2018, J NEUROSCI, V38, P10168, DOI 10.1523/JNEUROSCI.3411-17.2018; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou YX, 2020, J CELL MOL MED, V24, P8918, DOI 10.1111/jcmm.15641	66	6	6	22	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					878	+		10.1038/s41590-022-01208-z	http://dx.doi.org/10.1038/s41590-022-01208-z		MAY 2022	38	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35618831	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000805552300005
J	Calzetti, F; Finotti, G; Tamassia, N; Bianchetto-Aguilera, F; Castellucci, M; Cane, S; Lonardi, S; Cavallini, C; Matte, A; Gasperini, S; Signoretto, I; Benedetti, F; Bonifacio, M; Vermi, W; Ugel, S; Bronte, V; Tecchio, C; Scapini, P; Cassatella, MA				Calzetti, Federica; Finotti, Giulia; Tamassia, Nicola; Bianchetto-Aguilera, Francisco; Castellucci, Monica; Cane, Stefania; Lonardi, Silvia; Cavallini, Chiara; Matte, Alessandro; Gasperini, Sara; Signoretto, Ilaria; Benedetti, Fabio; Bonifacio, Massimiliano; Vermi, William; Ugel, Stefano; Bronte, Vincenzo; Tecchio, Cristina; Scapini, Patrizia; Cassatella, Marco A.			CD66b(-)CD64(dim)CD115(-) cells in the human bone marrow represent neutrophil-committed progenitors	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELL; MONOCYTE PROGENITORS; LINEAGE COMMITMENT; R-PACKAGE; DIFFERENTIATION; HEMATOPOIESIS; EXPRESSION; CD34(+); IDENTIFICATION; POPULATIONS	Cassatella and colleagues identify CD66b(-)CD64(dim)CD115(-) cells in the human bone marrow as the earliest neutrophil-committed progenitor cells described to date. Here we report the identification of human CD66b(-)CD64(dim)CD115(-) neutrophil-committed progenitor cells (NCPs) within the SSC(lo)CD45(dim)CD34(+) and CD34(dim/-) subsets in the bone marrow. NCPs were either CD45RA(+) or CD45RA(-), and in vitro experiments showed that CD45RA acquisition was not mandatory for their maturation process. NCPs exclusively generated human CD66b(+) neutrophils in both in vitro differentiation and in vivo adoptive transfer experiments. Single-cell RNA-sequencing analysis indicated NCPs fell into four clusters, characterized by different maturation stages and distributed along two differentiation routes. One of the clusters was characterized by an interferon-stimulated gene signature, consistent with the reported expansion of peripheral mature neutrophil subsets that express interferon-stimulated genes in diseased individuals. Finally, comparison of transcriptomic and phenotypic profiles indicated NCPs represented earlier neutrophil precursors than the previously described early neutrophil progenitors (eNePs), proNeus and COVID-19 proNeus. Altogether, our data shed light on the very early phases of neutrophil ontogeny.	[Calzetti, Federica; Finotti, Giulia; Tamassia, Nicola; Bianchetto-Aguilera, Francisco; Gasperini, Sara; Signoretto, Ilaria; Scapini, Patrizia; Cassatella, Marco A.] Univ Verona, Dept Med, Sect Gen Pathol, Verona, Italy; [Castellucci, Monica] Univ Verona, Ctr Piattaforme Tecnol, Verona, Italy; [Cane, Stefania; Ugel, Stefano; Bronte, Vincenzo] Univ Verona, Dept Med, Sect Immunol, Verona, Italy; [Lonardi, Silvia; Vermi, William] Univ Brescia, Dept Mol & Translat Med, Unit Pathol, Brescia, Italy; [Cavallini, Chiara] Univ Verona, Res Ctr LURM, Interdepartmental Lab Med Res, Verona, Italy; [Matte, Alessandro] Univ Verona, Dept Med, Sect Internal Med B, Verona, Italy; [Matte, Alessandro] AOUI Verona, Verona, Italy; [Benedetti, Fabio; Bonifacio, Massimiliano; Tecchio, Cristina] Univ Verona, Dept Med, Sect Hematol & Bone Marrow Transplant Unit, Verona, Italy	University of Verona; University of Verona; University of Verona; University of Brescia; University of Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Cassatella, MA (corresponding author), Univ Verona, Dept Med, Sect Gen Pathol, Verona, Italy.	marco.cassatella@univr.it	Ugel, Stefano/J-5535-2016; Bianchetto Aguilera, Francisco Miguel Angel/GNW-3583-2022; tecchio, cristina/GRX-9586-2022	Ugel, Stefano/0000-0002-6639-7608; Bianchetto Aguilera, Francisco Miguel Angel/0000-0003-3910-4715; Cane, Stefania/0000-0003-4324-4681; BONIFACIO, Massimiliano/0000-0003-0716-1686; Cavallini, Chiara/0000-0002-2470-0162	AIRC [IG-20339]; MIUR-PRIN grant [20177J4E75_004]; Fondazione Cariverona;  [GR-2016-02361263]	AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR-PRIN grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Cariverona(Fondazione Cariverona); 	This work was supported by grants to M.A.C. (from AIRC grant no. IG-20339; MIUR-PRIN grant no. 20177J4E75_004; and Fondazione Cariverona) and to N.T. (grant no. GR-2016-02361263). We thank P. Mazzi for preparing cytospins, E. Pietronigro for slide acquisition, S. Pasqualato (European Institute of Oncology, Milan, Italy) for providing Tn5 transposase and A. Carraro (Centro Trapianti Fegato, AOUI Verona, Italy) and V. Bergamini (UOC Ostetricia e Ginecologia B, AOUI Verona, Italy) for providing spleen and cord blood samples. We thank G. Zini (University Cattolica, Hematology Department, Rome) for her professional consultancy about NCP morphology. Centro Piattaforme Tecnologiche (CPT) of the University of Verona has been instrumental for the access to the flow cytometry/cell analysis and genomic/transcriptomic platforms.	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bianchetto-Aguilera F, 2020, FASEB J, V34, P9269, DOI 10.1096/fj.202000181R; Bost P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21702-6; Breton G, 2015, NAT PROTOC, V10, P1407, DOI 10.1038/nprot.2015.092; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calzetti F, 2017, J ALLERGY CLIN IMMUN, V139, P352, DOI 10.1016/j.jaci.2016.06.025; Cassatella MA, 2019, TRENDS IMMUNOL, V40, P648, DOI 10.1016/j.it.2019.05.003; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Dinh HQ, 2020, IMMUNITY, V53, P319, DOI 10.1016/j.immuni.2020.07.017; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Drissen R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7148; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Gorczyca W, 2011, METHOD CELL BIOL, V103, P221, DOI 10.1016/B978-0-12-385493-3.00010-3; Gross S, 1997, EUR J HAEMATOL, V59, P318; Gupta S, 2020, P NATL ACAD SCI USA, V117, P16481, DOI 10.1073/pnas.2003603117; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hahsler M, 2008, J STAT SOFTW, V25, P1; Jacobsen SEW, 2019, NAT CELL BIOL, V21, P2, DOI 10.1038/s41556-018-0227-8; Jie ZW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180832; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Kawamura S, 2017, IMMUNITY, V46, P835, DOI 10.1016/j.immuni.2017.04.019; Kwok I, 2020, IMMUNITY, V53, P303, DOI 10.1016/j.immuni.2020.06.005; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mistry P, 2019, P NATL ACAD SCI USA, V116, P25222, DOI 10.1073/pnas.1908576116; Mora-Jensen H, 2011, J LEUKOCYTE BIOL, V90, P629, DOI 10.1189/jlb.0311123; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Muench DE, 2020, NATURE, V582, P109, DOI 10.1038/s41586-020-2227-7; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Olweus J, 1996, BLOOD, V88, P3741, DOI 10.1182/blood.V88.10.3741.bloodjournal88103741; Olweus J, 1994, Immunomethods, V5, P179, DOI 10.1006/immu.1994.1054; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; OLWEUS J, 1995, BLOOD, V85, P2402, DOI 10.1182/blood.V85.9.2402.bloodjournal8592402; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pellin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10291-0; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; SERRA MC, 1994, IMMUNOLOGY, V82, P63; Sinha S, 2022, NAT MED, V28, P201, DOI 10.1038/s41591-021-01576-3; Tamassia N, 2007, J IMMUNOL, V178, P7344, DOI 10.4049/jimmunol.178.11.7344; Tura O, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-53; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Watcham S, 2019, BLOOD, V133, P1415, DOI 10.1182/blood-2018-08-835355; Weinreb C, 2020, SCIENCE, V367, DOI 10.1126/science.aaw3381; Xie XM, 2020, NAT IMMUNOL, V21, P1119, DOI 10.1038/s41590-020-0736-z; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zheng SW, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178041; Zhu YFPP, 2018, CELL REP, V24, P2329, DOI 10.1016/j.celrep.2018.07.097; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zimmermann M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19674	60	6	6	5	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					679	+		10.1038/s41590-022-01189-z	http://dx.doi.org/10.1038/s41590-022-01189-z		APR 2022	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35484408	Bronze			2022-12-18	WOS:000788458200003
J	Hsu, M; Laaker, C; Madrid, A; Herbath, M; Choi, YH; Sandor, M; Fabry, Z				Hsu, Martin; Laaker, Collin; Madrid, Andy; Herbath, Melinda; Choi, Yun Hwa; Sandor, Matyas; Fabry, Zsuzsanna			Neuroinflammation creates an immune regulatory niche at the meningeal lymphatic vasculature near the cribriform plate	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; AUTOIMMUNE ENCEPHALOMYELITIS; CELLS; PD-1; LYMPHANGIOGENESIS; QUANTIFICATION; TRANSMIGRATION; PODOPLANIN; TOLERANCE; DYNAMICS	Meningeal lymphatics near the cribriform plate undergo lymphangiogenesis during neuroinflammation to drain excess fluid. Here, we hypothesized that lymphangiogenic vessels may acquire an altered phenotype to regulate immunity. Using single-cell RNA sequencing of meningeal lymphatics near the cribriform plate from healthy and experimental autoimmune encephalomyelitis in the C57BL/6 model, we report that neuroinflammation induces the upregulation of genes involved in antigen presentation such as major histocompatibility complex class II, adhesion molecules including vascular cell adhesion protein 1 and immunoregulatory molecules such as programmed cell death 1 ligand 1, where many of these changes are mediated by interferon-gamma. The inflamed lymphatics retain CD11c(+) cells and CD4 T cells where they capture and present antigen, creating an immunoregulatory niche that represents an underappreciated interface in the regulation of neuroinflammation. We also found discontinuity of the arachnoid membrane near the cribriform plate, which provides unrestricted access to the cerebrospinal fluid. These findings highlight a previously unknown function of local meningeal lymphatics in regulating immunity that has only previously been characterized in draining lymph nodes. Fabry and colleagues show that cribriform plate-resident lymphatic endothelial cells respond to neuroinflammatory signals by inducing functional changes that enhance antigen capture and presentation from the cerebrospinal fluid and promote leukocyte interactions within the central nervous system.	[Hsu, Martin; Laaker, Collin; Madrid, Andy] Univ Wisconsin Madison, Neurosci Training Program, Madison, WI USA; [Herbath, Melinda; Sandor, Matyas; Fabry, Zsuzsanna] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53726 USA; [Choi, Yun Hwa] Univ Wisconsin Madison, Sch Pharm, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fabry, Z (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53726 USA.	zfabry@wisc.edu	Herbath, Melinda/ACC-5712-2022	Herbath, Melinda/0000-0002-8403-582X; Laaker, Collin/0000-0001-8532-9427	UWCCC [P30 CA014520]; National Institutes of Health [NS108497, NS103506, HL128778]; Neuroscience Training Program [T32-GM007507]; 10X Genomics Pilot grant	UWCCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Training Program; 10X Genomics Pilot grant	We thank K. Maclivay for his expertise in flow cytometry, L. Schmitt-Brunold for her expertise in molecular biology and all members of our laboratory for insightful discussions and constructive criticisms of this work. We thank members of the University of Wisconsin Flow Core Facility for their assistance and expertise in FACS sorting, T. Duellman and S. Splinter BonDurant for their expertise and assistance with scRNA-seq and B. Rauch and E. Meyerand at the UW Small Animal Imaging Facility supported by a UWCCC grant no. P30 CA014520 for the use of its facilities and services. This work was supported by National Institutes of Health grant nos. NS108497 and NS103506 awarded to Z.F., grant no. HL128778 awarded to M.S., a Neuroscience Training Program grant no. T32-GM007507 to M.H. and C.L. and a 10X Genomics Pilot grant to Z.E	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; Arellano G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00492; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Bendall SC, 2020, NAT BIOTECHNOL, V38, P559, DOI 10.1038/s41587-020-0511-6; Bianchi R, 2017, ARTERIOSCL THROM VAS, V37, P108, DOI 10.1161/ATVBAHA.116.308020; Bolte AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18113-4; Clarkson BD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42856; Clarkson BD, 2015, J IMMUNOL, V194, P531, DOI 10.4049/jimmunol.1401320; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Giladi A, 2020, NAT BIOTECHNOL, V38, P629, DOI 10.1038/s41587-020-0442-2; Harris MG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04422; Hauglund NL, 2020, J NEUROSCI, V40, P2371, DOI 10.1523/JNEUROSCI.2223-19.2020; Herz J, 2018, METHODS MOL BIOL, V1846, P141, DOI 10.1007/978-1-4939-8712-2_9; Hsu M, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.683676; Hsu MR, 2021, BIOL FUTURA, V72, P45, DOI 10.1007/s42977-021-00066-4; Hsu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08163-0; Hu XT, 2020, CELL RES, V30, P229, DOI 10.1038/s41422-020-0287-8; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274; Kretschmer S, 2016, LAB INVEST, V96, P918, DOI 10.1038/labinvest.2016.69; Lane RS, 2018, J EXP MED, V215, P3057, DOI 10.1084/jem.20180654; Lim TS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1085146; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucas ED, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00036; Lucas ED, 2018, J IMMUNOL, V201, P1735, DOI 10.4049/jimmunol.1800271; Marelli-Berg FM, 2013, J CELL SCI, V126, P2343, DOI 10.1242/jcs.124099; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Norwood JN, 2019, ELIFE, V8, DOI 10.7554/eLife.44278; Paddock C, 2016, BLOOD, V127, P1052, DOI 10.1182/blood-2015-07-660092; Palle Pushpalatha, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040023; Park SJ, 2014, J LEUKOCYTE BIOL, V95, P621, DOI 10.1189/jlb.0813443; Proulx ST, 2021, CELL MOL LIFE SCI, V78, P2429, DOI 10.1007/s00018-020-03706-5; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Raghunandan A, 2021, ELIFE, V10, DOI 10.7554/eLife.65958; Ran S, 2020, ADV EXP MED BIOL, V1234, P87, DOI 10.1007/978-3-030-37184-5_7; Rayasam A, 2018, J NEUROSCI, V38, P7058, DOI 10.1523/JNEUROSCI.0366-18.2018; Rinaldi E, 2018, CELL MOL IMMUNOL, V15, P663, DOI 10.1038/cmi.2017.126; Rouhani SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7771; Russo E, 2013, LYMPHAT RES BIOL, V11, P172, DOI 10.1089/lrb.2013.0008; Rustenhoven J, 2021, CELL, V184, P1000, DOI 10.1016/j.cell.2020.12.040; Santambrogio L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01033; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Song E, 2020, NATURE, V577, P689, DOI 10.1038/s41586-019-1912-x; Sosa RA, 2015, P NATL ACAD SCI USA, V112, pE5038, DOI 10.1073/pnas.1505955112; Takeda A, 2019, IMMUNITY, V51, P561, DOI 10.1016/j.immuni.2019.06.027; Tamburini BA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4989; Tewalt EF, 2012, BLOOD, V120, P4772, DOI 10.1182/blood-2012-04-427013; Tewalt EF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00305; Torzicky M, 2012, J INVEST DERMATOL, V132, P1149, DOI 10.1038/jid.2011.420; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Volk-Draper LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179257; Weller RO, 2018, ACTA NEUROPATHOL, V135, P363, DOI 10.1007/s00401-018-1809-z; Xiang M, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00052; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	64	6	6	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					581	+		10.1038/s41590-022-01158-6	http://dx.doi.org/10.1038/s41590-022-01158-6		MAR 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35347285	Green Accepted, Green Submitted			2022-12-18	WOS:000778224600003
J	Tomalka, JA; Suthar, MS; Deeks, SG; Sekaly, RP				Tomalka, Jeffrey A.; Suthar, Mehul S.; Deeks, Steven G.; Sekaly, Rafick Pierre			Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; ADAPTIVE IMMUNE-RESPONSES; MESSENGER-RNA VACCINES; DENDRITIC CELLS; INNATE IMMUNITY; TRANSLATING INNATE; FOXP3 EXPRESSION; IMMUNOGENICITY; EPIGENETICS; INFECTION	Host genetic and environmental factors including age, biological sex, diet, geographical location, microbiome composition and metabolites converge to influence innate and adaptive immune responses to vaccines. Failure to understand and account for these factors when investigating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine efficacy may impair the development of the next generation of vaccines. Most studies aimed at identifying mechanisms of vaccine-mediated immune protection have focused on adaptive immune responses. It is well established, however, that mobilization of the innate immune response is essential to the development of effective cellular and humoral immunity. A comprehensive understanding of the innate immune response and environmental factors that contribute to the development of broad and durable cellular and humoral immune responses to SARS-CoV-2 and other vaccines requires a holistic and unbiased approach. Along with optimization of the immunogen and vectors, the development of adjuvants based on our evolving understanding of how the innate immune system shapes vaccine responses will be essential. Defining the innate immune mechanisms underlying the establishment of long-lived plasma cells and memory T cells could lead to a universal vaccine for coronaviruses, a key biomedical priority. In part of a series of commissioned pieces on coronavirus disease 2019 (COVID-19), Sekaly and colleagues discuss COVID-19 vaccine progress, the underlying biology and prospects for the future.	[Tomalka, Jeffrey A.; Sekaly, Rafick Pierre] Emory Univ, Sch Med, Dept Pathol & Lab Med, Pathol Adv Translat Res Unit, Atlanta, GA 30322 USA; [Tomalka, Jeffrey A.; Suthar, Mehul S.; Sekaly, Rafick Pierre] Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; [Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Deeks, Steven G.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA	Emory University; Emory University; Emory University; University of California System; University of California San Francisco	Sekaly, RP (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Pathol Adv Translat Res Unit, Atlanta, GA 30322 USA.; Sekaly, RP (corresponding author), Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA.	rafick.sekaly@emory.edu		Sekaly, Rafick/0000-0002-7816-4828; Deeks, Steven/0000-0001-6371-747X	NCI/NHI [U54CA260563]; NIAID/NIH [U19AI128910]; National Institute of Allergy and Infectious Diseases (NIAID) [R56AI147623, U19AI057266, U19AI090023, 1U54CA260563]; National Institutes of Health (NIH), Department of Health and Human Services (NIAID Centers of Excellence for Influenza Research and Surveillance) [HHSN272201400004C, 75N93021C00017]; NIH [P51 OD011132]; Emory Executive Vice President for Health Affairs Synergy Fund award [75D30121C10084]; Woodruff Health Sciences Center; Emory School of Medicine; Pediatric Research Alliance Center for Childhood Infections and Vaccines; Children's Healthcare of Atlanta; Woodruff Health Sciences Center 2020 COVID-19 CURE award	NCI/NHI; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH), Department of Health and Human Services (NIAID Centers of Excellence for Influenza Research and Surveillance); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Executive Vice President for Health Affairs Synergy Fund award; Woodruff Health Sciences Center; Emory School of Medicine; Pediatric Research Alliance Center for Childhood Infections and Vaccines; Children's Healthcare of Atlanta; Woodruff Health Sciences Center 2020 COVID-19 CURE award	We acknowledge S. Shukla and S. Bal for contributions to the generation of figures 1-3 created with BioRender.com. This project was supported for R.P.S and J.A.T by NCI/NHI U54CA260563 and NIAID/NIH U19AI128910. This project has been funded for M.S.S. in part with federal funds from the National Institute of Allergy and Infectious Diseases (NIAID; R56AI147623, U19AI057266, U19AI090023 and 1U54CA260563 to Emory University) National Institutes of Health (NIH), Department of Health and Human Services (HHSN272201400004C and 75N93021C00017; NIAID Centers of Excellence for Influenza Research and Surveillance) and NIH P51 OD011132 to Emory University. This work was also supported in part by the Emory Executive Vice President for Health Affairs Synergy Fund award (75D30121C10084), COVID-Catalyst-I3 funds from the Woodruff Health Sciences Center and Emory School of Medicine, the Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children's Healthcare of Atlanta, and Woodruff Health Sciences Center 2020 COVID-19 CURE award.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Addeo A, 2021, CANCER CELL, V39, P1091, DOI 10.1016/j.ccell.2021.06.009; Agbarya A, 2021, CANCERS, V13, DOI 10.3390/cancers13164191; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ammitzboll C, 2021, ACR OPEN RHEUMATOL, V3, P622, DOI 10.1002/acr2.11299; [Anonymous], 2021, MMWR MORB MORTAL WKL, V70, P1731, DOI [DOI 10.15585/MMWR.MM7011A1EXTERNALICON, 10.1101/2021.12.07.21267432, 10.15585/mmwr.mm7050-1]; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Arroyo-Sanchez D, 2022, J CLIN IMMUNOL, V42, P240, DOI 10.1007/s10875-021-01174-5; Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Arunachalam PS, 2021, NATURE, V596, P410, DOI 10.1038/s41586-021-03791-x; Arunachalam PS, 2021, NATURE, V594, P253, DOI 10.1038/s41586-021-03530-2; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Barouch DH, 2021, NEW ENGL J MED, V385, P951, DOI 10.1056/NEJMc2108829; Blanc F, 2021, GENET SEL EVOL, V53, DOI 10.1186/s12711-021-00614-5; Boor PPC, 2013, CLIN EXP IMMUNOL, V174, P389, DOI 10.1111/cei.12191; Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P2204, DOI 10.1001/jama.2021.7489; Caballero AE, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107671; Cele Sandile, 2021, medRxiv, DOI 10.1101/2021.12.08.21267417; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chavarot N, 2021, TRANSPLANTATION, V105, pE94, DOI 10.1097/TP.0000000000003784; Choe YJ, 2020, INT J INFECT DIS, V92, P261, DOI 10.1016/j.ijid.2019.12.021; Corti C, 2022, ANN ONCOL, V33, P158, DOI 10.1016/j.annonc.2021.10.014; Cucchiari D, 2021, AM J TRANSPLANT, V21, P2727, DOI 10.1111/ajt.16701; de Jesus TJ, 2021, GLYCOBIOLOGY, V31, P812, DOI 10.1093/glycob/cwab001; de Jong SE, 2020, CELL HOST MICROBE, V28, P169, DOI 10.1016/j.chom.2020.06.014; Deepak P, 2021, ANN INTERN MED, V174, P1572, DOI 10.7326/M21-1757; Diamanti AP, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708848; Diaz A, 2017, VACCINE, V35, P2694, DOI 10.1016/j.vaccine.2017.03.078; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Divangahi M, 2021, NAT IMMUNOL, V22, P2, DOI 10.1038/s41590-020-00845-6; Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916; Edara VV, 2021, CELL HOST MICROBE, V29, P516, DOI 10.1016/j.chom.2021.03.009; Edara VV, 2021, NEW ENGL J MED, V385, P664, DOI 10.1056/NEJMc2107799; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fallerini C, 2021, ELIFE, V10, DOI 10.7554/eLife.67569; Fanucchi S, 2021, IMMUNITY, V54, P32, DOI 10.1016/j.immuni.2020.10.011; Ferri C, 2021, J AUTOIMMUN, V125, DOI 10.1016/j.jaut.2021.102744; Figueiredo J. C., 2021, CANCER RES, DOI [10.1158/0008-5472, DOI 10.1158/0008-5472]; Fink AL, 2021, J CLIN VIROL PLUS, V1, DOI 10.1016/j.jcvp.2021.100034; Fourati S., 2021, INNATE IMMUNE ACTIVA, DOI [10.1101/2021.09.26.461847(2021, DOI 10.1101/2021.09.26.461847(2021]; Fourati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10369; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gavriatopoulou M, 2021, BLOOD ADV, V5, P4398, DOI 10.1182/bloodadvances.2021005444; Geisen UM, 2021, ANN RHEUM DIS, V80, P1306, DOI 10.1136/annrheumdis-2021-220272; Gjini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02955-y; Haberman RH, 2021, ANN RHEUM DIS, V80, P1339, DOI 10.1136/annrheumdis-2021-220597; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Havlin J, 2021, J HEART LUNG TRANSPL, V40, P754, DOI 10.1016/j.healun.2021.05.004; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; Ho PY, 2010, J LEUKOCYTE BIOL, V88, P1073, DOI 10.1189/jlb.0809582; Holden IK, 2021, J INTERN MED, V290, P1264, DOI 10.1111/joim.13361; Huijts SM, 2017, VACCINE, V35, P4444, DOI 10.1016/j.vaccine.2017.01.071; Iancovici L, 2022, RHEUMATOLOGY, V61, P3439, DOI 10.1093/rheumatology/keab879; Jagannath C, 2012, METHODS MOL BIOL, V821, P295, DOI 10.1007/978-1-61779-430-8_18; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jego Gaetan, 2005, V8, P124; Jena A, 2022, AUTOIMMUN REV, V21, DOI 10.1016/j.autrev.2021.102927; Just S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0510-8; Kaplonek P., 2021, SUBTLE IMMUNOLOGICAL, DOI [10.1101/2021.08.31.458247(2021, DOI 10.1101/2021.08.31.458247(2021]; Kardava Lela, 2021, medRxiv, DOI 10.1101/2021.07.06.21259528; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Kawamura T, 2014, J DERMATOL SCI, V75, P159, DOI 10.1016/j.jdermsci.2014.05.004; Kedmi R, 2010, BIOMATERIALS, V31, P6867, DOI 10.1016/j.biomaterials.2010.05.027; Kennedy RB, 2014, EXPERT REV VACCINES, V13, P657, DOI 10.1586/14760584.2014.905744; Knudsen KEB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101499; Kouwaki T, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.700926; Krautkramer KA, 2021, NAT REV MICROBIOL, V19, P77, DOI 10.1038/s41579-020-0438-4; Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lederer Katlyn, 2021, medRxiv, DOI 10.1101/2021.09.16.21263686; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026; Ligumsky H, 2022, JNCI-J NATL CANCER I, V114, P203, DOI 10.1093/jnci/djab174; Linardou H, 2021, CANCERS, V13, DOI 10.3390/cancers13184621; Liu C., 2021, RETROSPECTIVE ANAL C, DOI 10.05.21264583; Logette E, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.695139; Lynch SV, 2021, AM J RESP CRIT CARE, V203, P802, DOI 10.1164/rccm.202010-3779PP; Lynn DJ, 2022, NAT REV IMMUNOL, V22, P33, DOI 10.1038/s41577-021-00554-7; Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marinaki S, 2021, AM J TRANSPLANT, V21, P2913, DOI 10.1111/ajt.16607; Massarweh A, 2021, JAMA ONCOL, V7, P1133, DOI 10.1001/jamaoncol.2021.2155; Mazzola A, 2022, CLIN INFECT DIS, V74, P1093, DOI 10.1093/cid/ciab580; McElhaney JE, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000140; Messali S., 2021, J MED VIROL, DOI [10.1002/jmv.27247(2021, DOI 10.1002/JMV.27247(2021]; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; Mostaghimi D, 2022, LANCET INFECT DIS, V22, pE52, DOI 10.1016/S1473-3099(21)00472-2; Nakade Y, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247303; Naranbhai V, 2022, J CLIN ONCOL, V40, P12, DOI 10.1200/JCO.21.01891; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Nutman TB, 2015, PARASITE IMMUNOL, V37, P304, DOI 10.1111/pim.12194; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Owen AM, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.622614; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Payne RP, 2021, CELL, V184, P5699, DOI 10.1016/j.cell.2021.10.011; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peeters M, 2021, ESMO OPEN, V6, DOI 10.1016/j.esmoop.2021.100274; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Pelletier A. N., 2021, PREVACCINATION VALID, DOI [10.1101/2021.09.25.21264123, DOI 10.1101/2021.09.25.21264123]; Peroni DG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080811; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Riksen NP, 2021, MOL ASPECTS MED, V77, DOI 10.1016/j.mam.2020.100897; Rubbert-Roth A, 2021, LANCET RHEUMATOL, V3, pE470, DOI 10.1016/S2665-9913(21)00186-7; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Salvi V, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.150542; Sattler A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI150175; Schramm R, 2021, CLIN RES CARDIOL, V110, P1142, DOI 10.1007/s00392-021-01880-5; Shannon CP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.578801; Shimizu H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53242-x; Simader E, 2022, ANN RHEUM DIS, V81, P416, DOI 10.1136/annrheumdis-2021-221347; Stathopoulou C, 2019, IMMUNOTHERAPY-UK, V11, P813, DOI 10.2217/imt-2019-0002; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stevens NE, 2022, VACCINE, V40, P1594, DOI 10.1016/j.vaccine.2021.03.084; Su HB, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144260; Suthar MS, 2022, MED-CAMBRIDGE, V3, P25, DOI 10.1016/j.medj.2021.12.005; Tan CW, 2021, NEW ENGL J MED, V385, P1401, DOI 10.1056/NEJMoa2108453; Tapsin S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03675-1; Tauzin A, 2021, CELL HOST MICROBE, V29, P1137, DOI 10.1016/j.chom.2021.06.001; Teijaro JR, 2021, NAT REV IMMUNOL, V21, P195, DOI 10.1038/s41577-021-00526-x; Thakkar A, 2021, CANCER CELL, V39, P1081, DOI 10.1016/j.ccell.2021.06.002; Tomalka JA, 2021, NAT IMMUNOL, V22, P1294, DOI 10.1038/s41590-021-01026-9; Torjesen I, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2943; Trefflich I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010047; Trovato M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02130; Ueno H, 2010, IMMUNOL CELL BIOL, V88, P376, DOI 10.1038/icb.2010.28; van der Heijden CDCC, 2018, ANTIOXID REDOX SIGN, V29, P1023, DOI 10.1089/ars.2017.7310; Vierboom MPM, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2020.100185; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wimmers F, 2021, CELL, V184, P3915, DOI 10.1016/j.cell.2021.05.039; Xia SL, 2021, LANCET INFECT DIS, V21, P39, DOI 10.1016/S1473-3099(20)30831-8; Xiao Y, 2020, VIRULENCE, V11, P39, DOI 10.1080/21505594.2019.1706305; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yang C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.566090; Yang DM, 2021, MILITARY MED RES, V8, DOI [10.1101/2021.02.10.430677, 10.1186/s40779-021-00340-5]; Yin X, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108628; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhang HX, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2005191118; Zhang YJ, 2021, LANCET INFECT DIS, V21, P181, DOI 10.1016/S1473-3099(20)30843-4; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zimmermann P, 2018, VACCINE, V36, P207, DOI 10.1016/j.vaccine.2017.08.069	155	6	6	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					360	370		10.1038/s41590-022-01130-4	http://dx.doi.org/10.1038/s41590-022-01130-4		FEB 2022	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35210622	Bronze			2022-12-18	WOS:000760706000001
J	Fujiwara, H; Seike, K; Brooks, MD; Mathew, AV; Kovalenko, I; Pal, A; Lee, HJ; Peltier, D; Kim, S; Liu, C; Oravecz-Wilson, K; Li, L; Sun, YP; Byun, J; Maeda, Y; Wicha, MS; Saunders, T; Rehemtulla, A; Lyssiotis, CA; Pennarthur, S; Reddy, P				Fujiwara, Hideaki; Seike, Keisuke; Brooks, Michael D.; Mathew, Anna, V; Kovalenko, Ilya; Pal, Anupama; Lee, Ho-Joon; Peltier, Daniel; Kim, Stephanie; Liu, Chen; Oravecz-Wilson, Katherine; Li, Lu; Sun, Yaping; Byun, Jaeman; Maeda, Yoshinobu; Wicha, Max S.; Saunders, Tom; Rehemtulla, Alnawaz; Lyssiotis, Costas A.; Pennarthur, Subramanian; Reddy, Pavan			Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology	NATURE IMMUNOLOGY			English	Article							VERSUS-HOST-DISEASE; ENERGY-METABOLISM; DENDRITIC CELL; SUCCINATE; MICROBIOME; APOPTOSIS; SUPPORTS; SUBUNIT; DAMAGE; STRESS	Intestinal epithelial cell (IEC) damage by T cells contributes to alloimmune, autoimmune and iatrogenic diseases such as graft-versus-host and inflammatory bowel disease. Here the authors identify a critical role for the alteration of the IEC-specific mitochondrial complex II component succinate dehydrogenase A in the regulation of the severity of T cell-mediated intestinal diseases. Intestinal epithelial cell (IEC) damage by T cells contributes to graft-versus-host disease, inflammatory bowel disease and immune checkpoint blockade-mediated colitis. But little is known about the target cell-intrinsic features that affect disease severity. Here we identified disruption of oxidative phosphorylation and an increase in succinate levels in the IECs from several distinct in vivo models of T cell-mediated colitis. Metabolic flux studies, complemented by imaging and protein analyses, identified disruption of IEC-intrinsic succinate dehydrogenase A (SDHA), a component of mitochondrial complex II, in causing these metabolic alterations. The relevance of IEC-intrinsic SDHA in mediating disease severity was confirmed by complementary chemical and genetic experimental approaches and validated in human clinical samples. These data identify a critical role for the alteration of the IEC-specific mitochondrial complex II component SDHA in the regulation of the severity of T cell-mediated intestinal diseases.	[Fujiwara, Hideaki; Seike, Keisuke; Brooks, Michael D.; Kim, Stephanie; Oravecz-Wilson, Katherine; Li, Lu; Sun, Yaping; Wicha, Max S.; Reddy, Pavan] Univ Michigan, Rogel Canc Ctr, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA; [Mathew, Anna, V; Byun, Jaeman; Pennarthur, Subramanian] Univ Michigan Hlth Syst, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA; [Kovalenko, Ilya; Lee, Ho-Joon; Lyssiotis, Costas A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Pal, Anupama; Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Peltier, Daniel] Univ Michigan Hlth Syst, Dept Pediat, Div Hematol Oncol & BMT, Ann Arbor, MI USA; [Liu, Chen] Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, New Brunswick, NJ USA; [Maeda, Yoshinobu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama, Japan; [Saunders, Tom] Univ Michigan, Sch Med, Transgen Anim Model Core, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center; Okayama University; University of Michigan System; University of Michigan	Reddy, P (corresponding author), Univ Michigan, Rogel Canc Ctr, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA.	reddypr@med.umich.edu		Pal, Anupama/0000-0003-0941-8123; Lee, Ho-Joon/0000-0003-3616-5387; Mathew, Anna/0000-0002-7043-4221; Li, Lu/0000-0002-5496-7837; Peltier, Daniel/0000-0001-6069-9894; Seike, Keisuke/0000-0002-3484-0265; Reddy, Pavan/0000-0001-7264-8429	US NIH [HL090775, CA173878, CA203542, HL149633, K08HL130944, DK081943, DK89503]; JSPS Postdoctoral Fellowships for Research Abroad; YASUDA Medical Foundation Grants for Research Abroad; JSPS KAKENHI [JP20K22901, JP21H02904]; Kawasaki Foundation of Medical Science and Medical Welfare; Ryobiteien Memorial Foundation; MSD Life Science Foundation Public Interest Incorporated Foundation; Okayama Medical Foundation; SENSHIN Medical Research Foundation; Kato Memorial Bioscience Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; NIH [CA46592]	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); YASUDA Medical Foundation Grants for Research Abroad; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kawasaki Foundation of Medical Science and Medical Welfare; Ryobiteien Memorial Foundation; MSD Life Science Foundation Public Interest Incorporated Foundation; Okayama Medical Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Kato Memorial Bioscience Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US NIH grants HL090775, CA173878, CA203542, HL149633 (to P.R.), K08HL130944 (to A.V.M.), DK081943 and DK89503 (to S.P.), JSPS Postdoctoral Fellowships for Research Abroad (to H.F.), The YASUDA Medical Foundation Grants for Research Abroad (to H.F.), JSPS KAKENHI grants JP20K22901 and JP21H02904 (to H.F.), The Kawasaki Foundation of Medical Science and Medical Welfare (to H.F.), The Ryobiteien Memorial Foundation (to H.F.), The MSD Life Science Foundation Public Interest Incorporated Foundation (to H.F.), The Okayama Medical Foundation (to H.F.), The SENSHIN Medical Research Foundation (to H.F.), The Kato Memorial Bioscience Foundation (to H.F.) and The NOVARTIS Foundation (Japan) for the Promotion of Science (to H.F.). We acknowledge use of the Microscopy & Image-analysis Laboratory (MIL) of the University of Michigan's Biomedical Research Core Facilities for the preparation of samples and images. Support for the MIL core is provided by the University of Michigan Rogel Cancer Center (NIH grant CA46592).	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dotiwala F, 2017, CELL, V171, P1125, DOI 10.1016/j.cell.2017.10.004; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fan YY, 2015, AM J PHYSIOL-GASTR L, V309, pG1, DOI 10.1152/ajpgi.00052.2015; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Hill GR, 1998, J CLIN INVEST, V102, P115, DOI 10.1172/JCI3132; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Ishizawa J, 2019, CANCER CELL, V35, P721, DOI 10.1016/j.ccell.2019.03.014; Jacquemin G, 2015, CELL DEATH DIFFER, V22, P862, DOI 10.1038/cdd.2014.180; Kuo CY, 2015, MITOCHONDRION, V23, P7, DOI 10.1016/j.mito.2015.04.004; Lemarie A, 2011, CELL DEATH DIFFER, V18, P338, DOI 10.1038/cdd.2010.93; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Lu YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11895-2; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mathew AV, 2015, J CARD FAIL, V21, P963, DOI 10.1016/j.cardfail.2015.10.003; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Na U, 2014, CELL METAB, V20, P253, DOI 10.1016/j.cmet.2014.05.014; Neurath MF, 2019, NAT IMMUNOL, V20, P970, DOI 10.1038/s41590-019-0415-0; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Perez-Ruiz E, 2019, NATURE, V569, P428, DOI 10.1038/s41586-019-1162-y; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Walch M, 2015, CELL, V161, P1229, DOI 10.1016/j.cell.2015.05.021; Wang F, 2018, P NATL ACAD SCI USA, V115, P157, DOI 10.1073/pnas.1712901115; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wu SR, 2017, BLOOD, V129, P1747, DOI 10.1182/blood-2016-09-740431; Zeiser R, 2017, NEW ENGL J MED, V377, P2167, DOI 10.1056/NEJMra1609337; Zhang ZB, 2020, NATURE, V579, P415, DOI 10.1038/s41586-020-2071-9	44	6	6	3	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1440	+		10.1038/s41590-021-01048-3	http://dx.doi.org/10.1038/s41590-021-01048-3		OCT 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34686860	Green Submitted, Green Accepted			2022-12-18	WOS:000710077900003
J	Stehle, C; Ruckert, T; Fiancette, R; Gajdasik, DW; Willis, C; Ulbricht, C; Durek, P; Mashreghi, MF; Finke, D; Hauser, AE; Withers, DR; Chang, HD; Zimmermann, J; Romagnani, C				Stehle, Christina; Rueckert, Timo; Fiancette, Remi; Gajdasik, Dominika W.; Willis, Claire; Ulbricht, Carolin; Durek, Pawel; Mashreghi, Mir-Farzin; Finke, Daniela; Hauser, Anja Erika; Withers, David R.; Chang, Hyun-Dong; Zimmermann, Jakob; Romagnani, Chiara			T-bet and ROR alpha control lymph node formation by regulating embryonic innate lymphoid cell differentiation	NATURE IMMUNOLOGY			English	Article							ORPHAN NUCLEAR RECEPTORS; GAMMA-T; LINEAGE; FETAL; PROGENITOR; NFIL3; REQUIREMENT; LYMPHOCYTES; ACTIVATION; EXPRESSION	Romagnani and colleagues discover an unexpected role for T-bet and ROR alpha during embryonic ILC function and highlight that ROR gamma t is crucial in counteracting the suppressive effects of T-bet. The generation of lymphoid tissues during embryogenesis relies on group 3 innate lymphoid cells (ILC3) displaying lymphoid tissue inducer (LTi) activity and expressing the master transcription factor ROR gamma t. Accordingly, ROR gamma t-deficient mice lack ILC3 and lymphoid structures, including lymph nodes (LN). Whereas T-bet affects differentiation and functions of ILC3 postnatally, the role of T-bet in regulating fetal ILC3 and LN formation remains completely unknown. Using multiple mouse models and single-cell analyses of fetal ILCs and ILC progenitors (ILCP), here we identify a key role for T-bet during embryogenesis and show that its deficiency rescues LN formation in ROR gamma t-deficient mice. Mechanistically, T-bet deletion skews the differentiation fate of fetal ILCs and promotes the accumulation of PLZF(hi) ILCP expressing central LTi molecules in a ROR alpha-dependent fashion. Our data unveil an unexpected role for T-bet and ROR alpha during embryonic ILC function and highlight that ROR gamma t is crucial in counteracting the suppressive effects of T-bet.	[Stehle, Christina; Rueckert, Timo; Romagnani, Chiara] German Rheumatism Res, Leibniz Inst, Innate Immun, Berlin, Germany; [Fiancette, Remi; Gajdasik, Dominika W.; Willis, Claire; Withers, David R.] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Ulbricht, Carolin; Hauser, Anja Erika] German Rheumatism Res Ctr, Leibniz Inst, Immune Dynam, Berlin, Germany; [Ulbricht, Carolin; Hauser, Anja Erika; Romagnani, Chiara] Charite Univ Med Berlin, Berlin, Germany; [Ulbricht, Carolin; Hauser, Anja Erika; Romagnani, Chiara] Free Univ Berlin, Berlin, Germany; [Ulbricht, Carolin; Hauser, Anja Erika] Humboldt Univ, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Durek, Pawel] German Rheumatism Res Ctr, Leibniz Inst, Cell Biol, Berlin, Germany; [Mashreghi, Mir-Farzin] German Rheumatism Res Ctr, Leibniz Inst, Therapeut Gene Regulat, Berlin, Germany; [Mashreghi, Mir-Farzin] Charite Univ Med Berlin, Berlin Inst Hlth BIH, BIH Ctr Regenerat Therapies BCRT, Berlin, Germany; [Finke, Daniela] Univ Basel, Dept Biomed, Basel, Switzerland; [Finke, Daniela] Univ Basel, Univ Childrens Hosp Basel, Basel, Switzerland; [Chang, Hyun-Dong] German Rheumatism Res Ctr, Schwiete Lab Microbiota & Inflammat, Leibniz Inst, Berlin, Germany; [Chang, Hyun-Dong] Tech Univ Berlin, Inst Biotechnol, Dept Cytometry, Berlin, Germany; [Zimmermann, Jakob] Univ Bern, Maurice Muller Labs, Univ Klin Viszerale Chirurg & Med, Inselspital, Bern, Switzerland; [Romagnani, Chiara] Humboldt Univ, Dept Gastroenterol, Infect Dis, Rheumatol, Berlin, Germany; [Romagnani, Chiara] Leibniz Sci Campus Chron Inflammat, Berlin, Germany	University of Birmingham; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Deutsches Rheuma-Forschungszentrum (DRFZ); Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; University of Basel; Deutsches Rheuma-Forschungszentrum (DRFZ); Technical University of Berlin; University of Bern; University Hospital of Bern; Humboldt University of Berlin	Romagnani, C (corresponding author), German Rheumatism Res, Leibniz Inst, Innate Immun, Berlin, Germany.; Romagnani, C (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Romagnani, C (corresponding author), Free Univ Berlin, Berlin, Germany.; Romagnani, C (corresponding author), Humboldt Univ, Dept Gastroenterol, Infect Dis, Rheumatol, Berlin, Germany.; Romagnani, C (corresponding author), Leibniz Sci Campus Chron Inflammat, Berlin, Germany.	romagnani@drfz.de	Zimmermann, Jakob/U-4766-2017; Withers, David/C-7055-2015	Zimmermann, Jakob/0000-0002-6302-6844; Withers, David/0000-0003-3757-7594; Hauser, Anja Erika/0000-0002-7725-9526; Ulbricht, Carolin/0000-0003-2983-6242; Mashreghi, Mir-Farzin/0000-0002-8015-6907; Finke, Daniela/0000-0003-4453-5958; Ruckert, Timo/0000-0003-1433-1372; Stehle, Christina/0000-0001-5016-0588				Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bando Jennifer K, 2015, Nat Immunol, V16, P153, DOI 10.1038/ni.3057; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Castro G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181868; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2007, TRENDS IMMUNOL, V28, P423, DOI 10.1016/j.it.2007.07.009; Fiancette R, 2021, NAT IMMUNOL, V22, P1245, DOI 10.1038/s41590-021-01024-x; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Ghaedi M, 2016, CELL REP, V15, P471, DOI 10.1016/j.celrep.2016.03.039; Guo YX, 2016, CELL REP, V17, P3206, DOI 10.1016/j.celrep.2016.11.073; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Haddad R, 2013, NAT NEUROSCI, V16, P949, DOI 10.1038/nn.3407; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; He YW, 2000, J IMMUNOL, V164, P5668, DOI 10.4049/jimmunol.164.11.5668; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hernandez PP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau5265; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lee Y, 2006, IMMUNITY, V25, P499, DOI 10.1016/j.immuni.2006.06.016; Lehmann FM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15612-2; Lun Aaron T L, 2016, F1000Res, V5, P2122; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Paclik D, 2015, EUR J IMMUNOL, V45, P2766, DOI 10.1002/eji.201545635; Philipp A., 2020, THEISLAB ANNDATA2RI, DOI 10.5281/ZENODO.3992373; Pokrovskii M, 2019, IMMUNITY, V51, P185, DOI 10.1016/j.immuni.2019.06.001; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14601; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roelli P., 2019, HOOHM CITE SEQ COUNT; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Simic M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108004; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sundrud MS, 2008, IMMUNITY, V28, P5, DOI 10.1016/j.immuni.2007.12.006; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; ZHENG GX, 2017, NATURE, V0008; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	77	6	6	4	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1231	+		10.1038/s41590-021-01029-6	http://dx.doi.org/10.1038/s41590-021-01029-6		SEP 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556887	Green Submitted			2022-12-18	WOS:000751833700013
J	Mukhtar, MM; Khogali, M				Mukhtar, Maowia M.; Khogali, Mustafa			The accelerating COVID-19 epidemic in Sudan	NATURE IMMUNOLOGY			English	Editorial Material								Mukhtar and Khogali discuss the many challenges Sudan has faced in coping with the COVID-19 pandemic.	[Mukhtar, Maowia M.] Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; [Mukhtar, Maowia M.] Ibn Sina Univ, Biosci Res Inst, TIBA Sudan Project, Khartoum, Sudan; [Khogali, Mustafa] Ahfad Univ Women, Sch Med, Omdurman, Sudan	University of Khartoum	Mukhtar, MM (corresponding author), Univ Khartoum, Inst Endem Dis, Khartoum, Sudan.; Mukhtar, MM (corresponding author), Ibn Sina Univ, Biosci Res Inst, TIBA Sudan Project, Khartoum, Sudan.	mmukhtar@tropmedicine.org		Mukhtar, Maowia/0000-0003-2183-5915					0	6	6	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					797	798		10.1038/s41590-021-00950-0	http://dx.doi.org/10.1038/s41590-021-00950-0		MAY 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34035525	Bronze			2022-12-18	WOS:000654102600001
J	Cheung, P; Schaffert, S; Chang, SE; Dvorak, M; Donato, M; Macaubas, C; Foecke, MH; Li, TM; Zhang, LC; Coan, JP; Schulert, GS; Grom, AA; Henderson, LA; Nigrovic, PA; Elias, JE; Gozani, O; Mellins, ED; Khatri, P; Utz, PJ; Kuo, AJ				Cheung, Peggie; Schaffert, Steven; Chang, Sarah E.; Dvorak, Mai; Donato, Michele; Macaubas, Claudia; Foecke, Mariko H.; Li, Tie-Mei; Zhang, Lichao; Coan, John P.; Schulert, Grant S.; Grom, Alexei A.; Henderson, Lauren A.; Nigrovic, Peter A.; Elias, Joshua E.; Gozani, Or; Mellins, Elizabeth D.; Khatri, Purvesh; Utz, Paul J.; Kuo, Alex J.			Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation	NATURE IMMUNOLOGY			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; SERINE PROTEASES; CATHEPSIN-G; FERRITIN; RECEPTOR; POLARIZATION; REQUIRES; ELASTASE; TRIALS; GENES	Chromatin undergoes extensive reprogramming during immune cell differentiation. Here Kuo and colleagues uncover an epigenetic mechanism that primes the chromatin to facilitate macrophage development. Chromatin undergoes extensive reprogramming during immune cell differentiation. Here we report the repression of controlled histone H3 amino terminus proteolytic cleavage (H3 Delta N) during monocyte-to-macrophage development. This abundant histone mark in human peripheral blood monocytes is catalyzed by neutrophil serine proteases (NSPs) cathepsin G, neutrophil elastase and proteinase 3. NSPs are repressed as monocytes mature into macrophages. Integrative epigenomic analysis reveals widespread H3 Delta N distribution across the genome in a monocytic cell line and primary monocytes, which becomes largely undetectable in fully differentiated macrophages. H3 Delta N is enriched at permissive chromatin and actively transcribed genes. Simultaneous NSP depletion in monocytic cells results in H3 Delta N loss and further increase in chromatin accessibility, which likely primes the chromatin for gene expression reprogramming. Importantly, H3 Delta N is reduced in monocytes from patients with systemic juvenile idiopathic arthritis, an autoinflammatory disease with prominent macrophage involvement. Overall, we uncover an epigenetic mechanism that primes the chromatin to facilitate macrophage development.	[Cheung, Peggie; Schaffert, Steven; Chang, Sarah E.; Dvorak, Mai; Donato, Michele; Foecke, Mariko H.; Khatri, Purvesh; Utz, Paul J.; Kuo, Alex J.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Cheung, Peggie; Chang, Sarah E.; Dvorak, Mai; Foecke, Mariko H.; Utz, Paul J.; Kuo, Alex J.] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Dept Med, Stanford, CA 94305 USA; [Schaffert, Steven; Donato, Michele; Khatri, Purvesh] Stanford Univ, Dept Med, Sch Med, Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Macaubas, Claudia; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Li, Tie-Mei; Coan, John P.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Zhang, Lichao; Elias, Joshua E.] Chan Zuckerberg Biohub, Stanford, CA USA; [Schulert, Grant S.; Grom, Alexei A.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA; [Schulert, Grant S.; Grom, Alexei A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Henderson, Lauren A.; Nigrovic, Peter A.] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Harvard University; Boston Children's Hospital; Harvard Medical School	Khatri, P; Utz, PJ; Kuo, AJ (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Utz, PJ; Kuo, AJ (corresponding author), Stanford Univ, Sch Med, Div Immunol & Rheumatol, Dept Med, Stanford, CA 94305 USA.; Khatri, P (corresponding author), Stanford Univ, Dept Med, Sch Med, Ctr Biomed Informat Res, Stanford, CA 94305 USA.; Mellins, ED (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Program Immunol, Stanford, CA 94305 USA.	mellins@stanford.edu; pkhatri@stanford.edu; pjutz@stanford.edu; alexjkuo0229@gmail.com		Macaubas, Claudia/0000-0002-5472-8086; Donato, Michele/0000-0002-9968-6027; Schaffert, Steven/0000-0001-8842-0218; Foecke, Mariko/0000-0002-9205-940X; Khatri, Purvesh/0000-0002-4143-4708; Mellins, Elizabeth/0000-0003-2577-139X	Donald E. and Delia B. Baxter Foundation; Henry Gustav Floren Trust; Bill & Melinda Gates Foundation [OPP1113682]; EMD Serono; Department of Defense [W81XWH-18-1-0253, W81XWH1910235]; Ralph & Marian Falk Medical Research Trust; sJIA Foundation; Lucile Packard Foundation for Children's Health; Fundacion Bechara; Arbuckle Family Foundation for Arthritis Research; Cincinnati Children's Research Foundation ARC Grant; NIH [U19 AI110491, R01 AI125197, U19 AI109662, U19 AI057229, R01 AR061297, R35 GM139569, P30 AR070253, R01 AR073201, K08 AR073339, R01 AR059049, P30 AR070549, K08 AR072075]	Donald E. and Delia B. Baxter Foundation; Henry Gustav Floren Trust; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); EMD Serono; Department of Defense(United States Department of Defense); Ralph & Marian Falk Medical Research Trust; sJIA Foundation; Lucile Packard Foundation for Children's Health; Fundacion Bechara; Arbuckle Family Foundation for Arthritis Research; Cincinnati Children's Research Foundation ARC Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank our colleagues at the Oklahoma Medical Research Foundation for helpful discussion. We also thank B. Nahal and the Division of Pediatric Rheumatology at the University of California San Francisco, led by E. von Scheven, for collection of several serum samples and associated clinical data. This work was supported in part by the Donald E. and Delia B. Baxter Foundation (to P.J.U.), Elizabeth F. Adler (to P.J.U.), the Henry Gustav Floren Trust (to P.J.U.), the Bill & Melinda Gates Foundation (grant no. OPP1113682 to P.J.U. and P.K.), EMD Serono (to P.J.U. and P.K.), the Department of Defense contracts no. W81XWH-18-1-0253 and no. W81XWH1910235 (to P.K.), the Ralph & Marian Falk Medical Research Trust (to P.K.), the sJIA Foundation (to E.D.M. and G.S.S.), the Lucile Packard Foundation for Children's Health (to E.D.M.), the Fundacion Bechara (to P.A.N.), the Arbuckle Family Foundation for Arthritis Research (to P.A.N.), Cincinnati Children's Research Foundation ARC Grant (to G.S.S. and A.A.G.) and the NIH grants no. U19 AI110491 (Autoimmunity Center of Excellence) (to P.J.U.), no. R01 AI125197 (to P.K. and P.J.U.), no. U19 AI109662 (to P.K.), no. U19 AI057229 (to P.K.), no. R01 AR061297 (to E.D.M.), no. R35 GM139569 (to O.G.), no. P30 AR070253 (to P.A.N.), no. R01 AR073201 (to P.A.N.), no. K08 AR073339 (to L.A.H.), no. R01 AR059049 (to A.A.G.), no. P30 AR070549 (to G.S.S. and A.A.G.) and no. K08 AR072075 (to G.S.S.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Cheung P, 2019, NAT REV RHEUMATOL, V15, P340, DOI 10.1038/s41584-019-0220-z; Cheung P, 2018, CLIN IMMUNOL, V196, P40, DOI 10.1016/j.clim.2018.06.009; Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; Dhaenens M, 2015, BIOESSAYS, V37, P70, DOI 10.1002/bies.201400118; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Grom AA, 2010, CURR OPIN RHEUMATOL, V22, P561, DOI 10.1097/01.bor.0000381996.69261.71; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Haney MS, 2018, NAT GENET, V50, P1716, DOI 10.1038/s41588-018-0254-1; Herrmann C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2175; HOLNESS CL, 1993, BLOOD, V81, P1607; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwasaki W, 2013, FEBS OPEN BIO, V3, P363, DOI 10.1016/j.fob.2013.08.007; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Khalkhali-Ellis Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103230; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim K, 2016, GENE DEV, V30, P208, DOI 10.1101/gad.268714.115; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lennartsson A, 2005, GENE, V356, P193, DOI 10.1016/j.gene.2005.05.004; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254; Ravelli A, 2016, ANN RHEUM DIS, V75, P481, DOI 10.1136/annrheumdis-2015-208982; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schulert GS, 2018, ARTHRIT CARE RES, V70, P409, DOI 10.1002/acr.23277; Schulz D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38127-9; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Waskom M., 2018, MWASKOM SEABORN V 0, DOI [10.5281/zenodo1313201, DOI 10.5281/ZEN0D01313201]; WILCOX D, 1992, BIOCHEM J, V285, P495, DOI 10.1042/bj2850495; Xie J, 2017, TRENDS CELL BIOL, V27, P527, DOI 10.1016/j.tcb.2017.02.001; Xue Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090496; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	64	6	6	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					711	+		10.1038/s41590-021-00928-y	http://dx.doi.org/10.1038/s41590-021-00928-y		MAY 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34017121	Green Accepted			2022-12-18	WOS:000652579200004
J	Kaufmann, KB; Zeng, AGX; Coyaud, E; Garcia-Prat, L; Papalexi, E; Murison, A; Laurent, EMN; Chan-Seng-Yue, M; Gan, OI; Pan, K; McLeod, J; Boutzen, H; Zandi, S; Takayanagi, SI; Satija, R; Raught, B; Xie, SZ; Dick, JE				Kaufmann, Kerstin B.; Zeng, Andy G. X.; Coyaud, Etienne; Garcia-Prat, Laura; Papalexi, Efthymia; Murison, Alex; Laurent, Estelle M. N.; Chan-Seng-Yue, Michelle; Gan, Olga I.; Pan, Kristele; McLeod, Jessica; Boutzen, Helena; Zandi, Sasan; Takayanagi, Shin-ichiro; Satija, Rahul; Raught, Brian; Xie, Stephanie Z.; Dick, John E.			A latent subset of human hematopoietic stem cells resists regenerative stress to preserve stemness	NATURE IMMUNOLOGY			English	Article							DNA-DAMAGE; QUIESCENCE; ACETYLATION; SIRT1; TRANSITION; CHROMATIN; REVEALS; EXIT; MOF	Continuous supply of immune cells throughout life relies on the delicate balance in the hematopoietic stem cell (HSC) pool between long-term maintenance and meeting the demands of both normal blood production and unexpected stress conditions. Here we identified distinct subsets of human long-term (LT)-HSCs that responded differently to regeneration-mediated stress: an immune checkpoint ligand CD112(lo) subset that exhibited a transient engraftment restraint (termed latency) before contributing to hematopoietic reconstitution and a primed CD112(hi) subset that responded rapidly. This functional heterogeneity and CD112 expression are regulated by INKA1 through direct interaction with PAK4 and SIRT1, inducing epigenetic changes and defining an alternative state of LT-HSC quiescence that serves to preserve self-renewal and regenerative capacity upon regeneration-mediated stress. Collectively, our data uncovered the molecular intricacies underlying HSC heterogeneity and self-renewal regulation and point to latency as an orchestrated physiological response that balances blood cell demands with preserving a stem cell reservoir. Dick and colleagues identify human LT-HSC subsets with distinct quiescent states. They link these differences to INKA1-mediated downregulation of the transmembrane protein CD112 and its interaction with the protein deacetylase SIRT1. INKA1 is inversely correlated with the histone H4K16Ac mark, which then distinguishes 'latent' CD112(lo) LT-HSCs from CD112(hi) LT-HSCs that are more readily activated in response to hematopoietic stress.	[Kaufmann, Kerstin B.; Zeng, Andy G. X.; Coyaud, Etienne; Garcia-Prat, Laura; Murison, Alex; Laurent, Estelle M. N.; Chan-Seng-Yue, Michelle; Gan, Olga I.; Pan, Kristele; McLeod, Jessica; Boutzen, Helena; Zandi, Sasan; Takayanagi, Shin-ichiro; Raught, Brian; Xie, Stephanie Z.; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Zeng, Andy G. X.; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Papalexi, Efthymia; Satija, Rahul] New York Genome Ctr, New York, NY USA; [Papalexi, Efthymia; Satija, Rahul] NYU, Ctr Genom & Syst Biol, New York, NY USA; [Chan-Seng-Yue, Michelle] Ontario Inst Canc Res, PanCuRx Translat Res Initiat, Toronto, ON, Canada; [Zandi, Sasan] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Takayanagi, Shin-ichiro] Kirin Holdings, R&D Div, Cell Therapy Project, Tokyo, Japan; [Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; New York University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Kirin Holdings Co Ltd; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Dick, JE (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	john.dick@uhnresearch.ca	Laurent, Estelle/AFV-5442-2022	COYAUD, Etienne/0000-0002-5893-4557; Kaufmann, Kerstin B./0000-0001-5013-6123; Xie, Stephanie/0000-0002-0284-494X	Deutsche Forschungsgemeinschaft; University of Toronto's Medicine by Design initiative from the Canada First Research Excellence Fund; Princess Margaret Cancer Centre Foundation; Canadian Institutes of Health Research [154293, 89932]; International Development Research Centre, Canadian Cancer Society [703212]; Terry Fox Research Institute Program; Ontario Institute for Cancer Research by the Government of Ontario, a Canada Research Chair; Ontario Ministry of Health and Long Term Care	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Toronto's Medicine by Design initiative from the Canada First Research Excellence Fund; Princess Margaret Cancer Centre Foundation(University of Toronto); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); International Development Research Centre, Canadian Cancer Society; Terry Fox Research Institute Program; Ontario Institute for Cancer Research by the Government of Ontario, a Canada Research Chair; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	We thank the obstetrics units of Trillium Health and William Osler Health Partners for CB, the UHN-SickKids Flow cytometry facility for cell sorting, and M. Minden and the Leukemia Tissue Bank at Princess Margaret Cancer Centre/UHN for providing primary mPB samples. We thank E. Laurenti and all members of the laboratory of J.E.D., in particular J. C. Y. Wang, for critical feedback. This research was supported by the Deutsche Forschungsgemeinschaft (K.B.K.) and is part of the University of Toronto's Medicine by Design initiative, which receives funding from the Canada First Research Excellence Fund. Work in the laboratory of J.E.D. is supported by funds from the Princess Margaret Cancer Centre Foundation, the Canadian Institutes of Health Research (Foundation no. 154293 (to J.E.D), operating grant nos. 154293 and 89932 (to J.E.D), International Development Research Centre, Canadian Cancer Society (grant no. 703212 (to J.E.D)), Terry Fox Research Institute Program Project grant, Ontario Institute for Cancer Research through funding provided by the Government of Ontario, a Canada Research Chair and the Ontario Ministry of Health and Long Term Care.	Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Andrews LP, 2019, NAT IMMUNOL, V20, P1425, DOI 10.1038/s41590-019-0512-0; Baskaran Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9681; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Belderbos ME, 2020, BIOL BLOOD MARROW TR, V26, P16, DOI 10.1016/j.bbmt.2019.08.026; Bernitz JM, 2016, CELL, V167, P1296, DOI 10.1016/j.cell.2016.10.022; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Cluntun AA, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0135-3; Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800; Dart AE, 2013, EUR J CELL BIOL, V92, P129, DOI 10.1016/j.ejcb.2013.03.002; Eraslan G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07931-2; Fares I, 2017, BLOOD, V129, P3344, DOI 10.1182/blood-2016-11-750729; Grigoryan A, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1557-3; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hay SB, 2018, EXP HEMATOL, V68, P51, DOI 10.1016/j.exphem.2018.09.004; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Hussein AM, 2020, DEV CELL, V52, P236, DOI 10.1016/j.devcel.2019.12.018; ITOH K, 1989, EXP HEMATOL, V17, P145; Kalia V, 2015, IMMUNITY, V42, P1116, DOI 10.1016/j.immuni.2015.05.023; Kaufmann KB, 2019, BLOOD, V133, P2198, DOI 10.1182/blood-2018-10-881441; Klose M, 2019, STEM CELLS, V37, P948, DOI 10.1002/stem.3005; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Khoa LTP, 2020, CELL STEM CELL, V27, P441, DOI 10.1016/j.stem.2020.06.005; Luo T, 2007, DEVELOPMENT, V134, P1279, DOI 10.1242/dev.02813; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Muller Ludmila, 2019, Subcell Biochem, V91, P21, DOI 10.1007/978-981-13-3681-2_2; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Reddy PNG, 2016, BLOOD, V127, P1967, DOI 10.1182/blood-2016-01-693572; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Rodriguez-Fraticelli AE, 2020, NATURE, V583, P585, DOI 10.1038/s41586-020-2503-6; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scala S, 2018, NAT MED, V24, P1683, DOI 10.1038/s41591-018-0195-3; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sullivan BA, 2010, METHODS MOL BIOL, V659, P99, DOI 10.1007/978-1-60761-789-1_7; Takayama N, 2021, CELL STEM CELL, V28, P488, DOI 10.1016/j.stem.2020.11.001; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wang Y, 2016, IMMUNITY, V44, P1337, DOI 10.1016/j.immuni.2016.05.009; Wooten M, 2020, NAT PROTOC, V15, P1188, DOI 10.1038/s41596-019-0283-y; Xie SZ, 2019, CELL STEM CELL, V25, P639, DOI 10.1016/j.stem.2019.09.008; Yamamoto R, 2018, CELL STEM CELL, V22, P600, DOI 10.1016/j.stem.2018.03.013; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104	53	6	6	3	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					723	+		10.1038/s41590-021-00925-1	http://dx.doi.org/10.1038/s41590-021-00925-1		MAY 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	33958784				2022-12-18	WOS:000648056600001
J	Bonaguro, L; Kohne, M; Schmidleithner, L; Schulte-Schrepping, J; Warnat-Herresthal, S; Horne, A; Kern, P; Gunther, P; ter Horst, R; Jaeger, M; Rahmouni, S; Georges, M; Falk, CS; Li, Y; Mass, E; Beyer, M; Joosten, LAB; Netea, MG; Ulas, T; Schultze, JL; Aschenbrenner, AC				Bonaguro, Lorenzo; Koehne, Maren; Schmidleithner, Lisa; Schulte-Schrepping, Jonas; Warnat-Herresthal, Stefanie; Horne, Arik; Kern, Paul; Guenther, Patrick; ter Horst, Rob; Jaeger, Martin; Rahmouni, Souad; Georges, Michel; Falk, Christine S.; Li, Yang; Mass, Elvira; Beyer, Marc; Joosten, Leo A. B.; Netea, Mihai G.; Ulas, Thomas; Schultze, Joachim L.; Aschenbrenner, Anna C.			CRELD1 modulates homeostasis of the immune system in mice and humans	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; BETA-CATENIN; STEM-CELLS; ACTIVATION; HEMATOPOIESIS	CRELD1 is a pivotal factor for heart development, the function of which is unknown in adult life. We here provide evidence that CRELD1 is an important gatekeeper of immune system homeostasis. Exploiting expression variance in large human cohorts contrasting individuals with the lowest and highest CRELD1 expression levels revealed strong phenotypic, functional and transcriptional differences, including reduced CD4(+) T cell numbers. These findings were validated in T cell-specific Creld1-deficient mice. Loss of Creld1 was associated with simultaneous overactivation and increased apoptosis, resulting in a net loss of T cells with age. Creld1 was transcriptionally and functionally linked to Wnt signaling. Collectively, gene expression variance in large human cohorts combined with murine genetic models, transcriptomics and functional testing defines CRELD1 as an important modulator of immune homeostasis. Within a human cohort, wide variation can occur with constitutively expressed proteins. Aschenbrenner and colleagues found that individuals with lower CRELD1 expression have decreased frequencies of naive CD4(+) T cells. Mice with conditional Creld1 deficiency also exhibit a phenotype associated with immunological aging.	[Bonaguro, Lorenzo; Koehne, Maren; Schmidleithner, Lisa; Schulte-Schrepping, Jonas; Warnat-Herresthal, Stefanie; Horne, Arik; Guenther, Patrick; Beyer, Marc; Ulas, Thomas; Schultze, Joachim L.; Aschenbrenner, Anna C.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, Bonn, Germany; [Bonaguro, Lorenzo; Kern, Paul] Univ Bonn, Life & Med Sci LIMES Inst, Dev Genet & Mol Physiol, Bonn, Germany; [Koehne, Maren; Schmidleithner, Lisa; Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, Bonn, Germany; [Kern, Paul; Mass, Elvira] Univ Bonn, Life & Med Sci LIMES Inst, Dev Biol Innate Immune Syst, Bonn, Germany; [ter Horst, Rob; Jaeger, Martin; Li, Yang; Joosten, Leo A. B.; Netea, Mihai G.; Aschenbrenner, Anna C.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [ter Horst, Rob; Jaeger, Martin; Li, Yang; Joosten, Leo A. B.; Netea, Mihai G.; Aschenbrenner, Anna C.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands; [Rahmouni, Souad; Georges, Michel] Univ Liege, Unit Anim Genom, GIGA Inst, Liege, Belgium; [Falk, Christine S.] Hannover Med Sch, Inst Transplant Immunol, Hannover, Germany; [Li, Yang] Helmholtz Ctr Infect Res HZI & Hannover Med Sch M, Ctr Individualised Infect Med CiiM & TWINCORE, Dept Computat Biol Individualised Infect Med, Hannover, Germany; [Netea, Mihai G.] Univ Bonn, Immunol & Metab Life & Med Sci Inst LIMES, Bonn, Germany; [Ulas, Thomas; Schultze, Joachim L.] DZNE, PRECISE Platform Single Cell Genom & Epigen, German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Bonn, Germany	University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Radboud University Nijmegen; Radboud University Nijmegen; University of Liege; Hannover Medical School; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Aschenbrenner, AC (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, Bonn, Germany.; Aschenbrenner, AC (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Aschenbrenner, AC (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, Nijmegen, Netherlands.	a.aschenbrenner@uni-bonn.de	Joosten, Leo AB/H-3138-2015; Mass, Elvira/AAH-3805-2019; Schultze, Joachim L./ABA-8176-2020; Li, Yang/HGT-8446-2022; Falk, Christine/Q-4143-2016	Joosten, Leo AB/0000-0001-6166-9830; Mass, Elvira/0000-0003-2318-2356; Schultze, Joachim L./0000-0003-2812-9853; Li, Yang/0000-0003-4022-7341; Bonaguro, Lorenzo/0000-0001-9675-7208; Aschenbrenner, Anna/0000-0002-9429-5457; Georges, Michel/0000-0003-4124-2375; Jaeger, Martin/0000-0001-6994-493X; Falk, Christine/0000-0003-1376-7318; Kern, Paul/0000-0002-1722-9974; Gunther, Patrick/0000-0002-9135-7819; ter Horst, Rob/0000-0003-0576-5873	Department of Genomics & Immunoregulation at the LIMES Institute; German Research Foundation (DFG) [EXC2151-390873048, SCHU 950/8-1, GRK 2168, TP11, SFB704]; BMBF; EU [733100]; Spinoza grant of the Netherlands Organization for Scientific Research; ERC [833247]; DFG [EXC2151-390873048, SFB738/TP3]; Benz Foundation; Fritz Thyssen Foundation; Daimler; University of Liege (ARC); University of Liege (Fonds Speciaux); Fonds de la Recherche Scientifique de Belgique (F.R.S.-FNRS) [EOS 30770923]	Department of Genomics & Immunoregulation at the LIMES Institute; German Research Foundation (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Spinoza grant of the Netherlands Organization for Scientific Research; ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Benz Foundation; Fritz Thyssen Foundation; Daimler; University of Liege (ARC); University of Liege (Fonds Speciaux)(University of Liege); Fonds de la Recherche Scientifique de Belgique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS)	We thank K. Handler, M. Kraut, H. Theis and M. Thielisch for technical assistance and K. Bassler, F. Gondorf, S. Burgdorf and M. Embgenbroich for technical advice. Furthermore, we acknowledge the assistance of the Flow Cytometry Core Facility at the Institute of Experimental Immunology, University of Bonn. We thank M. Hoch for his continuous support of our work; P. Rosenstiel, F. Berberich-Siebelt, M. Vath, D. Cantrell, D. Littmann and L. Fulle for helpful discussion of our work; and M. Davis, S. Turner, L. Klein, J. Bluestone and J. Riley for critically reading our manuscript. A.C.A. was supported by an intramural grant from the Department of Genomics & Immunoregulation at the LIMES Institute. The work was supported by the German Research Foundation (DFG) to J.L.S. under Germany's Excellence Strategy (EXC2151-390873048) as well as under SCHU 950/8-1; GRK 2168, TP11; SFB704, the BMBF-funded excellence project Diet-BodyBrain (DietBB) and the EU project SYSCID under grant number 733100. M.G.N. was supported by a Spinoza grant of the Netherlands Organization for Scientific Research and an ERC Advanced Grant (833247). E.M. was supported by the DFG under Germany's Excellence Strategy EXC2151-390873048, the Daimler and Benz Foundation and the Fritz Thyssen Foundation. S.R. and M.G. are supported by the University of Liege (ARC and Fonds Speciaux) and Fonds de la Recherche Scientifique de Belgique (F.R.S.-FNRS) under grant number EOS 30770923. C.S.F. was supported by the DFG (SFB738/TP3).	Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Aschenbrenner AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04370-9; Barnes PJ, 2017, ANNU REV PHYSIOL, V79, P517, DOI 10.1146/annurev-physiol-022516-034314; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Chae WJ, 2018, TRENDS IMMUNOL, V39, P830, DOI 10.1016/j.it.2018.08.006; De Jager PL, 2015, SEMIN IMMUNOL, V27, P51, DOI 10.1016/j.smim.2015.03.003; Driessens G, 2011, J IMMUNOL, V186, P784, DOI 10.4049/jimmunol.1001562; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Gullicksrud JA, 2017, J IMMUNOL, V199, P911, DOI 10.4049/jimmunol.1700595; Hamad A R, 2001, Int Rev Immunol, V20, P535, DOI 10.3109/08830180109045577; Henson SM, 2009, BLOOD, V113, P6619, DOI 10.1182/blood-2009-01-199588; Korotkevich G., 2019, BIORXIV, DOI 10.1101/060012v3; Leng SX, 2020, CELL IMMUNOL, V348, DOI 10.1016/j.cellimm.2019.104024; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Liston A, 2016, TRENDS IMMUNOL, V37, P637, DOI 10.1016/j.it.2016.08.002; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Ma J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024768; MacNee W, 2016, ANN AM THORAC SOC, V13, pS429, DOI 10.1513/AnnalsATS.201602-124AW; Mass E, 2014, DEV CELL, V28, P711, DOI 10.1016/j.devcel.2014.02.012; McQuate A, 2017, CELL REP, V21, P60, DOI 10.1016/j.celrep.2017.09.023; Momozawa Y, 2018, NAT COMMUN, V9; Netea MG, 2016, NAT MED, V22, P831, DOI 10.1038/nm.4140; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Redig JK, 2014, AIMS GENET, V1, P1, DOI 10.3934/genet.2014.1.1; Robinson SW, 2003, AM J HUM GENET, V72, P1047, DOI 10.1086/374319; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Scholz B, 2016, DEV CELL, V36, P79, DOI 10.1016/j.devcel.2015.12.015; Shi L, 2014, J IMMUNOL, V192, P649, DOI 10.4049/jimmunol.1302069; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Warnat-Herresthal S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100780; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.0000000000000011; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wright SC, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar5536; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570	56	6	6	7	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1517	+		10.1038/s41590-020-00811-2	http://dx.doi.org/10.1038/s41590-020-00811-2		NOV 2020	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33169013				2022-12-18	WOS:000587948700003
J	Chu, T; Berner, J; Zehn, D				Chu, Talyn; Berner, Jacqueline; Zehn, Dietmar			Two parallel worlds of memory T cells	NATURE IMMUNOLOGY			English	Editorial Material								In contrast with the classical dogma that the pathways generating either memory or 'exhausted' T cells are strictly segregated, data now identify a clonally distinct hybrid memory T cell subpopulation with an exhausted phenotype.	[Chu, Talyn; Berner, Jacqueline; Zehn, Dietmar] Tech Univ Munich TUM, TUM Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany	Technical University of Munich	Zehn, D (corresponding author), Tech Univ Munich TUM, TUM Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany.	dietmar.zehn@tum.de		Berner, Jacqueline/0000-0002-9056-8745; Zehn, Dietmar/0000-0003-1393-8527				Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Rendeiro Andre F, 2020, medRxiv, DOI 10.1101/2020.09.08.20189092; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sekine T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba7918; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x	15	6	6	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1484	1485		10.1038/s41590-020-00815-y	http://dx.doi.org/10.1038/s41590-020-00815-y		OCT 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33116302	Bronze			2022-12-18	WOS:000584926200001
J	Amann-Zalcenstein, D; Tian, LY; Schreuder, J; Tomei, S; Lin, DS; Fairfax, KA; Bolden, JE; McKenzie, MD; Jarratt, A; Hilton, A; Jackson, JT; Di Rago, L; McCormack, MP; de Graaf, CA; Stonehouse, O; Taoudi, S; Alexander, WS; Nutt, SL; Ritchie, ME; Ng, AP; Naik, SH				Amann-Zalcenstein, Daniela; Tian, Luyi; Schreuder, Jaring; Tomei, Sara; Lin, Dawn S.; Fairfax, Kirsten A.; Bolden, Jessica E.; McKenzie, Mark D.; Jarratt, Andrew; Hilton, Adrienne; Jackson, Jacob T.; Di Rago, Ladina; McCormack, Matthew P.; de Graaf, Carolyn A.; Stonehouse, Olivia; Taoudi, Samir; Alexander, Warren S.; Nutt, Stephen L.; Ritchie, Matthew E.; Ng, Ashley P.; Naik, Shalin H.			A new lymphoid-primed progenitor marked byDach1downregulation identified with single cell multi-omics	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; T-CELL; LINEAGE COMMITMENT; MULTIPOTENT PROGENITORS; C/EBP-ALPHA; RNA-SEQ; HETEROGENEITY; EXPRESSION; DACH1; MAP	Exploring transcriptional heterogeneity of cKit(+)Sca1(+)HSPCs using single cell RNA-sequencing, Naik and colleagues identify a population termed 'lymphoid primed progenitors' as the earliest stage of lymphoid lineage commitment, marked by downregulation of the stem/myeloid transcription factor Dach1. A classical view of blood cell development is that multipotent hematopoietic stem and progenitor cells (HSPCs) become lineage-restricted at defined stages. Lin(-)c-Kit(+)Sca-1(+)Flt3(+)cells, termed lymphoid-primed multipotent progenitors (LMPPs), have lost megakaryocyte and erythroid potential but are heterogeneous in their fate. Here, through single-cell RNA sequencing, we identify the expression ofDach1and associated genes in this fraction as being coexpressed with myeloid/stem genes but inversely correlated with lymphoid genes. Through generation ofDach1-GFP reporter mice, we identify a transcriptionally and functionally uniqueDach1-GFP(-)subpopulation within LMPPs with lymphoid potential with low to negligible classic myeloid potential. We term these 'lymphoid-primed progenitors' (LPPs). These findings define an early definitive branch point of lymphoid development in hematopoiesis and a means for prospective isolation of LPPs.	[Amann-Zalcenstein, Daniela; Tian, Luyi; Schreuder, Jaring; Tomei, Sara; Lin, Dawn S.; Jackson, Jacob T.; Nutt, Stephen L.; Naik, Shalin H.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Amann-Zalcenstein, Daniela; Naik, Shalin H.] Walter & Eliza Hall Inst Med Res, Single Cell Open Res Endeavour SCORE, Parkville, Vic, Australia; [Tian, Luyi; Tomei, Sara; Lin, Dawn S.; Stonehouse, Olivia] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic, Australia; [Tian, Luyi; Stonehouse, Olivia; Taoudi, Samir; Ritchie, Matthew E.] Walter & Eliza Hall Inst Med Res, Epigenet & Dev Div, Parkville, Vic, Australia; [Fairfax, Kirsten A.; Bolden, Jessica E.; McKenzie, Mark D.; Jarratt, Andrew; Hilton, Adrienne; Jackson, Jacob T.; de Graaf, Carolyn A.; Taoudi, Samir; Alexander, Warren S.; Nutt, Stephen L.; Ritchie, Matthew E.; Ng, Ashley P.; Naik, Shalin H.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Fairfax, Kirsten A.; Bolden, Jessica E.; Jarratt, Andrew; Hilton, Adrienne; Di Rago, Ladina; de Graaf, Carolyn A.; Alexander, Warren S.; Ng, Ashley P.] Walter & Eliza Hall Inst Med Res, Blood Cells & Blood Canc Div, Parkville, Vic, Australia; [Fairfax, Kirsten A.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [McKenzie, Mark D.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [McCormack, Matthew P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia; [Ng, Ashley P.] Peter MacCallum Canc Ctr, Clin Haematol, Parkville, Vic, Australia; [Ng, Ashley P.] Royal Melbourne Hosp, Parkville, Vic, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; Monash University; Peter Maccallum Cancer Center; Royal Melbourne Hospital	Naik, SH (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia.; Naik, SH (corresponding author), Walter & Eliza Hall Inst Med Res, Single Cell Open Res Endeavour SCORE, Parkville, Vic, Australia.; Naik, SH (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	naik.s@wehi.edu.au	Naik, Shalin/AFD-5605-2022; Ng, Ashley/D-3842-2011; Luyi, Tian/H-1192-2018; Nutt, Stephen/C-9256-2013	Ng, Ashley/0000-0001-9690-0879; Luyi, Tian/0000-0003-3420-3685; Amann-Zalcenstein, Daniela/0000-0003-4928-1846; Schreuder, Jaring/0000-0002-7579-0006; Stonehouse, Olivia/0000-0002-3694-8640; Nutt, Stephen/0000-0002-0020-6637; Naik, Shalin/0000-0003-0299-3301; Tomei, Sara/0000-0001-7832-5807	National Health & Medical Research Council [0516782, 0637403, 1035229, 1155342, 1058344, 1062820, 1124812, 1085765, 1060179, 1122783, 1113577]; Australian Research Council's special initiative Stem Cells Australia; Australian Cancer Research Fund; Victorian State Government Infrastructure Support; Australian Government NHMRC IRIIS; CSL Limited	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council's special initiative Stem Cells Australia(Australian Research Council); Australian Cancer Research Fund; Victorian State Government Infrastructure Support; Australian Government NHMRC IRIIS(National Health and Medical Research Council (NHMRC) of Australia); CSL Limited	We thank the WEHI flow cytometry facility, the Single Cell Open Research Endeavour, S. Wilcox for genomics support and Animal Bioservices for animal husbandry. This work was supported by the National Health & Medical Research Council, with fellowships to S.H.N. (0516782), J.E.B (0637403), C.d.G (1035229), S.L.N. (1155342) and W.S.A (1058344); project grants (1062820, 1124812, 1085765, 1060179, 1122783); a program grant (1113577), the Australian Research Council's special initiative Stem Cells Australia, an Australian Cancer Research Fund, Victorian State Government Infrastructure Support, Australian Government NHMRC IRIIS and CSL Limited.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Berthault C, 2017, NAT IMMUNOL, V18, P1139, DOI 10.1038/ni.3820; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Choi J, 2019, NUCLEIC ACIDS RES, V47, pD780, DOI 10.1093/nar/gky1020; Chopin M, 2019, IMMUNITY, V50, P77, DOI 10.1016/j.immuni.2018.11.010; Chung SS, 2017, HEMATOL-AM SOC HEMAT, P73, DOI 10.1182/asheducation-2017.1.73; De Graaf CA, 2016, STEM CELL REP, V7, P571, DOI 10.1016/j.stemcr.2016.07.007; De Obaldia ME, 2013, NAT IMMUNOL, V14, P1277, DOI 10.1038/ni.2760; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dorshkind K, 2020, NAT REV IMMUNOL, V20, P196, DOI 10.1038/s41577-019-0236-2; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Haas S, 2018, CELL STEM CELL, V22, P627, DOI 10.1016/j.stem.2018.04.003; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Jacobsen SEW, 2019, NAT CELL BIOL, V21, P2, DOI 10.1038/s41556-018-0227-8; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Lee JW, 2012, BIOCHEM BIOPH RES CO, V426, P299, DOI 10.1016/j.bbrc.2012.08.048; Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P91, DOI 10.1016/j.bbrc.2012.02.120; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lin DS, 2018, CELL REP, V22, P2557, DOI 10.1016/j.celrep.2018.02.046; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Metcalf D, 2010, P NATL ACAD SCI USA, V107, P16257, DOI 10.1073/pnas.1011881107; Naik S. H., 2009, DENDRITIC CELL DEV L; Naik SH, 2020, MOL IMMUNOL, V124, P190, DOI 10.1016/j.molimm.2020.06.012; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Nicola N. A., 1995, HEMOPOIETIC COLONY S; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tian LY, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006361; Vallejos CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004333; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	53	6	6	2	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1574	+		10.1038/s41590-020-0799-x	http://dx.doi.org/10.1038/s41590-020-0799-x		OCT 2020	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33077975				2022-12-18	WOS:000579704900001
J	Winkler, ES; Bailey, AL; Kafai, NM; Nair, S; McCune, BT; Yu, JS; Fox, JM; Chen, RE; Earnest, JT; Keeler, SP; Ritter, JH; Kang, LI; Dort, S; Robichaud, A; Head, R; Holtzman, MJ; Diamond, MS				Winkler, Emma S.; Bailey, Adam L.; Kafai, Natasha M.; Nair, Sharmila; McCune, Broc T.; Yu, Jinsheng; Fox, Julie M.; Chen, Rita E.; Earnest, James T.; Keeler, Shamus P.; Ritter, Jon H.; Kang, Liang-, I; Dort, Sarah; Robichaud, Annette; Head, Richard; Holtzman, Michael J.; Diamond, Michael S.			SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function (vol 51, pg 831, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				diamond@wusm.wustl.edu	Keeler, Shamus/ABC-1774-2020; Fox, Julie/GLQ-8895-2022	Keeler, Shamus/0000-0002-1301-0852; Fox, Julie/0000-0003-0567-738X	NHLBI NIH HHS [R35 HL145242] Funding Source: Medline; NIAID NIH HHS [F32 AI138392, F30 AI152327, R01 AI130591, 75N93019C00062, R01 AI127828] Funding Source: Medline; United States Department of Defense | Defense Advanced Research Projects Agency (DARPA) [HR001117S0019] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Defense | Defense Advanced Research Projects Agency (DARPA)		Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2	1	6	6	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1470	1470		10.1038/s41590-020-0794-2	http://dx.doi.org/10.1038/s41590-020-0794-2		SEP 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32879513	Bronze, Green Published			2022-12-18	WOS:000565474900001
J	Feng, SY; Man, SM				Feng, Shouya; Man, Si Ming			Captain GBP1: inflammasomes assemble, pyroptotic endgame	NATURE IMMUNOLOGY			English	Editorial Material							GUANYLATE-BINDING PROTEINS; AIM2 INFLAMMASOME; ACTIVATION; INFECTION	Guanylate-binding proteins (GBPs) promote immune defenses against infectious agents. Two studies reveal that GBP1 directly binds to cytosolic lipopolysaccharide (LPS), bringing caspase-4 to the surface of bacteria to induce pyroptosis.	[Feng, Shouya; Man, Si Ming] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research	Man, SM (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia.	siming.man@anu.edu.au	Man, Si Ming/AAE-9168-2019	Man, Si Ming/0000-0002-5079-2857; Feng, Shouya/0000-0002-3529-3822				Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Fisch D, 2019, EMBO J, V38, DOI 10.15252/embj.2018100926; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Kim BH, 2016, NAT IMMUNOL, V17, P481, DOI 10.1038/ni.3440; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kutsch M, 2020, EMBO J, V39, DOI 10.15252/embj.2020104926; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Santos JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16889-z; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2	13	6	6	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					829	830		10.1038/s41590-020-0727-0	http://dx.doi.org/10.1038/s41590-020-0727-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32699406				2022-12-18	WOS:000551573400007
J	Soumelis, V; Liu, YJ				Soumelis, Vassili; Liu, Yong-Jun			The discovery of human TSLP as a critical epithelial cytokine in type 2 immunity and allergic disease	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; INDUCE	Working on the function of a new cytokine always makes for exciting times. Vassili Soumelis and Yong-Jun Liu bring us back to the discovery and functional characterization of human TSLP, in the very stimulating environment of the DNAX Research Institute.	[Soumelis, Vassili] Univ Paris, Inst Rech St Louis, HIPI Unit, Inserm,U976, Paris, France; [Soumelis, Vassili] Hop St Louis, AP HP, Lab Immunol & Histocompatibil, Paris, France; [Liu, Yong-Jun] Sanofi R&D, Cambridge, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis	Soumelis, V (corresponding author), Univ Paris, Inst Rech St Louis, HIPI Unit, Inserm,U976, Paris, France.; Soumelis, V (corresponding author), Hop St Louis, AP HP, Lab Immunol & Histocompatibil, Paris, France.	vassili.soumelis@aphp.fr		Soumelis, Vassili/0000-0003-1849-9834				Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Carmi-Levy I, 2011, CLIN REV ALLERG IMMU, V41, P245, DOI 10.1007/s12016-010-8239-6; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Mitchell PD, 2017, PHARMACOL THERAPEUT, V169, P104, DOI 10.1016/j.pharmthera.2016.06.009; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886	11	6	6	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1471	1473		10.1038/s41590-020-0720-7	http://dx.doi.org/10.1038/s41590-020-0720-7		JUL 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	32616863				2022-12-18	WOS:000545059300004
J	Rocklov, J; Dubrow, R				Rocklov, Joacim; Dubrow, Robert			Climate change: an enduring challenge for vector-borne disease prevention and control (vol 21, pg 479, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				robert.dubrow@yale.edu		Rocklov, Joacim/0000-0003-4030-0449; Dubrow, Robert/0000-0002-5071-7742				Rocklov J, 2020, NAT IMMUNOL, V21, P479, DOI 10.1038/s41590-020-0648-y	1	6	6	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					695	695		10.1038/s41590-020-0692-7	http://dx.doi.org/10.1038/s41590-020-0692-7		APR 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32350458	Bronze, Green Published			2022-12-18	WOS:000529582000001
J	Mastellos, DC; Blom, AM; Connolly, ES; Daha, MR; Geisbrecht, BV; Ghebrehiwet, B; Gros, P; Hajishengallis, G; Holers, VM; Huber-Lang, M; Kinoshita, T; Mollnes, TE; Montgomery, RA; Morgan, BP; Nilsson, B; Pio, R; Ricklin, D; Risitano, AM; Taylor, RP; Mantovani, A; Ioannidis, JPA; Lambris, JD				Mastellos, Dimitrios C.; Blom, Anna M.; Connolly, E. Sander; Daha, Mohamed R.; Geisbrecht, Brian V.; Ghebrehiwet, Berhane; Gros, Piet; Hajishengallis, George; Holers, V. Michael; Huber-Lang, Markus; Kinoshita, Taroh; Mollnes, Tom E.; Montgomery, Robert A.; Morgan, B. Paul; Nilsson, Bo; Pio, Ruben; Ricklin, Daniel; Risitano, Antonio M.; Taylor, Ronald P.; Mantovani, Alberto; Ioannidis, John P. A.; Lambris, John D.			'Stealth' corporate innovation: an emerging threat for therapeutic drug development	NATURE IMMUNOLOGY			English	Article							COMPLEMENT		[Mastellos, Dimitrios C.] Natl Ctr Sci Res Demokritos, Athens, Greece; [Blom, Anna M.] Lund Univ, Dept Translat Med, Lund, Sweden; [Connolly, E. Sander] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Daha, Mohamed R.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Ghebrehiwet, Berhane] SUNY Stony Brook, Div Rheumatol Allergy & Immunol, Dept Med, New York, NY USA; [Gros, Piet] Univ Utrecht, Dept Chem, Fac Sci, Utrecht, Netherlands; [Hajishengallis, George] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Holers, V. Michael] Univ Colorado, Sch Med, Dept Med, Div Rheumatol, Denver, CO USA; [Holers, V. Michael] Univ Colorado, Sch Med, Dept Immunol, Div Rheumatol, Denver, CO USA; [Huber-Lang, Markus] Univ Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Kinoshita, Taroh] Osaka Univ, Lab Immunoglycobiol, Immunol Frontier Res Ctr, Osaka, Japan; [Mollnes, Tom E.] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Mollnes, Tom E.] Univ Oslo, Oslo, Norway; [Mollnes, Tom E.] Nordland Hosp, Res Lab, Bodo, Norway; [Mollnes, Tom E.] Univ Tromso, KG Jebsen TREC, Tromso, Norway; [Mollnes, Tom E.] NTNU, Ctr Mol Inflammatory Res, Trondheim, Norway; [Montgomery, Robert A.] NYU, Dept Surg, Langone Transplant Inst, New York, NY 10016 USA; [Morgan, B. Paul] Cardiff Univ, Syst Immun Res Inst, Sch Med, Cardiff, S Glam, Wales; [Nilsson, Bo] Uppsala Univ Hosp, Div Clin Immunol, Uppsala, Sweden; [Pio, Ruben] Univ Navarra, IDISNA, CIBERONC, Ctr Appl Med Res CIMA,Program Solid Tumors, Pamplona, Spain; [Ricklin, Daniel] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland; [Risitano, Antonio M.] Federico II Univ Naples, Dept Clin Med & Surg, Naples, Italy; [Taylor, Ronald P.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Mantovani, Alberto] Humanitas Univ, Ist Clin Humanitas, Milan, Italy; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	National Centre of Scientific Research "Demokritos"; Lund University; Columbia University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kansas State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Utrecht University; University of Pennsylvania; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Ulm University; Osaka University; Osaka University; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); New York University; Cardiff University; Uppsala University; Uppsala University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; University of Basel; University of Naples Federico II; University of Virginia; Humanitas University; IRCCS Humanitas Research Hospital; Stanford University; Stanford University; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine	Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	lambris@pennmedicine.upenn.edu	Mollnes, Tom/ABI-5183-2020; Blom, Anna/AFS-7369-2022; Huber-Lang, Markus/AAJ-2209-2020; Mantovani, Alberto/HCI-7449-2022; Pio, Ruben/F-5353-2017; Ioannidis, John P. A./G-9836-2011; Blom, Anna/B-9607-2009	Mantovani, Alberto/0000-0001-5578-236X; Pio, Ruben/0000-0002-6831-6111; Blom, Anna/0000-0002-1348-1734; Hajishengallis, George/0000-0001-7392-8852; Ioannidis, John P./0000-0003-3118-6859; Mastellos, Dimitrios/0000-0002-6634-3271	Roche Pharma; Orion Pharma; Genmab; Merus; Alexion; Hansa Medical; GuidePoint Global, Sucampo; Immune Tolerance Network; GSK; Alexion Pharmaceuticals; Novartis; Alnylam; Roche; Samsung; Amyndas Pharmaceuticals [(1MeW)7W/POT-4/APL-1]; Baxter; MRC [UKDRI-3002] Funding Source: UKRI	Roche Pharma; Orion Pharma; Genmab(Genmab); Merus; Alexion; Hansa Medical; GuidePoint Global, Sucampo; Immune Tolerance Network; GSK(GlaxoSmithKline); Alexion Pharmaceuticals; Novartis(Novartis); Alnylam; Roche(Roche Holding); Samsung(Samsung); Amyndas Pharmaceuticals; Baxter; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A.M.B. has provided paid consulting services to Zealand Pharma. B.V.G. collaborates with and has received research materials from SomaLogic and Roche Pharma and has also provided paid consulting services for ClearView Health Care Partners and 1776 Health Care. B.G. is the holder of a US patent for a monoclonal antibody for the treatment of angioedema and a patent for monoclonal antibodies to both C1q and C1qRs for the treatment of various types of cancer and has consulted for Diaccurate-Pasteur and Orion Pharma but has never received research support from any pharmaceutical company. P.G. has collaborated with and has received research funding and/or research materials from Genmab and Merus. G.H. is an inventor on patents or patent applications that describe the use of complement inhibitors for therapeutic purposes in periodontitis, some of which are being developed by Amyndas Pharmaceuticals. V.M.H. is a co-founder of Taligen Therapeutics and AdMIRx, receives Taligen-related licensing royalties from Alexion, has equity interest in and consulting income from AdMIRx, and is a recent or current consultant in non-complement areas to Janssen Research and Development, Amgen, Celgene, BMS and Trios. M.H.-L. holds a patent on compositions of matter and methods for the diagnosis and treatment of sepsis by C5a inhibitory strategies licensed to InflaRx. T.K. has received consultant fees and honoraria for lectures from Alexion. T.E.M. has received consultant fees from Ra Pharmaceuticals, SVAR Life Science and Alexion Pharmaceuticals. R.A.M. has received research funding from Alexion (the manufacturer of Soliris-Eculizumab) and Shire ViroPharma, has served as a paid consultant for Alexion, Shire ViroPharma and CSL Behring, has received travel honoraria from Alexion and Shire ViroPharma, has served on advisory boards for Genentech/Roche, True North/iPerian, Novartis and Hansa Medical, and received consulting fees from OrbidMed, GuidePoint Global, Sucampo, Astellas, and Shire and research grants from Immune Tolerance Network, ViroPharma, Hansa and Alexion. B.P.M. has received research support from GSK and served as an advisor for GSK, Roche, Alexion and Ra Pharma. B.N. is a shareholder and consultant in Tikomed and iCoat Medical. R.P. is the inventor on patents that describe the use of complement-related proteins for cancer diagnosis and has received consultant fees from Amadix and research funding from Dompe. D.R. is the inventor on patents or patent applications that describe the use of complement inhibitors for therapeutic purposes, some of which are developed by Amyndas Pharmaceuticals, and has provided paid consulting services to Roche Pharma. A.M.R. has received research support from Alexion Pharmaceuticals, Novartis, Alnylam and Ra Pharma and lecture fees from Alexion, Novartis, Pfizer and Apellis, and served as member of advisory-investigator boards for Alexion, Roche, Achillion, Novartis, Apellis and Samsung, and as a consultant for Amyndas. R.P.T. has collaborated with and received research funding and research materials from Genmab. J.D.L.; r is the founder of Amyndas Pharmaceuticals, which is developing complement inhibitors for therapeutic purposes, is the inventor of patents or patent applications that describe the use of complement inhibitors for therapeutic purposes, some of which are being developed by Amyndas Pharmaceuticals, is the inventor of the compstatin technology licensed to Apellis Pharmaceuticals (4(1MeW)7W/POT-4/APL-1 and PEGylated derivatives such as APL-2/pegcetacoplan), and has provided paid consulting services to Achillion, Ra Pharma, Viropharma, Sanofi, Shire, LipimetiX and Baxter.	Amann RI, 2019, SCIENCE, V363, P350, DOI 10.1126/science.aaw1280; Chin-Dusting J, 2005, NAT REV DRUG DISCOV, V4, P891, DOI 10.1038/nrd1879; Cristea IA, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13072; Dahlin JL, 2015, NAT REV DRUG DISCOV, V14, P279, DOI 10.1038/nrd4578; Grabowski HG, 2015, HEALTH AFFAIR, V34, P302, DOI 10.1377/hlthaff.2014.1047; High KA, 2019, NEW ENGL J MED, V381, P455, DOI 10.1056/NEJMra1706910; Ioannidis JPA, 2015, JAMA-J AM MED ASSOC, V313, P663, DOI 10.1001/jama.2014.17662; Kanni T, 2018, BRIT J DERMATOL, V179, P413, DOI 10.1111/bjd.16428; Luzzatto L, 2018, LANCET, V392, P791, DOI 10.1016/S0140-6736(18)31069-9; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; Miller J., 2019, REUTERS; Morrison C, 2018, NAT REV DRUG DISCOV, V17, P531, DOI 10.1038/nrd.2018.125; Ricklin D, 2018, NAT REV NEPHROL, V14, P26, DOI 10.1038/nrneph.2017.156; Yang K, 2013, ADV EXP MED BIOL, V735, P301, DOI 10.1007/978-1-4614-4118-2_21	14	6	6	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1409	1413		10.1038/s41590-019-0503-1	http://dx.doi.org/10.1038/s41590-019-0503-1			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31562490	Green Accepted			2022-12-18	WOS:000492309600002
J	Iwasaki, A				Iwasaki, Akiko			Why we need to increase diversity in the immunology research community	NATURE IMMUNOLOGY			English	Article							SCIENCE; LIFE		[Iwasaki, Akiko] Yale Univ, Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Iwasaki, Akiko] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Howard Hughes Medical Institute	Iwasaki, A (corresponding author), Yale Univ, Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	HHMI; Burroughs Wellcome Fund; NSF; NIH	HHMI(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank the members of my laboratory, past and present, for teaching me the value of diversity in science. Many of the insights I shared in this commentary came from posts by my fellow scientists on Twitter. I thank the funding agencies, including the HHMI, the Burroughs Wellcome Fund, NSF, and NIH for their commitment and effort in promoting diversity in science.	Bennett Jessica, 2019, NY TIMES; Chang EH, 2019, P NATL ACAD SCI USA, V116, P7778, DOI 10.1073/pnas.1816076116; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Education USDo. National Center for Education Statistics, 2017, INT POSTS ED DAT SYS; European Commission, 2012, COMM COMM EUR PARL C; Freeman RB, 2015, J LABOR ECON, V33, pS289, DOI 10.1086/678973; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Hewlett S., 2013, HARVARD BUSINESS REV; Iwasaki A, 2015, NAT IMMUNOL, V16, P787, DOI 10.1038/ni.3199; Lerchenmueller MJ, 2018, RES POLICY, V47, P1007, DOI 10.1016/j.respol.2018.02.009; Mervis J, 2018, SCIENCE, DOI [10.1126/science.aav4291, DOI 10.1126/SCIENCE.AAV4291]; National Center for Science and Engineering Statistics, 2017, 17310 NSF NAT CTR SC; National Research Council, 2010, GEND DIFF CRIT TRANS; Nielsen MW, 2017, P NATL ACAD SCI USA, V114, P1740, DOI 10.1073/pnas.1700616114; Phillips KW, 2014, SCI AM, V311, P42, DOI 10.1038/scientificamerican1014-42; Schultheiss Katrin, 2018, GHOST ADVISING CHRON; Valantine HA, 2015, P NATL ACAD SCI USA, V112, P12240, DOI 10.1073/pnas.1515612112	17	6	6	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1085	1088		10.1038/s41590-019-0470-6	http://dx.doi.org/10.1038/s41590-019-0470-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	IS5SK	31427777				2022-12-18	WOS:000482212600001
J	Murphy, MP				Murphy, Michael P.			IMMUNOMETABOLISM Rerouting metabolism to activate macrophages	NATURE IMMUNOLOGY			English	Editorial Material							SUCCINATE-DEHYDROGENASE; MITOCHONDRIAL; ITACONATE		[Murphy, Michael P.] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England	University of Cambridge	Murphy, MP (corresponding author), Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge, England.	mpm@mrc-mbu.cam.ac.uk	Murphy, Michael/C-2120-2009	Murphy, Michael/0000-0003-1115-9618				Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Ryan DG, 2019, NAT METAB, V1, P16, DOI 10.1038/s42255-018-0014-7; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	12	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1097	1099		10.1038/s41590-019-0455-5	http://dx.doi.org/10.1038/s41590-019-0455-5			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31384059	Green Submitted			2022-12-18	WOS:000482212600010
J	Hall, AO; Towne, JE; Plevy, SE				Hall, Aisling O'Hara; Towne, Jennifer E.; Plevy, Scott E.			Get the IL-17F outta here!	NATURE IMMUNOLOGY			English	Editorial Material							FECAL MICROBIOTA TRANSPLANTATION; PLACEBO-CONTROLLED PHASE-2; SEVERE CROHNS-DISEASE; ULCERATIVE-COLITIS; DOUBLE-BLIND; INTERLEUKIN-23; INFLAMMATION; INDUCTION; CELLS; AXIS	The cytokine IL-17F constrains the growth of immunoregulatory Clostridium cluster XIVa species and represents a potential therapeutic target for the treatment of inflammatory bowel disease.	[Hall, Aisling O'Hara; Plevy, Scott E.] Janssen Immunol Res & Dev, Spring House, PA 19477 USA; [Towne, Jennifer E.] Janssen Immunol Res & Dev, San Diego, CA USA		Plevy, SE (corresponding author), Janssen Immunol Res & Dev, Spring House, PA 19477 USA.	splevy@its.jnj.com		Hall, Aisling/0000-0001-8198-3245				Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Feagan BG, 2017, LANCET, V389, P1699, DOI 10.1016/S0140-6736(17)30570-6; Fuentes S, 2017, ISME J, V11, P1877, DOI 10.1038/ismej.2017.44; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Paramsothy S, 2017, J CROHNS COLITIS, V11, P1180, DOI 10.1093/ecco-jcc/jjx063; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Sands BE, 2017, GASTROENTEROLOGY, V153, P77, DOI 10.1053/j.gastro.2017.03.049; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Targan SR, 2016, AM J GASTROENTEROL, V111, P1599, DOI 10.1038/ajg.2016.298	13	6	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					648	650		10.1038/s41590-018-0141-z	http://dx.doi.org/10.1038/s41590-018-0141-z			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29915294				2022-12-18	WOS:000436341300007
J	Haining, WN; Weiss, SA				Haining, W. Nicholas; Weiss, Sarah A.			c-Maf in CD4(+) T cells: it's all about context	NATURE IMMUNOLOGY			English	Editorial Material							BINDING		[Haining, W. Nicholas; Weiss, Sarah A.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Haining, W. Nicholas] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Weiss, Sarah A.] Harvard Med Sch, Div Med Sci, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Haining, WN (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Haining, WN (corresponding author), Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA.; Haining, WN (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.	wnhaining@gmail.com			NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison K. A., 2016, LIFE SCI, V5; Baek S, 2017, CELL REP, V19, P1710, DOI 10.1016/j.celrep.2017.05.003; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Grossman SR, 2017, P NATL ACAD SCI USA, V114, pE1291, DOI 10.1073/pnas.1621150114; Johnson JL, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028779; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500	13	6	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					429	431		10.1038/s41590-018-0087-1	http://dx.doi.org/10.1038/s41590-018-0087-1			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29670237				2022-12-18	WOS:000430562400004
J	Smith, DE				Smith, Dirk E.			IL-33 meets allergens at the gate	NATURE IMMUNOLOGY			English	Editorial Material							INTERLEUKIN-33; ACTIVATION; IMMUNITY		[Smith, Dirk E.] Insight BioConsulting, Bainbridge Isl, WA 98110 USA		Smith, DE (corresponding author), Insight BioConsulting, Bainbridge Isl, WA 98110 USA.	smith@insightbioconsulting.com						Cayrol C., 2018, NAT IMMUNOL, DOI [10.1038/s415900180067-5, DOI 10.1038/S415900180067-5]; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Scott IC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21589-2; Snelgrove RJ, 2014, J ALLERGY CLIN IMMUN, V134, P583, DOI 10.1016/j.jaci.2014.02.002; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558	10	6	6	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					318	320		10.1038/s41590-018-0069-3	http://dx.doi.org/10.1038/s41590-018-0069-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563627				2022-12-18	WOS:000428151000009
J	Liston, A; Goris, A				Liston, Adrian; Goris, An			HUMAN SYSTEMS IMMUNOLOGY The origins of diversity in human immunity	NATURE IMMUNOLOGY			English	Editorial Material							DISEASE; TRAITS		[Liston, Adrian] VIB Ctr Brain & Dis Res, Leuven, Belgium; [Liston, Adrian] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Goris, An] KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Liston, A (corresponding author), VIB Ctr Brain & Dis Res, Leuven, Belgium.; Liston, A (corresponding author), KU Leuven Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.; Goris, A (corresponding author), KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium.	adrian.liston@vib.be; an.goris@kuleuven.be	Goris, An/L-5852-2019; Goris, An/F-2943-2010	Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682				Aguirre-Gamboa R, 2016, CELL REP, V17, P2474, DOI 10.1016/j.celrep.2016.10.053; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Carrillo-Bustamante P, 2016, IMMUNOGENETICS, V68, P3, DOI 10.1007/s00251-015-0869-7; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Mangino M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13850; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Patin E., 2018, NAT IMMUNOL; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046	9	6	6	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					209	210		10.1038/s41590-018-0047-9	http://dx.doi.org/10.1038/s41590-018-0047-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29476185				2022-12-18	WOS:000427007500009
J	Wang, S; Xie, F; Chu, F; Zhang, ZK; Yang, B; Dai, T; Gao, L; Wang, L; Ling, L; Jia, JL; van Dam, H; Jin, J; Zhang, L; Zhou, FF				Wang, Shuai; Xie, Feng; Chu, Feng; Zhang, Zhengkui; Yang, Bing; Dai, Tong; Gao, Liang; Wang, Lin; Ling, Li; Jia, Junling; van Dam, Hans; Jin, Jin; Zhang, Long; Zhou, Fangfang			YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKK epsilon-mediated phosphorylation (vol 18, pg 733, 2017)	NATURE IMMUNOLOGY			English	Correction														van Dam, Hans/0000-0002-8307-4325				Wang S, 2017, NAT IMMUNOL, V18, P733, DOI 10.1038/ni.3744	1	6	7	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1270	1270		10.1038/ni1117-1270d	http://dx.doi.org/10.1038/ni1117-1270d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044228	Bronze			2022-12-18	WOS:000413457300016
J	Della Mina, E; Rodero, MP; Crow, YJ				Della Mina, Erika; Rodero, Mathieu P.; Crow, Yanick J.			Polymorphisms in IFIH1: the good and the bad	NATURE IMMUNOLOGY			English	Editorial Material							AICARDI-GOUTIERES SYNDROME; AUTOIMMUNITY; MUTATIONS		[Della Mina, Erika; Rodero, Mathieu P.; Crow, Yanick J.] Inst Imagine, INSERM, UMR1163, Lab Neurogenet & Neuroinflammat, Paris, France; [Crow, Yanick J.] Paris Descartes Univ, Hop Necker Enfants Malad, AP HP, Sorbonne Paris Cite, Paris, France; [Crow, Yanick J.] Univ Manchester, Manchester Ctr Genom Med, Manchester, Lancs, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Manchester	Crow, YJ (corresponding author), Inst Imagine, INSERM, UMR1163, Lab Neurogenet & Neuroinflammat, Paris, France.; Crow, YJ (corresponding author), Paris Descartes Univ, Hop Necker Enfants Malad, AP HP, Sorbonne Paris Cite, Paris, France.; Crow, YJ (corresponding author), Univ Manchester, Manchester Ctr Genom Med, Manchester, Lancs, England.	yanickcrow@mac.com	rodero, mathieu/C-8083-2011	rodero, mathieu/0000-0002-1300-0187				Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; Domsgen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39378; Fischer A, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah5861; Gorman JA, 2017, NAT IMMUNOL, V18, P744, DOI 10.1038/ni.3766; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Yi GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077846	12	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					708	709		10.1038/ni.3765	http://dx.doi.org/10.1038/ni.3765			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28632717	Green Submitted			2022-12-18	WOS:000403676300002
J	Beyer, M; Huehn, J				Beyer, Marc; Huehn, Jochen			Epigenetic orchestration of thymic T-reg cell development	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTORS; SATB1; EXPRESSION; ELEMENTS; GENES	Regulatory T cells develop in the thymus as a distinct lineage of T cells instructed by the lineage-specifying transcription factor Foxp3. Epigenetic imprinting by the genome organizer Satb1 precedes this cell-fate 'decision' during thymocyte development.	[Beyer, Marc] Univ Bonn, Life & Med Sci Inst, Bonn, Germany; [Beyer, Marc] Ctr Neurodegenerat Dis, Single Cell Genom & Epigen Unit German, Bonn, Germany; [Beyer, Marc] Univ Bonn, Bonn, Germany; [Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center for Infection Research	Beyer, M (corresponding author), Univ Bonn, Life & Med Sci Inst, Bonn, Germany.; Beyer, M (corresponding author), Ctr Neurodegenerat Dis, Single Cell Genom & Epigen Unit German, Bonn, Germany.; Beyer, M (corresponding author), Univ Bonn, Bonn, Germany.	marc.beyer@uni-bonn.de; jochen.huehn@helmholtz-hzi.de	Beyer, Marc/ABE-1408-2021	Beyer, Marc/0000-0001-9704-148X				Alvarez JD, 2000, GENE DEV, V14, P521; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	12	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					144	146		10.1038/ni.3660	http://dx.doi.org/10.1038/ni.3660			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102221	Green Submitted			2022-12-18	WOS:000392360900006
J	Hombrink, P; Helbig, C; Backer, RA; Piet, B; Oja, AE; Stark, R; Brasser, G; Jongejan, A; Jonkers, RE; Nota, B; Basak, O; Clevers, HC; Moerland, PD; Amsen, D; van Lier, RAW				Hombrink, Pleun; Helbig, Christina; Backer, Ronald A.; Piet, Berber; Oja, Anna E.; Stark, Regina; Brasser, Giso; Jongejan, Aldo; Jonkers, Rene E.; Nota, Benjamin; Basak, Onur; Clevers, Hans C.; Moerland, Perry D.; Amsen, Derk; van Lier, Rene A. W.			Programs for the persistence, vigilance and control of human CD8(+) lung-resident memory T cells (vol 17, pg 1467, 2016)	NATURE IMMUNOLOGY			English	Correction													Piet, Berber/AAD-2746-2020; Basak, Onur/GLV-6113-2022; Moerland, Perry/AAG-1425-2020	Piet, Berber/0000-0002-9069-3597; Basak, Onur/0000-0002-6864-3403; Moerland, Perry/0000-0002-2357-3659; Stark, Regina/0000-0001-7693-799X				Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589	1	6	6	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					246	246		10.1038/ni0217-246d	http://dx.doi.org/10.1038/ni0217-246d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102212	Bronze			2022-12-18	WOS:000392360900021
J	Wijeyesinghe, S; Masopust, D				Wijeyesinghe, Sathi; Masopust, David			Resident memory T cells are a Notch above the rest	NATURE IMMUNOLOGY			English	Editorial Material							INFECTION; DISEASE	Notch signaling promotes the maintenance of lung-resident CD8(+) memory T cells that are transcriptionally poised for rapid effector responses but have heightened expression of inhibitory receptors, suggestive of tight regulation.	[Wijeyesinghe, Sathi; Masopust, David] Univ Minnesota, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Ctr Immunol, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA.	masopust@umn.edu	masopust, david/B-5027-2008	Wijeyesinghe, Sathi/0000-0002-8819-2654				Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; Li J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148351; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pichyangkul S, 2015, J IMMUNOL, V195, P4378, DOI 10.4049/jimmunol.1501702; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Wong MT, 2016, IMMUNITY, V45, P442, DOI 10.1016/j.immuni.2016.07.007; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180	12	6	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1337	1338		10.1038/ni.3617	http://dx.doi.org/10.1038/ni.3617			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27849200				2022-12-18	WOS:000388056400002
J	Wang, HG; Hogquist, KA				Wang, Haiguang; Hogquist, Kristin A.			How MAIT cells get their start	NATURE IMMUNOLOGY			English	Editorial Material							INVARIANT T-CELLS; MR1; IMMUNITY; MOUSE	By taking advantage of an MR1 tetramer to accurately detect mucosal-associated invariant T (MAIT) cells in both mice and humans, researchers defined the thymic development of MAIT cells.	[Wang, Haiguang; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wang, Haiguang; Hogquist, Kristin A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wang, HG (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Wang, HG (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu		Wang, Haiguang/0000-0001-5403-9179				Chen Z., 2016, MUCOSAL IMMUNOL; Engel I, 2014, CURR TOP MICROBIOL, V381, P51, DOI 10.1007/82_2014_375; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Pobezinsky LA, 2015, NAT IMMUNOL, V16, P517, DOI 10.1038/ni.3146; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Seach N, 2013, J IMMUNOL, V191, P6002, DOI 10.4049/jimmunol.1301212	12	6	6	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1238	1240		10.1038/ni.3584	http://dx.doi.org/10.1038/ni.3584			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27760106				2022-12-18	WOS:000386193200002
J	Dorfleutner, A; Stehlik, C				Dorfleutner, Andrea; Stehlik, Christian			A dRAStic RHOAdblock of Pyrin inflammasome activation	NATURE IMMUNOLOGY			English	Editorial Material								The Pyrin inflammasome guard is disabled if the activity of small cellular GTPase is compromised in response to defects in the mevalonate pathway and is disabled directly by mutations in the gene encoding Pyrin, which results in the interleukin 1 beta (IL-1 beta)-driven autoinflammatory diseases MKD and FMF.	[Dorfleutner, Andrea; Stehlik, Christian] Northwestern Univ, Interdept Immunobiol Ctr, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr,Dept Med,Div R, Chicago, IL 60611 USA; [Dorfleutner, Andrea; Stehlik, Christian] Northwestern Univ, Feinberg Sch Med, Skin Dis Res Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine	Dorfleutner, A (corresponding author), Northwestern Univ, Interdept Immunobiol Ctr, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr,Dept Med,Div R, Chicago, IL 60611 USA.; Dorfleutner, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Skin Dis Res Ctr, Chicago, IL 60611 USA.	a-dorfleutner@northwestern.edu; c-stehlik@northwestern.edu	Dorfleutner, Andrea/AAG-5504-2021; Stehlik, Christian/AAG-2132-2021	Dorfleutner, Andrea/0000-0003-4406-2986; Stehlik, Christian/0000-0002-3782-2484	NCI NIH HHS [P30 CA060553] Funding Source: Medline; NIAID NIH HHS [R21 AI120618, R01 AI120625, R01 AI099009] Funding Source: Medline; NIAMS NIH HHS [K01 AR066739, R01 AR064349] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120625, R21AI120618, R01AI099009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR066739, R01AR064349] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Bonardi V, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00237; Chu LH, 2015, APOPTOSIS, V20, P157, DOI 10.1007/s10495-014-1065-1; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Jeru I, 2005, ARTHRITIS RHEUM-US, V52, P1848, DOI 10.1002/art.21050; Lozano-Duran R, 2015, MOL PLANT MICROBE IN, V28, P511, DOI 10.1094/MPMI-10-14-0322-CR; Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449	11	6	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					900	902		10.1038/ni.3511	http://dx.doi.org/10.1038/ni.3511			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27434003	Green Accepted			2022-12-18	WOS:000380647000005
J	Rutz, S; Ouyang, WJ				Rutz, Sascha; Ouyang, Wenjun			The Itch to degrade ROR-gamma t	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE REGULATION; UBIQUITIN SYSTEM	The E3 ubiquitin ligase Itch limits interleukin 17A (IL-17A)-mediated intestinal inflammation by targeting the transcription factor ROR-gamma t for proteasomal degradation.	[Rutz, Sascha] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Amgen Inc, Dept Inflammat & Oncol, San Francisco, CA USA	Roche Holding; Genentech; Amgen	Rutz, S (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	saschar@gene.com; wouyang@amgen.com	Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864; Rutz, Sascha/0000-0003-2431-0938				Aki D, 2015, IMMUNOL REV, V266, P6, DOI 10.1111/imr.12301; Han L, 2014, J BIOL CHEM, V289, P25546, DOI 10.1074/jbc.M114.565291; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Kathania M, 2016, NAT IMMUNOL, V17, P997, DOI 10.1038/ni.3488; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Layman AAK, 2016, J IMMUNOL, V196, P3975, DOI 10.4049/jimmunol.1502660; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Park Y, 2014, ADV IMMUNOL, V124, P17, DOI 10.1016/B978-0-12-800147-9.00002-9; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Venuprasad K, 2015, IMMUNOL CELL BIOL, V93, P452, DOI 10.1038/icb.2014.118; Wang XW, 2015, J BIOL CHEM, V290, P29086, DOI 10.1074/jbc.M115.664573; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Yang J, 2015, J IMMUNOL, V194, P4094, DOI 10.4049/jimmunol.1401451	13	6	6	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					898	+		10.1038/ni.3516	http://dx.doi.org/10.1038/ni.3516			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27434002				2022-12-18	WOS:000380647000004
J	Delgoffe, GM				Delgoffe, Greg M.			PP2A's restraint of mTOR is critical for T-reg cell activity	NATURE IMMUNOLOGY			English	Editorial Material							PHOSPHATASE PP2A; KINASE	Regulatory T cells must limit activation of the metabolic checkpoint kinase mTOR to maintain their identity. The lipid ceramide serves a unique role in this process by inducing phosphatase PP2A-mediated inhibition of the mTORC1 complex.	[Delgoffe, Greg M.] Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA USA; [Delgoffe, Greg M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Delgoffe, GM (corresponding author), Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA USA.; Delgoffe, GM (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA.	gdelgoffe@pitt.edu	Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135				Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Liu C, 2016, FEBS J, V283, P2731, DOI 10.1111/febs.13656; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Sharma MD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500845; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	12	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					478	479		10.1038/ni.3442	http://dx.doi.org/10.1038/ni.3442			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27092798				2022-12-18	WOS:000374323100005
J	Arsenio, J; Kakaradov, B; Metz, P; Yeo, GW; Chang, JT				Arsenio, Janilyn; Kakaradov, Boyko; Metz, Patrick; Yeo, Gene W.; Chang, John T.			CD8(+) T cell diversification by asymmetric cell division Response	NATURE IMMUNOLOGY			English	Letter							IMMUNITY; FATES		[Arsenio, Janilyn; Metz, Patrick; Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kakaradov, Boyko; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, UCSD Stem Cell & Bioinformat Programs, La Jolla, CA 92093 USA; [Kakaradov, Boyko; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Yeo, Gene W.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Yeo, Gene W.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore, Singapore	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR)	Arsenio, J (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	geneyeo@ucsd.edu; changj@ucsd.edu	Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Chang, John/0000-0003-0873-6218	NHGRI NIH HHS [HG004659, R01 HG004659] Funding Source: Medline; NIAID NIH HHS [R01 AI095277, AI095277] Funding Source: Medline; NIDDK NIH HHS [T32 DK007202, R01 DK093507] Funding Source: Medline; NIGMS NIH HHS [R01 GM084317] Funding Source: Medline; NIH HHS [OD008469, DP2 OD008469] Funding Source: Medline; NINDS NIH HHS [NS076449] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093507, T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008469] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Flossdorf M, 2015, NAT IMMUNOL, V16, P891, DOI 10.1038/ni.3235; Friedman J., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859	5	6	6	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					893	894		10.1038/ni.3234	http://dx.doi.org/10.1038/ni.3234			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287585	Green Accepted			2022-12-18	WOS:000359876900002
J	Iwasaki, A				Iwasaki, Akiko			Balancing family life with a science career	NATURE IMMUNOLOGY			English	Article								Women are underrepresented in the science and engineering fields. Difficulties in balancing family life and work have a big role in women's opting out of scientific career paths. Institutions and funding agencies need to work harder to reverse this disparity.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol,Dept Mol Cellular & Dev Biol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol,Dept Mol Cellular & Dev Biol, New Haven, CT 06510 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI054359] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Gilmartin SK., 2010, ACADEME; Martinez ED, 2007, EMBO REP, V8, P977, DOI 10.1038/sj.embor.7401110; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Science Foundation, 2013, WOM MIN PERS DIS SCI; Reuben E, 2014, P NATL ACAD SCI USA, V111, P4403, DOI 10.1073/pnas.1314788111; Shalley CE, 2004, LEADERSHIP QUART, V15, P33, DOI 10.1016/j.leaqua.2003.12.004; US National Institutes of Health Office of Extramural Research, 2011, FREQ ASK QUEST POL R; Yale University, 2014, YAL U FAC HDB	8	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					787	790		10.1038/ni.3199	http://dx.doi.org/10.1038/ni.3199			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26194275				2022-12-18	WOS:000358299200001
J	Feng, YQ; Rudensky, AY				Feng, Yongqiang; Rudensky, Alexander Y.			DNA methylation secures CD4(+) and CD8(+) T cell lineage borders	NATURE IMMUNOLOGY			English	Editorial Material							MAINTENANCE; IDENTITY; DNMT1	Dynamic control of DNA methylation in the Cd4 locus serves an important role in reinforcing the binary fate stability of helper and cytotoxic T cells.	[Feng, Yongqiang; Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY 10032 USA; [Feng, Yongqiang; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Program Immunol, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Feng, YQ (corresponding author), Howard Hughes Med Inst, New York, NY 10032 USA.	rudenska@mskcc.org	Feng, Yongqiang/AAR-7719-2021; Feng, Yongqiang/N-2731-2018	Feng, Yongqiang/0000-0002-2320-5063; Feng, Yongqiang/0000-0002-2320-5063				Boucheron N, 2014, NAT IMMUNOL, V15, P439, DOI 10.1038/ni.2864; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sellars M, 2015, NAT IMMUNOL, V16, P746, DOI 10.1038/ni.3198; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019	15	6	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					681	683		10.1038/ni.3207	http://dx.doi.org/10.1038/ni.3207			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086134				2022-12-18	WOS:000356445600002
J	Fitzgerald, KA; Rathinam, VAK				Fitzgerald, Katherine A.; Rathinam, Vijay A. K.			GBPs take AIM at Francisella	NATURE IMMUNOLOGY			English	Editorial Material							HOST-DEFENSE; INFLAMMASOME; ACTIVATION	Guanylate-binding proteins (GBPs) induced by type I interferon signaling cause lysis of Francisella bacteria that have reached the host-cell cytosol. The liberated bacterial DNA is then sensed by the cytosolic AIM2 inflammasome, which activates caspase-1 and leads to pyroptotic cell death.	[Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun, Worcester, MA 01605 USA; [Rathinam, Vijay A. K.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA	University of Massachusetts System; University of Massachusetts Worcester; University of Connecticut	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun, Worcester, MA 01605 USA.	rathinam@uchc.edu	Fitzgerald, Katherine/ABE-6317-2020; Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Fitzgerald, Kate/0000-0003-3175-609X				Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009	11	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					443	444		10.1038/ni.3144	http://dx.doi.org/10.1038/ni.3144			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898190				2022-12-18	WOS:000353305200004
J	Netea, MG; van de Veerdonk, FL				Netea, Mihai G.; van de Veerdonk, Frank L.			TREML4 adds fuel to the TLR7 fire	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGENS; PROTEIN; MEMBER; LUPUS; CELLS	The cell-surface receptor TREML4 amplifies cellular responses to single-stranded RNA by regulating recruitment of the adaptor MyD88 to the receptor TLR7. Mice lacking TREML4 show impaired antiviral immunity but also reduced severity of lupus-like disease.	[Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	mihai.netea@radboudumc.nl; f.vandeveerdonk@radboudumc.nl	Netea, Mihai/N-5155-2014; van de Veerdonk, Frank L/C-7256-2008	van de Veerdonk, Frank L/0000-0002-1121-4894				Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Chen DY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4193; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dominguez-Villar M, 2015, NAT IMMUNOL, V16, P118, DOI 10.1038/ni.3036; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Hemmi H, 2012, J IMMUNOL, V188, P1147, DOI 10.4049/jimmunol.1102541; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175	13	6	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					445	446		10.1038/ni.3149	http://dx.doi.org/10.1038/ni.3149			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898191				2022-12-18	WOS:000353305200005
J	Vasanthakumar, A; Moro, K; Xin, A; Liao, Y; Gloury, R; Kawamoto, S; Fagarasan, S; Mielke, LA; Afshar-Sterle, S; Masters, SL; Nakae, S; Saito, H; Wentworth, JM; Li, P; Liao, W; Leonard, WJ; Smyth, GK; Shi, W; Nutt, SL; Koyasu, S; Kallies, A				Vasanthakumar, Ajithkumar; Moro, Kazuyo; Xin, Annie; Liao, Yang; Gloury, Renee; Kawamoto, Shimpei; Fagarasan, Sidonia; Mielke, Lisa A.; Afshar-Sterle, Shoukat; Masters, Seth L.; Nakae, Susumu; Saito, Hirohisa; Wentworth, John M.; Li, Peng; Liao, Wei; Leonard, Warren J.; Smyth, Gordon K.; Shi, Wei; Nutt, Stephen L.; Koyasu, Shigeo; Kallies, Axel			The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells (vol 16, pg 276, 2015)	NATURE IMMUNOLOGY			English	Correction													Fagarasan, Sidonia/A-5258-2016; Leonard, Warren/AAA-1397-2022; Masters, Seth L/N-2886-2013; Nutt, Stephen L/C-9256-2013; Koyasu, Shigeo/J-5583-2015	Fagarasan, Sidonia/0000-0003-2086-6402; Masters, Seth L/0000-0003-4763-576X; Nutt, Stephen L/0000-0002-0020-6637; Kallies, Axel/0000-0002-6312-6968; Wentworth, John/0000-0002-5197-3529; Saito, Hirohisa/0000-0002-6630-8337; Koyasu, Shigeo/0000-0001-9585-3038; VASANTHAKUMAR, AJITHKUMAR/0000-0002-1620-7781	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085	1	6	6	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					544	544		10.1038/ni0515-544d	http://dx.doi.org/10.1038/ni0515-544d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898200	Bronze			2022-12-18	WOS:000353305200020
J	Pathak, SK; Basu, S; Basu, KK; Banerjee, A; Pathak, S; Bhattacharyya, A; Kaisho, T; Kundu, M; Basu, J				Pathak, Sushil Kumar; Basu, Sanchita; Basu, Kunal Kumar; Banerjee, Anirban; Pathak, Shresh; Bhattacharyya, Asima; Kaisho, Tsuneyasu; Kundu, Manikuntala; Basu, Joyoti			Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages (vol 8, pg 610, 2007)	NATURE IMMUNOLOGY			English	Correction																		Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468	1	6	9	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					326	326		10.1038/ni0315-326b	http://dx.doi.org/10.1038/ni0315-326b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689444	Bronze			2022-12-18	WOS:000349842100017
J	Zouali, M				Zouali, Moncef			Tweaking the B lymphocyte compartment in autoimmune diseases	NATURE IMMUNOLOGY			English	Editorial Material							T-LYMPHOCYTES; AUTOPHAGY; CELLS; STIM1; INDUCTION; TOLERANCE; PEPTIDES		[Zouali, Moncef] INSERM, UMR S1132, Paris, France; [Zouali, Moncef] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zouali, M (corresponding author), INSERM, UMR S1132, Paris, France.	moncef.zouali@wanadoo.fr		Zouali, Moncef/0000-0002-8225-456X				Alessandri C, 2012, FASEB J, V26, P4722, DOI 10.1096/fj.12-206060; Arsov I, 2011, J IMMUNOL, V186, P2201, DOI 10.4049/jimmunol.1002223; Belogurov AA, 2013, FASEB J, V27, P222, DOI 10.1096/fj.12-213975; Cancro MP, 2009, NAT REV IMMUNOL, V9, P657, DOI 10.1038/nri2621; Chan AC, 2013, NAT IMMUNOL, V14, P106, DOI 10.1038/ni.2473; Chatterjee P, 2013, EUR J IMMUNOL, V43, P2441, DOI 10.1002/eji.201343412; Cheng KT, 2012, P NATL ACAD SCI USA, V109, P14544, DOI 10.1073/pnas.1207354109; Goenka R, 2014, J EXP MED, V211, P45, DOI 10.1084/jem.20130505; Gros F, 2012, AUTOPHAGY, V8, P1113, DOI 10.4161/auto.20275; Henry RA, 2012, DIABETES, V61, P2037, DOI 10.2337/db11-1746; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Ma JA, 2010, EUR J IMMUNOL, V40, P3028, DOI 10.1002/eji.201040614; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Owczarczyk K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002432; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Shaw P.J., 2012, J PHYSIOL-LONDON, V590, P4157; Steinman L, 2012, NAT MED, V18, P59, DOI 10.1038/nm.2625; Watanabe K, 2008, BIOCHEM BIOPH RES CO, V374, P274, DOI 10.1016/j.bbrc.2008.07.013	20	6	6	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					209	212		10.1038/ni.2827	http://dx.doi.org/10.1038/ni.2827			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24549062				2022-12-18	WOS:000331683100002
J	Deguine, J; Lee, BL; Newman, ZR; Barton, GM				Deguine, Jacques; Lee, Bettina L.; Newman, Zachary R.; Barton, Gregory M.			No antigen-presentation defect in Unc93b1(3d/3d) (3d) mice	NATURE IMMUNOLOGY			English	Letter							HUMAN UNC-93B; BINDING		[Deguine, Jacques; Lee, Bettina L.; Newman, Zachary R.; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Deguine, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	barton@berkeley.edu		Deguine, Jacques/0000-0001-9218-3040; Barton, Gregory/0000-0002-3793-0100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072429, R01AI104914, P01AI063302, R01AI095587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NIAID NIH HHS [AI072429, AI063302, P01 AI063302, R01 AI072429, R01 AI095587, R01 AI104914] Funding Source: Medline; NIGMS NIH HHS [T32 GM007232] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kim J, 2013, J IMMUNOL, V190, P5287, DOI 10.4049/jimmunol.1202767; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koehn J, 2007, HUM IMMUNOL, V68, P871, DOI 10.1016/j.humimm.2007.07.007; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; NIKOLICZUGIC J, 1990, EUR J IMMUNOL, V20, P2431, DOI 10.1002/eji.1830201111; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297	9	6	6	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1101	1102						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24145778	Green Accepted			2022-12-18	WOS:000326023400001
J	Schenkel, JM; Fraser, KA; Vezys, V; Masopust, D				Schenkel, Jason M.; Fraser, Kathryn A.; Vezys, Vaiva; Masopust, David			Sensing and alarm function of resident memory CD8(+) T cells (vol 14, pg 509, 2013)	NATURE IMMUNOLOGY			English	Correction													Vezys, Vaiva/N-3144-2013	Vezys, Vaiva/0000-0002-2520-809X				Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568	1	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					876	876		10.1038/ni0813-876c	http://dx.doi.org/10.1038/ni0813-876c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN		Bronze			2022-12-18	WOS:000322010600019
J	Jarrossay, D; Thelen, M				Jarrossay, David; Thelen, Marcus			Immune response: steroids drive dendritic cells	NATURE IMMUNOLOGY			English	Editorial Material							LOCALIZATION; HOMEOSTASIS	The newly identified steroid ligand of the receptor EBI2 (GPCR183), 7 alpha,25-dihydroxycholesterol, is required for the positioning of splenic CD4(+) dendritic cells in bridging channels to prime T cells for an efficient antibody response.	[Jarrossay, David; Thelen, Marcus] Biomed Res Inst, Bellinzona, Switzerland	Universita della Svizzera Italiana	Jarrossay, D (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	david.jarrossay@irb.usi.ch; marcus.thelen@irb.usi.ch						Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Czeloth N, 2007, J IMMUNOL, V179, P5855, DOI 10.4049/jimmunol.179.9.5855; Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555; Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015	12	6	6	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					424	426		10.1038/ni.2589	http://dx.doi.org/10.1038/ni.2589			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23598391				2022-12-18	WOS:000317732100006
J	Adams, EJ; Luoma, AM				Adams, Erin J.; Luoma, Adrienne M.			The yin and yang of CD1d recognition	NATURE IMMUNOLOGY			English	Editorial Material							NKT CELLS; T-CELLS; SULFATIDE	Structural studies identify considerable differences in the recognition of CD1d-lipid complexes by the TCRs of type II and type I (invariant) natural killer T cells.	[Adams, Erin J.; Luoma, Adrienne M.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Adams, EJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	ejadams@uchicago.edu						Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Exley MA, 2002, J IMMUNOL, V168, P1519, DOI 10.4049/jimmunol.168.4.1519; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Haig NA, 2011, J BIOL CHEM, V286, P37692, DOI 10.1074/jbc.M111.267948; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Rhost S., 2012, SCAND J IMMUNOL, DOI [10.1111/.1365-3083.2012.02750.x, DOI 10.1111/.1365-3083.2012.02750.X]	12	6	6	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					814	815		10.1038/ni.2401	http://dx.doi.org/10.1038/ni.2401			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22910387				2022-12-18	WOS:000307863600008
J	Hayday, A; Tigelaar, R				Hayday, Adrian; Tigelaar, Robert			Casting new light on the TCR	NATURE IMMUNOLOGY			English	Editorial Material							DELTA T-CELLS; LYMPHOID STRESS-SURVEILLANCE; INTERFERON-GAMMA; RECEPTOR	Dynamic imaging portrays intraepidermal T cells as truly autoreactive, constitutively transmitting signals from a putative ligand expressed by normal epithelial cells.	[Hayday, Adrian] Kings Coll London, Canc Res UK, London WC2R 2LS, England; [Hayday, Adrian] Kings Coll London, Peter Gorer Dept Immunobiol, London WC2R 2LS, England; [Tigelaar, Robert] Yale Univ, Dept Dermatol, New Haven, CT 06520 USA	Cancer Research UK; University of London; King's College London; University of London; King's College London; Yale University	Hayday, A (corresponding author), Kings Coll London, Canc Res UK, London WC2R 2LS, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793	Cancer Research UK Funding Source: Medline; Wellcome Trust [085780] Funding Source: Medline; Cancer Research UK [19309] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)		ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Chorro L, 2010, TRENDS IMMUNOL, V31, P438, DOI 10.1016/j.it.2010.09.003; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Uchida Y, 2011, J IMMUNOL, V186, P6945, DOI 10.4049/jimmunol.1003853; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698	16	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					209	211		10.1038/ni.2243	http://dx.doi.org/10.1038/ni.2243			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22344276				2022-12-18	WOS:000300510600005
J	Farrar, MA; Harris, LMH				Farrar, Michael A.; Harris, Lynn M. Heltemes			Turning transcription on or off with STAT5: when more is less	NATURE IMMUNOLOGY			English	Editorial Material							LIGHT-CHAIN RECOMBINATION; B-CELL-DEVELOPMENT	The transcription factor STAT5 can activate or repress gene expression depending on whether binding of dimer or tetrameric STAT5 occurs. Tetrameric STAT5 recruits the chromatin modifier Ezh2 to silence gene expression.	[Farrar, Michael A.; Harris, Lynn M. Heltemes] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Farrar, MA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	farra005@umn.edu	Farrar, Michael A/M-7802-2013	Farrar, Michael/0000-0002-5569-0366; Heltemes Harris, Lynn/0000-0002-2668-8005				Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Heltemes-Harris LM, 2011, ANN NY ACAD SCI, V1217, P18, DOI 10.1111/j.1749-6632.2010.05907.x; John S, 1999, MOL CELL BIOL, V19, P1910; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	11	6	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1139	1140		10.1038/ni.2163	http://dx.doi.org/10.1038/ni.2163			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22089213				2022-12-18	WOS:000297202700007
J	Beyaert, R				Beyaert, Rudi			SHP works a double shift to control TLR signaling	NATURE IMMUNOLOGY			English	Editorial Material							NUCLEAR RECEPTOR SHP; TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; SMALL HETERODIMER PARTNER; KAPPA-B; METABOLISM; GROWTH	Innate immune responses need to be tightly controlled to avoid autoimmune and inflammatory diseases. The atypical orphan nuclear receptor SHP has now been identified as a negative regulator of Toll-like receptor-induced activation of the transcription factor NF-kappa B.	[Beyaert, Rudi] VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium; [Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Beyaert, R (corresponding author), VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, Ghent, Belgium.	rudi.beyaert@dmbr.vib-ugent.be	Beyaert, Rudi/B-2589-2009	Beyaert, Rudi/0000-0002-5704-582X				Farhana L, 2007, CANCER RES, V67, P318, DOI 10.1158/0008-5472.CAN-06-2164; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YS, 2001, J BIOL CHEM, V276, P33736, DOI 10.1074/jbc.M101977200; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Ray M, 2010, J IMMUNOL, V185, P7309, DOI 10.4049/jimmunol.1000095; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09	12	6	9	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					725	727		10.1038/ni.2075	http://dx.doi.org/10.1038/ni.2075			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772282				2022-12-18	WOS:000292870700008
J	Liu, HM; Gale, M				Liu, Helene Minyi; Gale, Michael, Jr.			ZAPS electrifies RIG-I signaling	NATURE IMMUNOLOGY			English	Editorial Material							PROTEIN	ZAPS, a member of the poly(ADP-ribose) polymerase family, modulates innate antiviral immunity by boosting signaling of the RNA helicase RIG-I.	[Liu, Helene Minyi; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Liu, HM (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	mgale@uw.edu	Liu, Helene Minyi/Y-1834-2019	Liu, Helene Minyi/0000-0003-4837-5373; Gale, Michael/0000-0002-6332-7436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060389] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060389-11, R01 AI060389] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	10	6	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					11	12		10.1038/ni0111-11	http://dx.doi.org/10.1038/ni0111-11			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21169998				2022-12-18	WOS:000285465100005
J	Veldhoen, M				Veldhoen, Marc			A toxin-sensitive receptor able to reduce immunopathology	NATURE IMMUNOLOGY			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR; T-CELLS; DIFFERENTIATION; INFLAMMATION	Immunohomeostasis prevents pathology resulting from immune activation. Two new studies link its regulation with the activation of the aryl hydrocarbon receptor, a known mediator of the toxic effects of xenobiotic ligands, in a subset of T lymphocytes.	Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Veldhoen, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	marc.veldhoen@bbsrc.ac.uk	Veldhoen, Marc/AAJ-2759-2020; Veldhoen, Marc/AAM-5357-2021	Veldhoen, Marc/0000-0002-1478-9562; 				Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Funatake CJ, 2009, J IMMUNOTOXICOL, V6, P194, DOI 10.1080/15476910903124454; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	12	6	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					779	781		10.1038/ni0910-779	http://dx.doi.org/10.1038/ni0910-779			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20720583				2022-12-18	WOS:000281115500004
J	Krummel, MF				Krummel, Matthew F.			Illuminating emergent activity in the immune system by real-time imaging	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; IN-VIVO; ACTIVATION; DYNAMICS		Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu			NATIONAL CANCER INSTITUTE [U01CA141451] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052116] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA141451] Funding Source: Medline; NHLBI NIH HHS [P01 HL024136] Funding Source: Medline; NIAID NIH HHS [AI52116, R01 AI052116] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azar GA, 2010, P NATL ACAD SCI USA, V107, P3675, DOI 10.1073/pnas.0905901107; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Delmotte P, 2006, AM J RESP CELL MOL, V35, P110, DOI 10.1165/rcmb.2005-0417OC; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Filippi CM, 2008, DIABETES, V57, P2684, DOI 10.2337/db08-0609; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Koshland DE, 1998, SCIENCE, V280, P852, DOI 10.1126/science.280.5365.852; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	17	6	7	3	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					554	557		10.1038/ni0710-554	http://dx.doi.org/10.1038/ni0710-554			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562836				2022-12-18	WOS:000278926400006
J	Lillemeier, BF; Mortelmaier, MA; Forstner, MB; Huppa, JB; Groves, JT; Davis, MM				Lillemeier, Bjoern F.; Moertelmaier, Manuel A.; Forstner, Martin B.; Huppa, Johannes B.; Groves, Jay T.; Davis, Mark M.			TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation (vol 11, pg 90, 2010)	NATURE IMMUNOLOGY			English	Correction													Huppa, Johannes Bernhard/AAY-9471-2021	Huppa, Johannes Bernhard/0000-0003-2634-8198; Moertelmaier, Manuel/0000-0003-4239-9809				Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832	1	6	6	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					543	543		10.1038/ni0610-543b	http://dx.doi.org/10.1038/ni0610-543b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV		Bronze			2022-12-18	WOS:000277821300017
J	Tait, ED; Hunter, CA				Tait, Elia D.; Hunter, Christopher A.			The Foxo and the hound: chasing the in vivo regulation of T cell populations during infection	NATURE IMMUNOLOGY			English	Editorial Material							CTLA-4; ACTIVATION; SURVIVAL; CANCER	T cell expansion and contraction during the immune response to pathogens are regulated by a wide variety of cell-intrinsic and cell-extrinsic factors. A new study identifies a role for CTLA-4 signaling and activation of the Foxo3 transcription factor in modulating T cell populations.	[Tait, Elia D.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Tait, ED (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Hunter, Christopher/H-1970-2011	Tait Wojno, Elia/0000-0003-2822-296X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042334] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042334] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bachmann MF, 1998, J IMMUNOL, V160, P95; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Fong L, 2008, J CLIN ONCOL, V26, P5275, DOI 10.1200/JCO.2008.17.8954; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Masson F, 2008, IMMUNOL CELL BIOL, V86, P333, DOI 10.1038/icb.2008.15; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	14	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					457	458		10.1038/ni0509-457	http://dx.doi.org/10.1038/ni0509-457			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19381139	Bronze			2022-12-18	WOS:000265394400006
J	Godfrey, DI; Stankovic, S; Baxter, AG				Godfrey, Dale I.; Stankovic, Sanda; Baxter, Alan G.			Developing NKT cells need their calcium	NATURE IMMUNOLOGY			English	Editorial Material							THYMOCYTE DEVELOPMENT; DIFFERENTIATION; REGULATORS; SELECTION; SURVIVAL; EGR2	Although the development of natural killer T cells is a T cell antigen receptor-dependent process, the signaling pathways involved are poorly defined. New data demonstrate that the calcineurin-transcription factor NFAT pathway exerts a critical influence on this process by controlling the transcription factor Egr2.	[Godfrey, Dale I.; Stankovic, Sanda] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Baxter, Alan G.] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia	University of Melbourne; James Cook University	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au	Baxter, Alan G/A-1412-2010	Baxter, Alan G/0000-0002-6960-9821; Godfrey, Dale/0000-0002-3009-5472				Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; LeBlanc SE, 2005, J NEUROCHEM, V93, P737, DOI 10.1111/j.1471-4159.2005.03056.x; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Szigeti K, 2007, NEUROGENETICS, V8, P257, DOI 10.1007/s10048-007-0094-0; Wilkinson Beverley, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010264; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	15	6	6	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					231	233		10.1038/ni0309-231	http://dx.doi.org/10.1038/ni0309-231			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19221550				2022-12-18	WOS:000263456500003
J	Wallach, D; Kovalenko, A				Wallach, David; Kovalenko, Andrew			Self-termination of the terminator	NATURE IMMUNOLOGY			English	Editorial Material							B-INDUCING KINASE; NEGATIVE REGULATION; PATHWAYS; ACTIVATION; DOMAIN; CELLS; IAPS	The protein kinase NIK is regulated by a complex of ubiquitin ligases that destroys it. When NIK-activating receptors are triggered, the ubiquitin ligase complex self-destructs.	[Wallach, David; Kovalenko, Andrew] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	d.wallach@weizmann.ac.il						Ashwell JD, 2008, J CELL BIOL, V182, P15, DOI 10.1083/jcb.200806036; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Xiao GT, 2000, J BIOL CHEM, V275, P21081, DOI 10.1074/jbc.M002552200; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	16	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1325	1327		10.1038/ni1208-1325	http://dx.doi.org/10.1038/ni1208-1325			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	19008929				2022-12-18	WOS:000260888700004
J	Kawakami, T				Kawakami, Toshiaki			Basophils now enhance memory	NATURE IMMUNOLOGY			English	Editorial Material							CELL		La Jolla Inst Allergy & Immunol, Ctr Infect Dis, Div Cell Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Kawakami, T (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Infect Dis, Div Cell Biol, 9240 Athena Circle, La Jolla, CA 92037 USA.	toshi@liai.org	Kawakami, Toshiaki/O-1616-2015					Anderson SM, 2006, IMMUNOL REV, V211, P280, DOI 10.1111/j.0105-2896.2006.00398.x; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Marone Gianni, 2002, Trends in Immunology, V23, P425, DOI 10.1016/S1471-4906(02)02274-3; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tough D.F., 2003, FUNDAMENTAL IMMUNOLO, P865; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008	12	6	8	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					720	721		10.1038/ni0708-720	http://dx.doi.org/10.1038/ni0708-720			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18563081				2022-12-18	WOS:000256904900008
J	von Boehmer, H				von Boehmer, Harald			Positive and negative selection in Basel	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-RECEPTOR; CD4+8+ THYMOCYTES; TRANSGENIC MICE; BONE-MARROW; ANTIGEN; THYMUS; TOLERANCE; DIFFERENTIATION; LYMPHOCYTES; SPECIFICITY	Harald von Boehmer describes how he used mice transgenic for T cell receptor alpha beta to identify T cell receptor dependent cellular selection and lineage commitment as mechanisms responsible for generating an effective and self-tolerant adaptive immune system.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu						Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; REINHERZ EL, 1982, P NATL ACAD SCI-BIOL, V79, P6047, DOI 10.1073/pnas.79.19.6047; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; SHORTMAN K, 1974, CELL IMMUNOL, V12, P230, DOI 10.1016/0008-8749(74)90075-6; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Von Boehmer H, 1976, Nature, V261, P141, DOI 10.1038/261141a0; VONBOEHMER H, 1986, IMMUNOL TODAY, V7, P333; VONBOEHMER H, 1975, J EXP MED, V142, P989, DOI 10.1084/jem.142.4.989; VONBOEHMER H, 1975, J EXP MED, V141, P322; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882; ZINKERNAGEL RM, 1980, J EXP MED, V151, P376, DOI 10.1084/jem.151.2.376	25	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					571	573		10.1038/ni0608-571	http://dx.doi.org/10.1038/ni0608-571			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490902				2022-12-18	WOS:000256067900002
J	Farrar, J				Farrar, Jeremy			Global health science: a threat and an opportunity for collaborative clinical science	NATURE IMMUNOLOGY			English	Editorial Material							TROPICAL DISEASES; CHALLENGE	We will never have a better opportunity to improve public health globally. The question is whether we are shrewd enough, bold enough, and committed enough to make it happen.	Hosp Trop Dis, Ho Chi Minh City, Quan 5, Vietnam		Farrar, J (corresponding author), Hosp Trop Dis, Ho Chi Minh City, Quan 5, Vietnam.	jfarrar@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Garrett L, 2007, FOREIGN AFF, V86, P14; Gillies R, 2006, LANCET, V368, P1405, DOI 10.1016/S0140-6736(06)69584-6; Hien TT, 2004, NEW ENGL J MED, V351, P2363, DOI 10.1056/NEJMp048267; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Keusch GT, 2003, NATURE, V422, P561, DOI 10.1038/422561a; Rothwell PM, 2006, LANCET, V368, P262, DOI 10.1016/S0140-6736(06)69010-7; SHAKESPEARE W, JULIUS CAESAR, P269; White NJ, 2006, TROP MED INT HEALTH, V11, P1483, DOI 10.1111/j.1365-3156.2006.01765.x	9	6	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1277	1279		10.1038/ni1532	http://dx.doi.org/10.1038/ni1532			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17952076				2022-12-18	WOS:000251267000004
J	Crawford, A; Wherry, EJ				Crawford, Alison; Wherry, E. John			Inhibitory receptors: whose side are they on?	NATURE IMMUNOLOGY			English	Editorial Material							CD4(+) T-CELLS; DISEASE PROGRESSION; HIV-INFECTION; EXPRESSION; CTLA-4; PD-1; DYSFUNCTION; EXHAUSTION; BLOCKADE	A new study demonstrates involvement of the inhibitory receptor CTLA-4 in T cell exhaustion during infection with human immunodeficiency virus, adding complexity and diversity to the inhibitory pathways regulating T cell responses during chronic viral infections in humans.	Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA	The Wistar Institute	Wherry, EJ (corresponding author), Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA.	jwherry@wistar.org	Wherry, John/ABI-1280-2020; crawford, alison/AAS-3155-2020; Crawford, Alison/N-3234-2014	Crawford, Alison/0000-0002-4591-6341				Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; D'Souza M, 2007, J IMMUNOL, V179, P1979, DOI 10.4049/jimmunol.179.3.1979; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Steiner K, 1999, CLIN EXP IMMUNOL, V115, P451; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482	14	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1201	1203		10.1038/ni1107-1201	http://dx.doi.org/10.1038/ni1107-1201			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952048				2022-12-18	WOS:000250338900012
J	Jensen, CT; Kharazi, S; Boiers, C; Liuba, K; Jacobsen, SEW				Jensen, Christina T.; Kharazi, Shabnam; Boeiers, Charlotta; Liuba, Karina; Jacobsen, Sten Eirik W.			TSLP-mediated fetal B lymphopoiesis?	NATURE IMMUNOLOGY			English	Letter							THYMIC STROMAL LYMPHOPOIETIN; CELL DEVELOPMENT; IN-VITRO; RECEPTOR		Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden	Lund University	Jacobsen, SEW (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Jacobsen, Sten Eirik W/D-3974-2018	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Boiers, Charlotta/0000-0002-4876-1218	MRC [G0501838] Funding Source: UKRI; Medical Research Council [G0501838] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Levin SD, 1999, J IMMUNOL, V162, P677; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101	7	6	7	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					897	897		10.1038/ni0907-897	http://dx.doi.org/10.1038/ni0907-897			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17712336				2022-12-18	WOS:000248918200002
J	Kim, YM; Brinkmann, MM; Ploegh, HL				Kim, You-Me; Brinkmann, Melanie M.; Ploegh, Hidde L.			TLRs bent into shape	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTOR-3; CPG-DNA; BINDING; SIGNALS; ER	Toll-like receptors respond to ligands embedded in pathogen-derived macromolecules to induce immune responses. Binding of a stimulatory ligand to preexisting dimers of Toll-like receptor 9 induces conformational changes that lead to their full activation.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Kim, YM (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Kim, You-Me/I-5553-2013	Kim, You-Me/0000-0001-8780-704X				Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955	13	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					674	676		10.1038/nio707-675	http://dx.doi.org/10.1038/nio707-675			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ					2022-12-18	WOS:000247718100005
J	Underhill, DM; Shimada, T				Underhill, David M.; Shimada, Takahiro			A pair of 9s: it's in the CARDs	NATURE IMMUNOLOGY			English	Editorial Material							NF-KAPPA-B; CARMA1; INNATE; ACTIVATION; RECEPTORS; IMMUNITY; MALT1	New work shows that CARD9, the recently identified member of the caspase recruitment domain-containing family, directly interacts with the cytoplasmic protein Nod2 in the detection of intracellular bacteria.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Underhill, DM (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA.	david.underhill@cshs.org	UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X				Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744	11	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					122	124		10.1038/ni0207-122	http://dx.doi.org/10.1038/ni0207-122			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242682				2022-12-18	WOS:000243597600006
J	Mueller, DL				Mueller, Daniel L.			Linking diacylglycerol kinase to T cell anergy	NATURE IMMUNOLOGY			English	Editorial Material							CLONAL ANERGY; ACTIVATION; INDUCTION; UNRESPONSIVENESS; PROLIFERATION; TOLERANCE; ERK		Univ Minnesota, Dept Med, Sch Med, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Immunol, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mueller, DL (corresponding author), Univ Minnesota, Dept Med, Sch Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	muell002@umn.edu		Mueller, Daniel/0000-0003-1621-0419				Crespi D, 2002, EUR J IMMUNOL, V32, P2500, DOI 10.1002/1521-4141(200209)32:9<2500::AID-IMMU2500>3.0.CO;2-S; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; KAIBUCHI K, 1983, J BIOL CHEM, V258, P6701; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MUELLER DL, 1989, J IMMUNOL, V142, P2617; Powell JD, 1999, J IMMUNOL, V162, P2775; QUILL H, 1987, J IMMUNOL, V138, P3704; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	14	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1132	1134		10.1038/ni1106-1132	http://dx.doi.org/10.1038/ni1106-1132			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053795				2022-12-18	WOS:000241437200005
J	Linsley, PS				Linsley, PS			New look at an old costimulator	NATURE IMMUNOLOGY			English	Editorial Material							CD28; LIGATION; COMPLEX	The long-awaited structure of CD28 provides new understanding of its function and opens new avenues for probing this important costimulatory molecule.	Rosetta Inpharmat, Seattle, WA 98109 USA	Merck & Company	Linsley, PS (corresponding author), Rosetta Inpharmat, Seattle, WA 98109 USA.	peter_linsley@merck.com						Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Dennehy KM, 2003, INT IMMUNOL, V15, P655, DOI 10.1093/intimm/dxg063; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; LEDBETTER JA, 1990, BLOOD, V75, P1531; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Margulies DH, 2003, J EXP MED, V197, P949, DOI 10.1084/jem.20030303; Ottemann KM, 1998, BIOCHEMISTRY-US, V37, P7062, DOI 10.1021/bi980305e; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118	12	6	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					231	232		10.1038/ni0305-231	http://dx.doi.org/10.1038/ni0305-231			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15716969				2022-12-18	WOS:000227117400005
J	Bevins, CL				Bevins, CL			An important clue: fingerprints point to psoriasin in defense against E-coli	NATURE IMMUNOLOGY			English	Editorial Material							ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; SKIN	Human skin is surprisingly resistant to colonization by Escherichia coli, a prevalent commensal bacterium of the gut flora. An 11-kDa Zn2+-binding protein, psoriasin, is identified as the principal E. coli-bactericidal factor present at the surface of human skin.	Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Bevins, CL (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Tupper Hall Rm 3146,1 Shields Ave, Davis, CA 95616 USA.	clbevins@ucdavis.edu	Bevins, Charles L/P-4438-2015	Bevins, Charles L/0000-0003-2725-2622				Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; LEHRER RI, MUCOSAL IMMUNOLOGY; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	11	6	7	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					12	13		10.1038/ni0105-12	http://dx.doi.org/10.1038/ni0105-12			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15611775				2022-12-18	WOS:000225888500005
J	Wasserman, SA				Wasserman, SA			Nature's fortress against infection	NATURE IMMUNOLOGY			English	Editorial Material							ANTIMICROBIAL PEPTIDE; HOST-DEFENSE; SYSTEM	Correlative analyses of polymorphism and disease resistance in Drosophila melanogaster refine our understanding of the forces that maintain variation in innate immunity loci.	Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Wasserman, SA (corresponding author), Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92037 USA.	stevenw@ucsd.edu						Akira S, 2004, SEMIN IMMUNOL, V16, P1, DOI 10.1016/j.smim.2003.10.001; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; HEDENGRENOLCOTT M, IN PRESS J BIOL CHEM; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Qiu P, 1998, DEVELOPMENT, V125, P1909; Schlenke TA, 2003, GENETICS, V164, P1471; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999	11	6	8	2	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					474	475		10.1038/ni0504-474	http://dx.doi.org/10.1038/ni0504-474			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116113				2022-12-18	WOS:000221101100009
J	Engelhard, VH				Engelhard, VH			Creating new peptide antigens by slicing and splicing proteins	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-I MOLECULES; DISPLAY	The proteome universe may be best represented by the peptides caught by major histocompatibility complex proteins. Unusual peptides, such as the post-translationally spliced example seen by the authors of a recent Nature paper, would not be included in a protein world gleaned only from genomics.	Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA	University of Virginia	Engelhard, VH (corresponding author), Univ Virginia, Carter Immunol Ctr, Box 801386, Charlottesville, VA 22908 USA.	vhe@virginia.edu		Engelhard, Victor/0000-0002-1741-0925				Engelhard VH, 2002, MOL IMMUNOL, V39, P127, DOI 10.1016/S0161-5890(02)00096-2; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; MIN W, 1994, NAT STRUCT BIOL, V1, P502, DOI 10.1038/nsb0894-502; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; ROBBINS PF, 1995, J IMMUNOL, V154, P5944; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Yewdell J, 2002, MOL IMMUNOL, V39, P139, DOI 10.1016/S0161-5890(02)00097-4	9	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					128	129		10.1038/ni0204-128	http://dx.doi.org/10.1038/ni0204-128			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14749782				2022-12-18	WOS:000188512000007
J	Coyle, AJ; Gutierrez-Ramos, JC				Coyle, AJ; Gutierrez-Ramos, JC			More negative feedback?	NATURE IMMUNOLOGY			English	Editorial Material							RESPONSES; ICOS; BLOCKADE; CTLA-4; CELLS; PD-1	The identification of BLTA and its ligand B7x adds to the growing list of negative costimulatory molecules that can dampen the adaptive immune response.	Millennium Pharmaceut, Div Expt Med, Inflammat Dept, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Coyle, AJ (corresponding author), Millennium Pharmaceut, Div Expt Med, Inflammat Dept, Cambridge, MA 02139 USA.							Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6	10	6	7	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					647	648		10.1038/ni0703-647	http://dx.doi.org/10.1038/ni0703-647			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12830142				2022-12-18	WOS:000183952500009
J	Herberts, C; Reits, E; Neefjes, J				Herberts, C; Reits, E; Neefjes, J			Proteases, proteases and proteases for presentation	NATURE IMMUNOLOGY			English	Editorial Material							ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; PEPTIDES; AMINOPEPTIDASE; ERAP1; ER	Peptide epitope generation for MHC class I presentation is normally dependent upon proteasome activity. Yet this pathway fails to generate critical HIV epitopes. Instead, the protease TPPII is required for this activity.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Herberts, C (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211				Benham AM, 1998, J IMMUNOL, V161, P83; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; NEISIG A, 1995, J IMMUNOL, V154, P1273; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	13	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					306	308		10.1038/ni0403-306	http://dx.doi.org/10.1038/ni0403-306			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660727				2022-12-18	WOS:000181987700006
J	Ferrara, J				Ferrara, J			Location, location, location	NATURE IMMUNOLOGY			English	Editorial Material							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; PREVENTION; CELLS	Graft-versus-host disease results when donor T cells attack immunocompromised hosts. New data show the distinct environment of Peyer's patches triggers the activation of these aggressive anti-host responses.	Univ Michigan, Ctr Canc, Combined Bone Marrow Transplantat Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ferrara, J (corresponding author), Univ Michigan, Ctr Canc, Combined Bone Marrow Transplantat Program, Ann Arbor, MI 48109 USA.	ferrara@umich.edu						Cooke KR, 2001, J CLIN INVEST, V107, P1581, DOI 10.1172/JCI12156; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; KORNGOLD R, 1978, J EXP MED, V148, P1687; KORNGOLD R, 1999, HEMATOPOIETIC CELL T, P296; Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879; NESTEL FP, 1992, J EXP MED, V175, P405, DOI 10.1084/jem.175.2.405; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Panoskaltsis-Mortari A, 1998, BLOOD, V92, P3960, DOI 10.1182/blood.V92.10.3960.422k29_3960_3967; Reddy P, 2001, J EXP MED, V194, P1433, DOI 10.1084/jem.194.10.1433; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575	12	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					103	104		10.1038/ni0203-103	http://dx.doi.org/10.1038/ni0203-103			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555092				2022-12-18	WOS:000180686500006
J	Abraham, RT				Abraham, RT			Antigen receptors rap to integrin receptors	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; GENE	The biochemical events that mediate inside-out signaling to 1 and 2 integrin receptors after TCR ligation are poorly understood. Using a transgenic mouse model, investigators have implicated an unexpected candidate, Rap1, as a key mediator of inside-out signaling in activated T cells.	Burnham Inst, Program Signal Transduct Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Abraham, RT (corresponding author), Burnham Inst, Program Signal Transduct Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	abraham@burnham.org						Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765	10	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					212	213		10.1038/ni0302-212	http://dx.doi.org/10.1038/ni0302-212			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875457				2022-12-18	WOS:000174074000006
J	Kavathas, P; Soong, L				Kavathas, P; Soong, L			Gender inequity: challenging business as usual	NATURE IMMUNOLOGY			English	Editorial Material							WOMEN	Kavathas, Chair of the AAI Committee on the Status of Women (1998-2001) and Soong, a member of this committee, discuss the reasons for gender discrimination against women and what can be done to address the issue.	Yale Univ, New Haven, CT 06520 USA; Univ Texas, Med Branch, Galveston, TX 77555 USA	Yale University; University of Texas System; University of Texas Medical Branch Galveston	Kavathas, P (corresponding author), Yale Univ, New Haven, CT 06520 USA.							Dalton R, 2001, NATURE, V412, P844, DOI 10.1038/35091200; Fried LP, 1996, JAMA-J AM MED ASSOC, V276, P898, DOI 10.1001/jama.276.11.898; Lawler A, 1999, SCIENCE, V286, P1272, DOI 10.1126/science.286.5443.1272; Mark S, 2001, ACAD MED, V76, P39, DOI 10.1097/00001888-200101000-00011; *NIH NAT I ALL INF, 2001, INSTR REV SCI REV PR; Valian, 1999, WHY SO SLOW; WASSERMAN E, 2000, DOOR DREAM; Wenneras C, 2000, NATURE, V408, P647, DOI 10.1038/35047182; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; WHITNEY C, 2000, 9 COUNTING WOMEN SEN	10	6	6	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					985	987		10.1038/ni1101-985	http://dx.doi.org/10.1038/ni1101-985			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685216				2022-12-18	WOS:000172049800006
J	Haber, JE				Haber, JE			Hypermutation: give us a break	NATURE IMMUNOLOGY			English	News Item							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; SACCHAROMYCES-CEREVISIAE; IMMUNOGLOBULIN GENES; RECOMBINATION	Hypermutation and gene conversion appear to be distinct mechanisms that can explain somatic diversification of the antibody repertoire. Data in a recent Nature paper suggest unappreciated links between the two.	Brandeis Univ, Waltham, MA 02454 USA	Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Ctr Mailstop 029,415 South St, Waltham, MA 02454 USA.			Haber, James/0000-0002-1878-0610				BERMARK M, 2000, J EXP MED, V192, P1509; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Dalgaard JZ, 2001, TRENDS GENET, V17, P153, DOI 10.1016/S0168-9525(00)02203-4; Holbeck SL, 1997, GENETICS, V147, P1017; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X	14	6	6	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					902	903		10.1038/ni1001-902	http://dx.doi.org/10.1038/ni1001-902			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577343				2022-12-18	WOS:000171361500007
J	Moss, PAH				Moss, PAH			Redirecting T cell specificity by TCR gene transfer	NATURE IMMUNOLOGY			English	News Item							RECEPTOR GENES; LYMPHOCYTES	Potent cytotoxic T lymphocytes are needed for effective tumor eradication. Transfer of genes encoding tumor-specific receptors into T cells allows the efficient generation of an immune response.	Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England	University of Birmingham	Moss, PAH (corresponding author), Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England.		Moss, Paul/D-1728-2009	Moss, Paul/0000-0002-6895-1967				Clay TM, 1999, J IMMUNOL, V163, P507; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; Fujio K, 2000, J IMMUNOL, V165, P528, DOI 10.4049/jimmunol.165.1.528; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0	8	6	8	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					900	901		10.1038/ni1001-900	http://dx.doi.org/10.1038/ni1001-900			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577342				2022-12-18	WOS:000171361500006
J	Wu, L; Strasser, A				Wu, L; Strasser, A			"Decisions, decisions ...": beta-catenin-mediated activation of TCF-I and Lef-I influences the fate of developing T cells	NATURE IMMUNOLOGY			English	News Item							FADD/MORT1; APOPTOSIS; BCL-2; DIFFERENTIATION; PROLIFERATION; PATHWAYS; MUTANT; MICE	Successful passage through several developmental checkpoints determines whether thymocytes survive, proliferate or differentiate. New data show that Wnt-frizzled-induced activation of TCF-1 or Lef-1, via their coactivator beta -catenin, is critical during TCRB and TCRA gene rearrangement in thymocytes.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Wu, L (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.		Strasser, Andreas/C-7581-2013	Strasser, Andreas/0000-0002-5020-4891				Alfantis I, 2001, NATURE IMMUNOL, V2, P403; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	15	6	6	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					823	824		10.1038/ni0901-823	http://dx.doi.org/10.1038/ni0901-823			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526393				2022-12-18	WOS:000170781200018
J	Crowl, JT; Heeg, M; Ferry, A; Milner, JJ; Omilusik, KD; Toma, C; He, ZR; Chang, JT; Goldrath, AW				Crowl, John T.; Heeg, Maximilian; Ferry, Amir; Milner, J. Justin; Omilusik, Kyla D.; Toma, Clara; He, Zhaoren; Chang, John T.; Goldrath, Ananda W.			Tissue-resident memory CD8(+) T cells possess unique transcriptional, epigenetic and functional adaptations to different tissue environments	NATURE IMMUNOLOGY			English	Article							TGF-BETA; NONLYMPHOID TISSUE; ADIPOSE-TISSUE; MAINTENANCE; LANDSCAPES; PROGRAMS; PERSISTENCE; LYMPHOCYTES; INFECTION; RESERVOIR	Goldrath and colleagues define the diversity of gene expression and genome accessibility in mouse CD8(+) T-RM cells in distinct tissues and identify molecules critical forgeneration of CD8(+) T-RM cells in response to acute viral infection. Tissue-resident memory T cells (T-RM cells) provide protective immunity, but the contributions of specific tissue environments to T-RM cell differentiation and homeostasis are not well understood. In the present study, the diversity of gene expression and genome accessibility by mouse CD8(+) T-RM cells from distinct organs that responded to viral infection revealed both shared and tissue-specific transcriptional and epigenetic signatures. T-RM cells in the intestine and salivary glands expressed transforming growth factor (TGF)-beta-induced genes and were maintained by ongoing TGF-beta signaling, whereas those in the fat, kidney and liver were not. Constructing transcriptional-regulatory networks identified the transcriptional repressor Hic1 as a critical regulator of T-RM cell differentiation in the small intestine and showed that Hic1 overexpression enhanced T-RM cell differentiation and protection from infection. Provision of a framework for understanding how CD8(+) T-RM cells adapt to distinct tissue environments, and identification of tissue-specific transcriptional regulators mediating these adaptations, inform strategies to boost protective memory responses at sites most vulnerable to infection.	[Crowl, John T.; Heeg, Maximilian; Ferry, Amir; Milner, J. Justin; Omilusik, Kyla D.; Toma, Clara; Goldrath, Ananda W.] Univ Calif, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [He, Zhaoren; Chang, John T.] Univ Calif, Dept Med, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Goldrath, AW (corresponding author), Univ Calif, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu		Chang, John/0000-0003-0873-6218; Ferry, Amir/0000-0003-2884-083X; Goldrath, Ananda/0000-0002-5900-508X; Omilusik, Kyla/0000-0003-3675-048X	National Institutes of Health [AI067545, AI132122]; American Cancer Society Postdoctoral Fellowship [PF-20-048-01-LIB]; German Research Foundation fellowship [HE 8656/1-1];  [P30KC063491];  [P30CA023100]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); German Research Foundation fellowship(German Research Foundation (DFG)); ; 	This work was funded by the National Institutes of Health (grant no. AI067545 to A.W.G. and no. AI132122 to A.W.G. and J.T.Chang) and the American Cancer Society Postdoctoral Fellowship (grant no. PF-20-048-01-LIB to J.T.Crowl). ATAC-seq and scRNA-seq using the 10x Genomics platform was conducted at the IGM Genomics Center, UCSD and supported by grant nos. P30KC063491 and P30CA023100. A.W.G. is a UCSD Tata Chancellor's Professor. M.H. was supported by the German Research Foundation fellowship (no. HE 8656/1-1). We thank H. Nguyen for assistance with measuring LCMV titers, the Goldrath laboratory members for technical advice, helpful discussion and critical reading of the manuscript and the Immunological Genome Project for reagents and sample/data processing.	Adam M, 2017, DEVELOPMENT, V144, P3625, DOI 10.1242/dev.151142; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Beura LK, 2019, J EXP MED, V216, P1214, DOI 10.1084/jem.20181365; Boddupalli CS, 2016, J CLIN INVEST, V126, P3905, DOI 10.1172/JCI85329; Boland BS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb4432; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burrows K, 2017, MUCOSAL IMMUNOL, V10, P1518, DOI 10.1038/mi.2017.17; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; da Silva HB, 2020, IMMUNITY, V53, P158, DOI 10.1016/j.immuni.2020.06.010; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du N, 2014, P NATL ACAD SCI USA, V111, P16484, DOI 10.1073/pnas.1417215111; Frizzell H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay9283; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Hashimoto-Hill S, 2017, MUCOSAL IMMUNOL, V10, P912, DOI 10.1038/mi.2016.109; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Khan TN, 2016, J EXP MED, V213, P951, DOI 10.1084/jem.20151855; Kim D, 2014, DIABETOLOGIA, V57, P1456, DOI 10.1007/s00125-014-3237-5; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liao W, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101975; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Ma CY, 2017, J IMMUNOL, V198, P749, DOI 10.4049/jimmunol.1601500; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mani V, 2019, SCIENCE, V366, P202, DOI 10.1126/science.aav5728; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McFarland AP, 2021, IMMUNITY, V54, P1320, DOI 10.1016/j.immuni.2021.03.024; Milner JJ, 2020, P NATL ACAD SCI USA, V117, P25667, DOI 10.1073/pnas.2008571117; Milner JJ, 2020, IMMUNITY, V52, P808, DOI 10.1016/j.immuni.2020.04.007; Milner JJ, 2018, CURR OPIN IMMUNOL, V51, P162, DOI 10.1016/j.coi.2018.03.017; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mucida D, 2009, SEMIN IMMUNOL, V21, P14, DOI 10.1016/j.smim.2008.08.001; Nath AP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210495; O'Flanagan CH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1830-0; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Schenkel JM, 2016, J IMMUNOL, V196, P3920, DOI 10.4049/jimmunol.1502337; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Stark R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau1022; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Thom JT, 2015, CELL REP, V13, P1125, DOI 10.1016/j.celrep.2015.09.082; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Wu JX, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.048; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhang K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3262; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; ZHENG GX, 2017, NATURE, V0008	66	5	5	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1121	+		10.1038/s41590-022-01229-8	http://dx.doi.org/10.1038/s41590-022-01229-8		JUN 2022	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35761084				2022-12-18	WOS:000817057200006
J	Yang, X; Zhou, JF; Liu, CR; Qu, YF; Wang, WL; Xiao, MZX; Zhu, FX; Liu, ZS; Liang, QM				Yang, Xing; Zhou, Jingfan; Liu, Chengrong; Qu, Yafei; Wang, Weili; Xiao, Maggie Z. X.; Zhu, Fanxiu; Liu, Zhenshan; Liang, Qiming			KSHV-encoded ORF45 activates human NLRP1 inflammasome	NATURE IMMUNOLOGY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; INTERFERON; FIIND	At steady state, the NOD-like receptor (NLR)-containing pyrin domain (PYD) (NLRP)1 inflammasome is maintained in an auto-inhibitory complex by dipeptidyl peptidases 8 and 9 (DPP8 and DPP9) and is activated by pathogen-encoded proteases after infection. Here, we showed that the open reading frame (ORF)45 protein of the Kaposi's sarcoma-associated herpesvirus activated the human NLRP1 (hNLRP1) inflammasome in a non-protease-dependent manner, and we additionally showed that the Linker1 region of hNLRP1, situated between the PYD and NACHT domains, was required for the auto-inhibition and non-protease-dependent activation of hNLRP1. At steady state, the interaction between Linker1 and the UPA subdomain silenced the activation of hNLRP1 in auto-inhibitory complexes either containing DPP9 or not in a manner independent of DPP9. ORF45 binding to Linker1 displaced UPA from the Linker1-UPA complex and induced the release of the C-terminal domain of hNLRP1 for inflammasome assembly. The ORF45-dependent activation of the NLRP1 inflammasome was conserved in primates but was not observed for murine NLRP1b inflammasomes. Liang and colleagues show that the ORF45 protein from the Kaposi's sarcoma-associated herpesvirus activates NLRP1 by binding to its Linker1 region through a mechanism distinct from the previously described, host protease DPP9-dependent mechanism of NLRP1 activation.	[Yang, Xing; Zhou, Jingfan; Liu, Chengrong; Qu, Yafei; Wang, Weili; Liu, Zhenshan; Liang, Qiming] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Ctr Immune Related Dis,Shanghai Inst Immunol, Shanghai, Peoples R China; [Yang, Xing; Zhou, Jingfan; Liu, Chengrong; Qu, Yafei; Wang, Weili; Liu, Zhenshan; Liang, Qiming] Shanghai Jiao Tong Univ, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Dept Immunol & Microbiol,Sch Med, Shanghai, Peoples R China; [Xiao, Maggie Z. X.] Univ Alberta, Fac Med, Edmonton, AB, Canada; [Zhu, Fanxiu] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Liang, Qiming] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Res Ctr Translat Med, Shanghai, Peoples R China; [Liang, Qiming] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Liang, Qiming] Shanghai Jiao Tong Univ, Inst Pediat Infect Immun & Intens Care Med, Sch Med, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Alberta; State University System of Florida; Florida State University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liang, QM (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Ctr Immune Related Dis,Shanghai Inst Immunol, Shanghai, Peoples R China.; Liang, QM (corresponding author), Shanghai Jiao Tong Univ, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Dept Immunol & Microbiol,Sch Med, Shanghai, Peoples R China.; Liang, QM (corresponding author), Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Res Ctr Translat Med, Shanghai, Peoples R China.; Liang, QM (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.; Liang, QM (corresponding author), Shanghai Jiao Tong Univ, Inst Pediat Infect Immun & Intens Care Med, Sch Med, Shanghai, Peoples R China.	liangqiming@shsmu.edu.cn		Zhu, Fanxiu/0000-0002-4189-7008	National Key Research and Development Project of China [2018YFA0900802]; Shanghai Science and Technology Commission [22ZR1454500]; Shanghai Frontiers Science Center of Cellular Homeostasis and Human Disease; Shanghai Municipal Science and Technology Major Project [ZD2021CY001]; Innovative Research Team of High-level Local Universities in Shanghai; Shanghai Municipal Health Commission [201940179]	National Key Research and Development Project of China; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Frontiers Science Center of Cellular Homeostasis and Human Disease; Shanghai Municipal Science and Technology Major Project; Innovative Research Team of High-level Local Universities in Shanghai; Shanghai Municipal Health Commission	We thank J. U. Jung, K. Lan, X. Liang, J. Zhang, D.A. Leib, D. Pan, B. Du, J. Han, B. Fu, G. Long, G. Zou, N. Dong and F. Shao for providing plasmid constructs and different virus strains. We thank F. Shao (National Institute of Biological Sciences, China) for valuable suggestions. The Core Facility of Basic Medical Sciences at the Shanghai Jiao Tong University School of Medicine provided the cDNA plasmids for cloning. This work was supported by grants from the National Key Research and Development Project of China (2018YFA0900802, Q.L.), the Shanghai Science and Technology Commission (22ZR1454500, Q.L.), the Shanghai Frontiers Science Center of Cellular Homeostasis and Human Disease (Q.L.), the Shanghai Municipal Science and Technology Major Project (ZD2021CY001, Q.L.), the Innovative Research Team of High-level Local Universities in Shanghai (Q.L. and Z.L.) and the Shanghai Municipal Health Commission (201940179, Z.L.).	Alzhanova D, 2021, J VIROL, V95, DOI 10.1128/JVI.01459-21; Bauernfried S, 2021, SCIENCE, V371, P482, DOI 10.1126/science.abd0811; Becker-Hapak M., 2003, CURR PROTOC CELL BIO, VChapter 20, pUnit 20.2; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chavarria-Smith J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006052; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Fu BS, 2015, J VIROL, V89, P195, DOI 10.1128/JVI.01937-14; Gong Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20319-5; Gregory SM, 2011, SCIENCE, V331, P330, DOI 10.1126/science.1199478; Guo Haitao, 2020, Curr Protoc Immunol, V131, pe107, DOI 10.1002/cpim.107; Hollingsworth LR, 2021, NATURE, V592, P778, DOI 10.1038/s41586-021-03350-4; Hollingsworth LR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20320-y; Huang MH, 2021, NATURE, V592, P773, DOI 10.1038/s41586-021-03320-w; Jia X, 2016, J VIROL, V90, P7587, DOI 10.1128/JVI.03231-15; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Li JJ, 2021, MED-CAMBRIDGE, V2, P99, DOI 10.1016/j.medj.2020.07.002; Li XJ, 2009, J VIROL, V83, P2531, DOI 10.1128/JVI.02209-08; Liang QM, 2018, J VIROL, V92, DOI 10.1128/JVI.00914-17; Liang QM, 2012, J VIROL, V86, P10162, DOI 10.1128/JVI.05224-11; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Mitchell PS, 2019, CURR OPIN IMMUNOL, V60, P37, DOI 10.1016/j.coi.2019.04.015; Robinson KS, 2020, SCIENCE, V370, P1182, DOI 10.1126/science.aay2002; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Sharif H, 2021, IMMUNITY, V54, P1392, DOI 10.1016/j.immuni.2021.04.024; Taabazuing CY, 2020, IMMUNOL REV, V297, P13, DOI 10.1111/imr.12884; Tsu BV, 2021, ELIFE, V10, DOI 10.7554/eLife.60609; Wang X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005332; Xu H, 2019, EMBO J, V38, DOI 10.15252/embj.2019101996; Zeng JX, 2020, CELL STEM CELL, V27, P618, DOI 10.1016/j.stem.2020.07.012; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	38	5	5	5	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					916	+		10.1038/s41590-022-01199-x	http://dx.doi.org/10.1038/s41590-022-01199-x		MAY 2022	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35618833				2022-12-18	WOS:000805552300003
J	Moretti, J; Jia, BS; Hutchins, Z; Roy, S; Yip, H; Wu, JH; Shan, MM; Jaffrey, SR; Coers, J; Blander, JM				Moretti, Julien; Jia, Baosen; Hutchins, Zachary; Roy, Soumit; Yip, Hilary; Wu, Jiahui; Shan, Meimei; Jaffrey, Samie R.; Coers, Jorn; Blander, J. Magarian			Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome	NATURE IMMUNOLOGY			English	Article							BACTERIAL RNA; AGGREGATION BEHAVIOR; MICROBIAL VIABILITY; LIPOPOLYSACCHARIDE; PROTEIN; MECHANISM; TRIF; CELL	Caspase-11 detection of intracellular lipopolysaccharide (LPS) from invasive Gram-negative bacteria mediates noncanonical activation of the NLRP3 inflammasome. While avirulent bacteria do not invade the cytosol, their presence in tissues necessitates clearance and immune system mobilization. Despite sharing LPS, only live avirulent Gram-negative bacteria activate the NLRP3 inflammasome. Here, we found that bacterial mRNA, which signals bacterial viability, was required alongside LPS for noncanonical activation of the NLRP3 inflammasome in macrophages. Concurrent detection of bacterial RNA by NLRP3 and binding of LPS by pro-caspase-11 mediated a pro-caspase-11-NLRP3 interaction before caspase-11 activation and inflammasome assembly. LPS binding to pro-caspase-11 augmented bacterial mRNA-dependent assembly of the NLRP3 inflammasome, while bacterial viability and an assembled NLRP3 inflammasome were necessary for activation of LPS-bound pro-caspase-11. Thus, the pro-caspase-11-NLRP3 interaction nucleated a scaffold for their interdependent activation explaining their functional reciprocal exclusivity. Our findings inform new vaccine adjuvant combinations and sepsis therapy. Blander and colleagues show that concurrent detection of LPS and bacterial RNA triggers the interaction of procaspase-11 with NLRP3, upstream of the activation of either receptor and before NLRP3-ASC oligomerization.	[Moretti, Julien; Jia, Baosen; Hutchins, Zachary; Yip, Hilary; Shan, Meimei; Blander, J. Magarian] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA; [Moretti, Julien; Jia, Baosen; Hutchins, Zachary; Yip, Hilary; Shan, Meimei; Blander, J. Magarian] Cornell Univ, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA; [Roy, Soumit] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA; [Wu, Jiahui; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Cornell Med, New York, NY 10021 USA; [Coers, Jorn] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC USA; [Coers, Jorn] Duke Univ, Dept Immunol, Med Ctr, Durham, NC USA; [Blander, J. Magarian] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA; [Blander, J. Magarian] Cornell Univ, Sandra & Edward Meyer Canc Ctr, Weill Cornell Med, New York, NY 10021 USA; [Blander, J. Magarian] Weill Cornell Med, Immunol & Microbial Pathogenesis Program, Grad Sch Med Sci, New York, NY 10021 USA; [Hutchins, Zachary] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Roy, Soumit] 182 E 95th St, New York, NY USA; [Shan, Meimei] Patch Biosci, New York, NY USA	Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai; Cornell University; Duke University; Duke University; Cornell University; Cornell University; Cornell University; Jefferson University	Blander, JM (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA.; Blander, JM (corresponding author), Cornell Univ, Sandra & Edward Meyer Canc Ctr, Weill Cornell Med, New York, NY 10021 USA.; Blander, JM (corresponding author), Weill Cornell Med, Immunol & Microbial Pathogenesis Program, Grad Sch Med Sci, New York, NY 10021 USA.	jmblander@med.cornell.edu		Blander, Julie Magarian/0000-0001-9207-1700; Moretti, Julien/0000-0002-3415-9058; Wu, Jiahui (Chris)/0000-0003-2406-6728; Yip, Hilary/0000-0002-0432-1923	National Institutes of Health (NIH) [AI127658, AI139425, R35NS111631]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Awards; NIH [DK072201, DK111862, AI095245, AI123284]; Leukemia and Lymphoma Society	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	We are grateful to D. Amsen, N. Vabret, T. Kanneganti, K. Fitzgerald, V. Dixit, F. Shao, M. Goldberg, R. Ernst, J. Chipuk, J. Gelles-Hurwitz and R. Flavell for reagents and discussions. We thank D. Filipescu, C. Brou, P. Chastagner, A. Israel, A. Zanin-Zhorov, S. Waksal, M.A. Blander and S.J. Blander for their support. This work was supported by National Institutes of Health (NIH) grants AI127658 to J.M.B., AI139425 to J.C., R35NS111631 to S.R.J. and Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Awards to J.M.B and to J.C. The Blander laboratory was supported by NIH grants DK072201, DK111862, AI095245 and AI123284 to J.M.B. J.M.B. was supported by the Leukemia and Lymphoma Society.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; An J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36811-4; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; Barbet G, 2018, IMMUNITY, V48, P584, DOI 10.1016/j.immuni.2018.02.015; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Bergstrand A, 2006, COLLOID SURFACE B, V53, P9, DOI 10.1016/j.colsurfb.2006.06.007; Blander JM, 2018, CURR OPIN PHARMACOL, V41, P128, DOI 10.1016/j.coph.2018.05.012; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Cavaillon JM, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201810128; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Deets KA, 2021, NAT IMMUNOL, V22, P412, DOI 10.1038/s41590-021-00869-6; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Eigenbrod T, 2012, J IMMUNOL, V189, P328, DOI 10.4049/jimmunol.1103258; Finethy R, 2017, MBIO, V8, DOI 10.1128/mBio.01188-17; Gros M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00041; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hayward JA, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00015-18; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kutsch M, 2020, EMBO J, V39, DOI 10.15252/embj.2020104926; Lieberman J, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav1447; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lugrin J, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2292; Moretti J, 2018, METHODS MOL BIOL, V1714, P167, DOI 10.1007/978-1-4939-7519-8_11; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Munoz-Wolf N, 2018, FEBS J, V285, P2377, DOI 10.1111/febs.14467; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; NIERLICH DP, 1972, J MOL BIOL, V72, P765, DOI 10.1016/0022-2836(72)90190-8; Ramsby Melinda, 2011, Cold Spring Harb Protoc, V2011, pprot5592, DOI 10.1101/pdb.prot5592; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Reynolds CM, 2009, BIOCHEMISTRY-US, V48, P9627, DOI 10.1021/bi901391g; Sanchez-Garrido J, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13184; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sanders MG, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.186; Santos JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16889-z; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Sha WW, 2014, P NATL ACAD SCI USA, V111, P16059, DOI 10.1073/pnas.1412487111; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Strack R, 2019, NAT METHODS, V16, P1075, DOI 10.1038/s41592-019-0633-2; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Ugolini M, 2018, NAT IMMUNOL, V19, P386, DOI 10.1038/s41590-018-0068-4; Vanaja SK, 2014, P NATL ACAD SCI USA, V111, P7765, DOI 10.1073/pnas.1400075111; Wandel MP, 2020, NAT IMMUNOL, V21, P880, DOI 10.1038/s41590-020-0697-2; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wu JH, 2019, NAT METHODS, V16, P862, DOI 10.1038/s41592-019-0531-7	60	5	5	9	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					705	+		10.1038/s41590-022-01192-4	http://dx.doi.org/10.1038/s41590-022-01192-4		APR 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35487985	Green Accepted			2022-12-18	WOS:000788971400003
J	Shinzawa, M; Moseman, EA; Gossa, S; Mano, Y; Bhattacharya, A; Guinter, T; Alag, A; Chen, XF; Cam, M; McGavern, DB; Erman, B; Singer, A				Shinzawa, Miho; Moseman, E. Ashley; Gossa, Selamawit; Mano, Yasuko; Bhattacharya, Abhisek; Guinter, Terry; Alag, Amala; Chen, Xiongfong; Cam, Maggie; McGavern, Dorian B.; Erman, Batu; Singer, Alfred			Reversal of the T cell immune system reveals the molecular basis for T cell lineage fate determination in the thymus	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; LYMPHOCYTIC CHORIOMENINGITIS; TRANSCRIPTION FACTORS; NEGATIVE SELECTION; RUNX PROTEINS; TCR SIGNALS; CD4; DIFFERENTIATION; THYMOCYTES; EXPRESSION	To determine how T cell lineage fates are determined in the thymus, Singer and colleagues generated 'FlipFlop' mice with a functionally reversed T cell immune system that distinguishes TCR signal strength versus TCR signal duration. T cell specificity and function are linked during development, as MHC-II-specific TCR signals generate CD4 helper T cells and MHC-I-specific TCR signals generate CD8 cytotoxic T cells, but the basis remains uncertain. We now report that switching coreceptor proteins encoded by Cd4 and Cd8 gene loci functionally reverses the T cell immune system, generating CD4 cytotoxic and CD8 helper T cells. Such functional reversal reveals that coreceptor proteins promote the helper-lineage fate when encoded by Cd4, but promote the cytotoxic-lineage fate when encoded in Cd8-regardless of the coreceptor proteins each locus encodes. Thus, T cell lineage fate is determined by cis-regulatory elements in coreceptor gene loci and is not determined by the coreceptor proteins they encode, invalidating coreceptor signal strength as the basis of lineage fate determination. Moreover, we consider that evolution selected the particular coreceptor proteins that Cd4 and Cd8 gene loci encode to avoid generating functionally reversed T cells because they fail to promote protective immunity against environmental pathogens.	[Shinzawa, Miho; Mano, Yasuko; Bhattacharya, Abhisek; Guinter, Terry; Alag, Amala; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Moseman, E. Ashley; Gossa, Selamawit; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Moseman, E. Ashley] Duke Univ, Dept Immunol, Sch Med, Durham, NC USA; [Chen, Xiongfong; Cam, Maggie] NCI, Off Sci & Technol Resources, Off Director, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Chen, Xiongfong] Frederick Natl Lab Canc Res, CCR SF Bioinformat Grp, Adv Biomed Computat Sci Biomed Informat & Data Sc, Frederick, MD USA; [Erman, Batu] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Bogazici University	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	Singera@nih.gov	erman, batu/AAE-1963-2020; McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X; Shinzawa, Miho/0000-0001-7174-2464; Bhattacharya, Abhisek/0000-0002-1667-7169; Mano, Yasuko/0000-0001-9276-9527	Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health	Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health	We thank M. Kimura, J.-H. Park, D. Singer, and Y. Takahama for critical review of the manuscript; S. Sharrow, A. Crossman, W. Hajjar, T. Adams, and L. Granger for flow cytometry support; M. Kruhlak and J. Wisniewski for microscopy support; B. Tran and J. Shetty from Center for Cancer Research Sequencing Facility for sequencing; M. Watanabe and X. Tai for help and advice with experiments. This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health.	Adoro S, 2012, EMBO J, V31, P366, DOI 10.1038/emboj.2011.388; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bosselut R, 2001, IMMUNITY, V14, P483, DOI 10.1016/S1074-7613(01)00128-5; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cleveland SB, 2020, IMMUNITY, V53, P1126, DOI 10.1016/j.immuni.2020.11.014; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Erman B, 2006, J IMMUNOL, V177, P6613, DOI 10.4049/jimmunol.177.10.6613; Etzensperger R, 2017, NAT IMMUNOL, V18, P1218, DOI 10.1038/ni.3847; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; GODFREY VL, 1991, AM J PATHOL, V138, P1379; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Karimi MM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20306-w; Kimura MY, 2016, NAT IMMUNOL, V17, P1415, DOI 10.1038/ni.3560; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; LIAW CW, 1986, J IMMUNOL, V137, P1037; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; Luckey MA, 2014, NAT IMMUNOL, V15, P638, DOI 10.1038/ni.2917; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McFarland H. I., 2009, CURR PROTOC IMMUNOL; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Storm P, 2006, J VIROL, V80, P1222, DOI 10.1128/JVI.80.3.1222-1230.2006; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2018, ANNU REV IMMUNOL, V36, P579, DOI 10.1146/annurev-immunol-042617-053411; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X	56	5	5	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					731	+		10.1038/s41590-022-01187-1	http://dx.doi.org/10.1038/s41590-022-01187-1		APR 2022	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35523960	Green Published, hybrid			2022-12-18	WOS:000791669700001
J	Kaufmann, E; Landekic, M; Downey, J; Chronopoulos, J; Nezhad, ST; Tran, K; Vinh, DC; Barreiro, LB; Divangahi, M				Kaufmann, Eva; Landekic, Marija; Downey, Jeffrey; Chronopoulos, Julia; Nezhad, Sara Teimouri; Tran, Kim; Vinh, Donald C.; Barreiro, Luis B.; Divangahi, Maziar			Lack of evidence for intergenerational inheritance of immune resistance to infections	NATURE IMMUNOLOGY			English	Editorial Material									[Kaufmann, Eva; Landekic, Marija; Downey, Jeffrey; Chronopoulos, Julia; Nezhad, Sara Teimouri; Tran, Kim; Vinh, Donald C.; Divangahi, Maziar] McGill Univ, McGill Univ Hlth Ctr, Dept Microbiol & Immunol,Dept Pathol, Dept Med,McGill Int TB Ctr,Meakins Christie Labs, Montreal, PQ, Canada; [Barreiro, Luis B.] Univ Chicago, Genet Genom & Syst Biol, Chicago, IL 60637 USA	McGill University; University of Chicago	Divangahi, M (corresponding author), McGill Univ, McGill Univ Hlth Ctr, Dept Microbiol & Immunol,Dept Pathol, Dept Med,McGill Int TB Ctr,Meakins Christie Labs, Montreal, PQ, Canada.; Barreiro, LB (corresponding author), Univ Chicago, Genet Genom & Syst Biol, Chicago, IL 60637 USA.	lbarreiro@uchicago.edu; maziar.divangahi@mcgill.ca		Landekic, Marija/0000-0001-9678-6965; Barreiro, Luis/0000-0001-9456-367X; Tran, Kim A./0000-0003-0299-7417; Kaufmann, Eva/0000-0001-7965-9200				Adler ID, 1996, MUTAT RES-FUND MOL M, V352, P169, DOI 10.1016/0027-5107(95)00223-5; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Divangahi M, 2021, NAT IMMUNOL, V22, P2, DOI 10.1038/s41590-020-00845-6; Freyne B, 2018, J INFECT DIS, V217, P1798, DOI 10.1093/infdis/jiy069; Katzmarski N, 2021, NAT IMMUNOL, V22, P1382, DOI 10.1038/s41590-021-01052-7; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Mawa PA, 2017, VACCINE, V35, P273, DOI 10.1016/j.vaccine.2016.11.079; Radford EJ, 2018, NAT REV ENDOCRINOL, V14, P345, DOI 10.1038/s41574-018-0005-5; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Stensballe LG, 2017, ARCH DIS CHILD, V102, P224, DOI 10.1136/archdischild-2016-310760; Stewart KR, 2016, EPIGENOMICS-UK, V8, P1399, DOI 10.2217/epi-2016-0056; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Zhang YF, 2018, NAT CELL BIOL, V20, P535, DOI 10.1038/s41556-018-0087-2	16	5	5	3	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					203	+		10.1038/s41590-021-01102-0	http://dx.doi.org/10.1038/s41590-021-01102-0		JAN 2022	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35058614				2022-12-18	WOS:000744891300002
J	Behrens, G; Edelmann, SL; Raj, T; Kronbeck, N; Monecke, T; Davydova, E; Wong, EH; Kifinger, L; Giesert, F; Kirmaier, ME; Hohn, C; De Jonge, LS; Pisfil, MG; Fu, MG; Theurich, S; Feske, S; Kawakami, N; Wurst, W; Niessing, D; Heissmeyer, V				Behrens, Gesine; Edelmann, Stephanie L.; Raj, Timsse; Kronbeck, Nina; Monecke, Thomas; Davydova, Elena; Wong, Elaine H.; Kifinger, Lisa; Giesert, Florian; Kirmaier, Martin E.; Hohn, Christine; de Jonge, Laura S.; Pisfil, Mariano Gonzalez; Fu, Mingui; Theurich, Sebastian; Feske, Stefan; Kawakami, Naoto; Wurst, Wolfgang; Niessing, Dierk; Heissmeyer, Vigo			Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses	NATURE IMMUNOLOGY			English	Article							HELPER T-CELLS; MESSENGER-RNA DECAY; DIFFERENTIATION; LEADS; RECOGNITION; SUPPRESSES; EXPRESSION; CLEAVAGE; ELEMENT; REPRESS	Roquin and Regnase-1 proteins bind and post-transcriptionally regulate proinflammatory target messenger RNAs to maintain immune homeostasis. Either the sanroque mutation in Roquin-1 or loss of Regnase-1 cause systemic lupus erythematosus-like phenotypes. Analyzing mice with T cells that lack expression of Roquin-1, its paralog Roquin-2 and Regnase-1 proteins, we detect overlapping or unique phenotypes by comparing individual and combined inactivation. These comprised spontaneous activation, metabolic reprogramming and persistence of T cells leading to autoimmunity. Here, we define an interaction surface in Roquin-1 for binding to Regnase-1 that included the sanroque residue. Mutations in Roquin-1 impairing this interaction and cooperative regulation of targets induced T follicular helper cells, germinal center B cells and autoantibody formation. These mutations also improved the functionality of tumor-specific T cells by promoting their accumulation in the tumor and reducing expression of exhaustion markers. Our data reveal the physical interaction of Roquin-1 with Regnase-1 as a hub to control self-reactivity and effector functions in immune cell therapies. Mutations in the RNA-binding proteins Roquin-1 or Regnase-1 cause systemic autoimmunity. Heissmeyer and colleagues show that Roquin-1 and Regnase-1 physically interact and thereby regulate CD4(+) and CD8(+) T cell metabolism and functionality.	[Behrens, Gesine; Raj, Timsse; Kronbeck, Nina; Wong, Elaine H.; Hohn, Christine; Heissmeyer, Vigo] Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Inst Immunol, Planegg Martinsried, Germany; [Edelmann, Stephanie L.; Kifinger, Lisa; de Jonge, Laura S.; Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Res Unit Mol Immune Regulat, Munich, Germany; [Monecke, Thomas; Niessing, Dierk] Ulm Univ, Inst Pharmaceut Biotechnol, Ulm, Germany; [Davydova, Elena; Niessing, Dierk] Helmholtz Zentrum Munchen, Inst Struct Biol, Neuherberg, Germany; [Giesert, Florian; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Kirmaier, Martin E.; Theurich, Sebastian] Ludwig Maximilians Univ Munchen, Canc & Immunometab Res Grp, Gene Ctr, Munich, Germany; [Kirmaier, Martin E.; Theurich, Sebastian] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 3, Munich, Germany; [Pisfil, Mariano Gonzalez] Ludwig Maximilians Univ Munchen, Core Facil Bioimaging & Walter Brendel Ctr Expt M, Biomed Ctr, Planegg Martinsried, Germany; [Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO USA; [Feske, Stefan] NYU, Sch Med, Dept Pathol, New York, NY USA; [Kawakami, Naoto] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Clin Neuroimmunol, Planegg Martinsried, Germany; [Kawakami, Naoto] Ludwig Maximilians Univ Munchen, Biomed Ctr, Planegg Martinsried, Germany; [Wurst, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Site Munich, Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Lehrstuhl Entwicklungsgenet, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; University of Missouri System; University of Missouri Kansas City; New York University; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich	Heissmeyer, V (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Inst Immunol, Planegg Martinsried, Germany.; Heissmeyer, V (corresponding author), Helmholtz Zentrum Munchen, Res Unit Mol Immune Regulat, Munich, Germany.	vigo.heissmeyer@med.uni-muenchen.de	Theurich, Sebastian/AAB-2855-2022; Niessing, Dierk/M-4619-2014	Theurich, Sebastian/0000-0001-5706-8258; Niessing, Dierk/0000-0002-5589-369X; Wurst, Wolfgang/0000-0003-4422-7410; Davydova, Elena/0000-0002-3087-2163; Heissmeyer, Vigo/0000-0002-2263-8545; Raj, Timsse/0000-0002-5065-8092; Kawakami, Naoto/0000-0001-7693-3489; Giesert, Florian/0000-0001-6825-8858				Akira S, 2013, COLD SH Q B, V78, P51, DOI 10.1101/sqb.2013.78.019877; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Cui XT, 2017, J IMMUNOL, V199, P4066, DOI 10.4049/jimmunol.1701211; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Ellyard JI, 2012, BLOOD, V120, P812, DOI 10.1182/blood-2011-07-365130; Essig K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06184-3; Essig K, 2017, IMMUNITY, V47, P1067, DOI 10.1016/j.immuni.2017.11.008; Fu MG, 2017, NAT REV IMMUNOL, V17, P130, DOI 10.1038/nri.2016.129; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Heissmeyer V, 2013, IMMUNOL REV, V253, P273, DOI 10.1111/imr.12056; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoefig KP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25345-5; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Janowski R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11032; Jeltsch KM, 2016, CURR OPIN IMMUNOL, V39, P127, DOI 10.1016/j.coi.2016.01.011; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Li Y, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.66; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mino T, 2019, NUCLEIC ACIDS RES, V47, P8838, DOI 10.1093/nar/gkz628; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Murakawa Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8367; Nagahama Y, 2018, P NATL ACAD SCI USA, V115, P11036, DOI 10.1073/pnas.1809575115; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Schieweck R, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109279; Schlundt A, 2014, NAT STRUCT MOL BIOL, V21, P671, DOI 10.1038/nsmb.2855; Sgromo A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14307; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Song J, 2019, P NATL ACAD SCI USA, V116, P18619, DOI 10.1073/pnas.1909314116; Srivastava M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7253; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tan AHM, 2006, J BIOL CHEM, V281, P28666, DOI 10.1074/jbc.M604081200; Tan DZ, 2014, NAT STRUCT MOL BIOL, V21, P679, DOI 10.1038/nsmb.2857; Tavernier SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12704-6; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; von Gamm M, 2019, J EXP MED, V216, P1700, DOI 10.1084/jem.20181762; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zeitraeg J, 2020, EUR J IMMUNOL, V50, P603, DOI 10.1002/eji.201948461; Zheng WT, 2021, BLOOD, V138, P122, DOI 10.1182/blood.2020009309	49	5	5	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1563	+		10.1038/s41590-021-01064-3	http://dx.doi.org/10.1038/s41590-021-01064-3		NOV 2021	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34811541	Green Accepted			2022-12-18	WOS:000722315400008
J	von Andrian, UH				von Andrian, Ulrich H.			NK cell memory: discovery of a mystery	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; BACILLE CALMETTE-GUERIN; CONTACT SENSITIVITY; T-CELLS; HYPERSENSITIVITY; THERAPY; ALPHA; MOUSE; GAMMA; MICE		[von Andrian, Ulrich H.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [von Andrian, Ulrich H.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	von Andrian, UH (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; von Andrian, UH (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.	uva@hms.harvard.edu						ASHERSON GL, 1968, IMMUNOLOGY, V15, P405; ASHERSON GL, 1973, IMMUNOLOGY, V25, P485; Askenase PW, 2001, CLIN EXP IMMUNOL, V125, P345, DOI 10.1046/j.1365-2249.2001.01619.x; BELLAVIA A, 1993, INT ARCH ALLERGY IMM, V101, P402, DOI 10.1159/000236483; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Boehncke WH, 2005, EXP DERMATOL, V14, P70, DOI 10.1111/j.0906-6705.2005.290b.x; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Elmas OF, 2020, CLIN DERMATOL, V38, P176, DOI 10.1016/j.clindermatol.2019.10.003; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Gillard GO, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002141; Habib S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153223; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Majewska-Szczepanik M, 2013, IMMUNOLOGY, V140, P98, DOI 10.1111/imm.12120; MARCHAL G, 1982, J IMMUNOL, V129, P954; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Nikzad R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat8116; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; PHANUPHAK P, 1974, J IMMUNOL, V112, P849; RATLIFF TL, 1986, CLIN IMMUNOL IMMUNOP, V41, P108, DOI 10.1016/0090-1229(86)90055-3; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Rouzaire P, 2012, EUR J IMMUNOL, V42, P80, DOI 10.1002/eji.201141820; Stary V, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba6232; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Taniguchi K, 1999, CLIN EXP IMMUNOL, V115, P131; van den Boorn JG, 2016, IMMUNITY, V44, P1406, DOI 10.1016/j.immuni.2016.05.008; Vermijlen D, 2004, EUR J IMMUNOL, V34, P2529, DOI 10.1002/eji.200324712; Vermijlen D, 2002, J LEUKOCYTE BIOL, V72, P668; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407	35	5	5	4	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					669	671		10.1038/s41590-021-00890-9	http://dx.doi.org/10.1038/s41590-021-00890-9		APR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	33859406				2022-12-18	WOS:000640493700001
J	Raundhal, M; Ghosh, S; Myers, SA; Cuoco, MS; Singer, M; Carr, SA; Waikar, SS; Bonventre, JV; Ritz, J; Stone, RM; Steensma, DP; Regev, A; Glimcher, LH				Raundhal, Mahesh; Ghosh, Shrestha; Myers, Samuel A.; Cuoco, Michael S.; Singer, Meromit; Carr, Steven A.; Waikar, Sushrut S.; Bonventre, Joseph, V; Ritz, Jerome; Stone, Richard M.; Steensma, David P.; Regev, Aviv; Glimcher, Laurie H.			Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias	NATURE IMMUNOLOGY			English	Article								Patients with myelodysplastic syndromes (MDSs) display severe anemia but the mechanisms underlying this phenotype are incompletely understood. Right open-reading-frame kinase 2 (RIOK2) encodes a protein kinase located at 5q15, a region frequently lost in patients with MDS del(5q). Here we show that hematopoietic cell-specific haploinsufficient deletion of Riok2 (Riok2(f/+)Vav1(cre)) led to reduced erythroid precursor frequency leading to anemia. Proteomic analysis of Riok2(f/+)Vav1(cre) erythroid precursors suggested immune system activation, and transcriptomic analysis revealed an increase in p53-dependent interleukin (IL)-22 in Riok2(f/+)Vav1(cre) CD4(+) T cells (T(H)22). Further, we discovered that the IL-22 receptor, IL-22RA1, was unexpectedly present on erythroid precursors. Blockade of IL-22 signaling alleviated anemia not only in Riok2(f/+)Vav1(cre) mice but also in wild-type mice. Serum concentrations of IL-22 were increased in the subset of patients with del(5q) MDS as well as patients with anemia secondary to chronic kidney disease. This work reveals a possible therapeutic opportunity for reversing many stress-induced anemias by targeting IL-22 signaling. Growing evidence suggests that immune dysregulation is involved in the pathogenesis of myelodysplastic syndromes (MDSs). Glimcher and colleagues report haplosufficiency of the serine-threonine kinase RIOK2 leads to increased IL-22 production that, in turn, suppresses erythropoiesis. Blocking IL-22 rescues this defect in mice, suggesting that IL-22 blockade might be of therapeutic value in treating MDSs.	[Raundhal, Mahesh; Ghosh, Shrestha; Glimcher, Laurie H.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Raundhal, Mahesh; Ghosh, Shrestha; Singer, Meromit; Glimcher, Laurie H.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Raundhal, Mahesh; Ghosh, Shrestha; Glimcher, Laurie H.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Myers, Samuel A.; Singer, Meromit; Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Cuoco, Michael S.; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Singer, Meromit] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA; [Waikar, Sushrut S.; Bonventre, Joseph, V] Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Dept Med, Boston, MA 02115 USA; [Waikar, Sushrut S.] Boston Univ, Med Ctr, Renal Sect, Boston, MA USA; [Ritz, Jerome; Stone, Richard M.; Steensma, David P.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA; [Regev, Aviv] MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Raundhal, M; Glimcher, LH (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Raundhal, M; Glimcher, LH (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Raundhal, M; Glimcher, LH (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	Mahesh_Raundhal@dfci.harvard.edu; Laurie_Glimcher@dfci.harvard.edu		Bonventre, Joseph/0000-0001-7144-386X	Edward P. Evans Foundation; DFCI; NIH Leukemia SPORE [1P50CA206963, 2P01CA066996]; National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium grants [NIH/NCI U24-CA210986, NIH/NCI U01 CA214125]	Edward P. Evans Foundation; DFCI; NIH Leukemia SPORE; National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium grants	We thank R. Caspi (National Eye Institute, US NIH) and Genentech for providing Il22 knockout mice; B. L. Ebert (DFCI) for providing Rps14-floxed mice; R. Locksley (University of California San Francisco) for providing Catch-22 mice; and U. Klingmuller (Deutsches Krebsforschungszentrum) for providing Epor-cre mice. We also thank the Animal Resources Facility, the Ted and Eileen Pasquarello Tissue Bank in Hematologic Malignancies and flow cytometry core facility at DFCI for their valuable technical assistance. We thank E. Smith for assistance with creating the graphical illustration. We thank P. Majek (Ustav hematologie a krevni transfuse) for providing plasma proteomic profiling data of healthy controls and patients with MDSs. This work was supported by a Discovery Research Grant from the Edward P. Evans Foundation (to L.H.G.) and institutional funding from DFCI (to L.H.G). D.P.S. is supported by the Edward P. Evans Foundation and by NIH Leukemia SPORE 1P50CA206963 and 2P01CA066996. This work was supported in part by grants from the National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium grants NIH/NCI U24-CA210986 and NIH/NCI U01 CA214125 (to S.A.C.).	Allampallam K, 1999, ANTICANCER RES, V19, P5323; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Cai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059009; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fenaux P, 2020, NEW ENGL J MED, V382, P140, DOI 10.1056/NEJMoa1908892; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Fozza C, 2019, CRIT REV ONCOL HEMAT, V142, P51, DOI 10.1016/j.critrevonc.2019.07.018; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hofmann WK, 2004, HEMATOL J, V5, P1, DOI 10.1038/sj.thj.6200335; Khajuria RK, 2018, CELL, V173, P90, DOI 10.1016/j.cell.2018.02.036; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003091; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Maciejewski JP, 2002, BRIT J HAEMATOL, V117, P119, DOI 10.1046/j.1365-2141.2002.03381.x; Mattapallil MJ, 2019, J AUTOIMMUN, V102, P65, DOI 10.1016/j.jaut.2019.04.017; MEANS RT, 1995, STEM CELLS, V13, P32, DOI 10.1002/stem.5530130105; Muto T, 2020, NAT IMMUNOL, V21, P535, DOI 10.1038/s41590-020-0663-z; Myers SA, 2019, MOL CELL PROTEOMICS, V18, P995, DOI 10.1074/mcp.RA118.001259; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ribezzo F, 2019, LEUKEMIA, V33, P1759, DOI 10.1038/s41375-018-0350-3; Royer-Pokora B, 2006, CANCER GENET CYTOGEN, V167, P66, DOI 10.1016/j.cancergencyto.2005.08.003; Sakamoto K, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8371; Savage AK, 2017, J IMMUNOL, V199, P1912, DOI 10.4049/jimmunol.1700155; SCHIPPERUS MR, 1991, BRIT J HAEMATOL, V77, P515; Schnatter AR, 2012, J NATL CANCER I, V104, P1724, DOI 10.1093/jnci/djs411; Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051339; Shuga J, 2007, P NATL ACAD SCI USA, V104, P8737, DOI 10.1073/pnas.0701829104; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smith CL, 2013, J IMMUNOL, V191, P1845, DOI 10.4049/jimmunol.1202716; Smith MA, 2019, NAT CELL BIOL, V21, P640, DOI 10.1038/s41556-019-0314-5; Sole F, 2000, BRIT J HAEMATOL, V108, P346; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Starczynowski DT, 2010, HEMATOL ONCOL CLIN N, V24, P343, DOI 10.1016/j.hoc.2010.02.008; Starczynowski DT, 2010, CELL CYCLE, V9, P855, DOI 10.4161/cc.9.5.11156; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Tang GL, 2015, AM J CLIN PATHOL, V144, P78, DOI 10.1309/AJCPBADO22WXOFHJ; VERHOEF GEG, 1992, LEUKEMIA, V6, P1268; Wolach O, 2016, ACTA HAEMATOL-BASEL, V136, P108, DOI 10.1159/000446062; Yamamoto-Furusho JK, 2010, INFLAMM BOWEL DIS, V16, P1823, DOI 10.1002/ibd.21235; Yamashita M, 2019, CELL STEM CELL, V25, P357, DOI 10.1016/j.stem.2019.05.019; Yang LL, 2015, CELL MOL LIFE SCI, V72, P1959, DOI 10.1007/s00018-015-1846-x; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang TY, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax5104	68	5	5	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					520	+		10.1038/s41590-021-00895-4	http://dx.doi.org/10.1038/s41590-021-00895-4		MAR 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33753942	Green Accepted, Green Submitted			2022-12-18	WOS:000631489400002
J	Rabinovich, GA; Geffner, J				Rabinovich, Gabriel A.; Geffner, Jorge			Facing up to the COVID-19 pandemic in Argentina	NATURE IMMUNOLOGY			English	Editorial Material								From the onset of the SARS-CoV-2 pandemic and following the creation of the 'Coronavirus Unit', Argentinean scientists and technologists have contributed by leading basic and translational research initiatives, including developing diagnostic and serological kits, designing new therapeutic approaches, establishing epidemiological platforms, executing clinical trials and implementing social measures to protect the most vulnerable groups of the population.	[Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Inmunopatol, Buenos Aires, DF, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Geffner, Jorge] Univ Buenos Aires, CONICET, Fac Med, Inst Invest Biomed Retrovirus & SIDA, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rabinovich, GA (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Inmunopatol, Buenos Aires, DF, Argentina.; Rabinovich, GA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.	gabyrabi@gmail.com		Rabinovich, Gabriel A./0000-0002-0947-8735				Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; McAllister F, 2020, MEDICINA-BUENOS AIRE, V80, P82; Ojeda DS, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009161; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Zylberman V, 2020, MEDICINA-BUENOS AIRE, V80, P1	6	5	5	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					264	265		10.1038/s41590-021-00873-w	http://dx.doi.org/10.1038/s41590-021-00873-w			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33627880	Bronze			2022-12-18	WOS:000621567200007
J	Yan, J				Yan, Jun			Antitumor gamma delta T cells need oxygen to function	NATURE IMMUNOLOGY			English	Editorial Material								Brain tumors respire more oxygen, causing a hypoxic microenvironment that impairs innate gamma delta T cell-mediated antitumor activity. Reducing oxygen consumption by brain tumors or inhibiting hypoxia-inducible factor-1 alpha in gamma delta T cells reinvigorates gamma delta T cell tumor-killing activity, leading to prolonged survival in brain-tumor-bearing mice.	[Yan, Jun] Univ Louisville, Sch Med, James Graham Brown Canc Ctr,Immunooncol Program, Hiram C Polk Jr MD Dept Surg,Div Immunotherapy, Louisville, KY 40292 USA	University of Louisville	Yan, J (corresponding author), Univ Louisville, Sch Med, James Graham Brown Canc Ctr,Immunooncol Program, Hiram C Polk Jr MD Dept Surg,Div Immunotherapy, Louisville, KY 40292 USA.	jun.yan@louisville.edu	Yan, Jun/A-8988-2008	Yan, Jun/0000-0003-2922-422X	NCI NIH HHS [R01 CA213990] Funding Source: Medline; NIAID NIH HHS [R01 AI128818] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bahrambeigi S, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2019.113787; Barsoum IB, 2014, CANCER RES, V74, P7185, DOI 10.1158/0008-5472.CAN-14-2598; Bryant NL, 2009, NEURO-ONCOLOGY, V11, P357, DOI 10.1215/15228517-2008-111; Fleming C, 2017, TRENDS CANCER, V3, P561, DOI 10.1016/j.trecan.2017.06.003; Friese MA, 2003, CANCER RES, V63, P8996; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Hu XT, 2020, CELL RES, V30, P229, DOI 10.1038/s41422-020-0287-8; Kabelitz D, 2020, CELL MOL IMMUNOL, V17, P925, DOI 10.1038/s41423-020-0504-x; Li L, 2019, ONCOGENE, V38, P2830, DOI 10.1038/s41388-018-0627-z; Park, 2021, NAT IMMUNOL, DOI [10.1038/s41590-021-00874-9, DOI 10.1038/S41590-021-00874-9]; Siegers GM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01367; Song E, 2020, NATURE, V577, P689, DOI 10.1038/s41586-019-1912-x	12	5	5	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					268	269		10.1038/s41590-021-00874-9	http://dx.doi.org/10.1038/s41590-021-00874-9		FEB 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33574620				2022-12-18	WOS:000617117400001
J	Tavernarakis, N				Tavernarakis, Nektarios			Inflammation brakes mitochondrial metabolism in obesity	NATURE IMMUNOLOGY			English	Editorial Material							OPA1; THERMOGENESIS; DISEASE; MUSCLE	A vicious cycle, linking obesity with chronic inflammation, fuels the development and exacerbation of metabolic syndrome and other disorders. Modulation of mitochondrial energy metabolism via interleukin-1 beta signaling establishes a runaway positive-feedback loop that brings about and reinforces the sequelae of a high-fat diet.	[Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Tavernarakis, Nektarios] Univ Crete, Sch Med, Iraklion, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Tavernarakis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.; Tavernarakis, N (corresponding author), Univ Crete, Sch Med, Iraklion, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466				Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Duan YH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02649; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Juge-Aubry CE, 2004, J CLIN ENDOCR METAB, V89, P2652, DOI 10.1210/jc.2003-031219; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Stolarczyk E, 2017, CURR OPIN PHARMACOL, V37, P35, DOI 10.1016/j.coph.2017.08.006; Sun XJ, 2017, J BIOL CHEM, V292, P12339, DOI 10.1074/jbc.M117.779108; WHO, 2020, OBESITY; Zhou H, 2020, NAT IMMUNOL, V21, P1219, DOI 10.1038/s41590-020-0750-1	19	5	5	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1143	1145		10.1038/s41590-020-0780-8	http://dx.doi.org/10.1038/s41590-020-0780-8		AUG 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32855554				2022-12-18	WOS:000563237600002
J	Dang, EV; Madhani, HD; Vance, RE				Dang, Eric V.; Madhani, Hiten D.; Vance, Russell E.			Cholesterol in quarantine	NATURE IMMUNOLOGY			English	Editorial Material							25-HYDROXYCHOLESTEROL	Host cell cholesterol is often exploited by pathogens for entry and egress. Two new studies elucidate a new interferon-inducible mechanism by which cells limit plasma membrane cholesterol to promote antibacterial defense.	[Dang, Eric V.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Madhani, Hiten D.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu		Vance, Russell/0000-0002-6686-3912	NIAID NIH HHS [R37 AI075039] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrams ME, 2020, NAT MICROBIOL, V5, P929, DOI 10.1038/s41564-020-0701-5; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Zhou QD, 2020, NAT IMMUNOL, V21, P746, DOI 10.1038/s41590-020-0695-4	13	5	5	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					716	717		10.1038/s41590-020-0712-7	http://dx.doi.org/10.1038/s41590-020-0712-7		JUN 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32514065				2022-12-18	WOS:000539349000003
J	de Vos, AF; van der Poll, T				de Vos, Alex F.; van der Poll, Tom			SIRP-alpha instructs alveolar macrophages to stop eating after pneumonia	NATURE IMMUNOLOGY			English	Editorial Material							SEPSIS-INDUCED IMPAIRMENT	Injury or infection renders patients vulnerable to secondary pneumonia. A new study indicates that SIRP-alpha triggers prolonged impairment of the phagocytic capacity of alveolar macrophages after the resolution of primary bacterial or viral pneumonia.	[de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Amsterdam Univ, Ctr Expt & Mol Med, Med Ctr, Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Amsterdam Univ, Med Ctr, Div Infect Dis, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	van der Poll, T (corresponding author), Univ Amsterdam, Amsterdam Univ, Ctr Expt & Mol Med, Med Ctr, Amsterdam, Netherlands.; van der Poll, T (corresponding author), Univ Amsterdam, Amsterdam Univ, Med Ctr, Div Infect Dis, Amsterdam, Netherlands.	t.vanderpoll@amsterdamumc.nl						Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Cao J, 2014, THORAX, V69, P926, DOI 10.1136/thoraxjnl-2014-205777; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Hoogerwerf JJ, 2011, AM J RESP CRIT CARE, V183, P932, DOI 10.1164/rccm.201006-0934OC; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Morgan DJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02943; Roquilly A, 2020, NAT IMMUNOL, V21, P636, DOI 10.1038/s41590-020-0673-x; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Veillette A, 2018, TRENDS IMMUNOL, V39, P173, DOI 10.1016/j.it.2017.12.005	12	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					601	603		10.1038/s41590-020-0680-y	http://dx.doi.org/10.1038/s41590-020-0680-y		MAY 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32424360				2022-12-18	WOS:000533852800009
J	Tolar, P; Wack, A				Tolar, Pavel; Wack, Andreas			Monocytes work harder under pressure	NATURE IMMUNOLOGY			English	Editorial Material									[Tolar, Pavel; Wack, Andreas] Francis Crick Inst, London, England	Francis Crick Institute	Tolar, P (corresponding author), Francis Crick Inst, London, England.	pavel.tolar@crick.ac.uk; andreas.wack@crick.ac.uk		Wack, Andreas/0000-0001-5226-2991; Tolar, Pavel/0000-0003-4693-7299	MRC [MC_U117597139] Funding Source: UKRI; Medical Research Council [MC_U117597139] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Izquierdo HM, 2018, CELL REP, V24, P1738, DOI 10.1016/j.celrep.2018.07.034; Kowalczyk A, 2015, ARCH IMMUNOL THER EX, V63, P41, DOI 10.1007/s00005-014-0310-1; Li CX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22039-9; Lin YC, 2019, NATURE, V573, P230, DOI 10.1038/s41586-019-1499-2; Maruyama K, 2019, INFLAMM REGEN, V39, DOI 10.1186/s41232-019-0092-2; Murthy SE, 2017, NAT REV MOL CELL BIO, V18, P771, DOI 10.1038/nrm.2017.92; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Svedberg FR, 2019, NAT IMMUNOL, V20, P571, DOI 10.1038/s41590-019-0352-y; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Wang L, 2019, NATURE, V573, P225, DOI 10.1038/s41586-019-1505-8; Zhao QC, 2018, NATURE, V554, P487, DOI 10.1038/nature25743	14	5	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1422	1424		10.1038/s41590-019-0523-x	http://dx.doi.org/10.1038/s41590-019-0523-x			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31595058				2022-12-18	WOS:000492309600012
J	Verma, V; Shrimali, RK; Ahmad, S; Dai, WJ; Wang, H; Lu, SM; Nandre, R; Gaur, P; Lopez, J; Sade-Feldman, M; Yizhak, K; Bjorgaard, SL; Flaherty, KT; Wargo, JA; Boland, GM; Sullivan, RJ; Getz, G; Hammond, SA; Tan, M; Qi, JJ; Wong, P; Merghoub, T; Wolchok, J; Hacohen, N; Janik, JE; Mkrtichyan, M; Gupta, S; Khleif, SN				Verma, Vivek; Shrimali, Rajeev K.; Ahmad, Shamim; Dai, Winjie; Wang, Hua; Lu, Sumin; Nandre, Rahul; Gaur, Pankaj; Lopez, Jose; Sade-Feldman, Moshe; Yizhak, Keren; Bjorgaard, Stacey L.; Flaherty, Keith T.; Wargo, Jennifer A.; Boland, Genevieve M.; Sullivan, Ryan J.; Getz, Gad; Hammond, Scott A.; Tan, Ming; Qi, Jingjing; Wong, Phillip; Merghoub, Taha; Wolchok, Jedd; Hacohen, Nir; Janik, John E.; Mkrtichyan, Mikayel; Gupta, Seema; Khleif, Samir N.			PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance (vol 20, pg 1231, 2019)	NATURE IMMUNOLOGY			English	Correction									[Verma, Vivek] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Loop Immunooncol Lab, Washington, DC 20007 USA	Georgetown University	Verma, V (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Loop Immunooncol Lab, Washington, DC 20007 USA.		Gupta, Seema/AAK-9898-2020; Boland, Genevieve/AAP-2767-2021; Gaur, Pankaj/AAG-2765-2020; Merghoub, Taha/ABD-8362-2021; Verma, Vivek/AFL-8809-2022; Nandre, Rahul/AAR-5503-2020	Gupta, Seema/0000-0003-0106-595X; Gaur, Pankaj/0000-0002-9718-3565; Verma, Vivek/0000-0001-8129-4140; 	NCI NIH HHS [R01 CA056821] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Verma V, 2019, NAT IMMUNOL, V20, P1231, DOI 10.1038/s41590-019-0441-y	1	5	5	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1555	1555		10.1038/s41590-019-0519-6	http://dx.doi.org/10.1038/s41590-019-0519-6			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31551574	Bronze			2022-12-18	WOS:000492309600026
J	Feigal, EG; DeWitt, ND; Cantilena, C; Peck, C; Stroncek, D				Feigal, Ellen G.; DeWitt, Natalie D.; Cantilena, Cathy; Peck, Carl; Stroncek, David			At the end of the beginning: immunotherapies as living drugs	NATURE IMMUNOLOGY			English	Editorial Material							CYTOKINE RELEASE SYNDROME; T-CELLS; ANTIGEN; STEMNESS; CAR		[Feigal, Ellen G.; DeWitt, Natalie D.; Peck, Carl] NDA Partners, Rochelle, VA 22738 USA; [Feigal, Ellen G.] Arizona State Univ, Sandra Day OConnor Coll Law, Phoenix, AZ 85004 USA; [DeWitt, Natalie D.] Accendo Sci, Des Moines, IA USA; [Cantilena, Cathy; Stroncek, David] NIH, Bldg 10, Bethesda, MD 20892 USA; [Peck, Carl] Univ Calif San Francisco, San Francisco, CA 94143 USA	Arizona State University; Arizona State University-Downtown Phoenix; National Institutes of Health (NIH) - USA; University of California System; University of California San Francisco	Feigal, EG (corresponding author), NDA Partners, Rochelle, VA 22738 USA.; Feigal, EG (corresponding author), Arizona State Univ, Sandra Day OConnor Coll Law, Phoenix, AZ 85004 USA.	feigal_ellen@msn.com						[Anonymous], 1903, NY TIMES; Cafri G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08304-z; Cherkasova E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00243; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Grupp SA, 2018, 60 AM SOC HEM ANN M; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035; Mezher M., 2019, REGULATORY AFFAIRS P; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Riviere I, 2012, BLOOD, V119, P1107, DOI 10.1182/blood-2011-09-349993; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sadelain M, 2017, CELL, V171, P1471, DOI 10.1016/j.cell.2017.12.002; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; von Kalle C, 2014, HUM GENE THER, V25, P475, DOI 10.1089/hum.2014.2525; Wright O., 1903, DIARIES NOTEBOOKS O; Xu ZZ, 2018, STAT MED, V37, P4589, DOI 10.1002/sim.7937; Xu ZZ, 2017, STAT MED, V36, P592, DOI 10.1002/sim.7157	27	5	5	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					955	962		10.1038/s41590-019-0452-8	http://dx.doi.org/10.1038/s41590-019-0452-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31308544				2022-12-18	WOS:000476621200010
J	Billingham, LK; Chandel, NS				Billingham, Leah K.; Chandel, Navdeep S.			NAD-biosynthetic pathways regulate innate immunity	NATURE IMMUNOLOGY			English	Editorial Material							SUCCINATE	Recent studies indicate that macrophages utilize NAD(+)-biosynthetic pathways to control inflammation and cell survival during the immune response and aging.	[Billingham, Leah K.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	nav@northwestern.edu						Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Lopes Nair, 2019, LAB INVEST, V100, P120, DOI [10.1038/s41590-019-0336-y, DOI 10.1038/S41590-019-0336-Y, 10.1038/s41374-019-0336-4, DOI 10.1038/S41374-019-0336-4]; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	12	5	6	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					380	382		10.1038/s41590-019-0353-x	http://dx.doi.org/10.1038/s41590-019-0353-x			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30858621				2022-12-18	WOS:000461904200007
J	Finlay, DK				Finlay, David K.			N-myristoylation of AMPK controls T cell inflammatory function	NATURE IMMUNOLOGY			English	Editorial Material									[Finlay, David K.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Finlay, David K.] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Trinity Biomed Sci Inst, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Finlay, DK (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.; Finlay, DK (corresponding author), Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Trinity Biomed Sci Inst, Dublin, Ireland.	finlayd@tcd.ie	Finlay, David/H-5840-2018	Finlay, David/0000-0003-2716-6679				Bruyn GAW, 2008, ANN RHEUM DIS, V67, P1090, DOI 10.1136/ard.2007.078808; Deng L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1201-x; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Rampoldi F, 2015, J IMMUNOL, V195, P4228, DOI 10.4049/jimmunol.1500622; Udenwobele DI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00751; Wen ZK, 2019, NAT IMMUNOL, V20, P313, DOI 10.1038/s41590-018-0296-7; Weyand CM, 2017, CURR OPIN IMMUNOL, V46, P112, DOI 10.1016/j.coi.2017.04.010; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014	9	5	6	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					252	254		10.1038/s41590-019-0322-4	http://dx.doi.org/10.1038/s41590-019-0322-4			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30718915				2022-12-18	WOS:000458893600009
J	Wu, JJ; Yan, N				Wu, Jianjun; Yan, Nan			STIM1 moonlights as an anchor for STING	NATURE IMMUNOLOGY			English	Editorial Material							TRAFFICKING; ACTIVATION; ER	Activation of STING requires its translocation from the endoplasmic reticulum (ER) through the Golgi to vesicles, but the mechanisms that control its localization have been unclear. The ER calcium sensor STIM1 acts as an ER-retention factor that anchors STING on the ER and limits STING signaling.	[Wu, Jianjun; Yan, Nan] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Yan, Nan] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yan, N (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Yan, N (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	nan.yan@utsouthwestern.edu		Wu, Jianjun/0000-0003-4518-8361				Bouis D, 2019, J ALLERGY CLIN IMMUN, V143, P712, DOI 10.1016/j.jaci.2018.04.034; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Kim S, 2017, BIORXIV, DOI [10.1101/145854, DOI 10.1101/145854]; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lu F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005339; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Srikanth S, 2019, NAT IMMUNOL, V20, P152, DOI 10.1038/s41590-018-0287-8; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Weichselbaum RR, 2017, NAT REV CLIN ONCOL, V14, P365, DOI 10.1038/nrclinonc.2016.211; Yan N, 2017, J INTERF CYTOK RES, V37, P198, DOI 10.1089/jir.2016.0086; Zhou Q, 2014, CELL HOST MICROBE, V16, P450, DOI 10.1016/j.chom.2014.09.006	16	5	5	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					112	114		10.1038/s41590-018-0300-2	http://dx.doi.org/10.1038/s41590-018-0300-2			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643261				2022-12-18	WOS:000456279100006
J	Nikolich-Zugich, J				Nikolich-Zugich, Janko			The twilight of immunity: emerging concepts in aging of the immune system (vol 19, pg 10, 2018)	NATURE IMMUNOLOGY			English	Correction																		Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x	1	5	5	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1146	1146		10.1038/s41590-018-0205-0	http://dx.doi.org/10.1038/s41590-018-0205-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30177814	Bronze			2022-12-18	WOS:000445968600021
J	Biron, CA				Biron, Christine A.			IMMUNOPATHOLOGY Glucocorticoids and NK cell PD-1	NATURE IMMUNOLOGY			English	Editorial Material							MURINE CYTOMEGALOVIRUS; VIRAL-INFECTION; RESPONSES; INDUCTION; IMMUNITY	Immune responses have the potential to induce life-threatening conditions. A novel multi-system pathway in which neuroendocrine signaling induces expression of the checkpoint receptor PD-1 on NK cells is an important mechanism for protection against cytokine-mediated disease during viral infection.	[Biron, Christine A.] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Biron, Christine A.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University	Biron, CA (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.; Biron, CA (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	christine_biron@brown.edu						Beldi-Ferchiou A, 2016, ONCOTARGET, V7, P72961, DOI 10.18632/oncotarget.12150; Biron CA, 2015, MED MICROBIOL IMMUN, V204, P345, DOI 10.1007/s00430-015-0412-3; Della Chiesa M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00351; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Quatrini L., 2018, NAT IMMUNOL, DOI [10.1038/sXXXXX-XXX-XXXX, DOI 10.1038/SXXXXX-XXX-XXXX]; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Ruzek MC, 1999, J IMMUNOL, V162, P3527; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Vidal SM, 2011, CURR OPIN VIROL, V1, P497, DOI 10.1016/j.coviro.2011.10.017; Waggoner SN, 2016, CURR OPIN VIROL, V16, P15, DOI 10.1016/j.coviro.2015.10.008	11	5	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					908	+		10.1038/s41590-018-0190-3	http://dx.doi.org/10.1038/s41590-018-0190-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30127435				2022-12-18	WOS:000442365100011
J	Geng, J; Yu, SJ; Zhao, H; Sun, XF; Li, X; Wang, P; Xiong, XL; Hong, LX; Xie, CC; Gao, JH; Shi, YR; Peng, JQ; Johnson, RL; Xiao, NM; Lu, LR; Han, JH; Zhou, DW; Chen, LF				Geng, Jing; Yu, Shujuan; Zhao, Hao; Sun, Xiufeng; Li, Xun; Wang, Ping; Xiong, Xiaolin; Hong, Lixin; Xie, Changchuan; Gao, Jiahui; Shi, Yiran; Peng, Jiaqi; Johnson, Randy L.; Xiao, Nengming; Lu, Linrong; Han, Jiahuai; Zhou, Dawang; Chen, Lanfen			The transcriptional coactivator TAZ regulates reciprocal differentiation of T(H)17 cells and T-reg cells (vol 18, pg 800, 2017)	NATURE IMMUNOLOGY			English	Correction													xie, chang/GYJ-2493-2022					Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748	1	5	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1036	1036		10.1038/s41590-018-0055-9	http://dx.doi.org/10.1038/s41590-018-0055-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	29449628	Bronze			2022-12-18	WOS:000442365100028
J	Orange, JS; Mace, EM; French, AR; Yokoyama, WM; Fehniger, TA; Cooper, MA				Orange, Jordan S.; Mace, Emily M.; French, Anthony R.; Yokoyama, Wayne M.; Fehniger, Todd A.; Cooper, Megan A.			Comment on: Evidence of innate lymphoid cell redundancy in humans	NATURE IMMUNOLOGY			English	Letter							CANCER; TRANSPLANTATION; DEFICIENCY; INFECTION; DISEASE; MEMORY		[Orange, Jordan S.; Mace, Emily M.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [French, Anthony R.; Cooper, Megan A.] Washington Univ, Dept Pediat, Div Rheumatol, St Louis, MO 63130 USA; [Yokoyama, Wayne M.] Washington Univ, Dept Med, Div Rheumatol, St Louis, MO USA; [Fehniger, Todd A.] Washington Univ, Dept Med, Div Oncol, St Louis, MO USA	Columbia University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Cooper, MA (corresponding author), Washington Univ, Dept Pediat, Div Rheumatol, St Louis, MO 63130 USA.	cooper_m@wustl.edu		Cooper, Megan/0000-0002-5696-172X; orange, jordan/0000-0001-7117-7725; Fehniger, Todd/0000-0002-8705-2887	Celgene; Affimed; Altor BioScience; NATIONAL CANCER INSTITUTE [R01CA205239, P50CA171963] Funding Source: NIH RePORTER	Celgene(Bristol-Myers SquibbCelgene Corporation); Affimed; Altor BioScience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.A.F. is a member of the scientific advisory board for Cyto-Sen Therapeutics and receives research funding from Celgene, Affimed and Altor BioScience.	Fehniger TA, 2016, TRENDS IMMUNOL, V37, P877, DOI 10.1016/j.it.2016.09.005; Holmes TD, 2016, SEMIN IMMUNOL, V28, P368, DOI 10.1016/j.smim.2016.05.008; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Kamili QUA, 2014, J ALLERGY CLIN IMMUN, V134, P1451, DOI 10.1016/j.jaci.2014.07.009; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Mace E. M., 2017, J CLIN IMMUNOL, V37, P1; Mace EM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00545; Malmberg KJ, 2017, SEMIN IMMUNOL, V31, P20, DOI 10.1016/j.smim.2017.08.002; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Weinkove R, 2016, NAT IMMUNOL, V17, P1237, DOI 10.1038/ni.3567	12	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					788	789		10.1038/s41590-018-0164-5	http://dx.doi.org/10.1038/s41590-018-0164-5			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30026477	Green Accepted			2022-12-18	WOS:000439470900012
J	Dempsey, LA				Dempsey, Laurie A.			NKT cells aid antiviral responses	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					99	99		10.1038/s41590-017-0039-1	http://dx.doi.org/10.1038/s41590-017-0039-1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348503	Bronze			2022-12-18	WOS:000423435200005
J	Visan, I				Visan, Ioana			Myocardial infarct inflammation	NATURE IMMUNOLOGY			English	Editorial Material																			0	5	5	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					99	99		10.1038/s41590-017-0037-3	http://dx.doi.org/10.1038/s41590-017-0037-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348501	Bronze			2022-12-18	WOS:000423435200001
J	Manthiram, K; Zhou, Q; Aksentijevich, I; Kastner, DL				Manthiram, Kalpana; Zhou, Qing; Aksentijevich, Ivona; Kastner, Daniel L.			The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation	NATURE IMMUNOLOGY			English	Correction													Aksentijevich, Ivona/AAF-1335-2019		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200372] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777	1	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1271	1271		10.1038/ni1117-1271a	http://dx.doi.org/10.1038/ni1117-1271a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044244	Bronze			2022-12-18	WOS:000413457300017
J	Visan, I				Visan, Ioana			CMTM6 controls PD-L1	NATURE IMMUNOLOGY			English	Editorial Material																			0	5	5	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1067	1067						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926544	Bronze			2022-12-18	WOS:000411134000008
J	Amsen, D; Hombrink, P; van Lier, RAW				Amsen, Derk; Hombrink, Pleun; van Lier, Rene A. W.			Tumor immunity requires border patrol to fight the enemy within	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY T-CELLS; INFILTRATING LYMPHOCYTES; LUNG-CANCER; SURVIVAL	The infiltration of solid tumors by CD8(+) T cells is a favorable prognostic marker. Large-scale transcriptome analysis of tumor-infiltrating T cells from mucosal tumors shows that CD8(+) T cells with a CD103(+) tissue-resident memory T cell phenotype might be the most desirable.	[Amsen, Derk; Hombrink, Pleun; van Lier, Rene A. W.] Sanquin Res & Landsteiner Lab Blood Cell Res, Dept Hematopoiesis, Amsterdam, Netherlands		Amsen, D (corresponding author), Sanquin Res & Landsteiner Lab Blood Cell Res, Dept Hematopoiesis, Amsterdam, Netherlands.	d.amsen@sanquin.nl						Corrales L, 2017, CELL RES, V27, P96, DOI 10.1038/cr.2016.149; Djenidi F, 2015, J IMMUNOL, V194, P3475, DOI 10.4049/jimmunol.1402711; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Koh J, 2017, ONCOTARGET, V8, P13762, DOI 10.18632/oncotarget.14632; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Nizard M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15221; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Webb JR, 2014, CLIN CANCER RES, V20, P434, DOI 10.1158/1078-0432.CCR-13-1877	14	5	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					870	872		10.1038/ni.3792	http://dx.doi.org/10.1038/ni.3792			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722713				2022-12-18	WOS:000405821100007
J	Fang, J; Bolanos, LC; Choi, KM; Liu, XN; Christie, S; Akunuru, S; Kumar, R; Wang, DH; Chen, XT; Greis, KD; Stoilov, P; Filippi, MD; Maciejewski, JP; Garcia-Manero, G; Weirauch, MT; Salamonis, N; Geiger, H; Zheng, Y; Starczynowski, DT				Fang, Jing; Bolanos, Lyndsey C.; Choi, Kwangmin; Liu, Xiaona; Christie, Susanne; Akunuru, Shailaja; Kumar, Rupali; Wang, Dehua; Chen, Xiaoting; Greis, Kenneth D.; Stoilov, Peter; Filippi, Marie-Dominique; Maciejewski, Jaroslaw P.; Garcia-Manero, Guillermo; Weirauch, Matthew T.; Salamonis, Nathan; Geiger, Hartmut; Zheng, Yi; Starczynowski, Daniel T.			Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia (vol 18, pg 236, 2016)	NATURE IMMUNOLOGY			English	Correction														Bolanos, Lyndsey/0000-0002-5447-5277	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114582, R01HL111103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971, R01DK113639] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR027015] Funding Source: Medline; NHLBI NIH HHS [R01 HL114582, R01 HL111103] Funding Source: Medline; NIDDK NIH HHS [R01 DK113639, P30 DK090971] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fang J, 2017, NAT IMMUNOL, V18, P236, DOI 10.1038/ni.3654	1	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					474	474		10.1038/ni0417-474a	http://dx.doi.org/10.1038/ni0417-474a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323261	Bronze, Green Accepted			2022-12-18	WOS:000396815800015
J	Weinkove, R; Filbey, K; Le Gros, G				Weinkove, Robert; Filbey, Kara; Le Gros, Graham			Immunity without innate lymphoid cells	NATURE IMMUNOLOGY			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION; DEFICIENCY; PROMOTES	A cohort of immunodeficient children lead near-normal lives after bone marrow transplantation, despitea profound deficiency of innate lymphoid cells (ILCs).	[Weinkove, Robert; Filbey, Kara; Le Gros, Graham] Malaghan Inst Med Res, Wellington, New Zealand; [Weinkove, Robert] Capital & Coast Dist Hlth Board, Wellington Blood & Canc Ctr, Wellington, New Zealand; [Weinkove, Robert] Univ Otago, Dept Pathol & Mol Med, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; University of Otago	Le Gros, G (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	glegros@malaghan.org.nz	Weinkove, Robert/S-4457-2019; Weinkove, Robert/I-6991-2012; Filbey, Kara/S-8686-2019	Weinkove, Robert/0000-0003-3645-7988; Weinkove, Robert/0000-0003-3645-7988; Filbey, Kara/0000-0001-5758-5730; Le Gros, Graham/0000-0002-5721-0442				Bouchery T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7970; Chhabra A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aae0501; Dvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-y; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Mancusi A, 2015, BLOOD, V125, P3173, DOI 10.1182/blood-2014-09-599993; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Vivier E, 2016, NAT IMMUNOL, V17, P790, DOI 10.1038/ni.3459	15	5	5	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1237	1238		10.1038/ni.3567	http://dx.doi.org/10.1038/ni.3567			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27760103				2022-12-18	WOS:000386193200001
J	Cibrian, D; Saiz, ML; de la Fuente, H; Sanchez-Diaz, R; Moreno-Gonzalo, O; Jorge, I; Ferrarini, A; Vazquez, J; Punzon, C; Fresno, M; Vicente-Manzanares, M; Dauden, E; Fernandez-Salguero, PM; Martin, P; Sanchez-Madrid, F				Cibrian, Danay; Saiz, Maria Laura; de la Fuente, Hortensia; Sanchez-Diaz, Raquel; Moreno-Gonzalo, Olga; Jorge, Inmaculada; Ferrarini, Alessia; Vazquez, Jesus; Punzon, Carmen; Fresno, Manuel; Vicente-Manzanares, Miguel; Dauden, Esteban; Fernandez-Salguero, Pedro M.; Martin, Pilar; Sanchez-Madrid, Francisco			CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis (vol 17, pg 985, 2016)	NATURE IMMUNOLOGY			English	Correction													Vicente-Manzanares, Miguel/H-1010-2018; de la Fuente, Hortensia/J-9890-2014; Ferrarini, Alessia/ABD-6403-2021	Vicente-Manzanares, Miguel/0000-0001-5943-3220; de la Fuente, Hortensia/0000-0001-8708-753X; Ferrarini, Alessia/0000-0002-4587-6095; Jorge, Inmaculada/0000-0001-8645-9477				Cibrian D, 2016, NAT IMMUNOL, V17, P985, DOI 10.1038/ni.3504	1	5	5	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1235	1235		10.1038/ni1016-1235c	http://dx.doi.org/10.1038/ni1016-1235c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27648548	Bronze			2022-12-18	WOS:000384302900017
J	Ohne, Y; Silver, JS; Thompson-Snipes, L; Collet, MA; Blanck, JP; Cantarel, BL; Copenhaver, AM; Humbles, AA; Liu, YJ				Ohne, Yoichiro; Silver, Jonathan S.; Thompson-Snipes, LuAnn; Collet, Magalie A.; Blanck, Jean Philippe; Cantarel, Brandi L.; Copenhaver, Alan M.; Humbles, Alison A.; Liu, Yong-Jun			IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity (vol 17, pg 646, 2016)	NATURE IMMUNOLOGY			English	Correction													Cantarel, Brandi/ABF-5756-2020; Ohne, Yoichiro/AGE-6061-2022	Cantarel, Brandi/0000-0003-4126-4478; Copenhaver, Alan/0000-0001-5952-0455				Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447	1	5	5	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					1005	1005		10.1038/ni0816-1005a	http://dx.doi.org/10.1038/ni0816-1005a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27434012	Bronze			2022-12-18	WOS:000380647000019
J	Silver, JS; Kearley, J; Copenhaver, AM; Sanden, C; Mori, M; Yu, L; Pritchard, GH; Berlin, AA; Hunter, CA; Bowler, R; Erjefalt, JS; Kolbeck, R; Humbles, AA				Silver, Jonathan S.; Kearley, Jennifer; Copenhaver, Alan M.; Sanden, Caroline; Mori, Michiko; Yu, Li; Pritchard, Gretchen Harms; Berlin, Aaron A.; Hunter, Christopher A.; Bowler, Russell; Erjefalt, Jonas S.; Kolbeck, Roland; Humbles, Alison A.			Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs (vol 17, pg 626, 2016)	NATURE IMMUNOLOGY			English	Correction														Erjefalt, Jonas/0000-0002-6716-3010; Copenhaver, Alan/0000-0001-5952-0455				Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443	1	5	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					1005	1005		10.1038/ni0816-1005c	http://dx.doi.org/10.1038/ni0816-1005c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27434015	Bronze			2022-12-18	WOS:000380647000021
J	Greter, M				Greter, Melanie			Family ties among CNS macrophages	NATURE IMMUNOLOGY			English	Editorial Material							TISSUE-RESIDENT MACROPHAGES; DENDRITIC CELLS; ADULT LIFE; MICROGLIA; MONOCYTES; HOMEOSTASIS; BRAIN	Perivascular and subdural meningeal macrophages at the interface between the central nervous system and the periphery are self-renewing and arise from early embryonic precursors. Macrophages residing in the choroid plexus have dual origin, developing from circulating bone-marrow-derived monocytes and embryonic progenitors.	[Greter, Melanie] Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland	University of Zurich	Greter, M (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	greter@immunology.uzh.ch		Greter, Melanie/0000-0002-7220-5369				Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017	14	5	5	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					742	743		10.1038/ni.3490	http://dx.doi.org/10.1038/ni.3490			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27327994				2022-12-18	WOS:000378283200002
J	Sarrazin, S; Sieweke, MH				Sarrazin, Sandrine; Sieweke, Michael H.			Eosinophils and mast cells: a lineage apart	NATURE IMMUNOLOGY			English	Editorial Material							GATA-1; COMMITMENT; DIFFERENTIATION; PROGENITOR	Single-cell transcriptome analysis has identified progenitor populations with mast-cell and eosinophil potential that are distinct from the neutrophil-monocyte lineage, segregate early in hematopoietic development and can be discriminated by expression of the transcription factor GATA-1.	[Sarrazin, Sandrine; Sieweke, Michael H.] Univ Aix Marseille, CIML, UM2, Campus Luminy, Marseille, France; [Sarrazin, Sandrine; Sieweke, Michael H.] INSERM, U1104, F-13258 Marseille, France; [Sarrazin, Sandrine; Sieweke, Michael H.] CNRS, UMR7280, Marseille, France; [Sieweke, Michael H.] Helmholtz Gemeinschaft MDC, Max Delbruck Ctr Mol Med, Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sieweke, MH (corresponding author), Univ Aix Marseille, CIML, UM2, Campus Luminy, Marseille, France.; Sieweke, MH (corresponding author), INSERM, U1104, F-13258 Marseille, France.; Sieweke, MH (corresponding author), CNRS, UMR7280, Marseille, France.; Sieweke, MH (corresponding author), Helmholtz Gemeinschaft MDC, Max Delbruck Ctr Mol Med, Berlin, Germany.	sieweke@ciml.univ-mrs.fr	Sieweke, Michael/AAR-7515-2020	Sieweke, Michael/0000-0002-3228-9537				Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Sieweke MH, 2015, CELL STEM CELL, V16, P7, DOI 10.1016/j.stem.2014.12.009; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	14	5	5	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					609	611		10.1038/ni.3446	http://dx.doi.org/10.1038/ni.3446			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27196510				2022-12-18	WOS:000376162200002
J	Sonnenberg, GF				Sonnenberg, Gregory F.			Transcriptionally defining ILC heterogeneity in humans	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS	Single-cell RNA sequencing of human innate lymphoid cells (ILCs) reveals conserved transcriptional programs and defines previously unappreciated heterogeneity. These findings pave the way for future investigation of the function and therapeutic potential of ILCs in human health and disease.	[Sonnenberg, Gregory F.] Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY USA; [Sonnenberg, Gregory F.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Sonnenberg, Gregory F.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY USA	Cornell University; Cornell University; Cornell University	Sonnenberg, GF (corresponding author), Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY USA.; Sonnenberg, GF (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA.; Sonnenberg, GF (corresponding author), Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY USA.	gfsonnenberg@med.cornell.edu						Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Burkhard SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094196; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365	12	5	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					351	352		10.1038/ni.3413	http://dx.doi.org/10.1038/ni.3413			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002835				2022-12-18	WOS:000372508000005
J	Afonina, IS; Beyaert, R				Afonina, Inna S.; Beyaert, Rudi			Trabid epigenetically drives expression of IL-12 and IL-23	NATURE IMMUNOLOGY			English	Editorial Material							DEUBIQUITINASE	The production of interleukin 12 (IL-12) and IL-23 in dendritic cells is strictly regulated via epigenetic silencing. This transcriptional repression is overcome with the help of the deubiquitinase Trabid and has functional implications in a mouse model of multiple sclerosis.	[Afonina, Inna S.; Beyaert, Rudi] Univ Ghent, Inflammat Res Ctr VIB, B-9000 Ghent, Belgium; [Afonina, Inna S.; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Beyaert, R (corresponding author), Univ Ghent, Inflammat Res Ctr VIB, B-9000 Ghent, Belgium.; Beyaert, R (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.	rudi.beyaert@irc.vib-ugent.be	Beyaert, Rudi/B-2589-2009; Afonina, Inna/AAM-8978-2020	Afonina, Inna/0000-0001-8894-5305; Beyaert, Rudi/0000-0002-5704-582X				Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Jin J, 2016, NAT IMMUNOL, V17, P259, DOI 10.1038/ni.3347; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Shi Tong, 2012, BMC Chemical Biology, V12, P4, DOI 10.1186/1472-6769-12-4; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011	9	5	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					227	228		10.1038/ni.3388	http://dx.doi.org/10.1038/ni.3388			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE2PN	26882254				2022-12-18	WOS:000370469300006
J	Godfrey, DI; Uldrich, AP; McCluskey, J; Rossjohn, J; Moody, DB				Godfrey, Dale I.; Uldrich, Adam P.; McCluskey, James; Rossjohn, Jamie; Moody, D. Branch			The burgeoning family of unconventional T cells (vol 16, pg 1114, 2015)	NATURE IMMUNOLOGY			English	Correction													McCluskey, James/A-1291-2007; Uldrich, Adam/AAX-3785-2020; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Godfrey, Dale/0000-0002-3009-5472; Rossjohn, Jamie/0000-0002-2020-7522	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI049313] Funding Source: Medline; NIAMS NIH HHS [R01 AR048632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298	1	5	5	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					214	214		10.1038/ni0216-214a	http://dx.doi.org/10.1038/ni0216-214a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26784266	Bronze			2022-12-18	WOS:000368571500015
J	Klapproth, K; Lasitschka, F; Rodewald, HR				Klapproth, Kay; Lasitschka, Felix; Rodewald, Hans -Reimer			Multilayered ancestry of arterial macrophages	NATURE IMMUNOLOGY			English	Editorial Material							MONOCYTES; DYNAMICS; REVEALS; CELLS	Arteries are colonized by macrophages of multiple origins, derived prenatally from the yolk sac and during an early postnatal wave from the bone marrow. During sepsis, blood monocyte-derived macrophages transiently contribute to, but do not replace, resident arterial macrophages that largely self-renew in situ.	[Klapproth, Kay; Rodewald, Hans -Reimer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany; [Lasitschka, Felix] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany.	hr.rodewald@dkfz.de		Lasitschka, Felix/0000-0002-3212-1881				Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Akhavanpoor M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00296; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	11	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					117	118		10.1038/ni.3374	http://dx.doi.org/10.1038/ni.3374			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26784257				2022-12-18	WOS:000368571500003
J	Lee, JS; Cua, DJ				Lee, Jacob S.; Cua, Daniel J.			IL-26 AMPs up the T(H)17 arsenal	NATURE IMMUNOLOGY			English	Editorial Material							ANTIMICROBIAL PEPTIDES; CELLS; INDUCTION	A previously unknown function for T(H)17 cell-derived IL-26 as a direct antimicrobial agent and activator of DNA-sensing innate immunity is now reported.	[Lee, Jacob S.; Cua, Daniel J.] Merck Res Lab, Pathways Inflammat, Palo Alto, CA 94304 USA	Merck & Company	Lee, JS (corresponding author), Merck Res Lab, Pathways Inflammat, Palo Alto, CA 94304 USA.	daniel.cua@merck.com						Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	10	5	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					897	898		10.1038/ni.3256	http://dx.doi.org/10.1038/ni.3256			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287587				2022-12-18	WOS:000359876900004
J	Rasmussen, KD; Helin, K				Rasmussen, Kasper Dindler; Helin, Kristian			TET1: an epigenetic guardian of lymphomagenesis	NATURE IMMUNOLOGY			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MLL; PROTEIN	Due to their role in regulating DNA-methylation patterns, the TET proteins, in particular TET2, have emerged as key participants in tumorigenesis. Now the spotlight shifts to TET1 and its role as a tumor suppressor in lymphomagenesis.	[Rasmussen, Kasper Dindler; Helin, Kristian] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Rasmussen, Kasper Dindler; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Rasmussen, KD (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Helin, Kristian/0000-0003-1975-6097; Rasmussen, Kasper Dindler/0000-0002-7344-4177	Novo Nordisk Fonden [NNF15CC0018344] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Huang H, 2013, P NATL ACAD SCI USA, V110, P11994, DOI 10.1073/pnas.1310656110; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Ono R, 2002, CANCER RES, V62, P4075; Solary E, 2014, LEUKEMIA, V28, P485, DOI 10.1038/leu.2013.337; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wu BK, 2014, CELL REP, V9, P1827, DOI 10.1016/j.celrep.2014.10.063	10	5	5	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					592	594		10.1038/ni.3176	http://dx.doi.org/10.1038/ni.3176			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988898				2022-12-18	WOS:000354751900009
J	Spits, H				Spits, Hergen			TOX sets the stage for innate lymphoid cells	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; LINEAGES	Like T cells and B cells, innate lymphoid cells (ILCs) develop from common lymphoid progenitors, but how commitment to the ILC lineage is regulated has remained unclear. The transcriptional regulator TOX is important in this process.	Acad Med Ctr, Dept Cell Biol & Histol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Spits, H (corresponding author), Acad Med Ctr, Dept Cell Biol & Histol, Amsterdam, Netherlands.	hergen.spits@amc.uva.nl						Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406	11	5	6	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2015	16	6					594	595		10.1038/ni.3177	http://dx.doi.org/10.1038/ni.3177			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI4VM	25988899				2022-12-18	WOS:000354751900010
J	Lederman, MM				Lederman, Michael M.			A surprising role for TLR7	NATURE IMMUNOLOGY			English	Editorial Material							CELLS		Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Lederman, MM (corresponding author), Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA.	lederman.michael@clevelandactu.org						Baine I, 2009, IMMUNOL REV, V231, P225, DOI 10.1111/j.1600-065X.2009.00817.x; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dominguez- Villar M., 2015, NAT IMMUNOL, V16, P118; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; van Montfoort N., J CYTOKINE IN PRESS	7	5	5	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					8	9		10.1038/ni.3051	http://dx.doi.org/10.1038/ni.3051			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521672				2022-12-18	WOS:000346494200002
J	Wheeler, ML; Underhill, DM				Wheeler, Matthew L.; Underhill, David M.			Time to cast a larger net	NATURE IMMUNOLOGY			English	Editorial Material							PHAGOCYTOSIS; ACTIVATION; INDUCTION; SIZE		[Wheeler, Matthew L.; Underhill, David M.] Cedars Sinai Med Ctr, Div Biomed Sci, Los Angeles, CA 90048 USA; [Wheeler, Matthew L.; Underhill, David M.] Cedars Sinai Med Ctr, F Widjaja Inflammatory Bowel & Immunobiol Res Ins, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Wheeler, ML (corresponding author), Cedars Sinai Med Ctr, Div Biomed Sci, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X				Beningo KA, 2002, J CELL SCI, V115, P849; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brewer JM, 2004, J IMMUNOL, V173, P6143, DOI 10.4049/jimmunol.173.10.6143; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Henson P M, 1971, J Exp Med, V134, P114; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Rettig L, 2010, BLOOD, V115, P4533, DOI 10.1182/blood-2009-11-247817; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492	11	5	5	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1000	1001		10.1038/ni.3013	http://dx.doi.org/10.1038/ni.3013			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25329179				2022-12-18	WOS:000343640700002
J	Vahedi, G; Richard, AC; O'Shea, JJ				Vahedi, Golnaz; Richard, Arianne C.; O'Shea, John J.			Enhancing the understanding of asthma	NATURE IMMUNOLOGY			English	Editorial Material							CHROMATIN	The chromatin signature of genomic enhancers in CD4(+) T cells distinguishes asthmatic patients from healthy subjects.	[Vahedi, Golnaz; Richard, Arianne C.; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Vahedi, G (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov		Richard, Arianne/0000-0002-8708-9997	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AR041159-06] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Seumois G, 2014, NAT IMMUNOL, V15, P777, DOI 10.1038/ni.2937; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang IV, 2012, J ALLERGY CLIN IMMUN, V130, P1243, DOI 10.1016/j.jaci.2012.07.052; Zenewicz LA, 2010, CELL, V140, P791, DOI 10.1016/j.cell.2010.03.003	13	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					701	703		10.1038/ni.2946	http://dx.doi.org/10.1038/ni.2946			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	25045871	Green Accepted			2022-12-18	WOS:000339323000004
J	Reilly, SM; Saltiel, AR				Reilly, Shannon M.; Saltiel, Alan R.			Countering inflammatory signals in obesity	NATURE IMMUNOLOGY			English	Editorial Material							GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; INTERLEUKIN-6; RESISTANCE; MOUSE; BETA		[Reilly, Shannon M.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Reilly, SM (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@umich.edu	Saltiel, Alan/L-3632-2019; Reilly, Shannon Marie/ABB-6473-2021	Reilly, Shannon Marie/0000-0003-0412-2446; Saltiel, Alan/0000-0002-9726-9828	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060591] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK060591] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burysek L, 1997, FEBS LETT, V411, P83, DOI 10.1016/S0014-5793(97)00671-6; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	12	5	5	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					410	411		10.1038/ni.2874	http://dx.doi.org/10.1038/ni.2874			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24747704				2022-12-18	WOS:000334667900004
J	Njau, MN; Jacob, J				Njau, Modesta N.; Jacob, Joshy			Inducible nitric oxide synthase is crucial for plasma cell survival	NATURE IMMUNOLOGY			English	Editorial Material							APOPTOSIS		[Njau, Modesta N.; Jacob, Joshy] Emory Univ, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Njau, Modesta N.; Jacob, Joshy] Emory Univ, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Njau, MN (corresponding author), Emory Univ, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	joshy.jacob@emory.edu			NIAID NIH HHS [R56 AI095712, R01 AI100110] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095712, R01AI100110] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Guo FJ, 2010, CELL SIGNAL, V22, P1818, DOI 10.1016/j.cellsig.2010.07.006; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; Loweth AC, 1997, FEBS LETT, V400, P285, DOI 10.1016/S0014-5793(96)01392-0; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Saini AS, 2014, NAT IMMUNOL, V15, P275, DOI 10.1038/ni.2806; SALGO MG, 1995, BIOCHEM BIOPH RES CO, V215, P1111, DOI 10.1006/bbrc.1995.2578; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188	12	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					219	221		10.1038/ni.2831	http://dx.doi.org/10.1038/ni.2831			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24549066	Green Accepted			2022-12-18	WOS:000331683100006
J	Odegaard, JI; Chawla, A				Odegaard, Justin I.; Chawla, Ajay			Old HDL learns a new (anti-inflammatory) trick	NATURE IMMUNOLOGY			English	News Item							HIGH-DENSITY-LIPOPROTEINS; EMERGING ROLE; CHOLESTEROL	In addition to its canonical role in reverse cholesterol transport, high-density lipoprotein can suppress inflammation in target cells through the induction of Atf3, which encodes a well-known transcriptional repressor.	[Odegaard, Justin I.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Odegaard, JI (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	ajay.chawla@ucsf.edu						De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Drew BG, 2012, NAT REV ENDOCRINOL, V8, P237, DOI 10.1038/nrendo.2011.235; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Heinecke JW, 2012, NAT MED, V18, P1346, DOI 10.1038/nm.2930; Lerch PG, 1998, THROMB HAEMOSTASIS, V80, P316; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Nofer JR, 2010, CLIN EXP PHARMACOL P, V37, P726, DOI 10.1111/j.1440-1681.2010.05377.x; Norata GD, 2012, ATHEROSCLEROSIS, V220, P11, DOI 10.1016/j.atherosclerosis.2011.06.045; Patodia S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00008; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Zhu XW, 2012, ANNU REV NUTR, V32, P161, DOI 10.1146/annurev-nutr-071811-150709	12	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					138	139		10.1038/ni.2798	http://dx.doi.org/10.1038/ni.2798			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24448572				2022-12-18	WOS:000330150600006
J	Kronenberg, M; Zajonc, DM				Kronenberg, Mitchell; Zajonc, Dirk M.			A 'GEM' of a cell	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; MAIT CELLS	A third population of human T lymphocytes that express alpha beta T cell antigen receptors with restricted alpha-chain diversity has been identified. These cells recognize the lipid glucose monomycolate from Mycobacterium tuberculosis presented by CD1b.	[Kronenberg, Mitchell; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	La Jolla Institute for Immunology	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.	mitch@liai.org	Kronenberg, Mitchell/AAT-6078-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI071922] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI071922] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Felio K, 2009, J EXP MED, V206, P2497, DOI 10.1084/jem.20090898; Gapin L, 2009, PLOS BIOL, V7, P435, DOI 10.1371/journal.pbio.1000070; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Lopez-Sagaseta J, 2013, P NATL ACAD SCI USA, V110, pE1771, DOI 10.1073/pnas.1222678110; Skold M, 2000, J IMMUNOL, V165, P168, DOI 10.4049/jimmunol.165.1.168; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Van Rhijn I, 2013, NAT IMMUNOL, V14, P706, DOI 10.1038/ni.2630	10	5	5	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					694	695		10.1038/ni.2644	http://dx.doi.org/10.1038/ni.2644			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778804	Bronze			2022-12-18	WOS:000320509100009
J	Anderson, MK				Anderson, Michele K.			Changing course by lymphocyte lineage redirection	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL LINEAGE; DIFFERENTIATION; COMMITMENT; CHOICE; THPOK	The fate of T cells differentiating into the CD4 or CD8 lineage is typically fixed when cells leave the thymus. However, CD4(+) helper T cells can be reprogrammed to develop into CD44(+)CD8 alpha(+) cytotoxic T lymphocytes in the gut.	Univ Toronto, Dept Immunol, Div Biol, Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Anderson, MK (corresponding author), Univ Toronto, Dept Immunol, Div Biol, Sunnybrook Res Inst, Toronto, ON, Canada.	manderso@sri.utoronto.ca		Anderson, Michele/0000-0002-8820-5910				Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; FLEISCHER B, 1984, NATURE, V308, P365, DOI 10.1038/308365a0; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Nambu Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00642; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019	11	5	5	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					199	201		10.1038/ni.2544	http://dx.doi.org/10.1038/ni.2544			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416670				2022-12-18	WOS:000315065400007
J	Kumar, P; Kolls, JK				Kumar, Pawan; Kolls, Jay K.			Act1-hsp90 heats up T(H)17 inflammation	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; IL-17; MICE; INTERLEUKIN-22; SUSCEPTIBILITY; AUTOIMMUNE; PSORIASIS; DISEASE	Psoriasis is associated with the T(H)17 subset of helper T cells. Dysregulation of interleukin 17 (IL-17) signaling leads to enhanced T(H)17 differentiation, more production of IL-22 and IL-22-dependent skin inflammation.	[Kumar, Pawan; Kolls, Jay K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Med Ctr,Richard King Mellon Fdn,Inst Pediat Res, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kumar, P (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Med Ctr,Richard King Mellon Fdn,Inst Pediat Res, Pittsburgh, PA 15260 USA.	jay.kolls@chp.edu	Kumar, Pawan/GXF-7072-2022; Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304				Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreindler JL, 2009, AM J PHYSIOL-LUNG C, V296, pL257, DOI 10.1152/ajplung.00344.2007; Matsushima Y, 2010, J IMMUNOL, V185, P2340, DOI 10.4049/jimmunol.0900694; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Wang CH, 2013, NAT IMMUNOL, V14, P72, DOI 10.1038/ni.2479; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	15	5	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					16	17						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23238753				2022-12-18	WOS:000312433800005
J	Ma, AI				Ma, Averil I.			The ubiquitous nature of IL-17	NATURE IMMUNOLOGY			English	Editorial Material							INHIBITION; MECHANISM	The deubiquitinating enzyme USP25 restricts ubiquitination of the adaptors TRAF5 and TRAF6 and signaling via interleukin 17 and thus joins several ubiquitin-modifying enzymes already known to regulate this biomedically important pathway.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, AI (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu						Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Zepp JA, 2012, J IMMUNOL, V189, P33, DOI 10.4049/jimmunol.1200470; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427	10	5	6	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1034	1035		10.1038/ni.2448	http://dx.doi.org/10.1038/ni.2448			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23080197				2022-12-18	WOS:000310091700005
J	Olagnier, D; Hiscott, J				Olagnier, David; Hiscott, John			Breaking the barrier: membrane fusion triggers innate antiviral immunity	NATURE IMMUNOLOGY			English	Editorial Material							INTERFERON; RECEPTORS; INFLAMMASOME; ACTIVATION; CROSSTALK; ADAPTER	The sensing of viral infection by the innate immune system is dominated by the recognition of nucleic acids. New data now demonstrate that the fusion of viral and target-cell membranes leads to the activation of an immune response dependent on the adaptor STING.	[Olagnier, David; Hiscott, John] Vaccine & Gene Therapy Inst Florida, Div Infect Dis, Port St Lucie, FL USA	Vaccine & Gene Therapy Institute of Florida	Olagnier, D (corresponding author), Vaccine & Gene Therapy Inst Florida, Div Infect Dis, Port St Lucie, FL USA.	jhiscott@vgtifl.org		Olagnier, David/0000-0001-6912-0674				Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Noyce RS, 2011, J VIROL, V85, P10926, DOI 10.1128/JVI.00862-11; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	15	5	6	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					713	715		10.1038/ni.2373	http://dx.doi.org/10.1038/ni.2373			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22814341				2022-12-18	WOS:000306569600003
J	Gascoigne, NRJ; Fu, G				Gascoigne, Nicholas R. J.; Fu, Guo			Tespa1: another gatekeeper for positive selectione	NATURE IMMUNOLOGY			English	Editorial Material							ACTIN-INTERACTING PROTEIN; RECEPTOR; THYMOCYTES; THEMIS		[Gascoigne, Nicholas R. J.; Fu, Guo] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	gascoigne@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065230] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM065230] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Fujimoto T, 2011, BIOCHEM BIOPH RES CO, V408, P214, DOI 10.1016/j.bbrc.2011.03.112; Fujimoto T, 2011, BIOCHEM BIOPH RES CO, V408, P282, DOI 10.1016/j.bbrc.2011.04.016; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Wang D, 2012, NAT IMMUNOL, V13, P560, DOI 10.1038/ni.2301	12	5	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					530	532		10.1038/ni.2315	http://dx.doi.org/10.1038/ni.2315			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22610243				2022-12-18	WOS:000304203900006
J	Ceredig, R				Ceredig, Rhodri			Fates and potentials of thymus-seeding progenitors	NATURE IMMUNOLOGY			English	Editorial Material							LYMPHOID PROGENITORS; IN-VITRO; HEMATOPOIETIC PROGENITOR; LINEAGE COMMITMENT; CELLS	Controversies still surround the cellular and molecular processes involved in the differentiation of hematopoietic stem cells into their mature progeny. New insights into the lineage potential of early thymic progenitors at the single-cell level are presented here.	Natl Univ Ireland, Regenerat Med Inst, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Ceredig, R (corresponding author), Natl Univ Ireland, Regenerat Med Inst, Galway, Ireland.	rhodri.ceredig@nuigalway.ie		Ceredig, Rhodri/0000-0002-4393-727X				Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728; Ceredig R, 2009, NAT REV IMMUNOL, V9, P293, DOI 10.1038/nri2525; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Rolink A, 1995, Semin Immunol, V7, P155, DOI 10.1016/1044-5323(95)90043-8; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0	14	5	6	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					309	310						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430774				2022-12-18	WOS:000301886800001
J	Corbo-Rodgers, E; Staub, ES; Zou, T; Smith, A; Kambayashi, T; Maltzman, JS				Corbo-Rodgers, Evann; Staub, Elizabeth S.; Zou, Tao; Smith, Abigail; Kambayashi, Taku; Maltzman, Jonathan S.			Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells	NATURE IMMUNOLOGY			English	Letter							PARASITIC ECOLOGY; MYOBIA-MUSCULI; RODENT MITE; MICE		[Corbo-Rodgers, Evann; Staub, Elizabeth S.; Maltzman, Jonathan S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zou, Tao; Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Abigail] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Corbo-Rodgers, E (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	maltz@mail.med.upenn.edu		Maltzman, Jonathan/0000-0001-5722-269X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111501, R01HL107589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085160] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL107589, R01 HL111501] Funding Source: Medline; NIAID NIH HHS [R01 AI085160] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLAKLEY BR, 1991, AM J VET RES, V52, P593; Dourmishev AL, 2005, INT J DERMATOL, V44, P981, DOI 10.1111/j.1365-4632.2004.02253.x; Edwards Geoffrey, 2003, Filaria J, V2 Suppl 1, pS8, DOI 10.1186/1475-2883-2-S1-S8; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Canga AG, 2009, VET J, V179, P25, DOI 10.1016/j.tvjl.2007.07.011; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; WEISBROTH SH, 1974, LAB ANIM SCI, V24, P510; WEISBROTH SH, 1976, LAB ANIM SCI, V26, P725; Wu GF, 2011, EUR J IMMUNOL, V41, P2064, DOI 10.1002/eji.201040809	10	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					197	198		10.1038/ni.2232	http://dx.doi.org/10.1038/ni.2232			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22344272	Green Accepted			2022-12-18	WOS:000300510600001
J	Ayres, JS; Vance, RE				Ayres, Janelle S.; Vance, Russell E.			Cellular teamwork in antibacterial innate immunity	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; IFN-GAMMA; LISTERIA-MONOCYTOGENES; ACTIVATION; MECHANISMS; INFECTION; PROVIDE	IFN-gamma is a cytokine that is critical for defense against intracellular bacterial pathogens. New work provides evidence that the recognition of bacterial flagellin by the NLRC4 inflammasome in splenic dendritic cells triggers rapid release of IL-18, which leads to IFN-gamma production by memory CD8(+) T cells.	[Ayres, Janelle S.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ayres, JS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu						Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Berg RE, 2002, EUR J IMMUNOL, V32, P2807, DOI 10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; D'Orazio SEF, 2006, J IMMUNOL, V177, P7146, DOI 10.4049/jimmunol.177.10.7146; Ghanem ENB, 2009, INFECT IMMUN, V77, P1492, DOI 10.1128/IAI.01207-08; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	12	5	8	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					115	117		10.1038/ni.2212	http://dx.doi.org/10.1038/ni.2212			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22261960				2022-12-18	WOS:000299315000006
J	Cambronero, JG; Allen, LAH; Cathcart, MK; Justement, LB; Kovacs, EJ; McLeish, KR; Nauseef, WM				Cambronero, Julian G.; Allen, Lee-Ann H.; Cathcart, Martha K.; Justement, Louis B.; Kovacs, Elizabeth J.; McLeish, Kenneth R.; Nauseef, William M.			Writing a first grant proposal	NATURE IMMUNOLOGY			English	Article								A workshop organized by the Society for Leukocyte Biology offered advice to young scientists on how to decipher the grant-submission process of the US National Institutes of Health and compose a clear, compelling and fundable grant.	[Cambronero, Julian G.] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Allen, Lee-Ann H.; Nauseef, William M.] Univ Iowa, Iowa Inflammat Program, Coralville, IA USA; [Allen, Lee-Ann H.; Nauseef, William M.] Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Coralville, IA USA; [Cathcart, Martha K.] Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; [Justement, Louis B.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Kovacs, Elizabeth J.] Loyola Univ Chicago, Stritch Sch Med, Burn & Shock Trauma Inst, Maywood, IL USA; [Kovacs, Elizabeth J.] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Maywood, IL USA; [McLeish, Kenneth R.] Univ Louisville, Hlth Sci Ctr, Kidney Dis Program, Louisville, KY 40292 USA	Wright State University Dayton; University of Iowa; University of Iowa; Case Western Reserve University; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; Loyola University Chicago; Loyola University Chicago; University of Louisville	Cambronero, JG (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	william-nauseef@uiowa.edu	McLeish, Kenneth R./B-9819-2013	McLeish, Kenneth R./0000-0002-7816-3286; Justement, Louis/0000-0001-7058-867X; Allen, Lee-Ann/0000-0001-8929-6968; Nauseef, William/0000-0003-4032-757X	NATIONAL INSTITUTE ON AGING [R01AG018859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER; NIAAA NIH HHS [T32 AA013527, P30 AA019373] Funding Source: Medline; BLRD VA [I01 BX000513] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BLRD VA			0	5	5	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					105	108		10.1038/ni.2183	http://dx.doi.org/10.1038/ni.2183			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22261956				2022-12-18	WOS:000299315000002
J	Swamy, M; Hayday, A				Swamy, Mahima; Hayday, Adrian			Provocative exhibits at the Seventeen Gallery	NATURE IMMUNOLOGY			English	Editorial Material							CELLS	Two studies identify a tissue-autonomous innate immune mechanism whereby infection provokes epithelial cells to produce IL-17C that engages an epithelial receptor composed of IL-17RA and IL-17RE chains, which promotes host defense and immune activation.	[Swamy, Mahima; Hayday, Adrian] Kings Coll London, Guys Hosp, Peter Gorer Dept Immunobiol, London WC2R 2LS, England; [Swamy, Mahima; Hayday, Adrian] Canc Res UK, London Res Inst, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK	Swamy, M (corresponding author), Kings Coll London, Guys Hosp, Peter Gorer Dept Immunobiol, London WC2R 2LS, England.	adrian.hayday@kcl.ac.uk	Swamy, Mahima/J-7046-2019	Swamy, Mahima/0000-0003-3977-3425; HAYDAY, ADRIAN/0000-0002-9495-5793	Wellcome Trust [085780] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rutherford Jonathan, 1990, IDENTITY COMMUNITY C, P211; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	13	5	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1131	1133		10.1038/ni.2164	http://dx.doi.org/10.1038/ni.2164			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22089209				2022-12-18	WOS:000297202700003
J	Ablasser, A; Hornung, V				Ablasser, Andrea; Hornung, Veit			Where, in antiviral defense, does IFIT1 fit?	NATURE IMMUNOLOGY			English	Editorial Material							RIG-I; VIRUS-INFECTION; RNA; FAMILY; MDA5	New data show that the interferon-induced gene product IFIT1 is a sensor for 5'-triphosphorylated RNA of viral origin and that it functions within a larger IFIT complex to inhibit viral replication.	[Ablasser, Andrea; Hornung, Veit] Univ Bonn, Inst Clin Chem & Pharmacol, Unit Clin Biochem, Univ Hosp, D-5300 Bonn, Germany	University of Bonn	Ablasser, A (corresponding author), Univ Bonn, Inst Clin Chem & Pharmacol, Unit Clin Biochem, Univ Hosp, D-5300 Bonn, Germany.	veit.hornung@uni-bonn.de	Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X				Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	10	5	8	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					588	590		10.1038/ni.2061	http://dx.doi.org/10.1038/ni.2061			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21685951				2022-12-18	WOS:000291936400004
J	Cormier, SA; Kolls, JK				Cormier, Stephania A.; Kolls, Jay K.			Innate IL-13 in virus-induced asthma?	NATURE IMMUNOLOGY			English	Editorial Material							TYPE-2 IMMUNITY; LYMPHOID-CELLS; RESPONSES; CYTOKINE; DISEASE	Although the role of adaptive immunity in asthma is well characterized, there is relatively little understanding of the contribution of innate immunity to asthma. Studies now suggest that interleukin 13 produced by innate natural helper cells in the lungs has a substantial and underappreciated role in asthma exacerbation.	[Cormier, Stephania A.] Louisiana State Univ, Dept Pharmacol & Expt Therapeut, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Kolls, Jay K.] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Cormier, SA (corresponding author), Louisiana State Univ, Dept Pharmacol & Expt Therapeut, Hlth Sci Ctr, New Orleans, LA 70112 USA.	jkolls@lsuhsc.edu	Cormier, Stephania A/I-7382-2017; Kolls, Jay/AAH-1829-2019	Cormier, Stephania A/0000-0002-6050-6172; Kolls, Jay/0000-0001-5151-6304	NIAID NIH HHS [R01 AI090059] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090059] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ripple MJ, 2010, J IMMUNOL, V185, P4804, DOI 10.4049/jimmunol.1000484; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Strober W, 2010, NATURE, V463, P434, DOI 10.1038/463434a; Yang M, 2001, AM J RESP CELL MOL, V25, P522, DOI 10.1165/ajrcmb.25.4.4620	15	5	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					587	588		10.1038/ni.2056	http://dx.doi.org/10.1038/ni.2056			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21685950				2022-12-18	WOS:000291936400003
J	Malissen, B; Marguet, D				Malissen, Bernard; Marguet, Didier			La(s)t but not least	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOLOGICAL SYNAPSE	The T cell antigen receptor is functionally coupled to many kinases and adaptor proteins. Analysis of the spatiotemporal organization of the T cell antigen receptor signaling cascade suggests that adaptor-containing intracellular vesicles are essential for proper signal propagation.	[Malissen, Bernard; Marguet, Didier] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, INSERM, CNRS,U631,UMR 6102, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, INSERM, CNRS,U631,UMR 6102, Marseille, France.	bernardm@ciml.univ-mrs.fr	Marguet, Didier/AGO-5421-2022; Marguet, Didier/B-9946-2008; Malissen, Bernard/AAK-4659-2020	Marguet, Didier/0000-0003-3198-5095; Malissen, Bernard/0000-0003-1340-9342				Alcover A, 2010, CURR TOP MICROBIOL, V340, P191, DOI 10.1007/978-3-642-03858-7_10; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Roncagalli R, 2010, TRENDS IMMUNOL, V31, P253, DOI 10.1016/j.it.2010.05.001; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049	12	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					592	593		10.1038/ni.2054	http://dx.doi.org/10.1038/ni.2054			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21685953				2022-12-18	WOS:000291936400006
J	Moscat, J; Diaz-Meco, MT				Moscat, Jorge; Diaz-Meco, Maria T.			Fine tuning NF-kappa B: new openings for PKC-zeta	NATURE IMMUNOLOGY			English	Editorial Material							PHOSPHORYLATION	NF-kappa B is a critical transcription factor that is regulated by several post-transcriptional modifications. The characterization of their roles would help in the design of new therapeutic targets in cancer and inflammation.	[Moscat, Jorge; Diaz-Meco, Maria T.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA	University of Cincinnati	Moscat, J (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.	jorge.moscat@uc.edu		Diaz-Meco, Maria/0000-0003-0147-0998	NCI NIH HHS [R01 CA134530, R01 CA132847] Funding Source: Medline; NIAID NIH HHS [R01 AI072581] Funding Source: Medline; NIDDK NIH HHS [R01 DK088107] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA132847, R01CA134530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088107] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Moscat J, 2009, CELL DEATH DIFFER, V16, P1426, DOI 10.1038/cdd.2009.119; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	11	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					12	14		10.1038/ni0111-12	http://dx.doi.org/10.1038/ni0111-12			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21169999	Green Accepted			2022-12-18	WOS:000285465100006
J	Constantin, G; Laudanna, C				Constantin, Gabriela; Laudanna, Carlo			Leukocyte chemotaxis: from lysosomes to motility	NATURE IMMUNOLOGY			English	Editorial Material							SYNAPTOTAGMIN		[Constantin, Gabriela; Laudanna, Carlo] Univ Verona, Dept Pathol, Div Gen Pathol, I-37100 Verona, Italy	University of Verona	Constantin, G (corresponding author), Univ Verona, Dept Pathol, Div Gen Pathol, I-37100 Verona, Italy.	carlo.laudanna@univr.it		Constantin, Gabriela/0000-0001-8978-3539				Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Fowler KT, 2007, J IMMUNOL, V178, P1498, DOI 10.4049/jimmunol.178.3.1498; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Masztalerz A, 2007, J CELL SCI, V120, P219, DOI 10.1242/jcs.03328; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; WONG CH, 2010, CARDIOVASC RES, V86, P3	9	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					463	464		10.1038/ni0610-463	http://dx.doi.org/10.1038/ni0610-463			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20485271				2022-12-18	WOS:000277821300004
J	Horton, MR; Powell, JD				Horton, Maureen R.; Powell, Jonathan D.			Quieting T cells with Slfn2	NATURE IMMUNOLOGY			English	Editorial Material							LYMPHOCYTE QUIESCENCE; GENE; SCHLAFEN; FAMILY	The mechanisms that enforce T cell quiescence are incompletely understood. Slfn2 has now been identified as another participant in this process, functioning as a critical regulator of T cell-and monocyte-mediated immunity.	[Horton, Maureen R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Horton, MR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	poweljo@jhmi.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI077610] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Glynne R, 2000, IMMUNOL REV, V176, P216; Gubser C, 2007, J GEN VIROL, V88, P1667, DOI 10.1099/vir.0.82748-0; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Tzachanis D, 2004, LEUKEMIA LYMPHOMA, V45, P1959, DOI 10.1080/1042819042000219494; Tzachanis D, 2009, CELL CYCLE, V8, P1019, DOI 10.4161/cc.8.7.8033	11	5	8	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					281	282		10.1038/ni0410-281	http://dx.doi.org/10.1038/ni0410-281			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20300134	Green Accepted			2022-12-18	WOS:000275849500004
J	Reth, M; Dick, TP				Reth, Michael; Dick, Tobias P.			Voltage control for B cell activation	NATURE IMMUNOLOGY			English	Editorial Material							PROTEIN-TYROSINE PHOSPHATASES; NADPH OXIDASE; STRENGTH	Transient formation of reactive oxygen species (ROS) accompanies B cell signaling and activation. Now the voltage-gated proton channel HVCN1 has been linked to ROS formation and B cell activation.	[Reth, Michael] Univ Freiburg, Ctr Biol Signaling Studies, Freiburg, Germany; [Reth, Michael] Max Planck Inst Immunobiol, D-7800 Freiburg, Germany; [Dick, Tobias P.] German Canc Res Ctr, D-6900 Heidelberg, Germany	University of Freiburg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ)	Reth, M (corresponding author), Univ Freiburg, Ctr Biol Signaling Studies, Freiburg, Germany.	michael.reth@bioss.uni-freiburg.de						Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Richards SM, 2009, EUR J IMMUNOL, V39, P3395, DOI 10.1002/eji.200939587; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039	12	5	5	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					191	192		10.1038/ni0310-191	http://dx.doi.org/10.1038/ni0310-191			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20157299				2022-12-18	WOS:000274605800005
J	Wucherpfennig, KW; Gagnon, E				Wucherpfennig, Kai W.; Gagnon, Etienne			Positively selecting peptides: their job does not end in the thymus	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-RECEPTOR; SENSITIVITY	Peptides able to positively select major histocompatibility complex class II-restricted thymocytes have not yet been defined. Two new reports identify and ascribe important extrathymic functions to several positively selecting peptides for CD4(+) T cells.	[Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu						Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796	10	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1143	1144		10.1038/ni1109-1143	http://dx.doi.org/10.1038/ni1109-1143			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19841646				2022-12-18	WOS:000270955900005
J	Cheroutre, H; Mucida, D; Lambolez, F				Cheroutre, Hilde; Mucida, Daniel; Lambolez, Florence			The importance of being earnestly selfish	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; TOLERANCE; SELECTION; THYMUS; ELIMINATION; GENERATION; THYMOCYTES; PATHWAYS; DELETION; SUBSET	Agonist encounter can divert thymocytes into several unconventional T cell subsets, many of which exhibit regulatory properties. Unexpected findings indicate that agonist selection can drive the differentiation of interleukin 17-producing cells in the thymus.	[Cheroutre, Hilde; Mucida, Daniel; Lambolez, Florence] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	La Jolla Institute for Immunology	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.	hilde@liai.org		Mucida, Daniel/0000-0002-0000-0452	NIH HHS [DP1 OD006433-02, DP1 OD006433] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006433] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bendelac A, 2004, NAT IMMUNOL, V5, P557, DOI 10.1038/ni0604-557; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BLUTHMANN H, 1988, NATURE, V334, P156, DOI 10.1038/334156a0; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Ehrlich P., 1900, P R SOC            B, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	16	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1047	1049		10.1038/ni1009-1047	http://dx.doi.org/10.1038/ni1009-1047			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19767722	Green Accepted			2022-12-18	WOS:000270006900004
J	Glimcher, LH; Lieberman, J				Glimcher, Laurie H.; Lieberman, Judy			Harvard's women four years later	NATURE IMMUNOLOGY			English	Editorial Material								How have women fared at Harvard since the events of four years ago? Here, Judy Lieberman and Laurie Glimcher reflect on progress made and barriers still to be breached.	[Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lieberman@idi.med.harvard.edu; lglimcher@hsph.harvard.edu	Lieberman, Judy/A-2717-2015						0	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					559	561		10.1038/ni0609-559	http://dx.doi.org/10.1038/ni0609-559			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448653				2022-12-18	WOS:000266384100003
J	Iwasaki, A				Iwasaki, Akiko			Local advantage: skin DCs prime; skin memory T cells protect	NATURE IMMUNOLOGY			English	Editorial Material							LANGERIN(+) DENDRITIC CELLS; LANGERHANS CELLS; POPULATION; GENERATION; SUBSETS; VIRUS	How the immune system responds to local infection and establishes protective immunity in susceptible tissues remains unclear. Two new studies show that local tissue-resident dendritic cells prime cytotoxic T lymphocyte responses and that memory cytotoxic T lymphocytes remain in the tissue to provide antiviral immunity.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NIAID NIH HHS [R01 AI062428, R01 AI054359] Funding Source: Medline; NIBIB NIH HHS [R01 EB000487] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R01AI062428] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	12	5	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					451	453		10.1038/ni0509-451	http://dx.doi.org/10.1038/ni0509-451			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19381136	Green Accepted, Bronze			2022-12-18	WOS:000265394400003
J	Malissen, B				Malissen, Bernard			CD3 ITAMs count!	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; MICE; MUTATION; IMMUNITY	The T cell receptor (TCR) is functionally coupled to a constellation of ten immunoreceptor tyrosine-based activation motifs (ITAMs). A new study suggests that this large number of ITAMs is mandatory for preventing autoimmunity.	Univ Aix Marseille 2, CNRS, UMR6102, INSERM,U631,Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Univ Aix Marseille 2, CNRS, UMR6102, INSERM,U631,Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France.	bernardm@ciml.univ-mrs.fr	Malissen, Bernard/AAK-4659-2020	Malissen, Bernard/0000-0003-1340-9342				Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Lin SY, 1997, J EXP MED, V185, P707, DOI 10.1084/jem.185.4.707; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Nijnik A, 2006, INT IMMUNOL, V18, P1127, DOI 10.1093/intimm/dxl047; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	12	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					583	584		10.1038/ni0608-583	http://dx.doi.org/10.1038/ni0608-583			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490905				2022-12-18	WOS:000256067900005
J	Berstein, G; Abraham, RT				Berstein, Gabriel; Abraham, Robert T.			Moving out: mobilizing activated T cells from lymphoid tissues	NATURE IMMUNOLOGY			English	Editorial Material							MIGRATION; EGRESS; ORGANS	The intensity of cytokine-induced signaling by the kinase PI(3) K subunit p110 delta proves to be an important regulator of T cell migration patterns. High PI(3) K activity functions through the nutrient and bioenergetic sensor mTOR to modulate the transcription factor KLF2 and thereby the repertoire of tissue-homing receptors expressed on effector T cells.	[Berstein, Gabriel] Inflammat Discovery Res, Cambridge, MA 02140 USA; [Abraham, Robert T.] Oncol Discovery Res, Pearl River, NY 10960 USA		Berstein, G (corresponding author), Inflammat Discovery Res, Cambridge, MA 02140 USA.	abrahar@wyeth.com						Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kahan BD, 2004, TRANSPLANT P, V36, p531S, DOI 10.1016/j.transproceed.2004.01.092; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Rollins BJ, 2008, NAT IMMUNOL, V9, P233, DOI 10.1038/ni0308-233; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603	12	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					455	457		10.1038/ni0508-455	http://dx.doi.org/10.1038/ni0508-455			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425096				2022-12-18	WOS:000255153500002
J	Vestweber, D; Wild, MK				Vestweber, Dietmar; Wild, Martin K.			A new player in lymphocyte homing	NATURE IMMUNOLOGY			English	Editorial Material							LYSOPHOSPHATIDIC ACID; ENDOTHELIAL-CELLS; TRAFFICKING; SPHINGOSINE-1-PHOSPHATE; MIGRATION; ENIGMAS	The homing of lymphocytes to secondary lymphoid organs occurs at specialized blood vessels, the high endothelial venules. Autotaxin, a phospholipid-producing enzyme secreted by high endothelial venule endothelial, is a new participant found to facilitate the entry of lymphocytes into secondary lymphoid organs.	[Vestweber, Dietmar; Wild, Martin K.] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, D-48149 Munster, Germany	Max Planck Society	Vestweber, D (corresponding author), Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, D-48149 Munster, Germany.	vestweb@mpi-muenster.mpg.de; mwild@mpi-muenster.mpg.de		Vestweber, Dietmar/0000-0002-3517-732X				Clair T, 2003, CANCER RES, V63, P5446; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Palmeri D, 2004, J LEUKOCYTE BIOL, V75, P910, DOI 10.1189/jlb.0903408; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 1997, ADV IMMUNOL, V64, P139, DOI 10.1016/S0065-2776(08)60889-5; Schulze C, 1997, J NEUROCHEM, V68, P991; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x	15	5	5	2	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					347	348		10.1038/ni0408-347	http://dx.doi.org/10.1038/ni0408-347			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18349812				2022-12-18	WOS:000254123200008
J	Heissmeyer, V; Rao, A				Heissmeyer, Vigo; Rao, Anjana			Itching to end NF-kappa B	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; MICE; UBIQUITINATION; PROTEINS; LIGASE	Both activation and termination of transcription factor NF-kappa B signaling require ubiquitin modification of pathway components. The E3 ligase Itch teams up with the NF-kappa B inhibitor A20 to edit the composition of ubiquitin chains on the signaling adaptor RIP, thereby limiting inflammatory responses.	[Heissmeyer, Vigo] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Mol Immunol, D-81377 Munich, Germany; [Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Heissmeyer, V (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Mol Immunol, D-81377 Munich, Germany.	vigo.heissmeyer@helmholtz-muenchen.de		Heissmeyer, Vigo/0000-0002-2263-8545				Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963	13	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					227	229		10.1038/ni0308-227	http://dx.doi.org/10.1038/ni0308-227			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285770				2022-12-18	WOS:000253406700005
J	Rollins, BJ				Rollins, Barrett J.			Innocents abroad: regulating where naive T cells go	NATURE IMMUNOLOGY			English	Editorial Material							QUIESCENCE; THYMOCYTE; LKLF	Kruppel-like factor 2 is now shown to regulate chemokine receptor expression in lymphocytes, which leads to their homing to nonlymphoid organs after they leave the thymus.	[Rollins, Barrett J.] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Rollins, Barrett J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rollins, BJ (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	barrett_rollins@dfci.harvard.edu						Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565	7	5	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					233	235		10.1038/ni0308-233	http://dx.doi.org/10.1038/ni0308-233			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285773				2022-12-18	WOS:000253406700008
J	Sattentau, Q				Sattentau, Quentin			HIV's gut feeling	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; VIROLOGICAL SYNAPSE; INFECTION; ADHESION; TYPE-1; LFA-1; CCR5	Human immunodeficiency virus may direct its assault on gut-associated CD4(+) T cells by means of the gut-homing integrin alpha(4)beta(7).	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Sattentau, Q (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	quentin_sattentau@path.ox.ac.uk						Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Tardif MR, 2005, J IMMUNOL, V175, P926, DOI 10.4049/jimmunol.175.2.926; Tardif MR, 2005, J VIROL, V79, P13714, DOI 10.1128/JVI.79.21.13714-13724.2005	12	5	7	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					225	227		10.1038/ni0308-225	http://dx.doi.org/10.1038/ni0308-225			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285769				2022-12-18	WOS:000253406700004
J	Shaw, AS				Shaw, Andrey S.			How T cells 'find' the right dendritic cell	NATURE IMMUNOLOGY			English	Editorial Material							LYMPH-NODES; ACTIVATION; DYNAMICS	Naive T cells can spend hours 'sampling' dendritic cells before making a stable conjugate with a single dendritic cell. It is the antigen 'dose' that determines how long this process takes.	Washington Univ, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Shaw, AS (corresponding author), Washington Univ, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA.	ashaw@wustl.edu		Shaw, Andrey/0000-0001-5685-0272				Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Chakraborty AK, 2003, NAT IMMUNOL, V4, P933, DOI 10.1038/ni1003-933; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	13	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					229	230		10.1038/ni0308-229	http://dx.doi.org/10.1038/ni0308-229			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285771				2022-12-18	WOS:000253406700006
J	Colucci, F				Colucci, Francesco			Unexpected partnership between IL-15 and DAP10	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; NKG2D	Interleukin 15 ( IL-15) is essential for natural killer (NK) cell development and function, and the adaptor DAP10 transmits important signals in NK cells. New work shows that IL-15 and DAP10 cross regulate each other.	Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Colucci, F (corresponding author), Babraham Inst, Cambridge CB22 3AT, England.	francesco.colucci@bbsrc.ac.uk	Colucci, Francesco/F-2844-2010	Colucci, Francesco/0000-0001-5193-6376	British Heart Foundation [FS/12/4/29254] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Chang CW, 1999, J IMMUNOL, V163, P4651; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2006, IMMUNOL REV, V214, P5, DOI 10.1111/j.1600-065X.2006.00464.x; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325	11	5	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1289	1291		10.1038/ni1207-1289	http://dx.doi.org/10.1038/ni1207-1289			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	18026080				2022-12-18	WOS:000251267000009
J	Latz, E; Verma, A; Visintin, A; Gong, M; Sirois, CM; Klein, DCG; Monks, BG; McKnight, CJ; Lamphier, MS; Duprex, WP; Espevik, T; Golenbock, DT				Latz, Eicke; Verma, Anjali; Visintin, Alberto; Gong, Mei; Sirois, Cherilyn M.; Klein, Dionne C. G.; Monks, Brian G.; McKnight, C. James; Lamphier, Marc S.; Duprex, W. Paul; Espevik, Terje; Golenbock, Douglas T.			Ligand-induced conformational changes allosterically activate Toll-like receptor 9 (vol 8, pg 772, 2007)	NATURE IMMUNOLOGY			English	Correction													Verma, Anjali/HHN-5385-2022; Monks, Brian/B-8362-2015; Latz, Eicke/H-3951-2014	Monks, Brian/0000-0003-4008-3093; Latz, Eicke/0000-0003-1488-5666; Sirois, Cherilyn M./0000-0002-5472-4288; McKnight, Christopher/0000-0002-3237-0896				Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479	1	5	5	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1266	1266		10.1038/ni1107-1266c	http://dx.doi.org/10.1038/ni1107-1266c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR		Bronze			2022-12-18	WOS:000250338900021
J	Nossal, GJV				Nossal, G. J. V.			One cell-one antibody: prelude and aftermath	NATURE IMMUNOLOGY			English	Article							SINGLE CELLS; ANTIGENS	This year marks the 50th anniversary of Burnet's clonal selection theory. Here Gustav Nossal recounts his pioneering work that supported Burnet's theory and led to the death of the direct template hypothesis.	Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	University of Melbourne	Nossal, GJV (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.	dewhurst@wehi.edu.au						ADA GL, 1969, NATURE, V222, P1291, DOI 10.1038/2221291a0; ATTARDI G, 1959, BACTERIOL REV, V23, P213, DOI 10.1128/MMBR.23.4.213-223.1959; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet FM, 1949, PRODUCTION ANTIBODIE; FAFF MC, 1973, J EXP MED, V126, P443; FAGRAEUS A, 1948, J IMMUNOL, V58, P1; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; KOHLER G, 1976, EUR J IMMUNOL, V6, P511, DOI 10.1002/eji.1830060713; LWOFF A, 1955, VIROLOGY, V1, P128, DOI 10.1016/0042-6822(55)90010-6; MACKAY IR, 1958, ARCH INTERN MED, V101, P30, DOI 10.1001/archinte.1958.00260130044004; MAKELA O, 1967, COLD SPRING HARB SYM, V32, P423, DOI 10.1101/SQB.1967.032.01.054; MCDEVITT HO, 1966, IMMUNOLOGY, V11, P337; NAOR D, 1967, NATURE, V214, P687, DOI 10.1038/214687a0; NOSSAL GJV, 1953, NATURE, V172, P671, DOI 10.1038/172671a0; NOSSAL GJV, 1960, BRIT J EXP PATHOL, V41, P89; NOSSAL GJV, 1965, J EXP MED, V121, P945, DOI 10.1084/jem.121.6.945; NOSSAL GJV, 1962, J IMMUNOL, V88, P604; NOSSAL GJV, 1976, IMMUNOLOGY, V30, P189; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; WHITE RG, 1958, NATURE, V182, P1383, DOI [10.1038/1811419a0, 10.1038/1821383a0]; WHITE RG, 1958, NATURE, V183, P1383	23	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1015	1017		10.1038/ni1007-1015	http://dx.doi.org/10.1038/ni1007-1015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878906				2022-12-18	WOS:000249691400004
J	MacLennan, I				MacLennan, Ian			Holding antigen where B cells can find it	NATURE IMMUNOLOGY			English	Editorial Material							SUBCAPSULAR SINUS; LYMPH-NODE; FOLLICLES; TRANSPORT; RESPONSES; INTERACT; IMMUNITY	Specialized macrophage-like cells initiate antibody responses by trapping antigen in lymph. These antigen-trapping cells are located in the migration pathway of recirculating B cells, which can engage the trapped antigen.	Univ Birmingham, Biomed Res Inst, Med Res Council Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Birmingham	MacLennan, I (corresponding author), Univ Birmingham, Biomed Res Inst, Med Res Council Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	c.m.maclennan@bham.ac.uk			Medical Research Council [G8402371] Funding Source: Medline; MRC [G8402371] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BROWN JC, 1970, NATURE, V228, P367, DOI 10.1038/228367a0; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; Oetke C, 2006, IMMUNOL LETT, V106, P96, DOI 10.1016/j.imlet.2006.04.004; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Wykes M, 1998, J IMMUNOL, V161, P1313	11	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					909	910		10.1038/ni0907-909	http://dx.doi.org/10.1038/ni0907-909			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17712342				2022-12-18	WOS:000248918200007
J	Seth, RB; Chen, ZJ				Seth, Rashu B.; Chen, Zhijian J.			Smads keep TABs on inflammation	NATURE IMMUNOLOGY			English	Editorial Material							KAPPA-B PATHWAY; ACTIVATION; MECHANISM	Smad7 controls inflammation by negatively regulating activation of the transcription factor NF-kappa B. New work shows that Smad7 inhibits NF-kappa B by binding to the regulatory proteins TAB2 and TAB3, thereby blocking association of the E3 ubiquitin ligase TRAF2 with the kinase TAK1.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Seth, RB (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251				Bitzer M, 2000, GENE DEV, V14, P187; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Israel A, 2006, TRENDS IMMUNOL, V27, P395, DOI 10.1016/j.it.2006.07.003; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	11	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					477	478		10.1038/ni0507-477	http://dx.doi.org/10.1038/ni0507-477			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440456				2022-12-18	WOS:000245831600010
J	Nikolich-Zugich, J				Nikolich-Zugich, Janko			High specificity, not degeneracy, allows T cell alloresponses	NATURE IMMUNOLOGY			English	Editorial Material							LYMPHOCYTES; REPERTOIRE; HYPOTHESIS; PEPTIDES; RECEPTOR	Alloreactive T cell responses are considered the product of 'degenerate' recognition by T cells of many different complexes of peptide and major histocompatibility complex. New work shows instead that T cell receptor alloresponses are highly 'polyspecific' for such complexes.	Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Nikolich-Zugich, J (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	nikolich@ohsu.edu		Nikolich-Zugich, Janko/0000-0001-5830-5323	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066096] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI066096] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Frelinger JA, 1996, IMMUNOL REV, V154, P45, DOI 10.1111/j.1600-065X.1996.tb00929.x; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HUNIG TR, 1982, J EXP MED, V155, P111, DOI 10.1084/jem.155.1.111; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LINDAHL KF, 1977, J EXP MED, V145, P508, DOI 10.1084/jem.145.3.508; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Nesic D, 2002, TRANSPLANTATION, V73, P797; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0	14	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					335	337		10.1038/ni0407-335	http://dx.doi.org/10.1038/ni0407-335			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375093				2022-12-18	WOS:000245075900006
J	Fenner, F; Ada, G				Fenner, Frank; Ada, Gordon			Frank MacFarlane Burnet: two personal views	NATURE IMMUNOLOGY			English	Article							ANTIBODY-FORMATION		Australian Natl Univ, Canberra, ACT 2601, Australia	Australian National University	Fenner, F (corresponding author), Australian Natl Univ, GPO Box 4, Canberra, ACT 2601, Australia.	frank.fenner@anu.edu.au						BREINL F, 1930, PHYSIOL CHEM PHYS M, V192, P45; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet F. M., 1940, BIOL ASPECTS INFECT; Burnet F. Macfarlane, 1941, PRODUCTION ANTIBODIE; Burnet F. Macfarlane, 1956, ENZYME ANTIGEN VIRUS; Burnet FM, 1949, PRODUCTION ANTIBODIE; BURNET FM, 1959, CLONAL SELECTION THE; BURNET M, 1967, COLD SPRING HARB SYM, V9, P1; Burnet M., 1968, CHANGING PATTERNS; Fenner F, 1987, Hist Rec Aust Sci, V7, P39, DOI 10.1071/HR9870710039; GLENNY AT, 1931, SYSTEM BACTERIOLOGY, V6, P106; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; KELLAWAY CH, 1928, REPORT COMMISSION FA; Mudd S, 1932, J IMMUNOL, V23, P423; NOSSAL GJV, 1960, J EXP PATHOL, V41, P89; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; SEXTON C, 1999, LIFE; WHITE RG, 1958, NATURE, V182, P1383, DOI [10.1038/1811419a0, 10.1038/1821383a0]	18	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					111	113		10.1038/ni0207-111	http://dx.doi.org/10.1038/ni0207-111			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242678				2022-12-18	WOS:000243597600002
J	Crooks, GM; Weinberg, K				Crooks, Gay M.; Weinberg, Kenneth			The unpredictable stem cell	NATURE IMMUNOLOGY			English	Editorial Material							CORD-BLOOD; MAINTENANCE		Univ So Calif, Childrens Hosp Los Angeles, Div Res Immunol & Bone Marrow Transplantat, Los Angeles, CA 90027 USA; Stanford Univ, Sch Med, Div Stem Cell Transplantat, Dept Pediat,Lucile Packard Childrens Hosp, Stanford, CA 94305 USA	Children's Hospital Los Angeles; University of Southern California; Lucile Packard Children's Hospital (LPCH); Stanford University	Crooks, GM (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, Div Res Immunol & Bone Marrow Transplantat, Los Angeles, CA 90027 USA.	gcrooks@chla.usc.edu						ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; CIVIN CI, 1984, J IMMUNOL, V133, P157; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Gan OI, 1997, BLOOD, V90, P641, DOI 10.1182/blood.V90.2.641.641_641_650; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Schmidt M, 2003, NAT MED, V9, P463, DOI 10.1038/nm844; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; TILL JE, 1963, RADIAT RES, V18, P96, DOI 10.2307/3571429	15	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1129	1130		10.1038/ni1106-1129	http://dx.doi.org/10.1038/ni1106-1129			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053793				2022-12-18	WOS:000241437200003
J	Ho, L; Crabtree, G				Ho, Lena; Crabtree, Gerald			A Foxy tango with NFAT	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL FUNCTION; SCURFIN; TRANSCRIPTION; RESPONSES	The transcription factor Foxp3 is essential for regulatory T cell function, yet how Foxp3 operates has remained elusive until now.	Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Ho, L (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	lenaho@stanford.edu; crabtree@cmgm.stanford.edu						Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Kasprowicz DJ, 2003, J IMMUNOL, V171, P1216, DOI 10.4049/jimmunol.171.3.1216; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329	15	5	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					906	908		10.1038/ni0906-906	http://dx.doi.org/10.1038/ni0906-906			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16924253				2022-12-18	WOS:000239942300008
J	Kincade, PW				Kincade, PW			Supplying the demand for granulocytes	NATURE IMMUNOLOGY			English	Editorial Material							C/EBP-BETA; ALPHA; PHOSPHORYLATION; EXPRESSION; CELLS	The body responds to infections by rapidly 'ramping up' production of innate immune cells. New findings indicate that distinct transcription factors regulate 'basal' and 'emergency' leukocyte production.	Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu						Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; METCALF D, 1993, BLOOD, V82, P3515; NAGAI Y, IN PRESS IMMUNITY; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Suh HC, 2006, BLOOD, V107, P4308, DOI 10.1182/blood-2005-06-2216; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	11	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					701	702		10.1038/ni0706-701	http://dx.doi.org/10.1038/ni0706-701			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785885				2022-12-18	WOS:000238377700006
J	Fink, PJ				Fink, PJ			T cells join the Blimp-1 brigade	NATURE IMMUNOLOGY			English	Editorial Material							PLASMA; EXPRESSION	B lymphocyte-induced maturation protein 1 (Blimp-1) is known as a 'master regulator' of plasma cell differentiation. New findings suggest that the influence of this transcription factor extends beyond the B cell lineage.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fink, PJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	pfink@u.washington.edu						Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Martin S, 1997, EUR J IMMUNOL, V27, P2726, DOI 10.1002/eji.1830271037; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711	12	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					445	446		10.1038/ni0506-445	http://dx.doi.org/10.1038/ni0506-445			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622430				2022-12-18	WOS:000237008800008
J	Ishii, KJ; Coban, C; Kato, H; Takahashi, K; Torii, Y; Takeshita, F; Ludwig, H; Sutter, G; Suzuki, K; Hemmi, H; Sato, S; Yamamoto, M; Uematsu, S; Kawai, T; Takeuchi, O; Akira, S				Ishii, KJ; Coban, C; Kato, H; Takahashi, K; Torii, Y; Takeshita, F; Ludwig, H; Sutter, G; Suzuki, K; Hemmi, H; Sato, S; Yamamoto, M; Uematsu, S; Kawai, T; Takeuchi, O; Akira, S			A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA (vol 7, pg 40, 2005)	NATURE IMMUNOLOGY			English	Correction													Takeuchi, Osamu/D-6007-2011; Ishii, Ken J/B-1685-2012; Takeuchi, Osamu/AAG-9359-2019; Suzuki, Koichi/C-4177-2013	Ishii, Ken J/0000-0002-6728-3872; Takeuchi, Osamu/0000-0002-1260-6232; Sato, Shintaro/0000-0001-5156-3354; Suzuki, Koichi/0000-0001-8659-4660				Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282	1	5	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					427	427		10.1038/ni0406-427a	http://dx.doi.org/10.1038/ni0406-427a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX		Bronze			2022-12-18	WOS:000236171000017
J	Blankson, JN; Bailey, JR; Siliciano, RF				Blankson, JN; Bailey, JR; Siliciano, RF			Crosscurrents in HIV-1 evolution	NATURE IMMUNOLOGY			English	Editorial Material							CYTOTOXIC T-LYMPHOCYTES; PRIMARY INFECTION; ESCAPE; SELECTION; PROGRESSION; VARIANTS; EPITOPE; VIRUS; AIDS	Substitutions in CD8(+) T cell epitopes in viral proteins can alter the complex interaction between viruses and host immunity. Reduced viral fitness and recognition of altered and subdominant epitopes are possible outcomes.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Blankson, JN (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	rsilici1@jhmi.edu						Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Wagner R, 1999, J IMMUNOL, V162, P3727	11	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					121	122		10.1038/ni0206-121	http://dx.doi.org/10.1038/ni0206-121			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16424885	Bronze			2022-12-18	WOS:000234801700003
J	Hayday, A				Hayday, A			Orchestrated leak provokes a thymus reassessment	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INTRAEPITHELIAL LYMPHOCYTES; DIFFERENTIATION; EXPRESSION	The thymus is considered the source of mature lymphocytes and is not thought to produce progenitors with the capacity to develop into unconventional T cells in the periphery. That view requires revision.	Kings Coll London, Sch Med, Dept Immunobiol, London SE1 9RT, England	University of London; King's College London	Hayday, A (corresponding author), Kings Coll London, Sch Med, Dept Immunobiol, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793	Wellcome Trust [071534] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bas A, 2003, J IMMUNOL, V171, P3359, DOI 10.4049/jimmunol.171.7.3359; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978	12	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					9	11		10.1038/ni0106-9	http://dx.doi.org/10.1038/ni0106-9			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357849				2022-12-18	WOS:000234139700004
J	Ley, K; Morris, M				Ley, K; Morris, M			Signals for lymphocyte egress	NATURE IMMUNOLOGY			English	Editorial Material							S1P(1); RECIRCULATION; RECEPTOR-1; AGONISTS		Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; Univ Virginia, Dept Mol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ley, K (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.	klausley@virginia.edu						Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MORRIS MA, IN PRESS EUR J IMMUN; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269	12	5	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1215	1216		10.1038/ni1205-1215	http://dx.doi.org/10.1038/ni1205-1215			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16369564				2022-12-18	WOS:000233371900008
J	Kaufmann, SHE; Bade, K; Englich, S				Kaufmann, SHE; Bade, K; Englich, S			European Day of Immunology	NATURE IMMUNOLOGY			English	Letter									Max Planck Inst Infect Biol, D-10117 Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268					0	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					741	741		10.1038/ni0805-741	http://dx.doi.org/10.1038/ni0805-741			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16034425	Bronze			2022-12-18	WOS:000230646200002
J	Ramiro, AR; Jankovic, M; Nussenzweig, MC				Ramiro, AR; Jankovic, M; Nussenzweig, MC			Amplifying Igh translocations	NATURE IMMUNOLOGY			English	Letter							C-MYC; RECOMBINATIONS; CELLS; MICE		Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Ramiro, AR (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Ramiro, Almudena R/H-6037-2015	Ramiro, Almudena R/0000-0002-7539-3844				JANZ S, 1993, P NATL ACAD SCI USA, V90, P7361, DOI 10.1073/pnas.90.15.7361; Muller JR, 1996, CANCER RES, V56, P419; Muller JR, 1997, BLOOD, V89, P291, DOI 10.1182/blood.V89.1.291.291_291_296; MULLER JR, 1994, P NATL ACAD SCI USA, V91, P12066, DOI 10.1073/pnas.91.25.12066; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127	5	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					117	117		10.1038/ni0205-117	http://dx.doi.org/10.1038/ni0205-117			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15662434				2022-12-18	WOS:000226468100002
J	Dillon, SR; Sprecher, C; Hammond, A; Bilsborough, J; Rosenfeld-Franklin, M; Presnell, SR; Haugen, HS; Maurer, M; Harder, B; Johnston, J; Bort, S; Mudri, S; Kuijper, JL; Bukowski, T; Shea, P; Dong, DL; Dasovich, M; Grant, FJ; Lockwood, L; Levin, SD; LeCiel, C; Waggie, K; Day, H; Topouzis, S; Kramer, J; Kuestner, R; Chen, Z; Foster, D; Parrish-Novak, J; Gross, JA				Dillon, SR; Sprecher, C; Hammond, A; Bilsborough, J; Rosenfeld-Franklin, M; Presnell, SR; Haugen, HS; Maurer, M; Harder, B; Johnston, J; Bort, S; Mudri, S; Kuijper, JL; Bukowski, T; Shea, P; Dong, DL; Dasovich, M; Grant, FJ; Lockwood, L; Levin, SD; LeCiel, C; Waggie, K; Day, H; Topouzis, S; Kramer, J; Kuestner, R; Chen, Z; Foster, D; Parrish-Novak, J; Gross, JA			Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice (vol 5, pg 752, 2004)	NATURE IMMUNOLOGY			English	Correction																		Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084	1	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					114	114		10.1038/ni0105-114a	http://dx.doi.org/10.1038/ni0105-114a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA		Bronze			2022-12-18	WOS:000225888500025
J	Melchers, F				Melchers, F			The death of a dogma?	NATURE IMMUNOLOGY			English	Editorial Material								The one lymphocyte-one receptor idea is challenged by the recent finding of B cells capable of producing two functional immunoglobulin molecules. Such cells that survive selection might potentially contribute to autoimmunity.	Univ Basel, Basel, Switzerland; Max Planck Inst Infect Biol, Berlin, Germany	University of Basel; Max Planck Society	Melchers, F (corresponding author), Univ Basel, Basel, Switzerland.	fritz.melchers@unibas.ch						Gerdes T, 2004, NAT IMMUNOL, V5, P1282, DOI 10.1038/ni1133; Goldmit M, 2002, EMBO J, V21, P5255, DOI 10.1093/emboj/cdf518; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kouskoff V, 2001, LIFE SCI, V69, P1105, DOI 10.1016/S0024-3205(01)01219-X; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; MELCHERS F, 2004, MOL BIOL B CELLS, P97; Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7	9	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1199	1201		10.1038/ni1204-1199	http://dx.doi.org/10.1038/ni1204-1199			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549116				2022-12-18	WOS:000225353500004
J	Marth, JD				Marth, JD			Unmasking connections in transmembrane immune signaling	NATURE IMMUNOLOGY			English	Editorial Material							LIGAND-BINDING DOMAIN; B-CELLS; IMMUNOGLOBULIN SUPERFAMILY; CD22; MOLECULE	The B cell transmembrane glycoprotein modulates immune signaling. Mice containing specific Cd22 mutations show that the extracellular glycan-binding function is regulatory and indicate unexpected complexity in CD22-ligand interactions.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Marth, JD (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	jmarth@ucsd.edu						Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2002, GLYCOBIOLOGY, V12, P563, DOI 10.1093/glycob/cwf067; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; Danzer CP, 2003, INT IMMUNOL, V15, P1137, DOI 10.1093/intimm/dxg114; ENGEL P, 1995, J EXP MED, V181, P1581, DOI 10.1084/jem.181.4.1581; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Lanoue A, 2002, EUR J IMMUNOL, V32, P348, DOI 10.1002/1521-4141(200202)32:2<348::AID-IMMU348>3.0.CO;2-5; LAW CL, 1995, J IMMUNOL, V155, P3368; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; ZHANG M, 2004, GLYCOBIOLOGY    0707, DOI DOI 10.1093/GLYCOB/CWH126	16	5	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1008	1010		10.1038/ni1004-1008	http://dx.doi.org/10.1038/ni1004-1008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454927	Bronze			2022-12-18	WOS:000224156600015
J	Leibson, PJ; Pease, LR				Leibson, PJ; Pease, LR			Having it both ways: MHC recognition in cis and trans	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR REPERTOIRE; HEMATOPOIETIC-CELLS; EXPRESSION; FAMILY; LIGAND; MICE	Natural killer cells are kept in check by their inhibitory receptors. Data now indicate that these receptors can bind ligands that are next to them on the same cell surface, with unexpected functional consequences.	Mayo Clin Coll Med, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Leibson, PJ (corresponding author), Mayo Clin Coll Med, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	leibson.paul@mayo.edu						Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Faure M, 2003, J IMMUNOL, V170, P6107, DOI 10.4049/jimmunol.170.12.6107; Gumperz JE, 1996, J EXP MED, V183, P1817, DOI 10.1084/jem.183.4.1817; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; KARLHOFER FM, 1994, J IMMUNOL, V153, P2407; Lohwasser S, 1999, EUR J IMMUNOL, V29, P755, DOI 10.1002/(SICI)1521-4141(199903)29:03<755::AID-IMMU755>3.3.CO;2-O; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; OLSSONALHEIM MY, 1997, J IMMUNOL, V159, P189; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Salter RD, 1997, IMMUNOL REV, V155, P175, DOI 10.1111/j.1600-065X.1997.tb00950.x; Sentman C L, 1995, Semin Immunol, V7, P109, DOI 10.1006/smim.1995.0015; SYKES M, 1993, J EXP MED, V178, P223, DOI 10.1084/jem.178.1.223; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379	15	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					237	238		10.1038/ni0304-237	http://dx.doi.org/10.1038/ni0304-237			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985707				2022-12-18	WOS:000189344600003
J	Li, ZQ; Woo, CJ; Scharff, MD				Li, ZQ; Woo, CJ; Scharff, MD			Mutations in AID and UNG extend the function of AID	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION; DEAMINATION; ENZYME; MSH2		Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Li, ZQ (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.							Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Schrader CE, 2003, J EXP MED, V197, P1377, DOI 10.1084/jem.20022190; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964	12	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					945	946		10.1038/ni1003-945	http://dx.doi.org/10.1038/ni1003-945			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515126				2022-12-18	WOS:000185590100009
J	Schlissel, M				Schlissel, M			How pre-B cells know when they have it right	NATURE IMMUNOLOGY			English	Editorial Material							TRANSGENIC MICE; HEAVY-CHAIN; RECEPTOR; LAMBDA-5; LYMPHOCYTES; ABSENCE; DOMAINS; PROTEIN; MOUSE; GENE	Early B cell development faces a critical checkpoint at the pro-B --> pre-B transition stage, at which proper assembly and surface expression of an immunoglobulin heavy chain is somehow signaled by the pre-B cell receptor. Triggering of this signal might not require exogenous ligands.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schlissel, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 439 LSA, Berkeley, CA 94720 USA.							Bradl H, 2001, J IMMUNOL, V167, P6403, DOI 10.4049/jimmunol.167.11.6403; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Muljo SA, 2000, IMMUNOL REV, V175, P80, DOI 10.1034/j.1600-065X.2000.017509.x; Muljo SA, 2002, INT IMMUNOL, V14, P577, DOI 10.1093/intimm/dxf023; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; tenBoekel E, 1997, IMMUNITY, V7, P357	12	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					817	819		10.1038/ni0903-817	http://dx.doi.org/10.1038/ni0903-817			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942077				2022-12-18	WOS:000185002200003
J	Ramsden, D; Zhang, Y				Ramsden, D; Zhang, Y			Everything is E(Z): linking histone methylation to B cell development	NATURE IMMUNOLOGY			English	Editorial Material							MECHANISMS	The histone methyltransferases E(Z) and Ezh2 may control developmental fate by regulating homeobox gene expression. Emerging evidence suggests Ezh2 also plays a role in B cell development by controlling V(D)J recombination.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Ramsden, D (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.			Ramsden, Dale/0000-0003-1575-4748; Zhang, Yi/0000-0002-2789-0811	NATIONAL CANCER INSTITUTE [R01CA084442] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA084442] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Marshall AJ, 1996, J IMMUNOL, V156, P2077; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8	15	5	5	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					101	103		10.1038/ni0203-101	http://dx.doi.org/10.1038/ni0203-101			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555091				2022-12-18	WOS:000180686500005
J	Merad, M; Manz, MG; Karsunky, H; Wagers, A; Peters, W; Charo, I; Weissman, IL; Cyster, JG; Engleman, EG				Merad, M; Manz, MG; Karsunky, H; Wagers, A; Peters, W; Charo, I; Weissman, IL; Cyster, JG; Engleman, EG			Langerhans cells renew in the skin throughout life under steady-state conditions (vol 3, pg 1135, 2002)	NATURE IMMUNOLOGY			English	Correction																		Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852	1	5	5	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					92	92		10.1038/ni0103-92	http://dx.doi.org/10.1038/ni0103-92			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG		Bronze			2022-12-18	WOS:000180053000020
J	Robinson, HL				Robinson, HL			T cells versus HIV-1: fighting exhaustion as well as escape	NATURE IMMUNOLOGY			English	Editorial Material								A study in a recent issue of Nature showing the lack of cross-protective immunity in an infected patient to a closely related strain of HIV-1 suggests that vaccine strategy may need to be re-examined.	Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA	Emory University; Emory University	Robinson, HL (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.							Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; KAECH SM, IN PRESS CELL; KORBER BT, 2000, HIV MOL IMMUNOLOGY 2; Kostense S, 2002, BLOOD, V99, P2505, DOI 10.1182/blood.V99.7.2505; Kuiken C, 2001, HIV SEQUENCE COMPEND; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; Robinson HL, 2002, NAT REV IMMUNOL, V2, P239, DOI 10.1038/nri776; Tang YY, 2002, J VIROL, V76, P10147, DOI 10.1128/JVI.76.20.10147-10154.2002; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	12	5	7	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					12	13		10.1038/ni0103-12	http://dx.doi.org/10.1038/ni0103-12			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496971				2022-12-18	WOS:000180053000007
J	Niazi, KR; Porcelli, SA; Modlin, RL				Niazi, KR; Porcelli, SA; Modlin, RL			The CD1b structure: antigen presentation adapts to a high-fat diet	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL RECOGNITION; CRYSTAL-STRUCTURE; MOLECULES; RECEPTOR		Univ Calif Los Angeles, Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Div Dermatol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Niazi, KR (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X				De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Esmon CT, 2000, BBA-PROTEIN STRUCT M, V1477, P349, DOI 10.1016/S0167-4838(99)00266-6; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Grant EP, 2002, J IMMUNOL, V168, P3933, DOI 10.4049/jimmunol.168.8.3933; Kennedy MW, 2001, J BIOL CHEM, V276, P35008, DOI 10.1074/jbc.C100301200; Niazi KR, 2001, J IMMUNOL, V166, P2562, DOI 10.4049/jimmunol.166.4.2562; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Todorov PT, 1998, CANCER RES, V58, P2353; Wilson IA, 1998, CURR OPIN IMMUNOL, V10, P67, DOI 10.1016/S0952-7915(98)80034-4	15	5	5	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					703	704		10.1038/ni0802-703	http://dx.doi.org/10.1038/ni0802-703			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12145652				2022-12-18	WOS:000177118500004
J	Novak, N; Bieber, T				Novak, N; Bieber, T			To bend or not to bend ...	NATURE IMMUNOLOGY			English	Editorial Material							AFFINITY IGE RECEPTOR; FC-EPSILON-RI; ANTIBODIES; FRAGMENT; COMPLEX; DOMAIN	IgE-FcepsilonRI complex formation represents a critical step in the initiation of allergic responses. Conformational changes involving the C(epsilon)2 domain may underlie the persistent activation of FcepsilonRI-bearing cells.	Univ Bonn, Dept Dermatol, D-53105 Bonn, Germany	University of Bonn	Novak, N (corresponding author), Univ Bonn, Dept Dermatol, Sigmund Freud Str 25, D-53105 Bonn, Germany.							HELM B, 1989, P NATL ACAD SCI USA, V86, P9465, DOI 10.1073/pnas.86.23.9465; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; McDonnell JM, 2001, NAT STRUCT BIOL, V8, P437, DOI 10.1038/87603; PADLAN EA, 1986, MOL IMMUNOL, V23, P1063, DOI 10.1016/0161-5890(86)90005-2; Rigby LJ, 2000, J BIOL CHEM, V275, P9664, DOI 10.1074/jbc.275.13.9664; SECHI S, 1996, J BIOL CHEM, V271, P1925; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wilson BS, 2002, CL ALLER IM, V16, P197; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6	12	5	6	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					607	608		10.1038/ni0702-607	http://dx.doi.org/10.1038/ni0702-607			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087417				2022-12-18	WOS:000176441700009
J	Pan, Q; Matamoros, N; Bjorkander, J; Conley, ME; Hammarstrom, L				Pan, Q; Matamoros, N; Bjorkander, J; Conley, ME; Hammarstrom, L			Lack of IgA in C mu-deficient patients	NATURE IMMUNOLOGY			English	Letter							CHAIN GENE		Huddinge Hosp, Karolinska Inst, Div Clin Immunol, S-14186 Huddinge, Sweden; Son Dureta Hosp, Dept Immunol, Palma de Mallorca 07014, Spain; Sahlgrenska Hosp, Div Allergol, S-41345 Gothenburg, Sweden; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Karolinska Institutet; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Sahlgrenska University Hospital; St Jude Children's Research Hospital	Pan, Q (corresponding author), Huddinge Hosp, Karolinska Inst, Div Clin Immunol, S-14186 Huddinge, Sweden.	lennart.hammarstrom@biosci.ki.se	hammarstrom, qiang pan/ABA-4589-2021	pan-hammarstrom, qiang/0000-0003-1990-8804				KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KULNEFF N, 1955, Schweiz Med Wochenschr, V85, P363; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003	4	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					595	595		10.1038/ni0702-595	http://dx.doi.org/10.1038/ni0702-595			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087410				2022-12-18	WOS:000176441700002
J	Sheppard, D				Sheppard, D			Killed by leukocytes that don't know when to leave	NATURE IMMUNOLOGY			English	Editorial Material									Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Sheppard, D (corresponding author), Univ Calif San Francisco, Lung Biol Ctr, Box 0854, San Francisco, CA 94110 USA.							CORRY DB, 2002, NATURE IMMUNOL, V3; DUNHILL MS, 1960, J CLIN PATHOL, V13, P27; MOLFINO NA, 1991, NEW ENGL J MED, V324, P285, DOI 10.1056/NEJM199101313240502; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	6	5	5	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					337	338		10.1038/ni0402-337	http://dx.doi.org/10.1038/ni0402-337			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919573				2022-12-18	WOS:000174623600010
J	Bakker, TR; Van Der Merwe, PA				Bakker, TR; Van Der Merwe, PA			Self-help in T cell recognition?	NATURE IMMUNOLOGY			English	Editorial Material									Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Van Der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	anton.vandermerwe@path.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011					Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	7	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					11	12		10.1038/ni0102-11	http://dx.doi.org/10.1038/ni0102-11			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753401				2022-12-18	WOS:000173148700006
J	Gascoigne, NRJ				Gascoigne, NRJ			Positive selection in a Schnurri	NATURE IMMUNOLOGY			English	News Item							BETA		Scripps Res Inst, IMMI, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, IMMI, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; GASCOIGNE NRJ, 2001, EXP REV MOL MED 0212; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Massague J, 2000, GENE DEV, V14, P627; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Penninger JM, 1997, IMMUNITY, V7, P243, DOI 10.1016/S1074-7613(00)80527-0; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094	11	5	5	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					989	991		10.1038/ni1101-989	http://dx.doi.org/10.1038/ni1101-989			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685218				2022-12-18	WOS:000172049800008
J	von Andrian, UH				von Andrian, UH			PKC-beta(I): the whole ignition system of just a sparkplug for T cell migration?	NATURE IMMUNOLOGY			English	News Item							LYMPHOCYTES; CHEMOKINES; ARREST	The events that enable polarization of T cells and migration across the vasculature to the target are largely unknown. New evidence suggests that PKC-beta (I) may be pivotal in controlling this process.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008					Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HUGHES BJ, 1992, J CLIN INVEST, V90, P1687, DOI 10.1172/JCI116041; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407	14	5	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					477	478		10.1038/88660	http://dx.doi.org/10.1038/88660			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376328				2022-12-18	WOS:000169078000005
J	Gerondakis, S; Strasser, A				Gerondakis, S; Strasser, A			To live and let die	NATURE IMMUNOLOGY			English	News Item							TRANSCRIPTION FACTORS; TRANSGENIC MICE; BCL-3; ONCOPROTEIN		PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Gerondakis, S (corresponding author), PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Strasser, Andreas/C-7581-2013	Strasser, Andreas/0000-0002-5020-4891				Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Gugasyan R, 2000, IMMUNOL REV, V176, P134; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Newton K, 2001, ADV IMMUNOL, V76, P179, DOI 10.1016/S0065-2776(01)76020-8; Ong ST, 1998, ONCOGENE, V16, P2333, DOI 10.1038/sj.onc.1201771; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; Richard M, 1999, BLOOD, V93, P4318, DOI 10.1182/blood.V93.12.4318.412k09_4318_4327; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x	13	5	5	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					377	379		10.1038/87669	http://dx.doi.org/10.1038/87669			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323685				2022-12-18	WOS:000168549800005
J	Mirakian, R; Hammond, LJ; Bottazzo, GF				Mirakian, R; Hammond, LJ; Bottazzo, GF			T(H)1 and T(H)2 cytokine control of thyrocyte survival in thyroid autoimmunity	NATURE IMMUNOLOGY			English	Letter							GENE-EXPRESSION; HASHIMOTOS-THYROIDITIS; GRAVES-DISEASE; BCL-2		St Bartholomews & Royal London Med Sch, Dept Immunol, London EC1 A7BE, England; Pediat Hosp Bambino Gesu, Rome, Italy	IRCCS Bambino Gesu	Mirakian, R (corresponding author), St Bartholomews & Royal London Med Sch, Dept Immunol, London EC1 A7BE, England.							Ajjan RA, 1996, CLIN EXP IMMUNOL, V105, P523, DOI 10.1046/j.1365-2249.1996.d01-784.x; De La Vega JR, 1998, CLIN EXP IMMUNOL, V113, P126, DOI 10.1046/j.1365-2249.1998.00628.x; Hammond LJ, 1997, J PATHOL, V182, P138, DOI 10.1002/(SICI)1096-9896(199706)182:2<138::AID-PATH810>3.0.CO;2-F; Mitsiades N, 1998, J CLIN ENDOCR METAB, V83, P2199, DOI 10.1210/jc.83.6.2199; Mueller DL, 1996, J IMMUNOL, V156, P1764; PASCHKE R, 1994, J ENDOCRINOL, V141, P309, DOI 10.1677/joe.0.1410309; Roura-Mir C, 1997, EUR J IMMUNOL, V27, P3290, DOI 10.1002/eji.1830271228; Stassi G, 2000, NAT IMMUNOL, V1, P483, DOI 10.1038/82725; WATSON PF, 1994, J CLIN ENDOCR METAB, V79, P355, DOI 10.1210/jc.79.2.355	9	5	5	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					371	371		10.1038/87661	http://dx.doi.org/10.1038/87661			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323682	Bronze			2022-12-18	WOS:000168549800002
J	Hoffman, GR; Cerione, RA				Hoffman, GR; Cerione, RA			Rac inserts its way into the immune response	NATURE IMMUNOLOGY			English	News Item							RESPIRATORY BURST OXIDASE; NADPH OXIDASE; EFFECTOR REGION; CDC42 REQUIRES; P67(PHOX); BINDING; ACTIVATION; COMPLEX; DOMAIN; GTP		Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Hoffman, GR (corresponding author), Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA.							ABO A, 1992, J BIOL CHEM, V267, P16767; Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Henderson LM, 1996, BBA-BIOENERGETICS, V1273, P87, DOI 10.1016/0005-2728(95)00140-9; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Wu WJ, 1998, J BIOL CHEM, V273, P16655, DOI 10.1074/jbc.273.27.16655	15	5	5	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					194	196		10.1038/85240	http://dx.doi.org/10.1038/85240			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224514				2022-12-18	WOS:000167413800008
J	Malissen, B				Malissen, B			Les liaisons dangereuses	NATURE IMMUNOLOGY			English	News Item							T-CELL-RECEPTOR; PEPTIDE-MHC; TCR; BINDING; RECOGNITION; ANTAGONIST; AGONIST		Univ Med, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Univ Med, CNRS, INSERM, Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille 9, France.	bernardm@ciml.univ-mrs.fr	Nohr, Rolf/ABG-1528-2020; Malissen, Bernard/AAK-4659-2020	Nohr, Rolf/0000-0002-3817-4706; Malissen, Bernard/0000-0003-1340-9342				Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Bachmann MF, 1998, EUR J IMMUNOL, V28, P2571, DOI 10.1002/(SICI)1521-4141(199808)28:08<2571::AID-IMMU2571>3.0.CO;2-T; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 1999, CURR BIOL, V9, pR419; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	12	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					196	198		10.1038/85243	http://dx.doi.org/10.1038/85243			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224515				2022-12-18	WOS:000167413800009
J	Weiner, HL				Weiner, HL			The fine line between autoimmune and allergic encephalomyelitis	NATURE IMMUNOLOGY			English	News Item							PULSE CYCLOPHOSPHAMIDE THERAPY; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; ORAL TOLERANCE; IMMUNE-DEVIATION; DISEASE-ACTIVITY; T-CELLS; MECHANISMS; INTERLEUKIN-12; COPOLYMER-1		Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Weiner, HL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, 77 Ave Louis Pasteur, HIM 720, Boston, MA 02115 USA.							Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Chen YH, 1998, J NEUROIMMUNOL, V82, P149, DOI 10.1016/S0165-5728(97)00193-8; Comabella M, 1998, J CLIN INVEST, V102, P671, DOI 10.1172/JCI3125; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Gobbini MI, 1999, J NEUROIMMUNOL, V99, P142, DOI 10.1016/S0165-5728(99)00039-9; Johnson KP, 2000, MULT SCLER J, V6, P255, DOI 10.1191/135245800678827806; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; Miller A, 1998, J NEUROIMMUNOL, V92, P113, DOI 10.1016/S0165-5728(98)00191-X; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Rivers TM, 1933, J EXP MED, V58, P39, DOI 10.1084/jem.58.1.39; Schwartz M, 2000, IMMUNOL TODAY, V21, P265, DOI 10.1016/S0167-5699(00)01633-9; Smith DR, 1997, ANN NEUROL, V42, P313, DOI 10.1002/ana.410420307; Wang X, 2000, J IMMUNOL, V165, P548, DOI 10.4049/jimmunol.165.1.548; Weiner HL, 1999, P NATL ACAD SCI USA, V96, P3333, DOI 10.1073/pnas.96.7.3333; WINDHAGEN A, 1995, J EXP MED, V182, P1985, DOI 10.1084/jem.182.6.1985	18	5	5	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					193	194		10.1038/85237	http://dx.doi.org/10.1038/85237			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224513				2022-12-18	WOS:000167413800007
J	Schroeder, HW; Kirkham, PM				Schroeder, HW; Kirkham, PM			Marriage, divorce, and promiscuity in human B cells	NATURE IMMUNOLOGY			English	News Item							L-CHAIN; SELECTION; RECEPTOR	It is becoming more apparent that some B cells do not carry the same antigen receptors throughout their life. B cells that have edited their receptors have now been found in humans as rare cells that accumulate in arthritic joints.	Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Schroeder, HW (corresponding author), Univ Alabama, Dept Med, Birmingham, AL 35294 USA.			Schroeder, Harry/0000-0002-3767-6878	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007051] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRIDGES SL, 1995, J CLIN INVEST, V96, P831, DOI 10.1172/JCI118129; GUELPAFONLUPT V, 1994, MOL IMMUNOL, V31, P1099, DOI 10.1016/0161-5890(94)90105-8; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Kirkham P M, 1994, Semin Immunol, V6, P347, DOI 10.1006/smim.1994.1045; Kline GH, 1998, J IMMUNOL, V161, P1608; Meffre E, 2000, NAT IMMUNOL, V1, P207, DOI 10.1038/79739; Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Schettino EW, 1997, J IMMUNOL, V158, P2477; Shiokawa S, 1999, J IMMUNOL, V162, P6060; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	11	5	5	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					187	188		10.1038/79717	http://dx.doi.org/10.1038/79717			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973270				2022-12-18	WOS:000089815100005
J	Musella, M; Guarracino, A; Manduca, N; Galassi, C; Ruggiero, E; Potenza, A; Maccafeo, E; Manic, G; Mattiello, L; Rehim, SSA; Signore, M; Pietrosanto, M; Helmer-Citterich, M; Pallocca, M; Fanciulli, M; Bruno, T; De Nicola, F; Corleone, G; Di Benedetto, A; Ercolani, C; Pescarmona, E; Pizzuti, L; Guidi, F; Sperati, F; Vitale, S; Macchia, D; Spada, M; Schiavoni, G; Mattei, F; De Ninno, A; Businaro, L; Lucarini, V; Bracci, L; Arico, E; Ziccheddu, G; Facchiano, F; Rossi, S; Sanchez, M; Boe, A; Biffoni, M; De Maria, R; Vitale, I; Sistigu, A				Musella, Martina; Guarracino, Andrea; Manduca, Nicoletta; Galassi, Claudia; Ruggiero, Eliana; Potenza, Alessia; Maccafeo, Ester; Manic, Gwenola; Mattiello, Luca; Rehim, Sara Soliman Abdel; Signore, Michele; Pietrosanto, Marco; Helmer-Citterich, Manuela; Pallocca, Matteo; Fanciulli, Maurizio; Bruno, Tiziana; De Nicola, Francesca; Corleone, Giacomo; Di Benedetto, Anna; Ercolani, Cristiana; Pescarmona, Edoardo; Pizzuti, Laura; Guidi, Francesco; Sperati, Francesca; Vitale, Sara; Macchia, Daniele; Spada, Massimo; Schiavoni, Giovanna; Mattei, Fabrizio; De Ninno, Adele; Businaro, Luca; Lucarini, Valeria; Bracci, Laura; Arico, Eleonora; Ziccheddu, Giovanna; Facchiano, Francesco; Rossi, Stefania; Sanchez, Massimo; Boe, Alessandra; Biffoni, Mauro; De Maria, Ruggero; Vitale, Ilio; Sistigu, Antonella			Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B	NATURE IMMUNOLOGY			English	Article							INTRINSIC IMMUNITY; INTERFERON-ALPHA; HETEROGENEITY; CHEMOTHERAPY; EXPRESSION; RESISTANCE; THERAPY; NETWORK	Cancer stem cells (CSCs) are a subpopulation of cancer cells endowed with high tumorigenic, chemoresistant and metastatic potential. Nongenetic mechanisms of acquired resistance are increasingly being discovered, but molecular insights into the evolutionary process of CSCs are limited. Here, we show that type I interferons (IFNs-I) function as molecular hubs of resistance during immunogenic chemotherapy, triggering the epigenetic regulator demethylase 1B (KDM1B) to promote an adaptive, yet reversible, transcriptional rewiring of cancer cells towards stemness and immune escape. Accordingly, KDM1B inhibition prevents the appearance of IFN-I-induced CSCs, both in vitro and in vivo. Notably, IFN-I-induced CSCs are heterogeneous in terms of multidrug resistance, plasticity, invasiveness and immunogenicity. Moreover, in breast cancer (BC) patients receiving anthracycline-based chemotherapy, KDM1B positively correlated with CSC signatures. Our study identifies an IFN-I -> KDM1B axis as a potent engine of cancer cell reprogramming, supporting KDM1B targeting as an attractive adjunctive to immunogenic drugs to prevent CSC expansion and increase the long-term benefit of therapy. Type I interferons have been described to have protumor or antitumor functions depending on context. Here the authors show a protumor function for type I interferons in that they promote cancer stem cells by upregulating the chromatin remodeling factor KDM1B.	[Musella, Martina; Manduca, Nicoletta; Galassi, Claudia; Maccafeo, Ester; Guidi, Francesco; Vitale, Sara; De Maria, Ruggero; Sistigu, Antonella] Univ Cattolica Sacro Cuore, Dipartimento Med & Chirurg Traslaz, Rome, Italy; [Guarracino, Andrea; Rehim, Sara Soliman Abdel; Pietrosanto, Marco; Helmer-Citterich, Manuela] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Guarracino, Andrea] Human Technopole, Genom Res Ctr, Milan, Italy; [Galassi, Claudia] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA; [Ruggiero, Eliana; Potenza, Alessia] IRCCS, Expt Hematol Unit, San Raffaele Sci Inst, Milan, Italy; [Manic, Gwenola; Mattiello, Luca; Rehim, Sara Soliman Abdel; Vitale, Ilio] Italian Inst Genom Med IIGM, Candiolo, Italy; [Manic, Gwenola; Mattiello, Luca; Vitale, Ilio] FPO IRCCS, Candiolo Canc Inst, Candiolo, Italy; [Signore, Michele] Ist Super Sanita, RPPA Unit, Core Facil, Prote Area, Rome, Italy; [Pallocca, Matteo] IRCCS, UOSD Clin Trial Ctr, Biostat & Bioinformat, Regina Elena Natl Canc Inst, Rome, Italy; [Fanciulli, Maurizio; Bruno, Tiziana; De Nicola, Francesca; Corleone, Giacomo] IRCCS, SAFU Unit, Regina Elena Natl Canc Inst, Rome, Italy; [Di Benedetto, Anna; Ercolani, Cristiana; Pescarmona, Edoardo] IRCCS, Pathol Unit, Regina Elena Natl Canc Inst, Rome, Italy; [Pizzuti, Laura] IRCCS, Div Med Oncol 2, Regina Elena Natl Canc Inst, Rome, Italy; [Guidi, Francesco; De Maria, Ruggero; Sistigu, Antonella] IRCCS, Fdn Policlin Univ A Gemelli, Rome, Italy; [Sperati, Francesca] IRCCS, UOSD Clin Trial Ctr, Biostat & Bioinformat, San Gallicano Dermatol Inst, Rome, Italy; [Macchia, Daniele; Spada, Massimo] Ist Super Sanita, Ctr Anim Res & Welf, Rome, Italy; [Schiavoni, Giovanna; Mattei, Fabrizio; Bracci, Laura; Facchiano, Francesco; Rossi, Stefania; Biffoni, Mauro] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy; [De Ninno, Adele; Businaro, Luca] Italian Natl Res Council, Inst Photon & Nanotechnol, Rome, Italy; [Lucarini, Valeria] IRCCS, Dept Paediat Haematol Oncol & Cell & Gene Therapy, Osped Pediatr Bambino Gesu, Rome, Italy; [Arico, Eleonora] Ist Super Sanita, Core Facil, FaBioCell, Rome, Italy; [Ziccheddu, Giovanna] IRCCS, Oncogen & Epigenet, Regina Elena Natl Canc Inst, Rome, Italy; [Sanchez, Massimo; Boe, Alessandra] Ist Super Sanita, Cytometry Unit, Core Facil, Rome, Italy; [Sistigu, Antonella] IRCCS, Tumor Immunol & Immunotherapy Unit, Regina Elena Natl Canc Inst, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Human Technopole; Cornell University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Fondazione del Piemonte per l'Oncologia; Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	De Maria, R; Sistigu, A (corresponding author), Univ Cattolica Sacro Cuore, Dipartimento Med & Chirurg Traslaz, Rome, Italy.; Vitale, I (corresponding author), Italian Inst Genom Med IIGM, Candiolo, Italy.; Vitale, I (corresponding author), FPO IRCCS, Candiolo Canc Inst, Candiolo, Italy.; De Maria, R; Sistigu, A (corresponding author), IRCCS, Fdn Policlin Univ A Gemelli, Rome, Italy.; Sistigu, A (corresponding author), IRCCS, Tumor Immunol & Immunotherapy Unit, Regina Elena Natl Canc Inst, Rome, Italy.	ruggero.demaria@unicatt.it; ilio.vitale@gmail.com; antonella.sistigu@unicatt.it	Schiavoni, Giovanna/T-4418-2017; Signore, Michele/J-8563-2016; Bracci, Laura/AAL-4409-2020; De Nicola, Francesca/AAC-6887-2022; Mattiello, Luca/AAB-8384-2022; Sanchez, Massimo/K-4385-2018	Schiavoni, Giovanna/0000-0001-9135-0556; Signore, Michele/0000-0002-0262-842X; Bracci, Laura/0000-0002-2535-4353; Guarracino, Andrea/0000-0001-9744-131X; Sanchez, Massimo/0000-0003-3696-7582; Mattiello, Luca/0000-0003-3543-977X	Associazione Italiana per la Ricerca sul Cancro (AIRC) [18418, 20417]; Ministero Italiano della Salute [RF_GR-2013-02357273, RF_GR-2016-02364847, RF_RF-2018-12367044]; AIRC-FIRC Fellowship [25558]; AIRC Fellowship [26604]; AIRC (IG) [21366, 16895, 9979]; Italian Institute for Genomic Medicine; Compagnia di San Paolo	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute(Ministry of Health, Italy); AIRC-FIRC Fellowship(Fondazione AIRC per la ricerca sul cancro); AIRC Fellowship(Fondazione AIRC per la ricerca sul cancro); AIRC (IG)(Fondazione AIRC per la ricerca sul cancro); Italian Institute for Genomic Medicine; Compagnia di San Paolo(Compagnia di San Paolo)	We thank R. Dattilo, P. Di Matteo, R. Ricci, A. Pacca and M. T. D'Urso (Istituto Superiore di Sanita, Rome, Italy) for technical assistance, E. Proietti and P. Sestili (Istituto Superiore di Sanita, Rome, Italy) for providing IFN-I, L. Zitvogel (Gustave Roussy Cancer Campus, Villejuif, France) for providing MCA205-derived clones, M. Oliviero, R. Albano and the Cell Culture Center (CCC) facility (Candiolo Cancer Institute, FPO -IRCCS, Candiolo, Italy) for providing CT26, B16.F10, U2OS, MCF7 and MCF10 cells, O. Kepp and S. Zhang (Gustave Roussy Cancer Campus, Villejuif, France) for providing MCA205-OVA cells, R. Weinberg (Whitehead Institute for Biomedical Research, Cambridge, MA, USA) for providing HMLER cells and I. Tattoli (Universita Cattolica del Sacro Cuore, Rome, Italy) for language and grammar editing. In vivo experiments were performed at Istituto Superiore di Sanita (Rome, Italy).; This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, Start-Up 2016 No. 18418 to A.S. and IG 2017 No. 20417 to I.V.) and the Ministero Italiano della Salute (grant No. RF_GR-2013-02357273 to A.S.). M.M. is supported by the AIRC-FIRC Fellowship No. 25558. L.M. is supported by the AIRC Fellowship No. 26604. The other authors are supported by the AIRC (IG 2018 No. 21366 to G.S.; IG 2019 No. 16895 to M.H.C.; 5x1000 No. 9979 to R.D.M.), the Ministero Italiano della Salute (grant Nos. RF_GR-2016-02364847 to E.R.; RF_RF-2018-12367044 to R.D.M.), the Italian Institute for Genomic Medicine (start-up grant to I.V.) and the Compagnia di San Paolo (grant to I.V.).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barrat FJ, 2019, NAT IMMUNOL, V20, P1574, DOI 10.1038/s41590-019-0466-2; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Bocci F, 2019, P NATL ACAD SCI USA, V116, P148, DOI 10.1073/pnas.1815345116; Bracci L, 2017, CYTOKINE GROWTH F R, V36, P89, DOI 10.1016/j.cytogfr.2017.06.008; Bruno T, 2020, BLOOD ADV, V4, P5616, DOI 10.1182/bloodadvances.2020002566; Cao J, 2020, TRENDS CANCER, V6, P580, DOI 10.1016/j.trecan.2020.02.003; Castiello L, 2018, CANCER IMMUNOL RES, V6, P658, DOI 10.1158/2326-6066.CIR-17-0675; Chen JZ, 2019, J CLIN INVEST, V129, P4224, DOI 10.1172/JCI127458; Cheng Y, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0095-0; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dixon G, 2021, SCIENCE, V372, P146, DOI 10.1126/science.abd0875; Doherty MR, 2017, P NATL ACAD SCI USA, V114, P13792, DOI 10.1073/pnas.1713728114; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Fan JB, 2020, CANCER DISCOV, V10, P382, DOI 10.1158/2159-8290.CD-19-0608; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jacquelot N, 2019, CELL RES, V29, P846, DOI 10.1038/s41422-019-0224-x; Keklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3; Kroemer G, 2022, NAT IMMUNOL, V23, P487, DOI 10.1038/s41590-022-01132-2; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li SQ, 2015, J SURG RES, V193, P255, DOI 10.1016/j.jss.2014.06.055; Lorenzi S, 2011, J IMMUNOL, V186, P5142, DOI 10.4049/jimmunol.1004163; Lu HQ, 2020, J CLIN INVEST, V130, P4607, DOI 10.1172/JCI138577; Lucarini V, 2017, J INVEST DERMATOL, V137, P159, DOI 10.1016/j.jid.2016.08.024; Maccalli C, 2014, EUR J CANCER, V50, P649, DOI 10.1016/j.ejca.2013.11.014; Manic G, 2018, GUT, V67, P903, DOI 10.1136/gutjnl-2016-312623; Marine JC, 2020, NAT REV CANCER, V20, P743, DOI 10.1038/s41568-020-00302-4; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Miao YX, 2019, CELL, V177, P1172, DOI 10.1016/j.cell.2019.03.025; Musella M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1314424; Palmer NP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r71; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Qadir AS, 2017, CELL REP, V18, P2373, DOI 10.1016/j.celrep.2017.02.037; Qin Y, 2019, ONCOGENE, V38, P390, DOI 10.1038/s41388-018-0451-5; Rodriguez-Ruiz ME, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655964; Schiavoni G, 2011, CANCER RES, V71, P768, DOI 10.1158/0008-5472.CAN-10-2788; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Sheng WQ, 2018, CELL, V174, P549, DOI 10.1016/j.cell.2018.05.052; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Topper MJ, 2020, NAT REV CLIN ONCOL, V17, P75, DOI 10.1038/s41571-019-0266-5; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; Villanueva L, 2020, TRENDS IMMUNOL, V41, P676, DOI 10.1016/j.it.2020.06.002; Vitale I, 2021, NAT MED, V27, P212, DOI 10.1038/s41591-021-01233-9; Wainwright EN, 2017, TRENDS CANCER, V3, P372, DOI 10.1016/j.trecan.2017.04.004; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Wiedemann GM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1175794; Wu LZ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006134; Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018; Zhang WC, 2021, MOL CELL, V81, P2148, DOI 10.1016/j.molcel.2021.02.038; Zhu YF, 2014, EXP CELL RES, V324, P146, DOI 10.1016/j.yexcr.2014.03.020; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	64	4	4	10	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9					1379	+		10.1038/s41590-022-01290-3	http://dx.doi.org/10.1038/s41590-022-01290-3		AUG 2022	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O8VJ	36002648	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000844434100003
J	Gangopadhyay, A; Devi, S; Tenguria, S; Carriere, J; Nguyen, H; Jager, E; Khatri, H; Chu, LH; Ratsimandresy, RA; Dorfleutner, A; Stehlik, C				Gangopadhyay, Anu; Devi, Savita; Tenguria, Shivendra; Carriere, Jessica; Huyen Nguyen; Jager, Elisabeth; Khatri, Hemisha; Chu, Lan H.; Ratsimandresy, Rojo A.; Dorfleutner, Andrea; Stehlik, Christian			NLRP3 licenses NLRP11 for inflammasome activation in human macrophages	NATURE IMMUNOLOGY			English	Article							SPECK-LIKE PROTEIN; CRYSTAL-STRUCTURE; GASDERMIN D; DOMAIN; RECRUITMENT; REVEALS; NLRC4; NEK7; INFECTION; APOPTOSIS	Stehlik and colleagues show that NLRP11 is an essential component of the NLRP3 inflammasome in human macrophages. Intracellular sensing of stress and danger signals initiates inflammatory innate immune responses by triggering inflammasome assembly, caspase-1 activation and pyroptotic cell death as well as the release of interleukin 1 beta (IL-1 beta), IL-18 and danger signals. NLRP3 broadly senses infectious patterns and sterile danger signals, resulting in the tightly coordinated and regulated assembly of the NLRP3 inflammasome, but the precise mechanisms are incompletely understood. Here, we identified NLRP11 as an essential component of the NLRP3 inflammasome in human macrophages. NLRP11 interacted with NLRP3 and ASC, and deletion of NLRP11 specifically prevented NLRP3 inflammasome activation by preventing inflammasome assembly, NLRP3 and ASC polymerization, caspase-1 activation, pyroptosis and cytokine release but did not affect other inflammasomes. Restored expression of NLRP11, but not NLRP11 lacking the PYRIN domain (PYD), restored inflammasome activation. NLRP11 was also necessary for inflammasome responses driven by NLRP3 mutations that cause cryopyrin-associated periodic syndrome (CAPS). Because NLRP11 is not expressed in mice, our observations emphasize the specific complexity of inflammasome regulation in humans.	[Gangopadhyay, Anu; Devi, Savita; Tenguria, Shivendra; Carriere, Jessica; Huyen Nguyen; Jager, Elisabeth; Khatri, Hemisha; Ratsimandresy, Rojo A.; Dorfleutner, Andrea; Stehlik, Christian] Cedars Sinai Med Ctr, Dept Acad Pathol, Los Angeles, CA 90048 USA; [Gangopadhyay, Anu; Chu, Lan H.] Northwestern Univ, Feinberg Sch Med, Driskill Grad Program Life Sci, Chicago, IL USA; [Dorfleutner, Andrea; Stehlik, Christian] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Stehlik, Christian] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Gangopadhyay, Anu] Synthekine, Menlo Pk, CA USA; [Chu, Lan H.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Ratsimandresy, Rojo A.] Genentech Inc, Dept Immunol, San Francisco, CA USA	Cedars Sinai Medical Center; Northwestern University; Feinberg School of Medicine; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Washington; University of Washington Seattle; Roche Holding; Genentech	Dorfleutner, A; Stehlik, C (corresponding author), Cedars Sinai Med Ctr, Dept Acad Pathol, Los Angeles, CA 90048 USA.; Dorfleutner, A; Stehlik, C (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.; Stehlik, C (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	andrea.dorfleutner@cshs.org; christian.stehlik@csmc.edu		Nguyen, Huyen/0000-0002-6999-3544; Carriere, Jessica/0000-0003-1267-2122; Dorfleutner, Andrea/0000-0003-4406-2986	National Institutes of Health [AI099009, AR064349, AI134030, AI140702, AI165797, AI120625]; American Heart Association [834502]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	psPAX2 and pMD.2G were a gift from D. Trono, pSpCas9(BB)-2A-GFP and lentiCRISPRv1 were a gift from F. Zhang, pHIV-IRES-dTomato was a gift from B. Welm and pCMV-IRES-GFPv3 was a gift from F. Goodrum. This work was supported by the National Institutes of Health (grants AI099009 and AR064349 to C.S. and grants AI134030, AI140702, AI165797 and AI120625 to C.S. and A.D.) and the American Heart Association (grant 834502 to J.C.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Andreeva L, 2021, CELL, V184, P6299, DOI 10.1016/j.cell.2021.11.011; Booshehri LM, 2019, J CLIN IMMUNOL, V39, P277, DOI 10.1007/s10875-019-00638-z; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Caviness K, 2014, J VIROL, V88, P14412, DOI 10.1128/JVI.02711-14; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chu LH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03409-3; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; de Almeida L, 2015, IMMUNITY, V43, P264, DOI 10.1016/j.immuni.2015.07.018; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Ellwanger K, 2018, J BIOL CHEM, V293, P2701, DOI 10.1074/jbc.RA117.000152; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Hafner-Bratkovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07573-4; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kienes I, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.653883; Komatsu T, 2018, J VIROL, V92, DOI 10.1128/JVI.00842-18; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.97, 10.1038/nrd.2018.149]; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meissner TB, 2012, MICROBES INFECT, V14, P477, DOI 10.1016/j.micinf.2011.12.007; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moretti J, 2021, J LEUKOCYTE BIOL, V109, P561, DOI 10.1002/JLB.3MR0520-104RR; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Qin YF, 2017, EMBO REP, V18, P2160, DOI 10.15252/embr.201744480; Qu Y, 2016, J EXP MED, V213, P877, DOI 10.1084/jem.20132234; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratsimandresy RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15556; Ratsimandresy RA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00440; Reed JC, 2003, GENOME RES, V13, P1376, DOI 10.1101/gr.1053803; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; SHI HX, 2016, NAT IMMUNOL, V17, P250, DOI DOI 10.1038/NI.3333; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2007, J IMMUNOL, V179, P7993, DOI 10.4049/jimmunol.179.12.7993; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wu CL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02073-3; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789	60	4	4	11	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					892	+		10.1038/s41590-022-01220-3	http://dx.doi.org/10.1038/s41590-022-01220-3		MAY 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624206	Green Published, hybrid			2022-12-18	WOS:000805549900011
J	Mirchandani, AS; Jenkins, SJ; Bain, CC; Sanchez-Garcia, MA; Lawson, H; Coelho, P; Murphy, F; Griffith, DM; Zhang, AL; Morrison, T; Ly, T; Arienti, S; Sadiku, P; Watts, ER; Dickinson, RS; Reyes, L; Cooper, G; Clark, S; Lewis, D; Kelly, V; Spanos, C; Musgrave, KM; Delaney, L; Harper, I; Scott, J; Parkinson, NJ; Rostron, AJ; Baillie, JK; Clohisey, S; Pridans, C; Campana, L; Lewis, PS; Simpson, AJ; Dockrell, DH; Schwarze, J; Hirani, N; Ratcliffe, PJ; Pugh, CW; Kranc, K; Forbes, SJ; Whyte, MKB; Walmsley, SR				Mirchandani, Ananda S.; Jenkins, Stephen J.; Bain, Calum C.; Sanchez-Garcia, Manuel A.; Lawson, Hannah; Coelho, Patricia; Murphy, Fiona; Griffith, David M.; Zhang, Ailiang; Morrison, Tyler; Ly, Tony; Arienti, Simone; Sadiku, Pranvera; Watts, Emily R.; Dickinson, Rebecca S.; Reyes, Leila; Cooper, George; Clark, Sarah; Lewis, David; Kelly, Van; Spanos, Christos; Musgrave, Kathryn M.; Delaney, Liam; Harper, Isla; Scott, Jonathan; Parkinson, Nicholas J.; Rostron, Anthony J.; Baillie, J. Kenneth; Clohisey, Sara; Pridans, Clare; Campana, Lara; Lewis, Philip Starkey; Simpson, A. John; Dockrell, David H.; Schwarze, Jurgen; Hirani, Nikhil; Ratcliffe, Peter J.; Pugh, Christopher W.; Kranc, Kamil; Forbes, Stuart J.; Whyte, Moira K. B.; Walmsley, Sarah R.			Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; ALVEOLAR MACROPHAGES; MONOCYTES; EXPRESSION; CELLS; LIFE; LIPOPOLYSACCHARIDE; POPULATIONS; CARE	Hypoxemia is a defining feature of acute respiratory distress syndrome (ARDS), an often-fatal complication of pulmonary or systemic inflammation, yet the resulting tissue hypoxia, and its impact on immune responses, is often neglected. In the present study, we have shown that ARDS patients were hypoxemic and monocytopenic within the first 48 h of ventilation. Monocytopenia was also observed in mouse models of hypoxic acute lung injury, in which hypoxemia drove the suppression of type I interferon signaling in the bone marrow. This impaired monopoiesis resulted in reduced accumulation of monocyte-derived macrophages and enhanced neutrophil-mediated inflammation in the lung. Administration of colony-stimulating factor 1 in mice with hypoxic lung injury rescued the monocytopenia, altered the phenotype of circulating monocytes, increased monocyte-derived macrophages in the lung and limited injury. Thus, tissue hypoxia altered the dynamics of the immune response to the detriment of the host and interventions to address the aberrant response offer new therapeutic strategies for ARDS. Mirchandani and colleagues show that tissue hypoxia alters the number and phenotype of circulating monocytes and their differentiation into lung macrophages, with important implications for the resolution of inflammation in the lung.	[Mirchandani, Ananda S.; Jenkins, Stephen J.; Bain, Calum C.; Sanchez-Garcia, Manuel A.; Coelho, Patricia; Murphy, Fiona; Griffith, David M.; Zhang, Ailiang; Morrison, Tyler; Arienti, Simone; Sadiku, Pranvera; Watts, Emily R.; Dickinson, Rebecca S.; Reyes, Leila; Cooper, George; Delaney, Liam; Harper, Isla; Pridans, Clare; Dockrell, David H.; Schwarze, Jurgen; Hirani, Nikhil; Forbes, Stuart J.; Whyte, Moira K. B.; Walmsley, Sarah R.] Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Lawson, Hannah; Kranc, Kamil] Queen Mary Univ London, Barts Canc Inst, London, England; [Ly, Tony; Lewis, David; Kelly, Van; Spanos, Christos; Baillie, J. Kenneth] Univ Edinburgh, Wellcome Ctr Cell Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Clark, Sarah] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, NHS Lothian, Edinburgh, Midlothian, Scotland; [Musgrave, Kathryn M.; Scott, Jonathan; Rostron, Anthony J.; Simpson, A. John] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Musgrave, Kathryn M.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Resp Med, Newcastle Upon Tyne, Tyne & Wear, England; [Parkinson, Nicholas J.; Baillie, J. Kenneth; Clohisey, Sara] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Campana, Lara; Lewis, Philip Starkey; Forbes, Stuart J.] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Ratcliffe, Peter J.; Pugh, Christopher W.] Univ Oxford, Nuffield Dept Med, Nuffield Dept Med Res Bldg, Oxford, England; [Ratcliffe, Peter J.] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Oxford, England; [Ratcliffe, Peter J.] Francis Crick Inst, London, England	University of Edinburgh; University of London; Queen Mary University London; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Oxford; Ludwig Institute for Cancer Research; University of Oxford; Francis Crick Institute	Mirchandani, AS (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	Ananda.Mirchandani@ed.ac.uk	Baillie, John Kenneth/F-3124-2011; Baillie, Kenneth/AEK-6650-2022; Griffith, David/C-8367-2011	Baillie, John Kenneth/0000-0001-5258-793X; Baillie, Kenneth/0000-0001-5258-793X; Forbes, Shareen/0000-0002-9127-0641; Griffith, David/0000-0001-9500-241X; Cooper, George/0000-0002-3652-3837; Ly, Tony/0000-0002-8650-5215; Delaney, Liam/0000-0003-2894-1622; Simpson, John/0000-0003-4731-7294; Jenkins, Stephen/0000-0002-0233-5424	QMRI Flow Cytometry and Cell Sorting Facility, University of Edinburgh; Wellcome Trust [098516, 209220, 110086]; Wellcome Trust iTPA grant [PIII052]; UK Research and Innovation/National Institute for Health and Care Research (NIHR) through the UK Coronavirus Immunology Consortium; Sir Henry Dale Fellowship - Wellcome Trust [206234/Z/17/Z]; Sir Henry Dale Fellowship - Royal Society [206234/Z/17/Z]; Cancer Research UK [C29967A/14633, C29967/A26787]; MRC; Bart's Charity; Kay Kendall Leukaemia Fund; Blood Cancer UK	QMRI Flow Cytometry and Cell Sorting Facility, University of Edinburgh; Wellcome Trust(Wellcome Trust); Wellcome Trust iTPA grant; UK Research and Innovation/National Institute for Health and Care Research (NIHR) through the UK Coronavirus Immunology Consortium; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bart's Charity; Kay Kendall Leukaemia Fund; Blood Cancer UK	We thank D. Hume for providing the CSF-1-Fc used in these experiments. We thank Thomson Bioinformatics, Edinburgh, UK, for analyzing the NanoString data. Flow cytometry data were generated with support from the QMRI Flow Cytometry and Cell Sorting Facility, University of Edinburgh. We thank the Royal Infirmary of Edinburgh Critical Care Research Team for their assistance in recruiting, consenting and obtaining samples from patients with ARDS. This work was funded by a Wellcome Trust Senior Clinical fellowship awarded to S.R.W. (grant nos. 098516 and 209220), Wellcome Trust Post-doctoral Training Clinical Fellowship (grant no. 110086) and a Wellcome Trust iTPA grant (no. PIII052) awarded to A.S.M., and was partly funded by UK Research and Innovation/National Institute for Health and Care Research (NIHR) through the UK Coronavirus Immunology Consortium. C.C.B holds a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant no. 206234/Z/17/Z). K.K.'s laboratory is supported by grants from Cancer Research UK (nos. C29967A/14633 and C29967/A26787), MRC, the Bart's Charity, the Kay Kendall Leukaemia Fund and Blood Cancer UK. A.J.S. is an NIHR Senior Investigator. The views expressed in this article are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted manuscript version from this submission.	Abu-El-Rub E, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2634-6; Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Alivernini S, 2020, NAT MED, V26, P1295, DOI 10.1038/s41591-020-0939-8; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bhattacharyya S, 2010, EXP CELL RES, V316, P3317, DOI 10.1016/j.yexcr.2010.05.004; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chen WK, 2015, INT J MOL SCI, V16, P27921, DOI 10.3390/ijms161126067; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; HANNON JP, 1969, J APPL PHYSIOL, V26, P540, DOI 10.1152/jappl.1969.26.5.540; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Herold S, 2014, AM J RESP CRIT CARE, V189, P609, DOI 10.1164/rccm.201311-2041LE; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Kelly V, 2022, MOL CELL PROTEOMICS, V21, DOI 10.1016/j.mcpro.2021.100169; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Lasseaux C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16869-2; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Onnis B, 2013, J CLIN INVEST, V123, P1615, DOI 10.1172/JCI59623; Paine R, 2012, CRIT CARE MED, V40, P90, DOI 10.1097/CCM.0b013e31822d7bf0; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Sammarco MC, 2008, J BIOL CHEM, V283, P4578, DOI 10.1074/jbc.M703456200; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Sheikh MH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041045; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; TARLING JD, 1987, J LEUKOCYTE BIOL, V42, P443, DOI 10.1002/jlb.42.5.443; Thompson AAR, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2861; Watts ER, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI134073; Xu HP, 2008, BLOOD, V112, P1166, DOI 10.1182/blood-2007-06-098327; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zhou BS, 2020, NAT IMMUNOL, V21, P1430, DOI 10.1038/s41590-020-0764-8	50	4	4	7	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					927	+		10.1038/s41590-022-01216-z	http://dx.doi.org/10.1038/s41590-022-01216-z		MAY 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624205	Green Published, hybrid			2022-12-18	WOS:000803808400001
J	Doke, T; Abedini, A; Aldridge, DL; Yang, YW; Park, J; Hernandez, CM; Balzer, MS; Shrestra, R; Coppock, G; Rico, JMI; Han, SY; Kim, J; Xin, S; Piliponsky, AM; Angelozzi, M; Lefebvre, V; Siracusa, MC; Hunter, CA; Susztak, K				Doke, Tomohito; Abedini, Amin; Aldridge, Daniel L.; Yang, Ya-Wen; Park, Jihwan; Hernandez, Christina M.; Balzer, Michael S.; Shrestra, Rojesh; Coppock, Gaia; Rico, Juan M. Inclan; Han, Seung Yub; Kim, Junhyong; Xin, Sheng; Piliponsky, Adrian M.; Angelozzi, Marco; Lefebvre, Veronique; Siracusa, Mark C.; Hunter, Christopher A.; Susztak, Katalin			Single-cell analysis identifies the interaction of altered renal tubules with basophils orchestrating kidney fibrosis	NATURE IMMUNOLOGY			English	Article							MAST-CELLS; EXPRESSION; INFLAMMATION; RECRUITMENT; ACTIVATION; BLEOMYCIN; INJURY; TISSUE; BETA; IL-6	Inflammation is an important component of fibrosis but immune processes that orchestrate kidney fibrosis are not well understood. Here we apply single-cell sequencing to a mouse model of kidney fibrosis. We identify a subset of kidney tubule cells with a profibrotic-inflammatory phenotype characterized by the expression of cytokines and chemokines associated with immune cell recruitment. Receptor-ligand interaction analysis and experimental validation indicate that CXCL1 secreted by profibrotic tubules recruits CXCR2(+) basophils. In mice, these basophils are an important source of interleukin-6 and recruitment of the T(H)17 subset of helper T cells. Genetic deletion or antibody-based depletion of basophils results in reduced renal fibrosis. Human kidney single-cell, bulk gene expression and immunostaining validate a function for basophils in patients with kidney fibrosis. Collectively, these studies identify basophils as contributors to the development of renal fibrosis and suggest that targeting these cells might be a useful clinical strategy to manage chronic kidney disease. How fibrosis and inflammation are integrated is not entirely clear. Here the authors show that profibrotic proximal tubular cells in the kidneys recruit basophils and activate them to produce interleukin-6 and drive T(H)17 cell responses.	[Doke, Tomohito; Abedini, Amin; Yang, Ya-Wen; Park, Jihwan; Balzer, Michael S.; Shrestra, Rojesh; Coppock, Gaia; Xin, Sheng; Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Aldridge, Daniel L.; Coppock, Gaia; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Hernandez, Christina M.; Rico, Juan M. Inclan; Siracusa, Mark C.] Rutgers State Univ, Ctr Immun & Inflammat, New Jersey Med Sch, Dept Med, Newark, NJ USA; [Han, Seung Yub; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Piliponsky, Adrian M.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Angelozzi, Marco; Lefebvre, Veronique] Childrens Hosp Philadelphia, Div Orthopaed Surg, Dept Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Seattle Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Susztak, K (corresponding author), Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	ksusztak@pennmedicine.upenn.edu	Balzer, Michael S./GNH-1518-2022; Balzer, Michael S./GNH-1501-2022	Balzer, Michael S./0000-0003-0508-1260; Balzer, Michael S./0000-0003-0508-1260; Hernandez, Christina/0000-0001-5788-6138; doke, tomohito/0000-0003-1641-9351; Inclan-Rico, Juan/0000-0003-1134-9139; Shrestha, Rojesh/0000-0001-8742-5666	National Institutes of Health [R01 DK087635, DK076077, DK105821]; National Institutes of Health NIAMS R01 grant [AR068308]; German Research Foundation (Deutsche Forschungsgemeinschaft) [BA 6205/2-1]; University of Pennsylvania [P30-DK050306, P30-DK19525]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIAMS R01 grant; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Pennsylvania	This work has been supported in the Susztak laboratory by the National Institutes of Health R01 DK087635, DK076077 and DK105821 and in the Lefebvre laboratory by the National Institutes of Health NIAMS R01 grant AR068308. M.S.B. is supported by a German Research Foundation (Deutsche Forschungsgemeinschaft) grant (BA 6205/2-1). The authors thank the Molecular Pathology and Imaging Core (P30-DK050306) and Diabetes Research Center (P30-DK19525) at University of Pennsylvania for their services.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Baek JH, 2015, J CLIN INVEST, V125, P3198, DOI 10.1172/JCI81166; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bosch X, 2011, J IMMUNOL, V186, P6083, DOI 10.4049/jimmunol.1002648; Chen LH, 2021, J AM SOC NEPHROL, V32, P886, DOI 10.1681/ASN.2020101407; Cipolla E, 2017, FASEB J, V31, P5543, DOI 10.1096/fj.201700289R; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; Conway BR, 2020, J AM SOC NEPHROL, V31, P2833, DOI 10.1681/ASN.2020060806; Coppock GM, 2020, J IMMUNOL, V205, P377, DOI 10.4049/jimmunol.1901463; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Dhillon P, 2021, CELL METAB, V33, DOI 10.1016/j.cmet.2020.11.011; Doke T, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141801; El Hachem C, 2018, EUR J IMMUNOL, V48, P861, DOI 10.1002/eji.201747351; Fielding CA, 2014, IMMUNITY, V40, P40, DOI 10.1016/j.immuni.2013.10.022; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; GEISER T, 1993, J BIOL CHEM, V268, P15419; Gerhardt LMS, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026684118; Gewin LS, 2018, MATRIX BIOL, V68-69, P248, DOI 10.1016/j.matbio.2018.02.006; Gonzalez GE, 2015, J HYPERTENS, V33, P144, DOI 10.1097/HJH.0000000000000358; Guaraldi G, 2020, LANCET RHEUMATOL, V2, pE474, DOI 10.1016/S2665-9913(20)30173-9; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hewitt KJ, 2012, J CELL SCI, V125, P2276, DOI 10.1242/jcs.099192; Higashi AY, 2019, J AM SOC NEPHROL, V30, P80, DOI 10.1681/ASN.2018060644; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Inclan-Rico JM, 2020, NAT IMMUNOL, V21, P1181, DOI 10.1038/s41590-020-0753-y; Jager KJ, 2019, NEPHROL DIAL TRANSPL, V34, P1803, DOI 10.1093/ndt/gfz174; Khanna D, 2020, LANCET RESP MED, V8, P963, DOI 10.1016/S2213-2600(20)30318-0; Kirita Y, 2020, P NATL ACAD SCI USA, V117, P15874, DOI 10.1073/pnas.2005477117; Klinkhammer BM, 2018, MOL ASPECTS MED, V62, P44, DOI 10.1016/j.mam.2017.11.008; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kurts C, 2020, NAT REV NEPHROL, V16, P391, DOI 10.1038/s41581-020-0272-y; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Liang H, 2017, EUR J PHARMACOL, V812, P18, DOI 10.1016/j.ejphar.2017.06.031; Liang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28715; Liu SS, 2019, IMMUNITY, V51, P522, DOI 10.1016/j.immuni.2019.06.014; Madjene LC, 2015, MOL IMMUNOL, V63, P86, DOI 10.1016/j.molimm.2014.03.002; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; Muto Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22368-w; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Petrovic-Djergovic D, 2015, CLIN EXP IMMUNOL, V180, P305, DOI 10.1111/cei.12579; Qiu CX, 2018, NAT MED, V24, P1721, DOI 10.1038/s41591-018-0194-4; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Schiechl G, 2016, AM J TRANSPLANT, V16, P2574, DOI 10.1111/ajt.13764; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sicklinger F, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136778; Steen CB, 2020, METHODS MOL BIOL, V2117, P135, DOI 10.1007/978-1-0716-0301-7_7; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Turner JE, 2018, J AM SOC NEPHROL, V29, P389, DOI 10.1681/ASN.2017060599; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wakahara K, 2012, BLOOD, V120, P4761, DOI 10.1182/blood-2012-04-424226; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yuk CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41744	64	4	4	4	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					947	+		10.1038/s41590-022-01200-7	http://dx.doi.org/10.1038/s41590-022-01200-7		MAY 2022	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35552540				2022-12-18	WOS:000794083800001
J	Peng, V; Xing, XY; Bando, JK; Trsan, T; Di Luccia, B; Collins, PL; Li, DF; Wang, WL; Lee, HJ; Oltz, EM; Wang, T; Colonna, M				Peng, Vincent; Xing, Xiaoyun; Bando, Jennifer K.; Trsan, Tihana; Di Luccia, Blanda; Collins, Patrick L.; Li, Daofeng; Wang, Wei-Le; Lee, Hyung Joo; Oltz, Eugene M.; Wang, Ting; Colonna, Marco			Whole-genome profiling of DNA methylation and hydroxymethylation identifies distinct regulatory programs among innate lymphocytes	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; NATURAL-KILLER; LINEAGE COMMITMENT; SUPER-ENHANCERS; CELLS; 5-HYDROXYMETHYLCYTOSINE; ACTIVATION; DIFFERENTIATION; DEMETHYLATION	Innate lymphocytes encompass a diverse array of phenotypic identities with specialized functions. DNA methylation and hydroxymethylation are essential for epigenetic fidelity and fate commitment. The landscapes of these modifications are unknown in innate lymphocytes. Here, we characterized the whole-genome distribution of methyl-CpG and 5-hydroxymethylcytosine (5hmC) in mouse innate lymphoid cell 3 (ILC3), ILC2 and natural killer (NK) cells. We identified differentially methylated regions (DMRs) and differentially hydroxymethylated regions (DHMRs) between ILC and NK cell subsets and correlated them with transcriptional signatures. We associated lineage-determining transcription factors (LDTFs) with demethylation and demonstrated unique patterns of DNA methylation/hydroxymethylation in relationship to open chromatin regions (OCRs), histone modifications and TF-binding sites. We further identified an association between hydroxymethylation and NK cell superenhancers (SEs). Using mice lacking the DNA hydroxymethylase TET2, we showed the requirement for TET2 in optimal production of hallmark cytokines by ILC3s and interleukin-17A (IL-17A) by inflammatory ILC2s. These findings provide a powerful resource for studying innate lymphocyte epigenetic regulation and decode the regulatory logic governing their identity. Colonna and colleagues present a genome-wide characterization of DNA methylation and hydroxymethylation in innate lymphocytes and identify differentially methylated and hydroxymethylated regions between NK cells, ILC2s and ILC3s.	[Peng, Vincent; Bando, Jennifer K.; Trsan, Tihana; Di Luccia, Blanda; Wang, Wei-Le; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Xing, Xiaoyun; Li, Daofeng; Lee, Hyung Joo; Wang, Ting] Washington Univ, Edison Family Ctr Genome Sci & Syst Biol, Dept Genet, Sch Med, St Louis, MO 63110 USA; [Collins, Patrick L.; Oltz, Eugene M.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Wang, Ting] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63110 USA; [Bando, Jennifer K.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Washington University (WUSTL); Washington University (WUSTL); University System of Ohio; Ohio State University; Washington University (WUSTL); Stanford University	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Wang, T (corresponding author), Washington Univ, Edison Family Ctr Genome Sci & Syst Biol, Dept Genet, Sch Med, St Louis, MO 63110 USA.; Wang, T (corresponding author), Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63110 USA.	twang@wustl.edu; mcolonna@wustl.edu	Lee, Hyung Joo/D-1398-2009; Li, Daofeng/E-5386-2011	Lee, Hyung Joo/0000-0002-7030-5390; Wang, Wei-Le/0000-0002-6984-4514; Collins, Patrick/0000-0003-4550-4272; Li, Daofeng/0000-0001-7492-3703	NIH [F30 DK127540-01, T32 DK 77653-28, R00 DK118110, R21 AI156411, R01HG007175, U24ES026699, U01HG009391, U24HG012070, R01 AI134035, R01 DE025884, 1R01 AI134236-01, R01 DK124699]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Flow Cytometry core facility at the Department of Pathology and Immunology (Washington University in St. Louis). This research was supported by NIH grants F30 DK127540-01, T32 DK 77653-28 (to V.P.), R00 DK118110 (to J.K.B.), R21 AI156411 (to P.L.C.), R01HG007175, U24ES026699, U01HG009391, U24HG012070 (to X.X., D.L. and T.W.), R01 AI134035 (to M.C. and E.O.M.), R01 DE025884, 1R01 AI134236-01 and R01 DK124699 (to M.C.).	Adams NM, 2018, IMMUNITY, V48, P1172, DOI 10.1016/j.immuni.2018.04.018; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/NCHEM.2064, 10.1038/nchem.2064]; Bal SM, 2020, NAT REV IMMUNOL, V20, P552, DOI 10.1038/s41577-020-0282-9; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Dorner BG, 2004, J IMMUNOL, V172, P3119, DOI 10.4049/jimmunol.172.5.3119; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Han D, 2016, MOL CELL, V63, P711, DOI 10.1016/j.molcel.2016.06.028; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li DF, 2019, NUCLEIC ACIDS RES, V47, pW158, DOI 10.1093/nar/gkz348; Li DF, 2015, METHODS, V72, P29, DOI 10.1016/j.ymeth.2014.10.032; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lio CW, 2016, ELIFE, V5, DOI 10.7554/eLife.18290; Lio CWJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7523; Lio CWJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00210; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Orange JS, 1996, J IMMUNOL, V156, P1138; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Sciume G, 2020, IMMUNITY, V53, P745, DOI 10.1016/j.immuni.2020.09.008; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stark R., 2011, DIFFBIND DIFFERENTIA; Sun JC, 2016, CURR TOP MICROBIOL, V395, P1, DOI 10.1007/82_2015_452; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tsagaratou A, 2017, NAT IMMUNOL, V18, P45, DOI 10.1038/ni.3630; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Wang QL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay7501; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	78	4	4	4	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					619	+		10.1038/s41590-022-01164-8	http://dx.doi.org/10.1038/s41590-022-01164-8			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35332328	Green Accepted			2022-12-18	WOS:000779229500024
J	da Silva, RB; Leitao, RM; Pechuan-Jorge, X; Werneke, S; Oeh, J; Javinal, V; Wang, YY; Phung, W; Everett, C; Nonomiya, J; Arnott, D; Lu, C; Hsiao, YC; Koerber, JT; Hotzel, I; Ziai, J; Modrusan, Z; Pillow, TH; Roose-Girma, M; Schartner, JM; Merchant, M; Rutz, S; Eidenschenk, C; Mellman, I; Albert, ML				da Silva, Rosa Barreira; Leitao, Ricardo M.; Pechuan-Jorge, Ximo; Werneke, Scott; Oeh, Jason; Javinal, Vincent; Wang, Yingyun; Phung, Wilson; Everett, Christine; Nonomiya, Jim; Arnott, David; Lu, Cheng; Hsiao, Yi-Chun; Koerber, James T.; Hotzel, Isidro; Ziai, James; Modrusan, Zora; Pillow, Thomas H.; Roose-Girma, Merone; Schartner, Jill M.; Merchant, Mark; Rutz, Sascha; Eidenschenk, Celine; Mellman, Ira; Albert, Matthew L.			Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity	NATURE IMMUNOLOGY			English	Article							GLUTAMINYL CYCLASE; BONE-MARROW; T-CELLS; MACROPHAGES; MONOCYTES; REVEALS; INHIBITION; ANTIBODY; IDENTIFICATION; RESISTANCE	Tumor-associated macrophages are composed of distinct populations arising from monocytes or tissue macrophages, with a poorly understood link to disease pathogenesis. Here, we demonstrate that mouse monocyte migration was supported by glutaminyl-peptide cyclotransferase-like (QPCTL), an intracellular enzyme that mediates N-terminal modification of several substrates, including the monocyte chemoattractants CCL2 and CCL7, protecting them from proteolytic inactivation. Knockout of Qpctl disrupted monocyte homeostasis, attenuated tumor growth and reshaped myeloid cell infiltration, with loss of monocyte-derived populations with immunosuppressive and pro-angiogenic profiles. Antibody targeting of the receptor CSF1R, which more broadly eliminates tumor-associated macrophages, reversed tumor growth inhibition in Qpctl(-/-) mice and prevented lymphocyte infiltration. Modulation of QPCTL synergized with anti-PD-L1 to expand CD8(+) T cells and limit tumor growth. QPCTL inhibition constitutes an effective approach for myeloid cell-targeted cancer immunotherapy. Tumor-associated macrophages can restrict antitumor responses. Barreira da Silva and colleagues demonstrate that the intracellular enzyme QPCTL supports recruitment of immunomodulatory macrophages to the tumor microenvironment and its targeting can enhance tumor control.	[da Silva, Rosa Barreira; Leitao, Ricardo M.; Pechuan-Jorge, Ximo; Werneke, Scott; Oeh, Jason; Javinal, Vincent; Wang, Yingyun; Phung, Wilson; Everett, Christine; Nonomiya, Jim; Arnott, David; Lu, Cheng; Hsiao, Yi-Chun; Koerber, James T.; Hotzel, Isidro; Ziai, James; Modrusan, Zora; Pillow, Thomas H.; Roose-Girma, Merone; Schartner, Jill M.; Merchant, Mark; Rutz, Sascha; Eidenschenk, Celine; Mellman, Ira; Albert, Matthew L.] Genentech Inc, San Francisco, CA 94080 USA; [Albert, Matthew L.] HIBIO, San Francisco, CA 94080 USA	Roche Holding; Genentech	da Silva, RB; Mellman, I; Albert, ML (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.; Albert, ML (corresponding author), HIBIO, San Francisco, CA 94080 USA.	barreira.rosa@gene.com; mellman.ira@gene.com; matthew@hibio.com		Barreira da Silva, Rosa/0000-0002-2117-3280; Leitao, Ricardo/0000-0002-0916-7945; Phung, Wilson/0000-0001-7793-3931	Genentech	Genentech(Roche HoldingGenentech)	The authors acknowledge the following people for technical and intellectual support: Y. Lu, J. Wu, J. Payandeh, I. Lehoux and protein structure/purification teams; B. Haley, J. Lill, W. Sandoval and P. Liu; S. Warming, U. Segal, V. Arumugam, R. Asuncion, T. Scholl, M. Dempsey, K. Veliz, M. Lamoureux, W. Ortiz, M. Reich and animal care-takers and veterinarians; Y. Chestnut, M. Singh and A. Gutierrez; pathology, necropsy and antibody engineering/production teams; A. Cordrey and the cell culture team; and W. Fu for careful reading of the manuscript. This work was funded by Genentech. Illustrations were generated by the authors or adapted from Servier medical art (France) or BioRender.com.	Alaluf E, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133929; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Beffinger M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97792; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Brana I, 2015, TARGET ONCOL, V10, P111, DOI 10.1007/s11523-014-0320-2; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Cheng SJ, 2021, CELL, V184, P792, DOI 10.1016/j.cell.2021.01.010; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; da Silva RB, 2015, NAT IMMUNOL, V16, P850, DOI 10.1038/ni.3201; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Henningsson R, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vez028; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hollande C, 2019, NAT IMMUNOL, V20, P257, DOI 10.1038/s41590-019-0321-5; Jahchan NS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01611; Kalbasi A, 2017, CLIN CANCER RES, V23, P137, DOI 10.1158/1078-0432.CCR-16-0870; Kehlen A, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170712; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Lim SY, 2016, ONCOTARGET, V7, P28697, DOI 10.18632/oncotarget.7376; Logtenberg MEW, 2019, NAT MED, V25, P612, DOI 10.1038/s41591-019-0356-z; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Papadopoulos KP, 2017, CLIN CANCER RES, V23, P5703, DOI 10.1158/1078-0432.CCR-16-3261; Poeta VM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00379; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rivera LB, 2015, TRENDS IMMUNOL, V36, P240, DOI 10.1016/j.it.2015.02.005; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Scheltens P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0431-6; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Szymczak WA, 2009, J IMMUNOL, V183, P1964, DOI 10.4049/jimmunol.0901316; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Thoreau M, 2015, ONCOTARGET, V6, P27832, DOI 10.18632/oncotarget.4940; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Willemsen L, 2020, J PATHOL, V250, P705, DOI 10.1002/path.5392; Wu ZQ, 2019, CELL RES, V29, P502, DOI 10.1038/s41422-019-0177-0; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zappia L, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy083; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zheng YH, 2009, BLOOD, V114, P3625, DOI 10.1182/blood-2009-05-220285; Zhu XM, 2011, J NEURO-ONCOL, V104, P83, DOI 10.1007/s11060-010-0473-5; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	58	4	4	7	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					568	+		10.1038/s41590-022-01153-x	http://dx.doi.org/10.1038/s41590-022-01153-x		MAR 2022	38	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35314846	Green Submitted			2022-12-18	WOS:000771340600001
J	Andreakos, E				Andreakos, Evangelos			STINGing type I IFN-mediated immunopathology in COVID-19	NATURE IMMUNOLOGY			English	Editorial Material							INFECTION	The molecular basis for type I interferon (IFN)-mediated immunopathology is unclear. New data now identify the cGAS-STING pathway as a major driver of pathological type I IFN responses in COVID-19.	[Andreakos, Evangelos] Acad Athens, Lab Immunobiol, Ctr Clin Res Expt Surg & Translat Res, Biomed Res Fdn, Athens, Greece	Academy of Athens	Andreakos, E (corresponding author), Acad Athens, Lab Immunobiol, Ctr Clin Res Expt Surg & Translat Res, Biomed Res Fdn, Athens, Greece.	vandreakos@bioacademy.gr						Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Crow YJ, 2022, NAT REV IMMUNOL, V22, P471, DOI 10.1038/s41577-021-00633-9; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Di Domizio J, 2022, NATURE, V603, P145, DOI 10.1038/s41586-022-04421-w; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Kalil AC, 2021, LANCET RESP MED, V9, P1365, DOI 10.1016/S2213-2600(21)00384-2; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Neufeldt CJ, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-021-02983-5; Stukalov A, 2021, NATURE, V594, P246, DOI 10.1038/s41586-021-03493-4; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Zhang Q, 2022, NATURE, V603, P587, DOI [10.1038/s41586-022-04447-0, 10.1159/000524200]	14	4	4	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					478	480		10.1038/s41590-022-01174-6	http://dx.doi.org/10.1038/s41590-022-01174-6		MAR 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35301509	Bronze			2022-12-18	WOS:000770206000001
J	Sugiura, D; Okazaki, I; Maeda, TK; Maruhashi, T; Shimizu, K; Arakaki, R; Takemoto, T; Ishimaru, N; Okazaki, T				Sugiura, Daisuke; Okazaki, Il-mi; Maeda, Takeo K.; Maruhashi, Takumi; Shimizu, Kenji; Arakaki, Rieko; Takemoto, Tatsuya; Ishimaru, Naozumi; Okazaki, Taku			PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity	NATURE IMMUNOLOGY			English	Article							ANIMAL-MODEL; EXPRESSION; INDUCTION; ARTHRITIS; ANTIGEN; MICE; DISRUPTION; BLOCKADE; PHASE	Targeted blockade of the checkpoint molecule programmed cell death 1 (PD-1) can activate tumor-specific T cells to destroy tumors, whereas targeted potentiation of PD-1 is expected to suppress autoreactive T cells and alleviate autoimmune diseases. However, the development of methods to potentiate PD-1 remains challenging. Here we succeeded in eliciting PD-1 function by targeting the cis-PD-L1-CD80 duplex, formed by binding of CD80 to the PD-1 ligand PD-L1, that attenuates PD-L1-PD-1 binding and abrogates PD-1 function. By generating anti-CD80 antibodies that detach CD80 from the cis-PD-L1-CD80 duplex and enable PD-L1 to engage PD-1 in the presence of CD80, we demonstrate that the targeted dissociation of cis-PD-L1-CD80 duplex elicits PD-1 function in the condition where PD-1 function is otherwise restricted. We demonstrate using murine models that the removal of PD-1 restriction is effective in alleviating autoimmune disease symptoms. Our findings establish a method to potentiate PD-1 function and propose the removal of restraining mechanisms as an efficient strategy to potentiate the function of inhibitory molecules. Okazaki and colleagues develop and characterize monoclonal antibodies that co-opt T cell PD-1 activity. These antibodies can be used to ameliorate experimental autoimmune disease.	[Sugiura, Daisuke; Okazaki, Il-mi; Maruhashi, Takumi; Shimizu, Kenji; Okazaki, Taku] Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Tokyo, Japan; [Sugiura, Daisuke; Okazaki, Il-mi; Maeda, Takeo K.; Maruhashi, Takumi; Shimizu, Kenji; Okazaki, Taku] Tokushima Univ, Inst Adv Med Sci, Lab Immune Regulat, Tokushima, Japan; [Arakaki, Rieko; Ishimaru, Naozumi] Tokushima Univ, Grad Sch Biomed Sci, Dept Oral Mol Pathol, Tokushima, Japan; [Takemoto, Tatsuya] Tokushima Univ, Inst Adv Med Sci, Lab Embryol, Tokushima, Japan	University of Tokyo; Tokushima University; Tokushima University; Tokushima University	Okazaki, T (corresponding author), Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Tokyo, Japan.; Okazaki, T (corresponding author), Tokushima Univ, Inst Adv Med Sci, Lab Immune Regulat, Tokushima, Japan.	tokazaki@iqb.u-tokyo.ac.jp		Sugiura, Daisuke/0000-0002-3865-3889; Maruhashi, Takumi/0000-0003-2944-1611; Shimizu, Kenji/0000-0003-4204-555X; Takemoto, Tatsuya/0000-0003-1860-0269; Okazaki, Il-mi/0000-0001-8644-0100; Okazaki, Taku/0000-0003-4790-1925	Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development [JP18am0301007]; Japan Society for the Promotion of Science [JP18H05417, JP19H01029, JP21K06526]; Naito Foundation; Institute of Advanced Medical Sciences of Tokushima University	Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Institute of Advanced Medical Sciences of Tokushima University	We thank T. Kurosaki (IIA1.6), T. Kitamura (Plat-E), L. Ignatowicz (BW-1100.129.237), K. Murphy (DO11.10 TCR transgenic mouse) and T. Honjo (DO11.10 T, 2.4G2, J43, Sp2/O and 293T) for kindly providing materials; H. Tsuduki, Y. Okamoto, M. Aoki, J. Tsueda, A. Mikuniya, R. Matsumura and M. Saito for technical and secretarial assistance; and the other members of our laboratory for helpful discussions. This work was supported in part by grants from the Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development (JP18am0301007 to T.O.), Grant-in-Aid by the Japan Society for the Promotion of Science (JP18H05417 to T.O.; JP19H01029 to T.O.; JP21K06526 to D.S.), the Naito Foundation (to T.O.) and Joint Usage and Joint Research Programs by the Institute of Advanced Medical Sciences of Tokushima University (to T.O. and T.T.).	Alvarez-Sierra D, 2019, J AUTOIMMUN, V103, DOI 10.1016/j.jaut.2019.05.013; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brancati S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.661882; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Colli ML, 2018, EBIOMEDICINE, V36, P367, DOI 10.1016/j.ebiom.2018.09.040; Crivello P, 2019, J IMMUNOL, V202, P1895, DOI 10.4049/jimmunol.1800257; Edwards CK, 1996, J IMMUNOL, V157, P1758; Grebinoski S, 2020, CURR OPIN IMMUNOL, V67, P1, DOI 10.1016/j.coi.2020.06.001; HANEJI N, 1994, J IMMUNOL, V153, P2769; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6; Ishimaru N, 2009, J IMMUNOL, V182, P6576, DOI 10.4049/jimmunol.0802289; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Iwanami K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2545; Izawa T, 2007, BLOOD, V110, P242, DOI 10.1182/blood-2006-11-059980; Kobayashi M, 2005, J RHEUMATOL, V32, P2156; Legut M, 2018, BLOOD, V131, P311, DOI 10.1182/blood-2017-05-787598; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; Matsuda K, 2018, CLIN EXP MED, V18, P487, DOI 10.1007/s10238-018-0515-4; Maul RW, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.649458; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Mizuno R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00630; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2005, J EXP MED, V202, P1643, DOI 10.1084/jem.20051984; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Okazaki T, 2019, ADV EXP MED BIOL, V1189, P213, DOI 10.1007/978-981-32-9717-3_8; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Otsuka K, 2019, AM J PATHOL, V189, P2414, DOI 10.1016/j.ajpath.2019.08.008; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rincon-Arevalo H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.635615; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; SATO JD, 1988, IN VITRO CELL DEV B, V24, P1223; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shimizu K, 2020, MOL CELL, V77, P937, DOI 10.1016/j.molcel.2019.12.012; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Ushio A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02594; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang JA, 2010, INT IMMUNOL, V22, P443, DOI 10.1093/intimm/dxq026; WHITE J, 1983, J IMMUNOL, V130, P1033; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zhao SZ, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0769-6; Zhao YL, 2019, IMMUNITY, V51, P1059, DOI 10.1016/j.immuni.2019.11.003	57	4	5	7	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					399	+		10.1038/s41590-021-01125-7	http://dx.doi.org/10.1038/s41590-021-01125-7		FEB 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35145298				2022-12-18	WOS:000753930000002
J	Zhong, Y; Walker, SK; Pritykin, Y; Leslie, CS; Rudensky, AY; Van der Veeken, J				Zhong, Yi; Walker, Sarah K.; Pritykin, Yuri; Leslie, Christina S.; Rudensky, Alexander Y.; van der Veeken, Joris			Hierarchical regulation of the resting and activated T cell epigenome by major transcription factor families	NATURE IMMUNOLOGY			English	Article							DNA-BINDING; COOPERATIVE BINDING; FOXP3 GENE; ETS-1; DIFFERENTIATION; PROTEIN; MEMORY; PHOSPHORYLATION; REPRESSION; EXPRESSION	Zhong et al. utilize B6/Cast F1 hybrid mice to examine transcriptional regulation of T cell gene expression upon activation induced by viral challenge. They describe gene accessibility changes that lead to differential gene expression and report a hierarchy of transcription factor families that mediate the chromatin dynamics. T cell activation, a key early event in the adaptive immune response, is subject to elaborate transcriptional control. In the present study, we examined how the activities of eight major transcription factor (TF) families are integrated to shape the epigenome of naive and activated CD4 and CD8 T cells. By leveraging extensive polymorphisms in evolutionarily divergent mice, we identified the 'heavy lifters' positively influencing chromatin accessibility. Members of Ets, Runx and TCF/Lef TF families occupied the vast majority of accessible chromatin regions, acting as 'housekeepers', 'universal amplifiers' and 'placeholders', respectively, at sites that maintained or gained accessibility upon T cell activation. In addition, a small subset of strongly induced immune response genes displayed a noncanonical TF recruitment pattern. Our study provides a key resource and foundation for the understanding of transcriptional and epigenetic regulation in T cells and offers a new perspective on the hierarchical interactions between critical TFs.	[Zhong, Yi; Rudensky, Alexander Y.; van der Veeken, Joris] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhong, Yi; Rudensky, Alexander Y.; van der Veeken, Joris] Mem Sloan Kettering Canc Ctr, Immunol Program, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhong, Yi; Rudensky, Alexander Y.; van der Veeken, Joris] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Zhong, Yi; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, New York, NY USA; [Zhong, Yi] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Immune Therapy Inst, Sch Med, Shanghai, Peoples R China; [Walker, Sarah K.; Pritykin, Yuri] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA; [Walker, Sarah K.] Princeton Univ, Quantitat & Computat Biol Grad Program, Princeton, NJ USA; [Pritykin, Yuri] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [van der Veeken, Joris] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Shanghai Jiao Tong University; Princeton University; Princeton University; Princeton University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Rudensky, AY; Van der Veeken, J (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Howard Hughes Med Inst, New York, NY 10065 USA.; Rudensky, AY; Van der Veeken, J (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, Howard Hughes Med Inst, New York, NY 10065 USA.; Rudensky, AY; Van der Veeken, J (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA.; Van der Veeken, J (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria.	rudenska@mskcc.org; joris.van.derveeken@imp.ac.at	Pritykin, Yuri/ACA-0558-2022	van der Veeken, Joris/0000-0001-7299-2174; Pritykin, Yury/0000-0001-6589-981X; Zhong, Yi/0000-0003-2294-0995	NIH [R01AI034206, U54 CA209975]; NIH/National Cancer Institute (NCI) [P30 CA008748]; AACR-Bristol-Myers Squibb Immuno-oncology Research Fellowship [19-40-15-PRIT]; National Natural Science Foundation of China [32170883]; Ludwig Center at MSKCC; Parker Institute for Cancer Immunotherapy; NIH/NCI Cancer Center Support [P30 CA008748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AACR-Bristol-Myers Squibb Immuno-oncology Research Fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ludwig Center at MSKCC; Parker Institute for Cancer Immunotherapy; NIH/NCI Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	We thank all members of the Rudensky lab for discussions and technical assistance. We thank the NIH tetramer core for providing critical reagents. The present study was supported by NIH grants (nos. R01AI034206, U54 CA209975) and NIH/National Cancer Institute (NCI, grant no. P30 CA008748), AACR-Bristol-Myers Squibb Immuno-oncology Research Fellowship (no. 19-40-15-PRIT), National Natural Science Foundation of China (grant no. 32170883 to Y.Z.), the Ludwig Center at MSKCC and the Parker Institute for Cancer Immunotherapy. A.Y.R. is an investigator with the Howard Hughes Medical Institute. We acknowledge the use of the MSKCC Single Cell Research Initiative and the Integrated Genomics Operation Core, funded by the NIH/NCI Cancer Center Support (grant no. P30 CA008748), Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Cowley DO, 2000, GENE DEV, V14, P366; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hosokawa H, 2021, NAT REV IMMUNOL, V21, P162, DOI 10.1038/s41577-020-00426-6; Hota SK, 2016, DEVELOPMENT, V143, P2882, DOI 10.1242/dev.128892; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim CJ, 2018, IMMUNITY, V49, P1034, DOI 10.1016/j.immuni.2018.10.012; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Link VM, 2018, NUCLEIC ACIDS RES, V46, P7006, DOI 10.1093/nar/gky491; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Luo CT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01020-6; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Melet F, 1996, MOL CELL BIOL, V16, P2708; Milner JJ, 2018, CURR OPIN IMMUNOL, V51, P162, DOI 10.1016/j.coi.2018.03.017; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; POGNONEC P, 1988, EMBO J, V7, P977, DOI 10.1002/j.1460-2075.1988.tb02904.x; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; RABAULT B, 1994, J BIOL CHEM, V269, P28143; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shin B., P NATL ACAD SCI USA, DOI [10.1073/pnas.2019655118(2021), DOI 10.1073/PNAS.2019655118(2021)]; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; van der Veeken J, 2020, IMMUNITY, V53, P971, DOI 10.1016/j.immuni.2020.10.010; van der Veeken J, 2019, IMMUNITY, V50, P1202, DOI 10.1016/j.immuni.2019.03.031; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Verbaro DJ, 2018, J IMMUNOL, V200, P3891, DOI 10.4049/jimmunol.1701700; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	61	4	4	2	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					122	+		10.1038/s41590-021-01086-x	http://dx.doi.org/10.1038/s41590-021-01086-x		DEC 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937932	Green Accepted			2022-12-18	WOS:000733276000004
J	Basu, J; Reis, BS; Peri, S; Zha, JK; Hua, X; Ge, L; Ferchen, K; Nicolas, E; Czyzewicz, P; Cai, KQ; Tan, YF; Bass, JIF; Walhout, AJM; Grimes, HL; Grivennikov, SI; Mucida, D; Kappes, DJ				Basu, Jayati; Reis, Bernardo S.; Peri, Suraj; Zha, Jikun; Hua, Xiang; Ge, Lu; Ferchen, Kyle; Nicolas, Emmanuelle; Czyzewicz, Philip; Cai, Kathy Q.; Tan, Yinfei; Bass, Juan I. Fuxman; Walhout, Albertha J. M.; Grimes, H. Leighton; Grivennikov, Sergei, I; Mucida, Daniel; Kappes, Dietmar J.			Essential role of a ThPOK autoregulatory loop in the maintenance of mature CD4(+) T cell identity and function	NATURE IMMUNOLOGY			English	Article							ONE-HYBRID ASSAYS; TRANSCRIPTION FACTORS; SUPER-ENHANCERS; LINEAGE COMMITMENT; GENE-EXPRESSION; READ ALIGNMENT; DIFFERENTIATION; RECEPTOR; DISTINCT; DISEASE	The transcription factor ThPOK (encoded by the Zbtb7b gene) controls homeostasis and differentiation of mature helper T cells, while opposing their differentiation to CD4(+) intraepithelial lymphocytes (IELs) in the intestinal mucosa. Thus CD4 IEL differentiation requires ThPOK transcriptional repression via reactivation of the ThPOK transcriptional silencer element (Sil(ThPOK)). In the present study, we describe a new autoregulatory loop whereby ThPOK binds to the Sil(ThPOK) to maintain its own long-term expression in CD4 T cells. Disruption of this loop in vivo prevents persistent ThPOK expression, leads to genome-wide changes in chromatin accessibility and derepresses the colonic regulatory T (T-reg) cell gene expression signature. This promotes selective differentiation of naive CD4 T cells into GITR(lo)PD-1(lo)CD25(lo) (Triple(lo)) T-reg cells and conversion to CD4(+) IELs in the gut, thereby providing dominant protection from colitis. Hence, the ThPOK autoregulatory loop represents a key mechanism to physiologically control ThPOK expression and T cell differentiation in the gut, with potential therapeutic relevance. The transcription factor ThPOK is critical for homeostasis and differentiation of mature helper T cells. Here, Kappes and colleagues describe a ThPOK-mediated positive autoregulatory loop that is crucial for tissue-specific T-reg cell differentiation, maintenance of intestinal T-reg cell integrity and conversion of these cells into CD4(+) intraepithelial lymphocytes.	[Basu, Jayati; Zha, Jikun; Hua, Xiang; Ge, Lu; Nicolas, Emmanuelle; Czyzewicz, Philip; Kappes, Dietmar J.] Fox Chase Canc Ctr, Blood Cell Dev & Canc, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Reis, Bernardo S.; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA; [Peri, Suraj] Fox Chase Canc Ctr, Biostat & Bioinformat, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Ferchen, Kyle; Grimes, H. Leighton] Cincinnati Childrens Hosp 10 Med Ctr, Div Immunobiol, Cincinnati, OH USA; [Ferchen, Kyle; Grimes, H. Leighton] Cincinnati Childrens Hosp 10 Med Ctr, Ctr Syst Immunol, Cincinnati, OH USA; [Cai, Kathy Q.] Fox Chase Canc Ctr, Canc Signaling & Epigenet, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Tan, Yinfei] Fox Chase Canc Ctr, Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Bass, Juan I. Fuxman; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Program Mol Med, Worcester, MA USA; [Grivennikov, Sergei, I] Fox Chase Canc Ctr, Canc Prevent & Control, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Grivennikov, Sergei, I] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Grivennikov, Sergei, I] Cedars Sinai Med Ctr, Dept Biomed Sci, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Fox Chase Cancer Center; Rockefeller University; Fox Chase Cancer Center; University System of Ohio; University of Cincinnati; Fox Chase Cancer Center; Fox Chase Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; Fox Chase Cancer Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Kappes, DJ (corresponding author), Fox Chase Canc Ctr, Blood Cell Dev & Canc, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	dietmar.kappes@fccc.edu	Grivennikov, Sergei/AAE-7365-2019; Sgarbi Reis, Bernardo/E-3448-2012	Grivennikov, Sergei/0000-0003-2987-0555; Sgarbi Reis, Bernardo/0000-0002-6841-116X	NCI NIH HHS [P30 CA006927, T32 CA117846, R01 CA227629, R01 CA218133] Funding Source: Medline; NIAID NIH HHS [R01 AI068907] Funding Source: Medline; NIGMS NIH HHS [R01 GM107179, R01 GM082971, R35 GM122502] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antoniou E, 2016, ANN MED SURG, V11, P9, DOI 10.1016/j.amsu.2016.07.019; Bass JIF, 2015, CELL, V161, P661, DOI 10.1016/j.cell.2015.03.003; Bilate AM, 2020, IMMUNITY, V53, P1001, DOI 10.1016/j.immuni.2020.09.003; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Carpenter AC, 2017, J IMMUNOL, V199, P1716, DOI 10.4049/jimmunol.1700181; Chen HD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09670-4; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; De Obaldia ME, 2013, BLOOD, V121, P64, DOI 10.1182/blood-2012-08-451773; Diao Huitian, 2019, F1000Res, V8, DOI 10.12688/f1000research.18211.1; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Flamand L, 1998, P NATL ACAD SCI USA, V95, P3111, DOI 10.1073/pnas.95.6.3111; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Istaces N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11233-6; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larsson AJM, 2019, NATURE, V565, P251, DOI 10.1038/s41586-018-0836-1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marshall NB, 2017, J IMMUNOL, V198, P1142, DOI 10.4049/jimmunol.1601297; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Mookerjee-Basu J, 2019, MOL BIOL EVOL, V36, P39, DOI 10.1093/molbev/msy191; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/nmeth.1764, 10.1038/NMETH.1764]; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rothenberg EV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00228; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Snook JP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9103; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tu E, 2018, IMMUNITY, V48, P745, DOI 10.1016/j.immuni.2018.03.025; Vacchio MS, 2019, IMMUNITY, V51, P465, DOI 10.1016/j.immuni.2019.06.023; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Waid DM, 2004, EUR J IMMUNOL, V34, P1488, DOI 10.1002/eji.200324703; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wyss L, 2016, NAT IMMUNOL, V17, P1093, DOI 10.1038/ni.3522; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zheng SW, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178041; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008	63	4	4	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					969	+		10.1038/s41590-021-00980-8	http://dx.doi.org/10.1038/s41590-021-00980-8			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34312548	Green Accepted			2022-12-18	WOS:000677755900008
J	Patry, RT; Nagler, CR				Patry, Robert T.; Nagler, Cathryn R.			Fiber-poor Western diets fuel inflammation	NATURE IMMUNOLOGY			English	Editorial Material								The transition of Sub-Saharan Africans from rural settings and traditional plant-rich diets to urban settings and calorie-dense Westernized diets has led to specific shifts in serum metabolites and activates a heightened proinflammatory state in immune cells.	[Patry, Robert T.; Nagler, Cathryn R.] Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA; [Nagler, Cathryn R.] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Nagler, CR (corresponding author), Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA.; Nagler, CR (corresponding author), Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA.	cnagler@bsd.uchicago.edu						BURKITT DP, 1973, P NUTR SOC, V32, P145, DOI 10.1079/PNS19730032; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Maleki SJ, 2019, FOOD CHEM, V299, DOI 10.1016/j.foodchem.2019.125124; Napier BA, 2019, P NATL ACAD SCI USA, V116, P3688, DOI 10.1073/pnas.1814273116; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342; Tan JK, 2017, ANNU REV IMMUNOL, V35, P371, DOI 10.1146/annurev-immunol-051116-052235; Temba GS, 2021, NAT IMMUNOL, V22, P287, DOI 10.1038/s41590-021-00867-8; United Nations Department of Economic and Social Affairs Population Division, WORLD URB PROSP 2018; Zeng HW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051214	12	4	4	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					266	268		10.1038/s41590-021-00880-x	http://dx.doi.org/10.1038/s41590-021-00880-x		FEB 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33574618				2022-12-18	WOS:000617117400004
J	Liu, X; Peng, GY				Liu, Xia; Peng, Guangyong			Mitochondria orchestrate T cell fate and function	NATURE IMMUNOLOGY			English	Editorial Material							TUMOR MICROENVIRONMENT; DRIVER	An investigation of the molecular processes of mitochondrial reprogramming and metabolic stress in antigen-experienced T cells within tumor microenvironments reveals mechanisms responsible for T cell exhaustion and dysfunction and facilitates the development of new strategies for tumor immunotherapy.	[Peng, Guangyong] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63103 USA; [Peng, Guangyong] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA	Saint Louis University; Saint Louis University	Peng, GY (corresponding author), St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63103 USA.	guangyong.peng@health.slu.edu			NCI NIH HHS [R01 CA184379, R01 CA242188] Funding Source: Medline; NIA NIH HHS [R21 AG067441] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Li CF, 2019, IMMUNITY, V51, P491, DOI 10.1016/j.immuni.2019.08.013; Liu X, 2020, J CLIN INVEST, V130, P1073, DOI 10.1172/JCI133679; Ogando J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0628-7; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Xia LY, 2019, CELL METAB, V29, P103, DOI 10.1016/j.cmet.2018.09.020; Yu YR, 2020, NAT IMMUNOL, V21, P1540, DOI 10.1038/s41590-020-0793-3	13	4	4	3	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					276	278		10.1038/s41590-020-00861-6	http://dx.doi.org/10.1038/s41590-020-00861-6		JAN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33495653				2022-12-18	WOS:000611466600001
J	Rua, R; Pujol, N				Rua, Rejane; Pujol, Nathalie			IL-17: good fear no tears	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; AVOIDANCE; CYTOKINES; NEURONS		[Rua, Rejane; Pujol, Nathalie] Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM,Turing Ctr Living Syst, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Rua, R; Pujol, N (corresponding author), Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM,Turing Ctr Living Syst, Marseille, France.	rua@ciml.univ-mrs.fr; pujol@ciml.univ-mrs.fr	Rua, Rejane/GLQ-7139-2022; Pujol, Nathalie/K-3880-2012	Rua, Rejane/0000-0002-4289-3498; Pujol, Nathalie/0000-0001-8889-3197				de Lima KA, 2020, NAT IMMUNOL, V21, P1421, DOI 10.1038/s41590-020-0776-4; Brandt JP, 2015, CURR BIOL, V25, P2228, DOI 10.1016/j.cub.2015.07.037; Chen CC, 2017, NATURE, V542, P43, DOI 10.1038/nature20818; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Cipollini V, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00095; Ebbinghaus M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10509-5; Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39; Flynn SM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15872-y; Helfrich RF, 2019, HAND CLINIC, V163, P35, DOI 10.1016/B978-0-12-804281-6.00003-3; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Reed MD, 2020, NATURE, V577, P249, DOI 10.1038/s41586-019-1843-6; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; von Banchet GS, 2013, MOL CELL NEUROSCI, V52, P152, DOI 10.1016/j.mcn.2012.11.006	16	4	4	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1315	1316		10.1038/s41590-020-0792-4	http://dx.doi.org/10.1038/s41590-020-0792-4		SEP 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32958929	Green Submitted			2022-12-18	WOS:000571701700002
J	Acharya, N; Anderson, AC				Acharya, Nandini; Anderson, Ana C.			NRP1 cripples immunological memory	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS	Durable responses to immunotherapy require the development of robust CD8(+)T cell memory. A new study indicates that NRP1 differs from other checkpoint receptors as it functions as a checkpoint for the generation of memory.	[Acharya, Nandini; Anderson, Ana C.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Acharya, Nandini; Anderson, Ana C.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Acharya, Nandini; Anderson, Ana C.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Anderson, AC (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Anderson, AC (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Anderson, AC (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	acanderson@bwh.harvard.edu	Anderson, Ana C/ABD-6829-2021	Anderson, Ana C/0000-0002-0877-2932				Hwang JY, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00221-19; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Liu C, 2020, NAT IMMUNOL, V21, P1010, DOI 10.1038/s41590-020-0733-2; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	14	4	5	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					972	973		10.1038/s41590-020-0759-5	http://dx.doi.org/10.1038/s41590-020-0759-5		JUL 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32724188				2022-12-18	WOS:000553309500001
J	Weaver, CT				Weaver, Casey T.			One road to the T(H)17 pathway: how T(H)1 led to T(H)17 (and vice versa), and first came last	NATURE IMMUNOLOGY			English	Article							T-CELLS; DISTINCT; CYTOKINE; LINEAGE; BETA; DIFFERENTIATION; INFLAMMATION; IL-23; IL-12; TH17	Casey Weaver recounts how his group's discovery of the T(H)17 pathway resolved several conundrums that had arisen in the wake of the original T(H)1-T(H)2 hypothesis.	[Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	23	4	4	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					819	821		10.1038/s41590-020-0715-4	http://dx.doi.org/10.1038/s41590-020-0715-4		JUL 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32616862				2022-12-18	WOS:000545059300003
J	Patin, E				Patin, Etienne			Plague as a cause for familial Mediterranean fever	NATURE IMMUNOLOGY			English	Article							DAY WORLD DISTRIBUTION; ALLEGED CAUSES; CCR5	Evolutionary genetic and experimental analyses suggest that mutations causing familial Mediterranean fever have been positively selected in the Middle East, probably because they confer heightened resistance againstYersinia pestisinfection.	[Patin, Etienne] Inst Pasteur, CNRS, UMR 2000, Human Evolutionary Genet Unit, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Patin, E (corresponding author), Inst Pasteur, CNRS, UMR 2000, Human Evolutionary Genet Unit, Paris, France.	epatin@pasteur.fr		Patin, Etienne/0000-0002-9911-4459	Institut Pasteur; CNRS; French Government's Investissement d'Avenir program project; French Government's Laboratoires d'Excellence "Integrative Biology of Emerging Infectious Diseases" project [ANR-10-LABX-62-IBEID]; French Government's "Milieu Interieur" project [ANR-10-LABX-69-01]; Fondation pour la Recherche Medicale [Equipe FRM DEQ20180339214]; Agence Nationale de la Recherche grant 'MORTUI' [ANR-19-CE35-0005-01]	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Government's Investissement d'Avenir program project(French National Research Agency (ANR)); French Government's Laboratoires d'Excellence "Integrative Biology of Emerging Infectious Diseases" project; French Government's "Milieu Interieur" project; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche grant 'MORTUI'(French National Research Agency (ANR))	My laboratory is supported by the Institut Pasteur, the CNRS, the French Government's Investissement d'Avenir program, Laboratoires d'Excellence "Integrative Biology of Emerging Infectious Diseases" (ANR-10-LABX-62-IBEID) and "Milieu Interieur" (ANR-10-LABX-69-01) projects, the Fondation pour la Recherche Medicale (Equipe FRM DEQ20180339214) and the Agence Nationale de la Recherche grant 'MORTUI' (ANR-19-CE35-0005-01).	Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Dehasque M, 2020, EVOL LETT, V4, P94, DOI 10.1002/evl3.165; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; Koshy R, 2018, CLIN GENET, V93, P92, DOI 10.1111/cge.13070; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; Park YH, 2020, NAT IMMUNOL, V21, P857, DOI 10.1038/s41590-020-0705-6; PETTENKOFER HJ, 1962, NATURE, V193, P445, DOI 10.1038/193445a0; Randremanana R, 2019, LANCET INFECT DIS, V19, P537, DOI 10.1016/S1473-3099(18)30730-8; Schnappauf O, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01745; SPRINGER GF, 1962, NATURE, V193, P444, DOI 10.1038/193444a0; Spyrou MA, 2019, NAT REV GENET, V20, P323, DOI 10.1038/s41576-019-0119-1; Voight BF, 2006, PLOS BIOL, V4, P659, DOI 10.1371/journal.pbio.0040072	13	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					833	834		10.1038/s41590-020-0724-3	http://dx.doi.org/10.1038/s41590-020-0724-3		JUN 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32601468	Green Submitted			2022-12-18	WOS:000544156900001
J	Daniels, MA; Teixeiro, E				Daniels, Mark A.; Teixeiro, Emma			Forget 'ME' not virtual memory T cells	NATURE IMMUNOLOGY			English	Editorial Material							MAINTENANCE; PHENOTYPE; RESPONSES; NAIVE	CD8 memory-phenotype differentiation is a T cell antigen receptor-governed process that begins in Eomes(+) thymic precursors and is subsequently completed in the periphery. These CD8-MP cells can infiltrate tumors, where they express PD-1.	[Teixeiro, Emma] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; Univ Missouri, Sch Med, Dept Surg, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Teixeiro, E (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA.	teixeiropernase@missouri.edu		Teixeiro, Emma/0000-0002-3596-5481; Daniels, Mark/0000-0002-5175-9901	NIAID NIH HHS [R01 AI110420] Funding Source: Medline; NIBIB NIH HHS [R21 EB026560] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Drobek A, 2018, EMBO J, V37, DOI 10.15252/embj.201798518; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Jameson SC, 2015, ADV IMMUNOL, V126, P173, DOI 10.1016/bs.ai.2014.12.001; Lee JY, 2013, P NATL ACAD SCI USA, V110, P13498, DOI 10.1073/pnas.1307572110; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Miller CH, 2020, NAT IMMUNOL, V21, P567, DOI 10.1038/s41590-020-0653-1; Quinn KM, 2018, CELL REP, V23, P3512, DOI 10.1016/j.celrep.2018.05.057; Renkema KR, 2014, J IMMUNOL, V192, P151, DOI 10.4049/jimmunol.1301453; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; Smith NL, 2018, CELL, V174, P117, DOI 10.1016/j.cell.2018.05.029; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; White JT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11291	14	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					499	500		10.1038/s41590-020-0668-7	http://dx.doi.org/10.1038/s41590-020-0668-7		APR 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32284592				2022-12-18	WOS:000526627600005
J	Sun, SC				Sun, Shao-Cong			A20 restricts inflammation via ubiquitin binding	NATURE IMMUNOLOGY			English	Editorial Material							NF-KAPPA-B; CELL-DEATH	The ubiquitin-editing enzyme A20 has a pivotal role in restricting autoimmune and inflammatory responses. New studies suggest that A20 prevents inflammatory diseases using a non-catalytic mechanism involving ubiquitin binding.	[Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sun, Shao-Cong] MD Anderson UT Hlth Grad Sch, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sun, SC (corresponding author), MD Anderson UT Hlth Grad Sch, Houston, TX 77030 USA.	ssun@mdanderson.org		Sun, Shao-Cong/0000-0001-7353-9400				De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Martens A, 2020, NAT IMMUNOL, V21, P381, DOI 10.1038/s41590-020-0621-9; Martens A, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036418; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Razani B, 2020, NAT IMMUNOL, V21, P422, DOI 10.1038/s41590-020-0634-4; Sasaki K, 2015, IMMUNOL REV, V266, P175, DOI 10.1111/imr.12308; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015	12	4	5	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					362	364		10.1038/s41590-020-0632-6	http://dx.doi.org/10.1038/s41590-020-0632-6		MAR 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205879				2022-12-18	WOS:000519843600005
J	Horton, BL; Spranger, S				Horton, Brendan L.; Spranger, Stefani			CD36-the Achilles' heel of T-reg cells	NATURE IMMUNOLOGY			English	Editorial Material							APOPTOSIS	Regulatory T (T-reg) cells suppress antitumor immunity, but T-reg cell inhibition has been hampered by a lack of specific targets. CD36 expression by tumor-infiltrating T-reg cells may provide a way to specifically target T-reg cells in tumors.	[Horton, Brendan L.; Spranger, Stefani] MIT, Koch Inst Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Spranger, Stefani] MIT, Biol Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Spranger, Stefani] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Spranger, S (corresponding author), MIT, Koch Inst Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Spranger, S (corresponding author), MIT, Biol Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Spranger, S (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	Spranger@mit.edu		Spranger, Stefani/0000-0003-3257-4546	NCI NIH HHS [R00 CA204595] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Field CS, 2020, CELL METAB, V31, P422, DOI 10.1016/j.cmet.2019.11.021; Horton BL, 2018, CANCER IMMUNOL RES, V6, P14, DOI 10.1158/2326-6066.CIR-17-0249; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Maj T, 2017, NAT IMMUNOL, V18, P1332, DOI 10.1038/ni.3868; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sharma A, 2019, CLIN CANCER RES, V25, P1233, DOI 10.1158/1078-0432.CCR-18-0762; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	12	4	4	4	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					251	253		10.1038/s41590-020-0601-0	http://dx.doi.org/10.1038/s41590-020-0601-0		FEB 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066948				2022-12-18	WOS:000514067400004
J	Mori, L; De Libero, G				Mori, Lucia; De Libero, Gennaro			'Bohemian Rhapsody' of MR1T cells	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS	A T cell recognizing the MHC class I-related molecule MR1, expressed by a wide range of cancer cell types, might have great potential for adoptive cell therapy in cancer.	[Mori, Lucia; De Libero, Gennaro] Univ Basel, Expt Immunol, Dept Biomed, Basel, Switzerland; [Mori, Lucia; De Libero, Gennaro] Univ Hosp Basel, Basel, Switzerland	University of Basel; University of Basel	Mori, L (corresponding author), Univ Basel, Expt Immunol, Dept Biomed, Basel, Switzerland.; Mori, L (corresponding author), Univ Hosp Basel, Basel, Switzerland.	lucia.mori@unibas.ch	; De Libero, Gennaro/P-2694-2017	Mori, Lucia/0000-0002-5522-4648; De Libero, Gennaro/0000-0003-0853-7868				Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Crowther MD, 2020, NAT IMMUNOL, V21, P178, DOI 10.1038/s41590-019-0578-8; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Gold MC, 2014, J EXP MED, V211, P1601, DOI 10.1084/jem.20140507; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10198-w; Lepore M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01365; Lepore M, 2017, ELIFE, V6, DOI 10.7554/eLife.24476; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Meermeier EW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12506; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433	14	4	4	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					108	110		10.1038/s41590-019-0588-6	http://dx.doi.org/10.1038/s41590-019-0588-6		JAN 2020	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31959981				2022-12-18	WOS:000508964100004
J	Lee, S; Baldridge, MT				Lee, Sanghyun; Baldridge, Megan T.			Viruses RIG up intestinal immunity	NATURE IMMUNOLOGY			English	Editorial Material								The virome, increasingly recognized as a critical component of the mammalian microbiota, modulates host physiology. An antiviral treatment approach reveals that, via RIG-I signaling, the commensal virome is essential for the homeostasis of intestinal intraepithelial lymphocytes.	[Lee, Sanghyun; Baldridge, Megan T.] Washington Univ, Sch Med, Dept Med, Div Infect Dis,Edison Family Ctr Genome Sci & Sys, St Louis, MO 63110 USA	Washington University (WUSTL)	Baldridge, MT (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis,Edison Family Ctr Genome Sci & Sys, St Louis, MO 63110 USA.	mbaldridge@wustl.edu	Baldridge, Megan/T-7274-2019	Baldridge, Megan/0000-0002-7030-6131				Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Burgener EB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9748; Ingle H, 2019, NAT MICROBIOL, V4, P1120, DOI 10.1038/s41564-019-0416-7; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002; Liu L, 2019, NAT IMMUNOL, V20, P1681, DOI 10.1038/s41590-019-0513-z; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Sweere JM, 2019, SCIENCE, V363, P1416, DOI 10.1126/science.aat9691; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009	11	4	4	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1563	1564		10.1038/s41590-019-0530-y	http://dx.doi.org/10.1038/s41590-019-0530-y			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31636465				2022-12-18	WOS:000497949800009
J	Der, E; Suryawanshi, H; Morozov, P; Kustagi, M; Goilav, B; Ranabothu, S; Izmirly, P; Clancy, R; Belmont, HM; Koenigsberg, M; Mokrzycki, M; Rominieki, H; Graham, JA; Rocca, JP; Bornkamp, N; Jordan, N; Schulte, E; Wu, M; Pullman, J; Slowikowski, K; Raychaudhuri, S; Guthridge, J; James, J; Buyon, J; Tuschl, T; Putterman, C				Der, Evan; Suryawanshi, Hemant; Morozov, Pavel; Kustagi, Manjunath; Goilav, Beatrice; Ranabothu, Saritha; Izmirly, Peter; Clancy, Robert; Belmont, H. Michael; Koenigsberg, Mordecai; Mokrzycki, Michele; Rominieki, Helen; Graham, Jay A.; Rocca, Juan P.; Bornkamp, Nicole; Jordan, Nicole; Schulte, Emma; Wu, Ming; Pullman, James; Slowikowski, Kamil; Raychaudhuri, Soumya; Guthridge, Joel; James, Judith; Buyon, Jill; Tuschl, Thomas; Putterman, Chaim		Accelerating Med Partnership	Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways (vol 20, pg 915, 2019)	NATURE IMMUNOLOGY			English	Correction													Putterman, Chaim/AFR-0429-2022; Rocca, Juan/AAB-7007-2022; Rocca, Juan Pablo/AAU-3771-2020; Morozov, Pavel/GQP-7206-2022; Graham, Jay/AAL-5732-2020; Goilav, Beatrice/AAF-8349-2021	Rocca, Juan Pablo/0000-0002-1146-237X; Graham, Jay/0000-0003-2054-1253; Kalunian, Kenneth/0000-0003-0261-3102; Raychaudhuri, Soumya/0000-0002-1901-8265; Izmirly, Peter/0000-0001-5445-2182; Buyon, Jill/0000-0002-3852-7129; Belmont, Howard/0000-0003-3389-2976; Cunningham, Melissa/0000-0002-9207-1986	NIAMS NIH HHS [UH2 AR067689, UM2 AR067678] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Der E, 2019, NAT IMMUNOL, V20, P915, DOI 10.1038/s41590-019-0386-1	1	4	5	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1556	1556		10.1038/s41590-019-0529-4	http://dx.doi.org/10.1038/s41590-019-0529-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31605099	Bronze, Green Accepted			2022-12-18	WOS:000492309600028
J	Zhang, DW; Yue, T; Choi, JH; Nair-Gill, E; Zhong, X; Wang, KW; Zhan, XM; Li, XH; Choi, MW; Tang, M; Quan, JX; Hildebrand, S; Moresco, EMY; Beutler, B				Zhang, Duanwu; Yue, Tao; Choi, Jin Huk; Nair-Gill, Evan; Zhong, Xue; Wang, Kuan-wen; Zhan, Xiaoming; Li, Xiaohong; Choi, Mihwa; Tang, Miao; Quan, Jiexia; Hildebrand, Sara; Moresco, Eva Marie Y.; Beutler, Bruce			Syndromic immune disorder caused by a viable hypomorphic allele of spliceosome component Snrnp40	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; NATURAL-KILLER-CELLS; U5 SNRNP; GENE ONTOLOGY; C-TERMINUS; PROTEIN; RNA; THEMIS; REVEALS; ROLES	We report a new immunodeficiency disorder in mice caused by a viable hypomorphic mutation of Snrnp40, an essential gene encoding a subunit of the U5 small nuclear ribonucleoprotein (snRNP) complex of the spliceosome. Snrnp40 is ubiquitous but strongly expressed in lymphoid tissue. Homozygous mutant mice showed hypersusceptibility to infection by murine cytomegalovirus and multiple defects of lymphoid development, stability and function. Cell-intrinsic defects of hematopoietic stem cell differentiation also affected homozygous mutants. SNRNP40 deficiency in primary hematopoietic stem cells or T cells or the EL4 cell line increased the frequency of splicing errors, mostly intron retention, in several hundred messenger RNAs. Altered expression of proteins associated with immune cell function was also observed in Snrnp40-mutant cells. The immunological consequences of SNRNP40 deficiency presumably result from cumulative, moderate effects on processing of many different mRNA molecules and secondary reductions in the expression of critical immune proteins, yielding a syndromic immune disorder.	[Zhang, Duanwu; Yue, Tao; Choi, Jin Huk; Nair-Gill, Evan; Zhong, Xue; Wang, Kuan-wen; Zhan, Xiaoming; Li, Xiaohong; Choi, Mihwa; Tang, Miao; Quan, Jiexia; Hildebrand, Sara; Moresco, Eva Marie Y.; Beutler, Bruce] Univ Texas Southwestern Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Beutler, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA.	Bruce.Beutler@UTSouthwestern.edu	Zhang, Duanwu/AAH-1627-2020; li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	Zhang, Duanwu/0000-0003-2946-846X; Moresco, Eva Marie/0000-0002-2049-7291; Nair-Gill, Evan/0000-0002-9876-7853	National Institutes of Health [AI100627, AI125581, GM067759]; Rheumatology Research Foundation Tobe and Stephen E. Malawista, MD Endowment in Academic Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, R01AI125581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatology Research Foundation Tobe and Stephen E. Malawista, MD Endowment in Academic Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants (nos. AI100627, AI125581 and GM067759 to B.B.).Funding for this project was provided by the Rheumatology Research Foundation Tobe and Stephen E. Malawista, MD Endowment in Academic Rheumatology (to E. N.-G.).	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Bar E, 2014, IMMUNITY, V40, P117, DOI 10.1016/j.immuni.2013.12.002; Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Brenner TJ, 2005, GENETICS, V170, P1063, DOI 10.1534/genetics.105.042044; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chiara MD, 1997, EMBO J, V16, P4746, DOI 10.1093/emboj/16.15.4746; Clements JL, 2006, J IMMUNOL, V177, P905, DOI 10.4049/jimmunol.177.2.905; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Foudi A, 2014, J EXP MED, V211, P909, DOI 10.1084/jem.20131065; Fu G, 2013, NATURE, V504, P441, DOI 10.1038/nature12718; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Higuchi T, 2007, MOL CELL BIOL, V27, P3353, DOI 10.1128/MCB.01871-06; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Inoue D, 2016, GENE DEV, V30, P989, DOI 10.1101/gad.278424.116; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Kurtovic-Kozaric A, 2015, LEUKEMIA, V29, P126, DOI 10.1038/leu.2014.144; Laggerbauer B, 2005, RNA, V11, P598, DOI 10.1261/rna.2300805; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Papasaikas P, 2015, MOL CELL, V57, P7, DOI 10.1016/j.molcel.2014.10.030; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Reyes J, 1996, RNA, V2, P213; Rieger MA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008250; Ruzickova S, 2017, RNA BIOL, V14, P544, DOI 10.1080/15476286.2016.1191735; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; TEIGELKAMP S, 1995, NUCLEIC ACIDS RES, V23, P320, DOI 10.1093/nar/23.3.320; TEIGELKAMP S, 1995, EMBO J, V14, P2602, DOI 10.1002/j.1460-2075.1995.tb07258.x; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Turner IA, 2004, BIOCHEM SOC T, V32, P928, DOI 10.1042/BST0320928; UMEN JG, 1995, GENE DEV, V9, P855, DOI 10.1101/gad.9.7.855; Vassen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096636; Verma B, 2018, SEMIN CELL DEV BIOL, V79, P103, DOI 10.1016/j.semcdb.2017.09.036; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02806-4; Wang T, 2015, P NATL ACAD SCI USA, V112, pE440, DOI 10.1073/pnas.1423216112; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; White RA, 2009, BLOOD CELL MOL DIS, V43, P141, DOI 10.1016/j.bcmd.2009.03.009; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542	53	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1322	+		10.1038/s41590-019-0464-4	http://dx.doi.org/10.1038/s41590-019-0464-4			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31427773	Green Accepted			2022-12-18	WOS:000486615900016
J	Pernis, AB; Ivashkiv, LB				Pernis, Alessandra B.; Ivashkiv, Lionel B.			'-Omics' shed light on B cells in lupus	NATURE IMMUNOLOGY			English	Editorial Material							POPULATION		[Pernis, Alessandra B.; Ivashkiv, Lionel B.] Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA; [Pernis, Alessandra B.; Ivashkiv, Lionel B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Pernis, Alessandra B.; Ivashkiv, Lionel B.] Weill Cornell Med, Dept Med, New York, NY 10065 USA; [Pernis, Alessandra B.; Ivashkiv, Lionel B.] Weill Cornell Med, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA	Cornell University; Cornell University	Pernis, AB (corresponding author), Hosp Special Surg, Res Inst, 535 E 70th St, New York, NY 10021 USA.; Pernis, AB (corresponding author), Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA.; Pernis, AB (corresponding author), Weill Cornell Med, Dept Med, New York, NY 10065 USA.; Pernis, AB (corresponding author), Weill Cornell Med, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.	pernisa@hss.edu		Ivashkiv, Lionel/0000-0002-9951-0646; Pernis, Alessandra/0000-0001-8259-1446				Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Der E, 2019, NAT IMMUNOL, V20, P915, DOI 10.1038/s41590-019-0386-1; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Karnell JL, 2017, CELL IMMUNOL, V321, P40, DOI 10.1016/j.cellimm.2017.05.008; Kuo D, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau8587; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Manni M, 2018, NAT IMMUNOL, V19, P407, DOI 10.1038/s41590-018-0056-8; Myles A, 2019, CURR OPIN IMMUNOL, V57, P40, DOI 10.1016/j.coi.2019.01.002; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Rubtsova K, 2015, J IMMUNOL, V195, P1933, DOI 10.4049/jimmunol.1501209; Scharer CD, 2019, NAT IMMUNOL, V20, P1071, DOI 10.1038/s41590-019-0419-9; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	15	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					946	948		10.1038/s41590-019-0446-6	http://dx.doi.org/10.1038/s41590-019-0446-6			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31285628				2022-12-18	WOS:000476621200006
J	Dempsey, LA				Dempsey, Laurie A.			ADIPOSE-TISSUE HOMEOSTASIS Fat IL-33 sources	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					776	776		10.1038/s41590-019-0439-5	http://dx.doi.org/10.1038/s41590-019-0439-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31213722	Bronze			2022-12-18	WOS:000471891900008
J	Visan, I				Visan, Ioana			Mapping IL-1 in the brain	NATURE IMMUNOLOGY			English	Editorial Material																			0	4	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					245	245		10.1038/s41590-019-0337-x	http://dx.doi.org/10.1038/s41590-019-0337-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30778247				2022-12-18	WOS:000458893600001
J	Wiser, C; Kim, B; Ascano, M				Wiser, Caroline; Kim, Byungil; Ascano, Manuel			G3BP1 enhances cytoplasmic DNA pattern recognition	NATURE IMMUNOLOGY			English	Editorial Material								The stress-granule protein G3BP1 forms a high-molecular-weight protein complex with the sensor cGAS and enhances its detection of cytoplasmic DNA.	[Wiser, Caroline; Kim, Byungil; Ascano, Manuel] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Ascano, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	manuel.ascano@vanderbilt.edu	Ascano, Manuel/ABA-3586-2020	Ascano, Manuel/0000-0002-9370-5493; Kim, Byungil/0000-0002-1743-2657	NIGMS NIH HHS [R35 GM119569] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119569] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam U, 2019, BBA-MOL CELL RES, V1866, P360, DOI 10.1016/j.bbamcr.2018.09.001; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dhanwani R, 2018, CURR OPIN IMMUNOL, V50, P82, DOI 10.1016/j.coi.2017.11.004; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kuzuhara T, 2006, J BIOL CHEM, V281, P17446, DOI 10.1074/jbc.M601196200; Liu, 2018, NAT IMMUNOL, DOI [10.1038/s41590-018-0262-4, DOI 10.1038/S41590-018-0262-4]; Ohishi Tomokazu, 2016, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V15, P74, DOI 10.2174/1871523015666160915154443; Reineke LC, 2015, J VIROL, V89, P2575, DOI 10.1128/JVI.02791-14; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185	13	4	4	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					5	7		10.1038/s41590-018-0279-8	http://dx.doi.org/10.1038/s41590-018-0279-8			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538338				2022-12-18	WOS:000456273900008
J	Vivier, E; Vely, F; Fischer, A				Vivier, Eric; Vely, Frederic; Fischer, Alain			Reply to 'Comment on: Evidence of innate lymphoid cell redundancy in humans'	NATURE IMMUNOLOGY			English	Letter							CUTANEOUS PAPILLOMAVIRUS DISEASE; SEVERE COMBINED IMMUNODEFICIENCY; GROWTH-RETARDATION; DENDRITIC-CELL; DEFICIENCY; TRANSPLANTATION; INFECTION; MUTATIONS; RECEPTOR		[Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France; [Vivier, Eric; Vely, Frederic] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Vivier, Eric; Vely, Frederic] Hop La Timone, Serv Immunol, AP HM, Marseille Immunopole, Marseille, France; [Fischer, Alain] Hop Univ Necker Enfants Malad, AP HP, Ctr Reference Deficits Immunitaires Hereditaires, Paris, France; [Fischer, Alain] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [Fischer, Alain] INSERM, U1163, Paris, France; [Fischer, Alain] Hop Univ Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Fischer, Alain] Coll France, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Vivier, E (corresponding author), Innate Pharma, Innate Pharma Res Labs, Marseille, France.; Vivier, E (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.; Vivier, E (corresponding author), Hop La Timone, Serv Immunol, AP HM, Marseille Immunopole, Marseille, France.; Fischer, A (corresponding author), Hop Univ Necker Enfants Malad, AP HP, Ctr Reference Deficits Immunitaires Hereditaires, Paris, France.; Fischer, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France.; Fischer, A (corresponding author), INSERM, U1163, Paris, France.; Fischer, A (corresponding author), Hop Univ Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France.; Fischer, A (corresponding author), Coll France, Paris, France.	vivier@ciml.univ-mrs.fr; alain.fischer@aphp.fr	Vivier, Eric/F-8939-2010; Vély, Frédéric/HHM-3894-2022	Vivier, Eric/0000-0001-7022-8287; 				Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cottineau J, 2017, J CLIN INVEST, V127, P1991, DOI 10.1172/JCI90727; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Fischer A, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah5861; Gaspar HB, 2004, BRIT J HAEMATOL, V127, P232, DOI 10.1111/j.1365-2141.2004.05176.x; Gineau L, 2012, J CLIN INVEST, V122, P821, DOI 10.1172/JCI61014; Goldschmidt MH, 2006, J VIROL, V80, P6621, DOI 10.1128/JVI.02571-05; Grier JT, 2012, J CLIN INVEST, V122, P3769, DOI 10.1172/JCI64837; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Kamili QUA, 2014, J ALLERGY CLIN IMMUN, V134, P1451, DOI 10.1016/j.jaci.2014.07.009; Laffort C, 2004, LANCET, V363, P2051, DOI 10.1016/S0140-6736(04)16457-X; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; Orange JS, 2018, NAT IMMUNOL, V19, P788, DOI 10.1038/s41590-018-0164-5; Touzot F, 2016, BLOOD ADV, V1, P36, DOI 10.1182/bloodadvances.2016001313; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553	16	4	4	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					789	790		10.1038/s41590-018-0165-4	http://dx.doi.org/10.1038/s41590-018-0165-4			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30026478				2022-12-18	WOS:000439470900013
J	Dempsey, LA				Dempsey, Laurie A.			Immunoregulatory itaconate	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	4	4	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					511	511		10.1038/s41590-018-0123-1	http://dx.doi.org/10.1038/s41590-018-0123-1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777218	Bronze			2022-12-18	WOS:000433041500009
J	Zou, YR; Davidson, A				Zou, Yong-Rui; Davidson, Anne			Age-associated B cells acquire a new wrinkle	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNITY; LUPUS; SLE		[Zou, Yong-Rui; Davidson, Anne] Feinstein Inst Med Res, Ctr Autoimmun Musculoskeletal & Hematol Dis, Manhasset, NY 11030 USA	Northwell Health	Davidson, A (corresponding author), Feinstein Inst Med Res, Ctr Autoimmun Musculoskeletal & Hematol Dis, Manhasset, NY 11030 USA.	adavidsonl@northwell.edu						Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Karnell JL, 2017, CELL IMMUNOL, V321, P40, DOI 10.1016/j.cellimm.2017.05.008; Knode LMR, 2017, J IMMUNOL, V198, P1921, DOI 10.4049/jimmunol.1601106; Lazzari E, 2014, CLIN IMMUNOL, V153, P343, DOI 10.1016/j.clim.2014.06.001; Manni M., 2018, NAT IMMUNOL, DOI [10.1038/s4l590-0180056-8, DOI 10.1038/S4L590-0180056-8]; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Sun C, 2016, NAT GENET, V48, P323, DOI 10.1038/ng.3496; Watkins AA, 2015, J IMMUNOL, V194, P1467, DOI 10.4049/jimmunol.1402807	11	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					317	318		10.1038/s41590-018-0072-8	http://dx.doi.org/10.1038/s41590-018-0072-8			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563629				2022-12-18	WOS:000428151000008
J	Zhang, CC; Fu, YX				Zhang, Cheng Cheng; Fu, Yang-Xin			Another way to not get eaten	NATURE IMMUNOLOGY			English	Editorial Material							LEUKEMIA DEVELOPMENT; IMMUNE CHECKPOINT; DENDRITIC CELLS; TUMOR; CD47		[Zhang, Cheng Cheng] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX USA; [Fu, Yang-Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fu, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	yang-xin.fu@utsouthwestern.edu	Zhang, Cheng/GRS-8698-2022					Barkal A. A., 2017, NAT IMMUNOL; de Goeje PL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1014242; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Kang XL, 2016, CELL CYCLE, V15, P25, DOI 10.1080/15384101.2015.1121324; Kang XL, 2015, NAT CELL BIOL, V17, P665, DOI 10.1038/ncb3158; Liu XJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0381-z; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; Suciu-Foca N, 2007, J IMMUNOL, V178, P7432, DOI 10.4049/jimmunol.178.11.7432; Weiskopf K, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0031-2016; Xu MM, 2017, IMMUNITY, V47, P363, DOI 10.1016/j.immuni.2017.07.016; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	13	4	4	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					6	7		10.1038/s41590-017-0009-7	http://dx.doi.org/10.1038/s41590-017-0009-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29242546				2022-12-18	WOS:000419765300007
J	Petersone, L; Walker, LSK				Petersone, Lina; Walker, Lucy S. K.			MAIT cells in type 1 diabetes: a good friend turned bad	NATURE IMMUNOLOGY			English	Editorial Material							INVARIANT T-CELLS; MR1; MICROBIOTA; ONSET	Mucosal-associated invariant T cells (MAIT cells) normally preserve gut-barrier integrity but can switch their phenotype to have a pathogenic role in type 1 diabetes.	[Petersone, Lina; Walker, Lucy S. K.] UCL, Div Infect & Immun, Inst Immun & Transplantat, Royal Free Campus, London, England	University of London; University College London	Walker, LSK (corresponding author), UCL, Div Infect & Immun, Inst Immun & Transplantat, Royal Free Campus, London, England.	lucy.walker@ucl.ac.uk		Petersone, Lina/0000-0001-8571-9185; Walker, Lucy/0000-0001-5986-5015	Medical Research Council [1637487] Funding Source: researchfish; MRC [MR/N001435/1] Funding Source: UKRI; Medical Research Council [MR/N001435/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Costa FRC, 2016, J EXP MED, V213, P1223, DOI 10.1084/jem.20150744; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; Paun A, 2017, J IMMUNOL, V198, P590, DOI 10.4049/jimmunol.1601519; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Rouxel O, 2017, NAT IMMUNOL, V18, P1321, DOI 10.1038/ni.3854; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653	12	4	5	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1283	1285		10.1038/ni.3869	http://dx.doi.org/10.1038/ni.3869			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144503	Green Submitted			2022-12-18	WOS:000415324900005
J	Dale, GA; Shartouny, JR; Jacob, J				Dale, Gordon A.; Shartouny, Jessica R.; Jacob, Joshy			Quantifying the shifting landscape of B cell immunodominance	NATURE IMMUNOLOGY			English	Editorial Material							ANTIBODY-RESPONSES; INFLUENZA VACCINE; VIRUSES; HUMANS	Antibodies to neutralizing epitopes on hemagglutinin exhibit reproducible dynamic immunodominance patterns over time. Early responses target largely the Cb site, followed by Sb dominance and a concomitant rise in the diversity of neutralizing-antibody specificities.	[Dale, Gordon A.; Shartouny, Jessica R.; Jacob, Joshy] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Dale, Gordon A.; Shartouny, Jessica R.; Jacob, Joshy] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Jacob, J (corresponding author), Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.; Jacob, J (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	jjacob3@emory.edu						Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; Cao RG, 2014, J INFECT DIS, V210, P224, DOI 10.1093/infdis/jiu079; Cho A, 2016, CURR OPIN VIROL, V17, P110, DOI 10.1016/j.coviro.2016.03.002; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Fan X, 2015, MUCOSAL IMMUNOL, V8, P211, DOI 10.1038/mi.2014.59; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Tan YC, 2014, CLIN IMMUNOL, V151, P55, DOI 10.1016/j.clim.2013.12.008	9	4	4	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					367	368		10.1038/ni.3695	http://dx.doi.org/10.1038/ni.3695			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323262				2022-12-18	WOS:000396815800002
J	Gringhuis, SI; Hertoghs, N; Kaptein, TM; Zijlstra-Willems, EM; Sarrami-Fooroshani, R; Sprokholt, JK; van Teijlingen, NH; Kootstra, NA; Booiman, T; van Dort, KA; Ribeiro, CMS; Drewniak, A; Geijtenbeek, TBH				Gringhuis, Sonja I.; Hertoghs, Nina; Kaptein, Tanja M.; Zijlstra-Willems, Esther M.; Sarrami-Fooroshani, Ramin; Sprokholt, Joris K.; van Teijlingen, Nienke H.; Kootstra, Neeltje A.; Booiman, Thijs; van Dort, Karel A.; Ribeiro, Carla M. S.; Drewniak, Agata; Geijtenbeek, Teunis B. H.			HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3 (vol 18, pg 225, 2017)	NATURE IMMUNOLOGY			English	Correction														Sprokholt, Joris/0000-0001-8104-0028; hertoghs, nina/0000-0002-9294-6586; Gringhuis, Sonja/0000-0003-0383-4978				Gringhuis SI, 2017, NAT IMMUNOL, V18, P225, DOI 10.1038/ni.3647	1	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					474	474		10.1038/ni0417-474c	http://dx.doi.org/10.1038/ni0417-474c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323255	Bronze			2022-12-18	WOS:000396815800017
J	Dempsey, LA				Dempsey, Laurie A.			Neurophils aid successful pregnancy	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					151	151		10.1038/ni.3674	http://dx.doi.org/10.1038/ni.3674			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB8OX	28102213				2022-12-18	WOS:000406399400006
J	Pandit, A; Meyaard, L; Radstake, TRDJ				Pandit, Aridaman; Meyaard, Linde; Radstake, Timothy R. D. J.			Is sex bias orchestrated in the skin?	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE-RESPONSES; DISEASE; GENDER; CELL	The identification of VGLL3 as a transcription (co-)factor that underlies the sex bias of the human immune system further underscores the relevance of research into this area.	[Pandit, Aridaman; Radstake, Timothy R. D. J.] Univ Utrecht, Med Ctr, Dept Rheumatol & Clin Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Meyaard, Linde] Univ Utrecht, Med Ctr, Lab Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University	Radstake, TRDJ (corresponding author), Univ Utrecht, Med Ctr, Dept Rheumatol & Clin Immunol, Lab Translat Immunol, Utrecht, Netherlands.	t.r.d.j.radstake@umcutrecht.nl	Pandit, Aridaman/ABH-1221-2021	Pandit, Aridaman/0000-0003-2057-9737; Meyaard, Linde/0000-0003-0707-4793	ReumaFonds [14-2-201] Funding Source: researchfish	ReumaFonds		Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kong BY, 2016, J INVEST DERMATOL, V136, P12, DOI 10.1038/JID.2015.298; Liang Y, 2017, NAT IMMUNOL, V18, P152, DOI 10.1038/ni.3643; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Seillet C, 2012, BLOOD, V119, P454, DOI 10.1182/blood-2011-08-371831; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	12	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					142	143		10.1038/ni.3658	http://dx.doi.org/10.1038/ni.3658			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102210				2022-12-18	WOS:000392360900005
J	[Anonymous]				[Anonymous]			Neuroimmune communication	NATURE IMMUNOLOGY			English	Editorial Material								We present a special set of Review articles on neuroimmune communication that highlight how the immune system and nervous system are anatomically connected, mechanistically communicate and reciprocally influence the other's function.						Dempsey, Laurie/0000-0002-3304-796X					0	4	4	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					115	115		10.1038/ni.3676	http://dx.doi.org/10.1038/ni.3676			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28092377	Bronze			2022-12-18	WOS:000392360900001
J	Holmbeck, MA; Shadel, GS				Holmbeck, Marissa A.; Shadel, Gerald S.			Mitochondria provide a 'complex' solution to a bacterial problem	NATURE IMMUNOLOGY			English	Editorial Material							INNATE; ACTIVATION; IMMUNITY; ROS	Adaptations in the mitochondrial electron-transport chain mediate antibacterial responses in macrophages.	[Holmbeck, Marissa A.; Shadel, Gerald S.] Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Shadel, Gerald S.] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA; [Shadel, Gerald S.] Yale Ctr Res Aging, New Haven, CT 06520 USA	Yale University; Yale University	Shadel, GS (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Shadel, GS (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Shadel, GS (corresponding author), Yale Ctr Res Aging, New Haven, CT 06520 USA.	gerald.shadel@yale.edu						Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Andrade WA, 2016, CELL REP, V15, P2438, DOI 10.1016/j.celrep.2016.05.030; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Jabir MS, 2015, AUTOPHAGY, V11, P166, DOI 10.4161/15548627.2014.981915; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	12	4	4	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1009	1010		10.1038/ni.3534	http://dx.doi.org/10.1038/ni.3534			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27540983				2022-12-18	WOS:000381832000002
J	Bjorklund, AK; Forkel, M; Picelli, S; Konya, V; Theorell, J; Friberg, D; Sandberg, R; Mjosberg, J				Bjorklund, Asa K.; Forkel, Marianne; Picelli, Simone; Konya, Viktoria; Theorell, Jakob; Friberg, Danielle; Sandberg, Rickard; Mjosberg, Jenny			The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing (vol 17, pg 451, 2016)	NATURE IMMUNOLOGY			English	Correction																		Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368	1	4	5	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					740	740		10.1038/ni0616-740a	http://dx.doi.org/10.1038/ni0616-740a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK		Bronze			2022-12-18	WOS:000376162200019
J	Mumford, MD; Watts, LL; Medeiros, KE; Mulhearn, TJ; Steele, LM; Connelly, S				Mumford, Michael D.; Watts, Logan L.; Medeiros, Kelsey E.; Mulhearn, Tyler J.; Steele, Logan M.; Connelly, Shane			Biomedical ethics education may benefit from integrating compliance and analysis approaches	NATURE IMMUNOLOGY			English	Editorial Material							SENSEMAKING APPROACH; DECISION-MAKING; RESPONSIBLE CONDUCT; INSTRUCTION; SCIENCES; PROGRAM	Two approaches have been widely applied in ethics education in the biomedical sciences: field-specific compliance and professional decision processes. Both approaches offer unique benefits to trainees, but future courses that integrate these two approaches might prove particularly valuable.	[Mumford, Michael D.; Watts, Logan L.; Medeiros, Kelsey E.; Mulhearn, Tyler J.; Steele, Logan M.; Connelly, Shane] Univ Oklahoma, Ctr Appl Social Res, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Mumford, MD (corresponding author), Univ Oklahoma, Ctr Appl Social Res, Norman, OK 73019 USA.	mmumford@ou.edu	Watts, Logan L./I-5332-2019	Watts, Logan L./0000-0001-7629-0188; Medeiros, Kelsey/0000-0002-7388-3970; Steele, Logan/0000-0002-1377-3147				Antes AL, 2010, ACAD MED, V85, P519, DOI 10.1097/ACM.0b013e3181cd1cc5; Antes AL, 2009, ETHICS BEHAV, V19, P379, DOI 10.1080/10508420903035380; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Brock ME, 2008, SCI ENG ETHICS, V14, P449, DOI 10.1007/s11948-008-9076-3; Cho KC, 2014, NURS ETHICS, V21, P484, DOI 10.1177/0969733013505310; Chung EK, 2009, MED TEACH, V31, P1013, DOI 10.3109/01421590802590553; DuBois JM, 2008, ACAD MED, V83, P596, DOI 10.1097/ACM.0b013e3181723095; Ericsson KA, 2009, DEVELOPMENT OF PROFESSIONAL EXPERTISE: TOWARD MEASUREMENT OF EXPERT PERFORMANCE AND DESIGN OF OPTIMAL LEARNING ENVIRONMENTS, P1, DOI 10.1017/CBO9780511609817; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kligyte V, 2008, SCI ENG ETHICS, V14, P251, DOI 10.1007/s11948-007-9048-z; McCormack WT, 2014, ACCOUNT RES, V21, P34, DOI 10.1080/08989621.2013.822267; Mumford MD, 2000, LEADERSHIP QUART, V11, P11, DOI 10.1016/S1048-9843(99)00041-7; Mumford MD, 2006, ETHICS BEHAV, V16, P319, DOI 10.1207/s15327019eb1604_4; Mumford MD, 2015, ETHICS BEHAV, V25, P37, DOI 10.1080/10508422.2014.917417; Mumford MD, 2012, J CREATIVE BEHAV, V46, P30, DOI 10.1002/jocb.003; Mumford M, 2008, ETHICS BEHAV, V18, P315, DOI 10.1080/10508420802487815; van Kolfschooten F, 2002, NATURE, V416, P360, DOI 10.1038/416360a	17	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					605	608		10.1038/ni.3465	http://dx.doi.org/10.1038/ni.3465			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	DM2FK	27196509				2022-12-18	WOS:000376162200001
J	Ng, CP; Littman, DR				Ng, Charles P.; Littman, Dan R.			Tcf1 and Lef1 pack their own HDAC	NATURE IMMUNOLOGY			English	Editorial Material							CD4 EXPRESSION	The transcription factors Tcf1 and Lef1 have intrinsic histone-deacetylase activity that is required for the repression of CD4(+) T cell-lineage genes in CD8(+) T cells.	[Ng, Charles P.; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA	New York University; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA.; Littman, DR (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA.	dan.littman@med.nyu.edu			NIGMS NIH HHS [T32 GM007308] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boucheron N, 2014, NAT IMMUNOL, V15, P439, DOI 10.1038/ni.2864; Grausenburger R, 2010, J IMMUNOL, V185, P3489, DOI 10.4049/jimmunol.0903610; Henson DM, 2014, J IMMUNOL, V192, P4620, DOI 10.4049/jimmunol.1302374; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Sellars M, 2015, NAT IMMUNOL, V16, P746, DOI 10.1038/ni.3198; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456	9	4	4	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					615	616		10.1038/ni.3469	http://dx.doi.org/10.1038/ni.3469			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27196513	Green Accepted			2022-12-18	WOS:000376162200005
J	Pritchard, GH; Cross, EW; Strobel, M; Jameson, SC; Kedl, RM; Hogquist, KA; Hunter, CA				Pritchard, Gretchen Harms; Cross, Eric W.; Strobel, Marjorie; Jameson, Stephen C.; Kedl, Ross M.; Hogquist, Kristin A.; Hunter, Christopher A.			Spontaneous partial loss of the OT-I transgene	NATURE IMMUNOLOGY			English	Letter							LISTERIA-MONOCYTOGENES INFECTION		[Pritchard, Gretchen Harms; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Cross, Eric W.; Kedl, Ross M.] Univ Colorado Denver, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Strobel, Marjorie] Jackson Lab, Anim Resources, 600 Main St, Bar Harbor, ME 04609 USA; [Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Pennsylvania; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Jackson Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146	NCI NIH HHS [P30 CA077598] Funding Source: Medline; NIAID NIH HHS [R01 AI066121, R01 AI038903, P01 AI035296, R01 AI041158, R01 AI101205, T32 AI007532, R01 AI110201, R01 AI117918, R01 AI126899] Funding Source: Medline; NIGMS NIH HHS [T32 GM008497] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066121, T32AI007532, R01AI038903, R01AI126899, R01AI041158, R01AI101205, R01AI110201, R01AI117918, P01AI035296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Condotta SA, 2012, ADV IMMUNOL, V113, P51, DOI 10.1016/B978-0-12-394590-7.00005-1; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Miyagawa F, 2010, J AUTOIMMUN, V35, P192, DOI 10.1016/j.jaut.2010.06.007; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Von Boehmer H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00424; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013	8	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					471	471		10.1038/ni.3411	http://dx.doi.org/10.1038/ni.3411			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	27092794	Bronze, Green Accepted			2022-12-18	WOS:000374323100001
J	Godfrey, DI; Uldrich, AP; McCluskey, J; Rossjohn, J; Moody, DB				Godfrey, Dale I.; Uldrich, Adam P.; McCluskey, James; Rossjohn, Jamie; Moody, D. Branch			The burgeoning family of unconventional T cells (vol 16, pg 1114, 2015)	NATURE IMMUNOLOGY			English	Correction													McCluskey, James/A-1291-2007; Uldrich, Adam/AAX-3785-2020	McCluskey, James/0000-0002-8597-815X; 	NIAID NIH HHS [R01 AI049313] Funding Source: Medline; NIAMS NIH HHS [R01 AR048632] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298	1	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					469	469		10.1038/ni0416-469a	http://dx.doi.org/10.1038/ni0416-469a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002846	Bronze			2022-12-18	WOS:000372508000022
J	[Anonymous]				[Anonymous]			A complex cell	NATURE IMMUNOLOGY			English	Editorial Material								New data redefine macrophages as diverse, polyfunctional and plastic cells that respond to the needs of the tissue at steady state and during disturbed homeostasis.											0	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					1	1						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681455	Bronze			2022-12-18	WOS:000366675800001
J	Kaye, J				Kaye, Jonathan			ILC development: TCF-1 reporting in	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS; DIFFERENTIATION; PROGENITOR; LINEAGES; TOX	The transcriptional regulator TCF-1 marks rare progenitor cells in adult bone marrow that have lost the potential to develop into the lymphocyte lineage but can give rise to all innate lymphoid cell lineages.	[Kaye, Jonathan] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Immunol Res, Los Angeles, CA 90048 USA; [Kaye, Jonathan] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kaye, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaye, J (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Div Immunol Res, Los Angeles, CA 90048 USA.	kayej@csmc.edu		Kaye, Jonathan/0000-0002-1634-9069	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054977] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406	12	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1011	1012		10.1038/ni.3276	http://dx.doi.org/10.1038/ni.3276			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26382863				2022-12-18	WOS:000361686500005
J	Peterson, P				Peterson, Paert			Sirt-ainly Aire	NATURE IMMUNOLOGY			English	Editorial Material							THYMIC EPITHELIAL-CELLS; AUTOIMMUNE REGULATOR; GENE-EXPRESSION; BINDING	Sirtuin-1 (Sirt1), a protein deacetylase known for its multiple cellular functions, including roles in metabolism, stress response and aging, is a post-translational modulator of autoimmune regulator (Aire) in central immunotolerance.	Univ Tartu, Inst Biomed & Translat Med, Mol Pathol Res Grp, EE-50090 Tartu, Estonia	University of Tartu	Peterson, P (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Mol Pathol Res Grp, Ulikooli 18, EE-50090 Tartu, Estonia.	part.peterson@ut.ee	Peterson, Pärt/A-5788-2009	Peterson, Pärt/0000-0001-6755-791X				Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Biason-Lauber A, 2013, CELL METAB, V17, P448, DOI 10.1016/j.cmet.2013.02.001; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Chuprin A, 2015, NAT IMMUNOL, V16, P737, DOI 10.1038/ni.3194; Gaetani M, 2012, NUCLEIC ACIDS RES, V40, P11756, DOI 10.1093/nar/gks933; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koh AS, 2010, P NATL ACAD SCI USA, V107, P13016, DOI 10.1073/pnas.1004436107; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Saare M, 2012, EXP CELL RES, V318, P1767, DOI 10.1016/j.yexcr.2012.04.013; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902	15	4	4	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					680	681		10.1038/ni.3195	http://dx.doi.org/10.1038/ni.3195			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086133				2022-12-18	WOS:000356445600001
J	Villarino, AV; Laurence, A				Villarino, Alejandro V.; Laurence, Arian			IL-1 watches the watchmen	NATURE IMMUNOLOGY			English	Editorial Material							RETINOIC ACID; DIFFERENTIATION; EXPRESSION; RESPONSES; CELLS		[Villarino, Alejandro V.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Laurence, Arian] Freeman Rd Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Newcastle Freeman Hospital; Newcastle University - UK	Villarino, AV (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	alejandro.villarino@nih.gov; arian.laurence@nuth.nhs.uk	Laurence, Arian/H-5534-2019; Laurence, Arian/A-8770-2009; Villarino, Alejandro/AAE-3517-2020	Laurence, Arian/0000-0003-0942-8292; Laurence, Arian/0000-0003-0942-8292; Villarino, Alejandro/0000-0001-8068-2176				Basu R, 2015, NAT IMMUNOL, V16, P286, DOI 10.1038/ni.3099; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	10	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					226	227		10.1038/ni.3105	http://dx.doi.org/10.1038/ni.3105			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689436				2022-12-18	WOS:000349842100005
J	Taylor, PR; Roy, S; Leal, SM; Sun, Y; Howell, SJ; Cobb, BA; Li, XX; Pearlman, E				Taylor, Patricia R.; Roy, Sanhita; Leal, Sixto M., Jr.; Sun, Yan; Howell, Scott J.; Cobb, Brian A.; Li, Xiaoxia; Pearlman, Eric			Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, ROR gamma t and dectin-2 (vol 14, pg 143, 2014)	NATURE IMMUNOLOGY			English	Correction																		Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797	1	4	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					214	214		10.1038/ni0215-214a	http://dx.doi.org/10.1038/ni0215-214a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ		Bronze			2022-12-18	WOS:000348143100014
J	Grainger, JR; Grencis, RK				Grainger, John R.; Grencis, Richard K.			Neutrophils worm their way into macrophage long-term memory	NATURE IMMUNOLOGY			English	Editorial Material							INFECTION; IMMUNITY; RESOLUTION; HELMINTHS; MONOCYTES	Neutrophil function is perhaps best studied in bacterial infection, during which they are directly involved in pathogen killing. After helminth invasion, however, neutrophils acquire an alternative transcriptional profile that allows them to 'train' macrophages to acquire long-term protective features.	[Grainger, John R.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England; [Grainger, John R.; Grencis, Richard K.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Grainger, JR (corresponding author), Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England.	john.grainger-2@manchester.ac.uk; richard.k.grencis@manchester.ac.uk		Grainger, John/0000-0002-4052-5923	Wellcome Trust [100290] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Africa C. M., 1931, Journal of Parasitology Urbana, V18, P1, DOI 10.2307/3271737; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Obata-Ninomiya K, 2013, J EXP MED, V210, P2583, DOI 10.1084/jem.20130761; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006	13	4	6	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					902	904		10.1038/ni.2990	http://dx.doi.org/10.1038/ni.2990			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25232812	Bronze			2022-12-18	WOS:000342564800003
J	Man, K; Kallies, A				Man, Kevin; Kallies, Axel			Bcl-6 gets T cells off the sugar	NATURE IMMUNOLOGY			English	Editorial Material							EFFECTOR RESPONSES; MEMORY; METABOLISM; ACTIVATION; REGULATOR	The transcriptional regulator Bcl-6 represses aerobic glycolysis in CD8(+) and CD4(+) type 1 helper T cells.	[Man, Kevin; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Man, K (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au		Kallies, Axel/0000-0002-6312-6968; Man, Kevin/0000-0002-6585-9532				Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; LaPensee CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097090; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	15	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					904	905		10.1038/ni.2993	http://dx.doi.org/10.1038/ni.2993			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25232813				2022-12-18	WOS:000342564800004
J	Karmaus, PWF; Chi, HB				Karmaus, Peer W. F.; Chi, Hongbo			c-Myc and AP4: a relay team for metabolic reprogramming of CD8(+) T cells	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; MEMORY	AP4, a transcription factor induced by the functionally related transcription factor c-Myc, maintains the cellular metabolic program for the sustained activation and population expansion of CD8(+) T cells after the dynamic loss of c-Myc expression.	[Karmaus, Peer W. F.; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Karmaus, PWF (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018	Chi, Hongbo/0000-0002-9997-2496				Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chou C, 2014, NAT IMMUNOL, V15, P884, DOI 10.1038/ni.2943; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015	12	4	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					828	829		10.1038/ni.2962	http://dx.doi.org/10.1038/ni.2962			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137465				2022-12-18	WOS:000340739400008
J	Krishnaswamy, JK; Liu, D; Eisenbarth, SC				Krishnaswamy, Jayendra Kumar; Liu, Dong; Eisenbarth, Stephanie C.			POP goes the inflammasome	NATURE IMMUNOLOGY			English	Editorial Material							AIM2 INFLAMMASOME; DNA; ACTIVATION; INFECTION	The PYRIN domain-only protein POP3 sets limits for activation of the AIM2 inflammasome after cytosolic double-stranded DNA is sensed.	[Krishnaswamy, Jayendra Kumar; Liu, Dong; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Krishnaswamy, Jayendra Kumar; Liu, Dong; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Yale University	Krishnaswamy, JK (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.	stephanie.eisenbarth@yale.edu		Krishnaswamy, Jayendra Kumar/0000-0002-7939-6559; Eisenbarth, Stephanie/0000-0002-1244-208X				Atianand MK, 2013, CELL, V153, P272, DOI 10.1016/j.cell.2013.03.009; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Le HT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00275; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304	11	4	4	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					311	313		10.1038/ni.2848	http://dx.doi.org/10.1038/ni.2848			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24646588				2022-12-18	WOS:000333252000002
J	Victora, GD				Victora, Gabriel D.			ILCs in the zone	NATURE IMMUNOLOGY			English	Editorial Material							MARGINAL ZONE; CELLS	Innate lymphoid cells, marginal reticular cells and B cell-helper neutrophils interact to promote antibody secretion by B cells in the marginal zone of the spleen in humans and mice.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Victora, GD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	victora@wi.mit.edu		Victora, Gabriel/0000-0001-8807-348X				Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369	6	4	4	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					313	314		10.1038/ni.2854	http://dx.doi.org/10.1038/ni.2854			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24646589				2022-12-18	WOS:000333252000003
J	McMichael, AJ; Haynes, BF				McMichael, Andrew J.; Haynes, Barton F.			Influenza vaccines: mTOR inhibition surprisingly leads to protection	NATURE IMMUNOLOGY			English	Editorial Material							ANTIBODY; VIRUSES; COMPLEX	Mice immunized with influenza virus in the presence of rapamycin, which blocks the formation of germinal centers, make mostly IgM antibodies that protect against infection with multiple subtypes of influenza virus, including avian viruses.	[McMichael, Andrew J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Haynes, Barton F.] Duke Univ, Dept Med, Human Vaccine Inst, Durham, NC USA	University of Oxford; Duke University	McMichael, AJ (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	andrew.mcmichael@ndm.ox.ac.uk						BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Garrity RR, 1997, J IMMUNOL, V159, P279; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	13	4	6	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1205	1207		10.1038/ni.2764	http://dx.doi.org/10.1038/ni.2764			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24240151				2022-12-18	WOS:000327149400003
J	Gatto, D; Wood, K; Caminschi, I; Murphy-Durland, D; Schofield, P; Christ, D; Karupiah, G; Brink, R				Gatto, Dominique; Wood, Katherine; Caminschi, Irina; Murphy-Durland, Danielle; Schofield, Peter; Christ, Daniel; Karupiah, Gunasegaran; Brink, Robert			The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells (vol 14, pg 446, 2013)	NATURE IMMUNOLOGY			English	Correction													Christ, Daniel/C-1861-2018; Schofield, Peter/C-9669-2011	Christ, Daniel/0000-0002-7313-3977; Karupiah, Gunasegaran/0000-0001-6306-4405; Brink, Robert/0000-0002-9586-3655; Schofield, Peter/0000-0003-2967-9662				Gatto D, 2013, NAT IMMUNOL, V14, P446, DOI 10.1038/ni.2555	1	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					876	876		10.1038/ni0813-876e	http://dx.doi.org/10.1038/ni0813-876e			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN		Bronze			2022-12-18	WOS:000322010600021
J	Lahouassa, H; Daddacha, W; Hofmann, H; Ayinde, D; Logue, EC; Dragin, L; Bloch, N; Maudet, C; Bertrand, M; Gramberg, T; Pancino, G; Priet, S; Canard, B; Laguette, N; Benkirane, M; Transy, C; Landau, NR; Kim, B; Margottin-Goguet, F				Lahouassa, Hichem; Daddacha, Waaqo; Hofmann, Henning; Ayinde, Diana; Logue, Eric C.; Dragin, Loic; Bloch, Nicolin; Maudet, Claire; Bertrand, Matthieu; Gramberg, Thomas; Pancino, Gianfranco; Priet, Stephane; Canard, Bruno; Laguette, Nadine; Benkirane, Monsef; Transy, Catherine; Landau, Nathaniel R.; Kim, Baek; Margottin-Goguet, Florence			SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates (vol 13, pg 223, 2012)	NATURE IMMUNOLOGY			English	Correction													Priet, Stéphane/ABD-4869-2020; Gramberg, Thomas/AAW-8706-2020; Priet, Stéphane/N-7952-2017; Laguette, Nadine/A-2764-2019; Maudet, Claire/AAH-1728-2019; Margottin-Goguet, Florence/F-9272-2013	Priet, Stéphane/0000-0001-7102-3654; Priet, Stéphane/0000-0001-7102-3654; Maudet, Claire/0000-0001-8856-0819; Margottin-Goguet, Florence/0000-0002-3124-6690				Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236	1	4	4	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					877	877		10.1038/ni0813-877a	http://dx.doi.org/10.1038/ni0813-877a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN		Bronze			2022-12-18	WOS:000322010600022
J	Powell, JD				Powell, Jonathan D.			Slc7a5 helps T cells get with the program	NATURE IMMUNOLOGY			English	Editorial Material							MTOR; METABOLISM	T cell activation requires an influx of amino acids. Slc7a5, an amino-acid transporter induced by the T cell antigen receptor, facilitates the influx of large neutral amino acids and in doing so promotes metabolic reprogramming necessary for T cell differentiation.	Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Powell, JD (corresponding author), Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA.	poweljo@jhmi.edu						Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Heikamp EB, 2012, SEMIN IMMUNOL, V24, P414, DOI 10.1016/j.smim.2012.12.003; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	13	4	4	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					422	424		10.1038/ni.2594	http://dx.doi.org/10.1038/ni.2594			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23598390				2022-12-18	WOS:000317732100005
J	[Anonymous]				[Anonymous]			Raising standards	NATURE IMMUNOLOGY			English	Editorial Material																			0	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					415	415		10.1038/ni.2603	http://dx.doi.org/10.1038/ni.2603			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23598386	Bronze			2022-12-18	WOS:000317732100001
J	Blair, DA; Dustin, ML				Blair, David A.; Dustin, Michael L.			T cell priming goes through a new phase	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; MEMORY; EXPANSION; RESPONSES; DISTINCT	The priming of naive T cells requires antigen presentation by activated dendritic cells, yet the optimal generation of effector and memory CD8(+) T cells requires subsequent T cell-T cell interactions during the critical differentiation period.	[Blair, David A.; Dustin, Michael L.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA	New York University	Blair, DA (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA.	michael.dustin@med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Blair DA, 2011, J IMMUNOL, V187, P2310, DOI 10.4049/jimmunol.1100363; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cox MA, 2013, P NATL ACAD SCI USA, V110, P1416, DOI 10.1073/pnas.1213480110; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; KATZ FE, 1985, EUR J IMMUNOL, V15, P103, DOI 10.1002/eji.1830150121; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Thaventhiran JED, 2012, P NATL ACAD SCI USA, V109, pE2223, DOI 10.1073/pnas.1209115109; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	13	4	4	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					311	312		10.1038/ni.2575	http://dx.doi.org/10.1038/ni.2575			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23507636				2022-12-18	WOS:000316648700003
J	Macian, F				Macian, Fernando			Noncanonical NFATc1 activation in DN thymocytes	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL DEVELOPMENT; CALCINEURIN; IL-7	Double-negative (DN) thymocytes depend on interleukin 7 (IL-7) for survival. In DN2 and DN3 cells, a new role has now been identified for signaling via the IL-7 receptor and the kinase Jak3 that leads to noncanonical activation of the transcription factor NFATc1 and upregulation of expression of the antiapoptotic protein Bcl-2.	Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Macian, F (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	fernando.macian@einstein.yu.edu		Macian, Fernando/0000-0003-2666-035X				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Patra AK, 2013, NAT IMMUNOL, V14, P127, DOI 10.1038/ni.2507; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103	12	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					116	117		10.1038/ni.2522	http://dx.doi.org/10.1038/ni.2522			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23334826				2022-12-18	WOS:000313918400005
J	McSorley, SJ; Bevins, CL				McSorley, Stephen J.; Bevins, Charles L.			Paneth cells: targets of friendly fire	NATURE IMMUNOLOGY			English	Editorial Material							TOXOPLASMA-GONDII; T-CELLS; ACTIVATION; MICE	Severe intestinal pathology associated with infection with Toxoplasma gondii is a result of the loss of Paneth cells, an unexpected side effect of the secretion of IFN-gamma by protective CD4(+) T cells in the intestinal mucosa.	[McSorley, Stephen J.] Univ Calif Davis, UC Davis Sch Med, Ctr Comparat Med, Davis, CA 95616 USA; [Bevins, Charles L.] Univ Calif Davis, UC Davis Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	McSorley, SJ (corresponding author), Univ Calif Davis, UC Davis Sch Med, Ctr Comparat Med, Davis, CA 95616 USA.	sjmcsorley@ucdavis.edu; clbevins@ucdavis.edu	Bevins, Charles L/P-4438-2015	Bevins, Charles L/0000-0003-2725-2622; mendis, shanthi/0000-0002-8959-5738; McSorley, Stephen/0000-0002-6363-3222	NIAID NIH HHS [R01 AI032738, R37 AI032738, R21 AI099519] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032738, R21AI099519, R37AI032738] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Egan CE, 2012, IMMUNOL CELL BIOL, V90, P668, DOI 10.1038/icb.2011.93; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Srinivasan A, 2007, J IMMUNOL, V178, P6342, DOI 10.4049/jimmunol.178.10.6342; Wehkamp J, 2010, J CROHNS COLITIS, V4, P523, DOI 10.1016/j.crohns.2010.05.010; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	13	4	4	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					114	116		10.1038/ni.2519	http://dx.doi.org/10.1038/ni.2519			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23334825				2022-12-18	WOS:000313918400004
J	Franklin, BS; Latz, E				Franklin, Bernardo S.; Latz, Eicke			For gut's sake: NLRC4 inflammasomes distinguish friend from foe	NATURE IMMUNOLOGY			English	Editorial Material							INTESTINAL MACROPHAGES; CELLS; ACTIVATION; TOLERANCE; IMMUNITY	In the gut, cells of the immune system must tolerate commensal bacteria but also detect pathogens. To achieve this, intestinal phagocytes are hyporesponsive to Toll-like receptor stimulants released from commensals, but can detect invasion of pathogens via the intracellular NLRC4 inflammasome.	[Franklin, Bernardo S.; Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Franklin, BS (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany.	eicke.latz@umassmed.edu	Latz, Eicke/H-3951-2014; Franklin, Bernardo S/G-8186-2012	Latz, Eicke/0000-0003-1488-5666; Franklin, Bernardo S/0000-0003-2591-9833	NHLBI NIH HHS [R01 HL093262] Funding Source: Medline; NIAID NIH HHS [R01 AI083713] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bain CC, 2011, EUR J IMMUNOL, V41, P2494, DOI 10.1002/eji.201141714; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Wangdi T, 2010, INFECT IMMUN, V78, P4744, DOI 10.1128/IAI.00744-10; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	14	4	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					429	431		10.1038/ni.2289	http://dx.doi.org/10.1038/ni.2289			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22513324				2022-12-18	WOS:000303048400003
J	Duan, F; Srivastava, PK				Duan, Fei; Srivastava, Pramod K.			An invariant road to cross-presentation	NATURE IMMUNOLOGY			English	Editorial Material							MHC CLASS-I; ANTIGEN; ASSOCIATION; PEPTIDES; PROTEINS; CHAIN	The invariant chain CD74 prevents the loading of peptides derived from endogenously synthesized proteins onto major histocompatibility complex (MHC) class II molecules in the endoplasmic reticulum. CD74 is now shown to serve a similar function for some MHC class I molecules.	[Duan, Fei; Srivastava, Pramod K.] Univ Connecticut, Sch Med, Dept Immunol, Farmington, CT USA; [Duan, Fei; Srivastava, Pramod K.] Univ Connecticut, Sch Med, Carole & Ray Neag Comprehens Canc Ctr, Farmington, CT USA	University of Connecticut; University of Connecticut	Duan, F (corresponding author), Univ Connecticut, Sch Med, Dept Immunol, Farmington, CT USA.	srivastava@uchc.edu		Srivastava, Pramod/0000-0003-2837-2861; Duan, Fei/0000-0002-4659-0144				Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Lev A, 2008, IMMUNITY, V28, P787, DOI 10.1016/j.immuni.2008.04.015; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443	12	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					207	208		10.1038/ni.2235	http://dx.doi.org/10.1038/ni.2235			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22344275				2022-12-18	WOS:000300510600004
J	Tangye, SG; Brink, R				Tangye, Stuart G.; Brink, Robert			A helping hand from neutrophils in T cell-independent antibody responses?	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY B-CELLS; DENDRITIC CELLS; IMMUNITY	Neutrophils and B cells are thought to specialize in driving innate and adaptive immune responses to infection. New data suggest that these cells may also communicate in the splenic marginal zone to drive T cell-independent antibody responses.	[Tangye, Stuart G.; Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia; [Tangye, Stuart G.; Brink, Robert] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2033, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Tangye, SG (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia.	s.tangye@garvan.org.au	Tangye, Stuart G/H-4023-2014; Brink, Robert/B-7910-2010	Tangye, Stuart G/0000-0002-5360-5180; Brink, Robert/0000-0002-9586-3655				Dubois B, 1999, J LEUKOCYTE BIOL, V66, P224, DOI 10.1002/jlb.66.2.224; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Ettinger R, 2008, IMMUNOL REV, V223, P60, DOI 10.1111/j.1600-065X.2008.00631.x; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Severinson E, 2008, BLOOD, V112, P3921, DOI 10.1182/blood-2008-09-176685; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Ueno H, 2010, IMMUNOL CELL BIOL, V88, P376, DOI 10.1038/icb.2010.28	12	4	6	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					111	113		10.1038/ni.2214	http://dx.doi.org/10.1038/ni.2214			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22261958				2022-12-18	WOS:000299315000004
J	Cupedo, T				Cupedo, Tom			An unexpected role for IL-17 in lymphoid organogenesis	NATURE IMMUNOLOGY			English	Editorial Material							TISSUE-INDUCER CELLS; T-CELL; LYMPHOTOXIN; ORGANS; GAMMA; NALT; ID2	In response to inhaled pathogens, lymphoid tissues can form in the lung. The driving force behind this organogenic process turns out to be interleukin 17-mediated activation of lung stromal cells.	Erasmus MC, Dept Hematol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Cupedo, T (corresponding author), Erasmus MC, Dept Hematol, Rotterdam, Netherlands.	t.cupedo@erasmusmc.nl	Cupedo, Tom/GQQ-0614-2022					Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	13	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					590	592		10.1038/ni.2058	http://dx.doi.org/10.1038/ni.2058			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21685952				2022-12-18	WOS:000291936400005
J	Smolders, J; Thewissen, M; Damoiseaux, J				Smolders, Joost; Thewissen, Marielle; Damoiseaux, Jan			Control of T cell activation by vitamin D	NATURE IMMUNOLOGY			English	Letter							ANALOG; D-3		[Smolders, Joost] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Internal Med, Div Clin & Expt Immunol,Med Ctr, Maastricht, Netherlands; [Thewissen, Marielle] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Div Clin & Expt Immunol,Med Ctr, Maastricht, Netherlands; [Damoiseaux, Jan] Maastricht Univ, Clin Immunol Lab, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Smolders, J (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Internal Med, Div Clin & Expt Immunol,Med Ctr, Maastricht, Netherlands.	j.smolders@mumc.nl	Thewissen, Marielle/G-3545-2014; Damoiseaux, Jan/B-8993-2009; Smolders, Joost/B-7658-2009	Damoiseaux, Jan/0000-0003-4007-6985; Smolders, Joost/0000-0001-9766-8661				BUTTKE TM, 1983, ANTIMICROB AGENTS CH, V24, P478, DOI 10.1128/AAC.24.4.478; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Mizwicki MT, 2009, J BIOL CHEM, V284, P36292, DOI 10.1074/jbc.M109.042069; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Zugel U, 2009, EXP DERMATOL, V18, P619, DOI 10.1111/j.1600-0625.2009.00845.x; Zugel U, 2002, J INVEST DERMATOL, V119, P1434, DOI 10.1046/j.1523-1747.2002.19623.x	7	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					3	3		10.1038/ni0111-3a	http://dx.doi.org/10.1038/ni0111-3a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21169995	Bronze			2022-12-18	WOS:000285465100002
J	Weissman, I				Weissman, Irving			Lymphocytes, Jim Gowans and in vivo veritas	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOGENOUS LEUKEMIA; ANTIBODY-FORMATION; IMMUNOLOGICAL MEMORY; HOMING RECEPTOR; NORMAL MOUSE; MIGRATION; RATS; IDENTIFICATION; PROGENITORS	Jim Gowans opened a new era of immunology by combining physiological in vivo studies with prospective enrichment of small lymphocytes, validating the clonal selection theory, discovering lymphocyte homing and recirculation, and training others to follow.	Stanford Univ, Palo Alto, CA 94304 USA	Stanford University	Weissman, I (corresponding author), Stanford Univ, Palo Alto, CA 94304 USA.							Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; de Petris S, 1972, Eur J Immunol, V2, P523, DOI 10.1002/eji.1830020611; DUTTON RW, 1967, J EXP MED, V126, P443, DOI 10.1084/jem.126.3.443; ELLIS ST, 1973, PROC R SOC SER B-BIO, V183, P125, DOI 10.1098/rspb.1973.0009; FORD WL, 1967, PROC R SOC SER B-BIO, V168, P244, DOI 10.1098/rspb.1967.0064; GALLATIN M, 1986, CELL, V44, P673, DOI 10.1016/0092-8674(86)90832-9; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GOWANS JL, 1966, J EXP MED, V124, P1017, DOI 10.1084/jem.124.5.1017; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GOWANS JL, 1962, NATURE, V196, P651, DOI 10.1038/196651a0; GOWANS JL, 1962, ANN NY ACAD SCI, V99, P432, DOI 10.1111/j.1749-6632.1962.tb45326.x; GOWANS JL, 1959, J PHYSIOL-LONDON, V146, P54, DOI 10.1113/jphysiol.1959.sp006177; GUTMAN GA, 1972, IMMUNOLOGY, V23, P465; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; Maximow A, 1909, FOLIA HAEMATOL LEIPZ, V8, P125; MCGREGOR DD, 1967, PROC R SOC SER B-BIO, V168, P229, DOI 10.1098/rspb.1967.0063; MCGREGOR DD, 1963, J EXP MED, V117, P303, DOI 10.1084/jem.117.2.303; Miller JFAP, 2001, NAT IMMUNOL, V2, P981, DOI 10.1038/ni1101-981a; MITCHISON NA, 1955, J EXP MED, V102, P179, DOI 10.1084/jem.102.2.179; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; PARROTT DMV, 1966, J EXP MED, V123, P191, DOI 10.1084/jem.123.1.191; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; ROWLEY DA, 1972, J EXP MED, V136, P499, DOI 10.1084/jem.136.3.499; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; Silverstein AM, 2001, NAT IMMUNOL, V2, P569, DOI 10.1038/89706; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; WEISSMAN IL, 1967, J EXP MED, V126, P291, DOI 10.1084/jem.126.2.291; Weissman IL, 2002, IMMUNOL REV, V185, P159, DOI 10.1034/j.1600-065X.2002.18514.x; WEISSMAN IL, 1973, J EXP MED, V137, P504, DOI 10.1084/jem.137.2.504; WEISSMAN IL, 1978, HUM PATHOL, V9, P25, DOI 10.1016/S0046-8177(78)80005-7	44	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1073	1075		10.1038/ni1210-1073	http://dx.doi.org/10.1038/ni1210-1073			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21079628				2022-12-18	WOS:000284262200003
J	Karsten, CM; Kohl, J				Karsten, Christian M.; Koehl, Joerg			The complement receptor CD46 tips the scales in T(H)1 self-control	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; INNATE	The mechanisms driving IL-10 production by human T helper type 1 effector cells are poorly defined. New data link the complement regulator protein CD46 to this process and suggest an important role in autoimmune arthritis.	[Karsten, Christian M.; Koehl, Joerg] Med Univ Lubeck, Inst Syst Entzundungsforsch, D-23538 Lubeck, Germany; [Koehl, Joerg] Cincinnati Childrens Hosp, Div Mol Immunol, Cincinnati, OH USA; [Koehl, Joerg] Univ Cincinnati, Coll Med, Cincinnati, OH USA	University of Lubeck; Cincinnati Children's Hospital Medical Center; University of Cincinnati; University of Cincinnati	Karsten, CM (corresponding author), Med Univ Lubeck, Inst Syst Entzundungsforsch, D-23538 Lubeck, Germany.	joerg.koehl@uk-sh.de	Karsten, Christian/J-4372-2013; Koehl, Joerg/C-8531-2011	Koehl, Joerg/0000-0003-1121-3178				Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Bodor J, 2007, J LEUKOCYTE BIOL, V81, P161, DOI 10.1189/jlb.0706474; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Ivanov II, 2010, MUCOSAL IMMUNOL, V3, P209, DOI 10.1038/mi.2010.3; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001	13	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					775	777		10.1038/ni0910-775	http://dx.doi.org/10.1038/ni0910-775			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20720581				2022-12-18	WOS:000281115500002
J	Nutt, SL; Tarlinton, DM				Nutt, Stephen L.; Tarlinton, David M.			Give and take in the germinal center	NATURE IMMUNOLOGY			English	Editorial Material							CHRONIC VIRAL-INFECTION; T-CELLS		[Nutt, Stephen L.; Tarlinton, David M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Nutt, SL (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	nutt@wehi.edu.au; tarlinto@wehi.edu.au	Nutt, Stephen L/C-9256-2013	Nutt, Stephen L/0000-0002-0020-6637; Tarlinton, David/0000-0001-9928-686X				Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Okazaki T, 2006, CELL, V124, P459, DOI 10.1016/j.cell.2006.01.022; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	8	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					464	466		10.1038/ni0610-464	http://dx.doi.org/10.1038/ni0610-464			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20485272				2022-12-18	WOS:000277821300005
J	Tremblay, MJ				Tremblay, Michel J.			HIV-1 and pattern-recognition receptors: a marriage of convenience	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; DC-SIGN; TRANS-INFECTION; TRANSMISSION		CHU Laval, Ctr Rech Infectiol, Quebec City, PQ G1V 4G2, Canada	Laval University	Tremblay, MJ (corresponding author), CHU Laval, Ctr Rech Infectiol, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	michel.j.tremblay@crchul.ulaval.ca						Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baribaud F, 2002, J VIROL, V76, P9135, DOI 10.1128/JVI.76.18.9135-9142.2002; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Martinson JA, 2007, CELL IMMUNOL, V250, P75, DOI 10.1016/j.cellimm.2008.01.007; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960	15	4	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					363	365		10.1038/ni0510-363	http://dx.doi.org/10.1038/ni0510-363			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20404846				2022-12-18	WOS:000276852200002
J	Garrison, BS; Rossi, DJ				Garrison, Brian S.; Rossi, Derrick J.			Controlling stem cell fate one substrate at a time	NATURE IMMUNOLOGY			English	Editorial Material							UBIQUITIN LIGASE; C-MYC; SELF-RENEWAL; DIFFERENTIATION; FBXW7	Hematopoietic stem cell self-renewal is tightly regulated. Regulation of the stability of c-Myc protein contributes to this control of hematopoietic stem cell quiescence and repopulation.	[Garrison, Brian S.; Rossi, Derrick J.] Childrens Hosp Boston, Harvard Stem Cell Inst, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA USA; [Garrison, Brian S.; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Garrison, BS (corresponding author), Childrens Hosp Boston, Harvard Stem Cell Inst, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA USA.	rossi@di.harvard.edu						Baena E, 2007, EXP HEMATOL, V35, P1333, DOI 10.1016/j.exphem.2007.05.015; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Onoyama I, 2008, CELL CYCLE, V7, P3307, DOI 10.4161/cc.7.21.6931; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	13	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					193	194		10.1038/ni0310-193	http://dx.doi.org/10.1038/ni0310-193			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20157300				2022-12-18	WOS:000274605800006
J	Colucci, F; Cilio, CM				Colucci, Francesco; Cilio, Corrado M.			Taming killer cells may halt diabetes progression	NATURE IMMUNOLOGY			English	Editorial Material							MUCOSAL IMMUNITY; IN-VIVO; ABSENCE	Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.	[Colucci, Francesco] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Colucci, Francesco] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Cilio, Corrado M.] Lund Univ, Dept Clin Sci, Cellular Autoimmun Unit, Lund, Sweden	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Lund University	Colucci, F (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	francesco.colucci@bbsrc.ac.uk	Colucci, Francesco/F-2844-2010	Colucci, Francesco/0000-0001-5193-6376				Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Flodstrom-Tullberg M, 2009, CURR OPIN IMMUNOL, V21, P634, DOI 10.1016/j.coi.2009.09.012; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Richer MJ, 2009, AUTOIMMUN REV, V8, P611, DOI 10.1016/j.autrev.2009.02.006; Rodacki M, 2006, CLIN DEV IMMUNOL, V13, P101, DOI 10.1080/17402520600877182; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522	12	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					111	112		10.1038/ni0210-111	http://dx.doi.org/10.1038/ni0210-111			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20084067				2022-12-18	WOS:000273730200006
J	Boehm, T				Boehm, Thomas			One problem, two solutions	NATURE IMMUNOLOGY			English	Editorial Material							VARIABLE LYMPHOCYTE RECEPTORS; AGNATHAN SEA LAMPREY; IMMUNE-SYSTEM; DIVERSIFICATION; VERTEBRATES; EVOLUTION	Jawless fishes, the 'sister' group of jawed vertebrates, use leucine-rich repeat-containing proteins as antigen receptors. New work shows that the two isotypes of variable lymphocyte receptors are expressed in distinct lymphocyte lineages, which indicates that lymphocytes resembling T cells and B cells are an ancient feature of all vertebrates.	Max Planck Inst Immunobiol, Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunobiol, Freiburg, Germany.	boehm@immunbio.mpg.de						Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; BAJOGHLI B, 2009, CELL; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Kasahara M, 2008, ZOOL SCI, V25, P969, DOI 10.2108/zsj.25.969; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2004, P NATL ACAD SCI USA, V101, P13273, DOI 10.1073/pnas.0405529101; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463	13	4	4	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					811	813		10.1038/ni0809-811	http://dx.doi.org/10.1038/ni0809-811			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621042				2022-12-18	WOS:000268141400008
J	Hartner, JC; Walkley, CR; Lu, J; Orkin, SH				Hartner, Jochen C.; Walkley, Carl R.; Lu, Jun; Orkin, Stuart H.			ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling (vol 10, pg 109, 2009)	NATURE IMMUNOLOGY			English	Correction													Walkley, Carl/AAO-6021-2020	Walkley, Carl/0000-0002-4784-9031				Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680	1	4	4	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					551	551		10.1038/ni0509-551a	http://dx.doi.org/10.1038/ni0509-551a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC		Bronze			2022-12-18	WOS:000265394400017
J	[Anonymous]				[Anonymous]			Embrace the complexity	NATURE IMMUNOLOGY			English	Editorial Material								Immune cell signal transduction is just too complicated to be effectively queried using traditional methods and mindsets.											0	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					325	325		10.1038/ni0409-325	http://dx.doi.org/10.1038/ni0409-325			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295627	Bronze			2022-12-18	WOS:000264425800001
J	Thomas, PG; Doherty, PC				Thomas, Paul G.; Doherty, Peter C.			Rules to 'prime' by	NATURE IMMUNOLOGY			English	Editorial Material									[Thomas, Paul G.; Doherty, Peter C.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Doherty, Peter C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	St Jude Children's Research Hospital; University of Melbourne	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.doherty@stjude.org	Thomas, Paul G./H-1063-2018; Doherty, Peter Charles/C-4185-2013	Thomas, Paul G./0000-0001-7955-0256; Doherty, Peter Charles/0000-0002-5028-3489				Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787	5	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					14	16		10.1038/ni0109-14	http://dx.doi.org/10.1038/ni0109-14			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19088735				2022-12-18	WOS:000261788800006
J	Rao, KVS				Rao, Kanury V. S.			Immunology in India: an emerging story	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; LYMPHOCYTES; COMMITMENT; RESPONSES; ISOFORM; MEMORY	Although immunological research is of only recent origin in India, it is nevertheless rapidly becoming an area of choice for young researchers in this country.	Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India.	kanury.rao@gmail.com						Baily G V, 1980, Indian J Med Res, V72 Suppl, P1; Chaturvedi A, 2002, NAT IMMUNOL, V3, P951, DOI 10.1038/ni839; Murugaiyan G, 2007, TRENDS IMMUNOL, V28, P467, DOI 10.1016/j.it.2007.08.010; Nagpal K, 2005, J ALLERGY CLIN IMMUN, V115, P527, DOI 10.1016/j.jaci.2004.11.048; NATH I, 1980, CLIN EXP IMMUNOL, V41, P406; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Prasad DVR, 2002, J IMMUNOL, V169, P1801, DOI 10.4049/jimmunol.169.4.1801; Rajagopal D, 2006, EUR J IMMUNOL, V36, P828, DOI 10.1002/eji.200535326; Raman VS, 2003, J IMMUNOL, V171, P5876, DOI 10.4049/jimmunol.171.11.5876; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; SARAF A, 2007, INTERNET J PLASTIC S, V3, P2; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Subramanian N, 2006, NAT IMMUNOL, V7, P583, DOI 10.1038/ni1336; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; VERMA R C, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P20; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Vig M, 2002, MOL PHARMACOL, V62, P1471, DOI 10.1124/mol.62.6.1471	18	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1319	1322		10.1038/ni1208-1319	http://dx.doi.org/10.1038/ni1208-1319			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	19008927	Bronze			2022-12-18	WOS:000260888700002
J	Jaffe, HW				Jaffe, Harold W.			The early days of the HIV-AIDS epidemic in the USA	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNE-DEFICIENCY SYNDROME; KAPOSIS SARCOMA; HOMOSEXUAL MEN	The work of epidemiologists before the isolation of human immunodeficiency virus 25 years ago demonstrates the power of the epidemiological method to gain an understanding of disease pathogenesis.	Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Jaffe, HW (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	harold.jaffe@dphpc.ox.ac.uk						[Anonymous], 1981, MORBIDITY MORTALITY, V30, P250; AUERBACH DM, 1984, AM J MED, V76, P487, DOI 10.1016/0002-9343(84)90668-5; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; *CDC, 1982, MMWR-MORBID MORTAL W, V31, P652; *CDC, 1983, MMWR-MORBID MORTAL W, V31, P697; *CDC, 1982, MMWR-MORBID MORTAL W, V31, P665; CDC, 1983, MMWR-MORBID MORTAL W, V32, P101; Centers for Disease Control (CDC), 1981, MMWR-MORBID MORTAL W, V30, P305; CURRAN JW, 1982, NEW ENGL J MED, V306, P248; JAFFE HW, 1983, ANN INTERN MED, V99, P145, DOI 10.7326/0003-4819-99-2-145; SONNABEND JA, 1984, ANN NY ACAD SCI, V437, P177, DOI 10.1111/j.1749-6632.1984.tb37134.x	11	4	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1201	1203		10.1038/ni1108-1201	http://dx.doi.org/10.1038/ni1108-1201			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18936776				2022-12-18	WOS:000260248600003
J	Bell, JJ; Bhandoola, A				Bell, J. Jeremiah; Bhandoola, Avinash			Putting ThPOK in place	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL DEVELOPMENT; LINEAGE COMMITMENT; REGULATES CD4; DIFFERENTIATION; EXPRESSION; DURATION; GATA-3; POK		[Bell, J. Jeremiah; Bhandoola, Avinash] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bell, JJ (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu						Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	14	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1095	1097		10.1038/ni1008-1095	http://dx.doi.org/10.1038/ni1008-1095			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18800158				2022-12-18	WOS:000259315600004
J	Karin, M				Karin, Michael			Rsk Tolls the bell for endocytosis in DCs	NATURE IMMUNOLOGY			English	Editorial Material							KINASES; P38; PHOSPHORYLATION; REGULATORS; ACTIVATION; RECEPTOR; COMPLEX; MAPK; CREB; SITE	The mitogen-activated protein kinases Erk and p38 transduce Toll-like receptor signals that lead to antigen capture by dendritic cells. New work identifies 'downstream' effector kinases essential for these responses and traces a pathway of mitogen-activated protein kinase signaling apparently unique to dendritic cells.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct,Canc Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct,Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct,Canc Ctr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu						Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	16	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1197	1199		10.1038/ni1107-1197	http://dx.doi.org/10.1038/ni1107-1197			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952046				2022-12-18	WOS:000250338900010
J	O'Neill, DW; Bhardwaj, N				O'Neill, David W.; Bhardwaj, Nina			Armed and ready: How effector T cells deploy in reactive lymph nodes to modulate immunity	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; MEMORY	New evidence demonstrates how two different effector T cell subsets traffic in reactive lymph nodes to modulate T cell and B cell responses.	NYU, Sch Med, New York, NY 10016 USA	New York University	O'Neill, DW (corresponding author), NYU, Sch Med, 550 1St Ave, New York, NY 10016 USA.	nina.bhardwaj@med.nyu.edu		Bhardwaj, Nina/0000-0003-1865-4187				Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Hosmalin A, 2001, BLOOD, V97, P2695, DOI 10.1182/blood.V97.9.2695; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	12	4	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					679	681		10.1038/ni0707-679	http://dx.doi.org/10.1038/ni0707-679			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17579644	Bronze			2022-12-18	WOS:000247718100007
J	Schatz, DG				Schatz, David G.			DNA deaminases converge on adaptive immunity	NATURE IMMUNOLOGY			English	Editorial Material							GENES; RECEPTORS; EVOLUTION	AID acts to further refine the immunoglobulin response in fish, birds and mammals. Now, evidence is uncovered to suggest AID actually arose early in evolution and can diversify antigen receptors in lampreys.	Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2007, NAT STRUCT MOL BIOL, V14, P7, DOI 10.1038/nsmb0107-7; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; DINOIA JM, 2007, ANN REV BIOCH; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Lee SS, 2002, IMMUNITY, V16, P571, DOI 10.1016/S1074-7613(02)00300-X; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; RUBIO MAT, 2007, P NATL ACAD SCI US	12	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					551	553		10.1038/ni0607-551	http://dx.doi.org/10.1038/ni0607-551			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17514205				2022-12-18	WOS:000246703300005
J	Rincon, M; Davis, RJ				Rincon, Mercedes; Davis, Roger J.			Choreography of MAGUKs during T cell activation	NATURE IMMUNOLOGY			English	Editorial Material							P38 MAP KINASE; RECEPTOR; LYMPHOCYTES	T cell receptor activation requires the membrane-associated guanylate kinase CARMA1. A new study finds that a second such kinase, Dlgh1, is also required specifically for activation of the alternative p38 kinase pathway.	Univ Vermont, Dept Med, Program Immunol, Burlington, VT 05405 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Vermont; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Rincon, M (corresponding author), Univ Vermont, Dept Med, Program Immunol, Burlington, VT 05405 USA.	roger.davis@umassmed.edu		Davis, Roger/0000-0002-0130-1652				Abbas AK, 2003, IMMUNITY, V18, P721, DOI 10.1016/S1074-7613(03)00143-2; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Dodeller F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1905; GOMEZ DA, 2000, J BIOL CHEM, V275, P13872; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Pedraza-Alva G, 2006, EMBO J, V25, P763, DOI 10.1038/sj.emboj.7600972; Rincon M, 2003, IMMUNOL REV, V192, P131, DOI 10.1034/j.1600-065X.2003.00019.x; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044	15	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					126	127		10.1038/ni0207-126	http://dx.doi.org/10.1038/ni0207-126			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242684				2022-12-18	WOS:000243597600008
J	Grassl, GA; Finlay, BB				Grassl, Guntram A.; Finlay, B. Brett			Shigella rewrites host transcriptional responses	NATURE IMMUNOLOGY			English	Editorial Material							BACTERIAL; SYSTEM	Histone modification is an important means of 'fine tuning' gene expression. The Shigella flexneri dually specific phosphatase OspF shapes host inflammatory transcriptional responses by inducing epigenetic modifications.	Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Immunol & Microbiol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Grassl, GA (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca	Grassl, Guntram/B-3559-2010					Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Coombes BK, 2004, CURR BIOL, V14, pR856, DOI 10.1016/j.cub.2004.09.043; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Schmeck B, 2005, J IMMUNOL, V175, P2843, DOI 10.4049/jimmunol.175.5.2843; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	11	4	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					15	16		10.1038/ni0107-15	http://dx.doi.org/10.1038/ni0107-15			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17179964				2022-12-18	WOS:000242934400006
J	Friedman, RS; Jacobelli, J; Krummel, MF				Friedman, Rachel S.; Jacobelli, Jordan; Krummel, Matthew F.			Surface-bound chemokines capture and prime T cells for synapse formation (vol 7, pg 1101, 2006)	NATURE IMMUNOLOGY			English	Correction																		Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384	1	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE					2022-12-18	WOS:000241437100017
J	Godfrey, DI; Berzins, SP				Godfrey, Dale I.; Berzins, Stuart P.			NKT cells join the war on Lyme disease	NATURE IMMUNOLOGY			English	Editorial Material							KILLER T-CELLS; BORRELIA-BURGDORFERI; CUTTING EDGE; RECOGNITION; GLYCOSPHINGOLIPIDS; LIGANDS	Whether natural killer T cells recognize antigens derived from dangerous pathogens remains unclear. New data demonstrate that a glycolipid from Borrelia burgdorferi, the causative agent of Lyme disease, directly stimulates mouse and human natural killer T cells.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	University of Melbourne	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; berzins@unimelb.edu.au		Godfrey, Dale/0000-0002-3009-5472				Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	12	4	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					904	906		10.1038/ni0906-904	http://dx.doi.org/10.1038/ni0906-904			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16924252				2022-12-18	WOS:000239942300007
J	Savarese, F; Grosschedl, R				Savarese, Fabio; Grosschedl, Rudolf			FOXtrot and RAGtime in B cells	NATURE IMMUNOLOGY			English	Editorial Material							V(D)J RECOMBINATION; GENE; REARRANGEMENT; RAG2; PAX5	Networks of transcription factors regulate cell fate 'decisions'. The forkhead protein Foxp1 is now identified as a key regulator of B cell development that influences the expression of recombination-activating genes.	Max Planck Inst Immunol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany	Max Planck Society	Savarese, F (corresponding author), Max Planck Inst Immunol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany.	grosschedl@immunobio.mpg.de						Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Roessler S, 2006, SEMIN IMMUNOL, V18, P12, DOI 10.1016/j.smim.2005.12.001; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; West KL, 2005, IMMUNITY, V23, P203, DOI 10.1016/j.immuni.2005.07.004; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	14	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					793	794		10.1038/ni0806-793	http://dx.doi.org/10.1038/ni0806-793			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16855601				2022-12-18	WOS:000239147200005
J	Schoenberger, SP; Janssen, EM				Schoenberger, Stephen P.; Janssen, Edith M.			IL-2 gets with the program	NATURE IMMUNOLOGY			English	Editorial Material							CD4(+) T-CELLS; SECONDARY EXPANSION; MEMORY; INTERLEUKIN-2; HELP	Many aspects of the CD8(+) T lymphocyte response are 'programmed' by inductive stimuli during primary activation. A recent Nature paper shows that interleukin 2 signals endow CD8 T cells with the capacity for secondary population expansion during priming.	La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA 92037 USA.	sps@liai.org		janssen, edith/0000-0001-7881-6307				Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tham EL, 2002, J IMMUNOL, V168, P1190, DOI 10.4049/jimmunol.168.3.1190; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	13	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					798	800		10.1038/ni0806-798	http://dx.doi.org/10.1038/ni0806-798			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16855604				2022-12-18	WOS:000239147200008
J	Busch, R; Byrne, B; Gandrud, L; Sears, D; Meyer, E; Kattah, M; Kurihara, C; Haertel, E; Parnes, JR; Mellins, ED				Busch, Robert; Byrne, Belinda; Gandrud, Laurie; Sears, David; Meyer, Everett; Kattah, Michael; Kurihara, Christine; Haertel, Edward; Parnes, Jane R.; Mellins, Elizabeth D.			Medicine on a need-to-know basis	NATURE IMMUNOLOGY			English	Editorial Material							SCIENCE	Disease-oriented, introductory medical curricula can help overcome educational and institutional barriers that separate aspiring translational scientists in PhD programs from the world of medicine.	Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Ctr Mol & Genet Med, Stanford, CA 94305 USA; Stanford Univ, Sch Educ, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA; Stanford Univ, BioDesign Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Mellins, ED (corresponding author), KineMed, Emeryville, CA 94608 USA.	mellins@stanford.edu		Mellins, Elizabeth/0000-0003-2577-139X; Busch, Robert/0000-0002-4132-0751; Kattah, Michael/0000-0002-6067-6585	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brody JS, 2003, AM J RESP CRIT CARE, V168, P415, DOI 10.1164/rccm.2305005; Cech TR, 2005, JAMA-J AM MED ASSOC, V294, P1390, DOI 10.1001/jama.294.11.1390; Dauphinee D, 2000, ACAD MED, V75, P881, DOI 10.1097/00001888-200009000-00008; Fenderson BA, 2004, CROAT MED J, V45, P259; Gray ML, 2002, NAT MED, V8, P433, DOI 10.1038/nm0502-433; Mankoff Stacey P, 2004, J Transl Med, V2, P14, DOI 10.1186/1479-5876-2-14; Osler, 1932, AEQUANIMITAS OTHER A; Pober JS, 2001, FASEB J, V15, P2303, DOI 10.1096/fj.01-0540lsf; Russell John H, 2004, Mo Med, V101, P484; Sonntag KC, 2005, J TRANSL MED, V3; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352	12	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					543	547		10.1038/ni0606-543	http://dx.doi.org/10.1038/ni0606-543			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16715061				2022-12-18	WOS:000237751200004
J	Surh, CD; Sprent, J				Surh, CD; Sprent, J			On the TRAIL of homeostatic memory T cells	NATURE IMMUNOLOGY			English	Editorial Material							CD8-T-CELL MEMORY; CD4-T-CELL HELP; ACUTE INFECTION; PROLIFERATION	The resolution of immune responses typically leaves a population of memory T cells to respond to subsequent infection. The generation of 'memory-like' T cells can also occur during homeostatic proliferation, but are they 'true' memory cells?.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Scripps Research Institute; Garvan Institute of Medical Research	Surh, CD (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	csurh@scripps.edu						Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; VOS Q, 1992, J IMMUNOL, V149, P1204	13	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					439	441		10.1038/ni0506-439	http://dx.doi.org/10.1038/ni0506-439			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622427				2022-12-18	WOS:000237008800005
J	Rollins, BJ				Rollins, BJ			Release the hounds! A chemokine elicits monocytes from bone marrow	NATURE IMMUNOLOGY			English	Editorial Material							BACTERIAL-INFECTION; MICE; RESPONSES; ATHEROSCLEROSIS; RECRUITMENT; BINDING; CXCR4; CELLS		Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02116 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02116 USA; Harvard Univ, Sch Med, Boston, MA 02116 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rollins, BJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02116 USA.	barrett_rollins@dfci.harvard.edu						Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158	14	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					230	232		10.1038/ni0306-230	http://dx.doi.org/10.1038/ni0306-230			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482169				2022-12-18	WOS:000235360400006
J	Elliott, T				Elliott, T			The 'chop-and-change' of MHC class I assembly	NATURE IMMUNOLOGY			English	Editorial Material							PEPTIDE REPERTOIRE; TAPASIN; MOLECULES	CD8(+) T cell recognition of peptides presented by major histocompatibility complex class I molecules is essential for effective antiviral and antitumor immune responses. How the repertoire of peptides is selected, shaped and presented is becoming increasingly clear.	Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England	University of Southampton	Elliott, T (corresponding author), Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England.	tje@soton.ac.uk		Elliott, Tim/0000-0003-1097-0222	Cancer Research UK [10601] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Desjardins M, 2005, IMMUNOL REV, V207, P158, DOI 10.1111/j.0105-2896.2005.00319.x; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Lehner PJ, 2004, CURR OPIN IMMUNOL, V16, P82, DOI 10.1016/j.coi.2003.11.012; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074	10	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					7	9		10.1038/ni0106-7	http://dx.doi.org/10.1038/ni0106-7			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357848				2022-12-18	WOS:000234139700003
J	Wu, XS; Jelinek, DF				Wu, XS; Jelinek, DF			A-Miz-ing BCL6	NATURE IMMUNOLOGY			English	Editorial Material							B-CELL LYMPHOMA; SOMATIC HYPERMUTATION; DNA-DAMAGE; EXPRESSION; GENE	Germinal center formation requires BCL6 to silence specific genes in B cells. New data now show that the repertoire of genes repressed by BCL6 is larger than previously thought, because of its interaction with the DNA-binding protein Miz-1.	Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Wu, XS (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	jelinek.diane@mayo.edu						Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Suzuki H, 2005, BIOCHEM BIOPH RES CO, V326, P242, DOI 10.1016/j.bbrc.2004.11.016; Wanzel M, 2005, NAT CELL BIOL, V7, P30, DOI 10.1038/ncb1202; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934	12	4	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					964	966		10.1038/ni1005-964	http://dx.doi.org/10.1038/ni1005-964			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16177801				2022-12-18	WOS:000232027200005
J	Heissmeyer, V; Ansel, KM; Rao, AJ				Heissmeyer, V; Ansel, KM; Rao, AJ			A plague of autoantibodies	NATURE IMMUNOLOGY			English	Editorial Material							HELPER-CELLS; T-CELLS; AUTOIMMUNITY		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Heissmeyer, V (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu		Heissmeyer, Vigo/0000-0002-2263-8545				Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; HEISSMEYER V, 2004, SCI STKE; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Lohr J, 2005, IMMUNOL REV, V204, P116, DOI 10.1111/j.0105-2896.2005.00241.x; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Siess DC, 2000, J BIOL CHEM, V275, P33655, DOI 10.1074/jbc.M004461200; Villasenor J, 2005, IMMUNOL REV, V204, P156, DOI 10.1111/j.0105-2896.2005.00246.x; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555	12	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					642	644		10.1038/ni1214	http://dx.doi.org/10.1038/ni1214			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15991362				2022-12-18	WOS:000229975500004
J	John, M; Mallal, S				John, M; Mallal, S			CTL responses to HIV and SIV: wrestling with smoke	NATURE IMMUNOLOGY			English	Editorial Material							T-LYMPHOCYTE ESCAPE; TRANSMISSION; INFECTION; REVERSION; SELECTION; EVOLUTION; MUTATION	A new study uses experimental infection of naive macaques with simian immunodeficiency virus containing known cytotoxic T lymphocyte escape mutations to examine the host and viral forces governing reversion or persistence of escape during transmission between hosts.	Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Perth, WA 6000, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University	John, M (corresponding author), Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia.	S.Mallal@murdoch.edu.au	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309				Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; BAROUCH D, 2002, NAT IMMUNOL, V6, P247; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Kijak GH, 2004, AIDS REV, V6, P54; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660	9	4	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					232	234		10.1038/ni0305-232	http://dx.doi.org/10.1038/ni0305-232			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15716970				2022-12-18	WOS:000227117400006
J	Sallusto, F; Reiner, SL				Sallusto, F; Reiner, SL			Sliding doors in the immune response	NATURE IMMUNOLOGY			English	Editorial Material							GENE-EXPRESSION; CELL SUBSETS; DELETION; MEMORY; LOCUS; T(H)1	When confronted with a pathogen, the immune system must develop the appropriate type of immune response. Recent work provides new insight into how regulated gene activation and silencing occurs in helper T cells.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Universita della Svizzera Italiana; University of Pennsylvania	Sallusto, F (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	federica.sallusto@irb.unisi.ch; sreiner@maie.med.upenn.edu						Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	12	4	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					10	12		10.1038/ni0105-10	http://dx.doi.org/10.1038/ni0105-10			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15611774				2022-12-18	WOS:000225888500004
J	De Gregorio, E; Rappuoli, R				De Gregorio, E; Rappuoli, R			Inside sensors detecting outside pathogens	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTOR-4; PEPTIDOGLYCAN; NOD1; LIPOPOLYSACCHARIDE; RECOGNITION; SECRETION		Chiron Corp, Vaccines, I-53100 Siena, Italy	Novartis	De Gregorio, E (corresponding author), Chiron Corp, Vaccines, I-53100 Siena, Italy.	ennio.degrgorio@chiron.it; rino_rappouli@chiron.it	De Gregorio, Ennio/J-8073-2012					Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092	12	4	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1099	1100		10.1038/ni1104-1099	http://dx.doi.org/10.1038/ni1104-1099			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15496945				2022-12-18	WOS:000224692700003
J	Hailman, E; Allen, PM				Hailman, E; Allen, PM			Self help for T cells	NATURE IMMUNOLOGY			English	Editorial Material							RECOGNITION; CD4	A handful of agonist peptide-MHC complexes can evoke a sustained signal from the T cell receptor. A combination of mathematical models and imaging experiments suggests a key function for CD4 and endogenous ( self) peptides in the generation of this sensitive response.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hailman, E (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	hailman@pathology.wustl.edu; allen@pathology.wustl.edu						Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Janeway CA, 1998, IMMUNOLOGIST, V6, P5; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Moldovan MC, 2002, J IMMUNOL, V169, P6261, DOI 10.4049/jimmunol.169.11.6261; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	12	4	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					780	781		10.1038/ni0804-780	http://dx.doi.org/10.1038/ni0804-780			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282560				2022-12-18	WOS:000222955600008
J	Maestroni, G				Maestroni, G			Immunology needs the mind	NATURE IMMUNOLOGY			English	Letter									Ist Cantonale Patol, Ctr Expt Pathol, CH-6601 Locarno, Switzerland		Maestroni, G (corresponding author), Ist Cantonale Patol, Ctr Expt Pathol, POB, CH-6601 Locarno, Switzerland.	georges.maestroni@ti.ch	Maestroni, Georges/AAG-9117-2019					Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078	1	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					763	763		10.1038/ni0804-763	http://dx.doi.org/10.1038/ni0804-763			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282554				2022-12-18	WOS:000222955600002
J	Diefenbach, A; Tomasello, E; Lucas, M; Jamieson, AM; Hsia, JK; Vivier, E; Raulet, DH				Diefenbach, A; Tomasello, E; Lucas, M; Jamieson, AM; Hsia, JK; Vivier, E; Raulet, DH			Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D (vol 3, pg 1142, 2002)	NATURE IMMUNOLOGY			English	Correction													Vivier, Eric/F-8939-2010; Jamieson, Amanda/U-7169-2019	Vivier, Eric/0000-0001-7022-8287; Jamieson, Amanda/0000-0002-5781-9231				Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858	2	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					658	658		10.1038/ni0604-658b	http://dx.doi.org/10.1038/ni0604-658b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH		Bronze			2022-12-18	WOS:000221664000027
J	Purbhoo, MA; Irvine, DJ; Huppa, JB; Davis, MM				Purbhoo, MA; Irvine, DJ; Huppa, JB; Davis, MM			T cell killing does not require the formation of a stable mature immunological synapse (vol 5, pg 524, 2004)	NATURE IMMUNOLOGY			English	Correction																		Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058	2	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					658	658		10.1038/ni0604-658a	http://dx.doi.org/10.1038/ni0604-658a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH		Bronze			2022-12-18	WOS:000221664000026
J	Smith, KD; Andersen-Nissen, E; Hayashi, F; Strobe, K; Bergman, MA; Barrett, SLR; Cookson, BT; Aderem, A				Smith, KD; Andersen-Nissen, E; Hayashi, F; Strobe, K; Bergman, MA; Barrett, SLR; Cookson, BT; Aderem, A			Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility (vol 4, pg 1247, 2003)	NATURE IMMUNOLOGY			English	Correction																		Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011	1	4	4	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					451	451		10.1038/ni0404-451	http://dx.doi.org/10.1038/ni0404-451			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL		Bronze			2022-12-18	WOS:000220515900019
J	Kronenberg, M				Kronenberg, M			Presenting fats with SAPs	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGEN PRESENTATION; TRAFFICKING; AP-3; CD1	CD1 presents lipids to unique subsets of T cells, but how are these lipids loaded onto CD1? A series of three papers has shed light on the molecules that facilitate this process.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	mitch@liai.org						Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Schuette CG, 2001, GLYCOBIOLOGY, V11, p81R, DOI 10.1093/glycob/11.6.81R; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; ZHOU D, 2003, SCIENCE         1222, DOI DOI 10.1126/SCIENCE.1092009	12	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					126	127		10.1038/ni0204-126	http://dx.doi.org/10.1038/ni0204-126			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14749781				2022-12-18	WOS:000188512000006
J	Amigorena, S				Amigorena, S			Y in X priming	NATURE IMMUNOLOGY			English	Editorial Material							CROSS-PRESENTATION; DENDRITIC CELLS; IN-VIVO; T-CELLS; ANTIGENS	The importance of cross-priming in vivo is controversial because its relative contribution in the presence of conventional priming is unclear. However, data from the examination of a conserved tyrosine residue in the cytoplasmic tail of MHC class I favor the cross-priming hypothesis.	Inst Curie, INSERM, U365, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Amigorena, S (corresponding author), Inst Curie, INSERM, U365, 26 Rue Ulm, F-75005 Paris, France.			Amigorena, Sebastian/0000-0001-8583-8416				BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; DONALDSON JG, 2003, J BIOL CHEM, V11, P11; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Norbury CC, 2003, CURR OPIN IMMUNOL, V15, P82, DOI 10.1016/S0952791502000031; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V; ZUNIGA MC, 1983, CELL, V34, P535, DOI 10.1016/0092-8674(83)90386-0	12	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1047	1048		10.1038/ni1103-1047	http://dx.doi.org/10.1038/ni1103-1047			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14586419				2022-12-18	WOS:000186241100005
J	Murai, M; Yoneyama, H; Ezaki, T; Suematsu, M; Terashima, Y; Harada, A; Hamada, H; Asakura, H; Ishikawd, H; Matsushima, K				Murai, M; Yoneyama, H; Ezaki, T; Suematsu, M; Terashima, Y; Harada, A; Hamada, H; Asakura, H; Ishikawd, H; Matsushima, K			Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction (vol 4, pg 154, 2003)	NATURE IMMUNOLOGY			English	Correction													Suematsu, Makoto/O-5762-2018	Suematsu, Makoto/0000-0002-7165-6336				Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879	1	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					497	497		10.1038/ni0503-497	http://dx.doi.org/10.1038/ni0503-497			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN		Bronze			2022-12-18	WOS:000182665400019
J	Maizels, N				Maizels, N			Yin outwits Yang at the IgE locus	NATURE IMMUNOLOGY			English	Editorial Material							PROTEINS	Serum IgE concentrations are kept low to avoid potential allergic complications. New data show how Id2 suppresses class switching to the isotype and reduces IgE expression.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maizels, N (corresponding author), Univ Washington, Sch Med, Dept Immunol, 1959 NE Pacific St,HSB H474A, Seattle, WA 98195 USA.	maizels@u.washington.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039799, R01GM041712] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041712, R01 GM039799] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Corry DB, 1999, NATURE, V402, pB18; KUSUNOKI T, IN PRESS J ALLERGY C; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Roberts EC, 2001, MOL CELL BIOL, V21, P524, DOI 10.1128/MCB.21.2.524-533.2001; Sicherer SH, 2002, LANCET, V360, P701, DOI 10.1016/S0140-6736(02)09831-8; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042	10	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					7	8		10.1038/ni0103-7	http://dx.doi.org/10.1038/ni0103-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496968				2022-12-18	WOS:000180053000004
J	Chakraborty, AK				Chakraborty, AK			Lighting up TCR takes advantage of serial triggering	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL ACTIVATION; SIGNAL-TRANSDUCTION	The complex interaction with APCs that is required for T cell activation is not well understood. A combination of experimental data and mathematical modeling provides insight into the competition between serial triggering and kinetic proofreading.	Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Chakraborty, AK (corresponding author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.							Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; VALLITUTTI S, 1995, NATURE, V375, P148; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4	12	4	4	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					895	896		10.1038/ni1002-895	http://dx.doi.org/10.1038/ni1002-895			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352963				2022-12-18	WOS:000178242100006
J	Goldsmith, MA; Doms, RW				Goldsmith, MA; Doms, RW			HIV entry: are all receptors created equal?	NATURE IMMUNOLOGY			English	Editorial Material							CCR5; CHEMOKINE; DISTINCT		Genencor Int Inc, Palo Alto, CA 94304 USA; Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Goldsmith, MA (corresponding author), Genencor Int Inc, 925 Page Mill Rd, Palo Alto, CA 94304 USA.							Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; MATTHIAS LJ, 2002, NATURE IMMUNOL, V3; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998	8	4	7	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					709	710		10.1038/ni819	http://dx.doi.org/10.1038/ni819			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12089511				2022-12-18	WOS:000177118500007
J	Eisenbarth, GS; Nepom, GT				Eisenbarth, GS; Nepom, GT			Class II peptide multimers: promise for type 1A diabetes?	NATURE IMMUNOLOGY			English	Editorial Material							MHC CLASS-II; T-CELLS; TETRAMERS; COMPLEXES		Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA; Benaroya Res Inst, Seattle, WA 98101 USA	University of Colorado System; University of Colorado Denver; Benaroya Research Institute	Eisenbarth, GS (corresponding author), Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA.	george.eisenbarth@uchsc.edu; nepom@vmresearch.org		Nepom, Gerald/0000-0002-8063-1464				Abiru N, 2001, DIABETES, V50, P1274, DOI 10.2337/diabetes.50.6.1274; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Kwok WW, 2000, J IMMUNOL, V164, P4244, DOI 10.4049/jimmunol.164.8.4244; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Meyer AL, 2000, P NATL ACAD SCI USA, V97, P11433, DOI 10.1073/pnas.190335897; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; SHARMA SD, 1991, P NATL ACAD SCI USA, V88, P11465, DOI 10.1073/pnas.88.24.11465; Spack EG, 1995, J AUTOIMMUN, V8, P787, DOI 10.1016/S0896-8411(95)80018-2; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	11	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					344	345		10.1038/ni0402-344	http://dx.doi.org/10.1038/ni0402-344			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919577				2022-12-18	WOS:000174623600014
J	Manser, T				Manser, T			Effector BCRs: inside information on IgG	NATURE IMMUNOLOGY			English	Editorial Material							B-CELL DEVELOPMENT; POSITIVE SELECTION; ANTIGEN RECEPTORS; TAIL; MATURATION	Immunoglobulins secreted by memory B cells dominate secondary humoral responses. New evidence suggests the cytoplasmic tails of BCRs confer an advantage to cells expressing IgG, leading to their sustained proliferation and immunoglobulin production.	Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Manser, T (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.							Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Hande S, 1998, IMMUNITY, V8, P189, DOI 10.1016/S1074-7613(00)80471-9; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HONJO T, 1982, IMMUNOL TODAY, V3, P214, DOI 10.1016/0167-5699(82)90094-9; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; KENNY JJ, 1995, J IMMUNOL, V154, P5694; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; ROTH PE, 1993, J EXP MED, V178, P2007, DOI 10.1084/jem.178.6.2007; Tarlinton D, 1997, SCIENCE, V276, P374, DOI 10.1126/science.276.5311.374	14	4	4	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					114	116		10.1038/ni0202-114	http://dx.doi.org/10.1038/ni0202-114			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812985				2022-12-18	WOS:000173562400009
J	Jensen, PE				Jensen, PE			All peptide-MHC complexes are not created equal	NATURE IMMUNOLOGY			English	Editorial Material							IMMATURE DENDRITIC CELLS; CLASS-II MOLECULES; HLA-DM; MEMBRANE; SURFACE; RAFTS; CD82		Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Jensen, PE (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.							Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Arndt SO, 2000, EMBO J, V19, P1241, DOI 10.1093/emboj/19.6.1241; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Drbal K, 1999, INT IMMUNOL, V11, P491, DOI 10.1093/intimm/11.4.491; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hammond C, 1998, J IMMUNOL, V161, P3282; Jenei A, 1997, P NATL ACAD SCI USA, V94, P7269, DOI 10.1073/pnas.94.14.7269; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Szollosi J, 1996, J IMMUNOL, V157, P2939; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522	12	4	4	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					14	15		10.1038/ni0102-14	http://dx.doi.org/10.1038/ni0102-14			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753403				2022-12-18	WOS:000173148700008
J	Tough, DF; Kamath, AT				Tough, DF; Kamath, AT			Interferon with dendritic cells?	NATURE IMMUNOLOGY			English	Editorial Material									Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England		Tough, DF (corresponding author), Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England.							Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; KIRCHNER H, 1984, SPRINGER SEMIN IMMUN, V7, P347; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835	10	4	4	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1098	1100		10.1038/ni1201-1098	http://dx.doi.org/10.1038/ni1201-1098			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725298				2022-12-18	WOS:000172473200010
J	Rogozin, IB; Pavlov, YI; Kunkel, TA				Rogozin, IB; Pavlov, YI; Kunkel, TA			Smaller role for pol eta? Response 1	NATURE IMMUNOLOGY			English	Letter							GENES		NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk 630090, Russia; Natl Inst Environm Hlth Sci, Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kunkel, TA (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.							Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; Frank EG, 2001, EMBO J, V20, P2914, DOI 10.1093/emboj/20.11.2914; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	8	4	4	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					983	984		10.1038/ni1101-983	http://dx.doi.org/10.1038/ni1101-983			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY					2022-12-18	WOS:000172049800004
J	Rocha, B				Rocha, B			Trouble with peer review	NATURE IMMUNOLOGY			English	Letter									Inst Necker, INSERM, U345, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rocha, B (corresponding author), Inst Necker, INSERM, U345, Paris, France.								0	4	4	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					277	277		10.1038/86276	http://dx.doi.org/10.1038/86276			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276191	Bronze			2022-12-18	WOS:000167982900002
J	Porcelli, SA				Porcelli, SA			Cutting glycolipids down to size	NATURE IMMUNOLOGY			English	News Item							T-CELL RECOGNITION; ANTIGENS		Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Porcelli, SA (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	porcelli@aecom.yu.edu						Briken V, 2000, SEMIN IMMUNOL, V12, P517, DOI 10.1006/smim.2000.0274; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Moody DB, 1999, IMMUNOL LETT, V65, P85, DOI 10.1016/S0165-2478(98)00129-1; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404	12	4	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					191	192		10.1038/85234	http://dx.doi.org/10.1038/85234			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224512				2022-12-18	WOS:000167413800006
J	Kennedy, A; Waters, E; Rowshanravan, B; Hinze, C; Williams, C; Janman, D; Fox, TA; Booth, C; Pesenacker, AM; Halliday, N; Soskic, B; Kaur, S; Qureshi, OS; Morris, EC; Ikemizu, S; Paluch, C; Huo, JD; Davis, SJ; Boucrot, E; Walker, LSK; Sansom, DM				Kennedy, Alan; Waters, Erin; Rowshanravan, Behzad; Hinze, Claudia; Williams, Cayman; Janman, Daniel; Fox, Thomas A.; Booth, Claire; Pesenacker, Anne M.; Halliday, Neil; Soskic, Blagoje; Kaur, Satdip; Qureshi, Omar S.; Morris, Emma C.; Ikemizu, Shinji; Paluch, Christopher; Huo, Jiandong; Davis, Simon J.; Boucrot, Emmanuel; Walker, Lucy S. K.; Sansom, David M.			Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation	NATURE IMMUNOLOGY			English	Article							T-CELLS; CD28; DYSREGULATION; EXPRESSION; B7-1; COSTIMULATION; HOMEOSTASIS; ENDOCYTOSIS; SIGNALS; ROLES	CD28 and CTLA-4 (CD152) play essential roles in regulating T cell immunity, balancing the activation and inhibition of T cell responses, respectively. Although both receptors share the same ligands, CD80 and CD86, the specific requirement for two distinct ligands remains obscure. In the present study, we demonstrate that, although CTLA-4 targets both CD80 and CD86 for destruction via transendocytosis, this process results in separate fates for CTLA-4 itself. In the presence of CD80, CTLA-4 remained ligand bound, and was ubiquitylated and trafficked via late endosomes and lysosomes. In contrast, in the presence of CD86, CTLA-4 detached in a pH-dependent manner and recycled back to the cell surface to permit further transendocytosis. Furthermore, we identified clinically relevant mutations that cause autoimmune disease, which selectively disrupted CD86 transendocytosis, by affecting either CTLA-4 recycling or CD86 binding. These observations provide a rationale for two distinct ligands and show that defects in CTLA-4-mediated transendocytosis of CD86 are associated with autoimmunity. The inhibitory receptor CTLA-4 recognizes two ligands on opposing antigen-presenting cells, CD80 and CD86. Sansom and colleagues show CTLA-4 captures ligands by transendocytosis, whereupon low-affinity CD86 releases CTLA-4 at low pH to promote CTLA-4 recycling; however, high-affinity CD80 remains bound and targets CTLA-4 for ubiquitination and destruction.	[Kennedy, Alan; Waters, Erin; Rowshanravan, Behzad; Hinze, Claudia; Williams, Cayman; Janman, Daniel; Fox, Thomas A.; Pesenacker, Anne M.; Halliday, Neil; Soskic, Blagoje; Morris, Emma C.; Walker, Lucy S. K.; Sansom, David M.] UCL Inst Immun & Transplantat, London, England; [Booth, Claire] UCL Great Ormond St Inst Child Hlth, Mol & Cellular Immunol Sect, London, England; [Kaur, Satdip] Univ Birmingham, Sch Immun & Infect, Inst Biomed Res, Med Sch, Birmingham, W Midlands, England; [Qureshi, Omar S.] Celentyx Ltd, Birmingham, W Midlands, England; [Ikemizu, Shinji] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kumamoto, Japan; [Paluch, Christopher; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Med Res Council Human Immunol Unit, Oxford, England; [Huo, Jiandong] Rosalind Franklin Inst, Struct Biol, Didcot, Oxon, England; [Huo, Jiandong] Univ Oxford, Div Struct Biol, Oxford, England; [Huo, Jiandong] Wellcome Trust Ctr Human Genet, Oxford, England; [Huo, Jiandong] Rosalind Franklin Inst, Diamond Light Source, Prot Prod UK, Res Complex Harwell, Didcot, Oxon, England; [Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford, England; [Boucrot, Emmanuel] UCL, Inst Struct & Mol Biol, London, England	University of London; University College London; University of London; University College London; University of Birmingham; Kumamoto University; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Diamond Light Source; University of Oxford; University of London; Birkbeck University London; University College London	Sansom, DM (corresponding author), UCL Inst Immun & Transplantat, London, England.	d.sansom@ucl.ac.uk		Morris, Emma/0000-0003-4834-1130; Hinze, Claudia/0000-0002-8029-842X; Pesenacker, Anne/0000-0002-7968-0277; Kennedy, Alan/0000-0003-0384-3866; Paluch, Christopher/0000-0002-9087-1920	Wellcome Trust [204798/Z/16/Z, 110297/Z/15/Z, 102186/B/13/Z]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M009203/1]; Versus Arthritis [21147]; BBSRC [BB/H013598]; BBSRC Case studentship; Great Ormond Street Hospital National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC); Versus Arthritis Career Development fellowship [ARUK CDF 21738]; Medical Research Council [MR/N001435/1]; NIHR University College London Hospitals BRC	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Case studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Ormond Street Hospital National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC); Versus Arthritis Career Development fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR University College London Hospitals BRC	A.K., E.W., C.H., N.H., T.A.F. and D.M.S. were funded by the Wellcome Trust (grant nos. 204798/Z/16/Z, 110297/Z/15/Z and 102186/B/13/Z). B.R. and B.S. were funded by the Biotechnology and Biological Sciences Research Council (BBSRC; grant no. BB/M009203/1). C.W. was funded by Versus Arthritis (grant no. 21147). O.S.Q. was funded by BBSRC (grant no. BB/H013598). D.J. was funded by a BBSRC Case studentship. C.B. was supported by Great Ormond Street Hospital National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC). A.M.P. was funded by Versus Arthritis Career Development fellowship (no. ARUK CDF 21738). E.C.M. was supported by the NIHR University College London Hospitals BRC. L.S.K.W. and D.M.S. were funded by the Medical Research Council (grant no. MR/N001435/1). This research was funded in whole, or in part, by the Wellcome Trust (grant no. 204798/Z/16/Z). For the purpose of Open Access, the author has applied a CC BY public copyright license to any author-accepted manuscript version arising from this submission.	Bak RO, 2018, NAT PROTOC, V13, P358, DOI 10.1038/nprot.2017.143; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Halliday N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.600000; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Hou TZ, 2017, BLOOD, V129, P1458, DOI 10.1182/blood-2016-10-745174; Hou TZ, 2015, J IMMUNOL, V194, P2148, DOI 10.4049/jimmunol.1401876; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Janman D, 2021, IMMUNOLOGY, V164, P106, DOI 10.1111/imm.13343; June CH, 2017, NAT MED, V23, P540, DOI 10.1038/nm.4321; Khailaie S, 2018, BIOPHYS J, V115, P1330, DOI 10.1016/j.bpj.2018.08.020; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; LANIER LL, 1995, J IMMUNOL, V154, P97; Linterman MA, 2014, ELIFE, V3, DOI 10.7554/eLife.03180; Lo B, 2016, BLOOD, V128, P1037, DOI 10.1182/blood-2016-04-712612; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Manzotti CN, 2006, EUR J IMMUNOL, V36, P1413, DOI 10.1002/eji.200535170; Mund T, 2018, J BIOL CHEM, V293, P5200, DOI 10.1074/jbc.RA117.000934; Ovcinnikovs V, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0902; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sansom DM, 2015, SCIENCE, V349, P377, DOI 10.1126/science.aac7888; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Schwab C, 2018, J ALLERGY CLIN IMMUN, V142, P1932, DOI 10.1016/j.jaci.2018.02.055; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Soskic B, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.577655; Soskic B, 2014, ADV IMMUNOL, V124, P95, DOI 10.1016/B978-0-12-800147-9.00004-2; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Trzupek D, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00756-z; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Verma N, 2017, CLIN EXP IMMUNOL, V190, P1, DOI 10.1111/cei.12997; Walker LSK, 2015, TRENDS IMMUNOL, V36, P63, DOI 10.1016/j.it.2014.12.001; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Yu C, 2011, J BIOL CHEM, V286, P6685, DOI 10.1074/jbc.M110.182394; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013	53	3	3	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9					1365	+		10.1038/s41590-022-01289-w	http://dx.doi.org/10.1038/s41590-022-01289-w		AUG 2022	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O8VJ	35999394	Green Published, hybrid			2022-12-18	WOS:000843443500003
J	Ito-Kureha, T; Leoni, C; Borland, K; Cantini, G; Bataclan, M; Metzger, RN; Ammann, G; Krug, AB; Marsico, A; Kaiser, S; Canzar, S; Feske, S; Monticelli, S; Konig, J; Heissmeyer, V				Ito-Kureha, Taku; Leoni, Cristina; Borland, Kayla; Cantini, Giulia; Bataclan, Marian; Metzger, Rebecca N.; Ammann, Gregor; Krug, Anne B.; Marsico, Annalisa; Kaiser, Stefanie; Canzar, Stefan; Feske, Stefan; Monticelli, Silvia; Koenig, Julian; Heissmeyer, Vigo			The function of Wtap in N-6-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; INFLAMMATION; EXPRESSION; ORAI1; DEFICIENCY; MUTATION; METTL14; CALCIUM; DEATH; MODEL	T cell antigen-receptor (TCR) signaling controls the development, activation and survival of T cells by involving several layers and numerous mechanisms of gene regulation. N-6-methyladenosine (m(6)A) is the most prevalent messenger RNA modification affecting splicing, translation and stability of transcripts. In the present study, we describe the Wtap protein as essential for m(6)A methyltransferase complex function and reveal its crucial role in TCR signaling in mouse T cells. Wtap and m(6)A methyltransferase functions were required for the differentiation of thymocytes, control of activation-induced death of peripheral T cells and prevention of colitis by enabling gut ROR gamma t(+) regulatory T cell function. Transcriptome and epitranscriptomic analyses reveal that m(6)A modification destabilizes Orai1 and Ripk1 mRNAs. Lack of post-transcriptional repression of the encoded proteins correlated with increased store-operated calcium entry activity and diminished survival of T cells with conditional genetic inactivation of Wtap. These findings uncover how m(6)A modification impacts on TCR signal transduction and determines activation and survival of T cells. Heissmeyer and colleagues show that TCR stimulation-induced cell death is controlled by N-6-methyladenosine (m(6)A) modification of Orai1 and Ripk1 mRNAs. m(6)A is deposited by a 'writer' complex of Wtap and the N-6-methyltransferase and bound by the 'reader' protein Ythdf2. T cells lacking Wtap exhibit enhanced Ca2+ entry in response to TCR ligation and decreased survival due to activation-induced cell death.	[Ito-Kureha, Taku; Metzger, Rebecca N.; Krug, Anne B.; Heissmeyer, Vigo] Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr, Inst Immunol, Planegg Martinsried, Germany; [Leoni, Cristina; Bataclan, Marian; Monticelli, Silvia] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Borland, Kayla; Ammann, Gregor; Kaiser, Stefanie] Ludwig Maximilians Univ Munchen, Dept Chem, Munich, Germany; [Cantini, Giulia; Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Res Unit Mol Immune Regulat, Munich, Germany; [Cantini, Giulia; Marsico, Annalisa] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Canzar, Stefan] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Feske, Stefan] NYU, Sch Med, Dept Pathol, New York, NY USA; [Koenig, Julian] Inst Mol Biol, Mainz, Germany; [Kaiser, Stefanie] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany	University of Munich; Universita della Svizzera Italiana; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; New York University; Institute of Molecular Biology (IMB); Goethe University Frankfurt	Heissmeyer, V (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr, Inst Immunol, Planegg Martinsried, Germany.; Heissmeyer, V (corresponding author), Helmholtz Zentrum Munchen, Res Unit Mol Immune Regulat, Munich, Germany.	vigo.heissmeyer@med.uni-muenchen.de		Ammann, Gregor/0000-0003-2135-058X; Kureha, Taku/0000-0002-6239-9227	German Research Foundation [HE3359/8-1, 444891219, HE3359/7-1, 432656284, SFB 1054, 210592381, SPP 1935, 313381103, TRR338, 452881907]; SFB 1054 [210592381]; SPP 1935 [313381103]; TRR338 [452881907]	German Research Foundation(German Research Foundation (DFG)); SFB 1054; SPP 1935; TRR338	We thank C. Keplinger (Helmholtz Zentrum Munchen) and L. Esser (Ludwig-Maximilians-Universitat) for excellent technical support. We thank the BMC Core Facility (Ludwig-Maximilians-Universitat) for flow cytometry, H. Blum and S. Krebs (Ludwig-Maximilians-Universitat) for mRNA- and CLIP-seq and N. Angstman for initial processing of sequencing data. The present study was supported by the German Research Foundation grant nos. HE3359/8-1 (#444891219), HE3359/7-1 (#432656284) and SFB 1054 (project A03, #210592381), SPP 1935 (#313381103) and TRR338 (project C02, #452881907) to V.H.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bawankar P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23892-5; Borland K, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010026; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buchbender A, 2020, METHODS, V178, P33, DOI 10.1016/j.ymeth.2019.10.003; Busch A, 2020, METHODS, V178, P49, DOI 10.1016/j.ymeth.2019.11.008; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Daley SR, 2017, IMMUNOL REV, V277, P9, DOI 10.1111/imr.12532; Desvignes L, 2015, J CLIN INVEST, V125, P2347, DOI 10.1172/JCI80273; Dzialo-Hatton R, 2001, J IMMUNOL, V166, P4534, DOI 10.4049/jimmunol.166.7.4534; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao YM, 2020, IMMUNITY, V52, P1007, DOI 10.1016/j.immuni.2020.05.003; Grenov AC, 2021, J EXP MED, V218, DOI 10.1084/jem.20210360; Hoefig KP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25345-5; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim KD, 2011, J IMMUNOL, V187, P3620, DOI 10.4049/jimmunol.1100847; Knuckles P, 2018, GENE DEV, V32, P415, DOI 10.1101/gad.309146.117; Kortel N, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkab485; Krakau S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1364-2; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; Lasman L, 2020, GENE DEV, V34, P1373, DOI 10.1101/gad.340695.120; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu TX, 2020, CELL MOL GASTROENTER, V10, P747, DOI 10.1016/j.jcmgh.2020.07.001; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Paris J, 2019, CELL STEM CELL, V25, P137, DOI 10.1016/j.stem.2019.03.021; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shulman Z, 2020, NAT IMMUNOL, V21, P501, DOI 10.1038/s41590-020-0650-4; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Sprent J, 2017, IMMUNOL CELL BIOL, V95, P855, DOI 10.1038/icb.2017.67; Tong JY, 2018, CELL RES, V28, P253, DOI 10.1038/cr.2018.7; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Tummers B, 2017, IMMUNOL REV, V277, P76, DOI 10.1111/imr.12541; Vaeth M, 2020, TRENDS IMMUNOL, V41, P878, DOI 10.1016/j.it.2020.06.012; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Xiao S, 1999, EUR J IMMUNOL, V29, P3456, DOI 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.3.CO;2-2; Yao YP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21594-6; Yue YA, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0019-0; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhan YF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01809; Zhu YY, 2019, J EXP MED, V216, P1664, DOI 10.1084/jem.20190337	58	3	3	12	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1208	+		10.1038/s41590-022-01268-1	http://dx.doi.org/10.1038/s41590-022-01268-1		JUL 2022	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35879451				2022-12-18	WOS:000829717100001
J	Boukhaled, GM; Gadalla, R; Elsaesser, HJ; Abd-Rabbo, D; Quevedo, R; Yang, SYC; Guo, MD; Wang, BX; Noamani, B; Gray, D; Lau, SCM; Taylor, K; Aung, K; Spreafico, A; Hansen, AR; Saibil, SD; Hirano, N; Guidos, C; Pugh, TJ; McGaha, TL; Ohashi, PS; Sacher, AG; Butler, MO; Brooks, DG				Boukhaled, Giselle M.; Gadalla, Ramy; Elsaesser, Heidi J.; Abd-Rabbo, Diala; Quevedo, Rene; Yang, S. Y. Cindy; Guo, Mengdi; Wang, Ben X.; Noamani, Babak; Gray, Diana; Lau, Sally C. M.; Taylor, Kirsty; Aung, Kyaw; Spreafico, Anna; Hansen, Aaron R.; Saibil, Samuel D.; Hirano, Naoto; Guidos, Cynthia; Pugh, Trevor J.; McGaha, Tracy L.; Ohashi, Pamela S.; Sacher, Adrian G.; Butler, Marcus O.; Brooks, David G.			Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy	NATURE IMMUNOLOGY			English	Article							EXHAUSTED T-CELLS; DIFFERENTIATION; INFECTION; DYSFUNCTION; ACTIVATION; COOPERATE; BCL6	Predicting which patients will respond to checkpoint blocking therapies is a major challenge. Here the authors score the epigenetic imprinting of T cell responsiveness to type 1 interferons and use this information to predict response to anti-PD1 therapy and long-term survival of cancer patients. Type I interferons (IFN-Is) are central regulators of anti-tumor immunity and responses to immunotherapy, but they also drive the feedback inhibition underlying therapeutic resistance. In the present study, we developed a mass cytometry approach to quantify IFN-I-stimulated protein expression across immune cells and used multi-omics to uncover pre-therapy cellular states encoding responsiveness to inflammation. Analyzing peripheral blood cells from multiple cancer types revealed that differential responsiveness to IFN-Is before anti-programmed cell death protein 1 (PD1) treatment was highly predictive of long-term survival after therapy. Unexpectedly, IFN-I hyporesponsiveness efficiently predicted long-term survival, whereas high responsiveness to IFN-I was strongly associated with treatment failure and diminished survival time. Peripheral IFN-I responsive states were not associated with tumor inflammation, identifying a disconnect between systemic immune potential and 'cold' or 'hot' tumor states. Mechanistically, IFN-I responsiveness was epigenetically imprinted before therapy, poising cells for differential inflammatory responses and dysfunctional T cell effector programs. Thus, we identify physiological cell states with clinical importance that can predict success and long-term survival of PD1-blocking immunotherapy.	[Boukhaled, Giselle M.; Gadalla, Ramy; Elsaesser, Heidi J.; Abd-Rabbo, Diala; Quevedo, Rene; Yang, S. Y. Cindy; Guo, Mengdi; Wang, Ben X.; Noamani, Babak; Gray, Diana; Aung, Kyaw; Saibil, Samuel D.; Hirano, Naoto; Pugh, Trevor J.; McGaha, Tracy L.; Ohashi, Pamela S.; Butler, Marcus O.; Brooks, David G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Yang, S. Y. Cindy; Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Guo, Mengdi; Guidos, Cynthia; McGaha, Tracy L.; Ohashi, Pamela S.; Sacher, Adrian G.; Brooks, David G.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Lau, Sally C. M.; Taylor, Kirsty; Spreafico, Anna; Hansen, Aaron R.; Hirano, Naoto; Sacher, Adrian G.] Univ Hlth Network, Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Guidos, Cynthia] Hosp Sick Children Res Inst, Program Dev & Stem Cell Biol, Toronto, ON, Canada; [Pugh, Trevor J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Lau, Sally C. M.] NYU, NYU Langone Hlth, Dept Med Oncol, Perlmutter Canc Ctr,Grossman Sch Med, New York, NY USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; New York University; NYU Langone Medical Center	Boukhaled, GM; Brooks, DG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Brooks, DG (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	giselle.boukhaled@uhnresearch.ca; dbrooks@uhnresearch.ca	Pugh, Trevor/Y-2535-2019; Spreafico, Anna/AHD-6430-2022; Lau, Sally/AAD-9761-2021	Pugh, Trevor/0000-0002-8073-5888; Spreafico, Anna/0000-0002-3034-3042; Lau, Sally/0000-0001-9217-2368; Butler, Marcus/0000-0002-9840-7057; Boukhaled, Giselle/0000-0002-6567-6234	Canadian Institutes of Health Research Foundation [FDN148386]; Canadian Cancer Society [706230]; National Institutes of Health [AI085043]; Terry Fox New Frontiers grant; Scotiabank Research Chair; Princess Margaret Hold'em for Life Cancer Research Fellowship	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Fox New Frontiers grant; Scotiabank Research Chair; Princess Margaret Hold'em for Life Cancer Research Fellowship	We thank past and present members of the Brooks laboratory and Tumor Immunotherapy Program Immune Profiling Core for technical help and discussion. We thank the Biostatistics Department at the Princess Margaret Cancer Center, especially K. Lajkosz and Z. A. Liu for consultation and manuscript review. We thank Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA for providing the anti-PD1 used for the treatment of patients in the INSPIRE trial. This work was supported by the Canadian Institutes of Health Research Foundation (grant no. FDN148386 to D.G.B.), the Canadian Cancer Society (innovation award no. 706230 to D.G.B.), the National Institutes of Health (grant no. AI085043 to D.G.B.), The Terry Fox New Frontiers grant (to D.G.B. and T.L.M.), the Scotiabank Research Chair to D.G.B. and the Princess Margaret Hold'em for Life Cancer Research Fellowship (G.M.B.).	Abdel-Hakeem MS, 2021, NAT IMMUNOL, V22, P1008, DOI 10.1038/s41590-021-00975-5; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Boukhaled GM, 2021, ANNU REV PATHOL-MECH, V16, P167, DOI 10.1146/annurev-pathol-031920-093932; Cano-Gamez E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15543-y; Chen JZ, 2019, J CLIN INVEST, V129, P4224, DOI 10.1172/JCI127458; Chen ZY, 2021, CELL, V184, P1262, DOI 10.1016/j.cell.2021.02.019; Clouthier DL, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0541-0; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Cunningham CR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005356; Diskin B, 2020, NAT IMMUNOL, V21, P442, DOI 10.1038/s41590-020-0620-x; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fairfax BP, 2020, NAT MED, V26, P193, DOI 10.1038/s41591-019-0734-6; Feng D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00291; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Franco F, 2020, NAT METAB, V2, P1001, DOI 10.1038/s42255-020-00280-9; Gadalla R, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00415; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Legut M, 2022, MOL THER, V30, P45, DOI 10.1038/s41586-022-04494-7; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miron M, 2018, J IMMUNOL, V201, P2132, DOI 10.4049/jimmunol.1800716; Munz C, 2003, J BIOL CHEM, V278, P21510, DOI 10.1074/jbc.M212764200; Nance JP, 2015, P NATL ACAD SCI USA, V112, P13324, DOI 10.1073/pnas.1507312112; Nixon AB, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0799-2; Odunsi K, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abg8402; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Sato T, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026948; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Shakiba M, 2021, J EXP MED, V219, DOI 10.1084/jem.20201966; Shen E, 2018, P NATL ACAD SCI USA, V115, P6780, DOI 10.1073/pnas.1805239115; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Snell LM, 2021, NAT IMMUNOL, V22, P1524, DOI 10.1038/s41590-021-01060-7; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Stuart T, 2021, NAT METHODS, V18, P1333, DOI 10.1038/s41592-021-01282-5; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sumida TS, 2022, NAT IMMUNOL, V23, P632, DOI 10.1038/s41590-022-01152-y; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xu SA, 2021, IMMUNITY, V54, P1561, DOI 10.1016/j.immuni.2021.05.003; Yang SYC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25432-7; Yates KB, 2021, NAT IMMUNOL, V22, P1020, DOI 10.1038/s41590-021-00979-1; Yau HL, 2021, MOL CELL, V81, P1469, DOI 10.1016/j.molcel.2021.01.038; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zeng ZQ, 2020, CANCER BIOL MED, V17, P923, DOI 10.20892/j.issn.2095-3941.2020.0338; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhen A, 2017, J CLIN INVEST, V127, P260, DOI 10.1172/JCI89488; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	59	3	3	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1273	+		10.1038/s41590-022-01262-7	http://dx.doi.org/10.1038/s41590-022-01262-7		JUL 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35835962				2022-12-18	WOS:000825208300001
J	Liu, Z; Hu, XT; Liang, YQ; Yu, JT; Li, HB; Shokhirev, MN; Zheng, Y				Liu, Zhi; Hu, Xianting; Liang, Yuqiong; Yu, Jingting; Li, Huabin; Shokhirev, Maxim N.; Zheng, Ye			Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche	NATURE IMMUNOLOGY			English	Article							GENE; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; REVEALS; ACTIVATION; POPULATION; PHENOTYPE; FOXP3(+); HEALTH	Maintenance of tissue homeostasis is dependent on the communication between stem cells and supporting cells in the same niche. Regulatory T cells (T-reg cells) are emerging as a critical component of the stem-cell niche for supporting their differentiation. How T-reg cells sense dynamic signals in this microenvironment and communicate with stem cells is mostly unknown. In the present study, by using hair follicles (HFs) to study T-reg cell-stem cell crosstalk, we show an unrecognized function of the steroid hormone glucocorticoid in instructing skin-resident T-reg cells to facilitate HF stem-cell (HFSC) activation and HF regeneration. Ablation of the glucocorticoid receptor (GR) in T-reg cells blocks hair regeneration without affecting immune homeostasis. Mechanistically, GR and Foxp3 cooperate in T-reg cells to induce transforming growth factor beta 3 (TGF-beta 3), which activates Smad2/3 in HFSCs and facilitates HFSC proliferation. The present study identifies crosstalk between T-reg cells and HFSCs mediated by the GR-TGF-beta 3 axis, highlighting a possible means of manipulating T-reg cells to support tissue regeneration. Skin T-reg cell crosstalk with hair-follicle stem cells (HFSCs) can control hair regrowth. Here the authors show that glucocorticoid receptor signaling in skin T-reg cells induces TGF-beta 3, which in turn facilitates HFSC proliferation.	[Liu, Zhi; Hu, Xianting; Liang, Yuqiong; Zheng, Ye] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Hu, Xianting; Li, Huabin] Fudan Univ, Eye & ENT Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Yu, Jingting; Shokhirev, Maxim N.] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute; Fudan University; Salk Institute	Zheng, Y (corresponding author), Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yzheng@salk.edu			NOMIS fellowship; National Institutes of Health [R01-AI107027, R01-AI1511123, R21-AI154919, S10-OD023689, NCI CCSG P30-014195, NIA P01-AG073084, NIA-NMG RF1-AG064049, NIA P30-AG068635]; Leona M. and Harry B. Helmsley Charitable Trust; NOMIS Foundation; Crohn's and Colitis Foundation; NCI [P30-CA014195]	NOMIS fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; NOMIS Foundation; Crohn's and Colitis Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Hua and C. Gordon for mouse colony management, C. O'Connor for assistance in flow cytometry, U. Manor for assistance in confocal microscopy, N. Hah for assistance in RNA-seq and ChIP-seq experiments, X. Li (Tufts) for CRISPRi vectors, M. Kurita, J. C. I. Belmonte, N. He and R. M. Evans for helpful discussion, and S. P. Bapat (University of California, San Francisco), L. F. Lu (UCSD), C. Wu (National Cancer Institute (NCI)) and T. Mann for reviewing the manuscript. Z.L. was supported by a NOMIS fellowship. J.Y. and M.N.S were supported by the National Institutes of Health (grant nos.: NCI CCSG P30-014195, NIA P01-AG073084, NIA-NMG RF1-AG064049 and NIA P30-AG068635) and the Leona M. and Harry B. Helmsley Charitable Trust. Y.Z. was supported by the NOMIS Foundation, the Crohn's and Colitis Foundation, the Leona M. and Harry B. Helmsley Charitable Trust and the National Institutes of Health (grant nos. R01-AI107027, R01-AI1511123, R21-AI154919 and S10-OD023689). This work was also supported by the NCI-funded Salk Institute Cancer Center Core Facilities (grant no. P30-CA014195).	Ahmed A, 2019, DERMATOLOGY THER, V9, P421, DOI 10.1007/s13555-019-0313-2; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Andrews S., 2010, FASTQC QUALITY CONTR; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bittner-Eddy PD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02228; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cameron J, 2020, J IMMUNOL, V205, P2953, DOI 10.4049/jimmunol.2000537; Choi S, 2021, NATURE, V592, P428, DOI 10.1038/s41586-021-03417-2; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clavel C, 2012, DEV CELL, V23, P981, DOI 10.1016/j.devcel.2012.10.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doetschman T, 2012, GENESIS, V50, P59, DOI 10.1002/dvg.20789; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Flores A, 2017, NAT CELL BIOL, V19, P1017, DOI 10.1038/ncb3575; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Franckaert D, 2015, IMMUNOL CELL BIOL, V93, P417, DOI 10.1038/icb.2014.108; Genander M, 2014, CELL STEM CELL, V15, P619, DOI 10.1016/j.stem.2014.09.009; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Hou R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18873-z; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kalekar LA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw2910; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2020, IMMUNITY, V53, P581, DOI 10.1016/j.immuni.2020.07.002; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lay K, 2018, ELIFE, V7, DOI 10.7554/eLife.41661; Li JT, 2019, THERANOSTICS, V9, P4324, DOI 10.7150/thno.32734; Li YY, 2021, NAT IMMUNOL, V22, P1175, DOI 10.1038/s41590-021-01010-3; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Loo CS, 2020, IMMUNITY, V53, P143, DOI 10.1016/j.immuni.2020.06.011; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Malhotra N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao6923; Mathur AN, 2019, IMMUNITY, V50, P655, DOI 10.1016/j.immuni.2019.02.013; Mullen AC, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022186; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Munoz-Rojas AR, 2021, NAT REV IMMUNOL, V21, P597, DOI 10.1038/s41577-021-00519-w; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik S, 2018, CELL, V175, P908, DOI 10.1016/j.cell.2018.08.071; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Novak JSS, 2021, GENE DEV, V35, DOI 10.1101/gad.346973.120; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rahmani W, 2018, J INVEST DERMATOL, V138, P2111, DOI 10.1016/j.jid.2018.04.010; Rieckmann M, 2019, J CLIN INVEST, V129, P4922, DOI 10.1172/JCI123859; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocamora-Reverte L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00472; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Saxena A, 2014, AM J PHYSIOL-HEART C, V307, pH1233, DOI 10.1152/ajpheart.00328.2014; Shimba A, 2018, IMMUNITY, V48, P286, DOI 10.1016/j.immuni.2018.01.004; Slominski RM, 2020, GENES IMMUN, V21, P150, DOI 10.1038/s41435-020-0096-6; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taves MD, 2011, AM J PHYSIOL-ENDOC M, V301, pE11, DOI 10.1152/ajpendo.00100.2011; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Wu D, 2020, IMMUNOLOGY, V159, P231, DOI 10.1111/imm.13153; Zacchigna S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04908-z; ZHOU YY, 2019, NAT COMMUN, V10, DOI DOI 10.1038/S41467-019-09234-6	72	3	3	33	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1086	+		10.1038/s41590-022-01244-9	http://dx.doi.org/10.1038/s41590-022-01244-9		JUN 2022	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35739197				2022-12-18	WOS:000814987400001
J	Belk, JA; Daniel, B; Satpathy, AT				Belk, Julia A.; Daniel, Bence; Satpathy, Ansuman T.			Epigenetic regulation of T cell exhaustion	NATURE IMMUNOLOGY			English	Review							CHROMATIN-STRUCTURE; SUPER-ENHANCERS; IN-VIVO; TRANSCRIPTION FACTORS; CHRONIC INFECTION; MASS CYTOMETRY; P-TEFB; GENOME; CRISPR; RNA	Chronic antigen stimulation during viral infections and cancer can lead to T cell exhaustion, which is characterized by reduced effector function and proliferation, and the expression of inhibitory immune checkpoint receptors. Recent studies have demonstrated that T cell exhaustion results in wholescale epigenetic remodeling that confers phenotypic stability to these cells and prevents T cell reinvigoration by checkpoint blockade. Here, we review foundational technologies to profile the epigenome at multiple scales, including mapping the locations of transcription factors and histone modifications, DNA methylation and three-dimensional genome conformation. We discuss how these technologies have elucidated the development and epigenetic regulation of exhausted T cells and functional implications across viral infection, cancer, autoimmunity and engineered T cell therapies. Finally, we cover emerging multi-omic and genome engineering technologies, current and upcoming opportunities to apply these to T cell exhaustion, and therapeutic opportunities for T cell engineering in the clinic. Satpathy and colleagues review the epigenetic underpinnings that result in T cell exhaustion.	[Belk, Julia A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Belk, Julia A.; Daniel, Bence; Satpathy, Ansuman T.] Gladstone UCSF Inst Genom Immunol, San Francisco, CA USA; [Daniel, Bence; Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Parker Inst Canc Immunotherapy, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University	Satpathy, AT (corresponding author), Gladstone UCSF Inst Genom Immunol, San Francisco, CA USA.; Satpathy, AT (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Satpathy, AT (corresponding author), Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA.; Satpathy, AT (corresponding author), Stanford Univ, Parker Inst Canc Immunotherapy, Stanford, CA 94305 USA.	satpathy@stanford.edu		Belk, Julia/0000-0003-4724-6158; Satpathy, Ansuman/0000-0002-5167-537X; Daniel, Bence/0000-0002-2410-8767	National Institutes of Health [K08CA230188, U01CA260852, UM1HG012076]; Parker Institute for Cancer Immunotherapy; Burroughs Wellcome Fund; Cancer Research Institute Technology Impact Award; Baxter Foundation Faculty Scholar Award; Pew-Stewart Scholars for Cancer Research Award; Stanford Graduate Fellowship; National Science Foundation [DGE-1656518]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute Technology Impact Award; Baxter Foundation Faculty Scholar Award; Pew-Stewart Scholars for Cancer Research Award; Stanford Graduate Fellowship(Stanford University); National Science Foundation(National Science Foundation (NSF))	We thank S. Knemeyer at SciStories for illustrations. This work was supported by the National Institutes of Health awards K08CA230188, U01CA260852 and UM1HG012076, the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists from the Burroughs Wellcome Fund, a Cancer Research Institute Technology Impact Award, a Baxter Foundation Faculty Scholar Award, and a Pew-Stewart Scholars for Cancer Research Award. J.A.B. was supported by a Stanford Graduate Fellowship and a National Science Foundation Graduate Research Fellowship under grant no. DGE-1656518.	Satpathy A, 2021, bioRxiv, DOI 10.1101/2021.12.16.472900; Abdel-Hakeem MS, 2021, NAT IMMUNOL, V22, P1008, DOI 10.1038/s41590-021-00975-5; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Andersson R, 2020, NAT REV GENET, V21, P71, DOI 10.1038/s41576-019-0173-8; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartosovic M, 2021, NAT BIOTECHNOL, V39, P825, DOI 10.1038/s41587-021-00869-9; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bowling S, 2020, CELL, V181, P1410, DOI 10.1016/j.cell.2020.04.048; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burger ML, 2021, CELL, V184, P4996, DOI 10.1016/j.cell.2021.08.020; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carter B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11559-1; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen Y, 2021, NAT IMMUNOL, V22, P996, DOI 10.1038/s41590-021-00965-7; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dong MB, 2019, CELL, V178, P1189, DOI 10.1016/j.cell.2019.07.044; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Ford B. R., BIORXIV, DOI [10.1101/2021.07.11.451947(2021, DOI 10.1101/2021.07.11.451947(2021]; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gabriel SS, 2021, IMMUNITY, V54, P1698, DOI 10.1016/j.immuni.2021.06.007; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gennert DG, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2104758118; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Good CR, 2021, CELL, V184, P6081, DOI 10.1016/j.cell.2021.11.016; Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Harris CJ, 2018, SCIENCE, V362, P1182, DOI 10.1126/science.aar7854; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang HL, 2021, CELL, V184, P1245, DOI 10.1016/j.cell.2021.02.021; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Ku WL, 2019, NAT METHODS, V16, P323, DOI 10.1038/s41592-019-0361-7; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; Luecken MD, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188746; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Ma S, 2020, CELL, V183, P1103, DOI 10.1016/j.cell.2020.09.056; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Mathewson ND, 2021, CELL, V184, P1281, DOI 10.1016/j.cell.2021.01.022; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mimitou EP, 2021, NAT BIOTECHNOL, V39, P1246, DOI 10.1038/s41587-021-00927-2; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olins DE, 2003, NAT REV MOL CELL BIO, V4, P809, DOI 10.1038/nrm1225; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pai JA, 2021, NAT METHODS, V18, P881, DOI 10.1038/s41592-021-01201-8; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pierce SE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23213-w; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Prinzing B, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh0272; Pritykin Y, 2021, MOL CELL, V81, P2477, DOI 10.1016/j.molcel.2021.03.045; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Raju S, 2021, J IMMUNOL, V206, P2924, DOI 10.4049/jimmunol.2001348; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Replogle JM, 2020, NAT BIOTECHNOL, V38, P954, DOI 10.1038/s41587-020-0470-y; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Roth TL, 2020, CELL, V181, P728, DOI 10.1016/j.cell.2020.03.039; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Rubin AJ, 2019, CELL, V176, P361, DOI 10.1016/j.cell.2018.11.022; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Schmidt R, 2022, SCIENCE, V375, P513, DOI 10.1126/science.abj4008; Schoenfelder S, 2019, NAT REV GENET, V20, P437, DOI 10.1038/s41576-019-0128-0; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2021, NAT IMMUNOL, V22, P983, DOI 10.1038/s41590-021-00964-8; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shakiba M, 2021, J EXP MED, V219, DOI 10.1084/jem.20201966; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Tonnerre P, 2021, NAT IMMUNOL, V22, P1030, DOI 10.1038/s41590-021-00982-6; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weber EW, 2021, SCIENCE, V372, P49, DOI 10.1126/science.aba1786; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu SJ, 2021, NAT BIOTECHNOL, V39, P819, DOI 10.1038/s41587-021-00865-z; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Xia Y., 2021, BIORXIV, DOI [10.1101/2021.08.06.455141, DOI 10.1101/2021.08.06.455141]; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yao C, 2021, NAT IMMUNOL, V22, P370, DOI 10.1038/s41590-021-00868-7; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yates KB, 2021, NAT IMMUNOL, V22, P1020, DOI 10.1038/s41590-021-00979-1; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	173	3	3	34	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					848	860		10.1038/s41590-022-01224-z	http://dx.doi.org/10.1038/s41590-022-01224-z		MAY 2022	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624210				2022-12-18	WOS:000805549900006
J	Kobiyama, K; Ishii, KJ				Kobiyama, Kouji; Ishii, Ken J.			Making innate sense of mRNA vaccine adjuvanticity	NATURE IMMUNOLOGY			English	Editorial Material								mRNA vaccines such as those used to prevent COVID-19 owe part of their success to methylation that masks immunostimulatory properties of the mRNA, but the immunological mechanisms of adjuvanticity are unclear. Two new studies reveal distinct mechanisms for innate sensing of this hidden adjuvant.	[Kobiyama, Kouji; Ishii, Ken J.] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Vaccine Sci, Tokyo, Japan; [Kobiyama, Kouji; Ishii, Ken J.] Univ Tokyo, Inst Med Sci, Int Vaccine Design Ctr, Tokyo, Japan; [Kobiyama, Kouji; Ishii, Ken J.] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Vaccine Adjuvant Res, Osaka, Japan	University of Tokyo; University of Tokyo	Ishii, KJ (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Vaccine Sci, Tokyo, Japan.; Ishii, KJ (corresponding author), Univ Tokyo, Inst Med Sci, Int Vaccine Design Ctr, Tokyo, Japan.; Ishii, KJ (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Ctr Vaccine Adjuvant Res, Osaka, Japan.	kenishii@ims.u-tokyo.ac.jp	Ishii, Ken/B-1685-2012	Ishii, Ken/0000-0002-6728-3872				Alameh MG, 2021, IMMUNITY, V54, P2877, DOI 10.1016/j.immuni.2021.11.001; Mann CDC, 2021, EUR J IMMUNOL, V51, P1897, DOI 10.1002/eji.202049116; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Ishii KJ, 2005, IMMUNITY, V23, P111, DOI 10.1016/j.immuni.2005.08.003; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kobiyama K., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.03.04.433852, DOI 10.1101/2021.03.04.433852]; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Li CF, 2022, NAT IMMUNOL, V23, P543, DOI 10.1038/s41590-022-01163-9; Miao L, 2019, NAT BIOTECHNOL, V37, P1174, DOI 10.1038/s41587-019-0247-3; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Tahtinen S, 2022, NAT IMMUNOL, V23, P532, DOI 10.1038/s41590-022-01160-y; Zhang HX, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2005191118	12	3	3	11	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					474	476		10.1038/s41590-022-01168-4	http://dx.doi.org/10.1038/s41590-022-01168-4		MAR 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35354958	Bronze			2022-12-18	WOS:000775781500001
J	Lagattuta, KA; Kang, JB; Nathan, A; Pauken, KE; Jonsson, AH; Rao, DA; Sharpe, AH; Ishigaki, K; Raychaudhuri, S				Lagattuta, Kaitlyn A.; Kang, Joyce B.; Nathan, Aparna; Pauken, Kristen E.; Jonsson, Anna Helena; Rao, Deepak A.; Sharpe, Arlene H.; Ishigaki, Kazuyoshi; Raychaudhuri, Soumya			Repertoire analyses reveal T cell antigen receptor sequence features that influence T cell fate	NATURE IMMUNOLOGY			English	Article							THYMIC SELECTION; EXPRESSION; GENERATION; TOLERANCE; PROTEINS; PROMOTE	Raychaudhuri and colleagues identify TCR-intrinsic features that govern development of regulatory T cells. T cells acquire a regulatory phenotype when their T cell antigen receptors (TCRs) experience an intermediate- to high-affinity interaction with a self-peptide presented via the major histocompatibility complex (MHC). Using TCR beta sequences from flow-sorted human cells, we identified TCR features that promote regulatory T cell (T-reg) fate. From these results, we developed a scoring system to quantify TCR-intrinsic regulatory potential (TiRP). When applied to the tumor microenvironment, TiRP scoring helped to explain why only some T cell clones maintained the conventional T cell (T-conv) phenotype through expansion. To elucidate drivers of these predictive TCR features, we then examined the two elements of the T-reg TCR ligand separately: the self-peptide and the human MHC class II molecule. These analyses revealed that hydrophobicity in the third complementarity-determining region (CDR3 beta) of the TCR promotes reactivity to self-peptides, while TCR variable gene (TRBV gene) usage shapes the TCR's general propensity for human MHC class II-restricted activation.	[Lagattuta, Kaitlyn A.; Kang, Joyce B.; Nathan, Aparna; Ishigaki, Kazuyoshi; Raychaudhuri, Soumya] Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA; [Lagattuta, Kaitlyn A.; Kang, Joyce B.; Nathan, Aparna; Ishigaki, Kazuyoshi; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Lagattuta, Kaitlyn A.; Kang, Joyce B.; Nathan, Aparna; Jonsson, Anna Helena; Rao, Deepak A.; Ishigaki, Kazuyoshi; Raychaudhuri, Soumya] Harvard Med Sch, Boston, MA 02115 USA; [Lagattuta, Kaitlyn A.; Kang, Joyce B.; Nathan, Aparna; Jonsson, Anna Helena; Rao, Deepak A.; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA; [Lagattuta, Kaitlyn A.; Kang, Joyce B.; Nathan, Aparna; Raychaudhuri, Soumya] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Lagattuta, Kaitlyn A.; Kang, Joyce B.; Nathan, Aparna; Sharpe, Arlene H.; Ishigaki, Kazuyoshi; Raychaudhuri, Soumya] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Pauken, Kristen E.; Sharpe, Arlene H.] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA USA; [Pauken, Kristen E.; Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Pauken, Kristen E.; Sharpe, Arlene H.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ishigaki, Kazuyoshi] RIKEN, Lab Human Immunogenet, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Raychaudhuri, Soumya] Univ Manchester, Manchester Acad, Ctr Genet & Genom Versus Arthrit, Hlth Sci Ctr, Manchester, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; RIKEN; University of Manchester	Ishigaki, K; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA.; Ishigaki, K; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA.; Ishigaki, K; Raychaudhuri, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Ishigaki, K; Raychaudhuri, S (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Ishigaki, K (corresponding author), RIKEN, Lab Human Immunogenet, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.; Raychaudhuri, S (corresponding author), Univ Manchester, Manchester Acad, Ctr Genet & Genom Versus Arthrit, Hlth Sci Ctr, Manchester, Lancs, England.	kazuyoshi.ishigaki@riken.jp; soumya@broadinstitute.org		Sharpe, Arlene/0000-0002-9736-2109; Raychaudhuri, Soumya/0000-0002-1901-8265; Nathan, Aparna/0000-0002-5975-2851; Rao, Deepak/0000-0001-9672-7746; Jonsson, Anna Helena/0000-0002-9558-2474; Ishigaki, Kazuyoshi/0000-0003-2881-0657	National Institute of General Medical Sciences [T32GM007753]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [T32AR007530]; National Institutes of Health (NIH) NIAMS [K08 AR072791]; Career Award for Medical Sciences from the Burroughs Wellcome Fund; NIH [U19-AI111224-01, P01AI148102-01A1, U01-HG009379-04S1, 1R01AR063759, UH2-AR067677, P01 AI039671, P01 CA236749, P01 AI108545]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health (NIH) NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Career Award for Medical Sciences from the Burroughs Wellcome Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M.B. Brenner for helpful scientific conversations regarding this work. K.A.L. and J.B.K. are each supported by award number T32GM007753 from the National Institute of General Medical Sciences. A.N. is supported by award number T32AR007530 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. D.A.R. is supported by National Institutes of Health (NIH) NIAMS K08 AR072791 and a Career Award for Medical Sciences from the Burroughs Wellcome Fund. A.H.S. is supported by NIH P01 AI039671, P01 CA236749 and P01 AI108545. S.R. is supported by NIH grants U19-AI111224-01, P01AI148102-01A1, U01-HG009379-04S1, 1R01AR063759 and UH2-AR067677.	Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Daley SR, 2019, J ALLERGY CLIN IMMUN, V144, P333, DOI 10.1016/j.jaci.2019.03.022; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gomez-Tourino I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01925-2; Ihara S., 1993, INFORM THEORY CONTIN; Joller N, 2014, NAT MED, V20, P15, DOI 10.1038/nm.3439; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Kang JB., 2021, NAT COMMUN, V12; Khosravi-Maharlooei M, 2019, J CLIN INVEST, V129, P2446, DOI 10.1172/JCI124358; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Lide D. R., 1991, CRC HDB CHEM PHYS; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nathan A, 2021, NAT IMMUNOL, V22, P781, DOI 10.1038/s41590-021-00933-1; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Romagnoli P, 2010, PROG MOL BIOL TRANSL, V92, P251, DOI 10.1016/S1877-1173(10)92010-3; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Schuldt NJ, 2019, J IMMUNOL, V202, P637, DOI 10.4049/jimmunol.1800904; Seay HR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88242; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shannon C.E., 1998, MATH THEORY COMMUNIC; Sharon E, 2016, NAT GENET, V48, P995, DOI 10.1038/ng.3625; Shugay M, 2018, NUCLEIC ACIDS RES, V46, pD419, DOI 10.1093/nar/gkx760; Sidwell T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14112-2; Soto C, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107882; Stadinski BD, 2016, NAT IMMUNOL, V17, P946, DOI 10.1038/ni.3491; Thornton AM, 2019, EUR J IMMUNOL, V49, P398, DOI 10.1002/eji.201847935; Tickotsky N, 2017, BIOINFORMATICS, V33, P2924, DOI 10.1093/bioinformatics/btx286; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Witten I.H., 2005, P DATA MINING LAS VE, P4; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Yun TJ, 2001, NAT IMMUNOL, V2, P13, DOI 10.1038/83118; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zarembka P., 1999, FRONTIERS ECONOMETRI; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	48	3	3	5	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					446	+		10.1038/s41590-022-01129-x	http://dx.doi.org/10.1038/s41590-022-01129-x		FEB 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35177831	Green Accepted, Green Submitted			2022-12-18	WOS:000757129600001
J	Katzmarski, N; Dominguez-Andres, J; Cirovic, B; Renieris, G; Ciarlo, E; Le Roy, D; Lepikhov, K; Kattler, K; Gasparoni, G; Handler, K; Theis, H; Beyer, M; van der Meer, JWM; Joosten, LAB; Walter, J; Schultze, JL; Roger, T; Giamarellos-Bourboulis, EJ; Schlitzer, A; Netea, MG				Katzmarski, Natalie; Dominguez-Andres, Jorge; Cirovic, Branko; Renieris, Georgios; Ciarlo, Eleonora; Le Roy, Didier; Lepikhov, Konstantin; Kattler, Kathrin; Gasparoni, Gilles; Haendler, Kristian; Theis, Heidi; Beyer, Marc; van der Meer, Jos W. M.; Joosten, Leo A. B.; Walter, Jorn; Schultze, Joachim L.; Roger, Thierry; Giamarellos-Bourboulis, Evangelos J.; Schlitzer, Andreas; Netea, Mihai G.			Reply to: 'Lack of evidence for intergenerational inheritance of immune resistance to infections'	NATURE IMMUNOLOGY			English	Editorial Material									[Katzmarski, Natalie; Cirovic, Branko; Schlitzer, Andreas] Univ Bonn, Life & Med Sci Inst, Quantitat Syst Biol, Bonn, Germany; [Dominguez-Andres, Jorge; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Dominguez-Andres, Jorge; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Dominguez-Andres, Jorge; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Renieris, Georgios; Giamarellos-Bourboulis, Evangelos J.] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 4, Athens, Greece; [Ciarlo, Eleonora; Le Roy, Didier; Roger, Thierry] Lausanne Univ Hosp, Dept Med, Infect Dis Serv, Epalinges, Switzerland; [Ciarlo, Eleonora; Le Roy, Didier; Roger, Thierry] Univ Lausanne, Epalinges, Switzerland; [Lepikhov, Konstantin; Kattler, Kathrin; Gasparoni, Gilles; Walter, Jorn] Saarland Univ, Dept Genet Epigenet, Saarbrucken, Germany; [Haendler, Kristian; Theis, Heidi; Beyer, Marc] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, PRECISE, Bonn, Germany; [Haendler, Kristian; Theis, Heidi; Beyer, Marc] Univ Bonn, Bonn, Germany; [Beyer, Marc; Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Mol Immunol Neurodegenerat, Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, Life & Med Sci Inst, Dept Genom & Immunoregulat, Bonn, Germany; [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst, Dept Immunol & Metab, Bonn, Germany	University of Bonn; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; National & Kapodistrian University of Athens; University of Lausanne; Saarland University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Dominguez-Andres, J (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Dominguez-Andres, J (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.; Dominguez-Andres, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	jorge.dominguezandres@radboudumc.nl	Walter, Jörn/AFN-6428-2022; Dominguez-Andres, Jorge/S-6211-2017	Walter, Jörn/0000-0003-0563-7417; Dominguez-Andres, Jorge/0000-0002-9091-1961; Cirovic, Branko/0000-0002-0754-0099				Berendsen MLT, 2021, ECLINICALMEDICINE, V39, DOI 10.1016/j.eclinm.2021.101049; Bomans K, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0522-z; Gee S, 2021, NAT IMMUNOL, V22, P1490, DOI 10.1038/s41590-021-01049-2; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Katzmarski N, 2021, NAT IMMUNOL, V22, P1382, DOI 10.1038/s41590-021-01052-7; Kaufmann E., NAT IMMUNOL, DOI [10.1038/s41590-021-01102-0(2021, DOI 10.1038/S41590-021-01102-0(2021]; Lim AI, 2021, SCIENCE, V373, DOI 10.1126/science.abf3002; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Mondotte JA, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108506; Rokade S, 2021, AM J REPROD IMMUNOL, V86, DOI 10.1111/aji.13401	10	3	3	2	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					208	+		10.1038/s41590-021-01103-z	http://dx.doi.org/10.1038/s41590-021-01103-z		JAN 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35058615	Bronze, Green Submitted			2022-12-18	WOS:000744891300003
J	Di Pietro, A; Polmear, J; Cooper, L; Damelang, T; Hussain, T; Hailes, L; O'Donnell, K; Udupa, V; Mi, T; Preston, S; Shtewe, A; Hershberg, U; Turner, SJ; La Gruta, NL; Chung, AW; Tarlinton, DM; Scharer, CD; Good-Jacobson, KL				Di Pietro, Andrea; Polmear, Jack; Cooper, Lucy; Damelang, Timon; Hussain, Tabinda; Hailes, Lauren; O'Donnell, Kristy; Udupa, Vibha; Mi, Tian; Preston, Simon; Shtewe, Areen; Hershberg, Uri; Turner, Stephen J.; La Gruta, Nicole L.; Chung, Amy W.; Tarlinton, David M.; Scharer, Christopher D.; Good-Jacobson, Kim L.			Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; GERMINAL CENTER FORMATION; PLASMA-CELLS; C-MYC; ACQUIRED-IMMUNODEFICIENCY; HIGH-THROUGHPUT; FC-RECEPTOR; IN-VIVO; GENE; EXPRESSION	Ineffective antibody-mediated responses are a key characteristic of chronic viral infection. However, our understanding of the intrinsic mechanisms that drive this dysregulation are unclear. Here, we identify that targeting the epigenetic modifier BMI-1 in mice improves humoral responses to chronic lymphocytic choriomeningitis virus. BMI-1 was upregulated by germinal center B cells in chronic viral infection, correlating with changes to the accessible chromatin landscape, compared to acute infection. B cell-intrinsic deletion of Bmi1 accelerated viral clearance, reduced splenomegaly and restored splenic architecture. Deletion of Bmi1 restored c-Myc expression in B cells, concomitant with improved quality of antibody and coupled with reduced antibody-secreting cell numbers. Specifically, BMI-1-deficiency induced antibody with increased neutralizing capacity and enhanced antibody-dependent effector function. Using a small molecule inhibitor to murine BMI-1, we could deplete antibody-secreting cells and prohibit detrimental immune complex formation in vivo. This study defines BMI-1 as a crucial immune modifier that controls antibody-mediated responses in chronic infection. Chronic viral infection leads to a dysregulation of germinal center B cell responses. Di Pietro et al. show that the epigenetic modifier BMI-1 promotes this dysfunctional response and that targeting BMI-1 in B cells can restore humoral immunity and accelerate viral clearance.	[Di Pietro, Andrea; Polmear, Jack; Cooper, Lucy; Hussain, Tabinda; Hailes, Lauren; La Gruta, Nicole L.; Good-Jacobson, Kim L.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Di Pietro, Andrea; Polmear, Jack; Cooper, Lucy; Hussain, Tabinda; Hailes, Lauren; Udupa, Vibha; Turner, Stephen J.; La Gruta, Nicole L.; Good-Jacobson, Kim L.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Damelang, Timon; Udupa, Vibha; Chung, Amy W.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [O'Donnell, Kristy; Tarlinton, David M.] Monash Univ, Dept Immunol & Pathol, Alfred Res Alliance, Melbourne, Vic, Australia; [Udupa, Vibha; Turner, Stephen J.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia; [Mi, Tian; Scharer, Christopher D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Preston, Simon] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Preston, Simon] Walter & Eliza Hall Inst Med Res, Div Mol Immunol, Parkville, Vic, Australia; [Preston, Simon] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Shtewe, Areen; Hershberg, Uri] Univ Haifa, Fac Sci, Dept Human Biol, Haifa, Israel	Monash University; Monash University; University of Melbourne; Monash University; Monash University; Emory University; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; University of Haifa	Good-Jacobson, KL (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Good-Jacobson, KL (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.	kim.jacobson@monash.edu	Hershberg, Uri/AAQ-6255-2020; Turner, Stephen/GXM-4654-2022; Di Pietro, Andrea/X-6373-2018	Hershberg, Uri/0000-0002-6425-5980; Polmear, Jack/0000-0003-3449-4128; Damelang, Timon/0000-0002-6150-4435; Di Pietro, Andrea/0000-0003-2497-3862; Chung, Amy/0000-0003-0020-9704; Hussain, Tabinda/0000-0003-2672-2004; Good-Jacobson, Kim/0000-0003-1891-7274; La Gruta, Nicole/0000-0001-5358-9363; Preston, Simon/0000-0001-8969-8297	Bellberry-Viertel Senior Medical Research Fellowship; National Health and Medical Research Council (NHMRC) Career Development Fellowships [1108066, 1140509]; American Association of Immunologists Careers in Immunology Fellowship and Travel for Techniques program; Australian Research Council [FT170100174, DP200102776, DP170102020]; NHMRC [1182086, 1183478, 1054925, 1175411]; Monash University Biomedicine Discovery Institute Scholarship; Monash University Scholarship for Excellence; Bonn University - Melbourne University; National Institutes of Health [P01 AI106697]; European Union's Horizon 2020 Research and Innovation program [825821]; Monash University Graduate Scholarship; Monash International Postgraduate Research Scholarship	Bellberry-Viertel Senior Medical Research Fellowship; National Health and Medical Research Council (NHMRC) Career Development Fellowships(National Health and Medical Research Council (NHMRC) of Australia); American Association of Immunologists Careers in Immunology Fellowship and Travel for Techniques program; Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Monash University Biomedicine Discovery Institute Scholarship; Monash University Scholarship for Excellence; Bonn University - Melbourne University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union's Horizon 2020 Research and Innovation program; Monash University Graduate Scholarship(Monash University); Monash International Postgraduate Research Scholarship(Monash University)	We thank J. Groom (Walter and Eliza Hall Institute), I. Parish (Peter MacCallum Cancer Centre), C. Zaph and J. Rossjohn for critical reading of this manuscript and/or discussions; M. Pellegrini (Walter and Eliza Hall Institute), M. Degli-Esposti (Monash University) and A. Papa (Monash University) for generously providing, respectively, LCMV stocks, IL-2 and c-Myc antibody; J. Sun and members of the Good-Jacobson laboratory for technical assistance; O. Chernyavskiy and the staff of Monash Micro Imaging for the provision of instrumentation training and technical support; Monash FlowCore, Bioinformatics and Animal Research Platforms; and MHTP Medical Genomics Facility. This work was supported by a Bellberry-Viertel Senior Medical Research Fellowship (K.L.G.-J.); National Health and Medical Research Council (NHMRC) Career Development Fellowships 1108066 (K.L.G.-J.) and 1140509 (A.W.C.); American Association of Immunologists Careers in Immunology Fellowship and Travel for Techniques program (A.D.P. and K.L.G.-J.); Australian Research Council Future Fellowship FT170100174 and Discovery Project DP200102776, NHMRC Ideas grant 1182086 (N.L.L.G.); NHMRC Program grant 1054925 and Investigator award 1175411 (D.M.T. and K.O.D.); Australian Research Council Discovery Project DP170102020 and NHMRC Ideas grant 1183478 (S.J.T.); Monash University Biomedicine Discovery Institute Scholarship (L.C.); Monash University Scholarship for Excellence (J.P.); Monash University Graduate Scholarship and Monash International Postgraduate Research Scholarship (T.H.); Postgraduate Scholarship from the Bonn University -Melbourne University joining PhD program (V.U.); National Institutes of Health P01 AI106697 and the European Union's Horizon 2020 Research and Innovation program 825821 (U.H. and A.S.). The contents of this document can under no circumstances be regarded as reflecting the position of the European Union.	APPEL GB, 1993, NEW ENGL J MED, V328, P505, DOI 10.1056/NEJM199302183280711; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Beguelin W, 2016, CANCER CELL, V30, P197, DOI 10.1016/j.ccell.2016.07.006; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Cantor DJ, 2019, CELL REP, V26, P108, DOI 10.1016/j.celrep.2018.12.030; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Caskey M, 2019, NAT MED, V25, P547, DOI 10.1038/s41591-019-0412-8; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Cooper L, 2020, IMMUNOL CELL BIOL, V98, P456, DOI 10.1111/imcb.12338; De Vos J, 2002, ONCOGENE, V21, P6848, DOI 10.1038/sj.onc.1205868; Dey A, 2018, MOL CANCER THER, V17, P39, DOI 10.1158/1535-7163.MCT-17-0574; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fallet B, 2020, CELL REP, V30, P1013, DOI 10.1016/j.celrep.2019.12.023; Finkin S, 2019, IMMUNITY, V51, P324, DOI 10.1016/j.immuni.2019.06.013; Francica JR, 2017, BLOOD ADV, V1, P2329, DOI 10.1182/bloodadvances.2017011411; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Giudicelli V., 2011, COLD SPRING HARB PRO, V2011, P695, DOI DOI 10.1101/PDB.PR0T5633; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Good-Jacobson KL, 2015, J EXP MED, V212, P1001, DOI 10.1084/jem.20150191; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hiepe F, 2016, NAT REV NEPHROL, V12, P232, DOI 10.1038/nrneph.2016.20; Huang R, 2011, FASEB J, V25, P4138, DOI 10.1096/fj.11-185033; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jagani Z, 2010, CANCER RES, V70, P5528, DOI 10.1158/0008-5472.CAN-09-4229; Kao D, 2017, EUR J IMMUNOL, V47, P2070, DOI 10.1002/eji.201747208; Kealy L, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108504; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kong Y, 2018, CELL CYCLE, V17, P1199, DOI 10.1080/15384101.2018.1469872; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lofano G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7796; Lopez E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02415; Louten J, 2006, J IMMUNOL, V177, P3266, DOI 10.4049/jimmunol.177.5.3266; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Low M, 2016, IMMUNOL REV, V270, P78, DOI 10.1111/imr.12388; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Mahan AE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005456; Mahan AE, 2015, J IMMUNOL METHODS, V417, P34, DOI 10.1016/j.jim.2014.12.004; Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669; Morera L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0223-4; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; OLDSTONE MB, 1970, J EXP MED, V131, P1, DOI 10.1084/jem.131.1.1; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Piovesan D, 2017, CELL REP, V19, P461, DOI 10.1016/j.celrep.2017.03.060; Quinn KM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16633-7; Raaphorst FM, 2000, J IMMUNOL, V164, P1, DOI 10.4049/jimmunol.164.1.1; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Rosenfeld AM, 2017, BIOINFORMATICS, V33, P292, DOI 10.1093/bioinformatics/btw593; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sarosiek KA, 2010, BLOOD, V115, P570, DOI 10.1182/blood-2009-08-239996; Scharer CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27030; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Staupe R. P., 2019, BIORXIV, DOI [DOI 10.1101/849844, 10.1101/849844]; Straub T, 2013, EUR J IMMUNOL, V43, P2338, DOI 10.1002/eji.201343565; Tanaka S, 2020, NAT IMMUNOL, V21, P950, DOI 10.1038/s41590-020-0700-y; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tsyganov K., 2018, J OPEN SOURCE SOFTWA, V3, P583, DOI [10.21105/joss.00583, DOI 10.21105/JOSS.00583]; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2013, FEBS J, V280, P2929, DOI 10.1111/febs.12299; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Wieland A, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao3125; Wieland A, 2015, IMMUNITY, V42, P367, DOI 10.1016/j.immuni.2015.01.009; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457; Yamada DH, 2015, IMMUNITY, V42, P379, DOI 10.1016/j.immuni.2015.01.005; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Zhang BC, 2015, J IMMUNOL METHODS, V427, P105, DOI 10.1016/j.jim.2015.10.009; Zhang Y, 2019, IMMUNOL REV, V288, P75, DOI 10.1111/imr.12733; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zohar T, 2020, CELL, V183, P1508, DOI 10.1016/j.cell.2020.10.052; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	101	3	3	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					86	+		10.1038/s41590-021-01077-y	http://dx.doi.org/10.1038/s41590-021-01077-y		NOV 2021	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34845392	Bronze			2022-12-18	WOS:000723578300001
J	Doane, AS; Chu, CS; Di Giammartino, DC; Rivas, MA; Hellmuth, JC; Jiang, YW; Yusufova, N; Alonso, A; Roeder, RG; Apostolou, E; Melnick, AM; Elemento, O				Doane, Ashley S.; Chu, Chi-Shuen; Di Giammartino, Dafne Campigli; Rivas, Martin A.; Hellmuth, Johannes C.; Jiang, Yanwen; Yusufova, Nevin; Alonso, Alicia; Roeder, Robert G.; Apostolou, Effie; Melnick, Ari M.; Elemento, Olivier			OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER B; TRANSCRIPTION-FACTOR; GENE; BCL6; COACTIVATOR; GENOME; EXPRESSION; PROMOTER; DYNAMICS; ENCODE	During the germinal center (GC) reaction, B cells undergo profound transcriptional, epigenetic and genomic architectural changes. How such changes are established remains unknown. Mapping chromatin accessibility during the humoral immune response, we show that OCT2 was the dominant transcription factor linked to differential accessibility of GC regulatory elements. Silent chromatin regions destined to become GC-specific super-enhancers (SEs) contained pre-positioned OCT2-binding sites in naive B cells (NBs). These preloaded SE 'seeds' featured spatial clustering of regulatory elements enriched in OCT2 DNA-binding motifs that became heavily loaded with OCT2 and its GC-specific coactivator OCAB in GC B cells (GCBs). SEs with high abundance of pre-positioned OCT2 binding preferentially formed long-range chromatin contacts in GCs, to support expression of GC-specifying factors. Gain in accessibility and architectural interactivity of these regions were dependent on recruitment of OCAB. Pre-positioning key regulators at SEs may represent a broadly used strategy for facilitating rapid cell fate transitions. Elemento, Melnick and colleagues examine the chromatin and transcriptional changes that occur during differentiation of human primary B cells into antibody-secreting cells. In naive B cells, the transcription factor OCT2 is preloaded at high-affinity super-enhancer sites present in repressed 'silent' chromatin; upon activation, OCAB is recruited to these regions, where it facilitates arrays of OCT2 binding to lower-affinity octamer motifs, leading to active formation of germinal center B cell-specific super-enhancers.	[Doane, Ashley S.; Jiang, Yanwen; Elemento, Olivier] Weill Cornell Med, Inst Computat Biomed, Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA; [Doane, Ashley S.] Weill Cornell Med, Computat Biol & Med Triinst PhD Program, New York, NY USA; [Chu, Chi-Shuen; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10021 USA; [Di Giammartino, Dafne Campigli; Rivas, Martin A.; Hellmuth, Johannes C.; Jiang, Yanwen; Yusufova, Nevin; Alonso, Alicia; Apostolou, Effie; Melnick, Ari M.] Weill Cornell Med, Div Hematol & Oncol, Dept Med, New York, NY 10021 USA	Cornell University; Cornell University; Rockefeller University; Cornell University	Elemento, O (corresponding author), Weill Cornell Med, Inst Computat Biomed, Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA.; Melnick, AM (corresponding author), Weill Cornell Med, Div Hematol & Oncol, Dept Med, New York, NY 10021 USA.	amm2014@med.cornell.edu; ole2001@med.cornell.edu	; Doane, Ashley Stephen/B-7027-2008	Hellmuth, Johannes C./0000-0001-8409-3037; Rivas, Martin/0000-0002-9603-6897; Doane, Ashley Stephen/0000-0002-1489-1786; Campigli di Giammartino, Dafne/0000-0002-3130-3536				Agirre X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08679-z; Arnold CN, 2012, P NATL ACAD SCI USA, V109, P12286, DOI 10.1073/pnas.1209134109; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Cao YQ, 2020, BIOINFORMATICS, V36, P666, DOI 10.1093/bioinformatics/btz651; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Chen SW, 2016, MOL CELL BIOL, V36, P2543, DOI 10.1128/MCB.00150-16; Chu CS, 2020, MOL CELL, V80, P845, DOI 10.1016/j.molcel.2020.10.036; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Di Giammartino DC, 2019, NAT CELL BIOL, V21, P1179, DOI 10.1038/s41556-019-0390-6; Dominguez PM, 2015, CELL REP, V12, P2086, DOI 10.1016/j.celrep.2015.08.036; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Fernando TM, 2019, CANCER DISCOV, V9, P662, DOI 10.1158/2159-8290.CD-17-1444; Fulco CP, 2019, NAT GENET, V51, P1664, DOI 10.1038/s41588-019-0538-0; Gaspar JM, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2579-2; Golay J, 1998, J IMMUNOL, V160, P2786; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; Hatzi K, 2019, NAT IMMUNOL, V20, P86, DOI 10.1038/s41590-018-0273-1; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hodson DJ, 2016, P NATL ACAD SCI USA, V113, pE2039, DOI 10.1073/pnas.1600557113; Huang CX, 2014, CELL REP, V8, P1497, DOI 10.1016/j.celrep.2014.07.059; Imielinski M, 2017, CELL, V168, P460, DOI 10.1016/j.cell.2016.12.025; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Kostka D, 2015, STAT INTERFACE, V8, P463, DOI 10.4310/SII.2015.v8.n4.a6; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malik V, 2018, CELL MOL LIFE SCI, V75, P1587, DOI 10.1007/s00018-018-2748-5; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Michael AK, 2020, SCIENCE, V368, P1460, DOI 10.1126/science.abb0074; Mlynarczyk C, 2019, IMMUNOL REV, V288, P214, DOI 10.1111/imr.12755; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Raviram R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004780; Rivas MA, 2021, NAT IMMUNOL, V22, P240, DOI 10.1038/s41590-020-00827-8; Saez AI, 2002, MODERN PATHOL, V15, P211, DOI 10.1038/modpathol.3880518; Saint-Andre V, 2016, GENOME RES, V26, P385, DOI 10.1101/gr.197590.115; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Schoenfelder S, 2019, NAT REV GENET, V20, P437, DOI 10.1038/s41576-019-0128-0; Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Song S, 2021, BLOOD, V137, P2920, DOI 10.1182/blood.2020010175; Song S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Wang S, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01986-5; Willis SN, 2014, J IMMUNOL, V192, P3200, DOI 10.4049/jimmunol.1303216; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Yusufova N, 2021, NATURE, V589, P299, DOI 10.1038/s41586-020-3017-y; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhu FJ, 2018, NATURE, V562, P76, DOI 10.1038/s41586-018-0549-5	62	3	3	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1327	+		10.1038/s41590-021-01025-w	http://dx.doi.org/10.1038/s41590-021-01025-w		SEP 2021	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556886				2022-12-18	WOS:000751833700010
J	Li, X; Rawat, K; Jakubzick, CV				Li, Xin; Rawat, Kavita; Jakubzick, Claudia V.			Targeting resident macrophages in cancer	NATURE IMMUNOLOGY			English	Editorial Material									[Li, Xin; Rawat, Kavita; Jakubzick, Claudia V.] Dartmouth Coll, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College	Jakubzick, CV (corresponding author), Dartmouth Coll, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	claudia.jakubzick@dartmouth.edu		Li, Xin/0000-0002-2050-2628				Casanova-Acebes M, 2021, NATURE, V595, P578, DOI 10.1038/s41586-021-03651-8; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Mould KJ, 2021, AM J RESP CRIT CARE, V203, P946, DOI 10.1164/rccm.202005-1989OC; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Ural BB, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax8756; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	10	3	4	4	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1078	1079		10.1038/s41590-021-01002-3	http://dx.doi.org/10.1038/s41590-021-01002-3		AUG 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34354280	Green Accepted			2022-12-18	WOS:000681536100001
J	Visan, I				Visan, Ioana			A STING in the tail for SARS-CoV-2	NATURE IMMUNOLOGY			English	Editorial Material												i.visan@us.nature.com							0	3	3	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					800	800		10.1038/s41590-021-00971-9	http://dx.doi.org/10.1038/s41590-021-00971-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB1FO	34183855	Bronze			2022-12-18	WOS:000667688400002
J	Schiller, HB; van Breugel, M; Nawijn, MC				Schiller, Herbert B.; van Breugel, Merlijn; Nawijn, Martijn C.			SARS-CoV-2-specific hotspots in virus-host interaction networks	NATURE IMMUNOLOGY			English	Editorial Material									[Schiller, Herbert B.] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Munich, Germany; [Schiller, Herbert B.] German Ctr Lung Res DZL, Munich, Germany; [van Breugel, Merlijn] MIcompany, Amsterdam, Netherlands; [van Breugel, Merlijn] Univ Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Univ Med Ctr Groningen, Groningen, Netherlands; [van Breugel, Merlijn; Nawijn, Martijn C.] Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Groningen; University of Groningen; University of Groningen	Nawijn, MC (corresponding author), Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands.; Nawijn, MC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	m.c.nawijn@umcg.nl		Nawijn, Martijn/0000-0003-3372-6521				Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9; Bosl K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02186; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Denney L, 2018, MUCOSAL IMMUNOL, V11, P523, DOI 10.1038/mi.2017.77; Fung TS, 2018, FUTURE VIROL, V13, P405, DOI 10.2217/fvl-2018-0008; George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3; Melms JC, 2021, NATURE, V595, P114, DOI 10.1038/s41586-021-03569-1; Reyna MA, 2018, BIOINFORMATICS, V34, P972, DOI 10.1093/bioinformatics/bty613; Ziegler C. G. K., PREPRINT BIORXIV, DOI [10.1101/2021.02.20.431155(2021, DOI 10.1101/2021.02.20.431155(2021]	10	3	3	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					806	808		10.1038/s41590-021-00963-9	http://dx.doi.org/10.1038/s41590-021-00963-9		JUN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34155406	Green Submitted, Bronze			2022-12-18	WOS:000663993300002
J	Hammer, GE; Schwab, SR; Sun, JSC				Hammer, Gianna E.; Schwab, Susan R.; Sun, Joseph C.			obituary Nilabh Shastri 1952-2021	NATURE IMMUNOLOGY			English	Biographical-Item									[Hammer, Gianna E.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA; [Schwab, Susan R.] NYU, Grossman Sch Med, Skirball Inst Biomol Med, New York, NY 10003 USA; [Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Duke University; New York University; Memorial Sloan Kettering Cancer Center; Cornell University	Hammer, GE (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA.; Schwab, SR (corresponding author), NYU, Grossman Sch Med, Skirball Inst Biomol Med, New York, NY 10003 USA.; Sun, JSC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Sun, JSC (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	giannahammer@duke.edu; Susan.Schwab@med.nyu.edu; sunj@mskcc.org		Schwab, Susan/0000-0002-0834-0822; Sun, Joseph/0000-0001-8062-9033					0	3	3	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					533	534		10.1038/s41590-021-00912-6	http://dx.doi.org/10.1038/s41590-021-00912-6		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33782613	Bronze			2022-12-18	WOS:000634614300001
J	Perez-Potti, A; Lange, J; Buggert, M				Perez-Potti, Andre; Lange, Joshua; Buggert, Marcus			Deciphering the ins and outs of SARS-CoV-2-specific T cells	NATURE IMMUNOLOGY			English	Editorial Material								Comprehensive analysis of specific and cross-reactive SARS-CoV-2 epitopes reveals functional T cell responses against specific viral regions in essentially all convalescent individuals and a majority of unexposed donors, demonstrating that cross-reactive responses to COVID-19 are widespread.	[Perez-Potti, Andre; Lange, Joshua; Buggert, Marcus] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Buggert, M (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, Stockholm, Sweden.	marcus.buggert@ki.se	Buggert, Marcus/F-4663-2018	Buggert, Marcus/0000-0003-0633-1719; Potti, Andre/0000-0002-5998-5700				Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Buggert M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4526; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006	12	3	3	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					8	9		10.1038/s41590-020-00838-5	http://dx.doi.org/10.1038/s41590-020-00838-5		NOV 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33244183	Bronze			2022-12-18	WOS:000592970200001
J	Farris, AD; Guthridge, JM				Farris, A. Darise; Guthridge, Joel M.			Overlapping B cell pathways in severe COVID-19 and lupus	NATURE IMMUNOLOGY			English	Editorial Material									[Farris, A. Darise; Guthridge, Joel M.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Farris, AD; Guthridge, JM (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Darise-Farris@omrf.org; Joel-Guthridge@omrf.org		Guthridge, Joel/0000-0002-9308-237X				Chen LY, 2020, HUM MOL GENET, V29, P1745, DOI 10.1093/hmg/ddaa030; Fujii H, 2020, CLIN RHEUMATOL, V39, P3171, DOI 10.1007/s10067-020-05359-y; Geginat J, 2019, SEMIN IMMUNOL, V44, DOI 10.1016/j.smim.2019.101330; Jenks SA, 2019, IMMUNOL REV, V288, P136, DOI 10.1111/imr.12741; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kaneko N, 2020, CELL, V183, P143, DOI 10.1016/j.cell.2020.08.025; Kim L, 2020, MMWR-MORBID MORTAL W, V69, P1081, DOI 10.15585/mmwr.mm6932e3; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Maier-Moore JS, 2014, ARTHRITIS RHEUMATOL, V66, P2521, DOI 10.1002/art.38716; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Zhou YQ, 2020, CTS-CLIN TRANSL SCI, V13, P1077, DOI 10.1111/cts.12805	12	3	5	2	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1478	1480		10.1038/s41590-020-00822-z	http://dx.doi.org/10.1038/s41590-020-00822-z		NOV 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33139917	Bronze			2022-12-18	WOS:000584409800003
J	Marichal, T				Marichal, Thomas			Endothelial cells instruct macrophages on how to Rspond to lung injury	NATURE IMMUNOLOGY			English	Editorial Material									[Marichal, Thomas] Univ Liege, GIGA Inst, Lab Immunophysiol, Liege, Belgium; [Marichal, Thomas] Univ Liege, Fac Vet Med, Liege, Belgium; [Marichal, Thomas] Walloon Excellence Life Sci & Biotechnol, WELBIO, Wallonia, Belgium	University of Liege; University of Liege; WELBIO	Marichal, T (corresponding author), Univ Liege, GIGA Inst, Lab Immunophysiol, Liege, Belgium.; Marichal, T (corresponding author), Univ Liege, Fac Vet Med, Liege, Belgium.; Marichal, T (corresponding author), Walloon Excellence Life Sci & Biotechnol, WELBIO, Wallonia, Belgium.	t.marichal@uliege.be						Artyomov MN, 2016, SEMIN IMMUNOL, V28, P417, DOI 10.1016/j.smim.2016.10.004; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Huang CK, 2020, CIRC RES, V127, P953, DOI 10.1161/CIRCRESAHA.119.315807; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Schyns J, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5160794; Ural BB, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax8756; Zhou BS, 2020, NAT IMMUNOL, V21, P1430, DOI 10.1038/s41590-020-0764-8	13	3	3	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1317	1318		10.1038/s41590-020-00806-z	http://dx.doi.org/10.1038/s41590-020-00806-z		OCT 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	33009520	Bronze, Green Submitted			2022-12-18	WOS:000574740000001
J	Carbone, FR				Carbone, Francis R.			Immovable memories: the journey to permanent residency	NATURE IMMUNOLOGY			English	Article							T-CELLS; LYMPH-NODE; TISSUE; INFECTION	Frank Carbone describes how his lab identified a new class of memory T cells that permanently reside in the tissues.	[Carbone, Francis R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of Melbourne	Carbone, FR (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	fcarbone@unimelb.edu.au	Carbone, Francis/ABF-2141-2020					Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Gebhardt T, 2018, IMMUNOL REV, V283, P54, DOI 10.1111/imr.12650; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shiohara T, 1997, J INVEST DERMATOL, V109, P271, DOI 10.1111/1523-1747.ep12335465; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	17	3	3	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					698	699		10.1038/s41590-020-0651-3	http://dx.doi.org/10.1038/s41590-020-0651-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32577007				2022-12-18	WOS:000542863800002
J	Schmidt, FI; Latz, E				Schmidt, Florian I.; Latz, Eicke			Jack of all trades inhibits inflammation (in sober people)	NATURE IMMUNOLOGY			English	Editorial Material							GASDERMIN D	Caspase-cleaved gasdermin D forms pores in cellular membranes, thus executing proinflammatory cell death by pyroptosis. Disulfiram - a drug used to treat chronic alcoholism - is now found to be an inhibitor of pore formation, which may therapeutically counteract exacerbated inflammation in sepsis and beyond.	[Schmidt, Florian I.; Latz, Eicke] Univ Bonn, Inst Innate Immun, Biomed Ctr, Venusberg Campus 1, Bonn, Germany; [Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Latz, Eicke] UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA USA	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Massachusetts System; University of Massachusetts Worcester	Schmidt, FI (corresponding author), Univ Bonn, Inst Innate Immun, Biomed Ctr, Venusberg Campus 1, Bonn, Germany.	fschmidt@uni-bonn.de	Schmidt, Florian Ingo/J-1672-2019; Latz, Eicke/H-3951-2014	Schmidt, Florian Ingo/0000-0002-9979-9769; Latz, Eicke/0000-0003-1488-5666	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SCHM 3336-1-1, SPP1923, SFB1403, TRR237, EXC2151 - 390873048]; Klaus Tschira Boost Fund	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Klaus Tschira Boost Fund	F.I.S. is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the Emmy Noether Programme (SCHM 3336-1-1), SPP1923, SFB1403, TRR237 and Germany's Excellence Strategy - EXC2151 - 390873048, as well as by the Klaus Tschira Boost Fund. E.L. is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through SPP1923, SFB1403, TRR237 and Germany's Excellence Strategy - EXC2151 - 390873048.	Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Buonopane A, 2005, SUBST USE MISUSE, V40, P2001, DOI 10.1080/10826080500294890; Hu JJ, 2020, NAT IMMUNOL, V21, P736, DOI 10.1038/s41590-020-0669-6; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Mulvihill E, 2018, EMBO J, V37, DOI 10.15252/embj.201798321; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Ridker PM, 2019, CIRC RES, V124, P437, DOI 10.1161/CIRCRESAHA.118.313129; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	15	3	3	3	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					718	719		10.1038/s41590-020-0693-6	http://dx.doi.org/10.1038/s41590-020-0693-6			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32577009				2022-12-18	WOS:000542863800010
J	Ramesh, V; Locasale, JW				Ramesh, Vijyendra; Locasale, Jason W.			A reactive metabolite as an immune suppressant	NATURE IMMUNOLOGY			English	Editorial Material							METHYLGLYOXAL	Myeloid-derived suppressor cells (MDSCs) occupy sites of chronic inflammation and suppress CD8(+) T cell function. A new study describes the transfer of the metabolite methylglyoxal (MG) to T cells, which mediates this immunosuppressive mechanism.	[Ramesh, Vijyendra; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA	Duke University	Locasale, JW (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA.	dr.jason.locasale@gmail.com	Locasale, Jason W/ABE-6505-2020	Locasale, Jason W/0000-0002-7766-3502				Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Baumann T, 2020, NAT IMMUNOL, V21, P555, DOI 10.1038/s41590-020-0666-9; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Bollong MJ, 2018, NATURE, V562, P600, DOI 10.1038/s41586-018-0622-0; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Luengo A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13419-4; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Nokin MJ, 2016, ELIFE, V5, DOI [10.7554/eLife.19375, 10.7554/elife.19375]; O'Sullivan D, 2019, NAT REV IMMUNOL, V19, P324, DOI 10.1038/s41577-019-0140-9; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x	12	3	3	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					497	498		10.1038/s41590-020-0664-y	http://dx.doi.org/10.1038/s41590-020-0664-y			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32327751				2022-12-18	WOS:000528265700011
J	Pepper, M				Pepper, Marion			Hey man	NATURE IMMUNOLOGY			English	Editorial Material								Men have a role to play as well in leveling the playing field for women scientists. This includes creating inclusive environments and accepting women as equal partners in the pursuit of science.	[Pepper, Marion] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Pepper, M (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	mpepper@uw.edu						Klein RS, 2017, NAT IMMUNOL, V18, P475, DOI 10.1038/ni.3707	1	3	3	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					236	236		10.1038/s41590-020-0619-3	http://dx.doi.org/10.1038/s41590-020-0619-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32094648	Bronze			2022-12-18	WOS:000544940600004
J	Pierce, SK; Schwartzberg, PL; Shah, NN; Taylor, N				Pierce, Susan K.; Schwartzberg, Pamela L.; Shah, Nirali N.; Taylor, Naomi			Women in immunology: 2020 and beyond	NATURE IMMUNOLOGY			English	Article							ACADEMIC MEDICINE; GENDER-DIFFERENCES; T-CELLS; FACULTY; EXCELLENCE; AUTHORSHIP; LEADERSHIP; MUTATIONS; INFECTION; ONSET	Women have been at the forefront of tremendous achievements in immunology in the past decade. However, disparities still exist, limiting upward potential and further advancements. As four NIH intramural women scientists who care deeply about scientific progress and the progress of women in our field, we review ongoing challenges and discuss potential approaches to help advance the promotion of women in the sciences.	[Pierce, Susan K.] NIAID, Lab Immunogenet, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Schwartzberg, Pamela L.] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Shah, Nirali N.; Taylor, Naomi] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Taylor, Naomi] Univ Montpellier, CNRS, IGMM, Montpellier, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Pierce, SK (corresponding author), NIAID, Lab Immunogenet, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	spierce@niaid.nih.gov; pams@nih.gov; nirali.shah@nih.gov; taylorn4@mail.nih.gov	Taylor, Naomi/H-4016-2014	Pierce, Susan/0000-0001-7261-3437; Schwartzberg, Pamela/0000-0001-6318-9187	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Cynthia Dunbar, Brigitte Widemann, Carl Hashimoto, Hannah Valantine, Carol Thiele, Meredith Shaffer, Deborah Citrin and Tom Misteli for critical reading. Funding was provided in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (S.K.P. and P.L.S.) and National Cancer Institute (N.N.S. and N.T.), National Institutes of Health. The content of this publication does not reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government.	Akkaya M, 2018, NAT IMMUNOL, V19, P871, DOI 10.1038/s41590-018-0156-5; Arango D, 2018, CELL, V175, P1872, DOI 10.1016/j.cell.2018.10.030; Arbore G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06706-z; Barabino G, 2020, SCI ENG ETHICS, V26, P275, DOI 10.1007/s11948-019-00097-0; Bendels MHK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189136; Bhatia B, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006959; Bohrer AC, 2018, J IMMUNOL, V201, P1645, DOI 10.4049/jimmunol.1800438; Boiko JR, 2017, JAMA INTERN MED, V177, P722, DOI 10.1001/jamainternmed.2016.9646; Boso G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47720-5; Boukhvalova AK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00740; Broderick NA, 2019, ELIFE, V8, DOI 10.7554/eLife.36399; Brown MA, 2020, CLIN ORTHOP RELAT R, V478, P1542, DOI 10.1097/CORR.0000000000000849; Butkus R, 2018, ANN INTERN MED, V168, P721, DOI 10.7326/M17-3438; Cagigi A, 2018, J INFECT DIS, V218, pS528, DOI 10.1093/infdis/jiy333; Carr PL, 2018, ACAD MED, V93, P1694, DOI 10.1097/ACM.0000000000002146; Carter C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222178; Castillo JC, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal1505; Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032; Chen Z., 2018, P NATL ACAD SCI USA, V115; Chiramel AI, 2019, CELL REP, V27, P3269, DOI 10.1016/j.celrep.2019.05.040; Clerc I, 2019, NAT METAB, V1, P717, DOI 10.1038/s42255-019-0084-1; Crompton JG, 2019, JAMA SURG, V154, P375, DOI 10.1001/jamasurg.2018.5645; Dey A, 2019, EMBO J, V38, DOI 10.15252/embj.2018100293; Dominguez C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94296; Dutzan N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0797; Dworkin J. D., 2020, BIORXIV, DOI [10.1101/2020.01.03.894378, DOI 10.1101/2020.01.03.894378]; Faris R, 2017, J VIROL, V91, DOI [10.1128/JVI.00524-17, 10.1128/JVI.0524-17]; Fassiotto M, 2018, ACAD MED, V93, P881, DOI 10.1097/ACM.0000000000002121; Fox CW, 2018, ECOL EVOL, V8, P11492, DOI 10.1002/ece3.4584; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Furuyama W, 2019, ANNU REV VIROL, V6, P435, DOI 10.1146/annurev-virology-092818-015708; Gegonne A, 2018, CELL REP, V24, P117, DOI 10.1016/j.celrep.2018.06.007; Gibbs KD, 2016, ELIFE, V5, DOI 10.7554/eLife.21393; Goldin C, 2000, AM ECON REV, V90, P715, DOI 10.1257/aer.90.4.715; Hait SH, 2019, J VIROL, V93, DOI 10.1128/JVI.01687-18; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Hechtman LA, 2018, P NATL ACAD SCI USA, V115, P7943, DOI 10.1073/pnas.1800615115; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ishii H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05023-9; Jessop F, 2018, INFECT IMMUN, V86, DOI [10.1128/iai.00044-18, 10.1128/IAI.00044-18]; Joglekar P, 2017, CELL, V169, P378, DOI 10.1016/j.cell.2017.04.009; Johnson KEE, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a038422; Kardava L, 2018, NAT IMMUNOL, V19, P1001, DOI 10.1038/s41590-018-0180-5; Khan MM, 2018, J PROTEOMICS, V189, P34, DOI 10.1016/j.jprot.2018.03.016; Kim MY, 2018, CELL, V173, P1439, DOI 10.1016/j.cell.2018.05.013; Kuang FL, 2019, NEW ENGL J MED, V380, P1336, DOI 10.1056/NEJMoa1812185; Kwong B, 2017, NAT IMMUNOL, V18, P1117, DOI 10.1038/ni.3816; Lambert LH, 2014, INFECT IMMUN, V82, P4842, DOI 10.1128/IAI.02097-14; Lamborn IT, 2017, J EXP MED, V214, P1949, DOI 10.1084/jem.20161759; Lathrop Stephanie K, 2018, Curr Protoc Microbiol, V50, pe56, DOI 10.1002/cpmc.56; Laver KE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020380; Lerchenmueller MJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6573; Lisco A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127113; Lo MK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9242; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Matsuda K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006538; Maul RW, 2016, J EXP MED, V213, P1675, DOI 10.1084/jem.20151227; Mistry P, 2019, P NATL ACAD SCI USA, V116, P25222, DOI 10.1073/pnas.1908576116; Murray D., 2019, BIORXIV, DOI [10.1101/400515v3, DOI 10.1101/400515V3]; Nittrouer CL, 2018, P NATL ACAD SCI USA, V115, P104, DOI 10.1073/pnas.1708414115; Oh KS, 2017, IMMUNITY, V47, P298, DOI 10.1016/j.immuni.2017.07.012; Percopo CM, 2019, J IMMUNOL, V202, P871, DOI 10.4049/jimmunol.1800927; Preite S, 2018, NAT IMMUNOL, V19, P986, DOI 10.1038/s41590-018-0182-3; Prokunina-Olsson L, 2019, J INTERF CYTOK RES, V39, P599, DOI 10.1089/jir.2019.0043; Ramsuran V, 2018, SCIENCE, V359, P86, DOI 10.1126/science.aam8825; Read S, 2018, ANN INTERN MED, V169, P658, DOI 10.7326/M18-0693; Renfrow JJ, 2018, NEUROSURGERY, V82, P576, DOI 10.1093/neuros/nyx251; Reynoso GV, 2019, NAT IMMUNOL, V20, P602, DOI 10.1038/s41590-019-0342-0; Richman RC, 2001, J WOMEN HEALTH GEN-B, V10, P271, DOI 10.1089/152460901300140022; Riggle BA, 2020, J CLIN INVEST, V130, P1128, DOI 10.1172/JCI133474; Ritter AT, 2017, P NATL ACAD SCI USA, V114, pE6585, DOI 10.1073/pnas.1710751114; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Schumann K, 2010, PSYCHOL SCI, V21, P1649, DOI 10.1177/0956797610384150; Sheridan JT, 2010, ACAD MED, V85, P999, DOI 10.1097/ACM.0b013e3181dbf75a; Sil P, 2018, CURR OPIN IMMUNOL, V50, P21, DOI 10.1016/j.coi.2017.10.004; Silver JK, 2019, NEUROLOGY, V93, P538, DOI 10.1212/WNL.0000000000008022; Silver JK, 2017, PM&R, V9, P804, DOI 10.1016/j.pmrj.2017.06.001; Sing DC, 2017, SPINE J, V17, P1749, DOI 10.1016/j.spinee.2017.06.041; Singh A, 2019, AGING CELL, V18, DOI 10.1111/acel.12949; Sommers C., 2019, WALL STREET J; Spector ND, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2149; Strolger L., 2019, PHYS TODAY, DOI [10.1063/PT.6.3.20190301a/full/, DOI 10.1063/PT.6.3.20190301A/FULL/]; Sun WX, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02452; Thomas EG, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13682; Tirosh O, 2018, NAT MED, V24, P1815, DOI 10.1038/s41591-018-0211-7; Vaccari M, 2018, NAT MED, V24, P847, DOI 10.1038/s41591-018-0025-7; van Loben Sels J. M., 2019, VIRUSES, V11, pE432; Warburton A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007179; Weissler KA, 2019, CURR OPIN IMMUNOL, V60, P54, DOI 10.1016/j.coi.2019.05.002; Wiler JL, 2019, ACAD EMERG MED, V26, P286, DOI 10.1111/acem.13694; Williams J. C., 2014, HARVARD BUSINESS REV; Winkler CW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1614-1; Wong EY, 2001, J WOMEN HEALTH GEN-B, V10, P541, DOI 10.1089/15246090152543120; Xiao WB, 2019, BLOOD, V132, P986, DOI 10.1182/blood.2019001443; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zhu F, 2017, CELL HOST MICROBE, V21, P478, DOI 10.1016/j.chom.2017.03.006	99	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					254	258		10.1038/s41590-020-0618-4	http://dx.doi.org/10.1038/s41590-020-0618-4			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32094649				2022-12-18	WOS:000544940600019
J	Xu, HN; Jiang, Y; Xu, XQ; Su, XP; Liu, Y; Ma, YW; Zhao, Y; Shen, ZY; Huang, B; Cao, XT				Xu, Henan; Jiang, Yan; Xu, Xiaoqing; Su, Xiaoping; Liu, Yang; Ma, Yuanwu; Zhao, Yong; Shen, Zhongyang; Huang, Bo; Cao, Xuetao			Inducible degradation of lncRNA Sros1 promotes IFN-gamma-mediated activation of innate immune responses by stabilizing Stat1 mRNA (vol 20, pg 1621, 2019)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				caoxt@immunol.org						Xu HN, 2019, NAT IMMUNOL, V20, P1621, DOI 10.1038/s41590-019-0542-7	1	3	3	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					477	478		10.1038/s41590-020-0630-8	http://dx.doi.org/10.1038/s41590-020-0630-8		FEB 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32099101	Bronze			2022-12-18	WOS:000516339100001
J	Sarker, G; Larabee, CM; Domingos, AI				Sarker, Gitalee; Larabee, Chelsea M.; Domingos, Ana I.			ILC3s gut rhythm	NATURE IMMUNOLOGY			English	Editorial Material							INNATE LYMPHOID-CELLS	Group 3 innate lymphoid cells (ILC3s) are critical for maintaining gut epithelial integrity and tissue repair. Recent research identifies mechanisms by which circadian machinery and feeding behavior regulate enteric ILC3s to maintain gut homeostasis.	[Sarker, Gitalee; Larabee, Chelsea M.; Domingos, Ana I.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Domingos, Ana I.] HHMI, New York, NY 10065 USA	University of Oxford; Howard Hughes Medical Institute	Domingos, AI (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.; Domingos, AI (corresponding author), HHMI, New York, NY 10065 USA.	ana.domingos@dpag.ox.ac.uk		Domingos, Ana/0000-0002-7938-4814; Larabee, Chelsea/0000-0001-8828-6995	Wellcome Trust [208576/Z/17/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Godinho-Silva C, 2019, NATURE, V574, P254, DOI 10.1038/s41586-019-1579-3; Hughes ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002835; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Maywood ES, 2013, P NATL ACAD SCI USA, V110, P9547, DOI 10.1073/pnas.1220894110; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Seillet C, 2020, NAT IMMUNOL, V21, P168, DOI 10.1038/s41590-019-0567-y; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; von Burg N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00416	11	3	4	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					106	108		10.1038/s41590-019-0580-1	http://dx.doi.org/10.1038/s41590-019-0580-1		JAN 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31900463				2022-12-18	WOS:000508158000001
J	Kanekiyo, M; Joyce, MG; Gillespie, RA; Gallagher, JR; Andrews, SF; Yassine, HM; Wheatley, AK; Fisher, BE; Ambrozak, DR; Creanga, A; Leung, K; Yang, ES; Boyoglu-Barnum, S; Georgiev, IS; Tsybovsky, Y; Prabhakaran, MS; Andersen, H; Kong, WP; Baxa, U; Zephir, KL; Ledgerwood, JE; Koup, RA; Kwong, PD; Harris, AK; McDermott, AB; Mascola, JR; Graham, BS				Kanekiyo, Masaru; Joyce, M. Gordon; Gillespie, Rebecca A.; Gallagher, John R.; Andrews, Sarah F.; Yassine, Hadi M.; Wheatley, Adam K.; Fisher, Brian E.; Ambrozak, David R.; Creanga, Adrian; Leung, Kwanyee; Yang, Eun Sung; Boyoglu-Barnum, Seyhan; Georgiev, Ivelin S.; Tsybovsky, Yaroslav; Prabhakaran, Madhu S.; Andersen, Hanne; Kong, Wing-Pui; Baxa, Ulrich; Zephir, Kathryn L.; Ledgerwood, Julie E.; Koup, Richard A.; Kwong, Peter D.; Harris, Audray K.; McDermott, Adrian B.; Mascola, John R.; Graham, Barney S.			Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses (vol 20, pg 362, 2019)	NATURE IMMUNOLOGY			English	Correction													YASSINE, HADI M./AAW-6475-2020; Prabhakaran, Madhu/AEY-7127-2022; Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019; Kanekiyo, Masaru/Y-9820-2018	YASSINE, HADI M./0000-0001-7592-2788; Graham, Barney S./0000-0001-8112-0853; Kanekiyo, Masaru/0000-0001-5767-1532; Gallagher, John/0000-0002-1954-8872; Wheatley, Adam/0000-0002-5593-9387; McDermott, Adrian/0000-0003-0616-9117	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003, ZIAAI005014, ZIAAI005143] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Kanekiyo M, 2019, NAT IMMUNOL, V20, P362, DOI 10.1038/s41590-018-0305-x	1	3	4	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					765	765		10.1038/s41590-019-0395-0	http://dx.doi.org/10.1038/s41590-019-0395-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	30980067	Green Submitted, Bronze			2022-12-18	WOS:000468505100019
J	Wang, A; Medzhitov, R				Wang, Andrew; Medzhitov, Ruslan			Not the usual suspect: type I interferon responsive T cells drive infection-induced cachexia	NATURE IMMUNOLOGY			English	Editorial Material							TOLERANCE; METABOLISM; LIPOLYSIS; ALPHA	Cachexia is a reversible feature of inflammatory states that can become maladaptive in many diseases. A new study reveals a role for type I interferons on CD8(+) T cells in mediating cachexia during viral infection.	[Wang, Andrew] Dept Med Rheumatol, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Dept Immunobiol, New Haven, CT USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Wang, A (corresponding author), Dept Med Rheumatol, New Haven, CT 06510 USA.	andrew.wang@yale.edu; ruslan.medzhitov@yale.edu		Wang, Andrew/0000-0002-6951-8081	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI128745] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI128745] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Advani SM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5080-4; Baazim H., 2019, NAT IMMUNOL, DOI [10.1038/s41559-019-0397-y, DOI 10.1038/S41559-019-0397-Y]; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Gordon EB, 2015, P NATL ACAD SCI USA, V112, P13075, DOI 10.1073/pnas.1516544112; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; MEMON RA, 1992, ENDOCRINOLOGY, V131, P1695, DOI 10.1210/en.131.4.1695; Rao S, 2017, CELL, V168, P503, DOI 10.1016/j.cell.2017.01.006; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Talisa VB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01502; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang Q, 2018, P NATL ACAD SCI USA, V115, pE8104, DOI 10.1073/pnas.1812987115; Weis S, 2017, CELL, V169, P1263, DOI 10.1016/j.cell.2017.05.031; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Zhou J, 2016, TRENDS ENDOCRIN MET, V27, P335, DOI 10.1016/j.tem.2016.03.002	17	3	3	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					666	667		10.1038/s14590-019-0374-05	http://dx.doi.org/10.1038/s14590-019-0374-05			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31110313				2022-12-18	WOS:000468505100006
J	Zundler, S; Becker, E; Spocinska, M; Slawik, M; Parga-Vidal, L; Stark, R; Wiendl, M; Atreya, R; Rath, T; Leppkes, M; Hildner, K; Lopez-Posadas, R; Lukassen, S; Ekici, AB; Neufert, C; Atreya, I; van Gisbergen, KPJM; Neurath, MF				Zundler, Sebastian; Becker, Emily; Spocinska, Marta; Slawik, Monique; Parga-Vidal, Loreto; Stark, Regina; Wiendl, Maximilian; Atreya, Raja; Rath, Timo; Leppkes, Moritz; Hildner, Kai; Lopez-Posadas, Rocio; Lukassen, Soren; Ekici, Arif B.; Neufert, Clemens; Atreya, Imke; van Gisbergen, Klaas P. J. M.; Neurath, Markus F.			Hobit- and Blimp-1-driven CD4(+) tissue-resident memory T cells control chronic intestinal inflammation (vol 20, pg 288, 2019)	NATURE IMMUNOLOGY			English	Correction													Leppkes, Moritz/ABG-7617-2020; Ekici, Arif B/C-3971-2013; Leppkes, Moritz/N-2932-2017	Leppkes, Moritz/0000-0003-2311-090X; Ekici, Arif B/0000-0001-6099-7066; van Gisbergen, Klaas/0000-0003-3623-7555; Parga-Vidal, Loreto/0000-0003-4348-1679; Rath, Timo/0000-0002-7728-9338; Stark, Regina/0000-0001-7693-799X				Zundler S, 2019, NAT IMMUNOL, V20, P288, DOI 10.1038/s41590-018-0298-5	1	3	3	2	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					514	514		10.1038/s41590-019-0360-y	http://dx.doi.org/10.1038/s41590-019-0360-y			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30846879	Bronze			2022-12-18	WOS:000461904200021
J	Sok, D; Burton, DR				Sok, Devin; Burton, Dennis R.			Recent progress in broadly neutralizing antibodies to HIV (vol 19, pg 1179, 2018)	NATURE IMMUNOLOGY			English	Correction														Burton, Dennis/0000-0001-6711-9864				Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7	1	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					374	374		10.1038/s41590-019-0329-x	http://dx.doi.org/10.1038/s41590-019-0329-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30705417	Bronze			2022-12-18	WOS:000458893600025
J	Fehervari, Z				Fehervari, Zoltan			Vaccine sex differences	NATURE IMMUNOLOGY			English	Editorial Material																			0	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					111	111		10.1038/s41590-018-0310-0	http://dx.doi.org/10.1038/s41590-018-0310-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30664761	Bronze			2022-12-18	WOS:000456279100004
J	Martin, R				Martin, Roland			Targeting fibrin in neurodegeneration	NATURE IMMUNOLOGY			English	Editorial Material							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ALZHEIMERS-DISEASE; PLASMINOGEN-ACTIVATOR; PATHOLOGY; INNATE	Deposition of fibrin in the brain and central nervous system occurs after injury or disease. This process unmasks a conserved cryptic epitope of fibrin that activates microglia; blocking this interaction can limit inflammation and neurotoxicity.	[Martin, Roland] Univ Zurich, Univ Hosp Zurich, Neurol Clin, Neuroimmunol & Multiple Sclerosis Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Martin, R (corresponding author), Univ Zurich, Univ Hosp Zurich, Neurol Clin, Neuroimmunol & Multiple Sclerosis Res, Zurich, Switzerland.	roland.martin@usz.ch		Martin, Roland/0000-0002-0982-1329				Adams RA, 2004, MOL INTERV, V4, P163; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; COLVIN RB, 1975, J EXP MED, V142, P1377, DOI 10.1084/jem.142.6.1377; Cortes-Canteli M, 2012, J ALZHEIMERS DIS, V32, P599, DOI 10.3233/JAD-2012-120820; Cuyvers E, 2016, LANCET NEUROL, V15, P857, DOI 10.1016/S1474-4422(16)00127-7; KOH CS, 1987, CELL IMMUNOL, V107, P52, DOI 10.1016/0008-8749(87)90265-6; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Luo DY, 2013, J IMMUNOL, V190, P4149, DOI 10.4049/jimmunol.1203253; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Ryu K. R., 2018, NAT IMMUNOL, DOI [10.1038/s41590-018-0232-x, DOI 10.1038/S41590-018-0232-X]; SATOH J, 1987, J IMMUNOL, V138, P179; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; SOBEL RA, 1989, AM J PATHOL, V135, P161; Takada Y, 2010, J AUTOIMMUN, V34, P453, DOI 10.1016/j.jaut.2009.11.017	15	3	3	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1149	1150		10.1038/s41590-018-0241-9	http://dx.doi.org/10.1038/s41590-018-0241-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323342	Green Accepted			2022-12-18	WOS:000447632200007
J	Chen, PD; Liao, KY; Xiao, CC				Chen, Pengda; Liao, Kunyu; Xiao, Changchun			MicroRNA says no to mass production	NATURE IMMUNOLOGY			English	Editorial Material									[Chen, Pengda; Liao, Kunyu; Xiao, Changchun] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Xiamen University	Xiao, CC (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	cxiao@xmu.edu.cn		Xiao, Changchun/0000-0001-8754-3208				Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Erson-Bensan Ayse Elif, 2017, Microrna, V6, P97, DOI 10.2174/2211536606666170511102219; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Hsin JP, 2018, NAT IMMUNOL, V19, P1137, DOI 10.1038/s41590-018-0208-x; Jin HY, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006623; Jin HY, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00328; Jin HY, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00340; Lai MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12207; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lewis CJT, 2017, NAT REV MOL CELL BIO, V18, P202, DOI 10.1038/nrm.2016.163; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4	13	3	3	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1040	1042		10.1038/s41590-018-0215-y	http://dx.doi.org/10.1038/s41590-018-0215-y			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30224820				2022-12-18	WOS:000445968600007
J	Dempsey, LA				Dempsey, Laurie A.			Anti-tumor role of metformin	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	3	3	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1039	1039		10.1038/s41590-018-0224-x	http://dx.doi.org/10.1038/s41590-018-0224-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30250180				2022-12-18	WOS:000445968600004
J	Ryu, H; Lim, H; Choi, G; Park, YJ; Cho, M; Na, H; Ahn, CW; Kim, YC; Kim, WU; Lee, SH; Chung, Y				Ryu, Heeju; Lim, Hoyong; Choi, Garam; Park, Young-Jun; Cho, Minkyoung; Na, Hyeongjin; Ahn, Chul Won; Kim, Young Chul; Kim, Wan-Uk; Lee, Sang-Hak; Chung, Yeonseok			Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27 (vol 19, pg 583, 2018)	NATURE IMMUNOLOGY			English	Correction													Kim, Wan-Uk/AAO-8502-2020					Ryu H, 2018, NAT IMMUNOL, V19, P583, DOI 10.1038/s41590-018-0102-6	1	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1036	1036		10.1038/s41590-018-0158-3	http://dx.doi.org/10.1038/s41590-018-0158-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	29921921	Bronze			2022-12-18	WOS:000442365100027
J	Balyan, R; Brzostek, J; Gascoigne, NRJ				Balyan, Renu; Brzostek, Joanna; Gascoigne, Nicholas R. J.			CD8(+) T cells have commitment issues	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; THRESHOLD; SELECTION		[Balyan, Renu; Brzostek, Joanna; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore	National University of Singapore	Gascoigne, NRJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.	micnrjg@nus.edu.sg		Brzostek, Joanna/0000-0002-5621-2649; Balyan, Renu/0000-0002-9378-040X				Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Au-Yeung BB, 2017, J IMMUNOL, V198, P2445, DOI 10.4049/jimmunol.1601453; Balyan R, 2017, J IMMUNOL, V198, P1823, DOI 10.4049/jimmunol.1600083; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Richard AC, 2018, NAT IMMUNOL, V19, P849, DOI 10.1038/s41590-018-0160-9; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042	12	3	3	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					797	799		10.1038/s41590-018-0169-0	http://dx.doi.org/10.1038/s41590-018-0169-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30013145				2022-12-18	WOS:000439470900016
J	Wilson, JL; Weichhart, T				Wilson, Jayne Louise; Weichhart, Thomas			TORching a semaphore for alternative macrophage activation	NATURE IMMUNOLOGY			English	Editorial Material							POLARIZATION; TSC1		[Wilson, Jayne Louise; Weichhart, Thomas] Med Univ Vienna, Inst Med Genet, Ctr Pathobiochem & Genet, Vienna, Austria	Medical University of Vienna	Weichhart, T (corresponding author), Med Univ Vienna, Inst Med Genet, Ctr Pathobiochem & Genet, Vienna, Austria.	thomas.weichhart@meduniwien.ac.at	Weichhart, Thomas/J-3531-2014	Weichhart, Thomas/0000-0002-4349-0797; Wilson, Jayne Louise/0000-0003-0560-6207				Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Fang CM, 2015, CELL PHYSIOL BIOCHEM, V36, P1406, DOI 10.1159/000430306; Kang SJ, 2018, NAT IMMUNOL, V19, P561, DOI 10.1038/s41590-018-0108-0; Kimura T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13130; Linke M, 2017, NAT IMMUNOL, V18, P293, DOI 10.1038/ni.3655; Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	12	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					512	514		10.1038/s41590-018-0117-z	http://dx.doi.org/10.1038/s41590-018-0117-z			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777214				2022-12-18	WOS:000433041500014
J	Zemmour, D; Zilionis, R; Kiner, E; Klein, AM; Mathis, D; Benoist, C				Zemmour, David; Zilionis, Rapolas; Kiner, Evgeny; Klein, Allon M.; Mathis, Diane; Benoist, Christophe			Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR (vol 19, pg 291, 2018)	NATURE IMMUNOLOGY			English	Correction																		Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0	1	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					645	645		10.1038/s41590-018-0104-4	http://dx.doi.org/10.1038/s41590-018-0104-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29725080	Bronze			2022-12-18	WOS:000433041500030
J	Kelleher, P; Xu, XN				Kelleher, Peter; Xu, Xiao-Ning			Hard-to-kill macrophages lead to chronic inflammation in HIV	NATURE IMMUNOLOGY			English	Editorial Material							CELLS; INFECTION; CD4(+); AIDS		[Kelleher, Peter; Xu, Xiao-Ning] Imperial Coll London, Chelsea & Westminster Hosp, Ctr Immunol & Vaccinol, Dept Med, London, England	Imperial College London	Xu, XN (corresponding author), Imperial Coll London, Chelsea & Westminster Hosp, Ctr Immunol & Vaccinol, Dept Med, London, England.	x.xu@imperial.ac.uk						Clayton KL, 2018, NAT IMMUNOL, V19, P475, DOI 10.1038/s41590-018-0085-3; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Honeycutt JB, 2017, NAT MED, V23, P638, DOI 10.1038/nm.4319; Hunt PW, 2016, J INFECT DIS, V214, pS44, DOI 10.1093/infdis/jiw275; Johnson S, 2015, J VIROL, V89, P7494, DOI 10.1128/JVI.00438-15; Leibman RS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006613; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Riou C, 2012, J IMMUNOL, V188, P2198, DOI 10.4049/jimmunol.1102813; Tan J, 2013, TRENDS MICROBIOL, V21, P405, DOI 10.1016/j.tim.2013.05.001; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	13	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					433	434		10.1038/s41590-018-0089-z	http://dx.doi.org/10.1038/s41590-018-0089-z			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29670235				2022-12-18	WOS:000430562400006
J	Fehervari, Z				Fehervari, Zoltan			Mast cells in autoimmune disease	NATURE IMMUNOLOGY			English	Editorial Material																			0	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					316	316		10.1038/s41590-018-0080-8	http://dx.doi.org/10.1038/s41590-018-0080-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563623	Bronze			2022-12-18	WOS:000428151000005
J	Stik, G; Graf, T				Stik, Gregoire; Graf, Thomas			INDUCED HEMATOPOIESIS Hoxb5, a Trojan horse to generate T cells	NATURE IMMUNOLOGY			English	Editorial Material							STEM-CELLS; PROGENITOR CELLS; B-CELLS; CONVERSION		[Stik, Gregoire; Graf, Thomas] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain; [Stik, Gregoire; Graf, Thomas] Univ Pompeu Fabra, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Graf, T (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain.; Graf, T (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.	thomas.graf@crg.eu	stik, gregoire/R-1342-2016; Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117; Stik, Gregoire/0000-0002-1404-1992				Bian Q, 2016, TRENDS BIOTECHNOL, V34, P993, DOI 10.1016/j.tibtech.2016.05.010; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Daniel MG, 2016, TRENDS CELL BIOL, V26, P202, DOI 10.1016/j.tcb.2015.10.002; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Lis R, 2017, NATURE, V545, P439, DOI 10.1038/nature22326; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang M., 2017, NAT IMMUNOL	13	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					210	212		10.1038/s41590-018-0053-y	http://dx.doi.org/10.1038/s41590-018-0053-y			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29476186				2022-12-18	WOS:000427007500010
J	Jakobsen, MR				Jakobsen, Martin Roelsgaard			ERAdP standing in the shadow of STING innate immune signaling	NATURE IMMUNOLOGY			English	Editorial Material							CYCLIC DINUCLEOTIDE; ACTIVATION; CGAS; PATHWAY; IFI16	ERAdP, an endoplasmic reticulum (ER)-resident protein with similar mechanistic features as the innate immune adaptor STING, controls inflammatory cytokine release, but not that of type I interferon, in response to bacterial cyclic di-AMP.	[Jakobsen, Martin Roelsgaard] Aarhus Univ, Fac Hlth, Dept Biomed, Aarhus, Denmark	Aarhus University	Jakobsen, MR (corresponding author), Aarhus Univ, Fac Hlth, Dept Biomed, Aarhus, Denmark.	mrj@biomed.au.dk		, Martin/0000-0001-8847-9201				Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Chen J, 2015, J IMMUNOL, V194, P1292, DOI 10.4049/jimmunol.1402593; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Hansen K, 2014, EMBO J, V33, P1654, DOI 10.15252/embj.201488029; Jonsson KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14391; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Swanson KV, 2017, J EXP MED, V214, P3611, DOI 10.1084/jem.20171749; Xia P., 2018, NAT IMMUNOL	14	3	3	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					105	107		10.1038/s41590-017-0026-6	http://dx.doi.org/10.1038/s41590-017-0026-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348499				2022-12-18	WOS:000423435200010
J	Low, JS; Kaech, SM				Low, Jun Siong; Kaech, Susan M.			Trials and Tribble-ations of tissue T-RM cells	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY; DIFFERENTIATION; INFECTION; RESIDENCE		[Low, Jun Siong; Kaech, Susan M.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Yale University	Kaech, SM (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.	Susan.Kaech@yale.edu		Low, Jun Siong/0000-0002-1775-0778	NCI NIH HHS [R01 CA230275] Funding Source: Medline; NIAID NIH HHS [R01 AI123864] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123864] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beura L. K., 2018, NAT IMMUNOL; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Fraser KA, 2013, IMMUNITY, V39, P171, DOI 10.1016/j.immuni.2013.07.003; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Park S. L., 2018, NAT IMMUNOL; Schenkel JM, 2016, J IMMUNOL, V196, P3920, DOI 10.4049/jimmunol.1502337; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Takamura S, 2016, J EXP MED, V213, P3057, DOI 10.1084/jem.20160938; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107	14	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					102	103		10.1038/s41590-017-0031-9	http://dx.doi.org/10.1038/s41590-017-0031-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348504	Green Accepted			2022-12-18	WOS:000423435200008
J	Lee, YM; Ayres, JS				Lee, Yujung Michelle; Ayres, Janelle S.			Decoding the intestinal epithelium cell by cell	NATURE IMMUNOLOGY			English	Editorial Material							ENTEROENDOCRINE CELLS		[Lee, Yujung Michelle; Ayres, Janelle S.] Salk Inst Biol Studies, Nomis Ctr Immunol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Ayres, JS (corresponding author), Salk Inst Biol Studies, Nomis Ctr Immunol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jayres@salk.edu			NIAID NIH HHS [R01 AI114929] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Pyrski M, 2017, MOL CELL NEUROSCI, V80, P75, DOI 10.1016/j.mcn.2017.02.002; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161	9	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					7	9		10.1038/s41590-017-0011-0	http://dx.doi.org/10.1038/s41590-017-0011-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29242547				2022-12-18	WOS:000419765300008
J	de Laval, B; Sieweke, MH				de laval, Berengere; Sieweke, Michael H.			Trained macrophages support hygiene hypothesis	NATURE IMMUNOLOGY			English	Editorial Material							TISSUE-RESIDENT MACROPHAGES; SELF-RENEWAL; MONOCYTES	Replacement of resident alveolar macrophages by monocyte-derived macrophages after herpesvirus infection protects against asthma.	[de laval, Berengere; Sieweke, Michael H.] Aix Marseille Univ, Ctr Immunol Marseille Luminy, CNRS, INSERM, Marseille, France; [Sieweke, Michael H.] Helmholtzgemeinschaft, Max Delbruck Ctr Mol Med, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sieweke, MH (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, CNRS, INSERM, Marseille, France.	sieweke@ciml.univ-mrs.fr	Sieweke, Michael/AAR-7515-2020	Sieweke, Michael/0000-0002-3228-9537; de Laval, Berengere/0000-0002-5616-2338				Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Saghafian-Hedengren S, 2010, J ALLERGY CLIN IMMUN, V125, P433, DOI 10.1016/j.jaci.2009.09.033; Sieweke MH, 2015, CELL STEM CELL, V16, P7, DOI 10.1016/j.stem.2014.12.009; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017	12	3	3	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1279	1280		10.1038/ni.3874	http://dx.doi.org/10.1038/ni.3874			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144502				2022-12-18	WOS:000415324900003
J	Strauss, L; Patsoukis, N; Boussiotis, VA				Strauss, Laura; Patsoukis, Nikolaos; Boussiotis, Vassiliki A.			Feeling stressed? It might be your T cells	NATURE IMMUNOLOGY			English	Editorial Material							GLUTAMINE UPTAKE; METABOLISM; ACTIVATION; PD-1	Abolishing signals mediated by the inhibitory receptor PD-1 results in a systemic decrease in tryptophan and tyrosine, which leads to a striking deficiency in the neurotransmitters serotonin and dopamine in the brain and anxiety-like behavior and exacerbated fear.	[Strauss, Laura; Patsoukis, Nikolaos; Boussiotis, Vassiliki A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA; [Strauss, Laura; Patsoukis, Nikolaos; Boussiotis, Vassiliki A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Boussiotis, VA (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA.; Boussiotis, VA (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.	vboussio@bidmc.harvard.edu						Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Miyajima M, 2017, NAT IMMUNOL, V18, P1342, DOI 10.1038/ni.3867; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Repasky EA, 2015, CANCER J, V21, P97, DOI 10.1097/PPO.0000000000000107; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	12	3	3	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1281	1283		10.1038/ni.3872	http://dx.doi.org/10.1038/ni.3872			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144505				2022-12-18	WOS:000415324900004
J	Chen, L; Wilson, JE; Koenigsknecht, MJ; Chou, WC; Montgomery, SA; Truax, AD; Brickey, WJ; Packey, CD; Maharshak, N; Matsushima, GK; Plevy, SE; Young, VB; Sartor, RB; Ting, JPY				Chen, Liang; Wilson, Justin E.; Koenigsknecht, Mark J.; Chou, Wei-Chun; Montgomery, Stephanie A.; Truax, Agnieszka D.; Brickey, W. June; Packey, Christopher D.; Maharshak, Nitsan; Matsushima, Glenn K.; Plevy, Scott E.; Young, Vincent B.; Sartor, R. Balfour; Ting, Jenny P-Y			NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth (vol 18, pg 541, 2017)	NATURE IMMUNOLOGY			English	Correction													Young, Vincent B/B-3179-2009	Young, Vincent B/0000-0003-3687-2364				Chen L, 2017, NAT IMMUNOL, V18, P541, DOI 10.1038/ni.3690	1	3	4	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1270	1270		10.1038/ni1117-1270b	http://dx.doi.org/10.1038/ni1117-1270b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044233	Bronze			2022-12-18	WOS:000413457300014
J	Zikherman, J; Lowell, CA				Zikherman, Julie; Lowell, Clifford A.			B cell autoimmunity at the extremes	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; IMMUNODEFICIENCY; TOLERANCE; CAVEOLIN-1; SUSCEPTIBILITY; SELECTION; ZAP-70	Caveolin-1 has a critical role in orchestrating the membrane organization of B cells. In its absence, signaling via the B cell antigen receptor and B cell tolerance are impaired, which results in autoimmunity.	[Zikherman, Julie] Univ Calif San Francisco, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, San Francisco, CA USA; [Zikherman, Julie] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lowell, CA (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	clifford.lowell@ucsf.edu			NIAID NIH HHS [R01 AI113272] Funding Source: Medline; NIAMS NIH HHS [R01 AR069520] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069520] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bogaert DJA, 2016, J MED GENET, V53, P575, DOI 10.1136/jmedgenet-2015-103690; Chen LY, 2017, CURR OPIN RHEUMATOL, V29, P423, DOI 10.1097/BOR.0000000000000411; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Grimaldi C, 2005, J IMMUNOL, V174, P1775, DOI 10.4049/jimmunol.174.4.1775; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Medina FA, 2006, CELL CYCLE, V5, P1865, DOI 10.4161/cc.5.16.3132; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Minguet S, 2017, NAT IMMUNOL, V18, P1150, DOI 10.1038/ni.3813; Rawlings DJ, 2017, NAT REV IMMUNOL, V17, P421, DOI 10.1038/nri.2017.24; Romberg N, 2011, BLOOD, V118, P5977, DOI 10.1182/blood-2011-09-373969; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Schonle A, 2016, BLOOD, V127, P1930, DOI 10.1182/blood-2015-09-672428; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Tomassian T, 2011, J IMMUNOL, V187, P2993, DOI 10.4049/jimmunol.1101447	16	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1065	1066		10.1038/ni.3840	http://dx.doi.org/10.1038/ni.3840			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926534	Green Accepted			2022-12-18	WOS:000411134000004
J	Zhao, DM; Xue, HH				Zhao, Dong-Mei; Xue, Hai-Hui			MLL4 keeps Foxp3 in the loop	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; IDENTITY	The histone lysine methyltransferase MLL4 primes the locus encoding the transcription factor Foxp3 for transcriptional activation in thymus-derived and inducible regulatory T cells.	[Zhao, Dong-Mei] Iowa City Vet Affairs Hlth Care Syst, Dept Internal Med, Iowa City, IA USA; [Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Xue, HH (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.	hai-hui-xue@uiowa.edu		Xue, Hai-Hui/0000-0002-9163-7669	NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Delacher M, 2014, CURR TOP MICROBIOL, V381, P83, DOI 10.1007/82_2014_373; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Li XD, 2015, TRENDS IMMUNOL, V36, P344, DOI 10.1016/j.it.2015.04.006; Placek K, 2017, NAT IMMUNOL, V18, P1035, DOI 10.1038/ni.3812; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456	10	3	3	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					957	958		10.1038/ni.3811	http://dx.doi.org/10.1038/ni.3811			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28829449				2022-12-18	WOS:000408137700003
J	Chen, L; Wilson, JE; Koenigsknecht, MJ; Chou, WC; Montgomery, SA; Truax, AD; Brickey, WJ; Packey, CD; Maharshak, N; Matsushima, GK; Plevy, SE; Young, VB; Sartor, RB; Ting, JPY				Chen, Liang; Wilson, Justin E.; Koenigsknecht, Mark J.; Chou, Wei-Chun; Montgomery, Stephanie A.; Truax, Agnieszka D.; Brickey, W. June; Packey, Christopher D.; Maharshak, Nitsan; Matsushima, Glenn K.; Plevy, Scott E.; Young, Vincent B.; Sartor, R. Balfour; Ting, Jenny P-Y			NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth (vol 18, pg 541, 2017)	NATURE IMMUNOLOGY			English	Correction													Maharshak, Nitsan/AAK-5288-2020; Young, Vincent B/B-3179-2009	Young, Vincent B/0000-0003-3687-2364	NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016086] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen L, 2017, NAT IMMUNOL, V18, P541, DOI 10.1038/ni.3690	1	3	3	4	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					951	951		10.1038/ni0817-951e	http://dx.doi.org/10.1038/ni0817-951e			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722719	Bronze			2022-12-18	WOS:000405821100022
J	Locati, M; Mantovani, A; Bonecchi, R				Locati, Massimo; Mantovani, Alberto; Bonecchi, Raffaella			Atypical matters in myeloid differentiation	NATURE IMMUNOLOGY			English	Editorial Material							CHEMOKINES; IMMUNITY; RECEPTOR; CELLS		[Mantovani, Alberto; Bonecchi, Raffaella] Humanitas Univ, Humanitas Clin & Res Ctr, Rozzano, Italy; [Mantovani, Alberto; Bonecchi, Raffaella] Humanitas Univ, Dept Biomed Sci, Rozzano, Italy; [Locati, Massimo] Humanitas Clin & Res Ctr, Rozzano, Italy; [Locati, Massimo] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	Humanitas University; IRCCS Humanitas Research Hospital; Humanitas University; IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital; University of Milan	Bonecchi, R (corresponding author), Humanitas Univ, Humanitas Clin & Res Ctr, Rozzano, Italy.; Bonecchi, R (corresponding author), Humanitas Univ, Dept Biomed Sci, Rozzano, Italy.	raffaella.bonecchi@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022; Bonecchi, Raffaella/ABI-2390-2020; Locati, Massimo/ABF-6807-2021	Mantovani, Alberto/0000-0001-5578-236X; Bonecchi, Raffaella/0000-0003-3346-5333				BORRONI EM, 2013, SCI SIGNAL, V6, P1, DOI DOI 10.1126/SCISIGNAL.2003627; Borroni EM, 2013, SCI SIGNAL, V6, pS1; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Duchene J, 2017, NAT IMMUNOL, V18, P753, DOI 10.1038/ni.3763; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Horuk R, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00279; Hur J, 2016, CELL STEM CELL, V18, P508, DOI 10.1016/j.stem.2016.01.013; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Ottersbach K, 2001, BLOOD, V98, P3476, DOI 10.1182/blood.V98.12.3476; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360	12	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					711	712		10.1038/ni.3776	http://dx.doi.org/10.1038/ni.3776			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28632711				2022-12-18	WOS:000403676300004
J	Mowat, AM; Bain, CC				Mowat, Allan McI; Bain, Calum C.			Alternative monocytes settle in for the long term	NATURE IMMUNOLOGY			English	Editorial Material							TISSUE MACROPHAGES; ORIGINS	Monocytes recruited to the peritoneum under conditions of a type 2 inflammatory reaction can convert into resident-type macrophages under the control of vitamin A.	[Mowat, Allan McI] Univ Glasgow, Coll Med Vet Med & Life Sci, Ctr Immunobiol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Bain, Calum C.] Univ Edinburgh, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Edinburgh	Mowat, AM (corresponding author), Univ Glasgow, Coll Med Vet Med & Life Sci, Ctr Immunobiol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	allan.mowat@glasgow.ac.uk		Bain, Calum/0000-0001-8884-327X				Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Wiedermann U, 1996, SCAND J IMMUNOL, V44, P578, DOI 10.1046/j.1365-3083.1996.d01-351.x; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	14	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					599	600		10.1038/ni.3749	http://dx.doi.org/10.1038/ni.3749			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28518159	Green Submitted, Green Accepted			2022-12-18	WOS:000401520900003
J	Yu, BF; Zhang, K; Milner, JJ; Toma, C; Chen, RQ; Scott-Browne, JP; Pereira, RM; Crotty, S; Chang, JT; Pipkin, ME; Wang, W; Goldrath, AW				Yu, Bingfei; Zhang, Kai; Milner, J. Justin; Toma, Clara; Chen, Runqiang; Scott-Browne, James P.; Pereira, Renata M.; Crotty, Shane; Chang, John T.; Pipkin, Matthew E.; Wang, Wei; Goldrath, Ananda W.			Epigenetic landscapes reveal transcription factors that regulate CD8(+) T cell differentiation (vol 18, pg 573, 2017)	NATURE IMMUNOLOGY			English	Correction													Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR070310] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706	1	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ					2022-12-18	WOS:000401520900016
J	Dempsey, LA				Dempsey, Laurie A.			Antimicrobial IL-22	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					373	373		10.1038/ni.3722	http://dx.doi.org/10.1038/ni.3722			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3EM	28323264				2022-12-18	WOS:000447604400003
J	Fehervari, Z				Fehervari, Zoltan			Inflammasomes in human aging	NATURE IMMUNOLOGY			English	Editorial Material																			0	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					254	254						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU8PC	28198825	Bronze			2022-12-18	WOS:000424114800002
J	Amit, I; Winter, DR; Jung, S				Amit, Ido; Winter, Deborah R.; Jung, Steffen			The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis (vol 17, pg 18, 2016)	NATURE IMMUNOLOGY			English	Correction													Winter, Deborah R./AAQ-9253-2020	Winter, Deborah R./0000-0003-1806-673X				Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325	1	3	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					246	246		10.1038/ni0217-246b	http://dx.doi.org/10.1038/ni0217-246b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102219	Bronze			2022-12-18	WOS:000392360900019
J	Asquith, B; de Boer, RJ				Asquith, Becca; de Boer, Rob J.			How lymphocytes add up	NATURE IMMUNOLOGY			English	Editorial Material							CD8(+) T-CELLS; DIFFERENTIATION; INFECTION; EXPANSION; FATES; MICE	A surprising molecular mechanism underlying signal integration and programmed proliferation in adaptive immunity has been identified: the cell-cycle regulator Myc enables a lymphocyte to add up the strength of signals it receives and time its response accordingly.	[Asquith, Becca] Imperial Coll London, Dept Med, London, England; [de Boer, Rob J.] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands	Imperial College London; Utrecht University	Asquith, B (corresponding author), Imperial Coll London, Dept Med, London, England.	b.asquith@imperial.ac.uk	de Boer, Rob/B-6050-2011	de Boer, Rob/0000-0002-2130-691X; Asquith, Becca/0000-0002-5911-3160				Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Heinzel S., 2017, NAT IMMUNOL, V18, P96; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Lahoz-Beneytez J, 2016, BLOOD, V127, P3431, DOI 10.1182/blood-2016-03-700336; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; Smith DP, 2006, BLOOD, V108, P653, DOI 10.1182/blood-2006-01-0172; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864	14	3	3	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					12	13						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EF1JB					2022-12-18	WOS:000390080000005
J	Vely, F; Golub, R; Vivier, E				Vely, Frederic; Golub, Rachel; Vivier, Eric			HLA-Fatal attraction	NATURE IMMUNOLOGY			English	Editorial Material							EXPRESSION; RECEPTORS; KIR3DS1; LIGANDS; SURFACE; CANCER	Open conformers of the non-classical and monomorphic major histocompatibility complex (MHC) class I molecule HLA-F are ligands for the activating receptor KIR3DS1 and trigger the activation of natural killer (NK) cells.	[Vely, Frederic; Vivier, Eric] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, Marseille, France; [Vely, Frederic; Vivier, Eric] Aix Marseille Univ, Dept Immunol, Hop Concept, Assistance Publ Hop Marseille, Marseille, France; [Golub, Rachel] INSERM, Inst Pasteur, Unite Lymphopoiese, Paris, France; [Golub, Rachel] Univ Paris Diderot, Cellule Pasteur, Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Vivier, E (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, Marseille, France.; Vivier, E (corresponding author), Aix Marseille Univ, Dept Immunol, Hop Concept, Assistance Publ Hop Marseille, Marseille, France.	vivier@ciml.univ-mrs.fr	Moshous, Despina/B-7507-2017; Vély, Frédéric/HHM-3894-2022; Vivier, Eric/F-8939-2010; Rachel, GOLUB/M-7188-2014; GOLUB, rachel/X-8717-2019	Moshous, Despina/0000-0001-6719-3693; Vivier, Eric/0000-0001-7022-8287; Rachel, GOLUB/0000-0002-2306-5363; GOLUB, rachel/0000-0002-2306-5363				Della Chiesa M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00573; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Harada A, 2015, PATHOL INT, V65, P569, DOI 10.1111/pin.12343; Ishigami S, 2015, ANTICANCER RES, V35, P2279; Jucaud V, 2016, CLIN EXP IMMUNOL, V183, P326, DOI 10.1111/cei.12724; Lee N, 2010, EUR J IMMUNOL, V40, P2308, DOI 10.1002/eji.201040348; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Pascal V, 2007, J IMMUNOL, V179, P1625, DOI 10.4049/jimmunol.179.3.1625; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478	13	3	3	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1012	1014		10.1038/ni.3541	http://dx.doi.org/10.1038/ni.3541			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27540985				2022-12-18	WOS:000381832000004
J	Ablasser, A				Ablasser, Andrea			ReGLUation of cGAS	NATURE IMMUNOLOGY			English	Editorial Material							DNA SENSOR; PATHWAY; CELLS	The detection of cytosolic DNA by the sensor cGAS triggers potent antiviral responses. New data now propose that cGAS is regulated on a post-translational level by glutamylation.	[Ablasser, Andrea] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Ablasser, A (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland.	andrea.ablasser@epfl.ch						Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Ye BQ, 2014, J EXP MED, V211, P2439, DOI 10.1084/jem.20141123	9	3	3	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					347	349		10.1038/ni.3397	http://dx.doi.org/10.1038/ni.3397			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002833				2022-12-18	WOS:000372508000003
J	Fehervari, Z				Fehervari, Zoltan			cGAS ramps up autoinflammatory disease (vol 16, pg 1113, 2015)	NATURE IMMUNOLOGY			English	Correction																		[Anonymous], 2015, NAT IMMUNOL, V16, P1113	1	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					469	469		10.1038/ni0416-469d	http://dx.doi.org/10.1038/ni0416-469d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR		Bronze			2022-12-18	WOS:000372508000025
J	Bantug, GR; Hess, C				Bantug, Glenn R.; Hess, Christoph			Glycolysis and EZH2 boost T cell weaponry against tumors	NATURE IMMUNOLOGY			English	Editorial Material							EFFECTOR FUNCTION; CANCER; DIFFERENTIATION; IMMUNOTHERAPY; EXPRESSION; RESPONSES	Low availability of glucose in tumors negatively affects the activity of tumor-infiltrating T cells. Loss of T cell function under these conditions is mediated by the microRNAs miR-101 and miR-26a, which target expression of the methytransferase EZH2 and thereby diminish the expression of anti-tumor cytokines.	[Bantug, Glenn R.; Hess, Christoph] Univ Basel, Dept Biomed, Basel, Switzerland	University of Basel	Bantug, GR (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	chess@uhbs.ch		Bantug, Glenn Robert/0000-0003-2253-6028				Backer RA, 2014, NAT IMMUNOL, V15, P1143, DOI 10.1038/ni.3027; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Sierra RA, 2014, CANCER IMMUNOL RES, V2, P800, DOI 10.1158/2326-6066.CIR-14-0021; Siska PJ, 2015, TRENDS IMMUNOL, V36, P257, DOI 10.1016/j.it.2015.02.007; Tong Q, 2014, J IMMUNOL, V192, P5012, DOI 10.4049/jimmunol.1302943; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Zhao E., 2016, NAT IMMUNOL, V17, P95	13	3	3	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					41	42						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681461				2022-12-18	WOS:000366675800007
J	Kollias, G; Lambris, JD				Kollias, George; Lambris, John D.			A 'rule of 3' to revive Greek science, research and innovation	NATURE IMMUNOLOGY			English	Article								If research and technology are to become the driving force for turning Greece into a productive society, evidence-based governance, strategic restructuring of infrastructure and a substantial inflow of fresh human capital is urgently needed.	[Kollias, George] Univ Athens, Sch Med, Acad Athens, Dept Physiol, GR-11527 Athens, Greece; [Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Athens, Greece; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; Alexander Fleming Biomedical Sciences Research Center; University of Pennsylvania	Kollias, G (corresponding author), Univ Athens, Sch Med, Acad Athens, Dept Physiol, GR-11527 Athens, Greece.	kollias@fleming.gr; lambris@upenn.edu	Lambris, John/Q-5633-2018; Kollias, George/A-7079-2012	Lambris, John/0000-0002-9370-5776; Kollias, George/0000-0003-1867-3150				Eco U, 1997, EXPRESSO        0424; European Commission, 2014, RES INN PERF EU INN; Grueber M, 2011, R D MAGAZINE    1206; Kornberg R.D., 2014, PETITION SUPPORT SCI; National Documentation Centre, 2015, RES DEV EXP PERS GRE; National Documentation Centre, 2013, GREEK SCI PUBL 1996; Pascual C., 2015, 7 YEARS EXCELLENCE G; Tabucchi Antonio, 1999, GASTRITIS PLATON; Zur Hausen H, 2012, SCIENCE, V336, P978, DOI 10.1126/science.336.6084.978	9	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1206	1208		10.1038/ni.3322	http://dx.doi.org/10.1038/ni.3322			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26580499				2022-12-18	WOS:000365062100002
J	Brusselle, GG; Bracke, KR				Brusselle, Guy G.; Bracke, Ken R.			MicroRNA miR-22 drives T(H)17 responses in emphysema	NATURE IMMUNOLOGY			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; IL-17A; CELLS	The T(H)17 subset of helper T cells drives emphysema in smokers, but how these cells are elicited remains unknown. A study now links the microRNA miR-22 and the histone deacetylase HDAC4 to regulation of the activation of antigen-presenting cells after exposure to smoke.	[Brusselle, Guy G.; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Brusselle, Guy G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Brusselle, Guy G.] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Brusselle, GG (corresponding author), Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium.	guy.brusselle@ugent.be	Bracke, Ken R/GSN-7630-2022	Bracke, Ken R/0000-0001-5906-4605; Brusselle, Guy/0000-0001-7021-8505				Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu W, 2015, NAT IMMUNOL, V16, P1185, DOI 10.1038/ni.3292; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Roos AB, 2015, AM J RESP CRIT CARE, V192, P428, DOI 10.1164/rccm.201409-1689OC; Roos AB, 2015, AM J RESP CRIT CARE, V191, P1232, DOI 10.1164/rccm.201410-1861OC	12	3	3	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1109	1110		10.1038/ni.3295	http://dx.doi.org/10.1038/ni.3295			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26482970				2022-12-18	WOS:000363096000003
J	Stuart, LM; Lacy-Hulbert, A				Stuart, Lynda M.; Lacy-Hulbert, Adam			De-Mst-ifying microbicidal killing	NATURE IMMUNOLOGY			English	Editorial Material							PHAGOCYTOSIS; MACROPHAGES; AUTOPHAGY; PATHWAY	Mitochondria can contribute to an increase in the amount of phagosomal reactive oxygen species and thereby promote the effective killing of bacteria. Study of mice deficient in Mst1 and Mst2 reveals a role for these kinases in recruiting mitochondria to phagosomes.	[Stuart, Lynda M.; Lacy-Hulbert, Adam] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Stuart, Lynda M.] Bill & Melinda Gates Fdn, Discovery & Translat Sci, Seattle, WA USA	Benaroya Research Institute; Bill & Melinda Gates Foundation	Stuart, LM (corresponding author), Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA.	lstuart@benaroyaresearch.org						Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Du XR, 2015, ACTA BIOCH BIOPH SIN, V47, P60, DOI 10.1093/abbs/gmu112; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wilkinson DS, 2015, MOL CELL, V57, P55, DOI 10.1016/j.molcel.2014.11.019	11	3	4	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1107	1108		10.1038/ni.3291	http://dx.doi.org/10.1038/ni.3291			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26482969				2022-12-18	WOS:000363096000002
J	[Anonymous]				[Anonymous]			Don't eat me, activate me	NATURE IMMUNOLOGY			English	Editorial Material																			0	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1113	1113						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VB8EU					2022-12-18	WOS:000418279000003
J	[Anonymous]				[Anonymous]			Aging neutrophils	NATURE IMMUNOLOGY			English	Editorial Material																			0	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1113	1113						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VB8EU					2022-12-18	WOS:000418279000005
J	Winter, DR; Amit, I				Winter, Deborah R.; Amit, Ido			DCs are ready to commit	NATURE IMMUNOLOGY			English	Editorial Material							CELL-DEVELOPMENT; DENDRITIC CELLS; BONE-MARROW; IN-VIVO; IDENTIFICATION; PROGENITORS	Dendritic cell progenitors commit to a specific conventional dendritic cell fate earlier than previously thought, by initiating transcription-factor regulatory circuits unique to their subtype.	[Winter, Deborah R.; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Winter, DR (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	deborah.winter@weizmann.ac.il; ido.amit@weizmann.ac.il	Winter, Deborah R./AAQ-9253-2020	Winter, Deborah R./0000-0003-1806-673X				Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200	14	3	3	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					683	685		10.1038/ni.3208	http://dx.doi.org/10.1038/ni.3208			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086135				2022-12-18	WOS:000356445600003
J	Gadani, SP; Kipnis, J				Gadani, Sachin P.; Kipnis, Jonathan			Brainless immunity no more	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMATION	The mediobasal hypothalamus detects increased amounts of tumor necrosis factor during the early phases of inflammation and relays this information to cells of the adaptive immune system by mobilizing free fatty acids.	[Gadani, Sachin P.; Kipnis, Jonathan] Univ Virginia, Ctr Brain Immunol & Glia, Sch Med, Dept Neurosci, Charlottesville, VA 22903 USA	University of Virginia	Gadani, SP (corresponding author), Univ Virginia, Ctr Brain Immunol & Glia, Sch Med, Dept Neurosci, Charlottesville, VA 22903 USA.	kipnis@virginia.edu	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X; Giese, Karl Peter/0000-0003-4503-7344	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Kim MS, 2015, NAT IMMUNOL, V16, P525, DOI 10.1038/ni.3133; Kipnis J, 2004, J NEUROSCI, V24, P6133, DOI 10.1523/JNEUROSCI.0600-04.2004; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	15	3	3	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					440	441		10.1038/ni.3145	http://dx.doi.org/10.1038/ni.3145			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898188				2022-12-18	WOS:000353305200002
J	Rantakari, P; Auvinen, K; Jappinen, N; Kapraali, M; Valtonen, J; Karikoski, M; Gerke, H; Iftakhar-E-Khuda, I; Keuschnigg, J; Umemoto, E; Tohya, K; Miyasaka, M; Elima, K; Jalkanen, S; Salmi, M				Rantakari, Pia; Auvinen, Kaisa; Jappinen, Norma; Kapraali, Maria; Valtonen, Joona; Karikoski, Marika; Gerke, Heidi; Iftakhar-E-Khuda, Imtiaz; Keuschnigg, Johannes; Umemoto, Eiji; Tohya, Kazuo; Miyasaka, Masayuki; Elima, Kati; Jalkanen, Sirpa; Salmi, Marko			The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes (vol 16, pg 386, 2015)	NATURE IMMUNOLOGY			English	Correction													Miyasaka, Masayuki/AAM-6343-2020	Karikoski, Marika/0000-0001-6512-6331; Valtonen, Joona/0000-0003-2704-4663				Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101	1	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					544	544		10.1038/ni0515-544c	http://dx.doi.org/10.1038/ni0515-544c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898202	Bronze			2022-12-18	WOS:000353305200019
J	Mankan, AK; Hornung, V				Mankan, Arun K.; Hornung, Veit			Sox2 as a servant of two masters	NATURE IMMUNOLOGY			English	Editorial Material							CYTOSOLIC NUCLEIC-ACIDS; INNATE IMMUNITY; CELL FATE; PROTEINS; DIFFERENTIATION; REGULATORS; ACTIVATION; SENSOR; FAMILY		[Mankan, Arun K.; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Mol Med, Bonn, Germany	University of Bonn	Mankan, AK (corresponding author), Univ Bonn, Univ Hosp, Inst Mol Med, Bonn, Germany.	veit.hornung@uni-bonn.de	Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X				Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xia PY, 2015, NAT IMMUNOL, V16, P366, DOI 10.1038/ni.3117; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521	12	3	3	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					335	336		10.1038/ni.3121	http://dx.doi.org/10.1038/ni.3121			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25789674				2022-12-18	WOS:000351333700003
J	Seddon, B				Seddon, Benedict			Thymic IL-7 signaling goes beyond survival	NATURE IMMUNOLOGY			English	Editorial Material							LEUKEMIA; CELLS		UCL, Royal Free Hosp, Div Infect & Immun, Inst Immun & Transplantat, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Seddon, B (corresponding author), UCL, Royal Free Hosp, Div Infect & Immun, Inst Immun & Transplantat, London, England.	benedict.seddon@ucl.ac.uk		Seddon, Benedict/0000-0003-4352-3373				Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Boudil A, 2015, NAT IMMUNOL, V16, P397, DOI 10.1038/ni.3122; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Pearson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033998; Ribeiro Daniel, 2013, Adv Biol Regul, V53, P211, DOI 10.1016/j.jbior.2012.10.005; Seo YB, 2014, J VIROL, V88, P8998, DOI 10.1128/JVI.00534-14; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015	9	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					337	338		10.1038/ni.3128	http://dx.doi.org/10.1038/ni.3128			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25789675				2022-12-18	WOS:000351333700004
J	Mueller, SN				Mueller, Scott N.			Skin DCs cluster for efficient T cell activation	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; IMMUNE-SYSTEM; RESIDENT; TISSUE		Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3052, Australia	University of Melbourne	Mueller, SN (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3052, Australia.	smue@unimelb.edu.au	Mueller, Scott N/B-1918-2012	Mueller, Scott N/0000-0002-3838-3989				Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; BOS JD, 1987, J INVEST DERMATOL, V88, P569, DOI 10.1111/1523-1747.ep12470172; Eichmuller S, 1998, J HISTOCHEM CYTOCHEM, V46, P361, DOI 10.1177/002215549804600310; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Katou F, 2001, AM J PATHOL, V158, P1263, DOI 10.1016/S0002-9440(10)64077-1; Kim TG, 2014, J INVEST DERMATOL, V134, P1462, DOI 10.1038/jid.2013.534; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Macleod BL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004303; Mueller SN, 2013, IMMUNOL CELL BIOL, V91, P290, DOI 10.1038/icb.2012.75; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Weninger W, 2014, NAT REV IMMUNOL, V14, P232, DOI 10.1038/nri3641	12	3	3	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1004	1005		10.1038/ni.3012	http://dx.doi.org/10.1038/ni.3012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25329181				2022-12-18	WOS:000343640700004
J	Woodruff, MC; Turley, SJ				Woodruff, Matthew C.; Turley, Shannon J.			Chemokine 'grooming' by cLECs directs DC migration	NATURE IMMUNOLOGY			English	Editorial Material							HIGH ENDOTHELIAL VENULES; LYMPH-NODE; STEADY-STATE; CELLS; ANTIGEN	Migrating dendritic cells follow precise navigational chemokine gradients established by lymph node stromal cells through their asymmetric expression of the atypical chemokine receptor CCRL1.	[Woodruff, Matthew C.; Turley, Shannon J.] Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02163 USA; [Woodruff, Matthew C.] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Woodruff, Matthew C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Woodruff, MC (corresponding author), Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02163 USA.	shannon_turley@dfci.harvard.edu		Woodruff, Matthew/0000-0002-5252-7539				Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Ito K, 2014, P NATL ACAD SCI USA, V111, P3080, DOI 10.1073/pnas.1311022111; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; von Andnan U. H., 2003, NAT REV IMMUNOL, V3, P867	14	3	5	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					595	596		10.1038/ni.2926	http://dx.doi.org/10.1038/ni.2926			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24940945				2022-12-18	WOS:000337715600003
J	Subramanian, M; Tabas, I				Subramanian, Manikandan; Tabas, Ira			A new RIDDle in DC-mediated cross-presentation	NATURE IMMUNOLOGY			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; DENDRITIC CELLS; MESSENGER-RNA; ER STRESS; PATHWAY; DECAY; MICE		[Subramanian, Manikandan; Tabas, Ira] Columbia Univ, Dept Med, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Subramanian, Manikandan; Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, Med Ctr, New York, NY USA	Columbia University; Columbia University	Subramanian, M (corresponding author), Columbia Univ, Dept Med, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	iat1@columbia.edu		Subramanian, Manikandan/0000-0002-2608-3890	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107497, R01HL075662] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075662, R01 HL107497] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benhamron S, 2014, EUR J IMMUNOL, V44, P867, DOI 10.1002/eji.201343953; Coelho DS, 2013, CELL REP, V5, P791, DOI 10.1016/j.celrep.2013.09.046; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Iqbal J, 2008, CELL METAB, V7, P445, DOI 10.1016/j.cmet.2008.03.005; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Subramanian M., J CLIN INVE IN PRESS; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191	15	3	3	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					213	215		10.1038/ni.2826	http://dx.doi.org/10.1038/ni.2826			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24549063	Green Accepted			2022-12-18	WOS:000331683100003
J	Cella, M; Trinchieri, G				Cella, Marina; Trinchieri, Giorgio			A new VEGF connection between two old neighbors	NATURE IMMUNOLOGY			English	Editorial Material							PLASMACYTOID DENDRITIC CELLS; OVARIAN-CANCER; LYMPH-NODE; MICRORNAS; ANGIOGENESIS; IMMUNITY		[Cella, Marina] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Frederick, MD 21701 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cella, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcella@pathology.wustl.edu	Cella, Marina/ABA-8564-2020; Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464; Cella, Marina/0000-0003-1230-1313	NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC010793] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC010793-12] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agudo J., 2014, NAT IMMUNOL, V15, P54; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Curiel TJ, 2004, CANCER RES, V64, P5535, DOI 10.1158/0008-5472.CAN-04-1272; FACCHETTI F, 1989, IMMUNOL LETT, V20, P277, DOI 10.1016/0165-2478(89)90035-7; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Hong YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069926; Karrich JJ, 2013, BLOOD, V122, P3001, DOI 10.1182/blood-2012-12-475087; Kuipers H, 2010, MOL IMMUNOL, V48, P333, DOI 10.1016/j.molimm.2010.07.007; Labidi-Galy SI, 2012, ONCOIMMUNOLOGY, V1, P379, DOI 10.4161/onci.18801; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Vermi W, 2003, J PATHOL, V200, P255, DOI 10.1002/path.1344; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	15	3	4	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					8	9		10.1038/ni.2786	http://dx.doi.org/10.1038/ni.2786			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24352317	Green Accepted			2022-12-18	WOS:000328800500005
J	Fehervari, Z				Fehervari, Zoltan			Research Highlight: Latent Enhancement (vol 14 pg 204, 2013)	NATURE IMMUNOLOGY			English	Correction																		FEHERVARI Z, 2013, RES HIGHLIGHT LATENT, V14, P204	1	3	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					109	109						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ					2022-12-18	WOS:000328800500022
J	Tian, ZG				Tian, Zhigang			Outflanking HCV	NATURE IMMUNOLOGY			English	Editorial Material							HEPATITIS-C VIRUS; GENETIC-VARIATION; INFECTION; IL28B; CLEARANCE; CELLS		Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230026, Peoples R China.	tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013					Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Holder KA, 2013, J IMMUNOL, V191, P3308, DOI 10.4049/jimmunol.1300164; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; McFarland A., 2014, NAT IMMUNOL, V15, P72; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463	13	3	4	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					6	8		10.1038/ni.2783	http://dx.doi.org/10.1038/ni.2783			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24352316				2022-12-18	WOS:000328800500004
J	Yoshida, T; Georgopoulos, K				Yoshida, Toshimi; Georgopoulos, Katia			GATA-3 controls self-renewal in stressed HSCs	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; MAINTENANCE	The transcription factor GATA-3 is expressed in quiescent hematopoietic stem cells (HSCs) with long-term repopulating ability. Stress-mediated activation of HSCs promotes localization of GATA-3 to the nucleus in a manner dependent on the mitogen-activated protein kinase p38 alpha and restricts self-renewal.	[Yoshida, Toshimi; Georgopoulos, Katia] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA	Harvard University; Massachusetts General Hospital	Yoshida, T (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu	Yoshida, Toshimi/GSN-8717-2022	Yoshida, Toshimi/0000-0001-7080-6913				Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726	9	3	3	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1032	1033		10.1038/ni.2715	http://dx.doi.org/10.1038/ni.2715			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048133				2022-12-18	WOS:000324584700010
J	Kaplan, DH				Kaplan, Daniel H.			The IL-20 cytokine subfamily: bad guys in host defense?	NATURE IMMUNOLOGY			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; IMMUNITY	Resistance to infection of the skin with Staphylococcus aureus depends on early production of interleukin 1 beta (IL-1 beta) and IL-17A by skin-resident cells. However, several members of the IL-20 subfamily of cytokines (IL-19, IL-20 and IL-24) can inhibit the local generation of those two cytokines.	Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kaplan, DH (corresponding author), Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA.	dankaplan@umn.edu	Kaplan, Daniel H/N-2779-2013	Kaplan, Daniel H/0000-0002-7851-7320	NIAMS NIH HHS [R01 AR060744] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060744] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Myles IA, 2013, NAT IMMUNOL, V14, P804, DOI 10.1038/ni.2637; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	7	3	4	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					774	775		10.1038/ni.2664	http://dx.doi.org/10.1038/ni.2664			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23867927				2022-12-18	WOS:000322010600005
J	Yoshimura, A				Yoshimura, Akihiko			CIS: the late-blooming eldest son	NATURE IMMUNOLOGY			English	Editorial Material							SOCS PROTEINS; T-CELLS; CYTOKINE; SUPPRESSION; SURVIVAL	Members of the SOCS (suppressor of cytokine signaling) family negatively regulate STAT transcription factors. The SOCS family member CIS is now shown to negatively regulate differentiation into the TH2 and TH9 subsets of helper T cells through negative regulation of STAT3, STAT5 and STAT6.	Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Keio University	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013					Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Miah MA, 2012, EUR J IMMUNOL, V42, P58, DOI 10.1002/eji.201141846; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Wilhelm C, 2012, NAT IMMUNOL, V13, P637, DOI 10.1038/ni.2303; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	14	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					692	694		10.1038/ni.2645	http://dx.doi.org/10.1038/ni.2645			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778803				2022-12-18	WOS:000320509100008
J	Haseltine, D				Haseltine, Derek			Job-search basics: how to convert a CV into a resume	NATURE IMMUNOLOGY			English	Article								For broad scientific careers, resumes serve as critical job-search tools. This Commentary provides a strategy for writing an effective resume for searching for a nonacademic job.	Univ Maryland, Sch Med, Res Career Dev Program, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Haseltine, D (corresponding author), Univ Maryland, Sch Med, Res Career Dev Program, Baltimore, MD 21201 USA.	dhaseltine@som.umaryland.edu							0	3	3	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					6	9						4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23238749				2022-12-18	WOS:000312433800001
J	Held, W				Held, Werner			Nonclassical NK cell education	NATURE IMMUNOLOGY			English	News Item							NATURAL-KILLER-CELLS; CLASS-I MOLECULES; T-CELLS; LY49A	Diseased host cells are eliminated more effectively when natural killer cells grow up in the presence of classical major histocompatibility complex (MHC) class I molecules. The nonclassical MHC class I molecule H2-M3 can exert an analogous effect.	Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland	University of Lausanne	Held, W (corresponding author), Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland.	werner.held@unil.ch						Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Anfossi N, 2004, J IMMUNOL, V173, P3773, DOI 10.4049/jimmunol.173.6.3773; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; Chiu NM, 1999, J EXP MED, V190, P423, DOI 10.1084/jem.190.3.423; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Xu HL, 2006, J EXP MED, V203, P449, DOI 10.1084/jem.20051866	10	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2012	13	12					1135	1137		10.1038/ni.2470	http://dx.doi.org/10.1038/ni.2470			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	039BN	23160207				2022-12-18	WOS:000311217900003
J	Shaffer, AL; Staudt, LM				Shaffer, Arthur L., III; Staudt, Louis M.			The case of the missing c-Myc	NATURE IMMUNOLOGY			English	Editorial Material							B-CELL LYMPHOMAS	A fundamental mystery of the biology of germinal center B cells is why it seems that these rapidly dividing B cells lack expression of c-Myc, a transcriptional regulator intimately linked to cell metabolism and proliferation. This mystery has now been resolved.	[Shaffer, Arthur L., III; Staudt, Louis M.] Ctr Canc Res, Natl Canc Inst, Metab Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shaffer, AL (corresponding author), Ctr Canc Res, Natl Canc Inst, Metab Branch, Bethesda, MD USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019					Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380	12	3	3	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1029	1031		10.1038/ni.2455	http://dx.doi.org/10.1038/ni.2455			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23080195				2022-12-18	WOS:000310091700003
J	Monticelli, S; Sallusto, F				Monticelli, Silvia; Sallusto, Federica			Negative regulators take center stage	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; ACTIVATION; IL-10	The transcription factor Aiolos is upregulated in T lymphocytes in a manner dependent on the transcription factors STAT3 and AhR and leads to epigenetic silencing of the gene encoding interleukin 2. This acts as a cell-intrinsic safeguard mechanism for the differentiation of helper T cells into the T(H)17 subset.	[Monticelli, Silvia; Sallusto, Federica] Inst Res Biomed, Bellinzona, Switzerland	Universita della Svizzera Italiana	Monticelli, S (corresponding author), Inst Res Biomed, Bellinzona, Switzerland.	silvia.monticelli@irb.usi.ch	Monticelli, Silvia/ABE-7054-2020	Monticelli, Silvia/0000-0002-5909-8802				Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	11	3	4	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					719	720		10.1038/ni.2377	http://dx.doi.org/10.1038/ni.2377			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22814344				2022-12-18	WOS:000306569600006
J	Spaapen, RM; Neefjes, J				Spaapen, Robbert M.; Neefjes, Jacques			Immuno-waste exposure and further management	NATURE IMMUNOLOGY			English	Editorial Material							MHC CLASS-I; EXPRESSION	Since the definition of an immunoselective proteasome, the 'immunoproteasome', its function has been heavily disputed. A mouse with complete deficiency in immunoproteasomes has resolved one issue of the adaptation of the immune system to the proteasome but has raised other questions.	[Spaapen, Robbert M.; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Netherlands Cancer Institute	Spaapen, RM (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017; Spaapen, Robbert/AAF-9105-2021	Neefjes, Jacques J.C./0000-0001-6763-2211; Spaapen, Robbert/0000-0002-1329-8606				Berhane S, 2011, VIROLOGY, V421, P149, DOI 10.1016/j.virol.2011.09.025; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; MONACO JJ, 1984, NATURE, V309, P797, DOI 10.1038/309797a0; Murata S, 2008, CURR OPIN IMMUNOL, V20, P192, DOI 10.1016/j.coi.2008.03.002; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4	12	3	3	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					109	111		10.1038/ni.2204	http://dx.doi.org/10.1038/ni.2204			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22261957				2022-12-18	WOS:000299315000003
J	Constantin, G; Laudanna, C				Constantin, Gabriela; Laudanna, Carlo			Transmigration of effector T lymphocytes: changing the rules	NATURE IMMUNOLOGY			English	News Item							ACTIVATION; ADHESION	The transmigration of effector T lymphocytes is critical to adoptive immune response. The rules for the migration of effector T cells are now reported to be distinct from those that apply to naive and memory T cells.	[Constantin, Gabriela; Laudanna, Carlo] Univ Verona, Dept Pathol & Diag, Div Gen Pathol, I-37100 Verona, Italy; [Laudanna, Carlo] Univ Verona, Ctr Biomed Comp, I-37100 Verona, Italy	University of Verona; University of Verona	Constantin, G (corresponding author), Univ Verona, Dept Pathol & Diag, Div Gen Pathol, I-37100 Verona, Italy.	carlo.laudanna@univr.it		Constantin, Gabriela/0000-0001-8978-3539				BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189	10	3	3	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					15	16		10.1038/ni.2188	http://dx.doi.org/10.1038/ni.2188			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB	22179273				2022-12-18	WOS:000298412800005
J	Wertz, IE				Wertz, Ingrid E.			It takes two to tango: a new couple in the family of ubiquitin-editing complexes	NATURE IMMUNOLOGY			English	Editorial Material							ITCH	Improper termination of inflammatory signals can contribute to tumorigenesis. Cyld and Itch form an ubiquitin-editing complex that cooperatively downregulates the kinase Tak1 and thereby attenuates downstream activation of the transcription factor NF-kappa B.	Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Roche Holding; Genentech	Wertz, IE (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	ingrid@gene.com						Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350	12	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2011	12	12					1133	1135		10.1038/ni.2165	http://dx.doi.org/10.1038/ni.2165			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850NT	22089210				2022-12-18	WOS:000297202700004
J	De Santo, C; Salio, M; Dong, T; Reiter, Y; Cerundolo, V				De Santo, Carmela; Salio, Mariolina; Dong, Tao; Reiter, Yoram; Cerundolo, Vincenzo			Failure to detect production of IL-10 by activated human neutrophils Reply	NATURE IMMUNOLOGY			English	Letter							CELLS		[De Santo, Carmela; Salio, Mariolina; Dong, Tao; Cerundolo, Vincenzo] Univ Oxford, John Radcliffe Hosp, Med Res Council,Human Immunol Unit, Nuffield Dept Med,Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Reiter, Yoram] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; Technion Israel Institute of Technology	De Santo, C (corresponding author), Univ Oxford, John Radcliffe Hosp, Med Res Council,Human Immunol Unit, Nuffield Dept Med,Weatherall Inst Mol Med, Oxford OX3 9DU, England.	vincenzo.cerundolo@imm.ox.ac.uk		Dong, Tao/0000-0003-3545-3758	Medical Research Council [G0600520, G1001046] Funding Source: researchfish; MRC [G1001046, G0600520] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acorci-Valerio MJ, 2010, SCAND J IMMUNOL, V71, P99, DOI 10.1111/j.1365-3083.2009.02351.x; Bouabe H, 2011, J IMMUNOL, V187, P3165, DOI 10.4049/jimmunol.1101477; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Gomez-Hurtado I, 2011, HEPATOLOGY, V53, P935, DOI 10.1002/hep.24102; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Kwon S, 2011, J IMMUNOL, V186, P6263, DOI 10.4049/jimmunol.1003824; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	10	3	3	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1018	1020		10.1038/ni.2132	http://dx.doi.org/10.1038/ni.2132			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG					2022-12-18	WOS:000296500100002
J	Karakasiliotis, I; Kontoyiannis, DL				Karakasiliotis, Ioannis; Kontoyiannis, Dimitris L.			ASCertaining cytoskeletal rearrangements in antigen presentation and migration	NATURE IMMUNOLOGY			English	Editorial Material							DOCK2; CELLS; ASC	ASC has emerged as an adaptor for inflammasome sensors in cells of the innate immune response. New inflammasome-independent roles have been identified for ASC in the control of adaptive immunity; these include the post-transcriptional regulation of cytoskeletal rearrangements.	[Karakasiliotis, Ioannis; Kontoyiannis, Dimitris L.] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Greece	Alexander Fleming Biomedical Sciences Research Center	Karakasiliotis, I (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Greece.	kontoyiannis@fleming.gr	Karakasiliotis, Ioannis/ABG-9709-2021; Karakasiliotis, Yannis/AAP-5973-2021	Karakasiliotis, Ioannis/0000-0003-3004-8104; Kontoyiannis, Dimitris/0000-0003-4682-9490				Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Glorian V, 2011, CELL DEATH DIFFER, V18, P1692, DOI 10.1038/cdd.2011.35; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207	12	3	3	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					923	925		10.1038/ni.2114	http://dx.doi.org/10.1038/ni.2114			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21934669				2022-12-18	WOS:000295084500004
J	Boothby, M; Lee, K				Boothby, Mark; Lee, Keunwook			A 'Tsc, Tsc' keeps the kids quie(scen)t and holds down ROS	NATURE IMMUNOLOGY			English	Editorial Material							NAIVE T-CELLS; QUIESCENCE; SURVIVAL; METABOLISM; MAINTAINS; RAPAMYCIN; COMPLEX	Tuberins, the tumor-suppressor proteins that regulate signaling via the kinase mTOR, now emerge as essential enforcers of T cell quiescence that promote survival.	[Boothby, Mark; Lee, Keunwook] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA	Vanderbilt University	Boothby, M (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA.	mark.boothby@vanderbilt.edu		Lee, Keunwook/0000-0002-4713-8547				Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lacher MD, 2010, ONCOGENE, V29, P6543, DOI 10.1038/onc.2010.393; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Wu Q, 2011, J IMMUNOL, V187, P1106, DOI 10.4049/jimmunol.1003968; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	13	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					811	812		10.1038/ni.2092	http://dx.doi.org/10.1038/ni.2092			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21852776				2022-12-18	WOS:000294461200002
J	Milsom, MD; Trumpp, A				Milsom, Michael D.; Trumpp, Andreas			Bridging the information gap	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; CONNEXIN-43; JUNCTIONS; NICHES	The interaction between hematopoietic stem cells and their niche is critical for the lifelong maintenance of the blood system. New research shows that crosstalk between stromal components of the niche mediates secretion of the chemokine CXCL12.	[Milsom, Michael D.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med, Heidelberg, Germany; [Milsom, Michael D.; Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Milsom, MD (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med, Heidelberg, Germany.	a.trumpp@dkfz-heidelberg.de	Trumpp, Andreas/Z-2141-2019; Milsom, Michael/AAK-4600-2020	Trumpp, Andreas/0000-0002-6212-3466; /0000-0002-3567-254X				Cancelas JA, 2000, BLOOD, V96, P498; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Presley CA, 2005, CELL COMMUN ADHES, V12, P307, DOI 10.1080/15419060500514200; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779	10	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					377	379		10.1038/ni.2026	http://dx.doi.org/10.1038/ni.2026			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21502989				2022-12-18	WOS:000289666600006
J	Smith, KA; Maizels, RM				Smith, Katherine A.; Maizels, Rick M.			Defeating sepsis by misleading MyD88	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; IMMUNITY; RECEPTORS; RESPONSES; TH2	Helminth parasites are adept at dampening immunity. New data showing that intracellular degradative pathways are manipulated have important implications for therapy.	[Smith, Katherine A.; Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Edinburgh	Smith, KA (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh, Midlothian, Scotland.	r.maizels@ed.ac.uk	Smith, Katie Elizabeth/GXH-2114-2022; /D-8092-2015	/0000-0001-8150-5702				Correale J, 2009, J IMMUNOL, V183, P5999, DOI 10.4049/jimmunol.0900897; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368; Everts B, 2010, EUR J IMMUNOL, V40, P1525, DOI 10.1002/eji.200940109; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Harnett W, 2009, ADV EXP MED BIOL, V666, P88; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; Puneet P, 2011, NAT IMMUNOL, V12, P344, DOI 10.1038/ni.2004; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462	13	3	3	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					284	286		10.1038/ni0411-284	http://dx.doi.org/10.1038/ni0411-284			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21423223				2022-12-18	WOS:000288593400005
J	Le Bourhis, L; Martin, E; Peguillet, I; Guihot, A; Froux, N; Core, M; Levy, E; Dusseaux, M; Meyssonnier, V; Premel, V; Ngo, C; Riteau, B; Duban, L; Robert, D; Rottman, M; Soudais, C; Lantz, O				Le Bourhis, Lionel; Martin, Emmanuel; Peguillet, Isabelle; Guihot, Amelie; Froux, Nathalie; Core, Maxime; Levy, Eva; Dusseaux, Mathilde; Meyssonnier, Vanina; Premel, Virginie; Ngo, Charlotte; Riteau, Beatrice; Duban, Livine; Robert, Delphine; Rottman, Martin; Soudais, Claire; Lantz, Olivier			Antimicrobial activity of mucosal-associated invariant T cells (vol 11, pg 701, 2010)	NATURE IMMUNOLOGY			English	Correction													Rottman, Martin/AAD-9075-2021; Martin, Emmanuel/F-9743-2016; Lantz, Olivier J/J-4960-2012; Rottman, Martin/I-3005-2012	Martin, Emmanuel/0000-0003-4211-7373; Lantz, Olivier J/0000-0003-3161-7719; Rottman, Martin/0000-0001-5953-3344				Bourhis LL, 2010, NAT IMMUNOL, V11, P701	1	3	3	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					969	969		10.1038/ni1010-969a	http://dx.doi.org/10.1038/ni1010-969a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP		Bronze			2022-12-18	WOS:000281926900017
J	Ransohoff, RM				Ransohoff, Richard M.			Turning over the Chance card on MS susceptibility	NATURE IMMUNOLOGY			English	Editorial Material							ENVIRONMENTAL RISK-FACTORS; EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; T-CELLS; DISEASE-ACTIVITY		Cleveland Clin Neurosci & Neurol Cleveland, Cleveland, OH USA	Cleveland Clinic Foundation	Ransohoff, RM (corresponding author), Cleveland Clin Neurosci & Neurol Cleveland, Cleveland, OH USA.	ransohr@ccf.org						Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Buljevac D, 2005, J NEUROL NEUROSUR PS, V76, P1377, DOI 10.1136/jnnp.2004.048504; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; Furtado GD, 2001, IMMUNOL REV, V182, P122; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073	11	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					570	572		10.1038/ni0710-570	http://dx.doi.org/10.1038/ni0710-570			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562841				2022-12-18	WOS:000278926400011
J	Takada, K; Takahama, Y				Takada, Kensuke; Takahama, Yousuke			Another zinc finger in the pie of CD4-CD8 lineage choice	NATURE IMMUNOLOGY			English	Editorial Material							FACTOR TH-POK; DIFFERENTIATION; COMMITMENT; THPOK; CELLS; CD4		[Takada, Kensuke; Takahama, Yousuke] Univ Tokushima, Div Expt Immunol, Inst Genome Res, Tokushima 770, Japan	Tokushima University	Takada, K (corresponding author), Univ Tokushima, Div Expt Immunol, Inst Genome Res, Tokushima 770, Japan.	takahama@genome.tokushima-u.ac.jp	Takahama, Yousuke/A-5863-2010	Takahama, Yousuke/0000-0002-4992-9174				Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Fedele M, 2008, J PATHOL, V215, P39, DOI 10.1002/path.2323; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647	12	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					370	371		10.1038/ni0510-370	http://dx.doi.org/10.1038/ni0510-370			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20404849				2022-12-18	WOS:000276852200005
J	Gascoigne, NRJ				Gascoigne, Nicholas R. J.			CD8(+) thymocyte differentiation: T cell two-step	NATURE IMMUNOLOGY			English	Editorial Material							DOUBLE-POSITIVE THYMOCYTES; IL-7; MIGRATION; SELECTION; MEDULLA; SIGNALS	A new study demonstrates that commitment to the CD8 lineage in the thymus requires sequential T cell antigen receptor (TCR) and interleukin 7 (IL-7) signaling. The TCR signal first induces IL-7 responsiveness, then recognition of IL-7 induces the nuclear factor Runx3, which specifies the CD8 lineage.	Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	gascoigne@scripps.edu			NIAID NIH HHS [R01 AI074074] Funding Source: Medline; NIGMS NIH HHS [R01 GM065230] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065230] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Taniuchi I, 2009, CURR OPIN IMMUNOL, V21, P127, DOI 10.1016/j.coi.2009.03.012; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235, DOI 10.4049/jimmunol.172.7.4235; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765	15	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					189	190		10.1038/ni0310-189	http://dx.doi.org/10.1038/ni0310-189			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20157298				2022-12-18	WOS:000274605800004
J	Surh, CD; Sprent, J				Surh, Charles D.; Sprent, Jonathan			Glimpsing the real CD4(+) T cell response	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY; EFFECTOR; DIFFERENTIATION; ACTIVATION; PREDICTS; CD8(+); NAIVE	The present views of how CD4(+) T cells respond to antigen are based largely on artificial systems. A highly sensitive approach that allows normal T cell responses to be monitored in physiological conditions overturns some existing ideas about the differentiation of CD4(+) T cells.	[Surh, Charles D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Surh, Charles D.; Sprent, Jonathan] Pohang Univ Sci & Technol, World Class Univ Integrat Biosci & Biotechnol Pro, Pohang, South Korea; [Sprent, Jonathan] Garvan Inst Med Res, Sydney, NSW, Australia	Scripps Research Institute; Pohang University of Science & Technology (POSTECH); Garvan Institute of Medical Research	Surh, CD (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	csurh@scripps.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090610] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI090610] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	12	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					47	49		10.1038/ni0110-47	http://dx.doi.org/10.1038/ni0110-47			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016511				2022-12-18	WOS:000272855300009
J	Gardner, JM; Anderson, MS				Gardner, James M.; Anderson, Mark S.			The sickness unto Deaf	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL TOLERANCE; GENE-EXPRESSION; PROTEIN; SELF; ANTIGEN; INDUCTION; THYMUS; MICE	While promiscuous expression of tissue-specific antigens (TSAs) in the thymus is essential for self-tolerance, immunologically relevant TSA expression may also occur in the secondary lymphoid organs. A new study links the transcriptional regulator Deaf1 with altered TSA expression in the secondary lymphoid organs and autoimmune diabetes.	[Gardner, James M.; Anderson, Mark S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gardner, JM (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	manderson@diabetes.ucsf.edu		Gardner, James/0000-0003-3470-9520	NATIONAL EYE INSTITUTE [R01EY016408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016408, R01 EY016408-05] Funding Source: Medline; NIAID NIH HHS [P01 AI035297, P01 AI035297-180009] Funding Source: Medline; NIGMS NIH HHS [T32 GM007618] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ANTONIA SJ, 1995, INT IMMUNOL, V7, P715, DOI 10.1093/intimm/7.5.715; Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nichols LA, 2007, J IMMUNOL, V179, P993, DOI 10.4049/jimmunol.179.2.993; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Yip LD, 2009, NAT IMMUNOL, V10, P1026, DOI 10.1038/ni.1773	16	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					934	936		10.1038/ni0909-934	http://dx.doi.org/10.1038/ni0909-934			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19692991	Green Accepted			2022-12-18	WOS:000269120900004
J	Hogquist, KA; Moran, AE				Hogquist, Kristin A.; Moran, Amy E.			T-reg cells meet their limit	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR	T cell antigen receptor (TCR)-transgenic models have been enormously influential in studies of T cell development in the thymus, particularly in terms of positive and negative selection. New transgenic mice produced with TCR genes cloned from regulatory T cells show that TCR specificity does 'instruct' regulatory T cell fate, within limits.	[Hogquist, Kristin A.; Moran, Amy E.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu		Hogquist, Kristin/0000-0001-9963-5687				Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; DiPaolo RJ, 2009, EUR J IMMUNOL, V39, P234, DOI 10.1002/eji.200838772; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019	5	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					565	566		10.1038/ni0609-565	http://dx.doi.org/10.1038/ni0609-565			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448655				2022-12-18	WOS:000266384100005
J	Rada, C				Rada, Cristina			AID and RPA: PKA makes the connection local	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION-INDUCED DEAMINASE; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION; RECOMBINATION; REGION	How immunoglobulin gene loci are specifically targeted by activation-induced cytidine deaminase while the rest of the genome avoids potentially mutagenic events is becoming clearer.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Rada, C (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	car@mrc-lmb.cam.ac.uk						Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Min IM, 2003, IMMUNITY, V19, P515, DOI 10.1016/S1074-7613(03)00262-0; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Sernandez IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003927; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708	17	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					367	369		10.1038/ni0409-367	http://dx.doi.org/10.1038/ni0409-367			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295635				2022-12-18	WOS:000264425800008
J	Gerstein, RM				Gerstein, Rachel M.			Deciding the decider: Mef2c in hematopoiesis	NATURE IMMUNOLOGY			English	Editorial Material							CELL FATE; TRANSCRIPTION FACTOR; PROGENITORS; PU.1	Factors influencing progenitor cell 'choice' between lymphoid and myeloid lineage fates are incompletely understood. New work implicates the transcription factor Mef2c as one component needed to promote lymphoid and suppress myeloid lineage differentiation.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Grad Program Immunol Virol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Gerstein, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Grad Program Immunol Virol, Worcester, MA 01655 USA.	rachel.gerstein@umassmed.edu			NIAID NIH HHS [R01 AI043534] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043534] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Castilla LH, 2008, CANCER CELL, V13, P289, DOI 10.1016/j.ccr.2008.03.009; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; FABER J, 2008, BLOOD           1203; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schuler A, 2008, BLOOD, V111, P4532, DOI 10.1182/blood-2007-10-116343; Singh H, 2008, J IMMUNOL, V181, P1595, DOI 10.4049/jimmunol.181.3.1595; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Swanson BJ, 1998, MOL IMMUNOL, V35, P445, DOI 10.1016/S0161-5890(98)00058-3; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885	14	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					235	236		10.1038/ni0309-235	http://dx.doi.org/10.1038/ni0309-235			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19221552				2022-12-18	WOS:000263456500005
J	Kao, CY; Los, FCO; Aroian, RV				Kao, Cheng-Yuan; Los, Ferdinand C. O.; Aroian, Raffi V.			Nervous about immunity: neuronal signals control innate immune system	NATURE IMMUNOLOGY			English	Editorial Material							CAENORHABDITIS-ELEGANS; PATHOGENS	The molecular mechanisms by which the nervous system influences innate immunity to pathogens remain mysterious. Two new studies show that neuronal products modulate established innate immune signaling pathways operative in the Caenorhabditis elegans intestine.	[Kao, Cheng-Yuan; Los, Ferdinand C. O.; Aroian, Raffi V.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kao, CY (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	raroian@ucsd.edu	KAO, CHENG-YUAN/A-7531-2010	KAO, CHENG-YUAN/0000-0003-0946-9270				de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183	9	3	3	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1329	1330		10.1038/ni1208-1329	http://dx.doi.org/10.1038/ni1208-1329			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	19008931				2022-12-18	WOS:000260888700006
J	van den Hoorn, T; Neefjes, J				van den Hoorn, Tineke; Neefjes, Jacques			Activated pDCs: open to new antigen-presentation possibilities	NATURE IMMUNOLOGY			English	Editorial Material							MHC CLASS-II; DENDRITIC CELLS; SURFACE; EXPRESSION	Major histocompatibility complex class II molecules present peptides to CD4(+) T cells. New findings indicate that conventional and plasmacytoid dendritic cells handle these molecules differently after activation.	[van den Hoorn, Tineke; Neefjes, Jacques] Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	van den Hoorn, T (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211				Arndt SO, 2000, EMBO J, V19, P1241, DOI 10.1093/emboj/19.6.1241; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	12	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1208	1210		10.1038/ni1108-1208	http://dx.doi.org/10.1038/ni1108-1208			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18936779				2022-12-18	WOS:000260248600006
J	Virgin, H				Virgin, Herbert			A 'fly-by' killing with a primordial cellular weapon	NATURE IMMUNOLOGY			English	Editorial Material							ADAPTIVE IMMUNITY; AUTOPHAGY; INNATE; PATHOGENESIS; PROTEIN	Autophagy has been suggested-on the basis of in vitro studies-to be involved in defense against bacterial challenge. A study in drosophila now shows the importance of autophagy in vivo and links a pattern recognition receptor to the autophagy pathway.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Virgin, H (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu		Virgin, Herbert/0000-0001-8580-7628				Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Virgin HW, 2007, NAT IMMUNOL, V8, P1143, DOI 10.1038/ni1529; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zhao ZJ, 2007, AUTOPHAGY, V3, P581, DOI 10.4161/auto.4782	13	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					827	U11		10.1038/ni0808-827	http://dx.doi.org/10.1038/ni0808-827			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18645586	Green Published, Bronze			2022-12-18	WOS:000257780700001
J	Feske, S; Giltnane, J; Dolmetsch, R; Staudt, LM; Rao, A				Feske, Stefan; Giltnane, Jena; Dolmetsch, Ricardo; Staudt, Louis M.; Rao, Anjana			Gene regulation mediated by calcium signals in T lymphocytes (vol 2, pg 316, 2001)	NATURE IMMUNOLOGY			English	Correction													Giltnane, Jennifer/D-2584-2013; Feske, stefan/ABB-3554-2021; Staudt, Louis/AAC-5324-2019	Feske, stefan/0000-0001-5431-8178; 				Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318	1	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					328	329		10.1038/ni0308-328	http://dx.doi.org/10.1038/ni0308-328			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ		Bronze			2022-12-18	WOS:000253406700019
J	McMichael, AJ				McMichael, Andrew J.			From influenza to HIV-and back?	NATURE IMMUNOLOGY			English	Article							T-CELL RECOGNITION; LYMPHOCYTES-T; SYNTHETIC PEPTIDES; PRIMARY INFECTION; VIRUS; NUCLEOPROTEIN; ANTIGEN; ESCAPE; GENE; RESTRICTION	Andrew McMichael recounts the seminal data he and colleagues produced demonstrating that cytotoxic T lymphocytes kill cells expressing antigenic peptides presented on major histocompatibility complex class I molecules.	John Radcliffe Hosp, Weatherall Inst Mol Med, Immunol Unit, Oxford OX3 9DS, England	University of Oxford	McMichael, AJ (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Immunol Unit, Oxford OX3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk			MRC [MC_U137884177] Funding Source: UKRI; Medical Research Council [MC_U137884177] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BENNINK JR, 1982, NATURE, V296, P75, DOI 10.1038/296075a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; MCMICHAEL AJ, 1977, NATURE, V270, P524, DOI 10.1038/270524a0; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; SLEIGH MJ, 1979, NUCLEIC ACIDS RES, V7, P879, DOI 10.1093/nar/7.4.879; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TOWNSEND ARM, 1984, CELL, V39, P13, DOI 10.1016/0092-8674(84)90187-9; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; ZIEGLER K, 1981, J IMMUNOL, V127, P1869; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	22	3	3	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1149	1151		10.1038/ni1107-1149	http://dx.doi.org/10.1038/ni1107-1149			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17952038				2022-12-18	WOS:000250338900003
J	Jones, EY; Salio, M; Cerundolo, V				Jones, E. Yvonne; Salio, Mariolina; Cerundolo, Vincenzo			T cell receptors get back to basics	NATURE IMMUNOLOGY			English	Editorial Material							NKT CELLS	For both mice and humans, an invariant T cell receptor mediates the recognition of glycolipid antigens presented in the context of CD1d molecules. Crystal structure and mutagenesis-based analyses now identify a minimalist binding mode well suited to an 'innate-style' pattern-recognition function.	Henry Wellcome Bldg Genomic Med, Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England; Univ Oxford, Weather Inst Mol Med, Nuffield Dept Med, Canc Res UK Tumor Immunol Grp, Oxford OX3 9DS, England	Cancer Research UK; University of Oxford; University of Oxford	Jones, EY (corresponding author), Henry Wellcome Bldg Genomic Med, Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; vincenzo.cerundolo@imm.ox.ac.uk	Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Salio, Mariolina/0000-0002-4821-3801; Cerundolo, Vincenzo/0000-0003-0040-3793	Medical Research Council [MC_U137884181, G9900061] Funding Source: Medline; MRC [G9900061, MC_U137884181] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; COTTBROWNE JP, 2007, NAT IMMUNOL, V8, P1105; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Hermans IF, 2007, J IMMUNOL, V178, P2721, DOI 10.4049/jimmunol.178.5.2721; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Smith CL, 2005, J IMMUNOL, V175, P8431, DOI 10.4049/jimmunol.175.12.8431; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373	11	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1033	1035		10.1038/ni1007-1033	http://dx.doi.org/10.1038/ni1007-1033			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878911				2022-12-18	WOS:000249691400010
J	Zuniga-Pflucker, JC				Zuniga-Pfluecker, Juan Carlos			CD8(+) T cells are kept in tune by modulating IL-7 responsiveness	NATURE IMMUNOLOGY			English	Editorial Material							IN-VIVO; HOMEOSTASIS	The survival of naive CD8(+) T cells depends on the receipt of 'tonic' T cell receptor signals, but overt self-reactivity must be avoided. New work traces an intricate regulatory loop responsible for 'tuning' CD8 coreceptor expression to a 'balance point' appropriate for each T cell receptor.	Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Sunnybrook Res Inst, Dept Immunol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jczp@sri.utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178				Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Maile R, 2005, J IMMUNOL, V174, P619, DOI 10.4049/jimmunol.174.2.619; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795	7	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1027	1028		10.1038/ni1007-1027	http://dx.doi.org/10.1038/ni1007-1027			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878908				2022-12-18	WOS:000249691400007
J	Allman, D; Northrup, D				Allman, David; Northrup, Dan			Giving B cell tolerance the 'TSLiP'	NATURE IMMUNOLOGY			English	Editorial Material							THYMIC STROMAL LYMPHOPOIETIN	Self-reactive B cells are subject to several mechanisms to ensure self-tolerance. The epithelium-derived cytokine TSLP acts to regulate B cell tolerance by targeting B cell precursors rather than mature B cells.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Allman, D (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	dallman@mail.med.upenn.edu						Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Meffre E, 2000, NAT IMMUNOL, V1, P207, DOI 10.1038/79739; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	12	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					481	483		10.1038/ni0507-481	http://dx.doi.org/10.1038/ni0507-481			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440458				2022-12-18	WOS:000245831600012
J	McHeyzer-Williams, M				McHeyzer-Williams, Michael			Local sentries for class switching	NATURE IMMUNOLOGY			English	Editorial Material							THYMIC STROMAL LYMPHOPOIETIN; CELLS; INHIBITOR	Epithelial cells responding to inflammatory stimuli can initiate class switching and antibody secretion in naive B cells. TSLP, BAFF and SLPI are epithelial cell-derived local regulators of effector B cell responses in mucosal environments.	Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, M (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu						Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	12	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					230	232		10.1038/ni0307-230	http://dx.doi.org/10.1038/ni0307-230			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304230				2022-12-18	WOS:000244275100006
J	Zehn, D; Bevan, MJ				Zehn, Dietmar; Bevan, Michael J.			More promiscuity resulting in more tolerance	NATURE IMMUNOLOGY			English	Editorial Material							THYMUS; CELLS; PROTEIN	Tolerance to self is engendered by multiple mechanisms. Lymph node stromal cells are now found to contribute to self-tolerance by their endogenous expression of peripheral tissue antigens.	Univ Washington, Howard Hughes Med Ctr, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zehn, D (corresponding author), Univ Washington, Howard Hughes Med Ctr, Dept Immunol, Seattle, WA 98195 USA.	mbevan@u.washington.edu						Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2	10	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					120	122		10.1038/ni0207-120	http://dx.doi.org/10.1038/ni0207-120			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242681				2022-12-18	WOS:000243597600005
J	Vosshenrich, CAJ; Garcia-Ojeda, ME; Samson-Villeger, SI; Pasqualetto, V; Enault, L; Goff, ORL; Corcuff, E; Guy-Grand, D; Rocha, B; Cumano, A; Rogge, L; Ezine, S; Di Santo, JP				Vosshenrich, Christian A. J.; Garcia-Ojeda, Marcos E.; Samson-Villeger, Sandrine I.; Pasqualetto, Valerie; Enault, Laurence; Goff, Odile Richard-Le; Corcuff, Erwan; Guy-Grand, Delphine; Rocha, Benedita; Cumano, Ana; Rogge, Lars; Ezine, Sophie; Di Santo, James P.			A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 (vol 7, pg 1217, 2006)	NATURE IMMUNOLOGY			English	Correction													Rogge, Lars/GYJ-6142-2022; GOFF, odile RICHARD-LE/ABH-9553-2020; Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862; RICOUX-PASQUALETTO, Valerie/0000-0002-9812-8701				Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395	1	3	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1343	1343		10.1038/ni1206-1343b	http://dx.doi.org/10.1038/ni1206-1343b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU		Bronze			2022-12-18	WOS:000242125200018
J	Haynes, L; Pfeffer, S; Boss, JM; Kavathas, P; Kuchroo, V				Haynes, Laura; Pfeffer, Suzanne; Boss, Jeremy M.; Kavathas, Paula; Kuchroo, Vijay			Lab management: insights for the new investigator	NATURE IMMUNOLOGY			English	Editorial Material								A well functioning lab is a productive lab. Here the guiding principles of good lab management are discussed.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Trudeau Institute; Stanford University; Emory University; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Haynes, L (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	lhaynes@trudeauinstitute.org							0	3	3	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					895	897		10.1038/ni0906-895	http://dx.doi.org/10.1038/ni0906-895			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16924248				2022-12-18	WOS:000239942300003
J	Bonneville, M				Bonneville, Marc			Selection of intraepithelial gamma delta cells: the Holy GrIEL at last?	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; POSITIVE SELECTION; RECEPTORS; SPECIFICITY; RECOGNITION; PRECURSORS; THYMUS	Although gamma delta cells were discovered fortuitously more than 20 years ago, their development remains enigmatic. Genetic evidence now suggests that gamma delta T lymphocytes undergo intrathymic positive selection.	INSERM, U601, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonneville, M (corresponding author), INSERM, U601, F-44035 Nantes, France.	bonnevil@nantes.inserm.fr						Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Ferrero I, 2001, J EXP MED, V194, P1473, DOI 10.1084/jem.194.10.1473; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008	12	3	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					791	792		10.1038/ni0806-791	http://dx.doi.org/10.1038/ni0806-791			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16855600				2022-12-18	WOS:000239147200004
J	Li, CYC; Ramirez-Carrozzi, VR; Smale, ST				Li, Caiyi C.; Ramirez-Carrozzi, Vladimir R.; Smale, Stephen T.			Pursuing gene regulation 'logic' via RNA interference and chromatin immunoprecipitation	NATURE IMMUNOLOGY			English	Editorial Material							MAMMALIAN-CELLS; DNA INTERACTIONS; B-CELLS; TRANSCRIPTION; EXPRESSION; PROTEIN; BINDING; DIFFERENTIATION; ASSOCIATIONS; SILENCER	RNA interference and chromatin immunoprecipitation are now firmly established as useful methods for studying mechanisms of gene regulation in vivo. Their combined use can help elucidate gene regulation 'logic' by aiding in target gene identification for transcription factors and chromatin-modifying complexes.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, CYC (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAREY M, 2000, TRANSCRIPTIONAL REGU, P137; Cullen BR, 2005, NAT GENET, V37, P1163, DOI 10.1038/ng1105-1163; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hanlon SE, 2004, CURR OPIN GENET DEV, V14, P697, DOI 10.1016/j.gde.2004.09.008; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Huppi K, 2005, MOL CELL, V17, P1, DOI 10.1016/j.molcel.2004.12.017; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Li QM, 2001, MOL CELL BIOL, V21, P2467, DOI 10.1128/MCB.21.7.2467-2474.2001; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Mak TW, 2001, NAT REV IMMUNOL, V1, P11, DOI 10.1038/35095551; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Sikder D, 2005, CURR OPIN CHEM BIOL, V9, P38, DOI 10.1016/j.cbpa.2004.12.008; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; WALTER J, 1994, GENE DEV, V8, P1678, DOI 10.1101/gad.8.14.1678; Weinmann AS, 2004, NAT REV IMMUNOL, V4, P381, DOI 10.1038/nri1353; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; 2005, METHODS ENZYMOL, V392, P1	37	3	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					692	697		10.1038/ni0706-692	http://dx.doi.org/10.1038/ni0706-692			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785883				2022-12-18	WOS:000238377700004
J	Yokoyama, WM				Yokoyama, WM			Contact hypersensitivity: not just T cells!	NATURE IMMUNOLOGY			English	Editorial Material							NATURAL-KILLER-CELLS; NK CELLS; ACTIVATION; NKG2D	Contact hypersensitivity is a form of delayed-type hypersensitivity, a classic T cell-mediated, clinically important phenomenon. Unexpectedly, a new study indicates that natural killer cells may mediate contact hypersensitivity and demonstrate adaptive, memory-like activity.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med,Rheumatol Div, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med,Rheumatol Div, St Louis, MO 63110 USA.	yokoyama@im.wustl.edu						Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BELSITO DV, 1999, FITZPATRICKS DERMATO, P1447; Charles A, 2001, IMMUNOBIOL IMMUNE SY, V5; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yokoyama W. M., 1999, FUNDAMENTAL IMMUNOLO, P575	12	3	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					437	439		10.1038/ni0506-437	http://dx.doi.org/10.1038/ni0506-437			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16622426				2022-12-18	WOS:000237008800004
J	Dunn, GP; Bruce, AT; Sheehan, KCF; Shankaran, V; Uppaluri, R; Bui, JD; Diamond, MS; Koebel, CM; Arthur, C; White, JM; Schreiber, RD				Dunn, GP; Bruce, AT; Sheehan, KCF; Shankaran, V; Uppaluri, R; Bui, JD; Diamond, MS; Koebel, CM; Arthur, C; White, JM; Schreiber, RD			A critical function for type I interferons in cancer immunoediting (vol 6, pg 722, 2005)	NATURE IMMUNOLOGY			English	Correction													uppaluri, ravi/AAU-2132-2020; Schreiber, Robert D/A-1276-2013; Diamond, Michael/AAH-1733-2019	Schreiber, Robert D/0000-0001-6311-0432; Diamond, Michael/0000-0002-8791-3165				DUNN GP, 2005, A CRITICAL FUNCTION, V6, P722	1	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					852	852		10.1038/ni0805-852b	http://dx.doi.org/10.1038/ni0805-852b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM		Bronze			2022-12-18	WOS:000230646200028
J	Sambandam, A; Maillard, I; Zediak, VP; Xu, LW; Gerstein, RM; Aster, JC; Pear, WS; Bhandoola, A				Sambandam, A; Maillard, I; Zediak, VP; Xu, LW; Gerstein, RM; Aster, JC; Pear, WS; Bhandoola, A			Notch signaling controls the generation and differentiation of early T lineage progenitors (vol 6, pg 663, 2005)	NATURE IMMUNOLOGY			English	Correction														Maillard, Ivan/0000-0003-1312-6748				MAILLARD I, 2005, NOTCH SIGNALING, V6, P663	1	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					852	852		10.1038/ni0805-852a	http://dx.doi.org/10.1038/ni0805-852a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM		Bronze			2022-12-18	WOS:000230646200027
J	Johansson, C; Kelsall, BL				Johansson, C; Kelsall, BL			Affecting the effectors: a kick in the gut?	NATURE IMMUNOLOGY			English	Editorial Material							RESPONSES IN-VIVO; T-CELL RESPONSES; COSTIMULATION; TOLERANCE		NIAID, Mucosal Immunobiol Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Johansson, C (corresponding author), NIAID, Mucosal Immunobiol Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.	cjohansson@niaid.nih.gov; bkelsall@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000833] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Choi J, 2004, ANNU REV IMMUNOL, V22, P683, DOI 10.1146/annurev.immunol.22.012703.104639; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Klonowski KD, 2005, SEMIN IMMUNOL, V17, P219, DOI 10.1016/j.smim.2005.02.004; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Rowley TF, 2004, J IMMUNOL, V172, P6039, DOI 10.4049/jimmunol.172.10.6039; Saada JI, 2004, ANN NY ACAD SCI, V1029, P379, DOI 10.1196/annals.1309.023; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; Tesselaar K, 2003, J IMMUNOL, V170, P33, DOI 10.4049/jimmunol.170.1.33; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Yamada A, 2005, J IMMUNOL, V174, P1357, DOI 10.4049/jimmunol.174.3.1357	12	3	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					644	646		10.1038/ni0705-644	http://dx.doi.org/10.1038/ni0705-644			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15970934				2022-12-18	WOS:000229975500005
J	Struik, SS; Maxwell, CA; Malecela-Lazaro, M; Eckstein, S; Porter, JDH; Riley, EM				Struik, SS; Maxwell, CA; Malecela-Lazaro, M; Eckstein, S; Porter, JDH; Riley, EM			Integrating HIV testing into immunological studies of non-HIV-related diseases	NATURE IMMUNOLOGY			English	Editorial Material							DEVELOPING-COUNTRIES; INFECTION; MALARIA	HIV testing is now required for non-HIV-AIDS-related immunological studies in areas of high HIV prevalence. Ethical guidelines for testing in these circumstances need clarification and sensitive protocols need to be developed.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Natl Inst Med Res, Dar Es Salaam, Tanzania; Kings Coll London, Ctr Med Law & Eth, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; University of London; King's College London	Struik, SS (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.		Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570				*CIOMS, 2002, INT ETH GUID BIOM RE; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Doyal L, 1997, BMJ-BRIT MED J, V314, P1107, DOI 10.1136/bmj.314.7087.1107; hhs, 1979, BELM REP ETH PRINC G; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; *MIN HLTH UN REP T, 2001, 16 MIN HLTH UN REP T; Moatti JP, 2003, NAT MED, V9, P1449, DOI 10.1038/nm1203-1449; Nicoll A, 2000, BRIT MED J, V320, P1275; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC, P1; Obaro SK, 2004, LANCET INFECT DIS, V4, P510, DOI 10.1016/S1473-3099(04)01106-5; Rowland-Jones SL, 2002, MICROBES INFECT, V4, P1265, DOI 10.1016/S1286-4579(02)01655-6; Wendler D, 2004, AM J PUBLIC HEALTH, V94, P923, DOI 10.2105/AJPH.94.6.923; *WHO, 2005, 3 5 PROGR REP DEC 20, P11; World Health Organization, 2004, RISK PROTECTIVE FACT, P17; *WORLD MED ASS, 2000, B MED ETHICS, V162, P8	16	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					423	426		10.1038/ni0505-423	http://dx.doi.org/10.1038/ni0505-423			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15843793				2022-12-18	WOS:000228634300002
J	Cahalan, MD				Cahalan, MD			STOP! In the name of positive selection	NATURE IMMUNOLOGY			English	Editorial Material							2-PHOTON MICROSCOPY; DENDRITIC CELLS; T-LYMPHOCYTES; LYMPH-NODES; ANTIGEN; MOTILITY; CALCIUM; DYNAMICS; SHAPE	Calcium signaling is essential during thymocyte development. It seems that calcium oscillations trigger thymocytes to become immotile, prolonging interactions with stromal cells that are critical for positive selection.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu						Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4	13	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					126	128		10.1038/ni0205-126	http://dx.doi.org/10.1038/ni0205-126			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15662438				2022-12-18	WOS:000226468100006
J	Saeanu, L; van Endert, P				Saeanu, L; van Endert, P			Dendritic cells: open for presentation business	NATURE IMMUNOLOGY			English	Editorial Material							CROSS-PRESENTATION; EXOGENOUS ANTIGENS; COMPARTMENT; PHAGOSOMES	Dendritic cells have the unique capacity of processing soluble exogenous proteins for presentation to killer T lymphocytes. Now Cresswell associates show that this is possible because pinocytosed material gains access to the perinuclear endoplasmic reticulum of dendritic cells.	INSERM, U580, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Saeanu, L (corresponding author), INSERM, U580, 161 Rue Sevres, F-75015 Paris, France.	vanender@necker.fr	van Endert, Peter/R-4606-2017; SAVEANU, Loredana/Q-1241-2019	van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968				Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4	10	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					7	8		10.1038/ni0105-7	http://dx.doi.org/10.1038/ni0105-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15611772				2022-12-18	WOS:000225888500002
J	Vilcek, J				Vilcek, J			Why are rabbits uniquely sensitive to myxoma virus? Cherchez l'interferon!	NATURE IMMUNOLOGY			English	Editorial Material							POSITIVE FEEDBACK; INTERFERON; INDUCTION; TRANSCRIPTION; GENES	Rabbits are the only animals susceptible to myxoma virus. The induction of interferon alphabeta by myxoma virus in nonpermissive mouse cells seems to be crucial to maintaining this species restriction.	NYU, Sch Med, New York, NY 10016 USA	New York University	Vilcek, J (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	jan.vilcek@med.nyu.edu						Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Biron C.A., 2001, FIELDS VIROLOGY, P321; Esposito JJ, 2001, FIELDS VIROLOGY, P2885; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Moss B, 2007, FIELDS VIROLOGY, P2849; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132	10	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1205	1206		10.1038/ni1204-1205	http://dx.doi.org/10.1038/ni1204-1205			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549119				2022-12-18	WOS:000225353500007
J	Giallourakis, C; Alt, FW; Bassing, CH				Giallourakis, C; Alt, FW; Bassing, CH			V(D)J recombinational accessibility - heading in the opposite direction?	NATURE IMMUNOLOGY			English	Editorial Material							B-CELL; HETEROCHROMATIN; SELECTION	The assembly of antigen receptor genes in developing lymphocytes through V(D)J recombination is regulated through a mostly undefined but broadly relevant process referred to as 'accessibility'. New findings raise the possibility that wide-ranging, antisense transcription through unrearranged antigen receptor loci could be involved in modulating recombinational accessibility.	Harvard Univ, Sch Med, CBR, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Giallourakis, C (corresponding author), Harvard Univ, Sch Med, CBR, Inst Biomed Res, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu						Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Krangel MS, 2003, NAT IMMUNOL, V4, P624, DOI 10.1038/ni0703-624; Senoo M, 2003, J IMMUNOL, V171, P829, DOI 10.4049/jimmunol.171.2.829; Sikes ML, 2002, P NATL ACAD SCI USA, V99, P12309, DOI 10.1073/pnas.182166699; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; ten Boekel E, 1999, CURR TOP MICROBIOL, V246, P3; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2	11	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					561	562		10.1038/ni0604-561	http://dx.doi.org/10.1038/ni0604-561			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15164012				2022-12-18	WOS:000221664000004
J	Stevenson, M				Stevenson, M			TRIMming HIV-1's mainsail	NATURE IMMUNOLOGY			English	Editorial Material							RESTRICTION FACTORS; ENZYME APOBEC3G; VIF PROTEIN; INFECTION; REPLICATION	HIV-1 is unable to infect cells from most nonhuman primates. In a recent Nature paper, a cellular protein of monkey cells, TRIM5, was shown to be responsible for this inhibition.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Stevenson, M (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	mario.stevenson@umassmed.edu	Liu, FL/D-1795-2009					Berthoux L, 2003, J VIROL, V77, P3167, DOI 10.1128/JVI.77.5.3167-3180.2003; Bieniasz PD, 2003, TRENDS MICROBIOL, V11, P286, DOI 10.1016/S0966-842X(03)00123-9; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6	10	3	3	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					355	356		10.1038/ni0404-355	http://dx.doi.org/10.1038/ni0404-355			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15052262				2022-12-18	WOS:000220515900005
J	Poli, G; Bordignon, C				Poli, G; Bordignon, C			Unplugging the T cell receptor	NATURE IMMUNOLOGY			English	Editorial Material							SIGNAL-TRANSDUCTION; LYMPHOCYTES; EXPRESSION; CHAIN; TCR		Ist Sci San Raffaele, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Poli, G (corresponding author), Ist Sci San Raffaele, I-20132 Milan, Italy.	claudio.bordignon@hsr.it		Poli, Guido/0000-0001-7241-4526				ALLAVENA P, 1985, CANCER IMMUNOL IMMUN, V19, P121; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; FINKE JH, 1993, CANCER RES, V53, P5613; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Gessani S, 1998, CYTOKINE GROWTH F R, V9, P117, DOI 10.1016/S1359-6101(98)00007-0; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Maurice MM, 1997, J IMMUNOL, V159, P2973; Paredes Roger, 2002, AIDS Reviews, V4, P36; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594; Walker RE, 2000, BLOOD, V96, P467; Zea AH, 1998, INFECT IMMUN, V66, P499, DOI 10.1128/IAI.66.2.499-504.1998	13	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					943	944		10.1038/ni1003-943	http://dx.doi.org/10.1038/ni1003-943			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14515125				2022-12-18	WOS:000185590100008
J	Shaw, ASY				Shaw, ASY			Slick signaling	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGENIC-STIMULATION; NAIVE	Lipid second messengers are thought to be important in T cell activation. Two studies show the spatial-temporal organization of these lipids during immunological synapse formation and raise new questions about their functions.	Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, ASY (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.			Shaw, Andrey/0000-0001-5685-0272				Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; HARRIAGUE, 2002, NATURE IMMUNOL, V3, P1090; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Shaw AS, 2001, IMMUNITY, V15, P683, DOI 10.1016/S1074-7613(01)00237-0; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5	12	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1058	1059		10.1038/ni1102-1058	http://dx.doi.org/10.1038/ni1102-1058			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407417				2022-12-18	WOS:000179073000012
J	Palmer, E				Palmer, E			Shc: a dominant player after ten seasons	NATURE IMMUNOLOGY			English	Editorial Material							ZETA-CHAIN; ACTIVATION; RECEPTOR; ADAPTER; ASSOCIATION; PATHWAY; ZAP-70		Univ Basel Hosp, Lab Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland	University of Basel	Palmer, E (corresponding author), Univ Basel Hosp, Lab Transplantat Immunol & Nephrol, Hebelstr 20, CH-4031 Basel, Switzerland.							Lai KMV, 2000, GENE DEV, V14, P1132; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Northrop JP, 1996, MOL CELL BIOL, V16, P2255; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; Pacini S, 1998, J BIOL CHEM, V273, P20487, DOI 10.1074/jbc.273.32.20487; Plyte S, 2000, ONCOGENE, V19, P1529, DOI 10.1038/sj.onc.1203451; Pratt JC, 1999, J IMMUNOL, V163, P2586; RAVICHANDRAN KS, 1995, MOL CELL BIOL, V15, P593; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; Zhang L, 2002, NAT IMMUNOL, V3, P749, DOI 10.1038/ni820; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	13	3	4	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					710	711		10.1038/ni0802-710	http://dx.doi.org/10.1038/ni0802-710			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12145655				2022-12-18	WOS:000177118500008
J	Darby, C; Hultgren, SJ				Darby, C; Hultgren, SJ			Innate defense evicts bacterial squatters	NATURE IMMUNOLOGY			English	Editorial Material							CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; LACTOFERRIN; INFECTIONS; BIOFILMS; AIRWAY	Biofilms offer cover for many pathogenic bacteria. A recent paper in Nature reveals that lactoferrin is an innate tool that inhibits biofilm formation.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Stanford University; Washington University (WUSTL)	Darby, C (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	cdarby@stanford.edu; hultgren@borcim.wustl.edu						BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621, DOI 10.1128/MMBR.63.3.621-641.1999; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Vorland LH, 1999, APMIS, V107, P971, DOI 10.1111/j.1699-0463.1999.tb01499.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	16	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					602	604		10.1038/ni0702-602	http://dx.doi.org/10.1038/ni0702-602			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087414				2022-12-18	WOS:000176441700006
J	Bokoch, GM				Bokoch, GM			Microbial killing: hold the bleach and pass the salt!	NATURE IMMUNOLOGY			English	Editorial Material							NEUTROPHILS; MYELOPEROXIDASE; SUPEROXIDE; OXIDASE		Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Bokoch, GM (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bokoch@scripps.edu						Aratani Y, 1999, INFECT IMMUN, V67, P1828; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; DINAUER MC, 2000, METABOLIC MOL BASIS, pCH133; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; Henderson LM, 1999, J GEN PHYSIOL, V114, P771, DOI 10.1085/jgp.114.6.771; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; NANDA A, 1994, J CLIN INVEST, V93, P1770, DOI 10.1172/JCI117162; RAUSCH PG, 1975, BLOOD, V46, P913; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9	12	3	3	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					340	342		10.1038/ni0402-340	http://dx.doi.org/10.1038/ni0402-340			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11919575				2022-12-18	WOS:000174623600012
J	Kioussis, D				Kioussis, D			Thymocyte differentiation: it's time to bend a little	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL DEVELOPMENT; GENE-EXPRESSION; SUBSETS	The development of new experimental tools is helping to unravel the molecular secrets of cell differentiation. The identification, by gene chip technology, of a HMG box protein called TOX has yielded valuable information about thymocyte differentiation.	Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research	Kioussis, D (corresponding author), Natl Inst Med Res, Div Mol Immunol, Ridgeway, London NW7 1AA, England.							Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Reya T, 1999, COLD SPRING HARB SYM, V64, P133, DOI 10.1101/sqb.1999.64.133; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Schmedt C, 2001, J EXP MED, V193, P815, DOI 10.1084/jem.193.7.815; Staal FJT, 2001, STEM CELLS, V19, P165, DOI 10.1634/stemcells.19-3-165; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	12	3	3	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					214	215		10.1038/ni0302-214	http://dx.doi.org/10.1038/ni0302-214			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875458				2022-12-18	WOS:000174074000007
J	Welsh, RM; Stepp, SE; Szomolanyi-Tsuda, S; Peacock, CD				Welsh, RM; Stepp, SE; Szomolanyi-Tsuda, S; Peacock, CD			Tumor viral escape from inhibited T cells	NATURE IMMUNOLOGY			English	Editorial Material							EXPRESSION; RECEPTORS; ANTIGEN; RESPONSES; VIRUS	Functionally active inhibitory receptors that impart negative signals have been found recently on T cells. One such inhibitory receptor, CD94-NKG2A, can induce cytolytic anergy in CTLs specific for polyomavirus.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Welsh, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	raymond.welsh@umassmed.edu						Andre P, 1999, EUR J IMMUNOL, V29, P1076, DOI 10.1002/(SICI)1521-4141(199904)29:04<1076::AID-IMMU1076>3.0.CO;2-Z; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; DeMaria A, 1997, P NATL ACAD SCI USA, V94, P10285, DOI 10.1073/pnas.94.19.10285; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; Mingari MC, 1998, IMMUNOL TODAY, V19, P153, DOI 10.1016/S0167-5699(97)01236-X; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Moser JM, 2001, J EXP MED, V193, P595, DOI 10.1084/jem.193.5.595; Peacock CD, 2000, J VIROL, V74, P7032, DOI 10.1128/JVI.74.15.7032-7038.2000; Ugolini S, 2001, NAT IMMUNOL, V2, P430, DOI 10.1038/87740; Vely F, 2001, J IMMUNOL, V166, P2487, DOI 10.4049/jimmunol.166.4.2487; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Welsh RM, 1999, CURR OPIN MICROBIOL, V2, P382	14	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					112	114		10.1038/ni0202-112	http://dx.doi.org/10.1038/ni0202-112			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812984				2022-12-18	WOS:000173562400008
J	Wills-Karp, M				Wills-Karp, M			Asthma genetics: not for the TIMid?	NATURE IMMUNOLOGY			English	Editorial Material							GENOME-WIDE SEARCH; IGE LEVELS; HYPERRESPONSIVENESS; SUSCEPTIBILITY; POLYMORPHISMS; LINKAGE; ATOPY		Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45208 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati	Wills-Karp, M (corresponding author), Childrens Hosp, Med Ctr, Div Immunobiol, 3333 Burnet Ave, Cincinnati, OH 45208 USA.							Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Gao PS, 1999, CLIN GENET, V56, P164; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Guler ML, 1999, J IMMUNOL, V162, P1339; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Marsh DG, 1997, NAT GENET, V15, P389; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Teuscher C, 1999, J IMMUNOL, V163, P2262; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806	15	3	3	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1095	1096		10.1038/ni1201-1095	http://dx.doi.org/10.1038/ni1201-1095			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725296				2022-12-18	WOS:000172473200008
J	[Anonymous]				[Anonymous]			Accepting stem cells	NATURE IMMUNOLOGY			English	Editorial Material																			0	3	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1085	1085						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725289				2022-12-18	WOS:000172473200001
J	Karrer, U; Oxenius, A; Phillips, R; Klenerman, P				Karrer, U; Oxenius, A; Phillips, R; Klenerman, P			Memory T cells: total recall or just a sense of deja vu?	NATURE IMMUNOLOGY			English	News Item							VIRUS		John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Oxford, Oxford OX1 3SY, England	University of Oxford; University of Oxford	Phillips, R (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.		Oxenius, Annette/G-7794-2015	klenerman, paul/0000-0003-4307-9161				Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Ciurea A, 1999, P NATL ACAD SCI USA, V96, P11964, DOI 10.1073/pnas.96.21.11964; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Watt G, 2000, LANCET, V356, P475, DOI 10.1016/S0140-6736(00)02557-5; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364	12	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					991	993		10.1038/ni1101-991	http://dx.doi.org/10.1038/ni1101-991			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685219				2022-12-18	WOS:000172049800009
J	Miller, JFAP				Miller, JFAP			How important was Murphy?	NATURE IMMUNOLOGY			English	Letter									Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Miller, JFAP (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.							GOWANS JL, 1962, NATURE, V196, P651, DOI 10.1038/196651a0; MURPHY JB, 1926, MONOGR ROCKEFELLER I, P1; Silverstein AM, 2001, NAT IMMUNOL, V2, P569, DOI 10.1038/89706	3	3	3	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					981	981		10.1038/ni1101-981a	http://dx.doi.org/10.1038/ni1101-981a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685211				2022-12-18	WOS:000172049800001
J	Hesslein, DGT; Fields, PE; Schatz, DG				Hesslein, DGT; Fields, PE; Schatz, DG			Location, location, location: the cell biology of immunoglobulin allelic control	NATURE IMMUNOLOGY			English	News Item								Individual lymphocytes express antigen receptors of a singular specificity. How this process, known as allelic exclusion, is established and maintained is unknown. Differences in subnuclear localization appear to contribute to enforcement of monoallelic receptor expression.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol,Sect Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Hesslein, DGT (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol,Sect Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.		Fields, Patrick E/G-4878-2012; Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176; Fields, Patrick/0000-0002-6797-4139				Bargagli R, 1999, ANTARCT SCI, V11, P3, DOI 10.1017/S0954102099000024; Berger SL, 2001, ONCOGENE, V20, P3007, DOI 10.1038/sj.onc.1204324; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hollander GA, 1999, SEMIN IMMUNOL, V11, P357; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; MEICHERS F, 1999, SEMIN IMMUNOL, V11, P307; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848	15	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					825	826		10.1038/ni0901-825	http://dx.doi.org/10.1038/ni0901-825			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526394				2022-12-18	WOS:000170781200019
J	Miller, JFAP				Miller, JFAP			Ruby anniversary: forty years of thymus immunology research	NATURE IMMUNOLOGY			English	Editorial Material								For years the function of the thymus remained a mystery. Investigations into murine leukemia led, 40 years ago next month, to the first connection of the thymus to immune function. We asked Jacques Miller to put this immunological milestone in perspective.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Miller, JFAP (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.							ARNASON BG, 1962, NATURE, V194, P99, DOI 10.1038/194099a0; BILINGHAM RE, 1962, J NATL CANCER I, V28, P365; Burnet F. Macfarlane, 1972, AUTO IMMUNITY AUTOIM, P45; BURNET FM, 1962, SCI AM, V207, P50; GOWANS JL, 1962, NATURE, V196, P651, DOI 10.1038/196651a0; GROSS L, 1951, P SOC EXP BIOL MED, V78, P342; MACLEAN LD, 1957, TRANSPLAN B, V4, P21; MARTINEZ C, 1962, P SOC EXP BIOL MED, V109, P193; Medawar P.B., 1963, IMMUNOLOGICALLY COMP, V16, P70; Miller J. F. A. P., 1962, P ROY SOC LOND B BIO, V156B, P410; MILLER JF, 1961, LANCET, V2, P748; MILLER JF, 1961, NATURE, V191, P248, DOI 10.1038/191248a0; MILLER JFA, 1962, NATURE, V195, P1318, DOI 10.1038/1951318a0; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821; WOLSTENHOLME GEW, 1960, CIBA FDN S	15	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					663	664		10.1038/90592	http://dx.doi.org/10.1038/90592			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477396				2022-12-18	WOS:000170230100003
J	Fields, PE; Flavell, RA				Fields, PE; Flavell, RA			Helper T cell differentiation: a role for SAP?	NATURE IMMUNOLOGY			English	News Item							LINKED LYMPHOPROLIFERATIVE-DISEASE; LYMPHOCYTIC ACTIVATION MOLECULE; GENE; PHOSPHATASE; RECEPTOR; CDW150; 2B4		Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Fields, PE (corresponding author), Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA.		Fields, Patrick E/G-4878-2012	Fields, Patrick/0000-0002-6797-4139				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Carballido JM, 1997, J IMMUNOL, V159, P4316; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; HARADA S, 1982, INT J CANCER, V30, P739, DOI 10.1002/ijc.2910300610; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; PURTILO D T, 1975, Lancet, V1, P935; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SEEMAYER TA, 1995, PEDIATR RES, V38, P471, DOI 10.1203/00006450-199510000-00001; Sylla BS, 2000, P NATL ACAD SCI USA, V97, P7470, DOI 10.1073/pnas.130193097; Tangye SG, 1999, J IMMUNOL, V162, P6981; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	15	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					382	384		10.1038/87679	http://dx.doi.org/10.1038/87679			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323688				2022-12-18	WOS:000168549800008
J	Giordano, C; Richiusa, P; Bagnasco, M; Salmaso, C; Pizzolanti, G; Galluzzo, A				Giordano, C; Richiusa, P; Bagnasco, M; Salmaso, C; Pizzolanti, G; Galluzzo, A			Thyrocytes - not innocent bystanders in autoimmune disease	NATURE IMMUNOLOGY			English	Letter									Univ Palermo, Fac Med, Inst Clin Med, Palermo, Italy; Univ Genoa, DIMI, Genoa, Italy	University of Palermo; University of Genoa	Giordano, C (corresponding author), Univ Palermo, Fac Med, Inst Clin Med, Palermo, Italy.		GIORDANO, Carla/R-4296-2017; Pizzolanti, Giuseppe/I-4547-2019; Pizzolanti, Giuseppe/K-7097-2016	GIORDANO, Carla/0000-0003-1731-9395; Pizzolanti, Giuseppe/0000-0001-6052-8438				Davies TF, 2000, THYROID, V10, P525, DOI 10.1089/thy.2000.10.525; GIORDANO C, 2001, IN PRESS THYROID, P11; Pinkoski MJ, 2000, NAT IMMUNOL, V1, P461, DOI 10.1038/82701; Stassi G, 2000, NAT IMMUNOL, V1, P483, DOI 10.1038/82725	4	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					183	183		10.1038/85224	http://dx.doi.org/10.1038/85224			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224508	Bronze			2022-12-18	WOS:000167413800002
J	Stassi, G; De Maria, R				Stassi, G; De Maria, R			Thyrocytes - not innocent bystanders in autoimmune disease - Response	NATURE IMMUNOLOGY			English	Letter							FAS-MEDIATED APOPTOSIS; HASHIMOTOS-THYROIDITIS; LIGAND; PATHOGENESIS; CELLS		Univ Palermo, Dept Surg Anat & Oncol Sci, Human Anat Sect, I-90127 Palermo, Italy; Ist Super Sanita, Lab Hematol & Oncol, I-00161 Rome, Italy	University of Palermo; Istituto Superiore di Sanita (ISS)	Stassi, G (corresponding author), Univ Palermo, Dept Surg Anat & Oncol Sci, Human Anat Sect, I-90127 Palermo, Italy.		De Maria, Ruggero/S-6385-2019; Stassi, Giorgio/AAC-1175-2022	De Maria, Ruggero/0000-0003-2255-0583; 				Borgatti R, 1999, SAGGI, V25, P1; Bretz JD, 1999, J BIOL CHEM, V274, P25433, DOI 10.1074/jbc.274.36.25433; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; Hammond LJ, 1997, J PATHOL, V182, P138, DOI 10.1002/(SICI)1096-9896(199706)182:2<138::AID-PATH810>3.0.CO;2-F; Kawakami A, 1997, CLIN EXP IMMUNOL, V110, P434, DOI 10.1046/j.1365-2249.1997.4301447.x; Kawakami A, 2000, LAB INVEST, V80, P471, DOI 10.1038/labinvest.3780053; Mitsiades N, 1998, J CLIN ENDOCR METAB, V83, P2199, DOI 10.1210/jc.83.6.2199; Stassi G, 2000, NAT IMMUNOL, V1, P483, DOI 10.1038/82725; Stassi G, 1999, J IMMUNOL, V162, P263; STOKES TA, 1998, SCIENCE, V279, P2015; TANIMOTO C, 1995, ENDOCR J, V42, P193, DOI 10.1507/endocrj.42.193	11	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					183	183		10.1038/85226	http://dx.doi.org/10.1038/85226			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224509				2022-12-18	WOS:000167413800003
J	Davenport, MP				Davenport, MP			Benefits of memory	NATURE IMMUNOLOGY			English	Letter									Univ New S Wales, Sch Pathol, Kensington, NSW 2052, Australia	University of New South Wales Sydney	Davenport, MP (corresponding author), Univ New S Wales, Sch Pathol, Kensington, NSW 2052, Australia.			Davenport, Miles/0000-0002-4751-1831				Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333; Zinkernagel RM, 2000, PHILOS T R SOC B, V355, P369, DOI 10.1098/rstb.2000.0576; Zinkernagel RM, 2000, NAT IMMUNOL, V1, P181, DOI 10.1038/79712	3	3	4	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					451	451		10.1038/82689	http://dx.doi.org/10.1038/82689			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101859				2022-12-18	WOS:000165724600002
J	Fink, PJ				Fink, PJ			If at first you don't succeed	NATURE IMMUNOLOGY			English	News Item							POSITIVE SELECTION; CHAIN GENE; B-CELLS; RECEPTOR; REARRANGEMENT; THYMOCYTES; MICE; TCR		Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fink, PJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.							Amsen D, 1998, IMMUNOL REV, V165, P209, DOI 10.1111/j.1600-065X.1998.tb01241.x; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kelsoe G, 1999, CURR OPIN IMMUNOL, V11, P70, DOI 10.1016/S0952-7915(99)80013-2; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McMahan CJ, 1998, IMMUNITY, V9, P637, DOI 10.1016/S1074-7613(00)80661-5; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Stockinger B, 1999, Adv Immunol, V71, P229; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Wang FP, 1998, P NATL ACAD SCI USA, V95, P11834, DOI 10.1073/pnas.95.20.11834; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355	13	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					271	+		10.1038/79707	http://dx.doi.org/10.1038/79707			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017092				2022-12-18	WOS:000089869700004
J	Baumgarth, N				Baumgarth, N			Secreted IgM versus BLyS in germinal center formation	NATURE IMMUNOLOGY			English	Letter									Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of California System; University of California Davis	Baumgarth, N (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.		Baumgarth, Nicole/AAI-6949-2020					Boes M, 1998, J IMMUNOL, V160, P4776; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889	3	3	12	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					179	179		10.1038/79708	http://dx.doi.org/10.1038/79708			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973267				2022-12-18	WOS:000089815100002
J	Pawelec, G				Pawelec, G			Working together for robust immune responses in the elderly	NATURE IMMUNOLOGY			English	Letter									Univ Tubingen, Tubingen Ageing & Tumor Immunol Grp ZMF, D-72072 Tubingen, Germany	Eberhard Karls University of Tubingen	Pawelec, G (corresponding author), Univ Tubingen, Tubingen Ageing & Tumor Immunol Grp ZMF, Room UG 25,Waldhornlestr 22, D-72072 Tubingen, Germany.		Pawelec, Graham/H-2713-2019	Pawelec, Graham/0000-0002-3600-0163					0	3	4	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					91	91		10.1038/77872	http://dx.doi.org/10.1038/77872			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248793	Bronze			2022-12-18	WOS:000089814900002
J	Ibrahim, MAA; Gotch, FM				Ibrahim, MAA; Gotch, FM			Making smarter immunotherapies	NATURE IMMUNOLOGY			English	Letter							SYSTEM		Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Immunol, London SW10 9NH, England	Imperial College London	Ibrahim, MAA (corresponding author), Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Immunol, 369 Fulham Rd, London SW10 9NH, England.		Ibrahim, Mohammad A. A./G-1387-2011	Ibrahim, Mohammad A. A./0000-0002-0116-597X				Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; IBRAHIM MAA, 1995, IMMUNOL TODAY, V16, P181, DOI 10.1016/0167-5699(95)80118-9; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015	5	3	3	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					3	3		10.1038/76850	http://dx.doi.org/10.1038/76850			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881162	Bronze			2022-12-18	WOS:000089814800002
J	Brasu, N; Elia, I; Russo, V; Montacchiesi, G; Stabile, SA; De Intinis, C; Fesi, F; Gizzi, K; Macagno, M; Montone, M; Mussolin, B; Grifoni, A; Faravelli, S; Marchese, S; Forneris, F; De Francesco, R; Sette, A; Barnaba, V; Sottile, A; Sapino, A; Pace, L				Brasu, Nadia; Elia, Ines; Russo, Valentina; Montacchiesi, Gaia; Stabile, Simona Aversano; De Intinis, Carlo; Fesi, Francesco; Gizzi, Katiuscia; Macagno, Marco; Montone, Monica; Mussolin, Benedetta; Grifoni, Alba; Faravelli, Silvia; Marchese, Silvia; Forneris, Federico; De Francesco, Raffaele; Sette, Alessandro; Barnaba, Vincenzo; Sottile, Antonino; Sapino, Anna; Pace, Luigia			Memory CD8(+) T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination	NATURE IMMUNOLOGY			English	Article								Understanding immune responses to SARS-CoV-2 messenger RNA (mRNA) vaccines is of great interest, principally because of the poor knowledge about the mechanisms of protection. In the present study, we analyzed longitudinally B cell and T cell memory programs against the spike (S) protein derived from ancestral SARS-CoV-2 (Wuhan-1), B.1.351 (beta), B.1.617.2 (delta) and B.1.1.529 (omicron) variants of concern (VOCs) after immunization with an mRNA-based vaccine (Pfizer). According to the magnitude of humoral responses 3 months after the first dose, we identified high and low responders. Opposite to low responders, high responders were characterized by enhanced antibody-neutralizing activity, increased frequency of central memory T cells and durable S-specific CD8(+) T cell responses. Reduced binding antibodies titers combined with long-term specific memory T cells that had distinct polyreactive properties were found associated with subsequent breakthrough with VOCs in low responders. These results have important implications for the design of new vaccines and new strategies for booster follow-up. Pace and colleagues assessed the antibody titers, B cell and T cell memory response against SARS-COV-2 in mRNA-vaccinated individuals to show that reduced antibody titers combined with a distinctive memory T cell profile in low vaccine responders correlated with breakthrough infection.	[Brasu, Nadia; Elia, Ines; Russo, Valentina; Montacchiesi, Gaia; Stabile, Simona Aversano; De Intinis, Carlo; Gizzi, Katiuscia; Pace, Luigia] IIGM, G Armenise Harvard Immune Regulat Unit, Candiolo, TO, Italy; [Brasu, Nadia; Russo, Valentina; Montacchiesi, Gaia] Univ Turin, Dept Oncol, Turin, Italy; [Elia, Ines; Stabile, Simona Aversano; De Intinis, Carlo; Fesi, Francesco; Gizzi, Katiuscia; Macagno, Marco; Montone, Monica; Mussolin, Benedetta; Sottile, Antonino; Sapino, Anna; Pace, Luigia] FPO IRCCS, Candiolo Canc Inst, Candiolo, TO, Italy; [Grifoni, Alba; Sette, Alessandro] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA; [Faravelli, Silvia; Forneris, Federico] Univ Pavia, Armenise Harvard Lab Struct Biol Dept Biol & Biot, Biol & Biotechnol, Pavia, Italy; [Marchese, Silvia; De Francesco, Raffaele] Ist Nazl Genet Mol Romeo & Invernizzi, Milan, Italy; [De Francesco, Raffaele] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Sette, Alessandro] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA USA; [Barnaba, Vincenzo] Fdn Cenci Bolognetti, Pasteur Inst Italy, Rome, Italy; [Barnaba, Vincenzo] Sapienza Univ, Dept Sci Clin Interist Anestesiol & Cardiovasc, Rome, Italy; [Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy	Italian Institute for Genomic Medicine (IIGM); University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; La Jolla Institute for Immunology; University of Pavia; University of Milan; University of California System; University of California San Diego; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Turin	Pace, L (corresponding author), IIGM, G Armenise Harvard Immune Regulat Unit, Candiolo, TO, Italy.; Pace, L (corresponding author), FPO IRCCS, Candiolo Canc Inst, Candiolo, TO, Italy.	luigia.pace@iigm.it	Sette, Alessandro/AFO-8916-2022	Aversano Stabile, Simona/0000-0003-0775-1774; Brasu, Nadia/0000-0001-7008-3727; De Intinis, Carlo/0000-0002-6791-7126; Macagno, Marco/0000-0002-1749-7813	Ministero della Salute [COVID-2020-12371849]; FPRC 5x 1,000 M.I.U.R 2017 'INTERONC-EMALAB'; FPO 5 x 1000 Ministero Salute 2018 'EMALAB'; Ministero Salute Ricerca Corrente 2021; Armenise-Harvard Foundation; AIRC [MFAG 20075, IG-2017, 19939]; NATO [SPS G5701]; Velux Stiftung [1375]; Mizutani Foundation for Glycoscience [200039]; MUR (Dipartimenti di Eccellenza 2018-2022); BEI Resources, the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH): vector pCAGGS containing the SARS-related coronavirus 2, Wuhan-Hu-1 spike glycoprotein receptor-binding domain (RBD) [NR-52309]; NIAID; NIH; Department of Health and Human Services [75N93021C00016]	Ministero della Salute(Ministry of Health, Italy); FPRC 5x 1,000 M.I.U.R 2017 'INTERONC-EMALAB'; FPO 5 x 1000 Ministero Salute 2018 'EMALAB'; Ministero Salute Ricerca Corrente 2021; Armenise-Harvard Foundation; AIRC(Fondazione AIRC per la ricerca sul cancro); NATO(NATO (North Atlantic Treaty Organisation)); Velux Stiftung; Mizutani Foundation for Glycoscience; MUR (Dipartimenti di Eccellenza 2018-2022)(Ministry of Education, Universities and Research (MIUR)); BEI Resources, the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH): vector pCAGGS containing the SARS-related coronavirus 2, Wuhan-Hu-1 spike glycoprotein receptor-binding domain (RBD); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services	We thank M. Olivero, L. Palmas, R. Albano and D. Baev for helpful discussion and technical support, the CCI and AVIS volunteers for donating their blood and the nurses for their assistance. We thank all the IIGM and CCI colleagues for helpful discussions and all technicians for help. We thank A. Pinnola for support with molecular cloning and A. Canciani for support with antigen purification. L.P. received founding from IIGM/CSP, Armenise-Harvard Foundation, Ministero della Salute 'COVID-2020-12371849', FPO/Candiolo Advance 5x 1000_2018 'Im-MEMORY'; A. Sapino received funding from FPRC 5x 1,000 M.I.U.R 2017 'INTERONC-EMALAB', FPO 5 x 1000 Ministero Salute 2018 'EMALAB', Ministero Salute Ricerca Corrente 2021. F.F. received funding from Armenise-Harvard Foundation, AIRC 'MFAG 20075', NATO 'SPS G5701', Velux Stiftung '1375', Mizutani Foundation for Glycoscience '200039' and MUR (Dipartimenti di Eccellenza 2018-2022); and obtained funding through BEI Resources, the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH): vector pCAGGS containing the SARS-related coronavirus 2, Wuhan-Hu-1 spike glycoprotein receptor-binding domain (RBD) (no. NR-52309). A.Sette received founding from federal funds from the NIAID, NIH and Department of Health and Human Services under contract no. 75N93021C00016, and V.B. from AIRC (no. IG-2017 ID 19939).	Abu-Raddad LJ, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100861; Altmann DM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6160; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bai J, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.786586; Barda N, 2021, NEW ENGL J MED, V385, P1078, DOI 10.1056/NEJMoa2110475; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Celardo I, 2020, BIOL DIRECT, V15, DOI 10.1186/s13062-020-00283-2; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chandrashekar A, 2022, CELL, V185, P1549, DOI 10.1016/j.cell.2022.03.024; Channappanavar R, 2014, J VIROL, V88, P11034, DOI 10.1128/JVI.01505-14; Fisher D, 2020, LANCET, V395, P1109, DOI 10.1016/S0140-6736(20)30679-6; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gallais F, 2021, EMERG INFECT DIS, V27, P113, DOI 10.3201/eid2701.203611; GeurtsvanKessel CH, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abo2202; Giles JR, 2022, IMMUNITY, V55, P557, DOI 10.1016/j.immuni.2022.02.004; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Grifoni A, 2021, CELL HOST MICROBE, V29, P1076, DOI 10.1016/j.chom.2021.05.010; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jarjour NN, 2021, IMMUNITY, V54, P14, DOI 10.1016/j.immuni.2020.12.009; Keeton R, 2022, NATURE, V603, P488, DOI 10.1038/s41586-022-04460-3; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Mateus J, 2021, SCIENCE, V374, P420, DOI 10.1126/science.abj9853; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Moderna, 2021, MOD REP 2 Q FISC YEA; Oberhardt V, 2021, NATURE, V597, P268, DOI 10.1038/s41586-021-03841-4; Pace L, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a037754; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Regev-Yochay G, 2021, LANCET REG HEALTH-EU, V7, DOI 10.1016/j.lanepe.2021.100150; Rodda LB, 2022, CELL, V185, P1588, DOI 10.1016/j.cell.2022.03.018; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmidt F, 2021, NATURE, V600, P512, DOI 10.1038/s41586-021-04005-0; Scognamiglio P, 1999, J IMMUNOL, V162, P6681; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Shapiro JR, 2022, CLIN INFECT DIS, V75, pS61, DOI 10.1093/cid/ciac397; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Thomas Stephen J, 2021, N Engl J Med, V385, P1761, DOI 10.1056/NEJMoa2110345; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9	50	2	2	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1445	+		10.1038/s41590-022-01313-z	http://dx.doi.org/10.1038/s41590-022-01313-z		SEP 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36138186	Bronze			2022-12-18	WOS:000856626700001
J	Liu, YB; Zhou, J; Li, XY; Zhang, XT; Shi, JT; Wang, XF; Li, H; Miao, S; Chen, HF; He, XX; Done, L; Lee, GR; Zheng, JK; Liu, RJ; Su, B; Ye, YQ; Flavell, RA; Yi, CQ; Wu, YZ; Li, HB				Liu, Yongbo; Zhou, Jing; Li, Xiaoyu; Zhang, Xiaoting; Shi, Jintong; Wang, Xuefei; Li, Hao; Miao, Shan; Chen, Huifang; He, Xiaoxiao; Done, Liting; Lee, Gap Ryol; Zheng, Junke; Liu, Ru-Juan; Su, Bing; Ye, Youqiong; Flavell, Richard A.; Yi, Chengqi; Wu, Yuzhang; Li, Hua-Bing			tRNA-m(1)A modification promotes T cell expansion via efficient MYC protein synthesis	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; DIFFERENTIATION; CD4	Naive T cells are quiescent but undergo dynamic changes upon antigenic activation. Li and colleagues show that upregulation of tRNA methyltransferase complex TRMT61A-TRMT6 and N-1-methyladenosine modification of tRNAs contribute to accelerated mRNA translation efficiency, in particular that of MYC protein, and are required for rapid T cell proliferation. Naive T cells undergo radical changes during the transition from dormant to hyperactive states upon activation, which necessitates de novo protein production via transcription and translation. However, the mechanism whereby T cells globally promote translation remains largely unknown. Here, we show that on exit from quiescence, T cells upregulate transfer RNA (tRNA) m(1)A58 'writer' proteins TRMT61A and TRMT6, which confer m(1)A58 RNA modification on a specific subset of early expressed tRNAs. These m(1)A-modified early tRNAs enhance translation efficiency, enabling rapid and necessary synthesis of MYC and of a specific group of key functional proteins. The MYC protein then guides the exit of naive T cells from a quiescent state into a proliferative state and promotes rapid T cell expansion after activation. Conditional deletion of the Trmt61a gene in mouse CD4(+) T cells causes MYC protein deficiency and cell cycle arrest, disrupts T cell expansion upon cognate antigen stimulation and alleviates colitis in a mouse adoptive transfer colitis model. Our study elucidates for the first time, to our knowledge, the in vivo physiological roles of tRNA-m(1)A58 modification in T cell-mediated pathogenesis and reveals a new mechanism of tRNA-m(1)A58-controlled T cell homeostasis and signal-dependent translational control of specific key proteins.	[Liu, Yongbo; Zhou, Jing; Shi, Jintong; Wang, Xuefei; Miao, Shan; Chen, Huifang; Su, Bing; Ye, Youqiong; Li, Hua-Bing] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Inst Immunol, Shanghai, Peoples R China; [Liu, Yongbo; Zhou, Jing; Wang, Xuefei; Miao, Shan; Su, Bing; Li, Hua-Bing] Shanghai Jiao Tong Univ, Sch Med, Yale Inst Immune Metab, Shanghai, Peoples R China; [Zhou, Jing; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Li, Xiaoyu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Biochem, Hangzhou, Peoples R China; [Li, Xiaoyu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou, Peoples R China; [Zhang, Xiaoting; Done, Liting; Yi, Chengqi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Li, Hao; Liu, Ru-Juan] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Chen, Huifang; Wu, Yuzhang; Li, Hua-Bing] Chongqing Int Inst Immunol, Chongqing, Peoples R China; [He, Xiaoxiao; Zheng, Junke] Shanghai Jiao Tong Univ, Hongqiao Int Inst Med, Fac Basic Med,Key Lab Cell Differentiat & Apoptos, Chinese Minist Educ,Sch Med,Shanghai Tongren Hosp, Shanghai, Peoples R China; [Done, Liting; Yi, Chengqi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Lee, Gap Ryol] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Yi, Chengqi] Peking Univ, Coll Chem & Mol Engn, Dept Chem Biol, Beijing, Peoples R China; [Yi, Chengqi] Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr, Beijing, Peoples R China; [Li, Hua-Bing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Geriatr,Med Ctr Aging, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Yale University; Zhejiang University; Zhejiang University; Peking University; ShanghaiTech University; Shanghai Jiao Tong University; Peking University; Sogang University; Howard Hughes Medical Institute; Yale University; Peking University; Peking University; Shanghai Jiao Tong University	Li, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Inst Immunol, Shanghai, Peoples R China.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Yale Inst Immune Metab, Shanghai, Peoples R China.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Yi, CQ (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China.; Wu, YZ; Li, HB (corresponding author), Chongqing Int Inst Immunol, Chongqing, Peoples R China.; Yi, CQ (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.; Yi, CQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, Dept Chem Biol, Beijing, Peoples R China.; Yi, CQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr, Beijing, Peoples R China.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Geriatr,Med Ctr Aging, Shanghai, Peoples R China.	richard.flavell@yale.edu; chengqi.yi@pku.edu.cn; wuyuzhang@iiicq.vip; huabing.li@shsmu.edu.cn	Liu, Yongbo/HHS-3301-2022; MIAO, SHAN/HGC-0800-2022	Liu, Yongbo/0000-0003-3569-0753; Liu, Ru-Juan/0000-0001-7459-3126	National Natural Science Foundation of China [82030042/32070917/82111540277, 31861143026/21825701/91940304, 81901580, 81901569, 32171283]; Chongqing International Institute for Immunology [2021YJC01]; Ministry of Science and Technology of China [2021YFA1100800]; National Key R&D Program of China [2019YFA0802200/2019YFA0110900]; Shanghai Science and Technology Commission [20JC1417400/201409005500, 20JC1410100, 20ZR1472900]; Shanghai Super Postdoctoral Program; China Postdoctoral Science Foundation [2019M651525, 2020M671149]; Postdoctoral Innovation Talent Support Program [BX20190214]; Innovative Research Team of High-Level Local Universities in Shanghai [SHSMU-ZDCX20212501, SHSMU-ZDCX20212500]; Howard Hughes Medical Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing International Institute for Immunology; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key R&D Program of China; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Super Postdoctoral Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Innovation Talent Support Program; Innovative Research Team of High-Level Local Universities in Shanghai; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank M. Yang, K. Mao and Y. Zhou for technical and administrative assistance. We also thank all members of the H.-B.L. laboratory for discussion. This work was supported by the National Natural Science Foundation of China (82030042/32070917/82111540277 to H.-B.L., 31861143026/21825701/91940304 to C.Y., 81901580 to Y.L., 81901569 to J. Zhou and 32171283 to X.L.), the Chongqing International Institute for Immunology (2021YJC01 to H.-B.L.), the Ministry of Science and Technology of China (2021YFA1100800 to H.-B.L.), the National Key R&D Program of China (2019YFA0802200/2019YFA0110900 to C.Y.), Shanghai Science and Technology Commission (20JC1417400/201409005500 to H-B.L., 20JC1410100 to J. Zheng and 20ZR1472900 to Y.Y.), the Shanghai Super Postdoctoral Program (Y.L. and J. Zhou), the China Postdoctoral Science Foundation (2019M651525 to Y.L. and 2020M671149 to J. Zhou), the Postdoctoral Innovation Talent Support Program (BX20190214 to J. Zhou), the Innovative Research Team of High-Level Local Universities in Shanghai (SHSMU-ZDCX20212501 to H.-B.L. and SHSMU-ZDCX20212500 to J. Zhou) and the Howard Hughes Medical Institute (R.A.F.).	BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cantara William A, 2011, Nucleic Acids Res, V39, pD195, DOI 10.1093/nar/gkq1028; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chou C, 2014, NAT IMMUNOL, V15, P884, DOI 10.1038/ni.2943; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Esposito Anthony M, 2010, J Vis Exp, DOI 10.3791/1948; Finer-Moore J, 2015, J MOL BIOL, V427, P3862, DOI 10.1016/j.jmb.2015.10.005; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gasper DJ, 2014, CRIT REV IMMUNOL, V34, P121, DOI 10.1615/CritRevImmunol.2014010373; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Hwang SS, 2020, SCIENCE, V367, P1255, DOI 10.1126/science.aax0194; Hydbring P, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070174; Jackson R, 2018, NATURE, V564, P434, DOI 10.1038/s41586-018-0794-7; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li P, 2017, P NATL ACAD SCI USA, V114, P12111, DOI 10.1073/pnas.1714019114; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Loo TT, 2018, J LEUKOCYTE BIOL, V104, P1069, DOI 10.1002/JLB.1RI0418-152RR; Lorenz C, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020035; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Marchingo JM, 2020, ELIFE, V9, DOI 10.7554/eLife.53725; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Oerum S, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010020; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; PAILLARD F, 1990, EMBO J, V9, P1867, DOI 10.1002/j.1460-2075.1990.tb08312.x; Pan T, 2018, CELL RES, V28, P395, DOI 10.1038/s41422-018-0013-y; Popmihajlov Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00102; Rak R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106556118; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; Saravia J, 2019, CELL MOL IMMUNOL, V16, P634, DOI 10.1038/s41423-019-0220-6; Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77; Snook JP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9103; Song JH, 2020, NAT CHEM BIOL, V16, P160, DOI 10.1038/s41589-019-0420-5; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang YY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26718-6; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yoshihisa T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00213; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zaborske JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002015	53	2	2	13	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1433	+		10.1038/s41590-022-01301-3	http://dx.doi.org/10.1038/s41590-022-01301-3		SEP 2022	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36138184				2022-12-18	WOS:000856626700003
J	Grisaru-Tal, S; Rothenberg, ME; Munitz, A				Grisaru-Tal, Sharon; Rothenberg, Marc E.; Munitz, Ariel			Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy	NATURE IMMUNOLOGY			English	Article							PROGRESSION-FREE SURVIVAL; CD4(+) T-CELLS; MELANOMA PATIENTS; NK CELLS; GM-CSF; INTERLEUKIN-2; METASTASIS; ACTIVATION; COUNTS; INHIBITION	The role of eosinophils in response to cancer is not well understood. Here the authors document evidence that eosinophils contribute to the immune response to cancer and to immunotherapies and postulate that these cells might be more important than expected in these contexts. Eosinophils are important effector cells and therapeutic targets in allergic diseases. Emerging data indicate that eosinophils infiltrate a variety of solid tumor types and have pleiotropic activities by at least two non-mutually exclusive mechanisms: direct interactions with tumor cells, and intricate cross-talk with lymphocytes. In light of the immune checkpoint inhibition revolution in cancer therapy, we review eosinophil-lymphocyte interactions in the tumor microenvironment. We also analyze potential interactions between eosinophils and lymphocyte subsets, including T cells, natural killer cells and innate lymphoid cells. We provide perspectives on the consequences of these interactions and how eosinophils are accessory cells that can affect the response to various forms of T cell-mediated immunotherapies and might be therapeutically targeted to improve cancer immunotherapy.	[Grisaru-Tal, Sharon; Munitz, Ariel] Tel Aviv Univ, Fac Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Rothenberg, Marc E.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy Immunol, Cincinnati, OH 45229 USA; [Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Tel Aviv University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Munitz, A (corresponding author), Tel Aviv Univ, Fac Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.	arielm@tauex.tau.ac.il		Rothenberg, Marc/0000-0001-9790-6332	US-Israel Bi-national Science Foundation [2015163]; Israel Science Foundation [886/15, 542/20]; Israel Cancer Research Fund; Richard Eimert Research Fund on Solid Tumors; Israel Cancer Association; Dotan Hemato Oncology fund; Cancer Biology Research Center; Tel Aviv University; Tel Aviv University Faculty of Medicine Recanati Fund; Azrieli Foundation Canada-Israel; National Institutes of Health [R37 AI045898, R01 AI124355, U19 AI070235, P30 DK078392]; Campaign Urging Research for Eosinophilic Disease (CURED); Sunshine Charitable Foundation	US-Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Richard Eimert Research Fund on Solid Tumors; Israel Cancer Association; Dotan Hemato Oncology fund; Cancer Biology Research Center; Tel Aviv University; Tel Aviv University Faculty of Medicine Recanati Fund; Azrieli Foundation Canada-Israel; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campaign Urging Research for Eosinophilic Disease (CURED); Sunshine Charitable Foundation	This work was supported by grants and fellowships to A.M. from the US-Israel Bi-national Science Foundation (grant no. 2015163, to A.M. and M.E.R.), Israel Science Foundation (grant nos. 886/15 and 542/20), Israel Cancer Research Fund, Richard Eimert Research Fund on Solid Tumors, Israel Cancer Association, Dotan Hemato Oncology fund, Cancer Biology Research Center, Tel Aviv University, The Tel Aviv University Faculty of Medicine Recanati Fund and Azrieli Foundation Canada-Israel.; M.E.R. was further supported by the National Institutes of Health (R37 AI045898, R01 AI124355, U19 AI070235 and P30 DK078392; Gene and Protein Expression Core), Campaign Urging Research for Eosinophilic Disease (CURED) and Sunshine Charitable Foundation and its supporters, D. A. Bunning and D. G. Bunning.	Akuthota P, 2008, CLIN EXP ALLERGY, V38, P1254, DOI 10.1111/j.1365-2222.2008.03037.x; Akuthota P, 2010, CURR OPIN ALLERGY CL, V10, P14, DOI 10.1097/ACI.0b013e328334f693; Alves A, 2021, J THORAC DIS, V13, P2716, DOI 10.21037/jtd-20-3525; Andreone S, 2019, CANCERS, V11, DOI 10.3390/cancers11111664; Arnold IC, 2020, J EXP MED, V217, DOI 10.1084/jem.20190706; Arnold IC, 2018, J EXP MED, V215, P2055, DOI 10.1084/jem.20172049; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Brusilovsky M, 2021, NAT IMMUNOL, V22, P1316, DOI 10.1038/s41590-021-01011-2; Carretero R, 2015, NAT IMMUNOL, V16, P609, DOI 10.1038/ni.3159; Cheng JN, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abc7609; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dolitzky A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.802839; Dougan M, 2019, IMMUNITY, V50, P796, DOI 10.1016/j.immuni.2019.03.022; Ellem KAO, 1997, CANCER IMMUNOL IMMUN, V44, P10, DOI 10.1007/s002620050349; Fallegger A, 2022, MUCOSAL IMMUNOL, V15, P504, DOI 10.1038/s41385-022-00484-0; Furubayashi N, 2021, CANCER MANAG RES, V13, P8049, DOI 10.2147/CMAR.S333823; Gao K, 2013, CANCER LETT, V335, P463, DOI 10.1016/j.canlet.2013.03.002; Gebhardt C, 2015, CLIN CANCER RES, V21, P5453, DOI 10.1158/1078-0432.CCR-15-0676; Ghebeh H, 2022, IMMUNOTHERAPY-UK, V14, P189, DOI 10.2217/imt-2021-0149; Grisaru-Tal S, 2021, CANCER RES, V81, P5555, DOI 10.1158/0008-5472.CAN-21-0839; Grisaru-Tal S, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2020.1859732; Grisaru-Tal S, 2020, NAT REV CANCER, V20, P594, DOI 10.1038/s41568-020-0283-9; Gurtner A., BIORXIV, DOI [10.1101/2021, DOI 10.1101/2021]; HANSEL TT, 1991, CLIN EXP IMMUNOL, V86, P271; Herrmann T, 2021, CANCER MED-US, V10, P6705, DOI 10.1002/cam4.4208; Hollande C, 2019, NAT IMMUNOL, V20, P257, DOI 10.1038/s41590-019-0321-5; Hude I, 2018, BRIT J HAEMATOL, V181, P837, DOI 10.1111/bjh.14705; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jacobsen EA, 2021, ANNU REV IMMUNOL, V39, P719, DOI 10.1146/annurev-immunol-093019-125918; Jacquelot N, 2022, NAT IMMUNOL, V23, P371, DOI 10.1038/s41590-022-01127-z; Jacquelot N, 2021, NAT IMMUNOL, V22, P851, DOI 10.1038/s41590-021-00943-z; Jia QZ, 2021, THERANOSTICS, V11, P4699, DOI 10.7150/thno.54546; Jia SG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49734-5; Lai WF, 2021, STEM CELL REP, V16, P1697, DOI 10.1016/j.stemcr.2021.06.005; Lang BM, 2018, MED ONCOL, V35, DOI 10.1007/s12032-018-1084-9; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Li MO, 2021, CANCER CELL, V39, P725, DOI 10.1016/j.ccell.2021.05.016; Lucarini V, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1317420; LUCEY DR, 1989, P NATL ACAD SCI USA, V86, P1348, DOI 10.1073/pnas.86.4.1348; Maggi E, 2020, CANCERS, V12, DOI 10.3390/cancers12113452; Martens A, 2016, CLIN CANCER RES, V22, P2908, DOI 10.1158/1078-0432.CCR-15-2412; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Moreira A, 2017, IMMUNOTHERAPY-UK, V9, P115, DOI 10.2217/imt-2016-0138; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Munitz A, 2005, J IMMUNOL, V174, P110, DOI 10.4049/jimmunol.174.1.110; Munitz A, 2006, J IMMUNOL, V177, P77, DOI 10.4049/jimmunol.177.1.77; Nishikawa D, 2021, CANCER SCI, V112, P339, DOI 10.1111/cas.14706; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Flaherty SM, 2017, SCAND J IMMUNOL, V85, P417, DOI 10.1111/sji.12554; Oh DY, 2021, IMMUNITY, V54, P2701, DOI 10.1016/j.immuni.2021.11.015; Onyema OO, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128241; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pesce S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00510; Qi L, 2020, INT J CANCER, V146, P1421, DOI 10.1002/ijc.32779; Rafei-Shamsabadi D, 2022, CANCERS, V14, DOI 10.3390/cancers14030540; Reichman H, 2019, CANCER IMMUNOL RES, V7, P388, DOI 10.1158/2326-6066.CIR-18-0494; Reinbach G., 1893, ARCH KLIN CHIR, V46, P486; Rodriguez-Rodriguez N, 2021, ANNU REV IMMUNOL, V39, P167, DOI 10.1146/annurev-immunol-110119-091711; Schuijs MJ, 2020, NAT IMMUNOL, V21, P998, DOI 10.1038/s41590-020-0745-y; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Simon HU, 2003, EUR J IMMUNOL, V33, P834, DOI 10.1002/eji.200323727; Simon SCS, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1727116; Sosman JA, 1995, CLIN CANCER RES, V1, P805; Sterner RC, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00459-7; Tay RE, 2021, CANCER GENE THER, V28, P5, DOI 10.1038/s41417-020-0183-x; Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5; Webster R, 2014, NAT REV DRUG DISCOV, V13, P883, DOI 10.1038/nrd4476; Weide B, 2016, CLIN CANCER RES, V22, P5487, DOI 10.1158/1078-0432.CCR-16-0127; Woerly G, 1999, J EXP MED, V190, P487, DOI 10.1084/jem.190.4.487; Zaynagetdinov R, 2015, CANCER RES, V75, P1624, DOI 10.1158/0008-5472.CAN-14-2379; Zheng XC, 2020, INT J CANCER, V146, P1730, DOI 10.1002/ijc.32829	74	2	2	10	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9					1309	1316		10.1038/s41590-022-01291-2	http://dx.doi.org/10.1038/s41590-022-01291-2		AUG 2022	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O8VJ	36002647				2022-12-18	WOS:000844434100002
J	Jarade, A; Garcia, Z; Marie, S; Demera, A; Prinz, I; Bousso, P; Di Santo, JP; Serafini, N				Jarade, Angelique; Garcia, Zacarias; Marie, Solenne; Demera, Abdi; Prinz, Immo; Bousso, Philippe; Di Santo, James P.; Serafini, Nicolas			Inflammation triggers ILC3 patrolling of the intestinal barrier	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; HOST-DEFENSE; IL-22; MACROPHAGES; HOMEOSTASIS; MIGRATION	Serafini and colleagues show that intestinal villus ILC3s, which are largely immotile at steady state, develop a patrolling behavior in response to inflammation. An orchestrated cellular network, including adaptive lymphocytes and group 3 innate lymphoid cells (ILC3s), maintains intestinal barrier integrity and homeostasis. T cells can monitor environmental insults through constitutive circulation, scanning tissues and forming immunological contacts, a process named immunosurveillance. In contrast, the dynamics of intestinal ILC3s are unknown. Using intravital imaging, we observed that villus ILC3s were largely immotile at steady state but acquired migratory 'patrolling' attributes and enhanced cytokine expression in response to inflammation. We showed that T cells, the chemokine CCL25 and bacterial ligands regulated intestinal ILC3 behavior and that loss of patrolling behavior by interleukin-22 (IL-22)-producing ILC3s altered the intestinal barrier through increased epithelial cell death. Collectively, we identified notable differences between the behavior of ILC3s and T cells, with a prominent adaptation of intestinal ILC3s toward mucosal immunosurveillance after inflammation.	[Jarade, Angelique; Marie, Solenne; Di Santo, James P.; Serafini, Nicolas] Univ Paris Cite, Inst Pasteur, Inst Natl Sante & Rech Med U1223, Innate Immun Unit, Paris, France; [Garcia, Zacarias; Bousso, Philippe] Univ Paris Cite, Inst Pasteur, Inst Natl Sante & Rech Med U1223, Dynam Immune Responses Unit, Paris, France; [Demera, Abdi; Prinz, Immo] Hanover Med Sch, Inst Immunol, Hanover, NH USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Serafini, N (corresponding author), Univ Paris Cite, Inst Pasteur, Inst Natl Sante & Rech Med U1223, Innate Immun Unit, Paris, France.	nicolas.serafini@pasteur.fr	SERAFINI, nicolas/S-5675-2019; Di Santo, James/M-4298-2014; Prinz, Immo/A-3026-2010	SERAFINI, nicolas/0000-0002-7440-4353; Di Santo, James/0000-0002-7146-1862; Prinz, Immo/0000-0002-8789-9578	Institut Pasteur; Institut National de la Sante et de la Recherche Medicale (INSERM); Agence National pour le Recherche [ANR-15-CE15-0004ILC3_MEMORY]; European Research Council (ERC) under the European Union [695467-ILC_REACTIVITY]; INSERM under an ERC grant; Fondation pour la Recherche Medicale through the `Espoirs de la Recherche' program	Institut Pasteur(European Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence National pour le Recherche(French National Research Agency (ANR)); European Research Council (ERC) under the European Union(European Research Council (ERC)); INSERM under an ERC grant; Fondation pour la Recherche Medicale through the `Espoirs de la Recherche' program	We thank G. Eberl, S. K. Durum and O. Mandelboim for the RorcGFP, Il22TdT and Ncr1GFP mice, respectively. At Institut Pasteur, we are grateful to the Central Animal Facility and especially to the animal caretakers, the CB UTechS platform for cytometry support and L. Guenin-Mace (Immunobiology and Therapy Unit) for her help with the permeability assay. We thank all the members of the Innate Immunity and Dynamics of Immune Responses Units for support and helpful discussions, with specific contributions from A. Schiavo, A. Bohineust, R. Thibaut, J. Postat and C. Grandjean. This work is supported by grants from Institut Pasteur, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Agence National pour le Recherche (ANR-15-CE15-0004ILC3_MEMORY) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (695467-ILC_REACTIVITY). A.J. is supported by INSERM under an ERC grant and the Fondation pour la Recherche Medicale through the `Espoirs de la Recherche' program.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Savage AK, 2017, J IMMUNOL, V199, P1912, DOI 10.4049/jimmunol.1700155; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Serafini N, 2022, SCIENCE, V375, P859, DOI 10.1126/science.aaz8777; Sonnenberg GE, 2019, NAT REV IMMUNOL, V19, P599, DOI 10.1038/s41577-019-0194-8; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	27	2	2	13	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9					1317	+		10.1038/s41590-022-01284-1	http://dx.doi.org/10.1038/s41590-022-01284-1		AUG 2022	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O8VJ	35999393	hybrid, Green Published			2022-12-18	WOS:000843443500007
J	Yan, ML; Komatsu, N; Muro, R; Huynh, NCN; Tomofuji, Y; Okada, Y; Suzuki, HI; Takaba, H; Kitazawa, R; Kitazawa, S; Pluemsakunthai, W; Mitsui, Y; Satoh, T; Okamura, T; Nitta, T; Im, SH; Kim, CJ; Kollias, G; Tanaka, S; Okamoto, K; Tsukasaki, M; Takayanagi, H				Yan, Minglu; Komatsu, Noriko; Muro, Ryunosuke; Huynh, Nam Cong-Nhat; Tomofuji, Yoshihiko; Okada, Yukinori; Suzuki, Hiroshi, I; Takaba, Hiroyuki; Kitazawa, Riko; Kitazawa, Sohei; Pluemsakunthai, Warunee; Mitsui, Yuichi; Satoh, Takashi; Okamura, Tadashi; Nitta, Takeshi; Im, Sin-Hyeog; Kim, Chan Johng; Kollias, George; Tanaka, Sakae; Okamoto, Kazuo; Tsukasaki, Masayuki; Takayanagi, Hiroshi			ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts	NATURE IMMUNOLOGY			English	Article							RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; ANIMAL-MODELS; TNFSF11 GENE; SINGLE-CELL; HUMAN COLON; EXPRESSION; RANKL; OSTEOCLASTOGENESIS; ACTIVATION	Fibroblasts, the most abundant structural cells, exert homeostatic functions but also drive disease pathogenesis. Single-cell technologies have illuminated the shared characteristics of pathogenic fibroblasts in multiple diseases including autoimmune arthritis, cancer and inflammatory colitis. However, the molecular mechanisms underlying the disease-associated fibroblast phenotypes remain largely unclear. Here, we identify ETS1 as the key transcription factor governing the pathological tissue-remodeling programs in fibroblasts. In arthritis, ETS1 drives polarization toward tissue-destructive fibroblasts by orchestrating hitherto undescribed regulatory elements of the osteoclast differentiation factor receptor activator of nuclear factor-kappa B ligand (RANKL) as well as matrix metalloproteinases. Fibroblast-specific ETS1 deletion resulted in ameliorated bone and cartilage damage under arthritic conditions without affecting the inflammation level. Cross-tissue fibroblast single-cell data analyses and genetic loss-of-function experiments lent support to the notion that ETS1 defines the perturbation-specific fibroblasts shared among various disease settings. These findings provide a mechanistic basis for pathogenic fibroblast polarization and have important therapeutic implications. Osteoclastic bone destruction is mediated by factors such as RANKL elaborated by tissue-destructive fibroblasts. Takayanagi and colleagues identify the transcription factor Ets1 as a major regulator of these pathogenic cells.	[Yan, Minglu; Komatsu, Noriko; Muro, Ryunosuke; Huynh, Nam Cong-Nhat; Takaba, Hiroyuki; Pluemsakunthai, Warunee; Nitta, Takeshi; Tsukasaki, Masayuki; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Yan, Minglu; Komatsu, Noriko; Muro, Ryunosuke; Huynh, Nam Cong-Nhat; Takaba, Hiroyuki; Pluemsakunthai, Warunee; Nitta, Takeshi; Okamoto, Kazuo; Tsukasaki, Masayuki; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo, Japan; [Huynh, Nam Cong-Nhat] Univ Med & Pharm Ho Chi Minh City, Fac Odonto Stomatol, Lab Oral Maxillofacial Biol, Ho Chi Minh City, Vietnam; [Tomofuji, Yoshihiko; Okada, Yukinori] Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka, Japan; [Okada, Yukinori] Univ Tokyo, Grad Sch Med, Dept Genome Informat, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Syst Genet, Yokohama, Kanagawa, Japan; [Suzuki, Hiroshi, I] Nagoya Univ, Ctr Neurol Dis & Canc, Div Mol Oncol, Grad Sch Med, Nagoya, Aichi, Japan; [Suzuki, Hiroshi, I] Nagoya Univ, Inst Glycocore Res iGCORE, Nagoya, Aichi, Japan; [Kitazawa, Riko] Ehime Univ Hosp, Div Diagnost Pathol, Toon City, Japan; [Kitazawa, Sohei] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Toon City, Japan; [Mitsui, Yuichi; Satoh, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo, Japan; [Mitsui, Yuichi; Satoh, Takashi] Innate Cell Therapy, Osaka, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Tokyo, Japan; [Im, Sin-Hyeog; Kim, Chan Johng] Pohang Univ Sci & Technol POSTECH, POSTECH Biotech Ctr, Dept Life Sci, Pohang, South Korea; [Im, Sin-Hyeog] ImmunoBiome, Pohang, South Korea; [Im, Sin-Hyeog] Yonsei Univ, Inst Convergence Sci, Seoul, South Korea; [Kollias, George] Biomed Sci Res Ctr BSRC Alexander Fleming, Inst Bioinnovat, Vari, Attika, Greece; [Kollias, George] Natl & Kapodistrian Univ Athens, Med Sch, Dept Physiol, Athens, Greece; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo, Japan; [Okamoto, Kazuo] Univ Tokyo, Grad Sch Med, Dept Osteoimmunol, Tokyo, Japan	University of Tokyo; University of Tokyo; Hochiminh City University of Medicine & Pharmacy; Osaka University; University of Tokyo; RIKEN; Nagoya University; Nagoya University; Ehime University; Ehime University; Tokyo Medical & Dental University (TMDU); National Center for Global Health & Medicine - Japan; Pohang University of Science & Technology (POSTECH); Yonsei University; Alexander Fleming Biomedical Sciences Research Center; National & Kapodistrian University of Athens; University of Tokyo; University of Tokyo	Takayanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan.; Takayanagi, H (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.	takayana@m.u-tokyo.ac.jp	; Im, Sin-Hyeog/E-6811-2013	Yan, Minglu/0000-0002-5910-1266; Im, Sin-Hyeog/0000-0002-3173-1856; Okada, Yukinori/0000-0002-0311-8472	Japan Agency for Medical Research and Development (AMED) [JP22ek0410073]; AMED-CREST [JP22gm1210008]; AMED-PRIME [JP22gm6310029h0001]; Japan Society for the Promotion of Science (JSPS) [15H05703, 21H05046, 21H03104, 22H02844, 20K21515, 21K18254]; JSPS Research Fellowship for Young Scientists [19J21942]; JSPS Postdoctoral Fellowships for Overseas Researchers [22F22108]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED-CREST; AMED-PRIME; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Postdoctoral Fellowships for Overseas Researchers	We thank A. Terashima, T. Asano, T. Sugita, H. Urabe, S. Yin, W. Yin, S. Zang, K. Kusubata, A. Suematsu, K. Kubo, Y. Omata, N. Kamiya, M. Hatakeyama, M. Miyoshi, G. Zhao, K. Ohmura, J. Nishio and K. Nakano for thoughtful discussion and valuable technical assistance. We appreciate the great contribution of K. Onimaru for the data analysis. This work was supported in part by the Japan Agency for Medical Research and Development (AMED) under grant number JP22ek0410073, AMED-CREST under grant number JP22gm1210008 and AMED-PRIME under grant number JP22gm6310029h0001; Japan Society for the Promotion of Science (JSPS): Grants-in-Aid for Specially Promoted Research (15H05703), Scientific Research S (21H05046), Scientific Research B (21H03104 and 22H02844) and Challenging Research (20K21515 and 21K18254). M.Y. was supported by a JSPS Research Fellowship for Young Scientists (19J21942) and a JSPS Postdoctoral Fellowships for Overseas Researchers (22F22108).	Alves CH, 2016, CLIN REV ALLERG IMMU, V51, P27, DOI 10.1007/s12016-015-8522-7; Amemiya HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45839-z; Andersson R, 2020, NAT REV GENET, V21, P71, DOI 10.1038/s41576-019-0173-8; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Bishop KA, 2015, J CELL BIOCHEM, V116, P320, DOI 10.1002/jcb.24974; Brugger MD, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3001032; Buckley CD, 2021, NAT IMMUNOL, V22, P1344, DOI 10.1038/s41590-021-01044-7; Buckley CD, 2021, NATURE, V593, P511, DOI 10.1038/d41586-021-01204-7; Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Cabrera S, 2019, AM J PHYSIOL-LUNG C, V316, pL961, DOI 10.1152/ajplung.00455.2017; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Conway BR, 2020, J AM SOC NEPHROL, V31, P2833, DOI 10.1681/ASN.2020060806; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Danks L, 2016, ANN RHEUM DIS, V75, P1187, DOI 10.1136/annrheumdis-2014-207137; Davidson, NAT REV IMMUNOL, DOI [10.1038/s41577-021-00540-z(2021, DOI 10.1038/S41577-021-00540-Z(2021]; De Tomaso D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12235-0; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Friedrich M, 2021, NAT MED, V27, P1970, DOI 10.1038/s41591-021-01520-5; Fukushima K, 2020, IMMUNITY, V52, P542, DOI 10.1016/j.immuni.2020.02.007; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hayer S, 2021, ANN RHEUM DIS, V80, P714, DOI 10.1136/annrheumdis-2020-219247; Jasso GJ, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001532; Karpus ON, 2019, CELL REP, V26, P3698, DOI 10.1016/j.celrep.2019.02.101; Khafipour A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01405; Kim CJ, 2019, IMMUNITY, V50, P272, DOI 10.1016/j.immuni.2018.12.023; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kitazawa R, 2008, J CELL BIOCHEM, V105, P1289, DOI 10.1002/jcb.21929; Koliaraki V, 2020, NAT IMMUNOL, V21, P974, DOI 10.1038/s41590-020-0741-2; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Komatsu, J CLIN INVEST, DOI [10.1172/JCI143060(2021, DOI 10.1172/JCI143060(2021]; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; Krishna V, 2021, J IMMUNOL, V206, P422, DOI 10.4049/jimmunol.2000286; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Liu X, 2020, GASTROENTEROLOGY, V158, P1728, DOI 10.1053/j.gastro.2020.01.027; Loh C, 2019, ANN RHEUM DIS, V78, P1205, DOI 10.1136/annrheumdis-2018-214783; Nagashima K, 2017, BIOCHEM BIOPH RES CO, V493, P437, DOI 10.1016/j.bbrc.2017.09.004; Nakamura Y, 2004, J IMMUNOL, V172, P1945, DOI 10.4049/jimmunol.172.3.1945; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Onal M, 2016, ENDOCRINOLOGY, V157, P482, DOI 10.1210/en.2015-1788; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pelka K, 2021, CELL, V184, P4734, DOI 10.1016/j.cell.2021.08.003; Plikus MV, 2021, CELL, V184, P3852, DOI 10.1016/j.cell.2021.06.024; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Ryu JH, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001881; Singhal R, 2020, J BIOL CHEM, V295, P10493, DOI 10.1074/jbc.REV120.011188; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Stephenson W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02659-x; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 1997, BIOCHEM BIOPH RES CO, V240, P279, DOI 10.1006/bbrc.1997.7404; Takeuchi T, 2016, ANN RHEUM DIS, V75, P983, DOI 10.1136/annrheumdis-2015-208052; Tsuchiya H, 2021, ANN RHEUM DIS, V80, P440, DOI 10.1136/annrheumdis-2020-218189; Tsukasaki M, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00318-y; Tsukasaki M, 2019, NAT REV IMMUNOL, V19, P626, DOI 10.1038/s41577-019-0178-8; Vasaikar S, 2019, CELL, V177, P1035, DOI 10.1016/j.cell.2019.03.030; Virchow R, 1858, CELLULARPATHOLOGIE I; Wei KV, 2020, NATURE, V582, P259, DOI 10.1038/s41586-020-2222-z; Wohlfahrt T, 2019, NATURE, V566, P344, DOI 10.1038/s41586-019-0896-x; Wu SZ, 2021, NAT GENET, V53, P1334, DOI 10.1038/s41588-021-00911-1; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	68	2	2	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9					1330	+		10.1038/s41590-022-01285-0	http://dx.doi.org/10.1038/s41590-022-01285-0		AUG 2022	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O8VJ	35999392				2022-12-18	WOS:000843443500005
J	Yin, YY; Yang, XY; Wu, SS; Ding, XY; Zhu, HM; Long, XH; Wang, YL; Zhai, SL; Chen, Y; Che, N; Chen, JJ; Wang, XM				Yin, Yuye; Yang, Xinyi; Wu, Shusheng; Ding, Xinyu; Zhu, Huamin; Long, Xuehui; Wang, Yuliang; Zhai, Sulan; Chen, Yun; Che, Nan; Chen, Jingjing; Wang, Xiaoming			Jmjd1c demethylates STAT3 to restrain plasma cell differentiation and rheumatoid arthritis	NATURE IMMUNOLOGY			English	Article							GERMINAL CENTER; TERMINAL DIFFERENTIATION; TARGETED THERAPIES; METHYLATION; INTERLEUKIN-6; EXPRESSION; RESPONSES; PHOSPHORYLATION; AFFINITY; SURVIVAL	Appropriate regulation of B cell differentiation into plasma cells is essential for humoral immunity while preventing antibody-mediated autoimmunity; however, the underlying mechanisms, especially those with pathological consequences, remain unclear. Here, we found that the expression of Jmjd1c, a member of JmjC domain histone demethylase, in B cells but not in other immune cells, protected mice from rheumatoid arthritis (RA). In humans with RA, JMJD1C expression levels in B cells were negatively associated with plasma cell frequency and disease severity. Mechanistically, Jmjd1c demethylated STAT3, rather than histone substrate, to restrain plasma cell differentiation. STAT3 Lys140 hypermethylation caused by Jmjd1c deletion inhibited the interaction with phosphatase Ptpn6 and resulted in abnormally sustained STAT3 phosphorylation and activity, which in turn promoted plasma cell generation. Germinal center B cells devoid of Jmjd1c also acquired strikingly increased propensity to differentiate into plasma cells. STAT3 Lys140Arg point mutation completely abrogated the effect caused by Jmjd1c loss. Mice with Jmjd1c overexpression in B cells exhibited opposite phenotypes to Jmjd1c-deficient mice. Overall, our study revealed Jmjd1c as a critical regulator of plasma cell differentiation and RA and also highlighted the importance of demethylation modification for STAT3 in B cells. The STAT3 pathway is activated in B cells by interleukin-6 and interleukin-21; however, methylation of Lys140 prevents its dephosphorylation and deactivation. Yin et al. report a noncanonical role for the histone demethylase Jmjd1c in demethylating phosphorylated STAT3, thereby terminating B cell activation and limiting plasma cell generation and potential B cell-mediated autoimmunity.	[Yin, Yuye; Yang, Xinyi; Wu, Shusheng; Ding, Xinyu; Zhu, Huamin; Long, Xuehui; Wang, Yuliang; Zhai, Sulan; Chen, Yun; Chen, Jingjing; Wang, Xiaoming] Nanjing Med Univ, Collaborat Innovat Ctr Personalized Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Immunol,NHC Key Lab Antibody Tech,Key Lab Im, Nanjing, Peoples R China; [Che, Nan] Nanjing Med Univ, Affiliated Hosp 1, Dept Rheumatol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University	Chen, JJ; Wang, XM (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Personalized Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Immunol,NHC Key Lab Antibody Tech,Key Lab Im, Nanjing, Peoples R China.; Che, N (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rheumatol, Nanjing, Peoples R China.	nche3850@126.com; chenjingjing@njmu.edu.cn; xmwang@njmu.edu.cn	chen, JJ/HGB-6029-2022; 殷, 玉叶/GVS-6761-2022; Wang, Xiaoming/E-9029-2015	殷, 玉叶/0000-0001-8924-5650; Wang, Xiaoming/0000-0003-0679-9768; chen, yun/0000-0002-4118-362X	National Natural Science Foundation of China [82101827, 31970828, 82171793]; National Key R&D Program of China [2018YFC1003900]; China Postdoctoral Science Foundation [2020M681665]; Jiangsu Outstanding Young Investigator Program [BK20200030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Outstanding Young Investigator Program	The authors thank all the members of the Wang laboratory for feedback. We thank W. Zhang, W. Zeng and J. Li for genetic mouse generation and technical support. This study was supported by grants from the National Natural Science Foundation of China (82101827 to J.C., 31970828 to X.W. and 82171793 to N.C.), National Key R&D Program of China (2018YFC1003900 to X.W.), China Postdoctoral Science Foundation (2020M681665 to J.C.) and Jiangsu Outstanding Young Investigator Program (BK20200030 to X.W.).	Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Anderson AE, 2019, RHEUMATOLOGY, V58, P1250, DOI 10.1093/rheumatology/kez003; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen JJ, 2018, CELL REP, V25, P3393, DOI 10.1016/j.celrep.2018.11.096; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Ciobanu DA, 2020, EXP THER MED, V20, P3498, DOI 10.3892/etm.2020.8982; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Eisenberg R, 2006, NAT CLIN PRACT RHEUM, V2, P20, DOI 10.1038/ncprheum0042; Elsner RA, 2020, IMMUNITY, V53, P1136, DOI 10.1016/j.immuni.2020.11.006; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hasegawa T, 2019, NAT IMMUNOL, V20, P1631, DOI 10.1038/s41590-019-0526-7; Ise W, 2019, IMMUNOL REV, V288, P64, DOI 10.1111/imr.12751; Kang SJ, 2019, IMMUNITY, V50, P1007, DOI 10.1016/j.immuni.2019.03.026; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092708; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Klarquist J, 2015, JOVE-J VIS EXP, DOI 10.3791/53319; Krause A, 2002, J IMMUNOL, V169, P6610, DOI 10.4049/jimmunol.169.11.6610; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Long XH, 2020, J EXP MED, V217, DOI 10.1084/jem.20190832; Luo D, 2017, P NATL ACAD SCI USA, V114, pE3071, DOI 10.1073/pnas.1613592114; Ma KY, 2018, ANN RHEUM DIS, V77, P1498, DOI 10.1136/annrheumdis-2018-213615; Malkiel S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00427; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Oike T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11233-w; Peeken JC, 2018, BLOOD, V131, P2065, DOI 10.1182/blood-2017-10-810622; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Syed AAS, 2020, GENES-BASEL, V11, DOI 10.3390/genes11070721; Tanaka S, 2020, NAT IMMUNOL, V21, P950, DOI 10.1038/s41590-020-0700-y; Thompson SD, 2012, ARTHRITIS RHEUM-US, V64, P2781, DOI 10.1002/art.34429; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Viscarra JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14617-1; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; Winter O, 2012, J IMMUNOL, V189, P5105, DOI 10.4049/jimmunol.1202317; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Young C, 2021, IMMUNITY, V54, P1652, DOI 10.1016/j.immuni.2021.07.015; Zhu N, 2016, J CLIN INVEST, V126, P997, DOI 10.1172/JCI82978; Zouein FA, 2011, GROWTH FACTORS, V29, P245, DOI 10.3109/08977194.2011.614949	62	2	2	9	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9					1342	+		10.1038/s41590-022-01287-y	http://dx.doi.org/10.1038/s41590-022-01287-y		AUG 2022	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O8VJ	35995859				2022-12-18	WOS:000842913200001
J	Herati, RS; Knorr, DA; Vella, LA; Silva, LV; Chilukuri, L; Apostolidis, SA; Huang, AC; Muselman, A; Manne, S; Kuthuru, O; Staupe, RP; Adamski, SA; Kannan, S; Kurupati, RK; Ertl, HCJ; Wong, JL; Bournazos, S; McGettigan, S; Schuchter, LM; Kotecha, RR; Funt, SA; Voss, MH; Motzer, RJ; Lee, CH; Bajorin, DF; Mitchell, TC; Ravetch, JV; Wherry, EJ				Herati, Ramin Sedaghat; Knorr, David A.; Vella, Laura A.; Silva, Luisa Victoria; Chilukuri, Lakshmi; Apostolidis, Sokratis A.; Huang, Alexander C.; Muselman, Alexander; Manne, Sasikanth; Kuthuru, Oliva; Staupe, Ryan P.; Adamski, Sharon A.; Kannan, Senthil; Kurupati, Raj K.; Ertl, Hildegund C. J.; Wong, Jeffrey L.; Bournazos, Stylianos; McGettigan, Suzanne; Schuchter, Lynn M.; Kotecha, Ritesh R.; Funt, Samuel A.; Voss, Martin H.; Motzer, Robert J.; Lee, Chung-Han; Bajorin, Dean F.; Mitchell, Tara C.; Ravetch, Jeffrey, V; Wherry, E. John			PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine	NATURE IMMUNOLOGY			English	Article							B-CELL SUBSETS; CD4 T-CELLS; ADVERSE EVENTS; CHECKPOINT INHIBITORS; HELPER-CELLS; SURVIVAL; AFFINITY; DIVERSIFICATION; ASSOCIATION; ANTIBODIES	Anti-programmed death-1 (anti-PD-1) immunotherapy reinvigorates CD8 T cell responses in patients with cancer but PD-1 is also expressed by other immune cells, including follicular helper CD4 T cells (Tfh) which are involved in germinal centre responses. Little is known, however, about the effects of anti-PD-1 immunotherapy on noncancer immune responses in humans. To investigate this question, we examined the impact of anti-PD-1 immunotherapy on the Tfh-B cell axis responding to unrelated viral antigens. Following influenza vaccination, a subset of adults receiving anti-PD-1 had more robust circulating Tfh responses than adults not receiving immunotherapy. PD-1 pathway blockade resulted in transcriptional signatures of increased cellular proliferation in circulating Tfh and responding B cells compared with controls. These latter observations suggest an underlying change in the Tfh-B cell and germinal centre axis in a subset of immunotherapy patients. Together, these results demonstrate dynamic effects of anti-PD-1 therapy on influenza vaccine responses and highlight analytical vaccination as an approach that may reveal underlying immune predisposition to adverse events. Patients with cancer undergoing anti-PD-1 immune checkpoint blockade can experience immune-related adverse effects. Wherry and colleagues examined the immunity elicited upon immunization of patients with cancer and report that anti-PD-1 immunotherapy dynamically affects influenza vaccine-induced immune responses.	[Herati, Ramin Sedaghat] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Knorr, David A.; Wong, Jeffrey L.; Bournazos, Stylianos; Ravetch, Jeffrey, V] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; [Knorr, David A.; Chilukuri, Lakshmi; Wong, Jeffrey L.; Kotecha, Ritesh R.; Funt, Samuel A.; Voss, Martin H.; Motzer, Robert J.; Lee, Chung-Han; Bajorin, Dean F.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Vella, Laura A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Vella, Laura A.; Silva, Luisa Victoria; Apostolidis, Sokratis A.; Huang, Alexander C.; Manne, Sasikanth; Kuthuru, Oliva; Staupe, Ryan P.; Adamski, Sharon A.; Wherry, E. John] Univ Penn, Inst Immunol, Sch Med, Philadelphia, PA 19104 USA; [Apostolidis, Sokratis A.; Huang, Alexander C.; Muselman, Alexander; McGettigan, Suzanne; Schuchter, Lynn M.; Mitchell, Tara C.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Huang, Alexander C.; McGettigan, Suzanne; Schuchter, Lynn M.; Mitchell, Tara C.] Univ Penn, Abramson Canc Ctr, Div Hematol Oncol, Sch Med, Philadelphia, PA USA; [Manne, Sasikanth; Kuthuru, Oliva; Adamski, Sharon A.; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Sch Med, Philadelphia, PA 19104 USA; [Kannan, Senthil; Kurupati, Raj K.; Ertl, Hildegund C. J.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Muselman, Alexander] Stanford Univ, Dept Immunol, Stanford, CA USA	New York University; Rockefeller University; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; The Wistar Institute; Stanford University	Herati, RS (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.; Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA.; Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Sch Med, Philadelphia, PA 19104 USA.	ramin.herati@nyulangone.org; ravetch@mail.rockefeller.edu; wherry@pennmedicine.upenn.edu		Kotecha, Ritesh/0000-0002-0223-3479; Knorr, David/0000-0002-0766-8914; Herati, Ramin/0000-0003-2613-4050	National Institutes of Health (NIH) [AI114852, AI082630, AI158617, AG047773]; Pediatric Infectious Diseases Society Fellowship Award; National Center for Advancing Translational Sciences (NCATS) [KL2TR001879, CA230157]; Parker Bridge Scholar Award [AI082630, AI155577, AI108545, AI112521, AI149680, AI117950]; US Broad Agency Announcement grant [HHSN272201100018C]; NIH [75N93021C00015]; Allen Institute for Immunology [U19-AI142737, R35-CA196620, K08-CA248966, R01-AI145870, P30-CA008748]; SPORE in Skin Cancer [P50-CA174523, P50-CA221745]; Parker Institute for Cancer Immunotherapy; NCATS Clinical and Translational Science Award (CTSA) program [UL1TR001866]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Infectious Diseases Society Fellowship Award; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Parker Bridge Scholar Award; US Broad Agency Announcement grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Institute for Immunology; SPORE in Skin Cancer; Parker Institute for Cancer Immunotherapy; NCATS Clinical and Translational Science Award (CTSA) program	We thank the participants who volunteered for our studies, as well as members of the Wherry and Ravetch laboratories who provided critical feedback in this project. This work was supported by National Institutes of Health (NIH) grants: no. AI114852 (R.S.H.), no. AI082630 (R.S.H.), no. AI158617 (R.S.H.) and no. AG047773 (R.S.H.); the Pediatric Infectious Diseases Society Fellowship Award (L.A.V.); National Center for Advancing Translational Sciences (NCATS) award no. KL2TR001879 (L.A.V.); grant no. CA230157 (A.C.H.) and the Parker Bridge Scholar Award (A.C.H.); grant nos. AI155577 (E.J.W.), AI108545 (E.J.W.), AI112521 (E.J.W.), AI082630 (E.J.W.), AI149680 (E.J.W.) and AI117950 (E.J.W.); the US Broad Agency Announcement grant no. HHSN272201100018C (to H.C.J.E. and E.J.W.), NIH contract number 75N93021C00015 (E.J.W.) and the Allen Institute for Immunology (E.J.W.); and grant nos. U19-AI142737 (J.V.R.), R35-CA196620 (J.V.R.), K08-CA248966 (D.A.K.), R01-AI145870 (J.V.R.) and P30-CA008748. Blood collection was supported by SPORE in Skin Cancer grant nos. P50-CA174523 and P50-CA221745. We thank K. Schmader and S. Doyle for their help in influenza vaccine studies. Thanks to J. Pippin and S. Grant (Children's Hospital of Philadelphia) for assistance with sequencing. We also thank the Flow Cytometry Core and the Human Immunology Core at the University of Pennsylvania for their advice and assistance in these experiments. E.J.W. is also supported by the Parker Institute for Cancer Immunotherapy which supports the cancer immunology program at UPenn. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The project described was also supported in part by grant no. UL1TR001866 from NCATS Clinical and Translational Science Award (CTSA) program. The following reagent was obtained through BEI Resources, NIAID, NIH: Influenza B Virus, B/Brisbane/33/2008 (Victoria Lineage), NR-42006.	Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Bayle A, 2020, ANN ONCOL, V31, P959, DOI 10.1016/j.annonc.2020.03.290; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bersanelli M, 2018, IMMUNOTHERAPY-UK, V10, P1229, DOI 10.2217/imt-2018-0080; Bournazos S, 2021, SCIENCE, V372, P1102, DOI 10.1126/science.abc7303; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Chong CR, 2020, CLIN INFECT DIS, V70, P193, DOI 10.1093/cid/ciz202; Cox RJ, 2013, HUM VACC IMMUNOTHER, V9, P405, DOI 10.4161/hv.22908; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Das R, 2018, J CLIN INVEST, V128, P715, DOI 10.1172/JCI96798; DeDiego ML, 2019, J VIROL, V93, DOI 10.1128/JVI.01159-19; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Failing JJ, 2020, JCO ONCOL PRACT, V16, P375, DOI 10.1200/JOP.19.00495; Freeman-Keller M, 2016, CLIN CANCER RES, V22, P886, DOI 10.1158/1078-0432.CCR-15-1136; Gallo P., 2017, MULT SCLER DEMYELINA, V2, P7, DOI [10.1186/s40893-017-0024-4, DOI 10.1186/S40893-017-0024-4]; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Grangeon M, 2019, CLIN LUNG CANCER, V20, P201, DOI 10.1016/j.cllc.2018.10.002; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Haratani K, 2018, JAMA ONCOL, V4, P374, DOI 10.1001/jamaoncol.2017.2925; Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Herati RS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100262; Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152; Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Ishihara H, 2019, UROL ONCOL-SEMIN ORI, V37, DOI 10.1016/j.urolonc.2019.03.003; Jing Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18742-9; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kennedy LB, 2019, ONCOL THER, V7, P101, DOI 10.1007/s40487-019-0096-8; Krammer F, 2019, NAT REV IMMUNOL, V19, P383, DOI 10.1038/s41577-019-0143-6; Laubli H, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0353-7; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Martinov T, 2019, J IMMUNOL, V203, P844, DOI 10.4049/jimmunol.1801535; Mimitou EP, 2019, NAT METHODS, V16, P409, DOI 10.1038/s41592-019-0392-0; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Ricciuti B, 2019, J CANCER RES CLIN, V145, P479, DOI 10.1007/s00432-018-2805-3; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sage PT, 2014, J CLIN INVEST, V124, P5191, DOI 10.1172/JCI76861; Sanmamed MF, 2021, CANCER DISCOV, V11, P1700, DOI 10.1158/2159-8290.CD-20-0962; Sato K, 2018, LUNG CANCER, V115, P71, DOI 10.1016/j.lungcan.2017.11.019; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Turner JS, 2020, NATURE, V586, P127, DOI 10.1038/s41586-020-2711-0; Vella LA, 2019, J CLIN INVEST, V129, P3185, DOI 10.1172/JCI125628; Verzoni E, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0579-z; Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5; Wang TT, 2019, J CLIN INVEST, V129, P3492, DOI 10.1172/JCI130029; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Weinmann SC, 2019, RHEUMATOLOGY, V58, P59, DOI 10.1093/rheumatology/kez308; Wijn DH, 2018, EUR J CANCER, V104, P182, DOI 10.1016/j.ejca.2018.09.012; Willsmore ZN, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.622442; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yang E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.605024; Zhang Sheng, 2005, J Biomol Tech, V16, P209; Zhang S, 2012, PROTEOMICS, V12, P1269, DOI 10.1002/pmic.201100474; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	66	2	2	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1183	+		10.1038/s41590-022-01274-3	http://dx.doi.org/10.1038/s41590-022-01274-3		JUL 2022	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35902637	Bronze			2022-12-18	WOS:000832482500001
J	Horsnell, HL; Tetley, RJ; De Belly, H; Makris, S; Millward, LJ; Benjamin, AC; Heeringa, LA; de Winde, CM; Paluch, EK; Mao, YL; Acton, SE				Horsnell, Harry L.; Tetley, Robert J.; De Belly, Henry; Makris, Spyridon; Millward, Lindsey J.; Benjamin, Agnesska C.; Heeringa, Lucas A.; de Winde, Charlotte M.; Paluch, Ewa K.; Mao, Yanlan; Acton, Sophie E.			Lymph node homeostasis and adaptation to immune challenge resolved by fibroblast network mechanics	NATURE IMMUNOLOGY			English	Article							RETICULAR CELLS; MEMBRANE TENSION; DENDRITIC CELLS; PODOPLANIN; SYSTEM; PROLIFERATION; ACTIVATION; MIGRATION; INTEGRITY; DYNAMICS	Acton and colleagues examine the mechanics of lymph node swelling during the course of an immune response. They find tissue tension regulates fibroblastic reticular cell (FRC) proliferation during lymph node expansion and that podoplanin (PDPN)-CLEC-2 signaling in FRCs regulates this process, which in turn regulates T cell activation. Emergent physical properties of tissues are not readily understood by reductionist studies of their constituent cells. Here, we show molecular signals controlling cellular, physical, and structural properties and collectively determine tissue mechanics of lymph nodes, an immunologically relevant adult tissue. Lymph nodes paradoxically maintain robust tissue architecture in homeostasis yet are continually poised for extensive expansion upon immune challenge. We find that in murine models of immune challenge, cytoskeletal mechanics of a cellular meshwork of fibroblasts determine tissue tension independently of extracellular matrix scaffolds. We determine that C-type lectin-like receptor 2 (CLEC-2)-podoplanin signaling regulates the cell surface mechanics of fibroblasts, providing a mechanically sensitive pathway to regulate lymph node remodeling. Perturbation of fibroblast mechanics through genetic deletion of podoplanin attenuates T cell activation. We find that increased tissue tension through the fibroblastic stromal meshwork is required to trigger the initiation of fibroblast proliferation and restore homeostatic cellular ratios and tissue structure through lymph node expansion.	[Horsnell, Harry L.; Makris, Spyridon; Millward, Lindsey J.; Benjamin, Agnesska C.; Heeringa, Lucas A.; de Winde, Charlotte M.; Acton, Sophie E.] UCL, MRC Lab Mol Cell Biol, Stromal Immunol Grp, London, England; [Tetley, Robert J.; Mao, Yanlan] UCL, MRC Lab Mol Cell Biol, Tissue Mech Grp, London, England; [De Belly, Henry; Paluch, Ewa K.] Univ Cambridge, Dept Physiol Dev & Neurosci, Physiol Lab, Cambridge, England; [Mao, Yanlan] UCL, Inst Phys Living Syst, London, England	MRC Laboratory Molecular Biology; University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; University of Cambridge; University of London; University College London	Acton, SE (corresponding author), UCL, MRC Lab Mol Cell Biol, Stromal Immunol Grp, London, England.	s.acton@ucl.ac.uk		Horsnell, Harry Lloyd/0000-0002-4321-6958	European Research Council Starting Grant (LNEXPANDS); Cancer Research UK Careers Development Fellowship [CRUK-A19763]; Medical Research Council [MC-U12266B]; MRC [MR/L009056/1, MR/T031646/1]; Lister Institute Research Prize; EMBO Young Investigator Programme; European Union [641639]; Medical Research Council UK (MRC) [MC_UU_12018/5]	European Research Council Starting Grant (LNEXPANDS); Cancer Research UK Careers Development Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute Research Prize; EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); European Union(European Commission); Medical Research Council UK (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a European Research Council Starting Grant (LNEXPANDS; to S.E.A.), a Cancer Research UK Careers Development Fellowship (CRUK-A19763; to S.E.A.), the Medical Research Council (MC-U12266B), MRC awards MR/L009056/1 and MR/T031646/1 (Y.M.), a Lister Institute Research Prize and the EMBO Young Investigator Programme (Y.M.), the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement 641639 (ITN Biopol, E.K.P.), and the Medical Research Council UK (MRC program award MC_UU_12018/5 (E.K.P.). We thank E. Sahai, G. Charras, and V. G. Martinez for critical reading of the manuscript. We also thank H. Clevers for supplying R26R-confetti mice and S. Watson and C. Buckley for providing the PDPNfl/fl mouse model.	Acton SE, 2021, TRENDS IMMUNOL, V42, P782, DOI 10.1016/j.it.2021.07.003; Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Belanger MC, 2021, ACS PHARMACOL TRANSL, V4, P128, DOI 10.1021/acsptsci.0c00143; Bozdag E., 2018, METHODS PROTOCOLS, V1763; Cadart C, 2019, NAT PHYS, V15, P993, DOI 10.1038/s41567-019-0629-y; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; De Belly H, 2022, NAT REV MOL CELL BIO, V23, P465, DOI 10.1038/s41580-022-00472-z; De Belly H, 2021, CELL STEM CELL, V28, P273, DOI 10.1016/j.stem.2020.10.018; de Winde CM, 2021, J CELL SCI, V134, DOI 10.1242/jcs.258610; Diz-Munoz A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002474; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Duda M, 2019, DEV CELL, V48, P245, DOI 10.1016/j.devcel.2018.12.020; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Etienne J, 2015, P NATL ACAD SCI USA, V112, P2740, DOI 10.1073/pnas.1417113112; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Groff BD, 2019, J IMMUNOL METHODS, V464, P119, DOI 10.1016/j.jim.2018.10.010; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hoshino K, 2018, SOFT MATTER, V14, P9693, DOI 10.1039/c8sm01854e; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kim Joo-Il, 2018, Lab Anim Res, V34, P166, DOI 10.5625/lar.2018.34.4.166; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02460-2; Lowe KL, 2015, BLOOD, V125, P3769, DOI 10.1182/blood-2014-09-603803; Makris S, 2022, DIS MODEL MECH, V15, DOI 10.1242/dmm.049256; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mandl JN, 2012, P NATL ACAD SCI USA, V109, P18036, DOI 10.1073/pnas.1211717109; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Martinez VG, 2019, CELL REP, V29, P2810, DOI 10.1016/j.celrep.2019.10.103; Matthews HK, 2020, DEV CELL, V52, P563, DOI 10.1016/j.devcel.2020.01.004; McGinn J, 2021, NAT CELL BIOL, V23, P511, DOI 10.1038/s41556-021-00679-w; Novkovic M, 2020, CELL REP, V30, P893, DOI 10.1016/j.celrep.2019.12.070; Novkovic M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002515; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Petridou NI, 2017, NAT CELL BIOL, V19, P581, DOI 10.1038/ncb3524; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Torrino S, 2018, J CELL BIOL, V217, P4092, DOI 10.1083/jcb.201801122; Wyatt T, 2016, CURR OPIN CELL BIOL, V38, P68, DOI 10.1016/j.ceb.2016.02.012; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	55	2	2	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1169	+		10.1038/s41590-022-01272-5	http://dx.doi.org/10.1038/s41590-022-01272-5		JUL 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35882934	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000830286700004
J	Shan, Q; Zhu, SQ; Chen, X; Liu, J; Yuan, S; Li, X; Peng, WQ; Xue, HH				Shan, Qiang; Zhu, Shaoqi; Chen, Xia; Liu, Jia; Yuan, Shuang; Li, Xiang; Peng, Weiqun; Xue, Hai-Hui			Tcf1-CTCF cooperativity shapes genomic architecture to promote CD8(+) T cell homeostasis	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; CTCF; NAIVE; TCF-1; GENE; CHROMATIN; ELEMENTS; TOPOLOGY; REGULATOR	CD8(+) T cell homeostasis is maintained by the cytokines IL-7 and IL-15. Here we show that transcription factors Tcf1 and Lef1 were intrinsically required for homeostatic proliferation of CD8(+) T cells. Multiomics analyses showed that Tcf1 recruited the genome organizer CTCF and that homeostatic cytokines induced Tcf1-dependent CTCF redistribution in the CD8(+) T cell genome. Hi-C coupled with network analyses indicated that Tcf1 and CTCF acted cooperatively to promote chromatin interactions and form highly connected, dynamic interaction hubs in CD8(+) T cells before and after cytokine stimulation. Ablating CTCF phenocopied the proliferative defects caused by Tcf1 and Lef1 deficiency. Tcf1 and CTCF controlled a similar set of genes that regulated cell cycle progression and promoted CD8(+) T cell homeostatic proliferation in vivo. These findings identified CTCF as a Tcf1 cofactor and uncovered an intricate interplay between Tcf1 and CTCF that modulates the genomic architecture of CD8(+) T cells to preserve homeostasis. Xue and colleagues show that Tcf1 and Lef1 recruit the genome organizer CTCF to promote chromatin interactions and form highly connected, dynamic interaction hubs in CD8(+) T cells undergoing homeostatic proliferation.	[Shan, Qiang; Chen, Xia; Liu, Jia; Xue, Hai-Hui] Hackensack Univ, Ctr Discovery & Innovat, Med Ctr, Nutley, NJ 07110 USA; [Zhu, Shaoqi; Yuan, Shuang; Li, Xiang; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Xue, Hai-Hui] New Jersey Vet Affairs Hlth Care Syst, E Orange, NJ 07018 USA	Hackensack University Medical Center; George Washington University	Xue, HH (corresponding author), Hackensack Univ, Ctr Discovery & Innovat, Med Ctr, Nutley, NJ 07110 USA.; Peng, WQ (corresponding author), George Washington Univ, Dept Phys, Washington, DC 20052 USA.; Xue, HH (corresponding author), New Jersey Vet Affairs Hlth Care Syst, E Orange, NJ 07018 USA.	wpeng@gwu.edu; haihui.xue@hmh-cdi.org		Li, Xiang/0000-0002-8931-3681; Yuan, Shuang/0000-0002-3147-4263; Xue, Hai-Hui/0000-0002-9163-7669; Peng, Weiqun/0000-0001-5521-9091	National Institutes of Health [AI112579, AI121080, AI139874]; Veteran Affairs [BX005771]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs	We thank the University of Iowa Flow Cytometry Core facility (J. Fishbaugh, H. Vignes and G. Rasmussen) and the HMH-CDI Flow Cytometry Core facility (M. Poulus and W. Tsao) for cell sorting and S. Xing for his contribution during the early phase of this study. We thank N. Galjart (Erasmus Medical Center, Netherlands) for permission to use the Ctcf-floxed mouse strain and A.M. Melnick and M.A. Rivas (Weill Cornell Medical College) for providing the mice. This study is supported in part by grants from the National Institutes of Health (AI112579 to H.-H.X., AI121080 and AI139874 to H.-H.X. and W.P.) and the Veteran Affairs (BX005771 to H.-H.X.).	Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Canela A, 2017, CELL, V170, P507, DOI 10.1016/j.cell.2017.06.034; Chisolm DA, 2017, IMMUNITY, V47, P251, DOI 10.1016/j.immuni.2017.07.015; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Emmanuel AO, 2018, NAT IMMUNOL, V19, P1366, DOI 10.1038/s41590-018-0254-4; Fang C, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02152-7; Fang DF, 2018, J EXP MED, V215, P1449, DOI 10.1084/jem.20171127; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Gong YX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03017-1; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Gullicksrud Jodi A, 2017, [Frontiers in Biology, 生物学前沿], V12, P83; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Hu YG, 2016, GENE DEV, V30, P1971, DOI 10.1101/gad.283762.116; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li F., P NATL ACAD SCI USA, DOI [10.1073/pnas.2014562118(2021, DOI 10.1073/PNAS.2014562118(2021]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li X., BIORXIV, DOI [10.1101/2022.04.16.488566(2022, DOI 10.1101/2022.04.16.488566(2022]; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Madsen JGS, 2020, NAT GENET, V52, P1227, DOI 10.1038/s41588-020-0709-z; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nishimura H, 2005, J IMMUNOL, V175, P4627, DOI 10.4049/jimmunol.175.7.4627; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Piazza R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04462-8; Pongubala JMR, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.633825; Qi Q, 2021, BLOOD, V137, P1327, DOI 10.1182/blood.2020005780; Ren G, 2017, MOL CELL, V67, P1049, DOI 10.1016/j.molcel.2017.08.026; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shan Q, 2022, NAT IMMUNOL, V23, P386, DOI 10.1038/s41590-022-01131-3; Shan Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26159-1; Shan Q, 2021, CELL MOL IMMUNOL, V18, P1262, DOI 10.1038/s41423-020-0436-5; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Shi HX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21711-5; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Velardi E, 2021, NAT REV IMMUNOL, V21, P277, DOI 10.1038/s41577-020-00457-z; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Xue HH, 2012, ANN NY ACAD SCI, V1247, P16, DOI 10.1111/j.1749-6632.2011.06302.x; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao X, 2020, ELIFE, V9, DOI 10.7554/eLife.55360; Zhao XD, 2022, NAT REV IMMUNOL, V22, P147, DOI 10.1038/s41577-021-00563-6; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	66	2	2	6	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1222	+		10.1038/s41590-022-01263-6	http://dx.doi.org/10.1038/s41590-022-01263-6		JUL 2022	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35882936				2022-12-18	WOS:000830286700002
J	Ming, QQ; Celias, DP; Wu, C; Cole, AR; Singh, S; Mason, C; Dong, S; Tran, TH; Amarasinghe, GK; Ruffell, B; Luca, VC				Ming, Qianqian; Celias, Daiana P.; Wu, Chao; Cole, Aidan R.; Singh, Srishti; Mason, Charlotte; Dong, Shen; Tran, Timothy H.; Amarasinghe, Gaya K.; Ruffell, Brian; Luca, Vincent C.			LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition	NATURE IMMUNOLOGY			English	Article							MHC CLASS-II; T-CELLS; CRYSTAL-STRUCTURE; IMMUNE-RESPONSES; ACTIVATION; PROTEIN; CD4; INTEGRATION; RESIDUES; BINDING	The immune checkpoint receptor lymphocyte activation gene 3 protein (LAG3) inhibits T cell function upon binding to major histocompatibility complex class II (MHC class II) or fibrinogen-like protein 1 (FGL1). Despite the emergence of LAG3 as a target for next-generation immunotherapies, we have little information describing the molecular structure of the LAG3 protein or how it engages cellular ligands. Here we determined the structures of human and murine LAG3 ectodomains, revealing a dimeric assembly mediated by Ig domain 2. Epitope mapping indicates that a potent LAG3 antagonist antibody blocks interactions with MHC class II and FGL1 by binding to a flexible 'loop 2' region in LAG3 domain 1. We also defined the LAG3-FGL1 interface by mapping mutations onto structures of LAG3 and FGL1 and established that FGL1 cross-linking induces the formation of higher-order LAG3 oligomers. These insights can guide LAG3-based drug development and implicate ligand-mediated LAG3 clustering as a mechanism for disrupting T cell activation. LAG3 inhibits T cell activation, but exactly how it does so has been unclear given a lack of structural information. Here the authors provide the crystal structure of the human and mouse LAG3 ectodomains, showing how they interact with known ligands and antibodies.	[Ming, Qianqian; Singh, Srishti; Mason, Charlotte; Luca, Vincent C.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33607 USA; [Celias, Daiana P.; Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA; [Wu, Chao; Cole, Aidan R.; Amarasinghe, Gaya K.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Dong, Shen] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Tran, Timothy H.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Washington University (WUSTL); University of California System; University of California San Francisco; H Lee Moffitt Cancer Center & Research Institute	Luca, VC (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33607 USA.	vince.luca@moffitt.org	WU, CHAO/J-7119-2019	WU, CHAO/0000-0002-9342-1968; Celias, Daiana/0000-0002-5122-6718	V Scholar grant from the V Foundation; Rita Allen Scholars grant; NIH [P01AI120943, R35GM133482]; NIH/National Cancer Institute [R01CA230610]; Moffitt Cancer Center Support NIH [P30CA076292]	V Scholar grant from the V Foundation; Rita Allen Scholars grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Cancer Center Support NIH	We thank the staff at the 23-ID-D, 22-ID and 19-ID beamlines of the Advanced Photon Source for assistance with remote X-ray data collection. We thank D. Gonzalez-Perez and E. Medina for proofreading and thoughtful comments. The following reagents were obtained through the NIH Tetramer Core Facility: biotinylated MHCII proteins including I-A(b)<SUP>MOG</SUP>, I-A(b)<SUP>CLIP</SUP>, I-A(d)<SUP>CLIP</SUP>, I-A(g7)<SUP>CLIP</SUP> and I-E(k)<SUP>CLIP</SUP>, HLA-DR4<SUP>CLIP</SUP>, HLA-DP2<SUP>CLIP</SUP> and HLA-DQ2<SUP>CLIP</SUP>. V.C.L., Q.M., S.S. and C.M. are supported by a V Scholar grant from the V Foundation, a Rita Allen Scholars grant and NIH grant no. R35GM133482. G.K.A., C.W. and A.C. are supported by NIH grant no. P01AI120943. B.R. is supported by an NIH/National Cancer Institute grant no. R01CA230610. Support for T.H.T. and shared resources were provided by a Moffitt Cancer Center Support NIH grant no. P30CA076292.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andrews LP, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc2728; Angin M, 2020, J IMMUNOL, V204, P810, DOI 10.4049/jimmunol.1900823; [Anonymous], 2014, PYMOL MOL GRAPHICS S; Ascione A, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-019-0559-x; Bhagwat B, 2018, J IMMUNOL METHODS, V456, P7, DOI 10.1016/j.jim.2018.02.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freed DM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8380; Grandal M. M., 2019, WIPO (PCT) patent, Patent No. [US20220056126A3, 20220056126]; Graydon CG, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.615317; Grebinoski S, 2020, CURR OPIN IMMUNOL, V67, P1, DOI 10.1016/j.coi.2020.06.001; GUY HR, 1985, BIOPHYS J, V47, P61, DOI 10.1016/S0006-3495(85)83877-7; Hannier S, 1998, J IMMUNOL, V161, P4058; Hoffmann-La Roche, OP LAB MULT DOS ESC; Holling TM, 2004, BLOOD, V103, P1438, DOI 10.1182/blood-2003-05-1491; Honorato RV, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.729513; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Incyte Corporation, PHAS 1 2 STUD COMB T; Iouzalen N, 2001, EUR J IMMUNOL, V31, P2885, DOI 10.1002/1521-4141(2001010)31:10<2885::AID-IMMU2885>3.0.CO;2-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadowaki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11639; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lecocq Q, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010075; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Leppanen VM, 2017, P NATL ACAD SCI USA, V114, P4376, DOI 10.1073/pnas.1616166114; Li NY, 2004, J IMMUNOL, V173, P6806, DOI 10.4049/jimmunol.173.11.6806; Liu ZL, 2008, BIOCHEM BIOPH RES CO, V365, P729, DOI 10.1016/j.bbrc.2007.11.069; Lui Y, 2018, NAT IMMUNOL, V19, P1278, DOI 10.1038/s41590-018-0257-1; MacLachlan BJ, 2021, EUR J IMMUNOL, V51, P331, DOI 10.1002/eji.202048753; Maeda TK, 2019, J BIOL CHEM, V294, P6017, DOI 10.1074/jbc.RA119.007455; Mao, 2021, BIORXIV, DOI [10.1101/2021.05.01.442157, DOI 10.1101/2021.05.01.442157]; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Maruhashi T, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001014; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; Miceli M C, 1991, Semin Immunol, V3, P133; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mohan K, 2019, SCIENCE, V364, P750, DOI 10.1126/science.aav7532; Moore JO, 2017, P NATL ACAD SCI USA, V114, P4382, DOI 10.1073/pnas.1617800114; Multiple Myeloma Research Consortium, PHAS 1 2 ASS COMB IM; Nagdas SK, 2016, INT J BIOCHEM CELL B, V80, P163, DOI 10.1016/j.biocel.2016.10.008; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Ohmura T, 2001, PROTEIN ENG, V14, P421, DOI 10.1093/protein/14.6.421; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen TR, 2004, EUR J IMMUNOL, V34, P165, DOI 10.1002/eji.200324669; Robert C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17670-y; Shrive AK, 2014, J BIOL CHEM, V289, P2880, DOI 10.1074/jbc.M113.520577; Su LF, 2016, P NATL ACAD SCI USA, V113, pE6192, DOI 10.1073/pnas.1611723113; Takamatsu K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25865-0; Tawbi HA, 2022, NEW ENGL J MED, V386, P24, DOI 10.1056/NEJMoa2109970; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; WEBER S, 1993, INT IMMUNOL, V5, P695, DOI 10.1093/intimm/5.6.695; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Xu F, 2014, CANCER RES, V74, P3418, DOI 10.1158/0008-5472.CAN-13-2690; Yap TA, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.TPS2652; Zhang QX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah4569; Zhang SN, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2011196118	69	2	2	11	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1031	+		10.1038/s41590-022-01238-7	http://dx.doi.org/10.1038/s41590-022-01238-7		JUN 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35761082				2022-12-18	WOS:000817057200008
J	Oikonomou, V; Lionakis, MS				Oikonomou, Vasileios; Lionakis, Michail S.			Extrathymic Aire primes Candida-specific T(H)17 cells	NATURE IMMUNOLOGY			English	Editorial Material							AUTOIMMUNE REGULATOR; LESSONS	Extrathymic MHCII(+)Rorc(+) Aire-expressing cells that share characteristics with type 3 innate lymphoid cells (ILC3s) internalize C. albicans and present its antigens, priming the development of Candida-specific T(H)17 cells.	[Oikonomou, Vasileios; Lionakis, Michail S.] NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lionakis, MS (corresponding author), NIAID, Fungal Pathogenesis Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lionakism@mail.nih.gov		Oikonomou, Vasileios/0000-0002-7553-0159	Division of Intramural Research of the NIAID [ZIA AI001175]	Division of Intramural Research of the NIAID	This work was supported by the Division of Intramural Research of the NIAID (ZIA AI001175 to M.S.L.).	Break TJ, 2021, SCIENCE, V371, P252, DOI 10.1126/science.aay5731; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Constantine GM, 2019, IMMUNOL REV, V287, P103, DOI 10.1111/imr.12714; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Dobes J, 2022, NAT IMMUNOL, V23, P1098, DOI 10.1038/s41590-022-01247-6; Fergusson JR, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02902; Gillis-Buck E, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf1968; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Lionakis MS, 2018, ANNU REV IMMUNOL, V36, P157, DOI 10.1146/annurev-immunol-042617-053318; Poliani PL, 2010, AM J PATHOL, V176, P1104, DOI 10.2353/ajpath.2010.090956; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Wang JX, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl5053; Yamano T, 2019, J EXP MED, V216, P1027, DOI 10.1084/jem.20181430	14	2	2	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					997	999		10.1038/s41590-022-01252-9	http://dx.doi.org/10.1038/s41590-022-01252-9		JUN 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35761087				2022-12-18	WOS:000817057200004
J	Galvez-Cancino, F; Lladser, A; Quezada, SA				Galvez-Cancino, Felipe; Lladser, Alvaro; Quezada, Sergio A.			Deciphering immunoregulatory vulnerabilities in human cancers	NATURE IMMUNOLOGY			English	Editorial Material								Regulatory T cells that express high levels of IL-1R and ICOS display transcriptional features of antigen specificity, are highly suppressive and distinguish tumors from non-malignant inflamed tissues	[Galvez-Cancino, Felipe; Quezada, Sergio A.] UCL, Dept Res Haematol, Canc Immunol Unit, Inst Canc, London, England; [Lladser, Alvaro] Fdn Ciencia & Vida, Ctr Cient & Tecnol Excelencia Ciencia & Vida, Santiago, Chile; [Lladser, Alvaro] Univ San Sebastian, Fac Med & Ciencia, Santiago, Chile	University of London; University College London; Universidad San Sebastian	Quezada, SA (corresponding author), UCL, Dept Res Haematol, Canc Immunol Unit, Inst Canc, London, England.; Lladser, A (corresponding author), Fdn Ciencia & Vida, Ctr Cient & Tecnol Excelencia Ciencia & Vida, Santiago, Chile.; Lladser, A (corresponding author), Univ San Sebastian, Fac Med & Ciencia, Santiago, Chile.	alladser@cienciavida.org; s.quezada@ucl.ac.uk		Quezada, Sergio/0000-0002-9763-1700				Ahmadzadeh M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aao4310; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138; Greene E, 2021, PATTERNS, V2, DOI 10.1016/j.patter.2021.100372; Jain A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05489-7; Kidani Y, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2114282119; Mair F, 2022, NATURE, V605, P728, DOI 10.1038/s41586-022-04718-w; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Solomon I, 2020, NAT CANCER, V1, P1153, DOI 10.1038/s43018-020-00133-0	10	2	2	9	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					995	996		10.1038/s41590-022-01251-w	http://dx.doi.org/10.1038/s41590-022-01251-w		JUN 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35726061				2022-12-18	WOS:000813680500002
J	Wang, WL; Chandra, A; Goldman, N; Yoon, S; Ferrari, EK; Nguyen, SC; Joyce, EF; Vahedi, G				Wang, Wenliang; Chandra, Aditi; Goldman, Naomi; Yoon, Sora; Ferrari, Emily K.; Nguyen, Son. C.; Joyce, Eric F.; Vahedi, Golnaz			TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; LINEAGE COMMITMENT; GENOME TOPOLOGY; IN-VIVO; DNA; EXPRESSION; PLATFORM; BINDING; TRANSFORMATION; IDENTITY	The high mobility group (HMG) transcription factor TCF-1 is essential for early T cell development. Although in vitro biochemical assays suggest that HMG proteins can serve as architectural elements in the assembly of higher-order nuclear organization, the contribution of TCF-1 on the control of three-dimensional (3D) genome structures during T cell development remains unknown. Here, we investigated the role of TCF-1 in 3D genome reconfiguration. Using gain- and loss-of-function experiments, we discovered that the co-occupancy of TCF-1 and the architectural protein CTCF altered the structure of topologically associating domains in T cell progenitors, leading to interactions between previously insulated regulatory elements and target genes at late stages of T cell development. The TCF-1-dependent gain in long-range interactions was linked to deposition of active enhancer mark H3K27ac and recruitment of the cohesin-loading factor NIPBL at active enhancers. These data indicate that TCF-1 has a role in controlling global genome organization during T cell development. Vahedi and colleagues show that TCF-1 promotes T cell development by minimizing the spatial distance between regulatory elements that are located within insulated neighborhoods in progenitor cells and are required for the expression of T cell genes.	[Wang, Wenliang; Chandra, Aditi; Goldman, Naomi; Yoon, Sora; Ferrari, Emily K.; Nguyen, Son. C.; Joyce, Eric F.; Vahedi, Golnaz] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Wenliang; Chandra, Aditi; Goldman, Naomi; Yoon, Sora; Ferrari, Emily K.; Vahedi, Golnaz] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Wenliang; Chandra, Aditi; Goldman, Naomi; Yoon, Sora; Ferrari, Emily K.; Nguyen, Son. C.; Joyce, Eric F.; Vahedi, Golnaz] Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Wenliang; Chandra, Aditi; Goldman, Naomi; Yoon, Sora; Ferrari, Emily K.; Vahedi, Golnaz] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vahedi, Golnaz] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Vahedi, G (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	vahedi@pennmedicine.upenn.edu		Nguyen, Son/0000-0003-2187-1027; Vahedi, Golnaz/0000-0002-2249-8247; Yoon, Sora/0000-0002-0107-0057; Ferrari, Emily/0000-0002-1453-9432	National Institutes of Health [UC4 DK112217, U01DK112217, R01HL145754, U01DK127768, U01DA052715]; Burroughs Wellcome Fund; Chan Zuckerberg Initiative; W. W. Smith Charitable Trust; Penn Epigenetics Institute pilot; Sloan Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Chan Zuckerberg Initiative; W. W. Smith Charitable Trust; Penn Epigenetics Institute pilot; Sloan Foundation(Alfred P. Sloan Foundation)	We thank R. B. Faryabi, K. Zaret, A. Karnay, E. J. Wherry and R. Jain for helpful discussions. We thank J. Shi and his laboratory for help and discussion about the CRISPR/Cas9 plasmids. This work was supported by National Institutes of Health grants UC4 DK112217, U01DK112217, R01HL145754, U01DK127768 and U01DA052715, the Burroughs Wellcome Fund, the Chan Zuckerberg Initiative, W. W. Smith Charitable Trust, the Penn Epigenetics Institute pilot and the Sloan Foundation awards to G.V.	Abdennur N, 2020, BIOINFORMATICS, V36, P311, DOI 10.1093/bioinformatics/btz540; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antoszewski M, 2022, BLOOD, V139, P2483, DOI 10.1182/blood.2021012077; Beagan JA, 2020, NAT NEUROSCI, V23, P707, DOI 10.1038/s41593-020-0634-6; Beagan JA, 2020, NAT GENET, V52, P8, DOI 10.1038/s41588-019-0561-1; Beliveau BJ, 2018, P NATL ACAD SCI USA, V115, pE2183, DOI 10.1073/pnas.1714530115; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carleton M, 1999, J IMMUNOL, V163, P2576; Chen ZY, 2021, CELL, V184, P1262, DOI 10.1016/j.cell.2021.02.019; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dekker J, 2017, NATURE, V549, P219, DOI 10.1038/nature23884; Di Giammartino DC, 2019, NAT CELL BIOL, V21, P1179, DOI 10.1038/s41556-019-0390-6; Dionne CJ, 2005, DEV BIOL, V280, P448, DOI 10.1016/j.ydbio.2005.01.027; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Emmanuel AO, 2018, NAT IMMUNOL, V19, P1366, DOI 10.1038/s41590-018-0254-4; Eres IE, 2021, TRENDS GENET, V37, P216, DOI 10.1016/j.tig.2020.10.009; Fasolino M, 2020, IMMUNITY, V52, P257, DOI 10.1016/j.immuni.2020.01.003; Flyamer IM, 2020, BIOINFORMATICS, V36, P2980, DOI 10.1093/bioinformatics/btaa073; Forcato M, 2017, NAT METHODS, V14, P679, DOI 10.1038/nmeth.4325; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Hansen AS, 2020, NUCLEUS-PHILA, V11, P132, DOI 10.1080/19491034.2020.1782024; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Johanson TM, 2018, NAT IMMUNOL, V19, P1257, DOI 10.1038/s41590-018-0234-8; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Kloetgen A, 2020, NAT GENET, V52, P388, DOI 10.1038/s41588-020-0602-9; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lareau CA, 2018, NAT METHODS, V15, P155, DOI 10.1038/nmeth.4583; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Moffitt JR, 2016, METHOD ENZYMOL, V572, P1, DOI 10.1016/bs.mie.2016.03.020; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ogilvy S, 1999, BLOOD, V94, P1855; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Petela NJ, 2018, MOL CELL, V70, P1134, DOI 10.1016/j.molcel.2018.05.022; Petrovic J, 2019, MOL CELL, V73, P1174, DOI 10.1016/j.molcel.2019.01.006; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rosin LF, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007393; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Shan Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26159-1; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Singh H, 2014, TRENDS IMMUNOL, V35, P211, DOI 10.1016/j.it.2014.03.006; Stadhouders R, 2019, NATURE, V569, P345, DOI 10.1038/s41586-019-1182-7; Stadhouders R, 2018, NAT GENET, V50, P238, DOI 10.1038/s41588-017-0030-7; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Wolff J, 2018, NUCLEIC ACIDS RES, V46, pW11, DOI 10.1093/nar/gky504; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yoon S, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29258-9; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou YQ, 2022, MOL CELL, V82, P1003, DOI 10.1016/j.molcel.2022.01.015; ZHOU YY, 2019, NAT COMMUN, V10, DOI DOI 10.1038/S41467-019-09234-6; Zhu YN, 2021, GENE DEV, V35, P65, DOI 10.1101/gad.343475.120	79	2	2	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1052	+		10.1038/s41590-022-01232-z	http://dx.doi.org/10.1038/s41590-022-01232-z		JUN 2022	37	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35726060	Green Accepted			2022-12-18	WOS:000813680500003
J	Breed, ER; Voboril, M; Ashby, KM; Martinez, RJ; Qian, L; Wang, HG; Salgado, OC; O'Connor, CH; Hogquist, KA				Breed, Elise R.; Voboril, Matous; Ashby, Katherine M.; Martinez, Ryan J.; Qian, Lily; Wang, Haiguang; Salgado, Oscar C.; O'Connor, Christine H.; Hogquist, Kristin A.			Type 2 cytokines in the thymus activate Sirp alpha(+) dendritic cells to promote clonal deletion	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; NEGATIVE SELECTION; SELF-TOLERANCE; CUTTING EDGE; INKT CELLS; THYMOCYTES; EXPRESSION; REPERTOIRE; SUBSETS; INNATE	Breed et al. identify a subset of thymic SIRP alpha(+) cDC2 dendritic cells that express CD301b, induced by type II cytokines, and high amounts of MHC-II. They find that the deletion of these cells can alter thymic CD4-single-positive repertoires, suggesting that they contribute to thymic tolerance. The thymus contains a diversity of dendritic cells (DCs) that exist in defined locations and have different antigen-processing and -presenting features. This suggests that they play nonredundant roles in mediating thymocyte selection. In an effort to eliminate SIRP alpha(+) classic DC2 subsets, we discovered that a substantial proportion expresses the surface lectin, CD301b, in the thymus. These cells resemble the CD301b(+) type 2 immune response promoting DCs that are present in the skin-draining lymph nodes. Transcriptional and phenotypic comparison to other DC subsets in the thymus revealed that thymic CD301b(+) cDCs represent an activated state that exhibits enhanced antigen processing and presentation. Furthermore, a CD301b(+) cDC2 subset demonstrated a type 2 cytokine signature and required steady-state interleukin-4 receptor signaling. Selective ablation of CD301b(+) cDC2 subsets impaired clonal deletion without affecting regulatory T cells (T-reg cells). The T cell receptor alpha repertoire sequencing confirmed that a cDC2 subset promotes deletion of conventional T cells with minimal effect on T-reg cell selection. Together, these findings suggest that cytokine-induced activation of DCs in the thymus substantially enforces central tolerance.	[Breed, Elise R.; Voboril, Matous; Ashby, Katherine M.; Martinez, Ryan J.; Qian, Lily; Wang, Haiguang; Salgado, Oscar C.; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [O'Connor, Christine H.] Minnesota Supercomp Inst, Lab Med & Pathol Grp, Res Informat Solut, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu		Voboril, Matous/0000-0002-3672-7629	National Institutes of Health [R37 AI39560, P01 AI35296, T32 AI007313, F30 AI131483, T32 GM008244]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Ding for technical assistance, J. Motl from the University Flow Cytometry Resource for cell sorting, T. Dileepan for providing tetramer reagents, the University of Minnesota Genomics Center for assistance with RNA-seq and the University of Minnesota Research Animal Resources for animal husbandry. This project was supported by the National Institutes of Health (grant nos. R37 AI39560 and P01 AI35296 to K.A.H., T32 AI007313 to K.M.A. and E.R.B., and F30 AI131483 and T32 GM008244 to E.R.B.).	Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Baba T, 2009, J IMMUNOL, V183, P3053, DOI 10.4049/jimmunol.0900438; Baller J, 2019, PEARC '19: PROCEEDINGS OF THE PRACTICE AND EXPERIENCE IN ADVANCED RESEARCH COMPUTING ON RISE OF THE MACHINES (LEARNING), DOI 10.1145/3332186.3333156; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Breed ER, 2019, J IMMUNOL, V202, P3226, DOI 10.4049/jimmunol.1900191; Breed ER, 2018, SEMIN CELL DEV BIOL, V84, P2, DOI 10.1016/j.semcdb.2017.07.045; Connor LM, 2014, J IMMUNOL, V193, P2709, DOI 10.4049/jimmunol.1400374; Cowan JE, 2014, J IMMUNOL, V193, P1204, DOI 10.4049/jimmunol.1400993; Erman B, 2002, NAT IMMUNOL, V3, P564, DOI 10.1038/ni800; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hu ZC, 2015, J EXP MED, V212, P1947, DOI 10.1084/jem.20150178; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kroger CJ, 2016, EUR J IMMUNOL, V46, P2352, DOI 10.1002/eji.201646354; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; Kurd NS, 2019, ELIFE, V8, DOI 10.7554/eLife.48097; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; Lee YJ, 2015, IMMUNITY, V43, P566, DOI 10.1016/j.immuni.2015.06.025; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Leventhal DS, 2016, IMMUNITY, V44, P847, DOI 10.1016/j.immuni.2016.01.025; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Lio CWJ, 2010, J IMMUNOL, V184, P6007, DOI 10.4049/jimmunol.1000019; Loschko J, 2016, J IMMUNOL METHODS, V434, P32, DOI 10.1016/j.jim.2016.04.004; MacNabb BW, 2019, J IMMUNOL, V202, P2628, DOI 10.4049/jimmunol.1801621; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Mayer JU, 2021, NAT IMMUNOL, V22, P1538, DOI 10.1038/s41590-021-01067-0; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Miller CH, 2020, NAT IMMUNOL, V21, P567, DOI 10.1038/s41590-020-0653-1; Miller CN, 2018, NATURE, V559, P627, DOI 10.1038/s41586-018-0345-2; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Pos W, 2013, TRENDS IMMUNOL, V34, P495, DOI 10.1016/j.it.2013.06.002; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tatsumi N, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg0336; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Voboril M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16081-3; Vollmann EH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26446-x; Wang HG, 2019, P NATL ACAD SCI USA, V116, P22262, DOI 10.1073/pnas.1910412116; Wang HG, 2018, ELIFE, V7, DOI 10.7554/eLife.34793; White AJ, 2017, J EXP MED, V214, P2205, DOI 10.1084/jem.20170271; Williams JA, 2014, J IMMUNOL, V192, P630, DOI 10.4049/jimmunol.1302550; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Xing LY, 2014, JOVE-J VIS EXP, DOI 10.3791/51138; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	62	2	2	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1042	+		10.1038/s41590-022-01218-x	http://dx.doi.org/10.1038/s41590-022-01218-x		MAY 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35637352				2022-12-18	WOS:000802948100001
J	Hultstrom, M; Frithiof, R; Grip, J; Lindelof, L; Rooijackers, O; Pigazzini, S; Niemi, M; Cordioli, M; Nkambule, L; Maricic, T; Ekdahl, KN; Nilsson, B; Lipcsey, M; Zeberg, H; Eriksson, O				Hultstrom, Michael; Frithiof, Robert; Grip, Jonathan; Lindelof, Linnea; Rooijackers, Olav; Pigazzini, Sara; Niemi, Mari; Cordioli, Mattia; Nkambule, Lindo; Maricic, Tomislav; Ekdahl, Kristina Nilsson; Nilsson, Bo; Lipcsey, Miklos; Zeberg, Hugo; Eriksson, Oskar			Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19	NATURE IMMUNOLOGY			English	Editorial Material									[Hultstrom, Michael; Frithiof, Robert; Lipcsey, Miklos] Uppsala Univ, Dept Surg Sci, Anesthesiol & Intens Care Med, Uppsala, Sweden; [Hultstrom, Michael] Uppsala Univ, Dept Med Cell Biol, Integrat Physiol, Uppsala, Sweden; [Hultstrom, Michael] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Hultstrom, Michael] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Grip, Jonathan; Rooijackers, Olav] Karolinska Univ Hosp, Dept Perioperat Med & Intens Care, Stockholm, Sweden; [Grip, Jonathan; Rooijackers, Olav] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Lindelof, Linnea; Ekdahl, Kristina Nilsson; Nilsson, Bo; Eriksson, Oskar] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Pigazzini, Sara; Niemi, Mari; Cordioli, Mattia; Nkambule, Lindo] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Maricic, Tomislav; Zeberg, Hugo] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Ekdahl, Kristina Nilsson] Linnaeus Univ, Linnaeus Ctr Biomat Chem, Kalmar, Sweden; [Lipcsey, Miklos] Uppsala Univ, Dept Surg Sci, Hedenstierna Lab, Uppsala, Sweden; [Zeberg, Hugo] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Uppsala University; Uppsala University; McGill University; Lady Davis Institute; McGill University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; University of Helsinki; Max Planck Society; Linnaeus University; Uppsala University; Karolinska Institutet	Eriksson, O (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.; Zeberg, H (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.; Zeberg, H (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	hugo.zeberg@ki.se; oskar.eriksson@igp.uu.se	Hultström, Michael/H-3642-2019; Zeberg, Hugo/A-7567-2012	Hultström, Michael/0000-0003-4675-1099; Cordioli, Mattia/0000-0002-4872-0520; Lindelof, Linnea/0000-0002-3654-8874	SciLifeLab/Knut and Alice Wallenberg national COVID-19 research program [KAW 2020.0182, KAW 2020.0241]; Swedish Heart-Lung Foundation [20210089, 20190639, 20190637, 20200822]; Swedish Research Council [2014-02569, 2014-07606, 2021-03050, 202102252]; Swedish Kidney Foundation [F2020-0054]; Swedish Society of Medicine [SLS-943007, SLS-938101]; Jeansson foundation [J2021-0062]; Goran Gustafsson Foundation	SciLifeLab/Knut and Alice Wallenberg national COVID-19 research program; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Kidney Foundation; Swedish Society of Medicine; Jeansson foundation; Goran Gustafsson Foundation	We thank research nurses J. Wessbergh and E. Soderman for their expertize in compiling patient data, and Biobank assistants P. Karlsson, E. Danielsson, L. Spang, A. Svensson and K. Kilsand for sample collection and patient inclusion. Genotyping was performed by the Genotyping Laboratory of the Institute for Molecular Medicine Finland (FIMM) Technology Centre, University of Helsinki, and by the National Genomics Infrastructure at SciLifeLab, Uppsala University. We thank the Science for Life Laboratory, the National Genomics Infrastructure (NGI) and Uppmax for providing assistance in genotyping and computational infrastructure. The study was funded by the SciLifeLab/Knut and Alice Wallenberg national COVID-19 research program (grant nos. KAW 2020.0182 and KAW 2020.0241 to M.H.) the Swedish Heart-Lung Foundation (grant nos. 20210089, 20190639 and 20190637 to M.H. and 20200822 to B.N.), Swedish Research Council (grant nos. 2014-02569 and 2014-07606 to R.F., 2021-03050 to H.Z. and 202102252 to B.N.), the Swedish Kidney Foundation (grant no. F2020-0054 to R.F.), the Swedish Society of Medicine (grant nos. SLS-943007 to O.E. and SLS-938101 to M.H.), the Jeansson foundation (grant no. J2021-0062 to O.E.) and the Goran Gustafsson Foundation (to O.E.). Funding bodies had no role in the design of the study, data collection, interpretation or writing of the manuscript.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Eriksson O, 2020, THROMB HAEMOSTASIS, V120, P1720, DOI 10.1055/s-0040-1715835; Eriksson O, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01590; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Gedebjerg A, 2020, DIABETES CARE, V43, P2190, DOI 10.2337/dc20-0345; Leentjens J, 2021, LANCET HAEMATOL, V8, DOI 10.1016/S2352-3026(21)00105-8; Leffler J, 2014, ANN RHEUM DIS, V73, P1601, DOI 10.1136/annrheumdis-2014-205287; Lipcsey M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.627579; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Maturana-Candelas A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99589-y; Miro O, 2021, EUR HEART J, V42, P3127, DOI 10.1093/eurheartj/ehab314; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; Stravalaci M, 2022, NAT IMMUNOL, V23, P275, DOI 10.1038/s41590-021-01114-w; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; SweCovid, GEN PRED SEV COVID 1	15	2	2	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					861	+		10.1038/s41590-022-01227-w	http://dx.doi.org/10.1038/s41590-022-01227-w		MAY 2022	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624204	Bronze			2022-12-18	WOS:000805549900001
J	Gounari, F; Khazaie, K				Gounari, Fotini; Khazaie, Khashayarsha			TCF-1: a maverick in T cell development and function	NATURE IMMUNOLOGY			English	Review							EDGE BETA-CATENIN; TRANSCRIPTION FACTORS; HMG DOMAIN; FACTOR-I; DIFFERENTIATION; EFFECTOR; LINEAGE; LEF-1; SPECIFICATION; CHROMATIN	The T cell-specific DNA-binding protein TCF-1 is a central regulator of T cell development and function along multiple stages and lineages. Because it interacts with beta-catenin, TCF-1 has been classically viewed as a downstream effector of canonical Wnt signaling, although there is strong evidence for beta-catenin-independent TCF-1 functions. TCF-1 co-binds accessible regulatory regions containing or lacking its conserved motif and cooperates with other nuclear factors to establish context-dependent epigenetic and transcription programs that are essential for T cell development and for regulating immune responses to infection, autoimmunity and cancer. Although it has mostly been associated with positive regulation of chromatin accessibility and gene expression, TCF-1 has the potential to reduce chromatin accessibility and thereby suppress gene expression. In addition, the binding of TCF-1 bends the DNA and affects the chromatin conformation genome wide. This Review discusses the current understanding of the multiple roles of TCF-1 in T cell development and function and their mechanistic underpinnings. The transcription factor TCF-1 has multiple roles during T cell development and in mature T cells. Gounari and Khazaie review the potential mechanisms by which TCF-1 regulates gene expression.	[Gounari, Fotini] Univ Chicago, Dept Med, Knapp Res Ctr, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Gounari, Fotini; Khazaie, Khashayarsha] Mayo Clin, Dept Immunol, Scottsdale, AZ 85259 USA	University of Chicago; Mayo Clinic; Mayo Clinic Phoenix	Gounari, F (corresponding author), Univ Chicago, Dept Med, Knapp Res Ctr, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Gounari, F (corresponding author), Mayo Clin, Dept Immunol, Scottsdale, AZ 85259 USA.	Gounari.Fotini@mayo.edu		Gounari, Fotini/0000-0003-2936-066X	US National Institutes of Health [R01 AI 108682, R01 AI 147652]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health grants R01 AI 108682 (to F.G. and K.K.) and R01 AI 147652 (to F.G.).	Abdel-Hakeem MS, 2021, NAT IMMUNOL, V22, P1008, DOI 10.1038/s41590-021-00975-5; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Barra MM, 2015, J IMMUNOL, V195, P3058, DOI 10.4049/jimmunol.1500821; Bellei B, 2006, BRIT J DERMATOL, V155, P1223, DOI 10.1111/j.1365-2133.2006.07527.x; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dennis KL, 2015, CANCER IMMUNOL RES, V3, P806, DOI 10.1158/2326-6066.CIR-14-0169; Dose M, 2014, P NATL ACAD SCI USA, V111, P391, DOI 10.1073/pnas.1315752111; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Emmanuel AO, 2018, NAT IMMUNOL, V19, P1366, DOI 10.1038/s41590-018-0254-4; Escobar G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb9726; Fahl SP, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108716; Ferreira DP, 2020, IMMUNITY, V53, P985, DOI 10.1016/j.immuni.2020.09.005; Gekas C, 2016, LEUKEMIA, V30, P2002, DOI 10.1038/leu.2016.106; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Groen RWJ, 2008, CANCER RES, V68, P6969, DOI 10.1158/0008-5472.CAN-08-1322; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Gullicksrud JA, 2017, J IMMUNOL, V199, P911, DOI 10.4049/jimmunol.1700595; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Harly C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00470; Hosokawa H, 2021, NAT REV IMMUNOL, V21, P162, DOI 10.1038/s41577-020-00426-6; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Ishizuka IE, 2016, ANNU REV IMMUNOL, V34, P299, DOI 10.1146/annurev-immunol-041015-055549; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Kasal DN, 2021, J EXP MED, V218, DOI 10.1084/jem.20200487; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Lento W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008011; Li FY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014562118; Liang CF, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-021-00275-y; Lin WHW, 2016, CELL REP, V17, P1773, DOI 10.1016/j.celrep.2016.10.032; Liu JJ, 2019, FASEB J, V33, P5615, DOI 10.1096/fj.201802072R; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Ma J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024768; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Mielke LA, 2019, J EXP MED, V216, P1682, DOI 10.1084/jem.20181778; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Ng OH, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.12; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Osman A, 2021, NAT IMMUNOL, V22, P1152, DOI 10.1038/s41590-021-00987-1; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Prlic M, 2011, J IMMUNOL, V187, P1542, DOI 10.4049/jimmunol.1100907; Quandt J, 2021, NAT IMMUNOL, V22, P471, DOI 10.1038/s41590-021-00889-2; Ram-Wolff C, 2010, AM J DERMATOPATH, V32, P755, DOI 10.1097/DAD.0b013e3181cfbfbf; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Saadalla A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02777; Saadalla AM, 2018, P NATL ACAD SCI USA, V115, P1588, DOI 10.1073/pnas.1716804115; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saravia J, 2019, CELL MOL IMMUNOL, V16, P634, DOI 10.1038/s41423-019-0220-6; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Shan Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26159-1; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Sumida T, 2018, NAT IMMUNOL, V19, P1391, DOI 10.1038/s41590-018-0236-6; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Veeken J, 2020, IMMUNITY, V53, P971, DOI 10.1016/j.immuni.2020.10.010; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Xu Z, 2017, J IMMUNOL, V198, P3404, DOI 10.4049/jimmunol.1602139; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang J, 2018, J IMMUNOL, V200, P3397, DOI 10.4049/jimmunol.1800193; Zhao X, 2020, ELIFE, V9, DOI 10.7554/eLife.55360; Zhao XD, 2022, NAT REV IMMUNOL, V22, P147, DOI 10.1038/s41577-021-00563-6; Zhong Y, 2022, NAT IMMUNOL, V23, P122, DOI 10.1038/s41590-021-01086-x; Zhou W., 2021, SINGLE CELL PERTURBA, DOI [10.1101/2021.09.03.458944, DOI 10.1101/2021.09.03.458944]; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	113	2	2	8	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					671	678		10.1038/s41590-022-01194-2	http://dx.doi.org/10.1038/s41590-022-01194-2		APR 2022	8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35487986	Green Accepted			2022-12-18	WOS:000788971400002
J	Subramanian, S; Busch, CJL; Molawi, K; Geirsdottir, L; Maurizio, J; Aguilar, SV; Belahbib, H; Gimenez, G; Yuda, RAA; Burkon, M; Favret, J; Najjar, SG; de Laval, B; Kandalla, PK; Sarrazin, S; Alexopoulou, L; Sieweke, MH				Subramanian, Sethuraman; Busch, Clara Jana-Lui; Molawi, Kaaweh; Geirsdottir, Laufey; Maurizio, Julien; Aguilar, Stephanie Vargas; Belahbib, Hassiba; Gimenez, Gregory; Yuda, Ridzky Anis Advent; Burkon, Michaela; Favret, Jeremy; Najjar, Sara Gholamhosseinian; de Laval, Berengere; Kandalla, Prashanth Kumar; Sarrazin, Sandrine; Alexopoulou, Lena; Sieweke, Michael H.			Long-term culture-expanded alveolar macrophages restore their full epigenetic identity after transfer in vivo	NATURE IMMUNOLOGY			English	Article							IMMUNE CELLS; GM-CSF; TISSUE; TRANSPLANTATION; INDUCTION; MONOCYTES; SELECTION	Sieweke and colleagues show that alveolar macrophages maintain a core gene expression program even after several months in culture and reacquire full transcriptional and epigenetic identity after transplantation into the lung. Alveolar macrophages (AMs) are lung tissue-resident macrophages that can be expanded in culture, but it is unknown to what extent culture affects their in vivo identity. Here we show that mouse long-term ex vivo expanded AMs (exAMs) maintained a core AM gene expression program, but showed culture adaptations related to adhesion, metabolism and proliferation. Upon transplantation into the lung, exAMs reacquired full transcriptional and epigenetic AM identity, even after several months in culture and could self-maintain long-term in the alveolar niche. Changes in open chromatin regions observed in culture were fully reversible in transplanted exAMs and resulted in a gene expression profile indistinguishable from resident AMs. Our results indicate that long-term proliferation of AMs in culture did not compromise cellular identity in vivo. The robustness of exAM identity provides new opportunities for mechanistic analysis and highlights the therapeutic potential of exAMs.	[Subramanian, Sethuraman; Busch, Clara Jana-Lui; Aguilar, Stephanie Vargas; Yuda, Ridzky Anis Advent; Burkon, Michaela; Favret, Jeremy; Najjar, Sara Gholamhosseinian; Kandalla, Prashanth Kumar; Sarrazin, Sandrine; Sieweke, Michael H.] Tech Univ Dresden, Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany; [Subramanian, Sethuraman; Molawi, Kaaweh; Geirsdottir, Laufey; Aguilar, Stephanie Vargas; Belahbib, Hassiba; Gimenez, Gregory; de Laval, Berengere; Sarrazin, Sandrine; Alexopoulou, Lena; Sieweke, Michael H.] Aix Marseille Univ, CIML, INSERM, CNRS, Marseille, France; [Subramanian, Sethuraman; Molawi, Kaaweh; Aguilar, Stephanie Vargas] Helmholtzgemeinschaft MDC, Max Delbruck Ctr Mol Med, Berlin, Germany; [Maurizio, Julien] Inovarion, Paris, France	Technische Universitat Dresden; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sieweke, MH (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany.; Sieweke, MH (corresponding author), Aix Marseille Univ, CIML, INSERM, CNRS, Marseille, France.	michael.sieweke@tu-dresden.de	subramanian, sethuraman/GRX-4591-2022; Alexopoulou, Lena/A-5041-2017	Yuda, Ridzky/0000-0002-9411-3780; Subramanian, Sethuraman/0000-0002-4917-084X; Alexopoulou, Lena/0000-0003-4619-697X; Vargas Aguilar, Stephanie/0000-0002-6584-0209	TU Dresden; Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique; Aix-Marseille University; Agence Nationale pour la Recherche [ANR-17-CE15-0007-01, ANR-18-CE12-0019-03]; Fondation ARC pour la Recherche sur le Cancer [PGA1 RF20170205515]; INSERM-Helmholtz cooperation; European Research Council under the European Union's Horizon 2020 Research and Innovation program [695093 MacAge]; MDC; Fondation ARC pour la Recherche sur le Cancer; Human Frontier Science Program long-term fellowship; Stiftung Charite; TU Dresden [FRA/1188926]	TU Dresden(European Commission); Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); INSERM-Helmholtz cooperation; European Research Council under the European Union's Horizon 2020 Research and Innovation program; MDC; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Human Frontier Science Program long-term fellowship(Human Frontier Science Program); Stiftung Charite; TU Dresden(European Commission)	We thank L. Chasson for histology (CIML), M. Barad, S. Bigot, A. Zouine (CIML), A. Gompf and K. Bernhardt (CMCB Technology Platform, TU Dresden) for flow cytometry, M. Sohn for sequencing and the K. Rajewsky laboratory for hosting and general support (MDC). We also thank L. Razafindramana, CIML and CRTD Animal facilities for mouse husbandry and the light microscopy facility of the CMCB technology platform, TU Dresden. This study was supported by institutional grants from TU Dresden, the Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique and Aix-Marseille University and grants to M.H.S. from the Agence Nationale pour la Recherche (ANR-17-CE15-0007-01 and ANR-18-CE12-0019-03), Fondation ARC pour la Recherche sur le Cancer (PGA1 RF20170205515), an INSERM-Helmholtz cooperation and the European Research Council under the European Union's Horizon 2020 Research and Innovation program (grant agreement no. 695093 MacAge). S. Subramanian and S.V.A. received doctoral fellowship from the MDC and S.V.A and L.G received doctoral fellowship from the Fondation ARC pour la Recherche sur le Cancer, respectively. K.M. received support from a Human Frontier Science Program long-term fellowship and Stiftung Charite. M.H.S. is an Alexander von Humboldt Professor at TU Dresden (FRA/1188926).	Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Busch CJL, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3302; Chan MWY, 2019, CYTOTHERAPY, V21, P393, DOI 10.1016/j.jcyt.2019.02.002; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; de Laval B, 2020, CELL STEM CELL, V26, P657, DOI 10.1016/j.stem.2020.01.017; Dolgin E, 2020, NAT BIOTECHNOL, V38, P509, DOI 10.1038/s41587-020-0520-5; Fuchs E, 2012, CELL STEM CELL, V10, P640, DOI 10.1016/j.stem.2012.03.010; Gal-Oz ST, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12348-6; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; GREEN H, 1991, SCI AM, V265, P64; Guilliams M, 2021, NAT IMMUNOL, V22, P118, DOI 10.1038/s41590-020-00849-2; Happle C, 2018, AM J RESP CRIT CARE, V198, P350, DOI 10.1164/rccm.201708-1562OC; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Imperatore F, 2017, EMBO J, V36, P2353, DOI 10.15252/embj.201695737; Klichinsky M, 2020, NAT BIOTECHNOL, V38, P947, DOI 10.1038/s41587-020-0462-y; Larsen SB, 2021, CELL STEM CELL, V28, P1758, DOI 10.1016/j.stem.2021.07.001; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lewis PJS, 2019, SEMIN LIVER DIS, V39, P442, DOI 10.1055/s-0039-1688502; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McQuattie-Pimentel AC, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140299; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Misharin AV, 2012, J LEUKOCYTE BIOL, V92, P325, DOI 10.1189/jlb.1111560; Morrissey MA, 2018, ELIFE, V7, DOI 10.7554/eLife.36688; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; Rauschmeier R, 2019, EMBO J, V38, DOI 10.15252/embj.2018101233; RIOTTOT MM, 1981, INFECT IMMUN, V31, P71, DOI 10.1128/IAI.31.1.71-77.1981; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Sieweke MH, 2015, CELL STEM CELL, V16, P7, DOI 10.1016/j.stem.2014.12.009; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Svedberg FR, 2019, NAT IMMUNOL, V20, P571, DOI 10.1038/s41590-019-0352-y; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007	54	2	2	8	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					458	+		10.1038/s41590-022-01146-w	http://dx.doi.org/10.1038/s41590-022-01146-w		FEB 2022	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35210623	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000760706000002
J	Andrisani, O; Liu, Q; Kehn, P; Leitner, WW; Moon, K; Vazquez-Maldonado, N; Fingerman, I; Gale, M				Andrisani, Ourania; Liu, Qian; Kehn, Patricia; Leitner, Wolfgang W.; Moon, Kyung; Vazquez-Maldonado, Nancy; Fingerman, Ian; Gale, Michael, Jr.			Biological functions of DEAD/DEAH-box RNA helicases in health and disease	NATURE IMMUNOLOGY			English	Editorial Material								On 15-16 November 2021, the National Institute of Allergy and Infectious Diseases (NIAID), the National Cancer Institute (NCR) and the National Heart, Lung, and Blood Institute (NHLBI) hosted a virtual workshop on DEAD/DEAH-box RNA helicases in health and disease. The goal of the workshop was to review current advances, and identify knowledge gaps and future research to improve our understanding of the function of RNA helicases, and leverage these molecules as molecular targets with translational potential.	[Andrisani, Ourania] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Andrisani, Ourania] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Liu, Qian; Kehn, Patricia; Leitner, Wolfgang W.; Vazquez-Maldonado, Nancy] NIAID, Div Allergy Immunol & Transplantat, Rockville, MD USA; [Moon, Kyung] NHLBI, Div Blood Dis & Resources, Bldg 10, Bethesda, MD 20892 USA; [Fingerman, Ian] NCI, Div Canc Biol, Rockville, MD USA; [Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98195 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle	Gale, M (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98195 USA.	mgale@uw.edu		Gale, Michael/0000-0002-6332-7436	NIH [DK044533-23, CA023168-38S1, AI143265, AI100625, AI145359]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants DK044533-23 and CA023168-38S1 (O.A.) and AI143265, AI100625 and AI145359 (M.G.).	Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Cargill M, 2021, GENES-BASEL, V12, DOI 10.3390/genes12101471; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Parisien JP, 2018, EMBO REP, V19, DOI 10.15252/embr.201745176; Patmore DM, 2020, DEV CELL, V54, P455, DOI 10.1016/j.devcel.2020.05.027; Pryszlak M, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108903; Quinodoz SA, 2021, CELL, V184, P5775, DOI 10.1016/j.cell.2021.10.014; Rice GI, 2020, HUM MUTAT, V41, P837, DOI 10.1002/humu.23975; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; van Voss MRH, 2017, BBA-REV CANCER, V1868, P510, DOI 10.1016/j.bbcan.2017.09.006; Weinreb JT, 2021, DEV CELL, V56, P627, DOI 10.1016/j.devcel.2021.02.006; Zhang H, 2016, HEPATOLOGY, V64, P1033, DOI 10.1002/hep.28698	13	2	2	6	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					354	357		10.1038/s41590-022-01149-7	http://dx.doi.org/10.1038/s41590-022-01149-7		FEB 2022	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35194205	Bronze			2022-12-18	WOS:000759350000002
J	Martinez, DR; Ooi, EE				Martinez, David R.; Ooi, Eng Eong			A potential silver lining of delaying the second dose	NATURE IMMUNOLOGY			English	Editorial Material									[Martinez, David R.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Ooi, Eng Eong] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore	University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore	Martinez, DR (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.; Ooi, EE (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.	david.rafael.martinez@gmail.com; engeong.ooi@duke-nus.edu.sg	martinez, david/GQI-0849-2022	Ooi, Eng Eong/0000-0002-0520-1544; Martinez, David/0000-0002-2940-8961				[Anonymous], 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMclde2101987; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Corbett KS, 2021, SCIENCE, V373, P1325, DOI 10.1126/science.abj0299; de Alwis R, 2021, MOL THER, V29, P1970, DOI 10.1016/j.ymthe.2021.04.001; Gebre MS, 2022, NATURE, V601, P410, DOI 10.1038/s41586-021-04231-6; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Guerrera G, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl5344; Hall VG, 2022, NAT IMMUNOL, V23, P380, DOI 10.1038/s41590-021-01126-6; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; Martinez DR, 2021, SCIENCE, V373, P991, DOI [10.1126/science.abi4506, 10.1101/2021.03.11.434872]; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Payne RP, 2021, CELL, V184, P5699, DOI 10.1016/j.cell.2021.10.011; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2	15	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					349	351		10.1038/s41590-022-01143-z	http://dx.doi.org/10.1038/s41590-022-01143-z		FEB 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35190721	Bronze			2022-12-18	WOS:000758974500001
J	Egwang, TG; Owalla, TJ; Kemigisha, M				Egwang, Thomas G.; Owalla, Tonny Jimmy; Kemigisha, Margaret			COVID-19 vaccine trials must include helminth-infected cohorts	NATURE IMMUNOLOGY			English	Letter									[Egwang, Thomas G.; Owalla, Tonny Jimmy] Med Biotech Labs, Kampala, Uganda; [Kemigisha, Margaret] Kiruddu Referral Hosp, Kampala, Uganda		Egwang, TG (corresponding author), Med Biotech Labs, Kampala, Uganda.	tgegwang@gmail.com						Allen JE, 1996, INT ARCH ALLERGY IMM, V109, P3, DOI 10.1159/000237225; Castells MC, 2021, NEW ENGL J MED, V384, P643, DOI 10.1056/NEJMra2035343; Hartmann W, 2019, CELL REP, V29, P2243, DOI 10.1016/j.celrep.2019.10.051; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; Nguyen SMT, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22157785; Smits HH, 2007, ANN MED, V39, P428, DOI 10.1080/07853890701436765; Wait LF, 2020, VACCINE, V38, P5582, DOI 10.1016/j.vaccine.2020.06.064; Weatherhead JE, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.594520	9	2	2	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					148	148		10.1038/s41590-021-01116-8	http://dx.doi.org/10.1038/s41590-021-01116-8		JAN 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35075281	Bronze			2022-12-18	WOS:000746478500001
J	Ghosh, S; Raundhal, M; Myers, SA; Carr, SA; Chen, X; Petsko, GA; Glimcher, LH				Ghosh, Shrestha; Raundhal, Mahesh; Myers, Samuel A.; Carr, Steven A.; Chen, Xi; Petsko, Gregory A.; Glimcher, Laurie H.			Identification of RIOK2 as a master regulator of human blood cell development	NATURE IMMUNOLOGY			English	Article							HUMAN ERYTHROID PROGENITORS; EXPRESSION; ANEMIA; GATA1; PU.1	Ghosh et al. report findings showing that the atypical kinase RIOK2 functions as a winged helix-turn-helix domain containing transcription factor that regulates the differentiation of human hematopoietic stem and progenitor cells toward erythroid, myeloid and megakaryocytic lineages. RIOK2 enhances GATA1 and KLF1 expression, while suppressing other transcription factors like RUNX3, SPI1 and GATA2. Anemia is a major comorbidity in aging, chronic kidney and inflammatory diseases, and hematologic malignancies. However, the transcriptomic networks governing hematopoietic differentiation in blood cell development remain incompletely defined. Here we report that the atypical kinase RIOK2 (right open reading frame kinase 2) is a master transcription factor (TF) that not only drives erythroid differentiation, but also simultaneously suppresses megakaryopoiesis and myelopoiesis in primary human stem and progenitor cells. Our study reveals the previously uncharacterized winged helix-turn-helix DNA-binding domain and two transactivation domains of RIOK2 that are critical to regulate key hematopoietic TFs GATA1, GATA2, SPI1, RUNX3 and KLF1. This establishes RIOK2 as an integral component of the transcriptional regulatory network governing human hematopoietic differentiation. Importantly, RIOK2 mRNA expression significantly correlates with these TFs and other hematopoietic genes in myelodysplastic syndromes, acute myeloid leukemia and chronic kidney disease. Further investigation of RIOK2-mediated transcriptional pathways should yield therapeutic approaches to correct defective hematopoiesis in hematologic disorders.	[Ghosh, Shrestha; Raundhal, Mahesh; Glimcher, Laurie H.] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Ghosh, Shrestha; Raundhal, Mahesh; Glimcher, Laurie H.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Myers, Samuel A.; Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Myers, Samuel A.] La Jolla Inst Immunol, La Jolla, CA USA; [Chen, Xi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Dan L Duncan Comprehens Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Petsko, Gregory A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Glimcher, Laurie H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Raundhal, Mahesh] Jnana Therapeut, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; La Jolla Institute for Immunology; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Petsko, GA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	gpetsko@bwh.harvard.edu; laurie_glimcher@dfci.harvard.edu			Edward P. Evans Foundation; National Institutes of Health (NIH) [1R03HL156574-01]; Dana-Farber Cancer Institute; Pussycat Foundation Helen Gurley Brown Presidential Initiative; National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (NIH/NCI) [U24-CA210986, U01 CA214125]; NIH [R01HL146642, R37CA228304]	Edward P. Evans Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Cancer Institute; Pussycat Foundation Helen Gurley Brown Presidential Initiative; National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (NIH/NCI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank V. Sankaran and R. Voit (Boston Children's hospital) for their valuable input in primary human HSPC culture techniques and for providing HMD-empty vector and HMD-GATA1 expression plasmids; S. Badrinath, N. Mathewson and K. Wucherpfennig for their kind assistance in CRISPR-Cas9 genome editing and for providing EF1a-MCS-IRES-ZsGreen lentiviral expression vector; and M. Katsuyama (Kyoto Prefectural University of Medicine) for generously providing GATA2 and GATA3 overexpression plasmids. We also thank A. Wight for assistance in analyzing RNA-seq results. This work was funed by a Discovery Research Grant, the Edward P. Evans Foundation (to L.H.G.), the National Institutes of Health (NIH) small grant program (1R03HL156574-01 to L.H.G.), institutional funding, the Dana-Farber Cancer Institute (to L.H.G.), The Pussycat Foundation Helen Gurley Brown Presidential Initiative (to S.G.), National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium grants (NIH/NCI U24-CA210986 and U01 CA214125 to S.A.C.) and NIH grants (R01HL146642 and R37CA228304 to X.C.).	Ameismeier M, 2018, NATURE, V558, P249, DOI 10.1038/s41586-018-0193-0; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Becktell K, 2019, LEUKEMIA RES, V80, P19, DOI 10.1016/j.leukres.2019.03.003; Bhatt VR, 2016, J ONCOL PRACT, V12, P786, DOI 10.1200/JOP.2016.015214; Bi XJ, 2019, MOL CELL, V75, P102, DOI 10.1016/j.molcel.2019.05.007; Bonifer C, FEBS J, DOI [10.1111/febs.15735(2021, DOI 10.1111/FEBS.15735(2021]; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; Chaparro CM, 2019, ANN NY ACAD SCI, V1450, P15, DOI 10.1111/nyas.14092; Chen CSY, 2000, BIOCHEMISTRY-US, V39, P10397, DOI 10.1021/bi0009284; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Daw S, 2021, MOL CELL BIOCHEM, V476, P535, DOI 10.1007/s11010-020-03920-6; Feld J, 2020, LEUKEMIA RES, V97, DOI 10.1016/j.leukres.2020.106430; Feld J, 2020, EXPERT REV ANTICANC, V20, P465, DOI 10.1080/14737140.2020.1770088; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Fujiwara T, 2017, TOHOKU J EXP MED, V242, P83, DOI 10.1620/tjem.242.83; Garcia-Manero G, 2020, AM J HEMATOL, V95, P1399, DOI 10.1002/ajh.25950; Gnanapragasam MN, 2017, CURR OPIN HEMATOL, V24, P183, DOI 10.1097/MOH.0000000000000327; Groopman JE, 1999, JNCI-J NATL CANCER I, V91, P1616, DOI 10.1093/jnci/91.19.1616; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Gutierrez L, 2020, IUBMB LIFE, V72, P89, DOI 10.1002/iub.2192; Harish B, 2017, PROTEINS, V85, P731, DOI 10.1002/prot.25252; Hong, 2020, HEMATOL ONCOL STEM C, P30178; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Khajuria RK, 2018, CELL, V173, P90, DOI 10.1016/j.cell.2018.02.036; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Ling T, 2020, IUBMB LIFE, V72, P106, DOI 10.1002/iub.2177; Lopes MB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79254-6; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Myers SA, 2019, MOL CELL PROTEOMICS, V18, P995, DOI 10.1074/mcp.RA118.001259; NAKAHATA T, 1994, LEUKEMIA LYMPHOMA, V13, P401, DOI 10.3109/10428199409049629; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Palapar L, 2021, AGE AGEING, V50, P113, DOI 10.1093/ageing/afaa178; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pellagatti A, 2015, EUR J HAEMATOL, V95, P3, DOI 10.1111/ejh.12515; Raundhal M, 2021, NAT IMMUNOL, V22, P520, DOI 10.1038/s41590-021-00895-4; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Saygin C, 2021, BLOOD REV, V48, DOI 10.1016/j.blre.2020.100791; Shimizu R, 2020, IUBMB LIFE, V72, P142, DOI 10.1002/iub.2188; Suzuki M, 2013, GENES CELLS, V18, P921, DOI 10.1111/gtc.12086; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Teichmann M, 2012, TRANSCR-AUSTIN, V3, P2, DOI 10.4161/trns.3.1.18917; Tothova Z, 2017, CELL STEM CELL, V21, P547, DOI 10.1016/j.stem.2017.07.015; Wang J, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190037; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yokomizo-Nakano T, 2020, CANCER RES, V80, P2523, DOI 10.1158/0008-5472.CAN-19-3167; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhong XX, 2018, BLOOD ADV, V2, P3137, DOI 10.1182/bloodadvances.2018025866	50	2	2	2	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					109	+		10.1038/s41590-021-01079-w	http://dx.doi.org/10.1038/s41590-021-01079-w		DEC 2021	34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937919				2022-12-18	WOS:000733276000001
J	Kolls, JK; Garry, RF				Kolls, Jay K.; Garry, Robert F.			Role of the T cell vitamin D receptor in severe COVID-19	NATURE IMMUNOLOGY			English	Editorial Material							D-3	New research provides evidence of an impaired vitamin D gene signature in CD4(+) T cells in patients with severe COVID-19. Mechanistically, it is shown that vitamin D alters the epigenetic landscape of CD4(+) T cells, as well as inducing key transcription factors such as STAT3, BACH2 and JUN that reduce levels of IFN-gamma and increase IL-10. These changes generate pro-resolving T(H)1 cells that may be beneficial in resolving or preventing severe COVID-19.	[Kolls, Jay K.] Tulane Sch Med, Dept Med & Pediat, New Orleans, LA 70112 USA; [Garry, Robert F.] Tulane Sch Med, Dept Microbiol & Immunol, New Orleans, LA USA	Tulane University; Tulane University	Kolls, JK (corresponding author), Tulane Sch Med, Dept Med & Pediat, New Orleans, LA 70112 USA.	jkolls1@tulane.edu						Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Chauss D, 2022, NAT IMMUNOL, V23, P62, DOI 10.1038/s41590-021-01080-3; Fernandez-Ruiz M, 2021, CURR OPIN INFECT DIS, V34, P654, DOI 10.1097/QCO.0000000000000790; Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596; Hidalgo AA, 2011, J BIOL CHEM, V286, P36228, DOI 10.1074/jbc.M111.244061; Kolev M, 2020, IMMUNITY, V52, P513, DOI 10.1016/j.immuni.2020.02.006; Kolls Jay K, 2020, N Engl J Med, V382, P1669, DOI 10.1056/NEJMc2000993; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Maghbooli Z, 2021, ENDOCR PRACT, V27, P1242, DOI 10.1016/j.eprac.2021.09.016; Nanda M, 2021, CLIN EPIDEMIOL GLOB, V12, DOI 10.1016/j.cegh.2021.100882; Palmer MT, 2011, J BIOL CHEM, V286, P997, DOI 10.1074/jbc.M110.163790; Zhou, 2021, DRUG DISCOV TODAY, DOI DOI 10.1016/J.DRUDIS.2021.10.016	12	2	2	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					5	6		10.1038/s41590-021-01098-7	http://dx.doi.org/10.1038/s41590-021-01098-7		DEC 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34931078	Bronze			2022-12-18	WOS:000731826500002
J	Ruggeri, ZM; Ruf, W				Ruggeri, Zaverio M.; Ruf, Wolfram			Is VITT really a HIT	NATURE IMMUNOLOGY			English	Editorial Material								Thrombosis complicates SARS-CoV-2 infection and vaccination. Recent data are being used to identify the autoimmune antibody repertoires responsible for the excessive activation of coagulation and platelets.	[Ruggeri, Zaverio M.] Scripps Res Inst, Dept Mol Med, MERU Roon Res Ctr Vasc Biol, La Jolla, CA 92037 USA; [Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Ruf, Wolfram] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Med Ctr, Mainz, Germany	Scripps Research Institute; Scripps Research Institute; Johannes Gutenberg University of Mainz	Ruggeri, ZM (corresponding author), Scripps Res Inst, Dept Mol Med, MERU Roon Res Ctr Vasc Biol, La Jolla, CA 92037 USA.; Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Ruf, W (corresponding author), Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Med Ctr, Mainz, Germany.	ruggeri@scripps.edu; ruf@uni-mainz.de		Ruf, Wolfram/0000-0002-6064-2166; Ruggeri, Zaverio/0000-0003-0807-1295				Althaus K, 2021, BLOOD, V137, P1061, DOI 10.1182/blood.2020008762; Arepally GM, 2017, BLOOD, V129, P2864, DOI 10.1182/blood-2016-11-709873; Arman M, 2015, J THROMB HAEMOST, V13, P893, DOI 10.1111/jth.12905; Bye AP, 2021, BLOOD, V138, P1481, DOI 10.1182/blood.2021011871; Crank MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166393; Greinacher A, 2017, J THROMB HAEMOST, V15, P2099, DOI 10.1111/jth.13813; Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840; Hollerbach A, 2021, J THROMB HAEMOST, V19, P2335, DOI 10.1111/jth.15455; Huynh A, 2021, NATURE, V596, P565, DOI 10.1038/s41586-021-03744-4; Muller-Calleja N, 2021, SCIENCE, V371, P1121, DOI 10.1126/science.abc0956; Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882; Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Zuo Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3876	14	2	2	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1352	1353		10.1038/s41590-021-01042-9	http://dx.doi.org/10.1038/s41590-021-01042-9		OCT 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34686863	Bronze			2022-12-18	WOS:000710077900004
J	de Candia, P; Matarese, G				de Candia, Paola; Matarese, Giuseppe			Reimagining an immunological dogma	NATURE IMMUNOLOGY			English	Editorial Material							TRANSGENERATIONAL INHERITANCE		[de Candia, Paola] IRCCS MultiMed, Milan, Italy; [Matarese, Giuseppe] Univ Napoli Federico II, Treg Cell Lab, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Matarese, Giuseppe] Consiglio Nazl Ric IEOS CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale G Salvatore, Naples, Italy	IRCCS Multimedica; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	de Candia, P (corresponding author), IRCCS MultiMed, Milan, Italy.; Matarese, G (corresponding author), Univ Napoli Federico II, Treg Cell Lab, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.; Matarese, G (corresponding author), Consiglio Nazl Ric IEOS CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale G Salvatore, Naples, Italy.	paola.decandia@multimedica.it; giuseppe.matarese@unina.it	Matarese, Giuseppe/AAO-4077-2021; de Candia, Paola/HGC-8826-2022	Matarese, Giuseppe/0000-0001-9429-0616; de Candia, Paola/0000-0003-4767-446X	Fondazione Italiana Sclerosi Multipla (FISM) [2016/R/18, 2018/S/5]; Progetti di Rilevante Interesse Nazionale (PRIN) [2017 K55HLC 001]; Ministero della Salute [RF-2019-12371111]; National Multiple Sclerosis Society (NMSS) [PP-1606-24687]; FISM [2016/R/10, 2018/R/4]; Juvenile Diabetes Research Foundation (JDRF) [1-SRA-2018-477-S-B]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation)	G.M. is funded by Fondazione Italiana Sclerosi Multipla (FISM; grants 2016/R/18 and 2018/S/5), Progetti di Rilevante Interesse Nazionale (PRIN; grant 2017 K55HLC 001), and Ministero della Salute (grant RF-2019-12371111). P.d.C. is supported by the National Multiple Sclerosis Society (NMSS; grant PP-1606-24687), FISM (grants 2016/R/10 and 2018/R/4), and the Juvenile Diabetes Research Foundation (JDRF; grant 1-SRA-2018-477-S-B). We thank F. Prattichizzo for critically reviewing the manuscript and S. Bruzzaniti for assistance with creating the illustration in Fig. 1.	Bard Jonathan Bl, 2011, Cell Commun Signal, V9, P30, DOI 10.1186/1478-811X-9-30; Berendsen MLT, 2021, ECLINICALMEDICINE, V39, DOI 10.1016/j.eclinm.2021.101049; De Rosa V, 2017, NAT IMMUNOL, V18, P1190, DOI 10.1038/ni.3851; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Katzmarski, 2021, NAT GENET, DOI [10.1038/s41590-021-01052-7, DOI 10.1038/S41590-021-01052-7]; Leentjens J, 2018, CIRC RES, V122, P664, DOI [10.1161/circresaha.117.312465, 10.1161/CIRCRESAHA.117.312465]; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Stegemann R, 2015, SEMIN CELL DEV BIOL, V43, P131, DOI 10.1016/j.semcdb.2015.04.007	12	2	2	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1355	1358		10.1038/s41590-021-01046-5	http://dx.doi.org/10.1038/s41590-021-01046-5		OCT 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34663980				2022-12-18	WOS:000708376800001
J	Yao, Y; Chen, ZA; Zhang, H; Chen, CL; Zeng, M; Yunis, J; Wei, YB; Wan, YM; Wang, NQ; Zhou, MZ; Qiu, C; Zeng, QX; Ong, HS; Wang, H; Makota, FV; Yang, Y; Yang, ZH; Wang, N; Deng, J; Shen, C; Xia, Y; Yuan, L; Lian, ZQ; Deng, YK; Guo, CL; Huang, A; Zhou, PC; Shi, HB; Zhang, WT; Yi, HL; Li, DM; Xia, M; Fu, J; Wu, N; de Haan, JB; Shen, N; Zhang, WH; Liu, Z; Yu, D				Yao, Yin; Chen, Zhian; Zhang, Hao; Chen, Cailing; Zeng, Ming; Yunis, Joseph; Wei, Yunbo; Wan, Yanmin; Wang, Naiqi; Zhou, Mingzhe; Qiu, Chao; Zeng, Qunxiong; Ong, Hong Sheng; Wang, Hao; Makota, Fadzai Victor; Yang, Yang; Yang, Zhaohui; Wang, Nan; Deng, Jun; Shen, Chao; Xia, Yan; Yuan, Lin; Lian, Zhaoqin; Deng, Yike; Guo, Cuilian; Huang, Ao; Zhou, Pengcheng; Shi, Haibo; Zhang, Weitian; Yi, Hongliang; Li, Dongmei; Xia, Ming; Fu, Jing; Wu, Ning; de Haan, Judy B.; Shen, Nan; Zhang, Wenhong; Liu, Zheng; Yu, Di			Selenium-GPX4 axis protects follicular helper T cells from ferroptosis (vol 22, pg 1127, 2021)	NATURE IMMUNOLOGY			English	Correction												zhengliuent@hotmail.com; di.yu@uq.edu.au	Wei, Yunbo/AHE-8248-2022; Chen, Zhian/ABA-6813-2021; hb, s/HGB-5402-2022; Shen, Nan/AGK-6807-2022; Zhou, Mingzhe/AED-5236-2022	Chen, Zhian/0000-0003-0073-2941; Wan, Yanmin/0000-0001-5027-9423; Yu, Di/0000-0003-1721-8922; Fu, Jing/0000-0002-7752-5417				Yao Y, 2021, NAT IMMUNOL, V22, P1127, DOI 10.1038/s41590-021-00996-0	1	2	2	7	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1599	1599		10.1038/s41590-021-01063-4	http://dx.doi.org/10.1038/s41590-021-01063-4		OCT 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34608307	Bronze			2022-12-18	WOS:000703365800001
J	Linterman, MA; Denton, AE				Linterman, Michelle A.; Denton, Alice E.			Selenium saves ferroptotic T-FH cells to fortify the germinal center	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNITY	Inhibition of ferroptosis via selenium supplementation promotes the survival of follicular helper T cells, boosting the germinal center and antibody response following vaccination in mice and people.	[Linterman, Michelle A.] Babraham Inst, Immunol Programme, Cambridge, England; [Denton, Alice E.] Imperial Coll London, Dept Immunol & Inflammat, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London	Linterman, MA (corresponding author), Babraham Inst, Immunol Programme, Cambridge, England.	Michelle.linterman@babraham.ac.uk		Denton, Alice/0000-0002-4580-3443; Linterman, Michelle/0000-0001-6047-1996	Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0428, BBS/E/B/000C0427] Funding Source: Medline; Medical Research Council [MR/V009591/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Elsner RA, 2020, IMMUNITY, V53, P1136, DOI 10.1016/j.immuni.2020.11.006; Faliti CE, 2019, J EXP MED, V216, P317, DOI 10.1084/jem.20171976; Hill DL, 2019, J EXP MED, V216, P1857, DOI 10.1084/jem.20190301; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; Linterman Michelle A, 2016, F1000Res, V5, DOI 10.12688/f1000research.7388.1; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Merkenschlager J, 2021, NATURE, V591, P458, DOI 10.1038/s41586-021-03187-x; Nielsen CM, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100207; Stebegg M, 2020, ELIFE, V9, DOI 10.7554/eLife.52473; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Yao Y, 2021, NAT IMMUNOL, V22, P1127, DOI 10.1038/s41590-021-00996-0	14	2	2	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1074	1076		10.1038/s41590-021-01007-y	http://dx.doi.org/10.1038/s41590-021-01007-y		AUG 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34413522	Green Submitted			2022-12-18	WOS:000686467300001
J	Kahlenberg, JM				Kahlenberg, J. Michelle			Mentorship of physician scientists: a critical imperative	NATURE IMMUNOLOGY			English	Editorial Material									[Kahlenberg, J. Michelle] Univ Michigan, Dept Internal Med, Div Rheumatol, Michigan Med, Ann Arbor, MI 48109 USA; [Kahlenberg, J. Michelle] Univ Michigan, Dept Dermatol, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kahlenberg, JM (corresponding author), Univ Michigan, Dept Internal Med, Div Rheumatol, Michigan Med, Ann Arbor, MI 48109 USA.; Kahlenberg, JM (corresponding author), Univ Michigan, Dept Dermatol, Michigan Med, Ann Arbor, MI 48109 USA.	mkahlenb@med.umich.edu		Kahlenberg, J. Michelle/0000-0002-4006-8945					0	2	2	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					930	931		10.1038/s41590-021-00983-5	http://dx.doi.org/10.1038/s41590-021-00983-5			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TQ1ME	34316071				2022-12-18	WOS:000678050800002
J	Visan, I				Visan, Ioana			Long COVID	NATURE IMMUNOLOGY			English	Editorial Material												i.visan@us.nature.com							0	2	2	23	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					934	935		10.1038/s41590-021-00992-4	http://dx.doi.org/10.1038/s41590-021-00992-4			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TQ1ME	34316076	Bronze			2022-12-18	WOS:000678050800004
J	Bruchard, M; Ghiringhelli, F				Bruchard, Melanie; Ghiringhelli, Francois			ILC2s in cancer: context matters	NATURE IMMUNOLOGY			English	Editorial Material							CELLS	The role of type 2 innate lymphoid cells (ILC2s) in cancer is currently under substantial scrutiny. New data show that ILC2s producing the proinflammatory cytokine GM-CSF coordinate eosinophils' recruitment and activation to enhance antitumor responses	[Bruchard, Melanie; Ghiringhelli, Francois] INSERM, UMR 1231, Dijon, France; [Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France; [Ghiringhelli, Francois] Univ Burgundy Franche Comte, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc	Ghiringhelli, F (corresponding author), INSERM, UMR 1231, Dijon, France.; Ghiringhelli, F (corresponding author), Ctr Georges Francois Leclerc, Dijon, France.; Ghiringhelli, F (corresponding author), Univ Burgundy Franche Comte, Dijon, France.	fghiringhelli@cgfl.fr	Bruchard, melanie/E-6508-2017	Bruchard, melanie/0000-0003-0004-2887; ghiringhelli, francois/0000-0002-5465-8305				Bie QL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/923135; Chevalier MF, 2017, J CLIN INVEST, V127, P2916, DOI 10.1172/JCI89717; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jacquelot N, 2021, NAT IMMUNOL, V22, P851, DOI 10.1038/s41590-021-00943-z; Kim J, 2016, J IMMUNOL, V196, P2410, DOI 10.4049/jimmunol.1501730; Long A, 2018, J IMMUNOL, V201, P3456, DOI 10.4049/jimmunol.1800173; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moral JA, 2020, NATURE, V579, P130, DOI 10.1038/s41586-020-2015-4; Schuijs MJ, 2020, NAT IMMUNOL, V21, P998, DOI 10.1038/s41590-020-0745-y; Trabanelli S, 2019, SEMIN IMMUNOL, V41, DOI 10.1016/j.smim.2019.04.004; Trabanelli S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00678-2; Wang S, 2020, CELL RES, V30, P610, DOI 10.1038/s41422-020-0312-y	12	2	2	2	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					804	806		10.1038/s41590-021-00945-x	http://dx.doi.org/10.1038/s41590-021-00945-x		JUN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34099921				2022-12-18	WOS:000658651000002
J	Zuo, JM; Dowell, AC; Pearce, H; Verma, K; Long, HM; Begum, J; Aiano, F; Amin-Chowdhury, Z; Hoschler, K; Brooks, T; Taylor, S; Hewson, J; Hallis, B; Stapley, L; Borrow, R; Linley, E; Ahmad, S; Parker, B; Horsley, A; Amirthalingam, G; Brown, K; Ramsay, ME; Ladhani, S; Moss, P				Zuo, Jianmin; Dowell, Alexander C.; Pearce, Hayden; Verma, Kriti; Long, Heather M.; Begum, Jusnara; Aiano, Felicity; Amin-Chowdhury, Zahin; Hoschler, Katja; Brooks, Tim; Taylor, Stephen; Hewson, Jacqueline; Hallis, Bassam; Stapley, Lorrain; Borrow, Ray; Linley, Ezra; Ahmad, Shazaad; Parker, Ben; Horsley, Alex; Amirthalingam, Gayatri; Brown, Kevin; Ramsay, Mary E.; Ladhani, Shamez; Moss, Paul			Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection (vol 22, pg 620, 2021)	NATURE IMMUNOLOGY			English	Correction												Shamez.Ladhani@phe.gov.uk; P.Moss@bham.ac.uk		Pearce, Hayden/0000-0002-8380-8122; Dowell, Alexander/0000-0002-1909-7047	RCUK | Medical Research Council (MRC) [MR/R011230/1] Funding Source: Medline; Bloodwise [17009] Funding Source: Medline	RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bloodwise		Zuo JM, 2021, NAT IMMUNOL, V22, P620, DOI 10.1038/s41590-021-00902-8	1	2	3	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					928	928		10.1038/s41590-021-00957-7	http://dx.doi.org/10.1038/s41590-021-00957-7		MAY 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34017126	Green Published, Bronze			2022-12-18	WOS:000652579200005
J	Moore, E; Reynolds, JA; Davidson, A; Gallucci, S; Morel, L; Rao, DA; Young, HA; Putterman, C				Moore, Erica; Reynolds, Joshua A.; Davidson, Anne; Gallucci, Stefania; Morel, Laurence; Rao, Deepak A.; Young, Howard A.; Putterman, Chaim			Promise and complexity of lupus mouse models	NATURE IMMUNOLOGY			English	Editorial Material								As a follow up to a 2010 meeting deliberating on the benefits of studying mouse models of systemic lupus erythematosus (SLE), the virtual conference "Mouse models of lupus 10 years later" convened on 10 December 2020 to address a challenging decade that saw few new therapies approved, despite leaps in knowledge.	[Moore, Erica; Reynolds, Joshua A.; Putterman, Chaim] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Davidson, Anne] Feinstein Inst Med Res, Manhasset, NY USA; [Gallucci, Stefania] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Morel, Laurence] Univ Florida, Coll Med, Miami, FL USA; [Rao, Deepak A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Rao, Deepak A.] Harvard Med Sch, Boston, MA 02115 USA; [Young, Howard A.] NCI, Frederick, MD 21701 USA; [Putterman, Chaim] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel; [Putterman, Chaim] Galilee Res Inst, Nahariyya, Israel	Yeshiva University; Albert Einstein College of Medicine; Northwell Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Bar Ilan University	Moore, E (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	erica.moore@einsteinmed.org	Putterman, Chaim/AFR-0429-2022; Young, Howard/A-6350-2008	Morel, Laurence/0000-0002-6622-1290; Rao, Deepak/0000-0001-9672-7746; Young, Howard/0000-0002-3118-5111; Moore, Erica/0000-0002-5789-1727	Intramural Research Program of the Center for Cancer Research, NCI; National Institute of General Medical Sciences [T32-GM007288]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR076557, K08AR072791]; Department of Defense, Lupus Research Alliance [W81XWH-17-1-0657]; National Institute of Allergy & Infectious Diseases [R01AI128901]; Burroughs Wellcome Fund Career Award in Medical Sciences	Intramural Research Program of the Center for Cancer Research, NCI; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Defense, Lupus Research Alliance(United States Department of Defense); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Career Award in Medical Sciences(Burroughs Wellcome Fund)	We thank all of the speakers for participating in the meeting's robust discussion on the usefulness of mouse models in lupus research. Additionally, we thank Jose Aragon, Luis Mendez, and the rest of the IT team at the National Cancer Institute (NCI) for their support both prior to and on the day of the meeting. This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. Funding support included T32-GM007288 from the National Institute of General Medical Sciences (E.M. and J.A.R.); R21AR076557 (A.D.) and K08AR072791 (D.A.R.) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (A.D); W81XWH-17-1-0657 from the Department of Defense, Lupus Research Alliance (A.D., S.G., and D.A.R.); R01AI128901 from the National Institute of Allergy & Infectious Diseases (L.M.); and a Burroughs Wellcome Fund Career Award in Medical Sciences (D.A.R.).	Azzouz D, 2019, ANN RHEUM DIS, V78, P947, DOI 10.1136/annrheumdis-2018-214856; Blanco LP, 2020, ARTHRITIS RHEUMATOL, V72, P454, DOI 10.1002/art.41128; Bocharnikov AV, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130062; Chalmers S, 2019, ARTHRITIS RHEUMATOL, V71; Der E, 2019, NAT IMMUNOL, V20, P915, DOI 10.1038/s41590-019-0386-1; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dong XM, 2021, ARTHRITIS RHEUMATOL, V73, P478, DOI 10.1002/art.41532; Elsner RA, 2019, CELL REP, V29, P2796, DOI 10.1016/j.celrep.2019.10.069; Gallo PM, 2015, IMMUNITY, V42, P1171, DOI 10.1016/j.immuni.2015.06.002; Hacohen N, 2020, ARTHRITIS RHEUMATOL, V72; Li W, 2017, CURR OPIN RHEUMATOL, V29, P434, DOI 10.1097/BOR.0000000000000412; Liu X, 2019, ANN RHEUM DIS, V78, P1070, DOI 10.1136/annrheumdis-2019-215442; Miller AL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008591; Misha R., 2019, ARTHRITIS RHEUMATOL, V71, Patent No. 1783; Moore E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01476; Mu QH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14223-0; Mu QH, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0300-8; Nestor J, 2018, J EXP MED, V215, P2554, DOI 10.1084/jem.20180776; Pachucki RJ, 2020, ARTHRITIS RHEUMATOL, V72, P1872, DOI 10.1002/art.41400; Richard ML, 2018, LUPUS SCI MED, V5, DOI 10.1136/lupus-2016-000199; Schickel JN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf7153; Stanley S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15986-3; Sun FF, 2020, LANCET RHEUMATOL, V2, pE210, DOI 10.1016/S2665-9913(20)30004-7; Titov AA, 2019, J IMMUNOL, V203, P338, DOI 10.4049/jimmunol.1801651; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Zegarra-Ruiz DF, 2019, CELL HOST MICROBE, V25, P113, DOI 10.1016/j.chom.2018.11.009; Zhang HS, 2014, APPL ENVIRON MICROB, V80, P7551, DOI 10.1128/AEM.02676-14	27	2	2	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					683	686		10.1038/s41590-021-00914-4	http://dx.doi.org/10.1038/s41590-021-00914-4		MAY 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	33972783	Green Accepted, Green Published			2022-12-18	WOS:000648833500001
J	Baptista, AP; Gerner, MY				Baptista, Antonio P.; Gerner, Michael Y.			Lymphoid stromal cells proGrem dendritic cell homeostasis	NATURE IMMUNOLOGY			English	Editorial Material								Single-cell technologies reveal the building blocks of secondary lymphoid organs, identifying Grem1(+) fibroblastic reticular cells (FRCs) as critical niche cells that contribute to resident dendritic cell homeostasis and T cell immunity.	[Baptista, Antonio P.] VIB UGhent Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Baptista, Antonio P.] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Gerner, Michael Y.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Flanders Institute for Biotechnology (VIB); Ghent University; University of Washington; University of Washington Seattle	Baptista, AP (corresponding author), VIB UGhent Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium.; Baptista, AP (corresponding author), Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium.; Gerner, MY (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	antonio.baptista@irc.vib-ugent.be; gernermy@uw.edu		Gerner, Michael/0000-0001-5406-8308; Baptista, Antonio P./0000-0001-8182-8982	Marie-Skodowska-Curie fellowship (EU) [898090]; NIH [R01AI134713, R21AI142667, R01AI1134246, 75N93019C00070, T32AI106677, T32GM007270]; National Science Foundation [NSF DGE-1762114]; Washington Research Foundation postdoctoral fellowship; Roche Glycart AG	Marie-Skodowska-Curie fellowship (EU); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Washington Research Foundation postdoctoral fellowship; Roche Glycart AG	A.P.B. is supported by a Marie-Skodowska-Curie fellowship (EU project 898090). Research in the Gerner laboratory is supported by NIH grants R01AI134713, R21AI142667, R01AI1134246, 75N93019C00070, T32AI106677 and T32GM007270; the National Science Foundation (NSF DGE-1762114); the Washington Research Foundation postdoctoral fellowship; and research funds from Roche Glycart AG.	Baptista AP, 2014, ELIFE, V3, DOI 10.7554/eLife.04433; Baptista AP, 2019, IMMUNITY, V50, P1188, DOI 10.1016/j.immuni.2019.04.001; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Kapoor VN, 2021, NAT IMMUNOL, V22, P571, DOI 10.1038/s41590-021-00920-6; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; Leal JM, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abb9435; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Pezoldt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06423-7; Pikor NB, 2021, J IMMUNOL, V206, P257, DOI 10.4049/jimmunol.2000914; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Stoltzfus CR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107523	14	2	2	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					541	543		10.1038/s41590-021-00924-2	http://dx.doi.org/10.1038/s41590-021-00924-2		APR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33903765	Green Published			2022-12-18	WOS:000644337400004
J	Day, EA; O'Neill, LAJ				Day, Emily A.; O'Neill, Luke A. J.			Targeting mitochondria to beat HIV-1	NATURE IMMUNOLOGY			English	Editorial Material								HIV-1 infection of CD4(+) T cells triggers the interaction of the mitochondrial proteins NLRX1 and FASTKD5 to promote oxidative phosphorylation, leading to increased viral replication. It has now been shown that this process can be blocked by metformin.	[Day, Emily A.; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748	Wellcome Trust [109443/Z/15/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Guo HT, 2021, NAT IMMUNOL, V22, P423, DOI 10.1038/s41590-021-00898-1; Nagai-Singer MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02419; Ryan DG, 2020, ANNU REV IMMUNOL, V38, P289, DOI 10.1146/annurev-immunol-081619-104850; Snaka T, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.609812; Williamson MK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030114	8	2	2	1	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					398	399		10.1038/s41590-021-00881-w	http://dx.doi.org/10.1038/s41590-021-00881-w		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33767428				2022-12-18	WOS:000632800300003
J	Netea, MG; Balkwill, F; Chonchol, M; Cominelli, F; Donath, MY; Giamarellos-Bourboulis, EJ; Golenbock, D; Gresnigt, MS; Heneka, MT; Hoffman, HM; Hotchkiss, R; Joosten, LAB; Kastner, DL; Korte, M; Latz, E; Libby, P; Mandrup-Poulsen, T; Mantovani, A; Mills, KHG; Nowak, KL; O'Neill, LA; Pickkers, P; van der Poll, T; Ridker, PM; Schalkwijk, J; Schwartz, DA; Siegmund, B; Steer, CJ; Tilg, H; van der Meer, JWM; van de Veerdonk, FL; Dinarello, CA				Netea, Mihai G.; Balkwill, Frances; Chonchol, Michel; Cominelli, Fabio; Donath, Marc Y.; Giamarellos-Bourboulis, Evangelos J.; Golenbock, Douglas; Gresnigt, Mark S.; Heneka, Michael T.; Hoffman, Hal M.; Hotchkiss, Richard; Joosten, Leo A. B.; Kastner, Daniel L.; Korte, Martin; Latz, Eicke; Libby, Peter; Mandrup-Poulsen, Thomas; Mantovani, Alberto; Mills, Kingston H. G.; Nowak, Kristen L.; O'Neill, Luke A.; Pickkers, Peter; van der Poll, Tom; Ridker, Paul M.; Schalkwijk, Joost; Schwartz, David A.; Siegmund, Britta; Steer, Clifford J.; Tilg, Herbert; van der Meer, Jos W. M.; van de Veerdonk, Frank L.; Dinarello, Charles A.			A guiding map for inflammation (vol 18, pg 826, 2017)	NATURE IMMUNOLOGY			English	Correction												mihai.netea@radboudumc.nl	Libby, Peter/AAY-6404-2021; Gresnigt, Mark/H-3530-2015; Schalkwijk, Joost/R-7509-2019; van de Veerdonk, Frank L/C-7256-2008; Mills, Kingston H/F-5684-2013; Mantovani, Alberto/HCI-7449-2022; Heneka, Michael/E-8072-2015; Siegmund, Britta/E-6929-2018; Latz, Eicke/H-3951-2014	Libby, Peter/0000-0002-1502-502X; Gresnigt, Mark/0000-0002-9514-4634; Schalkwijk, Joost/0000-0002-1308-1319; van de Veerdonk, Frank L/0000-0002-1121-4894; Mills, Kingston H/0000-0003-3646-8222; Mantovani, Alberto/0000-0001-5578-236X; Giamarellos-Bourboulis, Evangelos/0000-0003-4713-3911; Heneka, Michael/0000-0003-4996-1630; Siegmund, Britta/0000-0002-0055-958X; Latz, Eicke/0000-0003-1488-5666	European Research Council [669415]; AIRC; Fondazione Cariplo	European Research Council(European Research Council (ERC)European Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo)	In the version of this article initially published, in the Acknowledgments, a grant number was omitted for author A.M. The correct wording is "A.M. was supported by the European Research Council (PHII, grant no. 669415), AIRC and Fondazione Cariplo." The error has not been corrected in the original article.	Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790	1	2	2	3	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					254	254		10.1038/s41590-020-00846-5	http://dx.doi.org/10.1038/s41590-020-00846-5		DEC 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33288963	Bronze, Green Published			2022-12-18	WOS:000598994000001
J	Demetriou, P; Abu-Shah, E; Valvo, S; McCuaig, S; Mayya, V; Kvalvaag, A; Starkey, T; Korobchevskaya, K; Lee, LYW; Friedrich, M; Mann, E; Kutuzov, MA; Morotti, M; Wietek, N; Rada, H; Yusuf, S; Afrose, J; Siokis, A; Meyer-Hermann, M; Ahmed, AA; Depoil, D; Dustin, ML				Demetriou, Philippos; Abu-Shah, Enas; Valvo, Salvatore; McCuaig, Sarah; Mayya, Viveka; Kvalvaag, Audun; Starkey, Thomas; Korobchevskaya, Kseniya; Lee, Lennard Y. W.; Friedrich, Matthias; Mann, Elizabeth; Kutuzov, Mikhail A.; Morotti, Matteo; Wietek, Nina; Rada, Heather; Yusuf, Shamsideen; Afrose, Jehan; Siokis, Anastasios; Meyer-Hermann, Michael; Ahmed, Ahmed Ashour; Depoil, David; Dustin, Michael L.		Oxford IBD Cohort Investigators	A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals (September, 10.1038/s41590-020-0770-x, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				michael.dustin@kennedy.ox.ac.uk		Allan, Philip/0000-0003-2682-772X; Culver, Emma/0000-0001-9644-8392; Dustin, Michael/0000-0003-4983-6389; Barnes, Eleanor/0000-0002-0860-0831; klenerman, paul/0000-0003-4307-9161; Lee, Lennard/0000-0002-8993-8438; Kvalvaag, Audun/0000-0002-6437-2247; Abu-Shah, Enas/0000-0001-5033-8171; Starkey, Thomas/0000-0002-6692-9563; Braden, Barbara/0000-0002-8534-6873; Yusuf, Salim/0000-0003-4776-5601; Simmons, Alison/0000-0003-3454-0710				Demetriou P, 2020, NAT IMMUNOL, V21, P1232, DOI 10.1038/s41590-020-0770-x	1	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					99	99		10.1038/s41590-020-00825-w	http://dx.doi.org/10.1038/s41590-020-00825-w		OCT 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33122852	Bronze			2022-12-18	WOS:000584997500001
J	Bettelli, E; Campbell, DJ				Bettelli, Estelle; Campbell, Daniel J.			Circulating T-FH cells as a marker for early therapeutic intervention in T1D	NATURE IMMUNOLOGY			English	Editorial Material							ABATACEPT; MODULATION		[Bettelli, Estelle; Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Bettelli, Estelle; Campbell, Daniel J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Benaroya Research Institute; University of Washington; University of Washington Seattle	Bettelli, E; Campbell, DJ (corresponding author), Benaroya Res Inst, Seattle, WA 98101 USA.; Bettelli, E; Campbell, DJ (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	ebettelli@benaroyaresearch.org; dcampbell@benaroyaresearch.org			NIAID NIH HHS [UM1 AI109565] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Edner NM, 2020, NAT IMMUNOL, V21, P1244, DOI 10.1038/s41590-020-0744-z; Ferreira RC, 2015, DIABETOLOGIA, V58, P781, DOI 10.1007/s00125-015-3509-8; Fukuyo S, 2017, CLIN EXP RHEUMATOL, V35, P562; Glatigny S, 2019, J IMMUNOL, V202, P1373, DOI 10.4049/jimmunol.1801425; Kenefeck R, 2015, J CLIN INVEST, V125, P292, DOI 10.1172/JCI76238; Linsley PS, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126136; Orban T, 2014, DIABETES CARE, V37, P1069, DOI 10.2337/dc13-0604; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Verstappen GM, 2017, ARTHRITIS RHEUMATOL, V69, P1850, DOI 10.1002/art.40165; Viisanen T, 2017, DIABETES, V66, P437, DOI 10.2337/db16-0714; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	13	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1141	1142		10.1038/s41590-020-0766-6	http://dx.doi.org/10.1038/s41590-020-0766-6		SEP 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32873972				2022-12-18	WOS:000565126200001
J	Masuda, T; Amann, L; Sankowski, R; Staszewski, O; Lenz, M; d'Errico, P; Snaidero, N; Jordao, MJC; Bottcher, C; Kierdorf, K; Jung, S; Priller, J; Misgeld, T; Vlachos, A; Meyer-Luehmann, M; Knobeloch, KP; Prinz, M				Masuda, Takahiro; Amann, Lukas; Sankowski, Roman; Staszewski, Ori; Lenz, Maximilian; d'Errico, Paolo; Snaidero, Nicolas; Costa Jordao, Marta Joana; Boettcher, Chotima; Kierdorf, Katrin; Jung, Steffen; Priller, Josef; Misgeld, Thomas; Vlachos, Andreas; Meyer-Luehmann, Melanie; Knobeloch, Klaus-Peter; Prinz, Marco			Novel Hexb-based tools for studying microglia in the CNS (Aug, 10.1038/s41590-020-0774-6, 2020)	NATURE IMMUNOLOGY			English	Correction												masuda@phar.kyushu-u.ac.jp; marco.prinz@uniklinik-freiburg.de	Masuda, Takahiro/AAY-6719-2021; Kierdorf, Katrin/AAO-6288-2021; Lenz, Maximilian/GOK-0031-2022; Priller, Josef/ABW-3835-2022	Masuda, Takahiro/0000-0003-3687-452X; Amann, Lukas/0000-0002-8363-373X; Bottcher, Chotima/0000-0002-6226-586X; Lenz, Maximilian/0000-0003-3147-4949				Masuda T, 2020, NAT IMMUNOL, V21, P802, DOI 10.1038/s41590-020-0707-4	1	2	2	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1302	1302		10.1038/s41590-020-0774-6	http://dx.doi.org/10.1038/s41590-020-0774-6		AUG 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32782404	Bronze			2022-12-18	WOS:000558633400001
J	Marchingo, JM; Cantrell, DA				Marchingo, Julia M.; Cantrell, Doreen A.			The active inner life of naive T cells	NATURE IMMUNOLOGY			English	Editorial Material								Quantitative systems-level proteomics is cleverly used to reveal a dynamic program of protein turnover in naive and memory CD4(+)T cells that, alongside a stockpile of metabolic protein machinery, poises the cells for activation.	[Marchingo, Julia M.; Cantrell, Doreen A.] Univ Dundee, Sch Life Sci, Cell Signalling & Immunol Div, Dundee, Scotland	University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Sch Life Sci, Cell Signalling & Immunol Div, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk	Marchingo, Julia/AAQ-6970-2021	Cantrell, Doreen/0000-0001-7525-3350; Marchingo, Julia/0000-0001-8823-9718	Wellcome Trust [205023/Z/16/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Macallan Derek C, 2019, Curr Opin Syst Biol, V18, P77, DOI 10.1016/j.coisb.2019.10.002; Marchingo JM, 2020, ELIFE, V9, DOI 10.7554/eLife.53725; Merkley SD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02914; Ricciardi S, 2018, CELL METAB, V28, P961, DOI 10.1016/j.cmet.2018.09.010; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Salerno F, 2018, NAT IMMUNOL, V19, P828, DOI 10.1038/s41590-018-0155-6; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Voisinne G, 2019, NAT IMMUNOL, V20, P1530, DOI 10.1038/s41590-019-0489-8; Wolf T, 2020, NAT IMMUNOL, V21, P927, DOI 10.1038/s41590-020-0714-5	11	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					827	828		10.1038/s41590-020-0726-1	http://dx.doi.org/10.1038/s41590-020-0726-1		JUL 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32632288	Green Submitted			2022-12-18	WOS:000547687000003
